
<html lang="en"     class="pb-page"  data-request-id="c75a5fb8-be46-4697-9dbc-908711af5a1d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-5;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.5b01091;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Inhibiting the Inflammasome: A Chemical Perspective" /></meta><meta name="dc.Creator" content="Alex G.  Baldwin" /></meta><meta name="dc.Creator" content="David  Brough" /></meta><meta name="dc.Creator" content="Sally  Freeman" /></meta><meta name="dc.Description" content="Inflammasomes are high molecular weight complexes that sense and react to injury and infection. Their activation induces caspase-1 activation and release of interleukin-1β, a pro-inflammatory cytok..." /></meta><meta name="Description" content="Inflammasomes are high molecular weight complexes that sense and react to injury and infection. Their activation induces caspase-1 activation and release of interleukin-1β, a pro-inflammatory cytok..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 12, 2015" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01091" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01091" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01091" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01091" /></link>
        
    
    

<title>Inhibiting the Inflammasome: A Chemical Perspective | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01091" /></meta><meta property="og:title" content="Inhibiting the Inflammasome: A Chemical Perspective" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0026.jpeg" /></meta><meta property="og:description" content="Inflammasomes are high molecular weight complexes that sense and react to injury and infection. Their activation induces caspase-1 activation and release of interleukin-1β, a pro-inflammatory cytokine involved in both acute and chronic inflammatory responses. There is increasing evidence that inflammasomes, particularly the NLRP3 inflammasome, act as guardians against noninfectious material. Inappropriate activation of the NLRP3 inflammasome contributes to the progression of many noncommunicable diseases such as gout, type II diabetes, and Alzheimer’s disease. Inhibiting the inflammasome may significantly reduce damaging inflammation and is therefore regarded as a therapeutic target. Currently approved inhibitors of interleukin-1β are rilonacept, canakinumab, and anakinra. However, these proteins do not possess ideal pharmacokinetic properties and are unlikely to easily cross the blood–brain barrier. Because inflammation can contribute to neurological disorders, this review focuses on the development of small-molecule inhibitors of the NLRP3 inflammasome." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01091"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01091">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01091&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01091&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01091&amp;href=/doi/10.1021/acs.jmedchem.5b01091" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 1691-1710</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01009" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.5b01647" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Inhibiting the Inflammasome: A Chemical Perspective</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alex+G.++Baldwin">Alex G. Baldwin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Brough">David Brough</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sally++Freeman">Sally Freeman</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Manchester Pharmacy School, Faculty of Medical and Human Sciences, The University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, U.K.</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Faculty of Life Sciences, The University of Manchester, AV Hill Building, Oxford Road, Manchester M13 9PT, U.K.</span></div><div class="corresp-info"><strong>*</strong>Phone: 44-161-275-2366. Fax: 44-161-275-2396. E-mail: <a href="/cdn-cgi/l/email-protection#3142505d5d481f574354545c505f715c505f525954424554431f50521f445a"><span class="__cf_email__" data-cfemail="a1d2c0cdcdd88fc7d3c4c4ccc0cfe1ccc0cfc2c9c4d2d5c4d38fc0c28fd4ca">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01091&amp;href=/doi/10.1021%2Facs.jmedchem.5b01091" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 1691–1710</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 30, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 July 2015</li><li><span class="item_label"><b>Published</b> online</span>12 October 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 March 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01091" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01091</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1691%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAlex%2BG.%2BBaldwin%252C%2BDavid%2BBrough%252C%2BSally%2BFreeman%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D5%26contentID%3Dacs.jmedchem.5b01091%26title%3DInhibiting%2Bthe%2BInflammasome%253A%2BA%2BChemical%2BPerspective%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1710%26publicationDate%3DMarch%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01091"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">8088</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">80</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01091" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Inhibiting the Inflammasome: A Chemical Perspective&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Alex&quot;,&quot;last_name&quot;:&quot;G. Baldwin&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Brough&quot;},{&quot;first_name&quot;:&quot;Sally&quot;,&quot;last_name&quot;:&quot;Freeman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;1691-1710&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01091&quot;},&quot;abstract&quot;:&quot;Inflammasomes are high molecular weight complexes that sense and react to injury and infection. Their activation induces caspase-1 activation and release of interleukin-1β, a pro-inflammatory cytokine involved in both acute and chronic inflammatory responses. There is increasing evidence that inflammasomes, particularly the NLRP3 inflammasome, act as guardians against noninfectious material. Inappropriate activation of the NLRP3 inflammasome contributes to the progression of many noncommunicable diseases such as gout, type II diabetes, and Alzheimer’s disease. Inhibiting the inflammasome may significantly reduce damaging inflammation and is therefore regarded as a therapeutic target. Currently approved inhibitors of interleukin-1β are rilonacept, canakinumab, and anakinra. However, these proteins do not possess ideal pharmacokinetic properties and are unlikely to easily cross the blood–brain barrier. Because inflammation can contribute to neurological disorders, this review focuses on the development of small&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01091&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01091" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01091&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01091" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01091&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01091" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01091&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01091&amp;href=/doi/10.1021/acs.jmedchem.5b01091" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01091" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01091" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01091%26sid%3Dliteratum%253Aachs%26pmid%3D26422006%26genre%3Darticle%26aulast%3DBaldwin%26date%3D2016%26atitle%3DInhibiting%2Bthe%2BInflammasome%253A%2BA%2BChemical%2BPerspective%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D5%26spage%3D1691%26epage%3D1710%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291161" title="Inflammation">Inflammation</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/jmcmar.2016.59.issue-5/20160310-01/jmcmar.2016.59.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0026.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Inflammasomes are high molecular weight complexes that sense and react to injury and infection. Their activation induces caspase-1 activation and release of interleukin-1β, a pro-inflammatory cytokine involved in both acute and chronic inflammatory responses. There is increasing evidence that inflammasomes, particularly the NLRP3 inflammasome, act as guardians against noninfectious material. Inappropriate activation of the NLRP3 inflammasome contributes to the progression of many noncommunicable diseases such as gout, type II diabetes, and Alzheimer’s disease. Inhibiting the inflammasome may significantly reduce damaging inflammation and is therefore regarded as a therapeutic target. Currently approved inhibitors of interleukin-1β are rilonacept, canakinumab, and anakinra. However, these proteins do not possess ideal pharmacokinetic properties and are unlikely to easily cross the blood–brain barrier. Because inflammation can contribute to neurological disorders, this review focuses on the development of small-molecule inhibitors of the NLRP3 inflammasome.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43874" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43874" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Inflammation is an essential host response to infection and injury. At the heart of inflammation research is an attempt to understand the regulation of the pro-inflammatory cytokine interleukin-1β (IL-1β), which is central to host responses to infection<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> but also causes tissue injury when activated inappropriately.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> IL-1β is produced by many cells, most commonly those of hematopoietic lineage, as an inactive pro-IL-1β precursor. This precursor is expressed in response to pathogen associated molecular patterns (PAMPs) or damage associated molecular patterns (DAMPs) that bind to pattern recognition receptors (PRRs) on macrophages to upregulate pro-inflammatory gene expression.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> PAMPs are motifs carried by pathogens, such as bacterial endotoxin (or LPS) of Gram-negative bacteria, and DAMPs are commonly endogenous molecules released by necrosis. Inflammation that occurs in response to tissue injury in the absence of pathogen is mediated by DAMPs and is considered sterile and contributes to tissue damage and disease.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> IL-1β is one of the primary inflammatory cytokines associated with sterile inflammatory responses.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Pro-IL-1β is inactive and remains intracellular until a further PAMP or DAMP stimulation activates cytosolic PRRs, often of the NLR family, to form large multiprotein complexes called inflammasomes.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> These complexes consist of the PRR, pro-caspase-1, and an adaptor protein called <u class="uu">a</u>poptosis-associated <u class="uu">s</u>peck-like protein containing a <u class="uu">c</u>aspase recruitment domain (ASC), which interact via homology binding domains.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> A number of inflammasome forming PRRs have been identified including NLRP1, NLRP3, NLRP6, NLRP7, NLRP12, NLRC4, AIM2, IFI16, and RIG-I.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Of these inflammasomes identified to date, the best characterized and most strongly associated with sterile inflammation is formed by NLRP3.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> When NLRP3 senses PAMPs or DAMPs, it recruits ASC, which in turn recruits caspase-1 causing its activation. Caspase-1 then processes pro-IL-1β (and pro-IL-18) to their mature forms that are rapidly secreted from the cell.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">In cellular models, the NLRP3 inflammasome is proposed to follow a two-stage activation process.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The first stage is referred to as priming and requires the NF-κB-dependent upregulation of <i>NLRP3</i> and <i>IL-1β</i> gene expression (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> This priming step is typically achieved by the activation of PRRs such as TLR4 by PAMPs like bacterial endotoxin (or LPS). IL-1β is expressed as an inactive precursor (pro-IL-1β). In the second activation stage, the primed cell now encounters a second stimulus (typically a DAMP in sterile inflammation) which causes activation of the NLRP3 inflammasome and promotes release of active IL-1β (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). During sterile inflammation, there are a number of DAMPs that can activate the NLRP3 inflammasome. These include extracellular ATP acting via the P2X7 receptor,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> crystals of monosodium urate (MSU) and calcium pyrophosphate dihydrate (CPPD),<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> aggregated amyloid beta (Aβ),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> sphingosine,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and hypotonic stress.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> These diverse DAMPs are not thought to interact with NLRP3 directly but cause its activation via one or more of a number of mechanisms such as K<sup>+</sup> efflux,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> lysosomal membrane destabilization,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> reactive oxygen species (ROS) production,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and ubiquitin/deubiquitination post-translational modifications (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. NLRP3 priming through the TLR4-MyD88 signaling pathway. Macrophages/microglia are primed by PAMP/DAMP stimulation of a Toll-like receptor (TLR) to express pro-IL-1β and NLRP3 in an inactive state.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. NLRP3-dependent IL-1β release during sterile inflammation. (1) A DAMP signal induces recruitment of ASC and procaspase-1. (2) Recruitment causes oligomerization and NLRP3 inflammasome formation. (3) Autoactivation induces procaspase-1 cleavage and caspase-1 release. (4) Activated caspase-1 cleaves pro-IL-1β into mature IL-1β. (5) IL-1β is secreted in a caspase-1-dependent manner extracellularly through an as yet agreed mechanism.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Inappropriate activation of NLRP3 is associated with a number of noncommunicable diseases including gout,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> atherosclerosis,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and type II diabetes.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Aβ protein, which is associated with Alzheimer’s disease (AD), activates NLRP3 through phagocytosis and subsequent lysosomal destabilization in microglial cells.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> These results support a recent study reporting NLRP3-dependent inflammation contributing to disease progression in the APP/PS1 mouse model of AD.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Heneka and colleagues showed that memory deficits in APP/PS1 mice were entirely dependent upon NLRP3 and APP/PS1 mice lacking NLRP3 increased the clearance of Aβ in microglial cells isolated from cerebral lysates.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> From these results, the authors suggest that blocking NLRP3 inflammasome activity could impede the progression of AD. Gain-of-function mutations in NLRP3 lead to severe autoinflammatory disorders such as familial cold autoinflammatory syndrome (FCAS), Muckle–Wells syndrome (MWS,) and neonatal onset multisystem inflammatory disease (NOMID); these orphan diseases are classified as cyropyrin-associated periodic syndromes (CAPS) and can be treated with anti-IL-1β therapy.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p last">Given the importance of IL-1β in disease, a number of therapeutic biological IL-1β inhibitors were developed and are currently clinically available. These include the dimeric fusion protein rilonacept (Arcalyst) and human immunoglobulin Gκ monoclonal antibody canakinumab (Ilaris) which neutralize IL-1β directly. There is also a naturally occurring IL-1 receptor antagonist (IL-1Ra) or recombinant anakinra (Kineret) that blocks IL-1 signaling.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> However, there are some problems associated with their use. For example, rilonacept was recently rejected for FDA approval recently for the treatment of gout flares due to safety concerns,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and anakinra possesses poor pharmacokinetic properties with a short half-life,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> with acute gout patients requiring high dosages (100 mg daily).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The major adverse reaction of rilonacept and anakinra is injection-site reactions.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> They are also high molecular weight proteins that show poor penetration of the blood–brain barrier (BBB): 0.2–0.3% anakinra crossed healthy BBB into the cerebrospinal fluid (CSF) in nonhuman primates and 1.2–2.0% anakinra was detected in the CSF of subarachnoid hemorrhage patients in which the BBB is likely to be compromised.<a onclick="showRef(event, 'ref25 ref29'); return false;" href="javascript:void(0);" class="ref ref25 ref29">(25, 29)</a> Therefore, this limits their use for inflammatory diseases of the central nervous system such as stroke or AD. A preferable approach may be the development of small-molecule inhibitors of IL-1β release which may penetrate the brain more readily, have improved pharmacokinetic properties, and be more cost-effective.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Small-molecule inhibitors of the NLRP3 inflammasome will also be more valuable therapeutics as they can prevent inflammasome-dependent maturation of IL-18 (from pro-IL-18) and a form of ensuing cell death executed by caspase-1, termed pyroptosis (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> However, no approved small-molecule inhibitor of IL-1β release currently exists and there is an unmet need for the development of such a drug. This review considers the NLRP3 inflammasome as a therapeutic target and primarily discusses synthetic small-molecule inhibitors that have been developed to date. It should be noted that a number of natural products also inhibit NLRP3 inflammasome activation and although are outside the scope of this review, are reviewed elsewhere.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Glyburide</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52427" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52427" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>1</b> (glyburide),<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> also known as glibenclamide, is one of the front-line hypoglycaemic drugs used to treat type II diabetes mellitus (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Compound <b>1</b> inhibits insulin release by blocking islet chloride channels<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and ATP-sensitive potassium (K<sub>ATP</sub>) channels in pancreatic β cells.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> However, Gabel and colleagues later showed that <b>1</b> also inhibits IL-1β release in LPS-activated human monocytes with an IC<sub>50</sub> of 12 μM,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> but it is noteworthy that this concentration is likely to be much higher than the mean individual maximum serum concentration (<i>C</i><sub>max</sub>) that can be achieved clinically. Initially, compound <b>1</b> was proposed to inhibit <u class="uu">A</u>TP-<u class="uu">b</u>inding <u class="uu">c</u>assette (ABC) transporters based on comparison with the known ABC inhibitor <b>2</b> (4,4′-diisothiocyano-2,2′-stilbenedisulfonic acid, DIDS)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). It has been demonstrated that K<sup>+</sup> efflux acts as a trigger for NLRP3 inflammasome activation when [K<sup>+</sup>]<sub>int</sub> falls below 90 mM,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and therefore it was speculated that <b>1</b> disrupts potassium cation efflux from the cytosol. Indeed, compound <b>1</b> was suggested to inhibit IL-1β release during bronchial hyporesponsiveness through K<sub>ATP</sub> channels.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> However, a later study showed that K<sub>ATP</sub> channels are dispensable for inhibitory activity as IL-1β release was maintained even when K<sub>ATP</sub> channel subunits Kir6.1, Kir6.2, and SUR2 were knocked out.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The inhibitory effect of <b>1</b> on IL-1β release is NLRP3 specific as IL-1β secretion is not significantly affected in the presence of the NLRC4 activator <i>Salmonella typhimurium</i> or the AIM2 inflammasome activator Poly(dA:dT).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Compound <b>1</b> does not directly suppress caspase-1 activity in vitro<a onclick="showRef(event, 'ref37 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref40">(37, 40)</a> or in vivo<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> unless NLRP3, NF-κB, or P2X7 are knocked out.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> These results suggest that <b>1</b> may prevent ASC oligomerization during NLRP3 inflammasome assembly or affect NLRP3 inflammasome activation upstream of its assembly.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of NLRP3 inhibitors <b>1</b>/<b>3</b> and anion exchange inhibitor <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Preliminary SAR studies indicate that the cyclohexylurea moiety is dispensable for inhibitory activity, but both the benzamido and sulfonyl groups of <b>1</b> contribute to inhibition of LPS+ATP-stimulated caspase-1 activation and IL-1β secretion.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p">Compound <b>1</b> has also been shown to block NLRP3 inflammasome activation and IL-1β production stimulated by the DAMP islet amyloid polypeptide (IAPP) associated with type II diabetes.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Compound <b>1</b> also reduced mortality in 1160 patients suffering with infection of the Gram-negative bacterium <i>Burkholderia pseudomallei</i>, the causative agent of melioidosis,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and completely blocked IL-1β release 4 h following intraperitoneal injection of cyclophosphamide (CP) in a model of CP-induced cystitis.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Obesity is one risk factor associated with severe acute pancreatitis, a host-driven disease caused by chronic pancreatic inflammation, and obese ob/ob mice treated with <b>1</b> have significantly decreased pancreatic damage and disease severity caused by the pro-inflammatory cytokines IL-1β and IL-6 in an NLRP3 inflammasome-dependent manner.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> However, compound <b>1</b> is known to have some side effects. These are predominantly cardiovascular risks,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and a recent study on the clinical outcomes of diabetic patients on sulfonylurea drugs showed that <b>1</b> increases mortality rates over the more specific pancreatic β-cell sulfonylurea drugs gliclazide and glimepiride.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> In addition, the dosage required to significantly reduce IL-1β release would be in excess of the recommended dosage for type II diabetes treatment.</div><div class="NLM_p last">A recently developed analogue of <b>1</b> that lacks the cyclohexylurea group responsible for hypoglycemic activity, compound <b>3</b> (16673-34-0),<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> had no effect on glucose plasma levels with repeated injections of 500 mg/kg for 7 days and is largely protective in mouse models of reperfused and nonreperfused acute myocardial infarction (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a> Like <b>1</b>, compound <b>3</b> has good pharmacokinetic properties (<i>t</i><sub>1/2</sub> = 6–10 h). It also has a comparable mode of action by suppressing formation of the NLRP3 (but not NLRC4 or AIM2) inflammasome in J774A.1 murine macrophage cells and primary adult rat cardiomyocytes in response to diverse NLRP3 stimuli.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a> Importantly, <b>3</b> was still effective in bone marrow-derived macrophages (BMDMs) from a mutant mouse that elicits spontaneous NLRP3 inflammasome activation.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> These investigations are interesting for two reasons. First, <b>3</b> is posited to bind ASC directly as (i) compound <b>3</b> blocks NLRP3 aggregation downstream of NLRP3 inflammasome activation, (ii) inhibition of caspase-1 activation by <b>3</b> is unlikely because other inflammasome-forming protein complexes were unaffected, and (iii) stained ASC aggregation (as a read-out of NLRP3 inflammasome speck formation) was significantly reduced in the presence of <b>3</b> as determined using immunocytochemistry. Second, the mutant mouse used for constitutive NLRP3 inflammasome activation by Marchetti and colleagues<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> corresponds to the active NLRP3 mutation found in humans with MWS.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The authors are currently investigating the efficacy of <b>3</b> in patients with cardiac injury or heart failure, but given that treatment with <b>3</b> was still effective in preventing IL-1β release in a mouse mutant model of MWS, it would be interesting to scope the therapeutic potential of <b>3</b> in other research areas involving the NLRP3 inflammasome.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">CRIDs and MCC950</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87143" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87143" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">One class of IL-1β release inhibitors derived from compound <b>1</b> are the cytokine release inhibitory drugs (CRIDs). These diarylsufonylurea analogues lack the cyclohexylurea moiety necessary for insulin release and showed improved inhibitory activity against LPS plus ATP-, cytotoxic T lymphocyte (CTL)-, and hypotonic stress-induced IL-1β maturation in human monocytes in vitro.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Initially, reversible inhibitors <b>4</b> (CP-412,245) and <b>5</b> (CP-424,174)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> showed good potencies (IC<sub>50</sub> of 260 and 210 nM, respectively) against IL-1β processing (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). The irreversible diarylsulfonylurea inhibitors <b>6</b> (CRID1) and <b>7</b> (CRID2)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> were later developed by Gabel and co-workers (IC<sub>50</sub> of 350 and 250 nM, respectively). IL-6 and TNF-α were unaffected by CRID treatment, and the CRIDs do not target caspase-1 activity directly. Along with the observation that pro-IL-1β levels are not affected<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> suggests that the CRIDs do not target NLRP3 at the genetic level. Compounds <b>6</b> and <b>7</b> have been reported to modify cysteine residues on putative targets as a result of nucleophilic attack on the epoxide functional groups.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> However, more details on the mechanism of action of reversible inhibitors <b>4</b> and <b>5</b> is necessary as they do not contain epoxide functional groups and may not act through the same mode of action as <b>6</b>/<b>7</b>.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of IL-1β processing inhibitors <b>4</b>–<b>7</b> and NLRP3 inhibitor <b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Continued work by O’Neill and colleagues demonstrated that the related sulfonylurea, compound <b>8</b> (MCC950),<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> dose-dependently blocked LPS plus ATP-, nigericin-, MSU-, and silica-induced IL-1β release in BMDMs, human monocyte-derived macrophages (HMDMs), and peripheral blood mononuclear cells (PBMCs) (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). Compound <b>8</b> inhibits IL-1β release with high potency (IC<sub>50</sub> of 7.5 nM in BMDMs) and does not block TNF-α. The observed IL-1β inhibitory effect of <b>8</b> is NLRP3 specific and inhibits NLRP3-induced ASC speck formation in a manner independent of the NLRP3 priming, K<sup>+</sup> efflux, Ca<sup>2+</sup> influx, or preventing direct NLRP3-NLRP3/NLRP3-ASC interactions as determined by coimmunoprecipitation experiments. Compound <b>8</b> completely prevented the death of mice with MWS-associated NLRP3 mutations when compared to control mice. Even when the drug was withdrawn, MWS mice still survived for a further 10 days.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Compound <b>8</b> was also active in ex vivo samples of MWS patients by suppressing LPS-induced caspase-1 activation and IL-1β secretion in PBMCs at a concentration of ∼50 nM. In addition, <b>8</b> reduced the severity and occurrence of experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div><div class="NLM_p last">Compound <b>8</b> has excellent pharmacokinetic properties with high stability in human or mouse liver microsomes. Compound <b>8</b> has a half-life of approximately 3 h and a bioavailability of 68% in C57BL/6 mice upon intravenous (3 mg/kg) and oral (20 mg/kg) administration,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> making the CRIDs and in particular <b>8</b> promising candidates for further development for the treatment of NLRP3-dependent pathologies.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Auranofin</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06180" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06180" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>9</b> (auranofin)<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> is an Au-containing acetylated carbohydrate complex used for the treatment of rheumatoid arthritis (RA) (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). Monocytes and macrophages in the synovial fluid in RA patients secrete large quantities of IL-1β that leads to the pathophysiological changes associated with RA.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55, 56)</a> Compound <b>9</b> suppresses pro-IL-1β mRNA expression in response to LPS, zymosan, and <i>Fusobacterium nucleatum</i>/<i>Peptostreptococcus anaerobius</i> bacterial infection, and this reduces pro-IL-1β production in peritoneal cells and RAW 264.7 macrophages.<a onclick="showRef(event, 'ref55 ref57'); return false;" href="javascript:void(0);" class="ref ref55 ref57">(55, 57)</a> Compound <b>9</b> also significantly suppresses LPS-induced NLRP3 and IL-1-related gene expression in J774 cells and primary mouse peritoneal macrophages,<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> in addition to the expression of other pro-inflammatory cytokines, including IL-6 and TNF-α.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> These results are in line with the known mechanism of action of <b>9</b> by targeting inhibitor of kappa B (IκB) kinase (IKK), whose enzyme activity is critical for NF-κB activation. Compound <b>9</b> has been consistently shown to inhibit IKK phosphorylation of IκB protein bound to NF-κB and thus inhibits its ubiquitinylation and proteasomal degradation, preventing nuclear translocation of free NF-κB and induction of pro-IL-1β and NLRP3.<a onclick="showRef(event, 'ref56 ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref56 ref59 ref60">(56, 59, 60)</a> Compound <b>9</b> also inhibits two other major transcription factors important for cell signaling in response to pathogens, AP-1<a onclick="showRef(event, 'ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref61 ref62">(61, 62)</a> and IRF3.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Given that NF-κB, AP-1 and IRF3 are all regulated at the TLR4-MyD88 axis, it is posited that <b>9</b> prevents activation of the TLR4-MyD88 pathway. Indeed, <b>9</b> has also been demonstrated to prevent the homodimerization of TLR4 required for NF-κB and IRF3 activation.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Isakov and co-workers recently uncovered that thioredoxin reductase, a redox enzyme responsible in controlling macrophage activation, was another functionally relevant target of <b>9</b> in blocking LPS-induced pro-IL-1β and NLRP3 gene expression.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Taken together, these studies suggest that <b>9</b> inhibits IL-1β secretion by blocking NF-κB activation and subsequent NLRP3/pro-IL-1β transcription.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0006.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structure of NLRP1/NLRP3 inhibitor <b>9</b> and <i>N</i>6-benzyladenine analogues <b>10</b>–<b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Importantly, <b>9</b> also dose-dependently inhibits anthrax lethal toxin (LT)-induced NLRP1 and nigericin-stimulated NLRP3 inflammasome activation in a manner independent of LPS-induced NF-κB priming.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> How <b>9</b> blocks NLRP3 inflammasome formation without blocking the NF-κB pathway has not been fully elucidated. Potential modes of action include inhibition of cathepsin B activity<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> and enhancing protein <i>S</i>-nitrosylation of many proteins including Hsp90,<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> both mechanisms of which are understood to repress NLRP3 inflammasome assembly.<a onclick="showRef(event, 'ref7 ref15'); return false;" href="javascript:void(0);" class="ref ref7 ref15">(7, 15)</a></div><div class="NLM_p">A brief mention of the role for the Au atom in compound <b>9</b> is warranted. Incorporation of Au in drugs is uncommon: only small-molecule derivatives of <b>9</b> that contain Au suppress IL-1β secretion<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> and the related Au compound myochrysine significantly inhibits caspase-1 activation and IL-1β maturation at micromolar concentrations.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Compound <b>9</b> is suggested to act as a cysteine modifier at the Au center and has been demonstrated to modify the important catalytic Cys-179 residue present in the IKKβ subunit.<a onclick="showRef(event, 'ref59 ref69'); return false;" href="javascript:void(0);" class="ref ref59 ref69">(59, 69)</a> Importantly, derivatives of <b>9</b> react with cysteine at biologically relevant concentrations<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> and a low energy cysteine complex has been confirmed by mass spectrometry.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> These derivatives contain various <i>N</i>6-benzyladenine groups (<b>10</b>)<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> and show greater activity in suppressing IL-1β secretion than <b>9</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). It is noteworthy that <b>10</b> complexes showed markedly greater anti-inflammatory effects compared to trichlorido-Au(III)-<i>N</i>6-benzyladenine complexes (<b>11</b>)<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>), indicating that the oxidation state of Au is important for its anti-inflammatory actions.</div><div class="NLM_p last">Unfortunately, compound <b>9</b> possesses a number of poor pharmacological properties, including slow onset of action due to slow drug accumulation with blood concentration of the Au complex varying significantly from patient to patient.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> In particular, <b>9</b> binds readily to Cys-34 of human serum albumin in vitro<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> and in vivo,<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> which strongly influences its bioavailability and transport in the blood. Additionally, <b>9</b> does have some side-effects: diarrhea is the most common symptom associated with long-term use with 74% of patients affected.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Parthenolide and Bay 11-7082</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75653" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75653" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The herbal sesquiterpene lactone <b>12</b> (parthenolide)<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> inhibits ATP-, nigericin-, MSU-induced NLRP3 inflammasome activation as well as directly targeting caspase-1 at a concentration of 10 μM (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Compound <b>12</b> has been recently shown to inhibit IL-1β release from THP-1 cells with an IC<sub>50</sub> of 2.59 μM.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Compound <b>13</b> (Bay 11-7082)<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> inhibits ATP-, nigericin-, and MSU-induced NLRP3 inflammasomes at a concentration of 12 μM and does not inhibit caspase-1 activity directly (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Compounds <b>12</b> and <b>13</b> prevent ASC pyroptosome formation and NLRP3 inflammasome activity by directly alkylating critical cysteine residues within the ATPase region of NLRP3 in NG5 cells and mouse primary BMDMs in a dose-dependent manner.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Cysteine modification appears to be the major mode of action for these inflammasome inhibitors as addition of thiol-reactive agents including free glutathione and <i>N</i>-acetyl-<span class="smallcaps smallerCapital">l</span>-cysteine (NAC) ameliorated the inhibitory activity of <b>12</b> and <b>13</b>. SAR analysis of <b>13</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>) reveals that the olefin group and oxidized benzylic sulfone are essential for activity, while steric bulk on the benzyl substituent or at the C2 position are dispensable for inhibition of caspase-1 activation. Loss or exchange of the nitrile group for a weaker electrophile reduces caspase-1 activation. These observations support cysteine modification via Michael addition at the C3 position, and highly electron withdrawing groups at the C1 position are responsible for activating the vinyl sulfone toward alkylation. It was later confirmed that <b>13</b> modifies cysteine residues via Michael addition with formation of the appropriate cysteine conjugate and concomitant release of 4-methylbenzoic acid (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Similarly, <b>12</b> nonspecifically modifies cysteine residues of caspase-1 p20<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> through a Michael-type reaction with the α,β-unsaturated lactone, but the lack of α-hydrogen acidity leads to the addition product only (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79, 80)</a></div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0019.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Mechanism of Action of NLRP1/NLRP3 Inhibitor <b>12</b> via Michael Addition<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0020.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Mechanism of Action of NLRP3 Inhibitor <b>13</b> via Michael Addition<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0007.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. SAR summary of <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While the authors suggest that the inhibitory activity of <b>12</b> and <b>13</b> against the NLRP3 inflammasome was independent of NF-κB,<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> there are reports that both compounds could inhibit NF-κB-induced NLRP3 and pro-IL-1β gene expression in addition to directly targeting the NLRP3 inflammasome. Compound <b>12</b> has been shown to inhibit IKK<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> and NF-κB directly,<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> while <b>13</b> can inhibit IKK,<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> the ubiquitin system (E2/3 enzymes),<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> and a number of protein tyrosine phosphatases<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> which are important for NF-κB activation. Compounds <b>12</b> and <b>13</b> interact with all these targets by cysteine modification, and it is interesting to note that <b>12</b> modifies the exact same cysteine residue (Cys-179) present in the active site of the IKKβ subunit as <b>9</b>.<a onclick="showRef(event, 'ref69 ref85'); return false;" href="javascript:void(0);" class="ref ref69 ref85">(69, 85)</a></div><div class="NLM_p last">In the context of novel pharmacological therapeutics, <b>12</b> has been shown to be neuroprotective in a rat stroke model where decreased NF-κB and caspase-1 expression were observed in addition to decreased BBB permeability.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> However, the poor bioavailability and solubility of <b>12</b> means that it does not have suitable pharmacological properties for clinical trials and water-soluble analogues are being evaluated.<a onclick="showRef(event, 'ref87 ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref87 ref88 ref89">(87-89)</a> Furthermore, the pharmacophore responsible for sesquiterpene lactone anti-inflammatory activity correlates with their cytotoxicity, suggesting that side effects such as cytotoxicity will be difficult to separate from their beneficial effects.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> In contrast, vinyl sulfones, such as <b>13</b>, permeate cell membranes relatively easily<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> and were tolerated well in mice and dogs in a preclinical trial as antiparasitic agents.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">β-Hydroxybutyrate</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83571" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83571" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">It has been recently demonstrated that the ketone body <b>14</b> (β-hydroxybutyrate, BHB)<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> inhibits caspase-1 activation and IL-1β release in the presence of a large number of NLRP3 agonists, including ATP, nigericin, MSU, silica particles, sphingosine, and lipotoxic fatty acids palmitate and ceramide (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). Youm and colleagues believe that a high concentration of circulating levels of <b>14</b> during periods of starvation or strenuous exercise may solve the link between nutritional state and altered immune cell action, with <b>14</b> acting as an immune effector. The authors suggest that <b>14</b> dampens the innate immune system, in part, by inhibiting NLRP3 inflammasome activation. Compound <b>14</b> specifically inhibits NLRP3 inflammasome formation, in a manner independent of its well established mechanisms of action, at physiologically relevant concentrations (5–10 mM) that are observed during periods of fasting or high-intensity exercise.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Compound <b>14</b> is unlikely to be specific for NLRP3 at such high concentrations; indeed, one target of <b>14</b> is histone deacetylases (HDACs) and it was demonstrated that <b>14</b> induced H3 acetylation in BMDMs at similar concentrations.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Further experiments revealed that the suppressive effect of <b>14</b> on ATP-induced NLRP3 inflammasome activation could not be abrogated by rotenone-induced ROS accumulation intracellularly, but <b>14</b> efficiently prevented K<sup>+</sup> efflux in response to ATP, MSU, and ceramide in BMDMs. Compound <b>14</b> dose-dependently blocked constitutive NLRP3 inflammasome activation in mouse models of MWS and FCAS. Importantly, supplementation of FCAS mice with <b>14</b> in the form of 1,3-butanediol ketone diesters prior to a knock-in mutation of the NLRP3 gene (induced by tamoxifen-induced Cre mice containing mutant NLRP3<sup>L351P</sup>) protected mice from the etiologies associated with FCAS such as neutrophilia.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> It should be noted that the related ketone bodies acetoacetate, butyrate, and acetate did not block NLRP3 activation and that the stereochemistry of <b>14</b> was not important for its suppressive effects on caspase-1 activation.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Thus, this suggests that the β-hydroxy group is essential for inhibitory activity against IL-1β release.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0008.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures of NLRP3 inhibitors <b>14</b>–<b>15</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Fc11a-2</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68455" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68455" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">More specifically, synthetic inhibitors of inflammasome assembly have recently been developed such as the benzoimidazole <b>15</b> (Fc11a-2)<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). Compound <b>15</b> targets the NLRP3 inflammasome by interfering with the proximity-induced autocleavage of procaspase-1 which leads to less activated caspase-1 release from the NLRP3-ASC complex in a manner independent of NF-κB activation.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Compound <b>15</b> was shown to be highly effective in suppressing IL-1β/18 production in LPS+ATP-stimulated THP-1 cells at 3 μM and dextran sulfate sodium (DSS)-induced experimental colitis in mice at 10–30 mg/kg dosage via intragastric adminstration.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> These results are promising, and further studies are warranted to determine the target(s) of <b>15</b> and to evaluate efficacy in other NLRP3 inflammasome disease models.</div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">3,4-Methylenedioxy-β-nitrostyrene</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70600" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70600" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>16</b> (3,4-methylenedioxy-β-nitrostyrene, MNS)<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> has recently been demonstrated to bind to the NACHT and LRR domains and inhibits NLRP3 ATPase activity required for ATP-dependent oligomerization of the NLRP3 inflammasome (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). With an IC<sub>50</sub> of 2 μM, compound <b>16</b> has a modest potency but high specificity against NLRP3 inflammasome activation compared to NLRC4 and AIM2 inflammasomes. In contrast to previous suggestions, <b>16</b> does not target spleen tyrosine kinase (Syk), a key kinase that regulates the NLRP3 inflammasome (further discussed later).<a onclick="showRef(event, 'ref95 ref96'); return false;" href="javascript:void(0);" class="ref ref95 ref96">(95, 96)</a> In addition, excess <span class="smallcaps smallerCapital">l</span>-cysteine or <b>13</b> prevented isolation of NLRP3 protein in the presence of biotinylated <b>16</b>.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> These observations agree with the reported mode of action of <b>16</b> against tyrosine kinases<a onclick="showRef(event, 'ref96 ref97'); return false;" href="javascript:void(0);" class="ref ref96 ref97">(96, 97)</a> and confirms that the mechanism of action of <b>13</b> and <b>16</b> is shared. Similarly to <b>13</b>, a preliminary SAR study revealed that any modification to the nitrovinyl side chain ameliorates NLRP3 inhibitory activity (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). Ring opening of <b>16</b> to the <i>trans</i>-3-methoxy-4-hydroxy-β-nitrostyrene analogue retains NLRP3 inhibitory activity, but removal of the 3,4-methylenedioxy group gives a derivative with reduced potency compared to <b>16</b>. Taken together, compound <b>16</b> is proposed to irreversibly modify active site cysteine residues via Michael addition at the nitrovinyl group (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0021.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Proposed Mechanism of Action of NLRP3 Inhibitor <b>16</b> via Michael Addition</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0009.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. SAR summary of <b>16</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Caspase-1 Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86671" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86671" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">An approach to inhibit IL-1β secretion is to block the master protease responsible for maturation of the cytokine, caspase-1. Selected examples of caspase-1 inhibitors that prevent the cleavage of pro-IL-1β into IL-1β (and pro-IL-18 into IL-18) include compounds <b>17</b> (disulfiram) and <b>18</b> (ritonavir) (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>).<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Two further caspase-1 inhibitors, <b>19</b> (VX-740)<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> and analogue <b>21</b> (VX-765),<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> are prodrugs which are metabolized by plasma esterases to the corresponding aldo-acids <b>20</b> (VRT-18858) and <b>22</b> (VRT-043198), respectively (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Compound <b>19</b> showed activity in two murine models of osteoarthritis at 12.5 mg/kg administered orally,<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> and <b>21</b> significantly reduced the levels of IL-1β/18 in a mouse model of dermatitis caused by delayed-type hypersensitivity at 25 mg/kg administered orally.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Compound <b>21</b> also significantly suppressed both acute seizures and chronic epilepsy in mice<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> and was registered in clinical trials for psoriasis and epilepsy. Compound <b>21</b> appeared safe in a mouse model of RA, as no toxicity was observed even when 100 mg/kg was administered twice daily for 28 days.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Although compounds <b>19</b> and <b>21</b> entered clinical trials, they were not developed further due to potential hepatic toxicity.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a></div><figure id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0022.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Metabolism of Caspase-1 Prodrugs (A) <b>19</b> into <b>20</b> and (B) <b>21</b> into <b>22</b><a onclick="showRef(event, 'ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref99 ref100">(99, 100)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0010.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of caspase-1 inhibitors <b>17</b>–<b>18</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Other Indirect Inhibitors of the Inflammasome</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17114" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17114" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">While there are compounds that may directly target the inflammasome, there are many more inhibitors that indirectly target the inflammasome by blocking the expression of NLRP3, pro-caspase-1, and pro-IL-1β (the “priming” stage, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) or prevent deubiquitination, ion flux, ROS generation, or lysosomal destabilization (the “activation” step, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Some of these inhibitors are briefly described.</div></div><div id="sec11" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">TAK-242, Bromoxone, and 5<i>Z</i>-7-Oxozeaenol</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15082" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15082" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The small molecules <b>23</b> (TAK-242) (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>), <b>24</b> (bromoxone) (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>), and <b>25</b> (5<i>Z</i>-7-oxozeaenol)<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>) are effective NLRP3 inflammasome inhibitors that suppress LPS+ATP-induced IL-1β release upstream of IKK. Compound <b>23</b> binds to the intracellular domain of human TLR4, and Cys-747 is proposed to be irreversibly modified on TLR4 via Michael addition.<a onclick="showRef(event, 'ref104 ref105'); return false;" href="javascript:void(0);" class="ref ref104 ref105">(104, 105)</a> Compound <b>23</b> inhibits NF-κB activation and subsequently the expression and processing of pro-inflammatory cytokines including IL-1, IL-6, IL-8, and TNF-α, in addition to TLR4 itself in vitro.<a onclick="showRef(event, 'ref104 ref106 ref107'); return false;" href="javascript:void(0);" class="ref ref104 ref106 ref107">(104, 106, 107)</a> Specifically, <b>23</b> blocks IL-1β release with an IC<sub>50</sub> of 5.7 nM in LPS-stimulated peritoneal macrophages<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> and has a fast onset of action in vitro<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> and in vivo.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> The therapeutic benefit of <b>23</b> has been demonstrated in models of endotoxic shock and sepsis in mice and pigs by significantly reduced circulating serum levels of IL-1β.<a onclick="showRef(event, 'ref105 ref109 ref110 ref111'); return false;" href="javascript:void(0);" class="ref ref105 ref109 ref110 ref111">(105, 109-111)</a> Compound <b>23</b> is also capable of crossing the BBB and can suppress neuroinflammation in ischemia/reperfusion brain injury in mice.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></div><figure id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0011.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structure of TLR4 antagonist <b>23</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig11" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0012.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. SAR summary of <b>24</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch5" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0023.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Mechanism of Action of TAK1 Inhibitor <b>25</b> via Michael Addition<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>24</b> is an irreversible broad-spectrum inflammasome inhibitor (NLRP1, NLRP3, AIM2) and suppresses caspase-1 activation in a manner independent of caspase-1 activity, ASC, ROS accumulation, and transcription of NF-κB-encoded genes NLRP3 and TNF-α, with an IC<sub>50</sub> of 170 nM in PMA-differentiated THP-1 cells.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> The target of <b>24</b> is currently unknown, and while the known TAK1 inhibitor <b>25</b> specifically inhibited NLRP3 inflammasome activation in response to LPS, nigericin, and alum, <b>24</b> did not affect TAK1/TAB1/TAB2 complex formation using a coimmunoprecipitation assay nor inhibit TAK1/TAB1-induced IκB phosphorylation via IKK.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> However, Gong and colleagues did demonstrate that <b>24</b> is an inhibitor of pro-IL-1β expression and abolished NF-κB nuclear translocation without directly affecting NF-κB or by suppressing IKKβ kinase activity, confirming the target of <b>24</b> is upstream of IKK. A SAR study of <b>24</b> isomers revealed that the hydroxyl group is required to prevent IL-1β secretion; a protected acetate derivative (<b>26</b>)<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> showed no IL-1β inhibitory activity (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>). However, hydroxyl and epoxide analogues of <b>24</b> (<b>27</b>–<b>29</b>)<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> showed that the exact stereochemistry was not important for inhibitory activity (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>). Meanwhile, <b>25</b> completely inhibits TAK1 enzyme activity at a concentration of 3 μM and its mechanism of action involves covalent, irreversible attachment of Cys-174 of TAK1 at the α,β-unsaturated ketone in an irreversible manner (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a></div></div><div id="sec12" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">7-Desacetoxy-6,7-dehydrogedunin</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60365" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60365" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>30</b> (7-desacetoxy-6,7-dehydrogedunin, 7-DG)<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> is a small-molecule inhibitor of the NLRP1 and NLRP3 inflammasomes and affects protein–protein interactions between protein kinase R (PKR) and ASC, preventing activation of caspase-1 and production of IL-1β (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>). PKR autophosphorylates target proteins in response to PAMPs/DAMPs, and while one study demonstrates that a PKR kinase-dependent event was needed for inflammasome activation,<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> another proposes that PKR kinase-independent events are sufficient for inflammasome activation.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Compound <b>30</b> also interferes with PKR-IKK protein–protein interactions that prevent PKR-dependent IKK phosphorylation and subsequent proteasomal degradation, leaving NF-κB inactivated.<a onclick="showRef(event, 'ref114 ref116'); return false;" href="javascript:void(0);" class="ref ref114 ref116">(114, 116)</a> Compound <b>30</b> protects anthrax LT-induced J774 macrophage cell death with an IC<sub>50</sub> of 5 μM.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Compound <b>30</b> has not yet been tried in clinical trials and is currently being used to study autoimmune and other inflammasome-component diseases involving release of IL-1β.</div><figure id="fig12" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0013.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structure of IKK inhibitor <b>30</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec13" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">DUB Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47064" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47064" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">NLRP3 is regulated at both transcriptional and post-translational levels in order to avoid spontaneous activation. The regulation of NLRP3 at the post-translational level is poorly characterized, and an emerging hypothesis is the nontranscriptional regulation of inflammasome activation via deubiquitinylation, guided by deubiquitinating enzymes (DUBs). Juliana and co-workers initially discovered that, under normal resting conditions, NLRP3 is ubiquitinated and inactive.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Activation of the NLRP3 inflammasome (but not NLRC4 or AIM2) is induced by deubiquitination in the presence of either LPS plus ATP or ATP alone.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> LPS treatment alone (i.e., engaging TLR signaling) causes deubiquitination of NLRP3 but is not sufficient for its activation. There are conflicting studies regarding the role of autophagy in NLRP3 degradation,<a onclick="showRef(event, 'ref118 ref119'); return false;" href="javascript:void(0);" class="ref ref118 ref119">(118, 119)</a> but NLRP3 appears to be modified by mixed K48 and K63 ubiquitin chains on both the LRR and NACHT domains.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> BRCC3 was identified as the major DUB responsible for the specific deubiquitination of NLRP3 and its downregulation leads to polyubiquitination of Flag-NLRP3 in NG5 cell lysates and significant inhibition of ATP-induced IL-1β release.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Importantly, a number of DUB inhibitors can block caspase-1 activation and subsequent IL-1β maturation such as <b>31</b> (PR-619), <b>32</b> (WP1130),<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a><b>33</b> (G5),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a><b>34</b> (eeyarestatin I), and <b>35</b> (b-AP15)<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>). Therefore, the potential use of DUB inhibitors to act as therapeutic agents to combat diseases involving NLRP3 inflammasome overactivation is an interesting area for research.</div><figure id="fig13" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0014.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structures of DUB inhibitors <b>31</b>–<b>35</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec14" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">P2X7R Antagonists</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17501" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17501" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Blocking activation of the P2X7 purinoceptor (P2X7R) prevents NLRP3 inflammasome-mediated IL-1β maturation and release by blocking ATP-induced K<sup>+</sup> efflux in vitro<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> and in vivo.<a onclick="showRef(event, 'ref121 ref122 ref123'); return false;" href="javascript:void(0);" class="ref ref121 ref122 ref123">(121-123)</a> P2X7R activation via extracellular ATP causes pannexin 1 recruitment to the plasma membrane and its interaction with P2X7R leads to K<sup>+</sup> efflux from the cell<a onclick="showRef(event, 'ref8 ref9 ref124'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref124">(8, 9, 124)</a> and is sufficient for NLRP3 inflammasome activation.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> There has been significant interest in the design of P2X7R antagonists. A number of conformationally constrained analogues of <b>36</b> (KN62),<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> one of the first-generation P2X7R antagonists discovered (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>), have been synthesized which are highly potent and selective for P2X7R (IC<sub>50</sub> for hP2X7R < 100 nM). Further P2X7R antagonists have been disclosed and have entered clinical testing including <b>37</b> (AZD9056),<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a><b>38</b> (CE-224,535),<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> and <b>39</b> (GSK1482160)<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>). However, these antagonists were not efficacious in RA patients and were not considered an improvement over current therapies. The reasons are not fully understood, but it should be noted that there is large genetic variation in the P2X7R gene with more than 260 single nucleotide polymorphisms (SNPs) known.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> In fact, P2X7R SNPs were recently shown to account for chronic pain variability in human cohorts of mastectomy and osteoarthritis.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Additionally, the susceptibility of the Chinese population to the autoimmune disease, systemic lupus erthrymatosus (SLE), a condition that can cause excessive IL-1β secretion in response to host circulating dsDNA, was variable depending on P2X7R SNPs.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Therefore, P2X7R appears not to be a suitable therapeutic target, at least in the case of RA.</div><figure id="fig14" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0015.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Structures of P2X7R antagonists <b>36</b>–<b>39</b> and pannexin-1 inhibitor <b>40</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec15" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Probenecid</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20546" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20546" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Compound <b>40</b> (probenecid)<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> is a uricosuric drug (a drug that increases uric acid excretion in the urine) primarily used for the treatment of gout and conditions involving hyperuricemia (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>). Urate-lowering therapy is required for patients with serum urate levels greater than the MSU saturation point, and MSU crystal formation in joint synovial fluid is the main etiology associated with arthritic gout.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> The role of MSU crystals in NLRP3 inflammasome activation is well established.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Although compound <b>40</b> is widely believed to increase the rate of renal excretion of uric acid by inhibiting a renal anion tubular transporter,<a onclick="showRef(event, 'ref132 ref133'); return false;" href="javascript:void(0);" class="ref ref132 ref133">(132, 133)</a> it was discovered that <b>40</b> also inhibits pannexin 1 channels.<a onclick="showRef(event, 'ref134 ref135'); return false;" href="javascript:void(0);" class="ref ref134 ref135">(134, 135)</a> Silverman and colleagues first demonstrated that <b>40</b> binds pannexin 1 in multiple binding sites with an IC<sub>50</sub> of ∼150 μM and dose-dependently attenuated K<sup>+</sup> efflux-induced ATP release in oocytes expressing pannexin 1.<a onclick="showRef(event, 'ref134 ref136'); return false;" href="javascript:void(0);" class="ref ref134 ref136">(134, 136)</a> However, compound <b>40</b> is likely to be nonselective at this concentration, as a number of its pharmacological targets, namely kidney organic anion transporters (OATs), are inhibited at IC<sub>50</sub> values below 100 μM. Additionally, the mean plasma <i>C</i><sub>max</sub> levels that can be achieved from the administration of 500 mg probenecid tablets used in the clinic is 35.3 μg/mL (123.7 μM).<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> Thus, at this dosage, compound <b>40</b> may not be sufficient to inhibit pannexin-1 therapeutically. Silverman et al. later showed that <b>40</b> inhibited K<sup>+</sup>-induced caspase-1 activation in neurons and astrocytes in which the importance of pannexin 1 was confirmed using cells where pannexin 1 was knocked down.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> Specifically, inhibition of NLRP1, NLRP2, and NLRP3 inflammasomes has been documented in the presence of <b>40</b>.<a onclick="showRef(event, 'ref136 ref138 ref139 ref140'); return false;" href="javascript:void(0);" class="ref ref136 ref138 ref139 ref140">(136, 138-140)</a> However, a recent study provides evidence against <b>40</b> targeting pannexin 1 and in fact, suggested competition with ATP at the agonist binding site of P2X7R.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> A refinement of the mode of action of <b>40</b> is therefore required, particularly given the dispensable role of pannexin 1 in NLRP3-, NLRC4-, or AIM2-dependent caspase-1 activation and IL-1β secretion using knockout mice deficient in pannexin 1.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a></div></div><div id="sec16" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Ion Channel Blockers</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80605" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80605" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Many reported inhibitors of IL-1β maturation appear to affect the electrochemical gradient across the plasma membrane. These include ATP-binding cassette (ABC) chloride transporter blockers <b>2</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), <b>41</b> (tenidap), <b>42</b> (UK5099), and <b>43</b> (ethacrynic acid)<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> (<a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>). Ca<sup>2+</sup> channel blockers <b>44</b> (nimodipine) and related compound <b>45</b> (nitrendipine)<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> have also been demonstrated to inhibit Aβ-induced IL-1β release in vitro in microglial cells and in vivo (<a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>). Whether ion channel blockers suppress inflammasome activation by stopping movement of ionic species across membranes or via unknown direct interactions with inflammasome components is not known. Compan and colleagues recently demonstrated that the movement of K<sup>+</sup>, Cl<sup>–</sup>, and Ca<sup>2+</sup> ions play an important role in regulatory cell volume-induced NLRP3 inflammasome activation during cell swelling. Blocking their translocation with the chloride channel blocker <b>46</b> (5-nitro-2-(3-phenylpropylamino)benzoic acid, NPPB) or with the selective intracellular Ca<sup>2+</sup> chelator prodrug <b>47</b> (BAPTA-AM)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> abolished IL-1β release (<a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>). These observations suggest that ion channel blockers or chemicals that prevent large cytosolic changes in K<sup>+</sup>, Cl<sup>–</sup>, or Ca<sup>2+</sup> concentrations are potential therapeutics against the NLRP3 inflammasome.</div><figure id="fig15" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0016.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structures of ABC anion transporter inhibitors <b>41</b>–<b>43</b>, Ca<sup>2+</sup> channel blockers <b>44</b>–<b>45</b>, Cl<sup>–</sup> channel blocker <b>46</b>, and intracellular Ca<sup>2+</sup> chelator prodrug <b>47</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec17" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">ROS Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26080" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26080" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In 2013, Latz and co-workers identified that intracellular ROS generation, produced by NADPH oxidase (NOX), causes NLRP3 inflammasome formation and caspase-1 activation in response to particulate matter.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> However, the role of ROS in inflammasome activation is now disputed. Phagocytes from patients suffering from chronic granulomatous disease (CGD), whose etiology is well characterized as mutations in NOX subunits, have normal, if not increased, caspase-1 activity.<a onclick="showRef(event, 'ref145 ref146 ref147'); return false;" href="javascript:void(0);" class="ref ref145 ref146 ref147">(145-147)</a> In line with this, the NOX inhibitor <b>48</b> (diphenylene iodonium, DPI) and ROS inhibitor <b>49</b> (NAC)<a onclick="showRef(event, 'ref145 ref148'); return false;" href="javascript:void(0);" class="ref ref145 ref148">(145, 148)</a> reduced intracellular ROS levels that inhibited IL-1β secretion in SK-N-MC cells and phagocytes isolated from both healthy volunteers and CGD patients (<a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>). These results suggest that (i) increased intracellular ROS is strongly associated with NLRP3 inflammasome activation and (ii) compound <b>48</b> reduces ROS levels independently of its well characterized target, NOX. Indeed, compound <b>48</b> is beginning to be recognized as an inhibitor of NLRP3 priming by blocking the expression of pro-caspase-1, pro-IL-1β,<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> and NLRP3<a onclick="showRef(event, 'ref60 ref149'); return false;" href="javascript:void(0);" class="ref ref60 ref149">(60, 149)</a> at a concentration between 1 and 10 μM depending on cell type. Therefore, the use of ROS inhibitors to demonstrate the interplay between ROS and activation of the inflammasome should be used with caution. Liao and colleagues further demonstrate that <b>48</b> inhibits IκB phosphorylation upstream of IKK/NF-κB.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> It is debatable if <b>48</b> also suppresses NLRP3 activation in addition to NLRP3 expression.<a onclick="showRef(event, 'ref60 ref145 ref149 ref150'); return false;" href="javascript:void(0);" class="ref ref60 ref145 ref149 ref150">(60, 145, 149, 150)</a> Surprisingly, one study suggests that <b>48</b> induces de novo pro-IL-1β/NLRP3 translation, generates intracellular ROS production and exacerbates NLRP3-induced IL-1β secretion by disrupting mitochondrial membrane potential.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> It is clear that the mode of action of <b>48</b> and its ability to affect NLRP3 inflammasome priming and activation needs clarification, but in general, studies appear to support a beneficial role of <b>48</b> in decreasing IL-1β secretion.</div><figure id="fig16" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0017.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Structures of ROS inhibitors <b>48</b>–<b>49</b> and cathepsin B inhibitor <b>50</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec18" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Blocking Signaling via Lysosomal Destabilization</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14403" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14403" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">It has been reported that the lysosomal cysteine protease cathepsin B is partially responsible for crystalline particle-induced NLRP3 inflammasome activation via lysosomal destabilization.<a onclick="showRef(event, 'ref11 ref15 ref18 ref152'); return false;" href="javascript:void(0);" class="ref ref11 ref15 ref18 ref152">(11, 15, 18, 152)</a> In this regard, it is likely that cathepsin B release into the cytosol presents an endogenous danger signal that directly or indirectly targets NLRP3 inflammasome activation.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> However, some studies suggest that NLRP3 inflammasome activation by cathepsin B release is independent of lysosomal destabilization.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Nevertheless, the cathepsin B inhibitor <b>50</b> (Ca-074Me)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> significantly suppresses NLRP3 activation<a onclick="showRef(event, 'ref154 ref155 ref156 ref157'); return false;" href="javascript:void(0);" class="ref ref154 ref155 ref156 ref157">(154-157)</a> (<a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>) in addition to NLRP1 inflammasome activation<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> and may represent another potential therapeutic strategy to prevent excessive IL-1β release.</div></div><div id="sec19" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Syk Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26574" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26574" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The tyrosine kinase Syk is an essential modulator of NLRP3 inflammasome activation in both the priming step that leads to CARD9-dependent NF-κB-induced pro-IL-1β synthesis during fungal challenge and the activation step required for IL-1β processing in response to fungal or parasite pathogens.<a onclick="showRef(event, 'ref159 ref160'); return false;" href="javascript:void(0);" class="ref ref159 ref160">(159, 160)</a> Mechanistically, Syk has been suggested to activate the NLRP3 inflammasome by triggering ROS production<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> and phosphorylating ASC that is critical for promoting ASC oligomerization and procaspase-1 recruitment.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> Importantly, Syk deletion or use of the Syk small-molecule inhibitor <b>51</b> (R406)<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> at 1 μM concentration inhibits both <i>Candida albicans</i>-stimulated pro-IL-1β synthesis and LPS+<i>C. albincans</i>-induced IL-1β/18 release in murine bone marrow-derived dendritic cells (BMDCs). Oral administration of <b>51</b> or <b>52</b> (R788),<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> the phosphate pro-drug of <b>51</b> (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>), significantly prevented the progression and manifestations associated with the collagen-induced arthritis model of RA and prevented IL-1β/18 expression in the synovial fluid at a dose of 30 mg/kg in rats. An initial phase II clinical trial demonstrated excellent efficacy of <b>52</b> in active RA patients receiving methotrexate compared to placebo receiving methotrexate.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> However, AstraZeneca discontinued the use of <b>52</b> for the treatment of RA in 2013 due to mixed efficacy in further phase II/III trials and observed adverse effects such as hypertension and gastrointestinal side effects. Despite this, further Syk inhibitors are currently being developed such as <b>53</b> (GS-9973),<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> which is highly potent and selective for Syk (IC<sub>50</sub> = 7.7 nM) and possesses favorable pharmacokinetic properties (<a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>). Compound <b>53</b> is currently in clinical trials for autoimmune indications including RA.</div><figure id="sch6" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0024.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Metabolism of Syk Prodrug <b>52</b> into <b>51</b><a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig17" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0018.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Structures of selective Syk inhibitor <b>53</b> and IRAK1/4 inhibitor <b>54</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec20" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">IRAK1/4 Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84368" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84368" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">As discussed previously, two signals (priming and activation) are required for NLRP3 inflammasome activation. However, two independent studies have recently uncovered a TLR-MyD88-dependent pathway that causes early phase, acute NLRP3 inflammasome activation independent of priming.<a onclick="showRef(event, 'ref165 ref166'); return false;" href="javascript:void(0);" class="ref ref165 ref166">(165, 166)</a> Interleukin-1 receptor-associated kinase 1/4 (IRAK1/4) were identified as key modulators of this rapid nontranscriptional activation of NLRP3 and IRAK1/4 knockout BMDMs show significantly disrupted <i>Listeria monocytogenes</i>-induced or LPS+ATP-stimulated early phase NLRP3 activation.<a onclick="showRef(event, 'ref165 ref166'); return false;" href="javascript:void(0);" class="ref ref165 ref166">(165, 166)</a> The kinase activity of IRAK4 is required for the activation of IRAK1, as a IRAK4 kinase dead mutant cannot induce the rapid NLRP3 inflammasome activation pathway.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> Interestingly, immunoprecipitation experiments investigating IRAK1 binding partners in addition to IRAK1 knockout studies reveal that IRAK1 specifically associates with NLRP3 via direct binding to ASC and prevents both the relocalization and oligomerization of ASC. Additionally, IRAK1 knockout BMDMs blocked the release of high mobility group box 1 (HMGB1) that is indicative of preventing pyroptosis.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> IL-18 release is also prevented in IRAK1 knockout BMDMs in vitro in response to LPS+ATP stimulus that is independent of pro-IL-18 expression and in vivo when <i>L. monocytogenes</i> is injected into the peritoneal cavity in mice.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> Importantly, the IRAK1/4 inhibitor <b>54</b> (IRAK1/4-Inh)<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> at 5 μM concentration abolished NLRP3 speck formation, colocalization of IRAK1 with NLRP3, and caspase-1 cleavage in unprimed cells (<a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>). Despite few specific inhibitors of IRAK1 that currently exist, a number of potent and selective small-molecule inhibitors for IRAK4 have been developed.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> It would be interesting to evaluate some of the new generation IRAK4 inhibitors as small-molecule therapeutics against early phase, acute NLRP3 inflammasome activation.</div></div><div id="sec21" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62201" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62201" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Since the discovery of the inflammasome in 2002,<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> at least 20 small molecules have been identified as inflammasome inhibitors (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Importantly, they could be protective in a number of sterile inflammatory diseases including, but not limited to, acute myocardial infarction, AD, colitis, cystitis, gout, RA, and type II diabetes. Activation of the NLRP3 inflammasome is a strong indicator of sterile inflammation in these diseases and is therefore an important therapeutic target. Small-molecule inhibitors of NLRP3 are likely to be protective in other noncommunicable diseases involving sterile inflammation. Additionally, NLRP3 inflammasome inhibitors will block IL-1β, IL-18, and caspase-1-mediated pyroptosis in response to sterile DAMPs and are therefore considered more effective anti-inflammatory drugs than biologic agents in pathologies involving IL-18 and pyroptosis.<a onclick="showRef(event, 'ref31 ref169'); return false;" href="javascript:void(0);" class="ref ref31 ref169">(31, 169)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Current Small Molecule Inhibitors of the NLRP3 Inflammasome</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0025.gif" alt="" id="GRAPHIC-d3025e2252-autogenerated" /></img><div></div></div><div class="NLM_p">It is increasingly evident that many of these inhibitors not only target the inflammasome directly but can also act as NF-κB inhibitors. The NF-κB pathway presents another major inflammatory cascade whose activation induces NLRP3 and pro-IL-1β gene expression and is required to prime the cell before encountering a DAMP stimulus.<a onclick="showRef(event, 'ref60 ref170'); return false;" href="javascript:void(0);" class="ref ref60 ref170">(60, 170)</a> Thus, some inflammasome inhibitors have a dual mode of action, targeting both the expression of NLRP3 protein governed by NF-κB and NLRP3 inflammasome formation directly. On one hand, inhibitors that act on two pathways rather than one may be more effective therapeutics, requiring lower drug doses (and thus reducing risk of toxicity), as it presents an opportunity to simultaneously downregulate immature pro-IL-1β and NLRP3 expression.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> On the other hand, NF-κB regulates a host of other essential cellular processes beyond expression of NLRP3, pro-IL-1β, and pro-caspase-1; therefore, selectivity may become an issue. When investigating inflammasome biology, it is essential to selectively probe the NLRP3 inflammasome in order to fully appreciate its role, as well as the importance of other known and putative interacting proteins that regulate NLRP3, during sterile inflammation. Therefore, the use of such small molecules in molecular biology to study the inflammasome such as NLRP3 should be used with caution.</div><div class="NLM_p">The predominant mode of action of current small-molecule inflammasome inhibitors is reversible or irreversible cysteine modification. Two possibilities for cysteine modification exist: thiol(ate) nucleophilic substitution at a central electrophilic atom such as the Au atom in compound <b>9</b> or a Michael reaction with an activated alkene such as compound <b>16</b>. There is an interest in Michael acceptors as target covalent modifiers for the inflammasomes, and a recent study demonstrated that this type of inflammasome inhibitor can efficiently block caspase-1-driven pyroptosis.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> However, current inflammasome inhibitors target catalytically important cysteine residues in a nonspecific manner, leading to off-target activities and raises issues concerning cytotoxicity. We believe that the future medicinal chemistry of useful drugs lies with a good structural understanding of NLRP3 and the generation of more “drug-like” target covalent modifiers using a structure-based drug design approach. Such NLRP3 inhibitors that covalently target unconserved, suitably positioned, and accessible nucleophiles are likely to give high potency, selectivity, and extended duration of action. The crystal structure of human NLRP3 PYD has been solved and reveals that the unexpected Cys-8 and Cys-108 residues were highly conserved across species, and the formation of a disulfide bond between these two cysteine residues could be important in regulating NLRP3 activation via ROS and redox potential.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> Studies such as these entertain the possibility that key, unconserved residues and pockets could be selectively targeted to prevent NLRP3 inflammasome activation. This leads to the related question: will small-molecule inflammasome inhibitors that are cysteine modifiers be affected by the redox microenvironment? Indeed, cysteine modifying agents could also react with molecules associated with regulating redox such as glutathione, and the inhibitory activity of compound <b>17</b> was significantly reduced when the concentration of free cellular glutathione was increased.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> Regulation of the local redox microenvironment is essential for the secretion of pro-inflammatory cytokines including IL-1β.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> Therefore, it is important to consider the effect of inflammasome inhibitors on the redox state of the cell as well as their ability to suppress IL-1β processing and its release.</div><div class="NLM_p">IL-1β is an important mediator of macrophage and neutrophil recruitment to sites of infection, and its release is essential for neutrophil-mediated bacterial clearance in vivo.<a onclick="showRef(event, 'ref176 ref177 ref178'); return false;" href="javascript:void(0);" class="ref ref176 ref177 ref178">(176-178)</a> However, there is currently no evidence to indicate that the blockade of NLRP3 with small molecules is an improvement to biologic agents in terms of reducing the risk of infection. Indeed, it is documented that anakinra can increase the susceptibility of patients to serious life-threatening infections that require intravenous antibiotics and hospitalization.<a onclick="showRef(event, 'ref179 ref180 ref181'); return false;" href="javascript:void(0);" class="ref ref179 ref180 ref181">(179-181)</a> Although inactivation of NLRP3 is unlikely to lead to complete blockade of IL-1β, administration of an NLRP3 inhibitor could still result in an increased risk of infection and should be carefully monitored during clinical trials. Ultimately, a consideration of the benefits and drawbacks of treatment with an NLRP3 inflammasome inhibitor is essential, and the cost-benefit of treatment will be patient-dependent.</div><div class="NLM_p last">While researchers have been synthesizing molecules that target IL-1β release for some time,<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> the identification of the inflammasome<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> has focused the search around molecules that selectively target NLRP3. While the field is still relatively young, this review highlights a number of chemical entities that block NLRP3 activation. This offers great promise for the future development of NLRP3 inhibitors where these molecules may act as scaffolds for further chemical refinement and optimization. Thus, the design of inhibitors such as those reviewed herein could constitute an important class of anti-inflammatory drugs for the treatment of many noncommunicable, sterile diseases involving excessive IL-1β release.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01091" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77581" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77581" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sally Freeman</span> - <span class="hlFld-Affiliation affiliation">Manchester
Pharmacy School, Faculty of Medical and Human Sciences, The University of Manchester, Stopford Building, Oxford
Road, Manchester M13 9PT, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d0a3b1bcbca9feb6a2b5b5bdb1be90bdb1beb3b8b5a3a4b5a2feb1b3fea5bb"><span class="__cf_email__" data-cfemail="0c7f6d606075226a7e6969616d624c616d626f64697f78697e226d6f227967">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alex G. Baldwin</span> - <span class="hlFld-Affiliation affiliation">Manchester
Pharmacy School, Faculty of Medical and Human Sciences, The University of Manchester, Stopford Building, Oxford
Road, Manchester M13 9PT, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Brough</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Life Sciences, The University of Manchester, AV Hill Building, Oxford Road, Manchester M13 9PT, U.K.</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06044" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06044" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Alex G. Baldwin</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=BIO-d3025e2307-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Alex G. Baldwin</b> received his B.Sc. in Biological and Medicinal Chemistry from the University of Exeter, U.K., in 2013. Alex is the recipient of two scholarships and nine awards, including the Society of Biology Top Student Award and President’s Doctoral Scholar Award. Alex is currently studying for his Ph.D. in the Manchester Pharmacy School at the University of Manchester. Alex’s current work focuses on the design, synthesis, and evaluation of novel inhibitors of the NLRP3 inflammasome.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="25" class="article__inlineFigure"><h2 class="fig-label">David Brough</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=BIO-d3025e2312-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>David Brough</b> received his B.Sc. in Biosciences and Chemistry (1999) from the Robert Gordon University, Aberdeen, and Ph.D. in Biological Sciences (2002) from the University of Manchester. Following postdoctoral positions at the Universities of Cambridge, and then Manchester, David was awarded a Fellowship from the Wellcome Trust (2008) to establish research independence. Since 2013, David is a Lecturer at the University of Manchester.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Sally Freeman</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=BIO-d3025e2317-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Sally Freeman</b> received her B.Sc. in Chemistry (1982) and Ph.D. (1985) from the Department of Chemistry at the University of Leicester, U.K., prior to postdoctoral studies with Professor Jeremy Knowles at Harvard University. Sally was a lecturer in the Aston Pharmacy School, Aston University, from 1987, moving to the Manchester Pharmacy School at the University of Manchester in 1995, where she is currently a Reader in Medicinal Chemistry.</p></figure></div><div class="ack" id="ACK-d3025e2322-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38056" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38056" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the Manchester Pharmacy School and University of Manchester Presidential Doctoral Scholar award for financial support to A.G.B.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i33" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i33"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i34" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i34"> Abbreviations Used</h2><tr><td class="NLM_term">IL-1(β)</td><td class="NLM_def"><p class="first last">interleukin-1(β)</p></td></tr><tr><td class="NLM_term">PAMP</td><td class="NLM_def"><p class="first last">pathogen-associated molecular pattern</p></td></tr><tr><td class="NLM_term">DAMP</td><td class="NLM_def"><p class="first last">damage-associated molecular pattern</p></td></tr><tr><td class="NLM_term">PRR</td><td class="NLM_def"><p class="first last">pattern recognition receptor</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">ASC</td><td class="NLM_def"><p class="first last">apoptosis-associates speck-like protein containing a caspase recruitment domain</p></td></tr><tr><td class="NLM_term">NLRP1–12</td><td class="NLM_def"><p class="first last">NOD-like receptor family, pyrin domain-containing protein 1–12</p></td></tr><tr><td class="NLM_term">NLRC4</td><td class="NLM_def"><p class="first last">NOD-like receptor family, caspase recruitment domain-containing protein 4</p></td></tr><tr><td class="NLM_term">AIM2</td><td class="NLM_def"><p class="first last">absent in melanoma 2</p></td></tr><tr><td class="NLM_term">IFI16</td><td class="NLM_def"><p class="first last">interferon gamma-inducible protein 16</p></td></tr><tr><td class="NLM_term">RIG-1</td><td class="NLM_def"><p class="first last">retinoic acid-inducible gene 1</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor kappa-light-chain-enhancer of activated B cells</p></td></tr><tr><td class="NLM_term">TLR</td><td class="NLM_def"><p class="first last">Toll-like receptor</p></td></tr><tr><td class="NLM_term">P2X7R</td><td class="NLM_def"><p class="first last">P2X7 receptor</p></td></tr><tr><td class="NLM_term">MSU</td><td class="NLM_def"><p class="first last">monosodium urate</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">APP/PS1</td><td class="NLM_def"><p class="first last">amyloid precursor protein/presenilin 1 mutant</p></td></tr><tr><td class="NLM_term">IL-1Ra</td><td class="NLM_def"><p class="first last">IL-1 receptor antagonist</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">MyD88</td><td class="NLM_def"><p class="first last">myeloid differentiation primary response gene 88</p></td></tr><tr><td class="NLM_term">Ub</td><td class="NLM_def"><p class="first last">ubiquitination</p></td></tr><tr><td class="NLM_term">TAK1</td><td class="NLM_def"><p class="first last">transforming growth factor beta-activated kinase 1</p></td></tr><tr><td class="NLM_term">TAB1–3</td><td class="NLM_def"><p class="first last">TAK1-binding proteins (TAB) 1–3</p></td></tr><tr><td class="NLM_term">IκB</td><td class="NLM_def"><p class="first last">inhibitor of kappa B</p></td></tr><tr><td class="NLM_term">IKK</td><td class="NLM_def"><p class="first last">IκB kinase</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor kappa-light-chain-enhancer of activated B cells</p></td></tr><tr><td class="NLM_term">NLRP3</td><td class="NLM_def"><p class="first last">NOD-like receptor family, pyrin domain-containing protein 3</p></td></tr><tr><td class="NLM_term">LRR</td><td class="NLM_def"><p class="first last">leucine-rich repeat</p></td></tr><tr><td class="NLM_term">NACHT</td><td class="NLM_def"><p class="first last">nucleotide-binding and oligomerization</p></td></tr><tr><td class="NLM_term">PYD</td><td class="NLM_def"><p class="first last">pyrin domain</p></td></tr><tr><td class="NLM_term">CARD</td><td class="NLM_def"><p class="first last">caspase activation and recruitment domain</p></td></tr><tr><td class="NLM_term">ASC</td><td class="NLM_def"><p class="first last">apoptosis-associates speck-like protein containing a CARD</p></td></tr><tr><td class="NLM_term">DUBs</td><td class="NLM_def"><p class="first last">deubiquitinating enzymes</p></td></tr><tr><td class="NLM_term">BHB</td><td class="NLM_def"><p class="first last">β-hydroxybutryrate</p></td></tr><tr><td class="NLM_term">MNS</td><td class="NLM_def"><p class="first last">3,4-methylenedioxy-β-nitrostyrene</p></td></tr><tr><td class="NLM_term">7-DG</td><td class="NLM_def"><p class="first last">7-desacetoxy-6,7-dehydrogedunin</p></td></tr><tr><td class="NLM_term">K<sub>ATP</sub> channel</td><td class="NLM_def"><p class="first last">ATP-sensitive potassium channel</p></td></tr><tr><td class="NLM_term">SUR2</td><td class="NLM_def"><p class="first last">sulfonylurea receptor</p></td></tr><tr><td class="NLM_term">IAPP</td><td class="NLM_def"><p class="first last">islet amyloid polypeptide</p></td></tr><tr><td class="NLM_term">CP</td><td class="NLM_def"><p class="first last">cyclophosphamide</p></td></tr><tr><td class="NLM_term">CAPS</td><td class="NLM_def"><p class="first last">cyropyrin-associated periodic syndrome</p></td></tr><tr><td class="NLM_term">MWS</td><td class="NLM_def"><p class="first last">Muckle–Wells syndrome</p></td></tr><tr><td class="NLM_term">FCAS</td><td class="NLM_def"><p class="first last">familial cold autoinflammatory syndrome</p></td></tr><tr><td class="NLM_term">NOMID</td><td class="NLM_def"><p class="first last">neonatal onset multisystem inflammatory disease</p></td></tr><tr><td class="NLM_term">CRIDs</td><td class="NLM_def"><p class="first last">cytokine release inhibitory drugs</p></td></tr><tr><td class="NLM_term">CTL</td><td class="NLM_def"><p class="first last">cytotoxic T lymphocyte</p></td></tr><tr><td class="NLM_term">BMDM</td><td class="NLM_def"><p class="first last">bone marrow-derived macrophage</p></td></tr><tr><td class="NLM_term">HMDM</td><td class="NLM_def"><p class="first last">human monocyte-derived macrophage</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cell</p></td></tr><tr><td class="NLM_term">EAE</td><td class="NLM_def"><p class="first last">experimental autoimmune encephalomyelitis</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">rheumatoid arthritis</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor-alpha</p></td></tr><tr><td class="NLM_term">AP-1</td><td class="NLM_def"><p class="first last">activator protein 1</p></td></tr><tr><td class="NLM_term">IRF3</td><td class="NLM_def"><p class="first last">interferon regulatory factor 3</p></td></tr><tr><td class="NLM_term">Cys</td><td class="NLM_def"><p class="first last">cysteine</p></td></tr><tr><td class="NLM_term">DTT</td><td class="NLM_def"><p class="first last">dithiothreitol</p></td></tr><tr><td class="NLM_term">LT</td><td class="NLM_def"><p class="first last">lethal toxin</p></td></tr><tr><td class="NLM_term">NAC</td><td class="NLM_def"><p class="first last"><i>N</i>-acetyl-<span class="smallcaps smallerCapital">l</span>-cysteine</p></td></tr><tr><td class="NLM_term">DPI</td><td class="NLM_def"><p class="first last">diphenylene iodium</p></td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylase</p></td></tr><tr><td class="NLM_term">MNS</td><td class="NLM_def"><p class="first last">3,4-methylenedioxy-β-nitrostyrene</p></td></tr><tr><td class="NLM_term">Syk</td><td class="NLM_def"><p class="first last">spleen tyrosine kinase</p></td></tr><tr><td class="NLM_term">DSS</td><td class="NLM_def"><p class="first last">dextran sulfate sodium</p></td></tr><tr><td class="NLM_term">PKR</td><td class="NLM_def"><p class="first last">protein kinase R</p></td></tr><tr><td class="NLM_term">SNP</td><td class="NLM_def"><p class="first last">single nucleotide polymorphism</p></td></tr><tr><td class="NLM_term">ABC transporter</td><td class="NLM_def"><p class="first last">ATP-binding cassette transporter</p></td></tr><tr><td class="NLM_term">NOX</td><td class="NLM_def"><p class="first last">NADPH oxidase</p></td></tr><tr><td class="NLM_term">CGD</td><td class="NLM_def"><p class="first last">chronic granulomatous disease</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum serum concentration</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17524" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17524" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 183 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Koizumi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakasone, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span> </span><span class="NLM_article-title">Inflammasome activation via intracellular NLRs triggered by bacterial infection</span> <span class="citation_source-journal">Cell. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span><span class="refDoi"> DOI: 10.1111/j.1462-5822.2011.01707.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1111%2Fj.1462-5822.2011.01707.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=21995284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFGqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=149-154&author=Y.+Koizumiauthor=C.+Tomaauthor=N.+Higaauthor=T.+Noharaauthor=N.+Nakasoneauthor=T.+Suzuki&title=Inflammasome+activation+via+intracellular+NLRs+triggered+by+bacterial+infection&doi=10.1111%2Fj.1462-5822.2011.01707.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammasome activation via intracellular NLRs triggered by bacterial infection</span></div><div class="casAuthors">Koizumi, Yukiko; Toma, Claudia; Higa, Naomi; Nohara, Toshitsugu; Nakasone, Noboru; Suzuki, Toshihiko</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-154</span>CODEN:
                <span class="NLM_cas:coden">CEMIF5</span>;
        ISSN:<span class="NLM_cas:issn">1462-5814</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Members of the nucleotide-binding, oligomerization domain (NOD)-like receptor (NLR) proteins assemble into a multiprotein platform, known as the inflammasome, to induce caspase-1 activation followed by the subsequent secretion of IL-1β and IL-18.  In this review, we focus on the role of NLRs in inflammasome activation as part of the host defense against bacterial pathogens.  One of activators of the NLRC4 inflammasome is bacterial flagellin secreted through type III or IV secretion systems, which are important for the pathogenicity of many Gram-neg. bacteria.  The NLRP3 inflammasome is mainly activated by a large no. of bacterial pore-forming toxins.  Despite our knowledge of inflammasome activation upon bacterial infection, the function of antibacterial defense under in vivo conditions remains to be elucidated.  Further understanding of NLR function should provide new insights into the mechanisms of host pro-inflammatory responses and the pathogenesis of bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosZd8f_hk8KrVg90H21EOLACvtfcHk0lhihHQLHWWAcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFGqsrY%253D&md5=5e9065827392d3138cb5b6ed1cd843df</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1462-5822.2011.01707.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1462-5822.2011.01707.x%26sid%3Dliteratum%253Aachs%26aulast%3DKoizumi%26aufirst%3DY.%26aulast%3DToma%26aufirst%3DC.%26aulast%3DHiga%26aufirst%3DN.%26aulast%3DNohara%26aufirst%3DT.%26aulast%3DNakasone%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DT.%26atitle%3DInflammasome%2520activation%2520via%2520intracellular%2520NLRs%2520triggered%2520by%2520bacterial%2520infection%26jtitle%3DCell.%2520Microbiol.%26date%3D2012%26volume%3D14%26spage%3D149%26epage%3D154%26doi%3D10.1111%2Fj.1462-5822.2011.01707.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Dinarello, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Meer, J. W.</span><span> </span><span class="NLM_article-title">Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">652</span><span class="refDoi"> DOI: 10.1038/nrd3800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnrd3800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22850787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=633-652&author=C.+A.+Dinarelloauthor=A.+Simonauthor=J.+W.+van+der+Meer&title=Treating+inflammation+by+blocking+interleukin-1+in+a+broad+spectrum+of+diseases&doi=10.1038%2Fnrd3800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases</span></div><div class="casAuthors">Dinarello, Charles A.; Simon, Anna; van der Meer, Jos W. M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">633-652</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Interleukin-1 (IL-1) is a highly active pro-inflammatory cytokine that lowers pain thresholds and damages tissues.  Monotherapy blocking IL-1 activity in autoinflammatory syndromes results in a rapid and sustained redn. in disease severity, including reversal of inflammation-mediated loss of sight, hearing and organ function.  This approach can therefore be effective in treating common conditions such as post-infarction heart failure, and trials targeting a broad spectrum of new indications are underway.  So far, three IL-1-targeted agents have been approved: the IL-1 receptor antagonist anakinra, the sol. decoy receptor rilonacept and the neutralizing monoclonal anti-IL-1β antibody canakinumab.  In addn., a monoclonal antibody directed against the IL-1 receptor and a neutralizing anti-IL-1α antibody are in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6wcqDUVKRhLVg90H21EOLACvtfcHk0lhSbNwi-mtdog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmtrfJ&md5=9297c8530f9d2c75da0880a7df7c1fe2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd3800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3800%26sid%3Dliteratum%253Aachs%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BMeer%26aufirst%3DJ.%2BW.%26atitle%3DTreating%2520inflammation%2520by%2520blocking%2520interleukin-1%2520in%2520a%2520broad%2520spectrum%2520of%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D633%26epage%3D652%26doi%3D10.1038%2Fnrd3800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Chen, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuñez, G.</span><span> </span><span class="NLM_article-title">Sterile inflammation: sensing and reacting to damage</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">826</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span><span class="refDoi"> DOI: 10.1038/nri2873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnri2873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=21088683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVersLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=826-837&author=G.+Y.+Chenauthor=G.+Nu%C3%B1ez&title=Sterile+inflammation%3A+sensing+and+reacting+to+damage&doi=10.1038%2Fnri2873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Sterile inflammation: sensing and reacting to damage</span></div><div class="casAuthors">Chen, Grace Y.; Nunez, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">826-837</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Over the past several decades, much has been revealed about the nature of the host innate immune response to microorganisms, with the identification of pattern recognition receptors (PRRs) and pathogen-assocd. mol. patterns, which are the conserved microbial motifs sensed by these receptors.  It is now apparent that these same PRRs can also be activated by non-microbial signals, many of which are considered as damage-assocd. mol. patterns.  The sterile inflammation that ensues either resolves the initial insult or leads to disease.  Here, we review the triggers and receptor pathways that result in sterile inflammation and its impact on human health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosJXKQoxN6sbVg90H21EOLACvtfcHk0lhSbNwi-mtdog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVersLnM&md5=f77022de4a28f73f0e7a4255dfe013fd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnri2873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2873%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%2BY.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26atitle%3DSterile%2520inflammation%253A%2520sensing%2520and%2520reacting%2520to%2520damage%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D10%26spage%3D826%26epage%3D837%26doi%3D10.1038%2Fnri2873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Takeuchi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akira, S.</span><span> </span><span class="NLM_article-title">Pattern recognition receptors and inflammation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">–</span> <span class="NLM_lpage">820</span><span class="refDoi"> DOI: 10.1016/j.cell.2010.01.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.cell.2010.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20303872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2010&pages=805-820&author=O.+Takeuchiauthor=S.+Akira&title=Pattern+recognition+receptors+and+inflammation&doi=10.1016%2Fj.cell.2010.01.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Pattern recognition receptors and inflammation</span></div><div class="casAuthors">Takeuchi, Osamu; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">805-820</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Infection of cells by microorganisms activates the inflammatory response.  The initial sensing of infection is mediated by innate pattern recognition receptors (PRRs), which include Toll-like receptors, RIG-I-like receptors, NOD-like receptors, and C-type lectin receptors.  The intracellular signaling cascades triggered by these PRRs lead to transcriptional expression of inflammatory mediators that coordinate the elimination of pathogens and infected cells.  However, aberrant activation of this system leads to immunodeficiency, septic shock, or induction of autoimmunity.  In this Review, the authors discuss the role of PRRs, their signaling pathways, and how they control inflammatory responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0N2xgJRnA2bVg90H21EOLACvtfcHk0lhSbNwi-mtdog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSgu74%253D&md5=b0b11ee0ff10f679cea981997796fe6d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DO.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DPattern%2520recognition%2520receptors%2520and%2520inflammation%26jtitle%3DCell%26date%3D2010%26volume%3D140%26spage%3D805%26epage%3D820%26doi%3D10.1016%2Fj.cell.2010.01.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Rock, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ontiveros, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kono, H.</span><span> </span><span class="NLM_article-title">The sterile inflammatory response</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span><span class="refDoi"> DOI: 10.1146/annurev-immunol-030409-101311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1146%2Fannurev-immunol-030409-101311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20307211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=321-342&author=K.+L.+Rockauthor=E.+Latzauthor=F.+Ontiverosauthor=H.+Kono&title=The+sterile+inflammatory+response&doi=10.1146%2Fannurev-immunol-030409-101311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The sterile inflammatory response</span></div><div class="casAuthors">Rock, Kenneth L.; Latz, Eicke; Ontiveros, Fernando; Kono, Hajime</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">321-342</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The acute inflammatory response is a double-edged sword.  On the one hand, it plays a key role in initial host defense, particularly against many infections.  On the other hand, its aim is imprecise, and as a consequence, when it is drawn into battle, it can cause collateral damage in tissues.  In situations where the inciting stimulus is sterile, the cost-benefit ratio may be high; because of this, sterile inflammation underlies the pathogenesis of a no. of diseases.  Although there have been major advances in our understanding of how microbes trigger inflammation, much less has been learned about this process in sterile situations.  This review focuses on a subset of the many sterile stimuli that can induce inflammation-specifically dead cells and a variety of irritant particles, including crystals, minerals, and protein aggregates.  Although this subset of stimuli is structurally very diverse and might appear to be unrelated, there is accumulating evidence that the innate immune system may recognize them in similar ways and stimulate the sterile inflammatory response via common pathways.  Here we review established and emerging data about these responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoigSou6cTWKbVg90H21EOLACvtfcHk0lhtaE7baQ3VyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSms7s%253D&md5=506769335b2c6835d674d8791c2d67f6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1146%2Fannurev-immunol-030409-101311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-immunol-030409-101311%26sid%3Dliteratum%253Aachs%26aulast%3DRock%26aufirst%3DK.%2BL.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DOntiveros%26aufirst%3DF.%26aulast%3DKono%26aufirst%3DH.%26atitle%3DThe%2520sterile%2520inflammatory%2520response%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D28%26spage%3D321%26epage%3D342%26doi%3D10.1146%2Fannurev-immunol-030409-101311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Cassel, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutterwala, F. S.</span><span> </span><span class="NLM_article-title">Sterile inflammatory responses mediated by the NLRP3 inflammasome</span> <span class="citation_source-journal">Eur. J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span><span class="refDoi"> DOI: 10.1002/eji.200940207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1002%2Feji.200940207" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2010&pages=607-611&author=S.+L.+Casselauthor=F.+S.+Sutterwala&title=Sterile+inflammatory+responses+mediated+by+the+NLRP3+inflammasome&doi=10.1002%2Feji.200940207"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Feji.200940207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.200940207%26sid%3Dliteratum%253Aachs%26aulast%3DCassel%26aufirst%3DS.%2BL.%26aulast%3DSutterwala%26aufirst%3DF.%2BS.%26atitle%3DSterile%2520inflammatory%2520responses%2520mediated%2520by%2520the%2520NLRP3%2520inflammasome%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D2010%26volume%3D40%26spage%3D607%26epage%3D611%26doi%3D10.1002%2Feji.200940207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Latz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, A.</span><span> </span><span class="NLM_article-title">Activation and regulation of the inflammasomes</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span><span class="refDoi"> DOI: 10.1038/nri3452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnri3452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=23702978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFSgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=397-411&author=E.+Latzauthor=T.+S.+Xiaoauthor=A.+Stutz&title=Activation+and+regulation+of+the+inflammasomes&doi=10.1038%2Fnri3452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Activation and regulation of the inflammasomes</span></div><div class="casAuthors">Latz, Eicke; Xiao, T. Sam; Stutz, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">397-411</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Inflammasomes are key signalling platforms that detect pathogenic microorganisms and sterile stressors, and that activate the highly pro-inflammatory cytokines interleukin-1β (IL-1β) and IL-18.  In this Review, we discuss the complex regulatory mechanisms that facilitate a balanced but effective inflammasome-mediated immune response, and we highlight the similarities to another mol. signalling platform - the apoptosome - that monitors cellular health.  Extracellular regulatory mechanisms are discussed, as well as the intracellular control of inflammasome assembly, for example, via ion fluxes, free radicals and autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom16nKHEVN3bVg90H21EOLACvtfcHk0lhtaE7baQ3VyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFSgsLw%253D&md5=86c377fdd6dc6759679f4e410fad96af</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnri3452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3452%26sid%3Dliteratum%253Aachs%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DXiao%26aufirst%3DT.%2BS.%26aulast%3DStutz%26aufirst%3DA.%26atitle%3DActivation%2520and%2520regulation%2520of%2520the%2520inflammasomes%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2013%26volume%3D13%26spage%3D397%26epage%3D411%26doi%3D10.1038%2Fnri3452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Pelegrin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surprenant, A.</span><span> </span><span class="NLM_article-title">Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5071</span><span class="NLM_x">–</span> <span class="NLM_lpage">5082</span><span class="refDoi"> DOI: 10.1038/sj.emboj.7601378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fsj.emboj.7601378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=17036048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFChsrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=5071-5082&author=P.+Pelegrinauthor=A.+Surprenant&title=Pannexin-1+mediates+large+pore+formation+and+interleukin-1%CE%B2+release+by+the+ATP-gated+P2X7+receptor&doi=10.1038%2Fsj.emboj.7601378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor</span></div><div class="casAuthors">Pelegrin, Pablo; Surprenant, Annmarie</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5071-5082</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">P2X7 receptors are ATP-gated cation channels; their activation in macrophage also leads to rapid opening of a membrane pore permeable to dyes such as ethidium, and to release of the pro-inflammatory cytokine, interleukin-1β (IL-1β).  It has not been known what this dye-uptake path is, or whether it is involved in downstream signaling to IL-1β release.  Here, we identify pannexin-1, a recently described mammalian protein that functions as a hemichannel when ectopically expressed, as this dye-uptake pathway and show that signaling through pannexin-1 is required for processing of caspase-1 and release of mature IL-1β induced by P2X7 receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgKvoL27FfqbVg90H21EOLACvtfcHk0lhtaE7baQ3VyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFChsrzM&md5=9b4bb218bde9ee4145bd3f70d900012c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601378%26sid%3Dliteratum%253Aachs%26aulast%3DPelegrin%26aufirst%3DP.%26aulast%3DSurprenant%26aufirst%3DA.%26atitle%3DPannexin-1%2520mediates%2520large%2520pore%2520formation%2520and%2520interleukin-1%25CE%25B2%2520release%2520by%2520the%2520ATP-gated%2520P2X7%2520receptor%26jtitle%3DEMBO%2520J.%26date%3D2006%26volume%3D25%26spage%3D5071%26epage%3D5082%26doi%3D10.1038%2Fsj.emboj.7601378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Locovei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scemes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spray, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, G.</span><span> </span><span class="NLM_article-title">Pannexin1 is part of the pore forming unit of the P2X<sub>7</sub> receptor death complex</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">581</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span><span class="refDoi"> DOI: 10.1016/j.febslet.2006.12.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.febslet.2006.12.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2007&pages=483-488&author=S.+Locoveiauthor=E.+Scemesauthor=F.+Qiuauthor=D.+C.+Sprayauthor=G.+Dahl&title=Pannexin1+is+part+of+the+pore+forming+unit+of+the+P2X7+receptor+death+complex&doi=10.1016%2Fj.febslet.2006.12.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2006.12.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2006.12.056%26sid%3Dliteratum%253Aachs%26aulast%3DLocovei%26aufirst%3DS.%26aulast%3DScemes%26aufirst%3DE.%26aulast%3DQiu%26aufirst%3DF.%26aulast%3DSpray%26aufirst%3DD.%2BC.%26aulast%3DDahl%26aufirst%3DG.%26atitle%3DPannexin1%2520is%2520part%2520of%2520the%2520pore%2520forming%2520unit%2520of%2520the%2520P2X7%2520receptor%2520death%2520complex%26jtitle%3DFEBS%2520Lett.%26date%3D2007%26volume%3D581%26spage%3D483%26epage%3D488%26doi%3D10.1016%2Fj.febslet.2006.12.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Martinon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pétrilli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardivel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, J.</span><span> </span><span class="NLM_article-title">Gout-associated uric acid crystals activate the NALP3 inflammasome</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span><span class="refDoi"> DOI: 10.1038/nature04516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnature04516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=16407889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD28XitFGitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=237-241&author=F.+Martinonauthor=V.+P%C3%A9trilliauthor=A.+Mayorauthor=A.+Tardivelauthor=J.+Tschopp&title=Gout-associated+uric+acid+crystals+activate+the+NALP3+inflammasome&doi=10.1038%2Fnature04516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Gout-associated uric acid crystals activate the NALP3 inflammasome</span></div><div class="casAuthors">Martinon, Fabio; Petrilli, Virginie; Mayor, Annick; Tardivel, Aubry; Tschopp, Juerg</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7081</span>),
    <span class="NLM_cas:pages">237-241</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Development of the acute and chronic inflammatory responses known as gout and pseudogout are assocd. with the deposition of monosodium urate (MSU) or calcium pyrophosphate dihydrate (CPPD) crystals, resp., in joints and periarticular tissues.  Although MSU crystals were first identified as the etiol. agent of gout in the eighteenth century and more recently as a danger signal' released from dying cells, little is known about the mol. mechanisms underlying MSU- or CPPD-induced inflammation.  Here we show that MSU and CPPD engage the caspase-1-activating NALP3 (also called cryopyrin) inflammasome, resulting in the prodn. of active interleukin (IL)-1β and IL-18.  Macrophages from mice deficient in various components of the inflammasome such as caspase-1, ASC and NALP3 are defective in crystal-induced IL-1β activation.  Moreover, an impaired neutrophil influx is found in an in vivo model of crystal-induced peritonitis in inflammasome-deficient mice or mice deficient in the IL-1β receptor (IL-1R).  These findings provide insight into the mol. processes underlying the inflammatory conditions of gout and pseudogout, and further support a pivotal role of the inflammasome in several autoinflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Z0Lgw8VSWLVg90H21EOLACvtfcHk0lhoq81PDoJ4nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitFGitLg%253D&md5=e8694a6dc4096b44f07442df6feb791f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature04516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04516%26sid%3Dliteratum%253Aachs%26aulast%3DMartinon%26aufirst%3DF.%26aulast%3DP%25C3%25A9trilli%26aufirst%3DV.%26aulast%3DMayor%26aufirst%3DA.%26aulast%3DTardivel%26aufirst%3DA.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DGout-associated%2520uric%2520acid%2520crystals%2520activate%2520the%2520NALP3%2520inflammasome%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D237%26epage%3D241%26doi%3D10.1038%2Fnature04516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Halle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornung, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinheckel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golenbock, D. T.</span><span> </span><span class="NLM_article-title">The NALP3 inflammasome is involved in the innate immune response to amyloid-beta</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">865</span><span class="refDoi"> DOI: 10.1038/ni.1636</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fni.1636" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=18604209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=857-865&author=A.+Halleauthor=V.+Hornungauthor=G.+C.+Petzoldauthor=C.+R.+Stewartauthor=B.+G.+Monksauthor=T.+Reinheckelauthor=K.+A.+Fitzgeraldauthor=E.+Latzauthor=K.+J.+Mooreauthor=D.+T.+Golenbock&title=The+NALP3+inflammasome+is+involved+in+the+innate+immune+response+to+amyloid-beta&doi=10.1038%2Fni.1636"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The NALP3 inflammasome is involved in the innate immune response to amyloid-β</span></div><div class="casAuthors">Halle, Annett; Hornung, Veit; Petzold, Gabor C.; Stewart, Cameron R.; Monks, Brian G.; Reinheckel, Thomas; Fitzgerald, Katherine A.; Latz, Eicke; Moore, Kathryn J.; Golenbock, Douglas T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">857-865</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The fibrillar peptide amyloid-β (Aβ) has a chief function in the pathogenesis of Alzheimer's disease.  Interleukin 1β (IL-1β) is a key cytokine in the inflammatory response to Aβ.  Insol. materials such as crystals activate the inflammasome formed by the cytoplasmic receptor NALP3, which results in the release of IL-1β.  Here we identify the NALP3 inflammasome as a sensor of Aβ in a process involving the phagocytosis of Aβ and subsequent lysosomal damage and release of cathepsin B.  Furthermore, the IL-1β pathway was essential for the microglial synthesis of proinflammatory and neurotoxic factors, and the inflammasome, caspase-1 and IL-1β were crit. for the recruitment of microglia to exogenous Aβ in the brain.  Our findings suggest that activation of the NALP3 inflammasome is important for inflammation and tissue damage in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-KTzVDnDlb7Vg90H21EOLACvtfcHk0lhoq81PDoJ4nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCmu74%253D&md5=49eaff7db252ca630e801c6ea015f77f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fni.1636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1636%26sid%3Dliteratum%253Aachs%26aulast%3DHalle%26aufirst%3DA.%26aulast%3DHornung%26aufirst%3DV.%26aulast%3DPetzold%26aufirst%3DG.%2BC.%26aulast%3DStewart%26aufirst%3DC.%2BR.%26aulast%3DMonks%26aufirst%3DB.%2BG.%26aulast%3DReinheckel%26aufirst%3DT.%26aulast%3DFitzgerald%26aufirst%3DK.%2BA.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DMoore%26aufirst%3DK.%2BJ.%26aulast%3DGolenbock%26aufirst%3DD.%2BT.%26atitle%3DThe%2520NALP3%2520inflammasome%2520is%2520involved%2520in%2520the%2520innate%2520immune%2520response%2520to%2520amyloid-beta%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D857%26epage%3D865%26doi%3D10.1038%2Fni.1636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Luheshi, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Castejon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, D.</span><span> </span><span class="NLM_article-title">Sphingosine regulates the NLRP3-inflammasome and IL-1β release from macrophages</span> <span class="citation_source-journal">Eur. J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">716</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span><span class="refDoi"> DOI: 10.1002/eji.201142079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1002%2Feji.201142079" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=716-725&author=N.+M.+Luheshiauthor=J.+A.+Gilesauthor=G.+Lopez-Castejonauthor=D.+Brough&title=Sphingosine+regulates+the+NLRP3-inflammasome+and+IL-1%CE%B2+release+from+macrophages&doi=10.1002%2Feji.201142079"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Feji.201142079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.201142079%26sid%3Dliteratum%253Aachs%26aulast%3DLuheshi%26aufirst%3DN.%2BM.%26aulast%3DGiles%26aufirst%3DJ.%2BA.%26aulast%3DLopez-Castejon%26aufirst%3DG.%26aulast%3DBrough%26aufirst%3DD.%26atitle%3DSphingosine%2520regulates%2520the%2520NLRP3-inflammasome%2520and%2520IL-1%25CE%25B2%2520release%2520from%2520macrophages%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D2012%26volume%3D42%26spage%3D716%26epage%3D725%26doi%3D10.1002%2Feji.201142079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Compan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroja-Mazo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Castejon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angosto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montero, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herranz, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelegrin, P.</span><span> </span><span class="NLM_article-title">Cell volume regulation modulates NLRP3 inflammasome activation</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">487</span><span class="NLM_x">–</span> <span class="NLM_lpage">500</span><span class="refDoi"> DOI: 10.1016/j.immuni.2012.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.immuni.2012.06.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=487-500&author=V.+Companauthor=A.+Baroja-Mazoauthor=G.+Lopez-Castejonauthor=A.+I.+Gomezauthor=C.+M.+Martinezauthor=D.+Angostoauthor=M.+T.+Monteroauthor=A.+S.+Herranzauthor=E.+Bazanauthor=D.+Reimersauthor=V.+Muleroauthor=P.+Pelegrin&title=Cell+volume+regulation+modulates+NLRP3+inflammasome+activation&doi=10.1016%2Fj.immuni.2012.06.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2012.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2012.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DCompan%26aufirst%3DV.%26aulast%3DBaroja-Mazo%26aufirst%3DA.%26aulast%3DLopez-Castejon%26aufirst%3DG.%26aulast%3DGomez%26aufirst%3DA.%2BI.%26aulast%3DMartinez%26aufirst%3DC.%2BM.%26aulast%3DAngosto%26aufirst%3DD.%26aulast%3DMontero%26aufirst%3DM.%2BT.%26aulast%3DHerranz%26aufirst%3DA.%2BS.%26aulast%3DBazan%26aufirst%3DE.%26aulast%3DReimers%26aufirst%3DD.%26aulast%3DMulero%26aufirst%3DV.%26aulast%3DPelegrin%26aufirst%3DP.%26atitle%3DCell%2520volume%2520regulation%2520modulates%2520NLRP3%2520inflammasome%2520activation%26jtitle%3DImmunity%26date%3D2012%26volume%3D37%26spage%3D487%26epage%3D500%26doi%3D10.1016%2Fj.immuni.2012.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Munoz-Planillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuffa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Colon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajendiran, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunez, G.</span><span> </span><span class="NLM_article-title">K<sup>+</sup> efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1142</span><span class="NLM_x">–</span> <span class="NLM_lpage">1153</span><span class="refDoi"> DOI: 10.1016/j.immuni.2013.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.immuni.2013.05.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=1142-1153&author=R.+Munoz-Planilloauthor=P.+Kuffaauthor=G.+Martinez-Colonauthor=B.+L.+Smithauthor=T.+M.+Rajendiranauthor=G.+Nunez&title=K%2B+efflux+is+the+common+trigger+of+NLRP3+inflammasome+activation+by+bacterial+toxins+and+particulate+matter&doi=10.1016%2Fj.immuni.2013.05.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2013.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2013.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz-Planillo%26aufirst%3DR.%26aulast%3DKuffa%26aufirst%3DP.%26aulast%3DMartinez-Colon%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DB.%2BL.%26aulast%3DRajendiran%26aufirst%3DT.%2BM.%26aulast%3DNunez%26aufirst%3DG.%26atitle%3DK%252B%2520efflux%2520is%2520the%2520common%2520trigger%2520of%2520NLRP3%2520inflammasome%2520activation%2520by%2520bacterial%2520toxins%2520and%2520particulate%2520matter%26jtitle%3DImmunity%26date%3D2013%26volume%3D38%26spage%3D1142%26epage%3D1153%26doi%3D10.1016%2Fj.immuni.2013.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Hornung, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauernfeind, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samstad, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kono, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rock, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span> </span><span class="NLM_article-title">Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">856</span><span class="refDoi"> DOI: 10.1038/ni.1631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fni.1631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=18604214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCmurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=847-856&author=V.+Hornungauthor=F.+Bauernfeindauthor=A.+Halleauthor=E.+O.+Samstadauthor=H.+Konoauthor=K.+L.+Rockauthor=K.+A.+Fitzgeraldauthor=E.+Latz&title=Silica+crystals+and+aluminum+salts+activate+the+NALP3+inflammasome+through+phagosomal+destabilization&doi=10.1038%2Fni.1631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization</span></div><div class="casAuthors">Hornung, Veit; Bauernfeind, Franz; Halle, Annett; Samstad, Eivind O.; Kono, Hajime; Rock, Kenneth L.; Fitzgerald, Katherine A.; Latz, Eicke</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">847-856</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhalation of silica crystals causes inflammation in the alveolar space.  Prolonged exposure to silica can lead to the development of silicosis, an irreversible, fibrotic pulmonary disease.  The mechanisms by which silica and other crystals activate immune cells are not well understood.  Here we demonstrate that silica and aluminum salt crystals activated inflammasomes formed by the cytoplasmic receptor NALP3.  NALP3 activation required phagocytosis of crystals, and this uptake subsequently led to lysosomal damage and rupture. 'Sterile' lysosomal damage (without crystals) also induced NALP3 activation, and inhibition of either phagosomal acidification or cathepsin B activity impaired NALP3 activation.  Our results indicate that the NALP3 inflammasome senses lysosomal damage as an endogenous 'danger' signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp4tZdMdqXM7Vg90H21EOLACvtfcHk0lgRiObjf5DjPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCmurs%253D&md5=af9db69a6d9d8aed2f8119e6f9c22f49</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fni.1631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1631%26sid%3Dliteratum%253Aachs%26aulast%3DHornung%26aufirst%3DV.%26aulast%3DBauernfeind%26aufirst%3DF.%26aulast%3DHalle%26aufirst%3DA.%26aulast%3DSamstad%26aufirst%3DE.%2BO.%26aulast%3DKono%26aufirst%3DH.%26aulast%3DRock%26aufirst%3DK.%2BL.%26aulast%3DFitzgerald%26aufirst%3DK.%2BA.%26aulast%3DLatz%26aufirst%3DE.%26atitle%3DSilica%2520crystals%2520and%2520aluminum%2520salts%2520activate%2520the%2520NALP3%2520inflammasome%2520through%2520phagosomal%2520destabilization%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D847%26epage%3D856%26doi%3D10.1038%2Fni.1631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Zhou, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yazdi, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, J.</span><span> </span><span class="NLM_article-title">A role for mitochondria in NLRP3 inflammasome activation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">469</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span><span class="refDoi"> DOI: 10.1038/nature09663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnature09663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=21124315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2nsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=469&publication_year=2011&pages=221-225&author=R.+Zhouauthor=A.+S.+Yazdiauthor=P.+Menuauthor=J.+Tschopp&title=A+role+for+mitochondria+in+NLRP3+inflammasome+activation&doi=10.1038%2Fnature09663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A role for mitochondria in NLRP3 inflammasome activation</span></div><div class="casAuthors">Zhou, Rong-Bin; Yazdi, Amir S.; Menu, Philippe; Tschopp, Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">469</span>
        (<span class="NLM_cas:issue">7329</span>),
    <span class="NLM_cas:pages">221-225</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">An inflammatory response initiated by the NLRP3 inflammasome is triggered by a variety of situations of host 'danger', including infection and metabolic dysregulation.  Previous studies suggested that NLRP3 inflammasome activity is neg. regulated by autophagy and pos. regulated by reactive oxygen species (ROS) derived from an uncharacterized organelle.  Here we show that mitophagy/autophagy blockade leads to the accumulation of damaged, ROS-generating mitochondria, and this in turn activates the NLRP3 inflammasome.  Resting NLRP3 localizes to endoplasmic reticulum structures, whereas on inflammasome activation both NLRP3 and its adaptor ASC redistribute to the perinuclear space where they colocalize with endoplasmic reticulum and mitochondria organelle clusters.  Notably, both ROS generation and inflammasome activation are suppressed when mitochondrial activity is dysregulated by inhibition of the voltage-dependent anion channel.  This indicates that NLRP3 inflammasome senses mitochondrial dysfunction and may explain the frequent assocn. of mitochondrial damage with inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2S_8r04FZELVg90H21EOLACvtfcHk0lgRiObjf5DjPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2nsLrE&md5=f1a13fa2ad8568fbd6c9467121aa1d9d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnature09663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09663%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DYazdi%26aufirst%3DA.%2BS.%26aulast%3DMenu%26aufirst%3DP.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DA%2520role%2520for%2520mitochondria%2520in%2520NLRP3%2520inflammasome%2520activation%26jtitle%3DNature%26date%3D2011%26volume%3D469%26spage%3D221%26epage%3D225%26doi%3D10.1038%2Fnature09663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Py, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vakifahmetoglu-Norberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span> </span><span class="NLM_article-title">Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span><span class="refDoi"> DOI: 10.1016/j.molcel.2012.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.molcel.2012.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=23246432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCku7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=331-338&author=B.+F.+Pyauthor=M.+S.+Kimauthor=H.+Vakifahmetoglu-Norbergauthor=J.+Yuan&title=Deubiquitination+of+NLRP3+by+BRCC3+critically+regulates+inflammasome+activity&doi=10.1016%2Fj.molcel.2012.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Deubiquitination of NLRP3 by BRCC3 Critically Regulates Inflammasome Activity</span></div><div class="casAuthors">Py, Benedicte F.; Kim, Mi-Sung; Vakifahmetoglu-Norberg, Helin; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">331-338</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">NLRP3 is an important pattern recognition receptor involved in mediating inflammasome activation in response to viral and bacterial infections as well as various proinflammatory stimuli assocd. with tissue damage or malfunction.  Upon activation, NLRP3 assembles a multimeric inflammasome complex comprising the adaptor ASC and the effector pro-caspase-1 to mediate the activation of caspase-1.  Although NLRP3 expression is induced by the NF-κB pathway, the posttranscriptional mol. mechanism controlling the activation of NLRP3 remains elusive.  Using both pharmacol. and mol. approaches, we show that the activation of NLRP3 inflammasome is regulated by a deubiquitination mechanism.  We further identify the deubiquitinating enzyme, BRCC3, as a crit. regulator of NLRP3 activity by promoting its deubiquitination and characterizing NLRP3 as a substrate for the cytosolic BRCC3-contg. BRISC complex.  Our results elucidate a regulatory mechanism involving BRCC3-dependent NLRP3 regulation and highlight NLRP3 ubiquitination as a potential therapeutic target for inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4BbAkb645obVg90H21EOLACvtfcHk0lgRiObjf5DjPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCku7nL&md5=b84aeaec7e762a36b39abd55d705b30b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2012.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2012.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DPy%26aufirst%3DB.%2BF.%26aulast%3DKim%26aufirst%3DM.%2BS.%26aulast%3DVakifahmetoglu-Norberg%26aufirst%3DH.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DDeubiquitination%2520of%2520NLRP3%2520by%2520BRCC3%2520critically%2520regulates%2520inflammasome%2520activity%26jtitle%3DMol.%2520Cell%26date%3D2013%26volume%3D49%26spage%3D331%26epage%3D338%26doi%3D10.1016%2Fj.molcel.2012.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Duewell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kono, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rayner, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirois, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vladimer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauernfeind, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abela, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuñez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnurr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espevik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lien, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rock, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornung, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span> </span><span class="NLM_article-title">NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">464</span><span class="NLM_x">, </span> <span class="NLM_fpage">1357</span><span class="NLM_x">–</span> <span class="NLM_lpage">1361</span><span class="refDoi"> DOI: 10.1038/nature08938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnature08938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20428172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltl2mu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=464&publication_year=2010&pages=1357-1361&author=P.+Duewellauthor=H.+Konoauthor=K.+J.+Raynerauthor=C.+M.+Siroisauthor=G.+Vladimerauthor=F.+G.+Bauernfeindauthor=G.+S.+Abelaauthor=L.+Franchiauthor=G.+Nu%C3%B1ezauthor=M.+Schnurrauthor=T.+Espevikauthor=E.+Lienauthor=K.+A.+Fitzgeraldauthor=K.+L.+Rockauthor=K.+J.+Mooreauthor=S.+D.+Wrightauthor=V.+Hornungauthor=E.+Latz&title=NLRP3+inflammasomes+are+required+for+atherogenesis+and+activated+by+cholesterol+crystals&doi=10.1038%2Fnature08938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals</span></div><div class="casAuthors">Duewell, Peter; Kono, Hajime; Rayner, Katey J.; Sirois, Cherilyn M.; Vladimer, Gregory; Bauernfeind, Franz G.; Abela, George S.; Franchi, Luigi; Nunez, Gabriel; Schnurr, Max; Espevik, Terje; Lien, Egil; Fitzgerald, Katherine A.; Rock, Kenneth L.; Moore, Kathryn J.; Wright, Samuel D.; Hornung, Veit; Latz, Eicke</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">464</span>
        (<span class="NLM_cas:issue">7293</span>),
    <span class="NLM_cas:pages">1357-1361</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The inflammatory nature of atherosclerosis is well established but the agent(s) that incite inflammation in the artery wall remain largely unknown.  Germ-free animals are susceptible to atherosclerosis, suggesting that endogenous substances initiate the inflammation.  Mature atherosclerotic lesions contain macroscopic deposits of cholesterol crystals in the necrotic core, but their appearance late in atherogenesis had been thought to disqualify them as primary inflammatory stimuli.  However, using a new microscopic technique, the authors revealed that minute cholesterol crystals are present in early diet-induced atherosclerotic lesions and that their appearance in mice coincides with the first appearance of inflammatory cells.  Other cryst. substances can induce inflammation by stimulating the caspase-1-activating NLRP3 (NALP3 or cryopyrin) inflammasome, which results in cleavage and secretion of interleukin (IL)-1 family cytokines.  Here the authors show that cholesterol crystals activate the NLRP3 inflammasome in phagocytes in vitro in a process that involves phagolysosomal damage.  Similarly, when injected i.p., cholesterol crystals induce acute inflammation, which is impaired in mice deficient in components of the NLRP3 inflammasome, cathepsin B, cathepsin L or IL-1 mols.  Moreover, when mice deficient in low-d. lipoprotein receptor (LDLR) were bone-marrow transplanted with NLRP3-deficient, ASC (also known as PYCARD)-deficient or IL-1α/β-deficient bone marrow and fed on a high-cholesterol diet, they had markedly decreased early atherosclerosis and inflammasome-dependent IL-18 levels.  Minimally modified LDL can lead to cholesterol crystn. concomitant with NLRP3 inflammasome priming and activation in macrophages.  Although there is the possibility that oxidized LDL activates the NLRP3 inflammasome in vivo, the results demonstrate that cryst. cholesterol acts as an endogenous danger signal and its deposition in arteries or elsewhere is an early cause rather than a late consequence of inflammation.  These findings provide new insights into the pathogenesis of atherosclerosis and indicate new potential mol. targets for the therapy of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRFmxeie_MGrVg90H21EOLACvtfcHk0lhV6aok5Q_oXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltl2mu7w%253D&md5=593ac5b735c8d1151ae4f4b7861a3591</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnature08938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08938%26sid%3Dliteratum%253Aachs%26aulast%3DDuewell%26aufirst%3DP.%26aulast%3DKono%26aufirst%3DH.%26aulast%3DRayner%26aufirst%3DK.%2BJ.%26aulast%3DSirois%26aufirst%3DC.%2BM.%26aulast%3DVladimer%26aufirst%3DG.%26aulast%3DBauernfeind%26aufirst%3DF.%2BG.%26aulast%3DAbela%26aufirst%3DG.%2BS.%26aulast%3DFranchi%26aufirst%3DL.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26aulast%3DSchnurr%26aufirst%3DM.%26aulast%3DEspevik%26aufirst%3DT.%26aulast%3DLien%26aufirst%3DE.%26aulast%3DFitzgerald%26aufirst%3DK.%2BA.%26aulast%3DRock%26aufirst%3DK.%2BL.%26aulast%3DMoore%26aufirst%3DK.%2BJ.%26aulast%3DWright%26aufirst%3DS.%2BD.%26aulast%3DHornung%26aufirst%3DV.%26aulast%3DLatz%26aufirst%3DE.%26atitle%3DNLRP3%2520inflammasomes%2520are%2520required%2520for%2520atherogenesis%2520and%2520activated%2520by%2520cholesterol%2520crystals%26jtitle%3DNature%26date%3D2010%26volume%3D464%26spage%3D1357%26epage%3D1361%26doi%3D10.1038%2Fnature08938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Lee, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E. K.</span><span> </span><span class="NLM_article-title">Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.2337/db12-0420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.2337%2Fdb12-0420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=23086037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Grtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=194-204&author=H.+M.+Leeauthor=J.+J.+Kimauthor=H.+J.+Kimauthor=M.+Shongauthor=B.+J.+Kuauthor=E.+K.+Jo&title=Upregulated+NLRP3+inflammasome+activation+in+patients+with+type+2+diabetes&doi=10.2337%2Fdb12-0420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes</span></div><div class="casAuthors">Lee, Hye-Mi; Kim, Jwa-Jin; Kim, Hyun Jin; Shong, Minho; Ku, Bon Jeong; Jo, Eun-Kyeong</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">194-204</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Despite the recent attention focused on the roles of the nucleotide binding and oligomerization domain-like receptor family pyrin domain-contg. 3 (NLRP3) inflammasome in the pathogenesis of type 2 diabetes, little is known about the ex vivo profile of inflammasome activation in type 2 diabetic patients.  In this study, we investigated patterns of NLRP3 inflammasome activation in monocyte-derived macrophages (MDMs) from drug-naive patients with newly diagnosed type 2 diabetes.  Type 2 diabetic subjects had significantly increased mRNA and protein expression of NLRP3, apoptosis-assocd. speck-like protein contg. a CARD (ASC), and proinflammatory cytokines in MDMs cultured with autologous sera compared with healthy controls.  Upregulated interleukin (IL)-1β maturation, IL-18 secretion, and caspase-1 cleavage were obsd. in MDMs from type 2 diabetic patients after stimulation with various danger mols. (ATP, high-mobility group protein B1, free fatty acids, islet amyloid polypeptide, and monosodium uric acid crystals).  Mitochondrial reactive oxygen species and NLRP3 were required for IL-1β synthesis in MDMs.  Finally, 2 mo of therapy with the antidiabetic drug metformin significantly inhibited the maturation of IL-1β in MDMs from patients with type 2 diabetes through AMP-activated protein kinase (AMPK) activation.  Taken together, these data suggest that NLRP3 inflammasome activation is elevated in myeloid cells from type 2 diabetic patients and that antidiabetic treatment with metformin contributes to modulation of inflammasome activation in type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWj-f4MOH8DLVg90H21EOLACvtfcHk0lhV6aok5Q_oXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Grtg%253D%253D&md5=01921ee3ed7f038c650e8d339bd2e54f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2337%2Fdb12-0420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb12-0420%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BM.%26aulast%3DKim%26aufirst%3DJ.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DShong%26aufirst%3DM.%26aulast%3DKu%26aufirst%3DB.%2BJ.%26aulast%3DJo%26aufirst%3DE.%2BK.%26atitle%3DUpregulated%2520NLRP3%2520inflammasome%2520activation%2520in%2520patients%2520with%2520type%25202%2520diabetes%26jtitle%3DDiabetes%26date%3D2013%26volume%3D62%26spage%3D194%26epage%3D204%26doi%3D10.2337%2Fdb12-0420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Heneka, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kummer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delekate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira-Saecker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griep, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzeng, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelpi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golenbock, D. T.</span><span> </span><span class="NLM_article-title">NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">493</span><span class="NLM_x">, </span> <span class="NLM_fpage">674</span><span class="NLM_x">–</span> <span class="NLM_lpage">678</span><span class="refDoi"> DOI: 10.1038/nature11729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnature11729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=23254930" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=493&publication_year=2012&pages=674-678&author=M.+T.+Henekaauthor=M.+P.+Kummerauthor=A.+Stutzauthor=A.+Delekateauthor=S.+Schwartzauthor=A.+Vieira-Saeckerauthor=A.+Griepauthor=D.+Axtauthor=A.+Remusauthor=T.+C.+Tzengauthor=E.+Gelpiauthor=A.+Halleauthor=M.+Korteauthor=E.+Latzauthor=D.+T.+Golenbock&title=NLRP3+is+activated+in+Alzheimer%E2%80%99s+disease+and+contributes+to+pathology+in+APP%2FPS1+mice&doi=10.1038%2Fnature11729"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature11729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11729%26sid%3Dliteratum%253Aachs%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26aulast%3DKummer%26aufirst%3DM.%2BP.%26aulast%3DStutz%26aufirst%3DA.%26aulast%3DDelekate%26aufirst%3DA.%26aulast%3DSchwartz%26aufirst%3DS.%26aulast%3DVieira-Saecker%26aufirst%3DA.%26aulast%3DGriep%26aufirst%3DA.%26aulast%3DAxt%26aufirst%3DD.%26aulast%3DRemus%26aufirst%3DA.%26aulast%3DTzeng%26aufirst%3DT.%2BC.%26aulast%3DGelpi%26aufirst%3DE.%26aulast%3DHalle%26aufirst%3DA.%26aulast%3DKorte%26aufirst%3DM.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DGolenbock%26aufirst%3DD.%2BT.%26atitle%3DNLRP3%2520is%2520activated%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520contributes%2520to%2520pathology%2520in%2520APP%252FPS1%2520mice%26jtitle%3DNature%26date%3D2012%26volume%3D493%26spage%3D674%26epage%3D678%26doi%3D10.1038%2Fnature11729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Masters, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aksentijevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastner, D. L.</span><span> </span><span class="NLM_article-title">Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span><span class="refDoi"> DOI: 10.1146/annurev.immunol.25.022106.141627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1146%2Fannurev.immunol.25.022106.141627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=19302049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFSlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=621-668&author=S.+L.+Mastersauthor=A.+Simonauthor=I.+Aksentijevichauthor=D.+L.+Kastner&title=Horror+autoinflammaticus%3A+the+molecular+pathophysiology+of+autoinflammatory+disease&doi=10.1146%2Fannurev.immunol.25.022106.141627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Horror Autoinflammaticus: the molecular pathophysiology of autoinflammatory disease</span></div><div class="casAuthors">Masters, Seth L.; Simon, Anna; Aksentijevich, Ivona; Kastner, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">621-668</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The autoinflammatory diseases are characterized by seemingly unprovoked episodes of inflammation, without high-titer autoantibodies or antigen-specific T cells.  The concept was proposed ten years ago with the identification of the genes underlying hereditary periodic fever syndromes.  This nosol. has taken root because of the dramatic advances in our knowledge of the genetic basis of both mendelian and complex autoinflammatory diseases, and with the recognition that these illnesses derive from genetic variants of the innate immune system.  Herein we propose an updated classification scheme based on the mol. insights garnered over the past decade, supplanting a clin. classification that has served well but is opaque to the genetic, immunol., and therapeutic interrelationships now before us.  We define six categories of autoinflammatory disease: IL-1β activation disorders (inflammasomopathies), NF-κB activation syndromes, protein misfolding disorders, complement regulatory diseases, disturbances in cytokine signaling, and macrophage activation syndromes.  A system based on mol. pathophysiol. will bring greater clarity to our discourse while catalyzing new hypotheses both at the bench and at the beside.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodovOVe3sfuLVg90H21EOLACvtfcHk0lhV6aok5Q_oXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFSlt7w%253D&md5=9d5c2608de4e9c56630bc3197e5cf019</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.25.022106.141627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.25.022106.141627%26sid%3Dliteratum%253Aachs%26aulast%3DMasters%26aufirst%3DS.%2BL.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3DAksentijevich%26aufirst%3DI.%26aulast%3DKastner%26aufirst%3DD.%2BL.%26atitle%3DHorror%2520autoinflammaticus%253A%2520the%2520molecular%2520pathophysiology%2520of%2520autoinflammatory%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D27%26spage%3D621%26epage%3D668%26doi%3D10.1146%2Fannurev.immunol.25.022106.141627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Mitroulis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skendros, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritis, K.</span><span> </span><span class="NLM_article-title">Targeting IL-1β in disease; the expanding role of NLRP3 inflammasome</span> <span class="citation_source-journal">Eur. J. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span><span class="refDoi"> DOI: 10.1016/j.ejim.2010.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.ejim.2010.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20493414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVemt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=157-163&author=I.+Mitroulisauthor=P.+Skendrosauthor=K.+Ritis&title=Targeting+IL-1%CE%B2+in+disease%3B+the+expanding+role+of+NLRP3+inflammasome&doi=10.1016%2Fj.ejim.2010.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting IL-1β in disease; the expanding role of NLRP3 inflammasome</span></div><div class="casAuthors">Mitroulis, Ioannis; Skendros, Panagiotis; Ritis, Konstantinos</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Internal Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-163</span>CODEN:
                <span class="NLM_cas:coden">EJIMEJ</span>;
        ISSN:<span class="NLM_cas:issn">0953-6205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  NLRP3 inflammasome activation and IL-1β secretion have recently emerged as a central mechanism in the pathogenesis of disease.  Genetically defined syndromes like cryopyrin-assocd. periodic syndromes (CAPS, cryopyrinopathies) and familial Mediterranean fever (FMF) or diseases assocd. with NLRP3 activation by danger signals like gout, pseudogout, Alzheimer's disease or type 2 diabetes are included in this group of diseases.  The contribution of anakinra, a recombinant, nonglycosylated human IL-1 receptor antagonist, in both the identification and treatment of such syndromes was considerable.  Recently, rilonacept, a long-acting IL-1 receptor fusion protein, and canakinumab, a fully humanized anti-IL-1β monoclonal antibody, have been developed, with the intention to further extent IL-1β inhibition treatment strategies to a broader spectrum of disorders beyond the characterized autoinflammatory syndromes, offering a more favorable administration profile.  On the other hand, the developed caspase-1 inhibitors, even though effective in exptl. models, were not proven efficient in the treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyqt3vJqN3YLVg90H21EOLACvtfcHk0lgXRJ3_bHVESw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVemt78%253D&md5=17e671744de78aa115234f4e7b11ef16</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejim.2010.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejim.2010.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DMitroulis%26aufirst%3DI.%26aulast%3DSkendros%26aufirst%3DP.%26aulast%3DRitis%26aufirst%3DK.%26atitle%3DTargeting%2520IL-1%25CE%25B2%2520in%2520disease%253B%2520the%2520expanding%2520role%2520of%2520NLRP3%2520inflammasome%26jtitle%3DEur.%2520J.%2520Intern.%2520Med.%26date%3D2010%26volume%3D21%26spage%3D157%26epage%3D163%26doi%3D10.1016%2Fj.ejim.2010.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Dubois, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rissmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, A. F.</span><span> </span><span class="NLM_article-title">Rilonacept and canakinumab</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">639</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span><span class="refDoi"> DOI: 10.1111/j.1365-2125.2011.03958.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1111%2Fj.1365-2125.2011.03958.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=21375570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVSktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=639-641&author=E.+A.+Duboisauthor=R.+Rissmannauthor=A.+F.+Cohen&title=Rilonacept+and+canakinumab&doi=10.1111%2Fj.1365-2125.2011.03958.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">New drug mechanisms</span></div><div class="casAuthors">Dubois, Eline A.; Rissmann, Robert; Cohen, Adam F.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">639-641</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  In this series we draw attention to medicines that have entered the European market with an entirely new mechanism of action.  Publication is not to be confused with endorsement of use in clin. practice.  Copyright to the images belongs to Leiden University, but use of the images (also available at http://coo.lumc.nl/trc) is free.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVS8lZQg8-RLVg90H21EOLACvtfcHk0lgXRJ3_bHVESw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVSktrc%253D&md5=73bb0a428bbb5dac7fbddd83e09b4b4e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2011.03958.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2011.03958.x%26sid%3Dliteratum%253Aachs%26aulast%3DDubois%26aufirst%3DE.%2BA.%26aulast%3DRissmann%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DA.%2BF.%26atitle%3DRilonacept%2520and%2520canakinumab%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D71%26spage%3D639%26epage%3D641%26doi%3D10.1111%2Fj.1365-2125.2011.03958.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Kotz, J.</span><span> </span><span class="NLM_article-title">The gout pipeline crystallizes</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span><span class="refDoi"> DOI: 10.1038/nrd3748</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnrd3748" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=425-426&author=J.+Kotz&title=The+gout+pipeline+crystallizes&doi=10.1038%2Fnrd3748"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnrd3748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3748%26sid%3Dliteratum%253Aachs%26aulast%3DKotz%26aufirst%3DJ.%26atitle%3DThe%2520gout%2520pipeline%2520crystallizes%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D425%26epage%3D426%26doi%3D10.1038%2Fnrd3748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Galea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogungbenro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulme, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenhalgh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aarons, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grainger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothwell, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, P.</span><span> </span><span class="NLM_article-title">Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span><span class="refDoi"> DOI: 10.1038/jcbfm.2010.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fjcbfm.2010.103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20628399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=439-447&author=J.+Galeaauthor=K.+Ogungbenroauthor=S.+Hulmeauthor=A.+Greenhalghauthor=L.+Aaronsauthor=S.+Scarthauthor=P.+Hutchinsonauthor=S.+Graingerauthor=A.+Kingauthor=S.+J.+Hopkinsauthor=N.+Rothwellauthor=P.+Tyrrell&title=Intravenous+anakinra+can+achieve+experimentally+effective+concentrations+in+the+central+nervous+system+within+a+therapeutic+time+window%3A+results+of+a+dose-ranging+study&doi=10.1038%2Fjcbfm.2010.103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study</span></div><div class="casAuthors">Galea, James; Ogungbenro, Kayode; Hulme, Sharon; Greenhalgh, Andrew; Aarons, Leon; Scarth, Sylvia; Hutchinson, Peter; Grainger, Samantha; King, Andrew; Hopkins, Stephen J.; Rothwell, Nancy; Tyrrell, Pippa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">439-447</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The naturally occurring antagonist of interleukin-1, IL-1RA, is highly neuroprotective exptl., shows few adverse effects, and inhibits the systemic acute phase response to stroke.  A single regime pilot study showed slow penetration into cerebrospinal fluid (CSF) at exptl. therapeutic concns.  Twenty-five patients with subarachnoid hemorrhage (SAH) and external ventricular drains were sequentially allocated to five administration regimes, using i.v. bolus doses of 100 to 500 mg and 4 h i.v. infusions of IL-1RA ranging from 1 to 10 mg per kg per h.  Choice of regimes and timing of plasma and CSF sampling was informed by pharmacometric anal. of pilot study data.  Data were analyzed using nonlinear mixed effects modeling.  Plasma and CSF concns. of IL-1RA in all regimes were within the predicted intervals.  A 500-mg bolus followed by an i.v. infusion of IL-1RA at 10 mg per kg per h achieved exptl. therapeutic CSF concns. of IL-1RA within 45 min.  Exptl., neuroprotective CSF concns. in patients with SAH can be safely achieved within a therapeutic time window.  Pharmacokinetic anal. suggests that IL-1RA transport across the blood-CSF barrier in SAH is passive.  Identification of the practicality of this delivery regime allows further studies of efficacy of IL-1RA in acute cerebrovascular disease.  Journal of Cerebral Blood Flow & Metab. (2011) 31, 439-447; doi:10.1038/jcbfm.2010.103; published online 14 July 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBuGm9TEo7FrVg90H21EOLACvtfcHk0lgXRJ3_bHVESw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOmt7g%253D&md5=009f226842530db3e2425f432ac34bf6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2010.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2010.103%26sid%3Dliteratum%253Aachs%26aulast%3DGalea%26aufirst%3DJ.%26aulast%3DOgungbenro%26aufirst%3DK.%26aulast%3DHulme%26aufirst%3DS.%26aulast%3DGreenhalgh%26aufirst%3DA.%26aulast%3DAarons%26aufirst%3DL.%26aulast%3DScarth%26aufirst%3DS.%26aulast%3DHutchinson%26aufirst%3DP.%26aulast%3DGrainger%26aufirst%3DS.%26aulast%3DKing%26aufirst%3DA.%26aulast%3DHopkins%26aufirst%3DS.%2BJ.%26aulast%3DRothwell%26aufirst%3DN.%26aulast%3DTyrrell%26aufirst%3DP.%26atitle%3DIntravenous%2520anakinra%2520can%2520achieve%2520experimentally%2520effective%2520concentrations%2520in%2520the%2520central%2520nervous%2520system%2520within%2520a%2520therapeutic%2520time%2520window%253A%2520results%2520of%2520a%2520dose-ranging%2520study%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2011%26volume%3D31%26spage%3D439%26epage%3D447%26doi%3D10.1038%2Fjcbfm.2010.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">So, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Smedt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revaz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, J.</span><span> </span><span class="NLM_article-title">A pilot study of IL-1 inhibition by anakinra in acute gout</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">R28</span><span class="refDoi"> DOI: 10.1186/ar2143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1186%2Far2143" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=R28&author=A.+Soauthor=T.+De+Smedtauthor=S.+Revazauthor=J.+Tschopp&title=A+pilot+study+of+IL-1+inhibition+by+anakinra+in+acute+gout&doi=10.1186%2Far2143"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1186%2Far2143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far2143%26sid%3Dliteratum%253Aachs%26aulast%3DSo%26aufirst%3DA.%26aulast%3DDe%2BSmedt%26aufirst%3DT.%26aulast%3DRevaz%26aufirst%3DS.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DA%2520pilot%2520study%2520of%2520IL-1%2520inhibition%2520by%2520anakinra%2520in%2520acute%2520gout%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2007%26volume%3D9%26spage%3DR28%26doi%3D10.1186%2Far2143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Fleishmann, R. M.</span><span> </span><span class="NLM_article-title">Safety of anakinra, a recombinant interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis and comparison to anti-TNF-α agents</span> <span class="citation_source-journal">Clin. Exp. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 27</span><span class="NLM_x">) </span> <span class="NLM_fpage">S35</span><span class="NLM_x">–</span> <span class="NLM_lpage">S41</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=S35-S41&issue=Suppl+27&author=R.+M.+Fleishmann&title=Safety+of+anakinra%2C+a+recombinant+interleukin-1+receptor+antagonist+%28r-metHuIL-1ra%29%2C+in+patients+with+rheumatoid+arthritis+and+comparison+to+anti-TNF-%CE%B1+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFleishmann%26aufirst%3DR.%2BM.%26atitle%3DSafety%2520of%2520anakinra%252C%2520a%2520recombinant%2520interleukin-1%2520receptor%2520antagonist%2520%2528r-metHuIL-1ra%2529%252C%2520in%2520patients%2520with%2520rheumatoid%2520arthritis%2520and%2520comparison%2520to%2520anti-TNF-%25CE%25B1%2520agents%26jtitle%3DClin.%2520Exp.%2520Rheumatol.%26date%3D2002%26volume%3D20%26issue%3DSuppl%252027%26spage%3DS35%26epage%3DS41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Hoffman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Throne, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amar, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kivitz, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belomestnov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yancopoulos, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellis, S. J.</span><span> </span><span class="NLM_article-title">Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2443</span><span class="NLM_x">–</span> <span class="NLM_lpage">2452</span><span class="refDoi"> DOI: 10.1002/art.23687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1002%2Fart.23687" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=18668535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCjtbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=2443-2452&author=H.+M.+Hoffmanauthor=M.+L.+Throneauthor=N.+J.+Amarauthor=M.+Sebaiauthor=A.+J.+Kivitzauthor=A.+Kavanaughauthor=S.+P.+Weinsteinauthor=P.+Belomestnovauthor=G.+D.+Yancopoulosauthor=N.+Stahlauthor=S.+J.+Mellis&title=Efficacy+and+safety+of+rilonacept+%28interleukin-1+Trap%29+in+patients+with+cryopyrin-associated+periodic+syndromes%3A+results+from+two+sequential+placebo-controlled+studies&doi=10.1002%2Fart.23687"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies</span></div><div class="casAuthors">Hoffman, Hal M.; Throne, Martin L.; Amar, N. J.; Sebai, Mohamed; Kivitz, Alan J.; Kavanaugh, Arthur; Weinstein, Steven P.; Belomestnov, Pavel; Yancopoulos, George D.; Stahl, Neil; Mellis, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2443-2452</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To assess the efficacy and safety of rilonacept (Interleukin-1 [IL-1] Trap), a long-acting and potent inhibitor of IL-1, in patients with cryopyrin-assocd. periodic syndromes (CAPS), including familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS).  Forty-seven adult patients with CAPS, as defined by mutations in the causative NLRP3 (CIAS1) gene and pathognomonic symptoms, were enrolled in 2 consecutive phase III studies.  Study 1 involved a 6-wk randomized double-blind comparison of weekly s.c. injections of rilonacept (160 mg) vs. placebo.  Study 2 consisted of 9 wk of single-blind treatment with rilonacept (part A), followed by a 9-wk, randomized, double-blind, placebo-controlled withdrawal procedure (part B).  Primary efficacy was evaluated using a validated composite key symptom score.  Forty-four patients completed both studies.  In study 1, rilonacept therapy reduced the group mean composite symptom score by 84%, compared with 13% with placebo therapy (primary end point; P < 0.0001 vs. placebo).  Rilonacept also significantly improved all other efficacy end points in study 1 (nos. of multisymptom and single-symptom disease flare days, single-symptom scores, physician's and patient's global assessments of disease activity, limitations in daily activities, and C-reactive protein and serum amyloid A [SAA] levels).  In study 2 part B, rilonacept was superior to placebo for maintaining the improvements seen with rilonacept therapy, as shown by all efficacy parameters (primary end point; P < 0.0001 vs. placebo).  Rilonacept was generally well tolerated; the most common adverse events were injection site reactions.  Treatment with weekly rilonacept provided marked and lasting improvement in the clin. signs and symptoms of CAPS, and normalized the levels of SAA from those assocd. with risk of developing amyloidosis.  Rilonacept exhibited a generally favorable safety and tolerability profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB7wpZXXBmmbVg90H21EOLACvtfcHk0ljX0guUyV_Srg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCjtbfL&md5=7fe18f2d56d72bc94656d1c524951d1c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fart.23687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.23687%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DH.%2BM.%26aulast%3DThrone%26aufirst%3DM.%2BL.%26aulast%3DAmar%26aufirst%3DN.%2BJ.%26aulast%3DSebai%26aufirst%3DM.%26aulast%3DKivitz%26aufirst%3DA.%2BJ.%26aulast%3DKavanaugh%26aufirst%3DA.%26aulast%3DWeinstein%26aufirst%3DS.%2BP.%26aulast%3DBelomestnov%26aufirst%3DP.%26aulast%3DYancopoulos%26aufirst%3DG.%2BD.%26aulast%3DStahl%26aufirst%3DN.%26aulast%3DMellis%26aufirst%3DS.%2BJ.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520rilonacept%2520%2528interleukin-1%2520Trap%2529%2520in%2520patients%2520with%2520cryopyrin-associated%2520periodic%2520syndromes%253A%2520results%2520from%2520two%2520sequential%2520placebo-controlled%2520studies%26jtitle%3DArthritis%2520Rheum.%26date%3D2008%26volume%3D58%26spage%3D2443%26epage%3D2452%26doi%3D10.1002%2Fart.23687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Fox, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaprakash, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCully, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldbach-Mansky, R.</span><span> </span><span class="NLM_article-title">The serum and cerebrospinal fluid pharmacokinetics of anakinra after intravenous administration to non-human primates</span> <span class="citation_source-journal">J. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">223</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span><span class="refDoi"> DOI: 10.1016/j.jneuroim.2010.03.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.jneuroim.2010.03.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20421138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVanu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2010&pages=138-140&author=E.+Foxauthor=N.+Jayaprakashauthor=T.+H.+Phamauthor=A.+Rowleyauthor=C.+L.+McCullyauthor=F.+Pucinoauthor=R.+Goldbach-Mansky&title=The+serum+and+cerebrospinal+fluid+pharmacokinetics+of+anakinra+after+intravenous+administration+to+non-human+primates&doi=10.1016%2Fj.jneuroim.2010.03.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The serum and cerebrospinal fluid pharmacokinetics of anakinra after intravenous administration to non-human primates</span></div><div class="casAuthors">Fox, Elizabeth; Jayaprakash, Nalini; Pham, Tuyet-Hang; Rowley, Ayana; McCully, Cynthia L.; Pucino, Frank; Goldbach-Mansky, Raphaela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">138-140</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Anakinra improves the central nervous system manifestations of neonatal-onset multisystem inflammatory disease, which is mediated by IL-1ss oversecretion.  The cerebrospinal fluid (CSF) penetration of the IL-1 receptor antagonist anakinra was studied in rhesus monkeys after i.v. doses of 3 and 10 mg/kg.  Drug exposure (area under concn.-time curve) in CSF was 0.28% of that in serum.  The av. CSF concn. at 3 mg/kg was 1.8 ng/mL, which is 30-fold higher than endogenous CSF levels of IL-1Ra.  The CSF penetration was not dose-dependent, indicating that the CSF penetration was not satd. in the 3 to 10 mg/kg dose range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF26EOHDXCGrVg90H21EOLACvtfcHk0lgNnr1bj_jm-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVanu7w%253D&md5=f05ea8e7c5c53b8a77d1fbce9cc27e2a</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2010.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2010.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DE.%26aulast%3DJayaprakash%26aufirst%3DN.%26aulast%3DPham%26aufirst%3DT.%2BH.%26aulast%3DRowley%26aufirst%3DA.%26aulast%3DMcCully%26aufirst%3DC.%2BL.%26aulast%3DPucino%26aufirst%3DF.%26aulast%3DGoldbach-Mansky%26aufirst%3DR.%26atitle%3DThe%2520serum%2520and%2520cerebrospinal%2520fluid%2520pharmacokinetics%2520of%2520anakinra%2520after%2520intravenous%2520administration%2520to%2520non-human%2520primates%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2010%26volume%3D223%26spage%3D138%26epage%3D140%26doi%3D10.1016%2Fj.jneuroim.2010.03.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Fautrel, B.</span><span> </span><span class="NLM_article-title">Economic benefits of optimizing anchor therapy for rheumatoid arthritis</span> <span class="citation_source-journal">Rheumatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">iv21</span><span class="NLM_x">–</span> <span class="NLM_lpage">iv26</span><span class="refDoi"> DOI: 10.1093/rheumatology/kes088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1093%2Frheumatology%2Fkes088" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=iv21-iv26&issue=Suppl+4&author=B.+Fautrel&title=Economic+benefits+of+optimizing+anchor+therapy+for+rheumatoid+arthritis&doi=10.1093%2Frheumatology%2Fkes088"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fkes088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fkes088%26sid%3Dliteratum%253Aachs%26aulast%3DFautrel%26aufirst%3DB.%26atitle%3DEconomic%2520benefits%2520of%2520optimizing%2520anchor%2520therapy%2520for%2520rheumatoid%2520arthritis%26jtitle%3DRheumatology%26date%3D2012%26volume%3D51%26issue%3DSuppl%25204%26spage%3Div21%26epage%3Div26%26doi%3D10.1093%2Frheumatology%2Fkes088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Brydges, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broderick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeough, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, H. M.</span><span> </span><span class="NLM_article-title">Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">4695</span><span class="NLM_x">–</span> <span class="NLM_lpage">4705</span><span class="refDoi"> DOI: 10.1172/JCI71543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1172%2FJCI71543" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=4695-4705&author=S.+D.+Brydgesauthor=L.+Broderickauthor=M.+D.+McGeoughauthor=C.+A.+Penaauthor=J.+L.+Muellerauthor=H.+M.+Hoffman&title=Divergence+of+IL-1%2C+IL-18%2C+and+cell+death+in+NLRP3+inflammasomopathies&doi=10.1172%2FJCI71543"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1172%2FJCI71543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI71543%26sid%3Dliteratum%253Aachs%26aulast%3DBrydges%26aufirst%3DS.%2BD.%26aulast%3DBroderick%26aufirst%3DL.%26aulast%3DMcGeough%26aufirst%3DM.%2BD.%26aulast%3DPena%26aufirst%3DC.%2BA.%26aulast%3DMueller%26aufirst%3DJ.%2BL.%26aulast%3DHoffman%26aufirst%3DH.%2BM.%26atitle%3DDivergence%2520of%2520IL-1%252C%2520IL-18%252C%2520and%2520cell%2520death%2520in%2520NLRP3%2520inflammasomopathies%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D4695%26epage%3D4705%26doi%3D10.1172%2FJCI71543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Chuang, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J. Y.</span><span> </span><span class="NLM_article-title">Natural compounds and aging: between autophagy and inflammasome</span> <span class="citation_source-journal">BioMed Res. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2014</span><span class="NLM_x">, </span> <span class="NLM_fpage">297293</span><span class="refDoi"> DOI: 10.1155/2014/297293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1155%2F2014%2F297293" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=297293&author=S.+Y.+Chuangauthor=C.+H.+Linauthor=J.+Y.+Fang&title=Natural+compounds+and+aging%3A+between+autophagy+and+inflammasome&doi=10.1155%2F2014%2F297293"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1155%2F2014%2F297293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F297293%26sid%3Dliteratum%253Aachs%26aulast%3DChuang%26aufirst%3DS.%2BY.%26aulast%3DLin%26aufirst%3DC.%2BH.%26aulast%3DFang%26aufirst%3DJ.%2BY.%26atitle%3DNatural%2520compounds%2520and%2520aging%253A%2520between%2520autophagy%2520and%2520inflammasome%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2014%26volume%3D2014%26spage%3D297293%26doi%3D10.1155%2F2014%2F297293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Riddle, M. C.</span><span> </span><span class="NLM_article-title">Editorial: sulfonylureas differ in effects on ischemic preconditioning--is it time to retire glyburide?</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span><span class="refDoi"> DOI: 10.1210/jc.2002-021971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1210%2Fjc.2002-021971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=12574174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252FmtlKrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2003&pages=528-530&author=M.+C.+Riddle&title=Editorial%3A+sulfonylureas+differ+in+effects+on+ischemic+preconditioning%2D%2Dis+it+time+to+retire+glyburide%3F&doi=10.1210%2Fjc.2002-021971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Editorial: sulfonylureas differ in effects on ischemic preconditioning--is it time to retire glyburide?</span></div><div class="casAuthors">Riddle Matthew C</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical endocrinology and metabolism</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">528-30</span>
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAe95u6G0R1E2yPDyEFiigfW6udTcc2eYQ-nOOvvkSI7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252FmtlKrsQ%253D%253D&md5=f24cbcb4e560bd943758819b115dce92</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1210%2Fjc.2002-021971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2002-021971%26sid%3Dliteratum%253Aachs%26aulast%3DRiddle%26aufirst%3DM.%2BC.%26atitle%3DEditorial%253A%2520sulfonylureas%2520differ%2520in%2520effects%2520on%2520ischemic%2520preconditioning--is%2520it%2520time%2520to%2520retire%2520glyburide%253F%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2003%26volume%3D88%26spage%3D528%26epage%3D530%26doi%3D10.1210%2Fjc.2002-021971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Kinard, T. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satin, L. S.</span><span> </span><span class="NLM_article-title">An ATP-sensitive Cl<sup>–</sup> channel current that is activated by cell swelling, cAMP, and glyburide in insulin-secreting cells</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1461</span><span class="NLM_x">–</span> <span class="NLM_lpage">1466</span><span class="refDoi"> DOI: 10.2337/diab.44.12.1461</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.2337%2Fdiab.44.12.1461" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1995&pages=1461-1466&author=T.+A.+S.+Kinardauthor=L.+S.+Satin&title=An+ATP-sensitive+Cl%E2%80%93+channel+current+that+is+activated+by+cell+swelling%2C+cAMP%2C+and+glyburide+in+insulin-secreting+cells&doi=10.2337%2Fdiab.44.12.1461"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2337%2Fdiab.44.12.1461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiab.44.12.1461%26sid%3Dliteratum%253Aachs%26aulast%3DKinard%26aufirst%3DT.%2BA.%2BS.%26aulast%3DSatin%26aufirst%3DL.%2BS.%26atitle%3DAn%2520ATP-sensitive%2520Cl%25E2%2580%2593%2520channel%2520current%2520that%2520is%2520activated%2520by%2520cell%2520swelling%252C%2520cAMP%252C%2520and%2520glyburide%2520in%2520insulin-secreting%2520cells%26jtitle%3DDiabetes%26date%3D1995%26volume%3D44%26spage%3D1461%26epage%3D1466%26doi%3D10.2337%2Fdiab.44.12.1461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Ashcroft, F. M.</span><span> </span><span class="NLM_article-title">ATP-sensitive potassium channelopathies: focus on insulin secretion</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">2047</span><span class="NLM_x">–</span> <span class="NLM_lpage">2058</span><span class="refDoi"> DOI: 10.1172/JCI25495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1172%2FJCI25495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=16075046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntFCmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=2047-2058&author=F.+M.+Ashcroft&title=ATP-sensitive+potassium+channelopathies%3A+focus+on+insulin+secretion&doi=10.1172%2FJCI25495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">ATP-sensitive potassium channelopathies: Focus on insulin secretion</span></div><div class="casAuthors">Ashcroft, Frances M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2047-2058</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  ATP-sensitive potassium (KATP) channels, so named because they are inhibited by intracellular ATP, play key physiol. roles in many tissues.  In pancreatic β cells, these channels regulate glucose-dependent insulin secretion and serve as the target for sulfonylurea drugs used to treat type 2 diabetes.  This review focuses on insulin secretory disorders, such as congenital hyperinsulinemia and neonatal diabetes, that result from mutations in KATP channel genes.  It also considers the extent to which defective regulation of KATP channel activity contributes to the etiol. of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfwlNV6Q4l6LVg90H21EOLACvtfcHk0ljyjS2ilmvQGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntFCmt7s%253D&md5=6e46d4abf33b4364182d98aace1000ad</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1172%2FJCI25495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI25495%26sid%3Dliteratum%253Aachs%26aulast%3DAshcroft%26aufirst%3DF.%2BM.%26atitle%3DATP-sensitive%2520potassium%2520channelopathies%253A%2520focus%2520on%2520insulin%2520secretion%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26spage%3D2047%26epage%3D2058%26doi%3D10.1172%2FJCI25495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Perregaux, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNiff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laliberte, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawryluk, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peurano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stam, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffths, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombroski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span> </span><span class="NLM_article-title">Identification and characterization of a novel class of interleukin-1 post-translational processing inhibitors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=11561079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFWltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=187-197&author=D.+G.+Perregauxauthor=P.+McNiffauthor=R.+Laliberteauthor=N.+Hawrylukauthor=H.+Peuranoauthor=E.+Stamauthor=J.+Egglerauthor=R.+Griffthsauthor=M.+A.+Dombroskiauthor=C.+A.+Gabel&title=Identification+and+characterization+of+a+novel+class+of+interleukin-1+post-translational+processing+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of a novel class of interleukin-1 post-translational processing inhibitors</span></div><div class="casAuthors">Perregaux, David G.; McNiff, Patricia; Laliberte, Ronald; Hawryluk, Natalie; Peurano, Heather; Stam, Ethan; Eggler, Jim; Griffiths, Richard; Dombroski, Mark A.; Gabel, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">187-197</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Lipopolysaccharide (LPS)-activated monocytes and macrophages produce large quantities of pro-interleukin (IL)-1β but externalize little mature cytokine.  Efficient post-translational processing of the pro-cytokine occurs in vitro when these cells encounter a secretion stimulus such as ATP, cytolytic T cells, or hypotonic stress.  Each of these stimuli promotes rapid conversion of 31-kDa pro-IL-1β to its mature 17-kDa species and release of the 17-kDa cytokine.  In this study, two novel pharmacol. agents, CP-424,174 and CP-412,245, are identified as potent inhibitors of stimulus-coupled IL-1β post-translational processing.  These agents, both diarylsulfonylureas, block formation of mature IL-1β without increasing the amt. of pro-cytokine that is released extracellularly, and they inhibit independently of the secretion stimulus used.  Conditioned medium derived from LPS-activated/ATP-treated human monocytes maintained in the absence and presence of CP-424,174 contained comparable quantities of IL-6, tumor necrosis factor-α (TNFα), and IL-1RA, but 30-fold less IL-1β was generated in the test agent's presence.  As a result of this decrease, monocyte conditioned medium prepd. in the presence of CP-424,174 demonstrated a greatly diminished capacity to promote an IL-1-dependent response (induction of serum amyloid A synthesis by Hep3B cells).  Oral administration of CP-424,174 to mice resulted in inhibition of IL-1 in the absence of an effect on IL-6 and TNFα.  These novel agents, therefore, act as selective cytokine release inhibitors and define a new therapeutic approach for controlling IL-1 prodn. in inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnTnmtD12hMrVg90H21EOLACvtfcHk0ljyjS2ilmvQGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFWltL8%253D&md5=5da5f7fd4689c1dd7dc8e187a8f9d02f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerregaux%26aufirst%3DD.%2BG.%26aulast%3DMcNiff%26aufirst%3DP.%26aulast%3DLaliberte%26aufirst%3DR.%26aulast%3DHawryluk%26aufirst%3DN.%26aulast%3DPeurano%26aufirst%3DH.%26aulast%3DStam%26aufirst%3DE.%26aulast%3DEggler%26aufirst%3DJ.%26aulast%3DGriffths%26aufirst%3DR.%26aulast%3DDombroski%26aufirst%3DM.%2BA.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520novel%2520class%2520of%2520interleukin-1%2520post-translational%2520processing%2520inhibitors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D187%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Hamon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luciani, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becq, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verrier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubartelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimini, G.</span><span> </span><span class="NLM_article-title">Interleukin-1β secretion is impaired by inhibitors of the atp binding cassette transporter, ABC1</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">2911</span><span class="NLM_x">–</span> <span class="NLM_lpage">2915</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1997&pages=2911-2915&author=Y.+Hamonauthor=M.+F.+Lucianiauthor=F.+Becqauthor=B.+Verrierauthor=A.+Rubartelliauthor=G.+Chimini&title=Interleukin-1%CE%B2+secretion+is+impaired+by+inhibitors+of+the+atp+binding+cassette+transporter%2C+ABC1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHamon%26aufirst%3DY.%26aulast%3DLuciani%26aufirst%3DM.%2BF.%26aulast%3DBecq%26aufirst%3DF.%26aulast%3DVerrier%26aufirst%3DB.%26aulast%3DRubartelli%26aufirst%3DA.%26aulast%3DChimini%26aufirst%3DG.%26atitle%3DInterleukin-1%25CE%25B2%2520secretion%2520is%2520impaired%2520by%2520inhibitors%2520of%2520the%2520atp%2520binding%2520cassette%2520transporter%252C%2520ABC1%26jtitle%3DBlood%26date%3D1997%26volume%3D90%26spage%3D2911%26epage%3D2915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Pétrilli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dostert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, J.</span><span> </span><span class="NLM_article-title">Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1583</span><span class="NLM_x">–</span> <span class="NLM_lpage">1589</span><span class="refDoi"> DOI: 10.1038/sj.cdd.4402195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fsj.cdd.4402195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=17599094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptFymurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=1583-1589&author=V.+P%C3%A9trilliauthor=S.+Papinauthor=C.+Dostertauthor=A.+Mayorauthor=F.+Martinonauthor=J.+Tschopp&title=Activation+of+the+NALP3+inflammasome+is+triggered+by+low+intracellular+potassium+concentration&doi=10.1038%2Fsj.cdd.4402195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration</span></div><div class="casAuthors">Petrilli, V.; Papin, S.; Dostert, C.; Mayor, A.; Martinon, F.; Tschopp, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1583-1589</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inflammasomes are Nod-like receptor(NLR)- and caspase-1-contg. cytoplasmic multiprotein complexes, which upon their assembly, process and activate the proinflammatory cytokines interleukin (IL)-1β and IL-18.  The inflammasomes harboring the NLR members NALP1, NALP3 and IPAF have been best characterized.  While the IPAF inflammasome is activated by bacterial flagellin, activation of the NALP3 inflammasome is triggered not only by several microbial components, but also by a plethora of danger-assocd. host mols. such as uric acid.  How NALP3 senses these chem. unrelated activators is not known.  Here, we provide evidence that activation of NALP3, but not of the IPAF inflammasome, is blocked by inhibiting K+ efflux from cells.  Low intracellular K+ is also a requirement for NALP1 inflammasome activation by lethal toxin of Bacillus anthracis.  In vitro, NALP inflammasome assembly and caspase-1 recruitment occurs spontaneously at K+ concns. below 90 mM, but is prevented at higher concns.  Thus, low intracellular K+ may be the least common trigger of NALP-inflammasome activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_dQ8Ub0nztrVg90H21EOLACvtfcHk0ljyjS2ilmvQGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptFymurg%253D&md5=2bfb251f0e7b7d90ebed564cbd63c90f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4402195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4402195%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9trilli%26aufirst%3DV.%26aulast%3DPapin%26aufirst%3DS.%26aulast%3DDostert%26aufirst%3DC.%26aulast%3DMayor%26aufirst%3DA.%26aulast%3DMartinon%26aufirst%3DF.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DActivation%2520of%2520the%2520NALP3%2520inflammasome%2520is%2520triggered%2520by%2520low%2520intracellular%2520potassium%2520concentration%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2007%26volume%3D14%26spage%3D1583%26epage%3D1589%26doi%3D10.1038%2Fsj.cdd.4402195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Coelho, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavriani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixeira, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, P. C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudo-Hayashi, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muscará, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira-Filho, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargaftig, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taveres-de-Lima, W.</span><span> </span><span class="NLM_article-title">Lymphatic-borne IL-1β and the inducible isoform of nitric oxide synthase trigger the bronchial hyporesponsiveness after intestinal ischema/reperfusion in rats</span> <span class="citation_source-journal">Shock</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">694</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span><span class="refDoi"> DOI: 10.1097/shk.0b013e318053621d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1097%2Fshk.0b013e318053621d" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=694-699&author=F.+R.+Coelhoauthor=G.+Cavrianiauthor=A.+L.+Soaresauthor=S.+A.+Teixeiraauthor=P.+C.+L.+Almeidaauthor=L.+S.+Sudo-Hayashiauthor=M.+N.+Muscar%C3%A1author=R.+M.+Oliveira-Filhoauthor=B.+B.+Vargaftigauthor=W.+Taveres-de-Lima&title=Lymphatic-borne+IL-1%CE%B2+and+the+inducible+isoform+of+nitric+oxide+synthase+trigger+the+bronchial+hyporesponsiveness+after+intestinal+ischema%2Freperfusion+in+rats&doi=10.1097%2Fshk.0b013e318053621d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1097%2Fshk.0b013e318053621d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fshk.0b013e318053621d%26sid%3Dliteratum%253Aachs%26aulast%3DCoelho%26aufirst%3DF.%2BR.%26aulast%3DCavriani%26aufirst%3DG.%26aulast%3DSoares%26aufirst%3DA.%2BL.%26aulast%3DTeixeira%26aufirst%3DS.%2BA.%26aulast%3DAlmeida%26aufirst%3DP.%2BC.%2BL.%26aulast%3DSudo-Hayashi%26aufirst%3DL.%2BS.%26aulast%3DMuscar%25C3%25A1%26aufirst%3DM.%2BN.%26aulast%3DOliveira-Filho%26aufirst%3DR.%2BM.%26aulast%3DVargaftig%26aufirst%3DB.%2BB.%26aulast%3DTaveres-de-Lima%26aufirst%3DW.%26atitle%3DLymphatic-borne%2520IL-1%25CE%25B2%2520and%2520the%2520inducible%2520isoform%2520of%2520nitric%2520oxide%2520synthase%2520trigger%2520the%2520bronchial%2520hyporesponsiveness%2520after%2520intestinal%2520ischema%252Freperfusion%2520in%2520rats%26jtitle%3DShock%26date%3D2007%26volume%3D28%26spage%3D694%26epage%3D699%26doi%3D10.1097%2Fshk.0b013e318053621d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Lamkanfi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitari, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misaghi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, V. M.</span><span> </span><span class="NLM_article-title">Glyburide inhibits the Cryopyrin/Nalp3 inflammasome</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">187</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1083/jcb.200903124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1083%2Fjcb.200903124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=19805629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KrsrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2009&pages=61-70&author=M.+Lamkanfiauthor=J.+L.+Muellerauthor=A.+C.+Vitariauthor=S.+Misaghiauthor=A.+Fedorovaauthor=K.+Deshayesauthor=W.+P.+Leeauthor=H.+M.+Hoffmanauthor=V.+M.+Dixit&title=Glyburide+inhibits+the+Cryopyrin%2FNalp3+inflammasome&doi=10.1083%2Fjcb.200903124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Glyburide inhibits the Cryopyrin/Nalp3 inflammasome</span></div><div class="casAuthors">Lamkanfi, Mohamed; Mueller, James L.; Vitari, Alberto C.; Misaghi, Shahram; Fedorova, Anna; Deshayes, Kurt; Lee, Wyne P.; Hoffman, Hal M.; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-70</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Inflammasomes activate caspase-1 for processing and secretion of the cytokines interleukin-1β (IL-1β) and IL-18.  Cryopyrin/NALP3/NLRP3 is an essential component of inflammasomes triggered by microbial ligands, danger-assocd. mol. patterns (DAMPs), and crystals.  Inappropriate Cryopyrin activity has been incriminated in the pathogenesis of gouty arthritis, Alzheimer's, and silicosis.  Therefore, inhibitors of the Nalp3 inflammasome offer considerable therapeutic promise.  In this study, we show that the type 2 diabetes drug glyburide prevented activation of the Cryopyrin inflammasome.  Glyburide's cyclohexylurea group, which binds to ATPase (ATP)-sensitive K+ (KATP) channels for insulin secretion, is dispensable for inflammasome inhibition.  Macrophages lacking KATP subunits or ATP-binding cassette transporters also activate the Cryopyrin inflammasome normally.  Glyburide analogs inhibit ATP- but not hypothermia-induced IL-1β secretion from human monocytes expressing familial cold-assocd. autoinflammatory syndrome-assocd. Cryopyrin mutations, thus suggesting that inhibition occurs upstream of Cryopyrin.  Concurrent with the role of Cryopyrin in endotoxemia, glyburide significantly delays lipopolysaccharide-induced lethality in mice.  Therefore, glyburide is the first identified compd. to prevent Cryopyrin activation and microbial ligand-, DAMP-, and crystal-induced IL-1β secretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo-tgw9HwK8bVg90H21EOLACvtfcHk0lhbqHyX3HgsTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KrsrjK&md5=00481f501e14377c75031ca5af6aad12</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200903124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200903124%26sid%3Dliteratum%253Aachs%26aulast%3DLamkanfi%26aufirst%3DM.%26aulast%3DMueller%26aufirst%3DJ.%2BL.%26aulast%3DVitari%26aufirst%3DA.%2BC.%26aulast%3DMisaghi%26aufirst%3DS.%26aulast%3DFedorova%26aufirst%3DA.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DW.%2BP.%26aulast%3DHoffman%26aufirst%3DH.%2BM.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DGlyburide%2520inhibits%2520the%2520Cryopyrin%252FNalp3%2520inflammasome%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2009%26volume%3D187%26spage%3D61%26epage%3D70%26doi%3D10.1083%2Fjcb.200903124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Coll, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, L. A. J.</span><span> </span><span class="NLM_article-title">The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e29539</span><span class="refDoi"> DOI: 10.1371/journal.pone.0029539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1371%2Fjournal.pone.0029539" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e29539&author=R.+C.+Collauthor=L.+A.+J.+O%E2%80%99Neill&title=The+cytokine+release+inhibitory+drug+CRID3+targets+ASC+oligomerisation+in+the+NLRP3+and+AIM2+inflammasomes&doi=10.1371%2Fjournal.pone.0029539"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0029539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0029539%26sid%3Dliteratum%253Aachs%26aulast%3DColl%26aufirst%3DR.%2BC.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%2BJ.%26atitle%3DThe%2520cytokine%2520release%2520inhibitory%2520drug%2520CRID3%2520targets%2520ASC%2520oligomerisation%2520in%2520the%2520NLRP3%2520and%2520AIM2%2520inflammasomes%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De29539%26doi%3D10.1371%2Fjournal.pone.0029539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Lottaz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beleznay, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickel, M.</span><span> </span><span class="NLM_article-title">Inhibition of ATP-binding cassette transporter downregulates interleukin-1β-mediated autocrine activation of human dermal fibroblasts</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span><span class="refDoi"> DOI: 10.1046/j.0022-202x.2001.01451.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1046%2Fj.0022-202x.2001.01451.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2001&pages=871-876&author=D.+Lottazauthor=Z.+Beleznayauthor=M.+Bickel&title=Inhibition+of+ATP-binding+cassette+transporter+downregulates+interleukin-1%CE%B2-mediated+autocrine+activation+of+human+dermal+fibroblasts&doi=10.1046%2Fj.0022-202x.2001.01451.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1046%2Fj.0022-202x.2001.01451.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0022-202x.2001.01451.x%26sid%3Dliteratum%253Aachs%26aulast%3DLottaz%26aufirst%3DD.%26aulast%3DBeleznay%26aufirst%3DZ.%26aulast%3DBickel%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520ATP-binding%2520cassette%2520transporter%2520downregulates%2520interleukin-1%25CE%25B2-mediated%2520autocrine%2520activation%2520of%2520human%2520dermal%2520fibroblasts%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2001%26volume%3D117%26spage%3D871%26epage%3D876%26doi%3D10.1046%2Fj.0022-202x.2001.01451.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Kuipers, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janczy, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Sluijs, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlaar, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolthuis, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roelofs, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flavell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutterwala, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bresser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leemans, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Poll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieland, C. W.</span><span> </span><span class="NLM_article-title">Ventilator-induced lung injury is mediated by the NLRP3 inflammasome</span> <span class="citation_source-journal">Anesthesiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">1104</span><span class="NLM_x">–</span> <span class="NLM_lpage">1115</span><span class="refDoi"> DOI: 10.1097/ALN.0b013e3182518bc0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1097%2FALN.0b013e3182518bc0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2012&pages=1104-1115&author=M.+T.+Kuipersauthor=H.+Aslamiauthor=J.+R.+Janczyauthor=K.+F.+van+der+Sluijsauthor=A.+P.+Vlaarauthor=E.+K.+Wolthuisauthor=G.+Choiauthor=J.+J.+Roelofsauthor=R.+A.+Flavellauthor=F.+S.+Sutterwalaauthor=P.+Bresserauthor=J.+C.+Leemansauthor=T.+van+der+Pollauthor=M.+J.+Schultzauthor=C.+W.+Wieland&title=Ventilator-induced+lung+injury+is+mediated+by+the+NLRP3+inflammasome&doi=10.1097%2FALN.0b013e3182518bc0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1097%2FALN.0b013e3182518bc0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FALN.0b013e3182518bc0%26sid%3Dliteratum%253Aachs%26aulast%3DKuipers%26aufirst%3DM.%2BT.%26aulast%3DAslami%26aufirst%3DH.%26aulast%3DJanczy%26aufirst%3DJ.%2BR.%26aulast%3Dvan%2Bder%2BSluijs%26aufirst%3DK.%2BF.%26aulast%3DVlaar%26aufirst%3DA.%2BP.%26aulast%3DWolthuis%26aufirst%3DE.%2BK.%26aulast%3DChoi%26aufirst%3DG.%26aulast%3DRoelofs%26aufirst%3DJ.%2BJ.%26aulast%3DFlavell%26aufirst%3DR.%2BA.%26aulast%3DSutterwala%26aufirst%3DF.%2BS.%26aulast%3DBresser%26aufirst%3DP.%26aulast%3DLeemans%26aufirst%3DJ.%2BC.%26aulast%3Dvan%2Bder%2BPoll%26aufirst%3DT.%26aulast%3DSchultz%26aufirst%3DM.%2BJ.%26aulast%3DWieland%26aufirst%3DC.%2BW.%26atitle%3DVentilator-induced%2520lung%2520injury%2520is%2520mediated%2520by%2520the%2520NLRP3%2520inflammasome%26jtitle%3DAnesthesiology%26date%3D2012%26volume%3D116%26spage%3D1104%26epage%3D1115%26doi%3D10.1097%2FALN.0b013e3182518bc0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Kerur, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarallo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastos-Carvalho, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschning, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelfand, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambati, J.</span><span> </span><span class="NLM_article-title">TLR-independent and P2X7-dependent signaling mediate Alu RNA-induced NLRP3 inflammasome activation in geographic atrophy</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7395</span><span class="NLM_x">–</span> <span class="NLM_lpage">7401</span><span class="refDoi"> DOI: 10.1167/iovs.13-12500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1167%2Fiovs.13-12500" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=7395-7401&author=N.+Kerurauthor=Y.+Hiranoauthor=V.+Taralloauthor=B.+J.+Fowlerauthor=A.+Bastos-Carvalhoauthor=T.+Yasumaauthor=R.+Yasumaauthor=Y.+Kimauthor=D.+R.+Hintonauthor=C.+J.+Kirschningauthor=B.+D.+Gelfandauthor=J.+Ambati&title=TLR-independent+and+P2X7-dependent+signaling+mediate+Alu+RNA-induced+NLRP3+inflammasome+activation+in+geographic+atrophy&doi=10.1167%2Fiovs.13-12500"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1167%2Fiovs.13-12500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.13-12500%26sid%3Dliteratum%253Aachs%26aulast%3DKerur%26aufirst%3DN.%26aulast%3DHirano%26aufirst%3DY.%26aulast%3DTarallo%26aufirst%3DV.%26aulast%3DFowler%26aufirst%3DB.%2BJ.%26aulast%3DBastos-Carvalho%26aufirst%3DA.%26aulast%3DYasuma%26aufirst%3DT.%26aulast%3DYasuma%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DHinton%26aufirst%3DD.%2BR.%26aulast%3DKirschning%26aufirst%3DC.%2BJ.%26aulast%3DGelfand%26aufirst%3DB.%2BD.%26aulast%3DAmbati%26aufirst%3DJ.%26atitle%3DTLR-independent%2520and%2520P2X7-dependent%2520signaling%2520mediate%2520Alu%2520RNA-induced%2520NLRP3%2520inflammasome%2520activation%2520in%2520geographic%2520atrophy%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2013%26volume%3D54%26spage%3D7395%26epage%3D7401%26doi%3D10.1167%2Fiovs.13-12500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Masters, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanian, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hull, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tannahill, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshihara, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullooly, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mielke, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coll, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, K. H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mok, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newsholme, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuñez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yodoi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavelle, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Neill, L. A. J.</span><span> </span><span class="NLM_article-title">Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span><span class="refDoi"> DOI: 10.1038/ni.1935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fni.1935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20835230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFCnsbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=897-904&author=S.+L.+Mastersauthor=A.+Dunneauthor=S.+L.+Subramanianauthor=R.+L.+Hullauthor=G.+M.+Tannahillauthor=F.+A.+Sharpauthor=C.+Beckerauthor=L.+Franchiauthor=E.+Yoshiharaauthor=Z.+Chenauthor=N.+Mulloolyauthor=L.+A.+Mielkeauthor=J.+Harrisauthor=R.+C.+Collauthor=K.+H.+G.+Millsauthor=K.+H.+Mokauthor=P.+Newsholmeauthor=G.+Nu%C3%B1ezauthor=J.+Yodoiauthor=S.+E.+Kahnauthor=E.+D.+Lavelleauthor=L.+A.+J.+O%27Neill&title=Activation+of+the+NLRP3+inflammasome+by+islet+amyloid+polypeptide+provides+a+mechanism+for+enhanced+IL-1%CE%B2+in+type+2+diabetes&doi=10.1038%2Fni.1935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes</span></div><div class="casAuthors">Masters, Seth L.; Dunne, Aisling; Subramanian, Shoba L.; Hull, Rebecca L.; Tannahill, Gillian M.; Sharp, Fiona A.; Becker, Christine; Franchi, Luigi; Yoshihara, Eiji; Chen, Zhe; Mullooly, Niamh; Mielke, Lisa A.; Harris, James; Coll, Rebecca C.; Mills, Kingston H. G.; Mok, K. Hun; Newsholme, Philip; Nunez, Gabriel; Yodoi, Junji; Kahn, Steven E.; Lavelle, Ed C.; O'Neill, Luke A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">897-904</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Interleukin 1β (IL-1β) is an important inflammatory mediator of type 2 diabetes.  Here we show that oligomers of islet amyloid polypeptide (IAPP), a protein that forms amyloid deposits in the pancreas during type 2 diabetes, triggered the NLRP3 inflammasome and generated mature IL-1β.  One therapy for type 2 diabetes, glyburide, suppressed IAPP-mediated IL-1β prodn. in vitro.  Processing of IL-1β initiated by IAPP first required priming, a process that involved glucose metab. and was facilitated by minimally oxidized low-d. lipoprotein.  Finally, mice transgenic for human IAPP had more IL-1β in pancreatic islets, which localized together with amyloid and macrophages.  Our findings identify previously unknown mechanisms in the pathogenesis of type 2 diabetes and treatment of pathol. caused by IAPP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj6D_CKHz2ILVg90H21EOLACvtfcHk0lh0-DeeASKPDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFCnsbzF&md5=bcd5b8d8afdbc3f0cf850dbe9fb029a0</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fni.1935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1935%26sid%3Dliteratum%253Aachs%26aulast%3DMasters%26aufirst%3DS.%2BL.%26aulast%3DDunne%26aufirst%3DA.%26aulast%3DSubramanian%26aufirst%3DS.%2BL.%26aulast%3DHull%26aufirst%3DR.%2BL.%26aulast%3DTannahill%26aufirst%3DG.%2BM.%26aulast%3DSharp%26aufirst%3DF.%2BA.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DFranchi%26aufirst%3DL.%26aulast%3DYoshihara%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DMullooly%26aufirst%3DN.%26aulast%3DMielke%26aufirst%3DL.%2BA.%26aulast%3DHarris%26aufirst%3DJ.%26aulast%3DColl%26aufirst%3DR.%2BC.%26aulast%3DMills%26aufirst%3DK.%2BH.%2BG.%26aulast%3DMok%26aufirst%3DK.%2BH.%26aulast%3DNewsholme%26aufirst%3DP.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26aulast%3DYodoi%26aufirst%3DJ.%26aulast%3DKahn%26aufirst%3DS.%2BE.%26aulast%3DLavelle%26aufirst%3DE.%2BD.%26aulast%3DO%2527Neill%26aufirst%3DL.%2BA.%2BJ.%26atitle%3DActivation%2520of%2520the%2520NLRP3%2520inflammasome%2520by%2520islet%2520amyloid%2520polypeptide%2520provides%2520a%2520mechanism%2520for%2520enhanced%2520IL-1%25CE%25B2%2520in%2520type%25202%2520diabetes%26jtitle%3DNat.%2520Immunol.%26date%3D2010%26volume%3D11%26spage%3D897%26epage%3D904%26doi%3D10.1038%2Fni.1935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Koh, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weehuizen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kager, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoogendijk, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bast, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peacock, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Poll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmetz, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiersinga, W. J.</span><span> </span><span class="NLM_article-title">Glyburide reduces bacterial dissemination in a mouse model of melioidosis</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e2500</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0002500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1371%2Fjournal.pntd.0002500" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=e2500&author=G.+C.+Kohauthor=T.+A.+Weehuizenauthor=K.+Breitbachauthor=K.+Krauseauthor=H.+K.+de+Jongauthor=L.+M.+Kagerauthor=A.+J.+Hoogendijkauthor=A.+Bastauthor=S.+J.+Peacockauthor=T.+van+der+Pollauthor=I.+Steinmetzauthor=W.+J.+Wiersinga&title=Glyburide+reduces+bacterial+dissemination+in+a+mouse+model+of+melioidosis&doi=10.1371%2Fjournal.pntd.0002500"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0002500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0002500%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DG.%2BC.%26aulast%3DWeehuizen%26aufirst%3DT.%2BA.%26aulast%3DBreitbach%26aufirst%3DK.%26aulast%3DKrause%26aufirst%3DK.%26aulast%3Dde%2BJong%26aufirst%3DH.%2BK.%26aulast%3DKager%26aufirst%3DL.%2BM.%26aulast%3DHoogendijk%26aufirst%3DA.%2BJ.%26aulast%3DBast%26aufirst%3DA.%26aulast%3DPeacock%26aufirst%3DS.%2BJ.%26aulast%3Dvan%2Bder%2BPoll%26aufirst%3DT.%26aulast%3DSteinmetz%26aufirst%3DI.%26aulast%3DWiersinga%26aufirst%3DW.%2BJ.%26atitle%3DGlyburide%2520reduces%2520bacterial%2520dissemination%2520in%2520a%2520mouse%2520model%2520of%2520melioidosis%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2013%26volume%3D7%26spage%3De2500%26doi%3D10.1371%2Fjournal.pntd.0002500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Hughes, F. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivar, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennis, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt-Thomas, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaner, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nietert, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spruill, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purves, J. T.</span><span> </span><span class="NLM_article-title">Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation</span> <span class="citation_source-journal">Am. J. Physiol. Renal Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">F299</span><span class="NLM_x">–</span> <span class="NLM_lpage">F308</span><span class="refDoi"> DOI: 10.1152/ajprenal.00297.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1152%2Fajprenal.00297.2013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2014&pages=F299-F308&author=F.+M.+J.+Hughesauthor=N.+P.+Vivarauthor=J.+G.+Kennisauthor=J.+D.+Pratt-Thomasauthor=D.+W.+Loweauthor=B.+E.+Shanerauthor=P.+J.+Nietertauthor=L.+S.+Spruillauthor=J.+T.+Purves&title=Inflammasomes+are+important+mediators+of+cyclophosphamide-induced+bladder+inflammation&doi=10.1152%2Fajprenal.00297.2013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1152%2Fajprenal.00297.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajprenal.00297.2013%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DF.%2BM.%2BJ.%26aulast%3DVivar%26aufirst%3DN.%2BP.%26aulast%3DKennis%26aufirst%3DJ.%2BG.%26aulast%3DPratt-Thomas%26aufirst%3DJ.%2BD.%26aulast%3DLowe%26aufirst%3DD.%2BW.%26aulast%3DShaner%26aufirst%3DB.%2BE.%26aulast%3DNietert%26aufirst%3DP.%2BJ.%26aulast%3DSpruill%26aufirst%3DL.%2BS.%26aulast%3DPurves%26aufirst%3DJ.%2BT.%26atitle%3DInflammasomes%2520are%2520important%2520mediators%2520of%2520cyclophosphamide-induced%2520bladder%2520inflammation%26jtitle%3DAm.%2520J.%2520Physiol.%2520Renal%2520Physiol.%26date%3D2014%26volume%3D306%26spage%3DF299%26epage%3DF308%26doi%3D10.1152%2Fajprenal.00297.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">York, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellanos, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabay, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantuzzi, G.</span><span> </span><span class="NLM_article-title">Inhibition of the nucleotide-binding domain, leucine-rich containing family, pyrin-domain containing 3 inflammasome reduces the severity of experimentally induced acute pancreatitis in obese mice</span> <span class="citation_source-journal">Transl. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1016/j.trsl.2014.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.trsl.2014.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=25152324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2ltrjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2014&pages=259-269&author=J.+M.+Yorkauthor=K.+J.+Castellanosauthor=R.+J.+Cabayauthor=G.+Fantuzzi&title=Inhibition+of+the+nucleotide-binding+domain%2C+leucine-rich+containing+family%2C+pyrin-domain+containing+3+inflammasome+reduces+the+severity+of+experimentally+induced+acute+pancreatitis+in+obese+mice&doi=10.1016%2Fj.trsl.2014.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the nucleotide-binding domain, leucine-rich containing family, pyrin-domain containing 3 inflammasome reduces the severity of experimentally induced acute pancreatitis in obese mice</span></div><div class="casAuthors">York, Jason M.; Castellanos, Karla J.; Cabay, Robert J.; Fantuzzi, Giamila</div><div class="citationInfo"><span class="NLM_cas:title">Translational Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">259-269</span>CODEN:
                <span class="NLM_cas:coden">TRRECL</span>;
        ISSN:<span class="NLM_cas:issn">1878-1810</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Acute pancreatitis (AP), although most often a mild and self-limiting inflammatory disease, worsens to a characteristically necrotic severe acute pancreatitis (SAP) in about 20% of cases.  Obesity, affecting more than one-third of American adults, is a risk factor for the development of SAP, but the exact mechanism of this assocn. has not been identified.  Coincidental with chronic low-grade inflammation, activation of the nucleotide-binding domain, leucine-rich contg. family, pyrin-domain contg. 3 (NLRP3) inflammasome increases with obesity.  Lean mice genetically deficient in specific components of the NLRP3 inflammasome are protected from exptl. induced AP, indicating a direct involvement of this pathway in AP pathophysiol.  We hypothesized that inhibition of the NLRP3 inflammasome with the sulfonylurea drug glyburide would reduce disease severity in obese mice with caerulein-induced SAP.  Treatment with glyburide led to significantly reduced relative pancreatic mass and water content and less pancreatic damage and cell death in genetically obese ob/ob mice with SAP compared with vehicle-treated obese SAP mice.  Glyburide administration in ob/ob mice with caerulein-induced SAP also resulted in significantly reduced serum levels of interleukin 6, lipase, and amylase and led to lower prodn. of lipopolysaccharide-stimulated interleukin 1β release in cultured peritoneal cells, compared with vehicle-treated ob/ob mice with SAP.  Together, these data indicate involvement of the NLRP3 inflammasome in obesity-assocd. SAP and expose the possible utility of its inhibition in prevention or treatment of SAP in obese individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps95hySoHMRrVg90H21EOLACvtfcHk0lh-k_V3HLNcIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2ltrjO&md5=99de8ca21e7210f66446cd9ded64dc31</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.trsl.2014.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trsl.2014.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DYork%26aufirst%3DJ.%2BM.%26aulast%3DCastellanos%26aufirst%3DK.%2BJ.%26aulast%3DCabay%26aufirst%3DR.%2BJ.%26aulast%3DFantuzzi%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520the%2520nucleotide-binding%2520domain%252C%2520leucine-rich%2520containing%2520family%252C%2520pyrin-domain%2520containing%25203%2520inflammasome%2520reduces%2520the%2520severity%2520of%2520experimentally%2520induced%2520acute%2520pancreatitis%2520in%2520obese%2520mice%26jtitle%3DTransl.%2520Res.%26date%3D2014%26volume%3D164%26spage%3D259%26epage%3D269%26doi%3D10.1016%2Fj.trsl.2014.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Zeller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danchin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vahanian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorgis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueret, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyart, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deturck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabone, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machecourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leclercq, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drouet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bataille, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cambou, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrieres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, T.</span><span> </span><span class="NLM_article-title">Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">4993</span><span class="NLM_x">–</span> <span class="NLM_lpage">5002</span><span class="refDoi"> DOI: 10.1210/jc.2010-0449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1210%2Fjc.2010-0449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20702526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2nsbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2010&pages=4993-5002&author=M.+Zellerauthor=N.+Danchinauthor=D.+Simonauthor=A.+Vahanianauthor=L.+Lorgisauthor=Y.+Cottinauthor=J.+Berlandauthor=P.+Gueretauthor=P.+Wyartauthor=R.+Deturckauthor=X.+Taboneauthor=J.+Machecourtauthor=F.+Leclercqauthor=E.+Drouetauthor=G.+Mulakauthor=V.+Batailleauthor=J.+P.+Cambouauthor=J.+Ferrieresauthor=T.+Simon&title=Impact+of+type+of+preadmission+sulfonylureas+on+mortality+and+cardiovascular+outcomes+in+diabetic+patients+with+acute+myocardial+infarction&doi=10.1210%2Fjc.2010-0449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction</span></div><div class="casAuthors">Zeller, Marianne; Danchin, Nicolas; Simon, Dominique; Vahanian, Alec; Lorgis, Luc; Cottin, Yves; Berland, Jacques; Gueret, Pascal; Wyart, Pascal; Deturck, Regis; Tabone, Xavier; Machecourt, Jacques; Leclercq, Florence; Drouet, Elodie; Mulak, Genevieve; Bataille, Vincent; Cambou, Jean-Pierre; Ferrieres, Jean; Simon, Tabassome</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4993-5002</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The impact of antidiabetic medications on clin. outcomes in patients developing acute myocardial infarction (MI) is controversial.  We sought to det. whether in-hospital outcomes in patients who were on sulfonylureas (SUs) when they developed their MIs differed from that of diabetic patients not receiving SUs and whether clin. outcomes were related to the pancreatic cells specificity of SUs.  We analyzed the outcomes of the 1310 diabetic patients included in the nationwide French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction in 2005.  Medications used before the acute episode were recorded.  In-hospital complications were analyzed according to prior antidiabetic treatment.  Mortality was lower in patients previously treated with SUs (3.9%) vs. those on other oral medications (6.4%), insulin (9.4%), or no medication (8.4%) (P = 0.014).  Among SU-treated patients, in-hospital mortality was lower in patients receiving pancreatic cells-specific SUs (gliclazide or glimepiride) (2.7%), compared with glibenclamide (7.5%) (P = 0.019).  Arrhythmias and ischemic complications were also less frequent in patients receiving gliclazide/glimepiride.  The lower risk in patients receiving gliclazide/glimepiride vs. glibenclamide persisted after multivariate adjustment (odds ratio 0.15; 95% confidence interval 0.04-0.56) and in propensity score-matched cohorts.  In this nationwide registry of patients hospitalized for acute MI, no hazard was assocd. with the use of SUs before the acute episode.  In addn., patients previously receiving gliclazide/glimepiride had improved in-hospital outcomes, compared with those on glibenclamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiBAG9nO7Pv7Vg90H21EOLACvtfcHk0lh-k_V3HLNcIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2nsbjK&md5=b3da8cef05b488df056b574a164953a5</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1210%2Fjc.2010-0449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2010-0449%26sid%3Dliteratum%253Aachs%26aulast%3DZeller%26aufirst%3DM.%26aulast%3DDanchin%26aufirst%3DN.%26aulast%3DSimon%26aufirst%3DD.%26aulast%3DVahanian%26aufirst%3DA.%26aulast%3DLorgis%26aufirst%3DL.%26aulast%3DCottin%26aufirst%3DY.%26aulast%3DBerland%26aufirst%3DJ.%26aulast%3DGueret%26aufirst%3DP.%26aulast%3DWyart%26aufirst%3DP.%26aulast%3DDeturck%26aufirst%3DR.%26aulast%3DTabone%26aufirst%3DX.%26aulast%3DMachecourt%26aufirst%3DJ.%26aulast%3DLeclercq%26aufirst%3DF.%26aulast%3DDrouet%26aufirst%3DE.%26aulast%3DMulak%26aufirst%3DG.%26aulast%3DBataille%26aufirst%3DV.%26aulast%3DCambou%26aufirst%3DJ.%2BP.%26aulast%3DFerrieres%26aufirst%3DJ.%26aulast%3DSimon%26aufirst%3DT.%26atitle%3DImpact%2520of%2520type%2520of%2520preadmission%2520sulfonylureas%2520on%2520mortality%2520and%2520cardiovascular%2520outcomes%2520in%2520diabetic%2520patients%2520with%2520acute%2520myocardial%2520infarction%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2010%26volume%3D95%26spage%3D4993%26epage%3D5002%26doi%3D10.1210%2Fjc.2010-0449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Marchetti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chojnacki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toldo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezzaroma, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tranchida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Tassell, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbate, A.</span><span> </span><span class="NLM_article-title">A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span><span class="refDoi"> DOI: 10.1097/FJC.0000000000000053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1097%2FFJC.0000000000000053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=316-322&author=C.+Marchettiauthor=J.+Chojnackiauthor=S.+Toldoauthor=E.+Mezzaromaauthor=N.+Tranchidaauthor=S.+W.+Roseauthor=M.+Federiciauthor=B.+W.+Van+Tassellauthor=S.+Zhangauthor=A.+Abbate&title=A+novel+pharmacologic+inhibitor+of+the+NLRP3+inflammasome+limits+myocardial+injury+after+ischemia-reperfusion+in+the+mouse&doi=10.1097%2FFJC.0000000000000053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1097%2FFJC.0000000000000053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFJC.0000000000000053%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetti%26aufirst%3DC.%26aulast%3DChojnacki%26aufirst%3DJ.%26aulast%3DToldo%26aufirst%3DS.%26aulast%3DMezzaroma%26aufirst%3DE.%26aulast%3DTranchida%26aufirst%3DN.%26aulast%3DRose%26aufirst%3DS.%2BW.%26aulast%3DFederici%26aufirst%3DM.%26aulast%3DVan%2BTassell%26aufirst%3DB.%2BW.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DAbbate%26aufirst%3DA.%26atitle%3DA%2520novel%2520pharmacologic%2520inhibitor%2520of%2520the%2520NLRP3%2520inflammasome%2520limits%2520myocardial%2520injury%2520after%2520ischemia-reperfusion%2520in%2520the%2520mouse%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2014%26volume%3D63%26spage%3D316%26epage%3D322%26doi%3D10.1097%2FFJC.0000000000000053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Marchetti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toldo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chojnacki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezzaroma, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salloum, F. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauro, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalavadia, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halquist, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Tassell, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbate, A.</span><span> </span><span class="NLM_article-title">Pharmacologic inhibition of the NLRP3 inflammasome preserves cardiac function after ischemic and non-ischemic injury in the mouse</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1097/FJC.0000000000000247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1097%2FFJC.0000000000000247" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2015&pages=1-8&author=C.+Marchettiauthor=S.+Toldoauthor=J.+Chojnackiauthor=E.+Mezzaromaauthor=K.+Liuauthor=F.+N.+Salloumauthor=A.+Nordioauthor=S.+Carboneauthor=A.+G.+Mauroauthor=A.+Dasauthor=A.+A.+Zalavadiaauthor=M.+S.+Halquistauthor=M.+Federiciauthor=B.+W.+Van+Tassellauthor=S.+Zhangauthor=A.+Abbate&title=Pharmacologic+inhibition+of+the+NLRP3+inflammasome+preserves+cardiac+function+after+ischemic+and+non-ischemic+injury+in+the+mouse&doi=10.1097%2FFJC.0000000000000247"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1097%2FFJC.0000000000000247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFJC.0000000000000247%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetti%26aufirst%3DC.%26aulast%3DToldo%26aufirst%3DS.%26aulast%3DChojnacki%26aufirst%3DJ.%26aulast%3DMezzaroma%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DSalloum%26aufirst%3DF.%2BN.%26aulast%3DNordio%26aufirst%3DA.%26aulast%3DCarbone%26aufirst%3DS.%26aulast%3DMauro%26aufirst%3DA.%2BG.%26aulast%3DDas%26aufirst%3DA.%26aulast%3DZalavadia%26aufirst%3DA.%2BA.%26aulast%3DHalquist%26aufirst%3DM.%2BS.%26aulast%3DFederici%26aufirst%3DM.%26aulast%3DVan%2BTassell%26aufirst%3DB.%2BW.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DAbbate%26aufirst%3DA.%26atitle%3DPharmacologic%2520inhibition%2520of%2520the%2520NLRP3%2520inflammasome%2520preserves%2520cardiac%2520function%2520after%2520ischemic%2520and%2520non-ischemic%2520injury%2520in%2520the%2520mouse%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2015%26volume%3D66%26spage%3D1%26epage%3D8%26doi%3D10.1097%2FFJC.0000000000000247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Laliberte, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perregaux, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoth, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peese, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombroski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span> </span><span class="NLM_article-title">Glutathione <i>S</i>-transferase omega 1–1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1β posttranslational processing</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">16567</span><span class="NLM_x">–</span> <span class="NLM_lpage">16578</span><span class="refDoi"> DOI: 10.1074/jbc.M211596200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M211596200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=16567-16578&author=R.+E.+Laliberteauthor=D.+G.+Perregauxauthor=L.+R.+Hothauthor=P.+J.+Rosnerauthor=C.+K.+Jordanauthor=K.+M.+Peeseauthor=J.+F.+Egglerauthor=M.+A.+Dombroskiauthor=K.+F.+Geogheganauthor=C.+A.+Gabel&title=Glutathione+S-transferase+omega+1%E2%80%931+is+a+target+of+cytokine+release+inhibitory+drugs+and+may+be+responsible+for+their+effect+on+interleukin-1%CE%B2+posttranslational+processing&doi=10.1074%2Fjbc.M211596200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M211596200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M211596200%26sid%3Dliteratum%253Aachs%26aulast%3DLaliberte%26aufirst%3DR.%2BE.%26aulast%3DPerregaux%26aufirst%3DD.%2BG.%26aulast%3DHoth%26aufirst%3DL.%2BR.%26aulast%3DRosner%26aufirst%3DP.%2BJ.%26aulast%3DJordan%26aufirst%3DC.%2BK.%26aulast%3DPeese%26aufirst%3DK.%2BM.%26aulast%3DEggler%26aufirst%3DJ.%2BF.%26aulast%3DDombroski%26aufirst%3DM.%2BA.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26atitle%3DGlutathione%2520S-transferase%2520omega%25201%25E2%2580%25931%2520is%2520a%2520target%2520of%2520cytokine%2520release%2520inhibitory%2520drugs%2520and%2520may%2520be%2520responsible%2520for%2520their%2520effect%2520on%2520interleukin-1%25CE%25B2%2520posttranslational%2520processing%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D16567%26epage%3D16578%26doi%3D10.1074%2Fjbc.M211596200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Coll, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chae, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Planillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inserra, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dungan, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croker, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haneklaus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastner, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Neill, L. A.</span><span> </span><span class="NLM_article-title">A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1038/nm.3806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnm.3806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=25686105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVSit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=248-255&author=R.+C.+Collauthor=A.+A.+Robertsonauthor=J.+J.+Chaeauthor=S.+C.+Higginsauthor=R.+Munoz-Planilloauthor=M.+C.+Inserraauthor=I.+Vetterauthor=L.+S.+Dunganauthor=B.+G.+Monksauthor=A.+Stutzauthor=D.+E.+Crokerauthor=M.+S.+Butlerauthor=M.+Haneklausauthor=C.+E.+Suttonauthor=G.+Nunezauthor=E.+Latzauthor=D.+L.+Kastnerauthor=K.+H.+Millsauthor=S.+L.+Mastersauthor=K.+Schroderauthor=M.+A.+Cooperauthor=L.+A.+O%27Neill&title=A+small-molecule+inhibitor+of+the+NLRP3+inflammasome+for+the+treatment+of+inflammatory+diseases&doi=10.1038%2Fnm.3806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases</span></div><div class="casAuthors">Coll, Rebecca C.; Robertson, Avril A. B.; Chae, Jae Jin; Higgins, Sarah C.; Munoz-Planillo, Raul; Inserra, Marco C.; Vetter, Irina; Dungan, Lara S.; Monks, Brian G.; Stutz, Andrea; Croker, Daniel E.; Butler, Mark S.; Haneklaus, Moritz; Sutton, Caroline E.; Nunez, Gabriel; Latz, Eicke; Kastner, Daniel L.; Mills, Kingston H. G.; Masters, Seth L.; Schroder, Kate; Cooper, Matthew A.; O'Neill, Luke A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">248-255</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The NOD-like receptor (NLR) family, pyrin domain-contg. protein 3 (NLRP3) inflammasome is a component of the inflammatory process, and its aberrant activation is pathogenic in inherited disorders such as cryopyrin-assocd. periodic syndrome (CAPS) and complex diseases such as multiple sclerosis, type 2 diabetes, Alzheimer's disease and atherosclerosis.  We describe the development of MCC950, a potent, selective, small-mol. inhibitor of NLRP3.  MCC950 blocked canonical and noncanonical NLRP3 activation at nanomolar concns.  MCC950 specifically inhibited activation of NLRP3 but not the AIM2, NLRC4 or NLRP1 inflammasomes.  MCC950 reduced interleukin-1β (IL-1β) prodn. in vivo and attenuated the severity of exptl. autoimmune encephalomyelitis (EAE), a disease model of multiple sclerosis.  Furthermore, MCC950 treatment rescued neonatal lethality in a mouse model of CAPS and was active in ex vivo samples from individuals with Muckle-Wells syndrome.  MCC950 is thus a potential therapeutic for NLRP3-assocd. syndromes, including autoinflammatory and autoimmune diseases, and a tool for further study of the NLRP3 inflammasome in human health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBPny7QJdNA7Vg90H21EOLACvtfcHk0lgYheD0Yx2fBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVSit7g%253D&md5=5ffe3683cc33ded3c3b18421e987cac5</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fnm.3806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3806%26sid%3Dliteratum%253Aachs%26aulast%3DColl%26aufirst%3DR.%2BC.%26aulast%3DRobertson%26aufirst%3DA.%2BA.%26aulast%3DChae%26aufirst%3DJ.%2BJ.%26aulast%3DHiggins%26aufirst%3DS.%2BC.%26aulast%3DMunoz-Planillo%26aufirst%3DR.%26aulast%3DInserra%26aufirst%3DM.%2BC.%26aulast%3DVetter%26aufirst%3DI.%26aulast%3DDungan%26aufirst%3DL.%2BS.%26aulast%3DMonks%26aufirst%3DB.%2BG.%26aulast%3DStutz%26aufirst%3DA.%26aulast%3DCroker%26aufirst%3DD.%2BE.%26aulast%3DButler%26aufirst%3DM.%2BS.%26aulast%3DHaneklaus%26aufirst%3DM.%26aulast%3DSutton%26aufirst%3DC.%2BE.%26aulast%3DNunez%26aufirst%3DG.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DKastner%26aufirst%3DD.%2BL.%26aulast%3DMills%26aufirst%3DK.%2BH.%26aulast%3DMasters%26aufirst%3DS.%2BL.%26aulast%3DSchroder%26aufirst%3DK.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26aulast%3DO%2527Neill%26aufirst%3DL.%2BA.%26atitle%3DA%2520small-molecule%2520inhibitor%2520of%2520the%2520NLRP3%2520inflammasome%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DNat.%2520Med.%26date%3D2015%26volume%3D21%26spage%3D248%26epage%3D255%26doi%3D10.1038%2Fnm.3806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Kean, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, W. W.</span><span> </span><span class="NLM_article-title">Auranofin</span> <span class="citation_source-journal">Rheumatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span><span class="refDoi"> DOI: 10.1093/rheumatology/36.5.560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1093%2Frheumatology%2F36.5.560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADyaK2sXkt1ert70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=560-572&author=W.+F.+Keanauthor=L.+Hartauthor=W.+W.+Buchanan&title=Auranofin&doi=10.1093%2Frheumatology%2F36.5.560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Auranofin</span></div><div class="casAuthors">Kean, W. F.; Hart, L.; Buchanan, W. W.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Rheumatology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">560-572</span>CODEN:
                <span class="NLM_cas:coden">BJRHDF</span>;
        ISSN:<span class="NLM_cas:issn">0263-7103</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 110 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDkbAGdbOko7Vg90H21EOLACvtfcHk0lgYheD0Yx2fBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkt1ert70%253D&md5=988732af6d9cd13a33abb16114550422</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2F36.5.560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252F36.5.560%26sid%3Dliteratum%253Aachs%26aulast%3DKean%26aufirst%3DW.%2BF.%26aulast%3DHart%26aufirst%3DL.%26aulast%3DBuchanan%26aufirst%3DW.%2BW.%26atitle%3DAuranofin%26jtitle%3DRheumatology%26date%3D1997%26volume%3D36%26spage%3D560%26epage%3D572%26doi%3D10.1093%2Frheumatology%2F36.5.560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span> </span><span class="NLM_article-title">Auranofin inhibits overproduction of pro-inflammatory cytokines, cyclooxygenase expression and PGE2 production in macrophages</span> <span class="citation_source-journal">Arch. Pharmacal Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span><span class="refDoi"> DOI: 10.1007/s12272-008-1122-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1007%2Fs12272-008-1122-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=18277610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlyitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=67-74&author=S.+Hanauthor=K.+Kimauthor=H.+Kimauthor=J.+Kwonauthor=Y.+H.+Leeauthor=C.+K.+Leeauthor=Y.+Songauthor=S.+J.+Leeauthor=N.+Haauthor=K.+Kim&title=Auranofin+inhibits+overproduction+of+pro-inflammatory+cytokines%2C+cyclooxygenase+expression+and+PGE2+production+in+macrophages&doi=10.1007%2Fs12272-008-1122-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Auranofin inhibits overproduction of pro-inflammatory cytokines, cyclooxygenase expression and PGE2 production in macrophages</span></div><div class="casAuthors">Han, Shinha; Kim, Kwanghee; Kim, Hyunyul; Kwon, Jeunghak; Lee, Young-Hee; Lee, Chong-Kil; Song, Youngcheon; Lee, Sang-Jin; Ha, Namjoo; Kim, Kyungjae</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-74</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">Auranofin (AF), a gold compd., is an orally active therapeutic agent used to treat rheumatoid arthritis (RA), a self-perpetuating inflammatory disease.  RA is characterized by autoimmune-mediated proliferation of synovial cells that leads to inflammation, pain, and swelling in most major joints.  However, the mechanism as to how AF relieves RA symptoms has not been fully elucidated.  The object of this study was to examine the ability of AF to immunomodulate macrophages as antigen presenting cells (APCs).  Macrophages are recognized as playing an important role in the pathogenesis of RA, in that there is a relative abundance of macrophage-derived cytokines, such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and interleukin-6 (IL-6) in rheumatoid synovium.  In this work, we tested whether AF (2.5-20 mM) could inhibit inflammatory activity in the macrophage cell line RAW 264.7.  AF decreased prodn. of nitric oxide (NO) and the pro-inflammatory cytokines, TNF-α, IL-1β and IL-6 in macrophages.  Furthermore, AF inhibited cyclooxygenase-2 (COX-2)-dependent prostaglandin E2 (PGE2) prodn. in a concn.-dependent manner.  In conclusion, these findings may provide an explanation for the clin. effects of AF in patients with RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOHN1I7ymmfbVg90H21EOLACvtfcHk0lhaWrOFjJZuwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlyitLo%253D&md5=d050c6b43efddff06983e01e1652354a</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1007%2Fs12272-008-1122-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-008-1122-9%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DKwon%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DC.%2BK.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DHa%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DK.%26atitle%3DAuranofin%2520inhibits%2520overproduction%2520of%2520pro-inflammatory%2520cytokines%252C%2520cyclooxygenase%2520expression%2520and%2520PGE2%2520production%2520in%2520macrophages%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2008%26volume%3D31%26spage%3D67%26epage%3D74%26doi%3D10.1007%2Fs12272-008-1122-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Yamada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashiramoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukui, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsubouchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, M.</span><span> </span><span class="NLM_article-title">Auranofin inhibits interleukin-1β-induced transcript of cyclooxygenase-2 on cultured human synoviocytes</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span><span class="refDoi"> DOI: 10.1016/S0014-2999(99)00707-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2FS0014-2999%2899%2900707-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10594346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADyaK1MXnslGqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=1999&pages=71-79&author=R.+Yamadaauthor=H.+Sanoauthor=T.+Hlaauthor=A.+Hashiramotoauthor=W.+Fukuiauthor=S.+Miyazakiauthor=M.+Kohnoauthor=Y.+Tsubouchiauthor=Y.+Kusakaauthor=M.+Kondo&title=Auranofin+inhibits+interleukin-1%CE%B2-induced+transcript+of+cyclooxygenase-2+on+cultured+human+synoviocytes&doi=10.1016%2FS0014-2999%2899%2900707-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Auranofin inhibits interleukin-1β-induced transcript of cyclooxygenase-2 on cultured human synoviocytes</span></div><div class="casAuthors">Yamada, R.; Sano, H.; Hla, T.; Hashiramoto, A.; Fukui, W.; Miyazaki, S.; Kohno, M.; Tsubouchi, Y.; Kusaka, Y.; Kondo, M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-79</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The aim of this study was to characterize the effects of auranofin (2,3,4,6-tetra-O-acetyl-l-thio-β-D-glucopyranosato-S) on cyclooxygenase expression and prostaglandin E2 synthesis on cultured human synovial fibroblast-like cells (synoviocytes).  Synoviocytes were treated with auranofin in the presence or absence of interleukin-1β.  Cultured supernatants were harvested for prostaglandin E2 synthesis.  Cyclooxygenase-1 and -2 expression was analyzed with Western and Northern blotting.  Translocation of nuclear factor-κ B p65 was detd. by immunostaining.  Cytotoxicity was measured with 51Cr release assay.  Auranofin attenuated interleukin-1β-induced prostaglandin E2 prodn. of the cells in a dose-dependent fashion.  Auranofin selectively suppressed interleukin-1β-induced cyclooxygenase-2 mRNA and protein expression of the cells without alteration of cyclooxygenase-1 expression.  Also, auranofin interfered with interleukin-1β-induced translocation of nuclear factor-κ B.  These inhibitory effects did not originate in the cytotoxicity of the agent.  Our data indicate that auranofin inhibits interleukin-1β-induced prostaglandin E2 synthesis and cyclooxygenase-2 expression via suppression of nuclear factor-κ B activation on synoviocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbI7AOUCPL6rVg90H21EOLACvtfcHk0lhaWrOFjJZuwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslGqtL0%253D&md5=afc6721348429fb0108257e750995631</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2899%2900707-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252899%252900707-4%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DR.%26aulast%3DSano%26aufirst%3DH.%26aulast%3DHla%26aufirst%3DT.%26aulast%3DHashiramoto%26aufirst%3DA.%26aulast%3DFukui%26aufirst%3DW.%26aulast%3DMiyazaki%26aufirst%3DS.%26aulast%3DKohno%26aufirst%3DM.%26aulast%3DTsubouchi%26aufirst%3DY.%26aulast%3DKusaka%26aufirst%3DY.%26aulast%3DKondo%26aufirst%3DM.%26atitle%3DAuranofin%2520inhibits%2520interleukin-1%25CE%25B2-induced%2520transcript%2520of%2520cyclooxygenase-2%2520on%2520cultured%2520human%2520synoviocytes%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D385%26spage%3D71%26epage%3D79%26doi%3D10.1016%2FS0014-2999%2899%2900707-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Bondeson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundler, R.</span><span> </span><span class="NLM_article-title">Auranofin inhibits the induction of interleukin 1β and tumor necrosis factor α mRNA in macrophages</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1753</span><span class="NLM_x">–</span> <span class="NLM_lpage">1759</span><span class="refDoi"> DOI: 10.1016/0006-2952(95)02030-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2F0006-2952%2895%2902030-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1995&pages=1753-1759&author=J.+S.+Bondesonauthor=R.+Sundler&title=Auranofin+inhibits+the+induction+of+interleukin+1%CE%B2+and+tumor+necrosis+factor+%CE%B1+mRNA+in+macrophages&doi=10.1016%2F0006-2952%2895%2902030-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2895%2902030-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252895%252902030-6%26sid%3Dliteratum%253Aachs%26aulast%3DBondeson%26aufirst%3DJ.%2BS.%26aulast%3DSundler%26aufirst%3DR.%26atitle%3DAuranofin%2520inhibits%2520the%2520induction%2520of%2520interleukin%25201%25CE%25B2%2520and%2520tumor%2520necrosis%2520factor%2520%25CE%25B1%2520mRNA%2520in%2520macrophages%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D50%26spage%3D1753%26epage%3D1759%26doi%3D10.1016%2F0006-2952%2895%2902030-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Isakov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisman-Shomer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhar, M.</span><span> </span><span class="NLM_article-title">Suppression of the pro-inflammatory NLRP3/interleukin-1β pathway in macrophages by the thioredoxin reductase inhibitor auranofin</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Gen. Subj.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1840</span><span class="NLM_x">, </span> <span class="NLM_fpage">3153</span><span class="NLM_x">–</span> <span class="NLM_lpage">3161</span><span class="refDoi"> DOI: 10.1016/j.bbagen.2014.07.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.bbagen.2014.07.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=25065288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1KisLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1840&publication_year=2014&pages=3153-3161&author=E.+Isakovauthor=P.+Weisman-Shomerauthor=M.+Benhar&title=Suppression+of+the+pro-inflammatory+NLRP3%2Finterleukin-1%CE%B2+pathway+in+macrophages+by+the+thioredoxin+reductase+inhibitor+auranofin&doi=10.1016%2Fj.bbagen.2014.07.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of the pro-inflammatory NLRP3/interleukin-1β pathway in macrophages by the thioredoxin reductase inhibitor auranofin</span></div><div class="casAuthors">Isakov, Elina; Weisman-Shomer, Pnina; Benhar, Moran</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1840</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3153-3161</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The thioredoxin/thioredoxin reductase system, which is best known for its essential role in antioxidant defense and redox homeostasis, is increasingly implicated in the regulation of multiple cellular signaling pathways.  In the present study, we asked if the thioredoxin system in macrophages might regulate toll-like receptor 4 (TLR4)-dependent gene expression and consequent responses.Using microarray anal. we analyzed the effect of auranofin, a highly potent and specific inhibitor of thioredoxin reductase, on the transcriptional program activated in J774 macrophages by the TLR4 agonist, lipopolysaccharide (LPS).  We used quant. real-time PCR (qPCR), Western blotting, ELISA and cytotoxicity assays to confirm and extend the microarray results.  Global transcriptional profiling revealed that macrophage treatment with auranofin exerted a selective effect on LPS-induced gene expression, suppressing the induction of a small no. of genes.  Interestingly, among these suppressed genes were three members of the interleukin-1 (IL-1) family of genes, among which IL-1β was most affected.  QPCR analyses confirmed the repressive effects of auranofin on IL-1 genes.  In addn., qPCR and Western blot analyses showed that auranofin impaired TLR4-dependent induction of the inflammasome receptor NLRP3, which plays a crit. role in IL-1β processing.  Consistent with these findings, inflammasome-dependent release of IL-1β from stimulated macrophages was suppressed by auranofin as was inflammasome-mediated cell death.  Our findings suggest a regulatory role for the thioredoxin system in macrophage inflammatory signaling.  Inhibition of the thioredoxin system in macrophages exerts an anti-inflammatory effect by repressing the activation of the NLRP3/IL-1β pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV5WxiA-pLjbVg90H21EOLACvtfcHk0lhaWrOFjJZuwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1KisLbF&md5=bbd3a0041aaea5bf89f8099612db4b95</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2014.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2014.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DIsakov%26aufirst%3DE.%26aulast%3DWeisman-Shomer%26aufirst%3DP.%26aulast%3DBenhar%26aufirst%3DM.%26atitle%3DSuppression%2520of%2520the%2520pro-inflammatory%2520NLRP3%252Finterleukin-1%25CE%25B2%2520pathway%2520in%2520macrophages%2520by%2520the%2520thioredoxin%2520reductase%2520inhibitor%2520auranofin%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2014%26volume%3D1840%26spage%3D3153%26epage%3D3161%26doi%3D10.1016%2Fj.bbagen.2014.07.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Jeon, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jue, D. M.</span><span> </span><span class="NLM_article-title">Thiol-reactive metal compounds inhibit NF-κB activation by blocking IκB kinase</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">5981</span><span class="NLM_x">–</span> <span class="NLM_lpage">5989</span><span class="refDoi"> DOI: 10.4049/jimmunol.164.11.5981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.164.11.5981" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2000&pages=5981-5989&author=K.+I.+Jeonauthor=J.+Y.+Jeongauthor=D.+M.+Jue&title=Thiol-reactive+metal+compounds+inhibit+NF-%CE%BAB+activation+by+blocking+I%CE%BAB+kinase&doi=10.4049%2Fjimmunol.164.11.5981"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.164.11.5981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.164.11.5981%26sid%3Dliteratum%253Aachs%26aulast%3DJeon%26aufirst%3DK.%2BI.%26aulast%3DJeong%26aufirst%3DJ.%2BY.%26aulast%3DJue%26aufirst%3DD.%2BM.%26atitle%3DThiol-reactive%2520metal%2520compounds%2520inhibit%2520NF-%25CE%25BAB%2520activation%2520by%2520blocking%2520I%25CE%25BAB%2520kinase%26jtitle%3DJ.%2520Immunol.%26date%3D2000%26volume%3D164%26spage%3D5981%26epage%3D5989%26doi%3D10.4049%2Fjimmunol.164.11.5981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Bauernfeind, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes-Alnemri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornung, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span> </span><span class="NLM_article-title">Cutting edge: NF-κB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">183</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span><span class="refDoi"> DOI: 10.4049/jimmunol.0901363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.0901363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=19570822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFWgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2009&pages=787-791&author=F.+G.+Bauernfeindauthor=G.+Horvathauthor=A.+Stutzauthor=E.+S.+Alnemriauthor=K.+MacDonaldauthor=D.+Speertauthor=T.+Fernandes-Alnemriauthor=J.+Wuauthor=B.+G.+Monksauthor=K.+A.+Fitzgeraldauthor=V.+Hornungauthor=E.+Latz&title=Cutting+edge%3A+NF-%CE%BAB+activating+pattern+recognition+and+cytokine+receptors+license+NLRP3+inflammasome+activation+by+regulating+NLRP3+expression&doi=10.4049%2Fjimmunol.0901363"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression</span></div><div class="casAuthors">Bauernfeind, Franz G.; Horvath, Gabor; Stutz, Andrea; Alnemri, Emad S.; MacDonald, Kelly; Speert, David; Fernandes-Alnemri, Teresa; Wu, Jianghong; Monks, Brian G.; Fitzgerald, Katherine A.; Hornung, Veit; Latz, Eicke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">787-791</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The IL-1 family cytokines are regulated on transcriptional and posttranscriptional levels.  Pattern recognition and cytokine receptors control pro-IL-1β transcription whereas inflammasomes regulate the proteolytic processing of pro-IL-1β.  The NLRP3 inflammasome, however, assembles in response to extracellular ATP, pore-forming toxins, or crystals only in the presence of proinflammatory stimuli.  How the activation of gene transcription by signaling receptors enables NLRP3 activation remains elusive and controversial.  In this study, the authors show that cell priming through multiple signaling receptors induces NLRP3 expression, which the authors identified to be a crit. checkpoint for NLRP3 activation.  Signals provided by NF-κB activators are necessary but not sufficient for NLRP3 activation, and a second stimulus such as ATP or crystal-induced damage is required for NLRP3 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQUf4OrrejQ7Vg90H21EOLACvtfcHk0lhEqg4-HwW2ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFWgt78%253D&md5=1b04c9f756bb70d6292bd8bd5507ee1f</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0901363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0901363%26sid%3Dliteratum%253Aachs%26aulast%3DBauernfeind%26aufirst%3DF.%2BG.%26aulast%3DHorvath%26aufirst%3DG.%26aulast%3DStutz%26aufirst%3DA.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26aulast%3DMacDonald%26aufirst%3DK.%26aulast%3DSpeert%26aufirst%3DD.%26aulast%3DFernandes-Alnemri%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DMonks%26aufirst%3DB.%2BG.%26aulast%3DFitzgerald%26aufirst%3DK.%2BA.%26aulast%3DHornung%26aufirst%3DV.%26aulast%3DLatz%26aufirst%3DE.%26atitle%3DCutting%2520edge%253A%2520NF-%25CE%25BAB%2520activating%2520pattern%2520recognition%2520and%2520cytokine%2520receptors%2520license%2520NLRP3%2520inflammasome%2520activation%2520by%2520regulating%2520NLRP3%2520expression%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D183%26spage%3D787%26epage%3D791%26doi%3D10.4049%2Fjimmunol.0901363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Handel, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deFazio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherland, R. L.</span><span> </span><span class="NLM_article-title">Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">4497</span><span class="NLM_x">–</span> <span class="NLM_lpage">4501</span><span class="refDoi"> DOI: 10.1073/pnas.92.10.4497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1073%2Fpnas.92.10.4497" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=4497-4501&author=M.+L.+Handelauthor=C.+K.+Wattsauthor=A.+deFazioauthor=R.+O.+Dayauthor=R.+L.+Sutherland&title=Inhibition+of+AP-1+binding+and+transcription+by+gold+and+selenium+involving+conserved+cysteine+residues+in+Jun+and+Fos&doi=10.1073%2Fpnas.92.10.4497"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.10.4497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.10.4497%26sid%3Dliteratum%253Aachs%26aulast%3DHandel%26aufirst%3DM.%2BL.%26aulast%3DWatts%26aufirst%3DC.%2BK.%26aulast%3DdeFazio%26aufirst%3DA.%26aulast%3DDay%26aufirst%3DR.%2BO.%26aulast%3DSutherland%26aufirst%3DR.%2BL.%26atitle%3DInhibition%2520of%2520AP-1%2520binding%2520and%2520transcription%2520by%2520gold%2520and%2520selenium%2520involving%2520conserved%2520cysteine%2520residues%2520in%2520Jun%2520and%2520Fos%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1995%26volume%3D92%26spage%3D4497%26epage%3D4501%26doi%3D10.1073%2Fpnas.92.10.4497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Kataoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishizawa, M.</span><span> </span><span class="NLM_article-title">Induction of cellular antioxidative stress genes through heterodimeric transcription factor Nrf2/small Maf by antirheumatic gold(I) compounds</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">34074</span><span class="NLM_x">–</span> <span class="NLM_lpage">34081</span><span class="refDoi"> DOI: 10.1074/jbc.M105383200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M105383200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=34074-34081&author=K.+Kataokaauthor=H.+Handaauthor=M.+Nishizawa&title=Induction+of+cellular+antioxidative+stress+genes+through+heterodimeric+transcription+factor+Nrf2%2Fsmall+Maf+by+antirheumatic+gold%28I%29+compounds&doi=10.1074%2Fjbc.M105383200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M105383200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M105383200%26sid%3Dliteratum%253Aachs%26aulast%3DKataoka%26aufirst%3DK.%26aulast%3DHanda%26aufirst%3DH.%26aulast%3DNishizawa%26aufirst%3DM.%26atitle%3DInduction%2520of%2520cellular%2520antioxidative%2520stress%2520genes%2520through%2520heterodimeric%2520transcription%2520factor%2520Nrf2%252Fsmall%2520Maf%2520by%2520antirheumatic%2520gold%2528I%2529%2520compounds%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D34074%26epage%3D34081%26doi%3D10.1074%2Fjbc.M105383200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Youn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saitoh, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, D. H.</span><span> </span><span class="NLM_article-title">Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">866</span><span class="NLM_x">–</span> <span class="NLM_lpage">871</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2006.09.097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.bbrc.2006.09.097" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2006&pages=866-871&author=H.+S.+Younauthor=J.+Y.+Leeauthor=S.+I.+Saitohauthor=K.+Miyakeauthor=D.+H.+Hwang&title=Auranofin%2C+as+an+anti-rheumatic+gold+compound%2C+suppresses+LPS-induced+homodimerization+of+TLR4&doi=10.1016%2Fj.bbrc.2006.09.097"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2006.09.097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2006.09.097%26sid%3Dliteratum%253Aachs%26aulast%3DYoun%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DSaitoh%26aufirst%3DS.%2BI.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DHwang%26aufirst%3DD.%2BH.%26atitle%3DAuranofin%252C%2520as%2520an%2520anti-rheumatic%2520gold%2520compound%252C%2520suppresses%2520LPS-induced%2520homodimerization%2520of%2520TLR4%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D350%26spage%3D866%26epage%3D871%26doi%3D10.1016%2Fj.bbrc.2006.09.097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Newman, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirianni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mawhinney, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppla, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moayeri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, L. M.</span><span> </span><span class="NLM_article-title">Auranofin protects against anthrax lethal toxin-induced activation of the Nlrp1b inflammasome</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1028</span><span class="NLM_x">–</span> <span class="NLM_lpage">1035</span><span class="refDoi"> DOI: 10.1128/AAC.00772-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1128%2FAAC.00772-10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=1028-1035&author=Z.+L.+Newmanauthor=N.+Sirianniauthor=C.+Mawhinneyauthor=M.+S.+Leeauthor=S.+H.+Lepplaauthor=M.+Moayeriauthor=L.+M.+Johansen&title=Auranofin+protects+against+anthrax+lethal+toxin-induced+activation+of+the+Nlrp1b+inflammasome&doi=10.1128%2FAAC.00772-10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1128%2FAAC.00772-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00772-10%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DZ.%2BL.%26aulast%3DSirianni%26aufirst%3DN.%26aulast%3DMawhinney%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DLeppla%26aufirst%3DS.%2BH.%26aulast%3DMoayeri%26aufirst%3DM.%26aulast%3DJohansen%26aufirst%3DL.%2BM.%26atitle%3DAuranofin%2520protects%2520against%2520anthrax%2520lethal%2520toxin-induced%2520activation%2520of%2520the%2520Nlrp1b%2520inflammasome%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2011%26volume%3D55%26spage%3D1028%26epage%3D1035%26doi%3D10.1128%2FAAC.00772-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Gunatilleke, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrios, A. M.</span><span> </span><span class="NLM_article-title">Inhibition of lysosomal cysteine proteases by a series of Au(I) complexes: a detailed mechanistic investigation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3933</span><span class="NLM_x">–</span> <span class="NLM_lpage">3937</span><span class="refDoi"> DOI: 10.1021/jm060158f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060158f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3933-3937&author=S.+S.+Gunatillekeauthor=A.+M.+Barrios&title=Inhibition+of+lysosomal+cysteine+proteases+by+a+series+of+Au%28I%29+complexes%3A+a+detailed+mechanistic+investigation&doi=10.1021%2Fjm060158f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm060158f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060158f%26sid%3Dliteratum%253Aachs%26aulast%3DGunatilleke%26aufirst%3DS.%2BS.%26aulast%3DBarrios%26aufirst%3DA.%2BM.%26atitle%3DInhibition%2520of%2520lysosomal%2520cysteine%2520proteases%2520by%2520a%2520series%2520of%2520Au%2528I%2529%2520complexes%253A%2520a%2520detailed%2520mechanistic%2520investigation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3933%26epage%3D3937%26doi%3D10.1021%2Fjm060158f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Lopez-Sanchez, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrales, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Pedrera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aranda, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Ariza, A.</span><span> </span><span class="NLM_article-title">Pharmacological impairment of <i>S</i>-nitrosoglutathione or thioredoxin reductases augments protein <i>S</i>-Nitrosation in human hepatocarcinoma cells</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20332448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFCru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=415-421&author=L.+M.+Lopez-Sanchezauthor=F.+J.+Corralesauthor=C.+Lopez-Pedreraauthor=E.+Arandaauthor=A.+Rodriguez-Ariza&title=Pharmacological+impairment+of+S-nitrosoglutathione+or+thioredoxin+reductases+augments+protein+S-Nitrosation+in+human+hepatocarcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological impairment of S-Nitrosoglutathione or thioredoxin reductases augments protein S-nitrosation in human hepatocarcinoma cells</span></div><div class="casAuthors">Lopez-Sanchez, Laura M.; Corrales, Fernando J.; Lopez-Pedrera, Chary; Aranda, Enrique; Rodriguez-Ariza, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">415-422</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background/Aim: S-Nitrosoglutathione reductase (GSNOR) and thioredoxin enzyme systems participate in cellular defense against nitrosative stress.  Pharmacol. interventions against these enzyme systems might represent valuable strategies to impair S-nitrosothiol (SNO) homeostasis in tumor cells.  Materials and Methods: Human HepG2 cells were pre-treated with mithramycin A or auranofin and exposed to S-nitroso-L-cysteine.  GSNOR mRNA levels were analyzed by quant. real-time reverse transcriptase-polymerase chain reaction and S-nitrosated proteins were detected and purified using the biotin-switch approach.  Proteins were identified using electrospray ionization tandem mass spectrometry.  Results: Mithramycin interfered with GSNOR induction resulting in an increased cellular sensitivity to protein S-nitrosation.  Moreover, the thioredoxin reductase inhibitor auranofin also increased cellular susceptibility to S-nitrosoprotein formation.  The impairment of these two cellular defense systems against nitrosative stress resulted in different sets of S-nitrosated proteins, as revealed by the proteomics approach.  Conclusion: Our results suggest that pharmacol. intervention with mithramycin or auranofin may constitute promising tools for altering SNO homeostasis in tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0ysmmz7dON7Vg90H21EOLACvtfcHk0ljfhPUqZYQafw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFCru74%253D&md5=432b3df332768edccc448145dd62adc3</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Sanchez%26aufirst%3DL.%2BM.%26aulast%3DCorrales%26aufirst%3DF.%2BJ.%26aulast%3DLopez-Pedrera%26aufirst%3DC.%26aulast%3DAranda%26aufirst%3DE.%26aulast%3DRodriguez-Ariza%26aufirst%3DA.%26atitle%3DPharmacological%2520impairment%2520of%2520S-nitrosoglutathione%2520or%2520thioredoxin%2520reductases%2520augments%2520protein%2520S-Nitrosation%2520in%2520human%2520hepatocarcinoma%2520cells%26jtitle%3DAnticancer%2520Res.%26date%3D2010%26volume%3D30%26spage%3D415%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Krikavova, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutyra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travnicek, Z.</span><span> </span><span class="NLM_article-title">Gold(I)-triphenylphosphine complexes with hypoxanthine-derived ligands: in vitro evaluations of anticancer and anti-inflammatory activities</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e107373</span><span class="refDoi"> DOI: 10.1371/journal.pone.0107373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1371%2Fjournal.pone.0107373" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e107373&author=R.+Krikavovaauthor=J.+Hosekauthor=J.+Vancoauthor=J.+Hutyraauthor=Z.+Dvorakauthor=Z.+Travnicek&title=Gold%28I%29-triphenylphosphine+complexes+with+hypoxanthine-derived+ligands%3A+in+vitro+evaluations+of+anticancer+and+anti-inflammatory+activities&doi=10.1371%2Fjournal.pone.0107373"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0107373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0107373%26sid%3Dliteratum%253Aachs%26aulast%3DKrikavova%26aufirst%3DR.%26aulast%3DHosek%26aufirst%3DJ.%26aulast%3DVanco%26aufirst%3DJ.%26aulast%3DHutyra%26aufirst%3DJ.%26aulast%3DDvorak%26aufirst%3DZ.%26aulast%3DTravnicek%26aufirst%3DZ.%26atitle%3DGold%2528I%2529-triphenylphosphine%2520complexes%2520with%2520hypoxanthine-derived%2520ligands%253A%2520in%2520vitro%2520evaluations%2520of%2520anticancer%2520and%2520anti-inflammatory%2520activities%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De107373%26doi%3D10.1371%2Fjournal.pone.0107373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Seitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valbracht, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotz, M.</span><span> </span><span class="NLM_article-title">Gold sodium thiomalate and chloroquine inhibit cytokine production in monocytic THP-1 cells through distinct transcriptional and posttranslational mechanisms</span> <span class="citation_source-journal">J. Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">484</span><span class="refDoi"> DOI: 10.1023/B:JOCI.0000010424.41475.17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1023%2FB%3AJOCI.0000010424.41475.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=15031635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsF2n" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=477-484&author=M.+Seitzauthor=J.+Valbrachtauthor=J.+Quachauthor=M.+Lotz&title=Gold+sodium+thiomalate+and+chloroquine+inhibit+cytokine+production+in+monocytic+THP-1+cells+through+distinct+transcriptional+and+posttranslational+mechanisms&doi=10.1023%2FB%3AJOCI.0000010424.41475.17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Gold sodium thiomalate and chloroquine inhibit cytokine production in monocytic THP-1 cells through distinct transcriptional and posttranslational mechanisms</span></div><div class="casAuthors">Seitz, Michael; Valbracht, Jean; Quach, Jacqueline; Lotz, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">477-484</span>CODEN:
                <span class="NLM_cas:coden">JCIMDO</span>;
        ISSN:<span class="NLM_cas:issn">0271-9142</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Gold sodium thiomalate (GST), chloroquine (CQ), and methotrexate have been widely used in the therapy of rheumatoid arthritis and other inflammatory conditions.  Using the human monocytic cell line THP-1 we have analyzed effects of these drugs on cytokine prodn. and intracellular signaling.  GST and CQ were equally effective in reducing lipopolysaccharide (LPS)-induced IL-1β release while CQ was a more effective inhibitor of TNF-α prodn. than GST.  Methotrexate did not effect prodn. of these cytokines.  CQ reduced IL-1β mRNA expression and strongly inhibited phosphorylation of mitogen-activated protein kinase (MAPK) p38, and to a lesser extent c-Jun N-terminal kinase and extracellular signal-regulated kinase 1/2.  In contrast, GST did not effect cytokine mRNA expression or MAPK activation.  However, GST selectively inhibited the activity of the interleukin-1 converting enzyme (ICE)/caspase-1.  These data demonstrate that CQ inhibits IL-1β release from monocytes by interfering with pretranscriptional signaling and TNF-α release by posttranslational events whereas GST down-regulates IL-1β secretion by interfering with posttranslational IL-1β processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp36o-oRPxw4bVg90H21EOLACvtfcHk0ljFM2zg5sLbwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsF2n&md5=cf7995559e48562c010b4d05a3d255d2</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1023%2FB%3AJOCI.0000010424.41475.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253AJOCI.0000010424.41475.17%26sid%3Dliteratum%253Aachs%26aulast%3DSeitz%26aufirst%3DM.%26aulast%3DValbracht%26aufirst%3DJ.%26aulast%3DQuach%26aufirst%3DJ.%26aulast%3DLotz%26aufirst%3DM.%26atitle%3DGold%2520sodium%2520thiomalate%2520and%2520chloroquine%2520inhibit%2520cytokine%2520production%2520in%2520monocytic%2520THP-1%2520cells%2520through%2520distinct%2520transcriptional%2520and%2520posttranslational%2520mechanisms%26jtitle%3DJ.%2520Clin.%2520Immunol.%26date%3D2003%26volume%3D23%26spage%3D477%26epage%3D484%26doi%3D10.1023%2FB%3AJOCI.0000010424.41475.17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Jeon, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jue, D. M.</span><span> </span><span class="NLM_article-title">Gold compound auranofin inhibits IκB kinase (IKK) by modifying Cys-179 of IKKβ subunit</span> <span class="citation_source-journal">Exp. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><span class="refDoi"> DOI: 10.1038/emm.2003.9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Femm.2003.9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=12754408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktV2gsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=61-66&author=K.+I.+Jeonauthor=M.+S.+Byunauthor=D.+M.+Jue&title=Gold+compound+auranofin+inhibits+I%CE%BAB+kinase+%28IKK%29+by+modifying+Cys-179+of+IKK%CE%B2+subunit&doi=10.1038%2Femm.2003.9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Gold compound auranofin inhibits IκB kinase (IKK) by modifying Cys-179 of IKKβ subunit</span></div><div class="casAuthors">Jeon, Kye-Im; Byun, Mi-Sun; Jue, Dae-Myung</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Molecular Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">61-66</span>CODEN:
                <span class="NLM_cas:coden">EMMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1226-3613</span>.
    
            (<span class="NLM_cas:orgname">Korean Society of Medical Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Antirheumatic gold compds. have been shown to inhibit NF-κB activation by blocking IκB kinase (IKK) activity.  To examine the possible inhibitory mechanism of gold compds., we expressed wild type and mutant forms of IKKα and β subunits in COS-7 cells and detd. the effect of gold on the activity of these enzymes both in vivo and in vitro.  Substitution of Cys-179 of IKKβ with alanine (C179A) rendered the enzyme to become resistant to inhibition by a gold compd. auranofin, however, similar protective effect was not obsd. with an equiv. level of IKKα (C178A) mutant expressed in the cells.  Auranofin inhibited constitutively active IKKα and β and variants; IKKα (S176E, S180E) or IKKβ (S177E, S181E), suggesting that gold directly cause inhibition of activated enzyme.  The different inhibitory effect of auranofin on IKKα (C178A) and IKKβ (C179A) mutants indicates that gold could inhibit the two subunits of IKK in a different mode, and the inhibition of NF-κB and IKK activation induced by inflammatory signals in gold-treated cells appears through its interaction with Cys-179 of IKKβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqtYQQpMEm37Vg90H21EOLACvtfcHk0ljFM2zg5sLbwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktV2gsLY%253D&md5=d78da3e625a7137227e25e91c7e00d64</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Femm.2003.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femm.2003.9%26sid%3Dliteratum%253Aachs%26aulast%3DJeon%26aufirst%3DK.%2BI.%26aulast%3DByun%26aufirst%3DM.%2BS.%26aulast%3DJue%26aufirst%3DD.%2BM.%26atitle%3DGold%2520compound%2520auranofin%2520inhibits%2520I%25CE%25BAB%2520kinase%2520%2528IKK%2529%2520by%2520modifying%2520Cys-179%2520of%2520IKK%25CE%25B2%2520subunit%26jtitle%3DExp.%2520Mol.%2520Med.%26date%3D2003%26volume%3D35%26spage%3D61%26epage%3D66%26doi%3D10.1038%2Femm.2003.9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Travnicek, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starha, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silha, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchy, P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prazanova, G.</span><span> </span><span class="NLM_article-title">Anti-inflammatory active gold(I) complexes involving 6-substituted-purine derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4568</span><span class="NLM_x">–</span> <span class="NLM_lpage">4579</span><span class="refDoi"> DOI: 10.1021/jm201416p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201416p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4568-4579&author=Z.+Travnicekauthor=P.+Starhaauthor=J.+Vancoauthor=T.+Silhaauthor=J.+Hosekauthor=P.+Suchyauthor=G.+Prazanova&title=Anti-inflammatory+active+gold%28I%29+complexes+involving+6-substituted-purine+derivatives&doi=10.1021%2Fjm201416p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm201416p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201416p%26sid%3Dliteratum%253Aachs%26aulast%3DTravnicek%26aufirst%3DZ.%26aulast%3DStarha%26aufirst%3DP.%26aulast%3DVanco%26aufirst%3DJ.%26aulast%3DSilha%26aufirst%3DT.%26aulast%3DHosek%26aufirst%3DJ.%26aulast%3DSuchy%26aufirst%3DP.%26aulast%3DPrazanova%26aufirst%3DG.%26atitle%3DAnti-inflammatory%2520active%2520gold%2528I%2529%2520complexes%2520involving%25206-substituted-purine%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4568%26epage%3D4579%26doi%3D10.1021%2Fjm201416p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Shoeib, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, B. L.</span><span> </span><span class="NLM_article-title">Structural analysis of the anti-arthritic drug auranofin: its complexes with cysteine, selenocysteine and their fragmentation products</span> <span class="citation_source-journal">Inorg. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span><span class="refDoi"> DOI: 10.1016/j.ica.2009.08.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.ica.2009.08.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsV2js7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=184-192&author=T.+Shoeibauthor=D.+W.+Atkinsonauthor=B.+L.+Sharp&title=Structural+analysis+of+the+anti-arthritic+drug+auranofin%3A+its+complexes+with+cysteine%2C+selenocysteine+and+their+fragmentation+products&doi=10.1016%2Fj.ica.2009.08.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Structural analysis of the anti-arthritic drug Auranofin: Its complexes with cysteine, selenocysteine and their fragmentation products</span></div><div class="casAuthors">Shoeib, Tamer; Atkinson, Duncan W.; Sharp, Barry L.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganica Chimica Acta</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">184-192</span>CODEN:
                <span class="NLM_cas:coden">ICHAA3</span>;
        ISSN:<span class="NLM_cas:issn">0020-1693</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fragmentation of chloro(triethylphosphine)gold and the anti-arthritic agent Auranofin, [1-(thio-κS)-β-D-glucopyranose-2,3,4,6-tetraacetato](triethylphosphine)gold (1) in pos. mode MS electrospray conditions was studied in the presence of cysteine and Se-methylselenocysteine; relevant structures were calcd. at DFT B3LYP level of theory.  Evidence for all the complexes, with the exception of the Auranofin-selenocysteine complex, was obtained.  Several fragmentation products were examd. and their proposed structures reported.  Structural details of many exptl. obsd. ions including [Auranofin + H]+, [(Et3P)Au-cysteine]+ and [(Et3P)-Au-methylselenocysteine]+ were examd. by means of hybrid d. functional theory at the B3LYP/DZVP level.  Structural information and relative free energies are presented for several isomers of each ion considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow61KQUt_mgbVg90H21EOLACvtfcHk0ljFM2zg5sLbwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2js7fF&md5=cc443cf99701fb551747dcc179571179</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.ica.2009.08.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ica.2009.08.034%26sid%3Dliteratum%253Aachs%26aulast%3DShoeib%26aufirst%3DT.%26aulast%3DAtkinson%26aufirst%3DD.%2BW.%26aulast%3DSharp%26aufirst%3DB.%2BL.%26atitle%3DStructural%2520analysis%2520of%2520the%2520anti-arthritic%2520drug%2520auranofin%253A%2520its%2520complexes%2520with%2520cysteine%252C%2520selenocysteine%2520and%2520their%2520fragmentation%2520products%26jtitle%3DInorg.%2520Chim.%2520Acta%26date%3D2010%26volume%3D363%26spage%3D184%26epage%3D192%26doi%3D10.1016%2Fj.ica.2009.08.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Krikavova, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchy, P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travnicek, Z.</span><span> </span><span class="NLM_article-title">Diverse in vitro and in vivo anti-inflammatory effects of trichlorido-gold(III) complexes with N6-benzyladenine derivatives</span> <span class="citation_source-journal">J. Inorg. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1016/j.jinorgbio.2014.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.jinorgbio.2014.02.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2014&pages=92-99&author=R.+Krikavovaauthor=J.+Hosekauthor=P.+Suchyauthor=J.+Vancoauthor=Z.+Travnicek&title=Diverse+in+vitro+and+in+vivo+anti-inflammatory+effects+of+trichlorido-gold%28III%29+complexes+with+N6-benzyladenine+derivatives&doi=10.1016%2Fj.jinorgbio.2014.02.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2014.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2014.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DKrikavova%26aufirst%3DR.%26aulast%3DHosek%26aufirst%3DJ.%26aulast%3DSuchy%26aufirst%3DP.%26aulast%3DVanco%26aufirst%3DJ.%26aulast%3DTravnicek%26aufirst%3DZ.%26atitle%3DDiverse%2520in%2520vitro%2520and%2520in%2520vivo%2520anti-inflammatory%2520effects%2520of%2520trichlorido-gold%2528III%2529%2520complexes%2520with%2520N6-benzyladenine%2520derivatives%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2014%26volume%3D134%26spage%3D92%26epage%3D99%26doi%3D10.1016%2Fj.jinorgbio.2014.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Tett, S. E.</span><span> </span><span class="NLM_article-title">Clinical pharmacokinetics of slow-acting antirheumatic drugs</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span><span class="refDoi"> DOI: 10.2165/00003088-199325050-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.2165%2F00003088-199325050-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=7904547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADyaK2c7hs1amtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1993&pages=392-407&author=S.+E.+Tett&title=Clinical+pharmacokinetics+of+slow-acting+antirheumatic+drugs&doi=10.2165%2F00003088-199325050-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacokinetics of slow-acting antirheumatic drugs</span></div><div class="casAuthors">Tett S E</div><div class="citationInfo"><span class="NLM_cas:title">Clinical pharmacokinetics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">392-407</span>
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    </div><div class="casAbstract">The pharmacokinetics of the slow acting antirheumatic drugs (SAARDs), hydroxychloroquine, chloroquine, penicillamine, the gold complexes and sulphasalazine, in humans have been studied.  For all these drugs, both in controlled clinical trials and in empirical observations from rheumatological practice, delays of several months are reported before full clinical effects are achieved.  Variability in response is also characteristic of these agents.  Pharmacokinetic factors may partially explain these clinical observations.  Delays in the achievement of steady-state concentrations or of concentrations likely to have a therapeutic benefit may occur because of slow drug accumulation.  Variable concentrations may arise after standard administered doses because of interindividual pharmacokinetic variability.  These factors are likely to contribute to the delay in response and the variable response, respectively.  Pharmacokinetics of the antimalarials, hydroxychloroquine and chloroquine, are characterised by extensive tissue sequestration with reported volumes of distribution in the thousands of litres.  Both drugs have reported elimination half-lives of greater than 1 month.  A 2- to 3-fold range occurs in the fraction of an oral dose absorbed from a tablet formulation.  Variable interindividual clearance is also reported.  Hydroxychloroquine and chloroquine are administered as racemates.  Enantioselective disposition of both compounds occurs, again with notable interindividual variability.  Sulphasalazine is split in the large intestine into sulphapyridine, proposed to be the active compound in rheumatoid arthritis, and mesalazine (5-aminosalicylic acid).  Sulphapyridine is metabolised partly by acetylation, the rate of which is under genetic control.  A wide range of sulphapyridine steady-state concentrations are reported after standard doses of sulphasalazine.  The gold complexes are administered either intramuscularly or in an oral form (auranofin).  Gold is widely distributed in the body.  Very long terminal elimination half-lives and slow accumulation rates are reported.  Penicillamine is administered orally.  Its bioavailability is variable and may decrease by as much as 70% in the presence of food, antacids and iron salts.  Penicillamine forms disulphide bonds with many proteins in the blood and tissues, creating potential slow release reservoirs of the drug.  Like the other SAARDs, gold complexes and penicillamine are found in a wide range of blood concentrations after administration in standard doses to different individuals.  More research must be conducted into the concentration-effect relationships of the SAARDs before the pharmacokinetic characteristics of these drugs can be used effectively to optimise patient therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQUav1UOXD0MINpW7w2tapOfW6udTcc2eZFUBzl8GHLCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7hs1amtA%253D%253D&md5=8298ec9857970d6578b0382c757474ad</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.2165%2F00003088-199325050-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-199325050-00005%26sid%3Dliteratum%253Aachs%26aulast%3DTett%26aufirst%3DS.%2BE.%26atitle%3DClinical%2520pharmacokinetics%2520of%2520slow-acting%2520antirheumatic%2520drugs%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D1993%26volume%3D25%26spage%3D392%26epage%3D407%26doi%3D10.2165%2F00003088-199325050-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Roberts, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schliesman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, C. F.,  3rd.</span><span> </span><span class="NLM_article-title">Kinetics and mechanism of the reaction between serum albumin and auranofin (and its isopropyl analogue) in vitro</span> <span class="citation_source-journal">Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">424</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span><span class="refDoi"> DOI: 10.1021/ic9414280</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic9414280" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1996&pages=424-433&author=J.+R.+Robertsauthor=J.+Xiaoauthor=B.+Schliesmanauthor=D.+J.+Parsonsauthor=C.+F.+Shaw&title=Kinetics+and+mechanism+of+the+reaction+between+serum+albumin+and+auranofin+%28and+its+isopropyl+analogue%29+in+vitro&doi=10.1021%2Fic9414280"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fic9414280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic9414280%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DJ.%2BR.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DSchliesman%26aufirst%3DB.%26aulast%3DParsons%26aufirst%3DD.%2BJ.%26aulast%3DShaw%26aufirst%3DC.%2BF.%26atitle%3DKinetics%2520and%2520mechanism%2520of%2520the%2520reaction%2520between%2520serum%2520albumin%2520and%2520auranofin%2520%2528and%2520its%2520isopropyl%2520analogue%2529%2520in%2520vitro%26jtitle%3DInorg.%2520Chem.%26date%3D1996%26volume%3D35%26spage%3D424%26epage%3D433%26doi%3D10.1021%2Fic9414280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Talib, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, S. F.</span><span> </span><span class="NLM_article-title">A mass spectrometric investigation of the binding of gold antiarthritic agents and the metabolite [Au(CN)2]<sup>−</sup> to human serum albumin</span> <span class="citation_source-journal">J. Biol. Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span><span class="refDoi"> DOI: 10.1007/s00775-006-0103-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1007%2Fs00775-006-0103-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=16791640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVyjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=559-570&author=J.+Talibauthor=J.+L.+Beckauthor=S.+F.+Ralph&title=A+mass+spectrometric+investigation+of+the+binding+of+gold+antiarthritic+agents+and+the+metabolite+%5BAu%28CN%292%5D%E2%88%92+to+human+serum+albumin&doi=10.1007%2Fs00775-006-0103-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">A mass spectrometric investigation of the binding of gold antiarthritic agents and the metabolite [Au(CN)2]- to human serum albumin</span></div><div class="casAuthors">Talib, Jihan; Beck, Jennifer L.; Ralph, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">559-570</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Electrospray ionization (ESI) mass spectrometry was used to examine the reactions of the clin. used antiarthritic agent [Au(S2O3)2]3-, and AuPEt3Cl, a deriv. of another clin. used agent auranofin, with human serum albumin (HSA) obtained from a human volunteer.  Both compds. reacted readily with HSA to form complexes contg. one or more covalently attached gold fragments.  In the case of AuPEt3Cl, binding was accompanied by the loss of the chloride ligand, while for [Au(S2O3)2]3- the mass spectral data indicated binding of Au(S2O3) groups.  Expts. performed using HSA with Cys34 blocked by reaction with iodoacetamide were consistent with reaction of both gold compds. with this amino acid.  Sep. blocking expts. using diethylpyrocarbonate and AuPEt3Cl also provided evidence for histidine residues acting as lower-affinity binding sites for this gold compd.  ESI mass spectra of solns. contg. [Au(S2O3)2]3- or [Au(CN)2]-, and HSA, provided evidence for the formation of protein complexes in which intact gold mols. were noncovalently bound.  In the case of [Au(S2O3)2]3-, these noncovalent complexes proved to be transitory in nature.  However, for [Au(CN)2]- a noncovalent complex contg. a single gold mol. bound to HSA was found to be stable, and constituted the main adduct formed in solns. contg. low-to-medium Au-to-HSA ratios.  Evidence was also obtained for the formation of a covalent adduct in which a single Au(CN) moiety was bonded to Cys34 of the protein.  AuPEt3Cl reacted to a much lower extent with HSA that had Cys34 modified by formation of a disulfide bond to added cysteine, than with unmodified HSA.  This suggests that the extent of modification of the protein in vivo may have an important influence on the transport and bioavailability of gold antiarthritic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsi-NRWEcW0rVg90H21EOLACvtfcHk0lhLxGkeliwqDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVyjtbo%253D&md5=5f4e5fd0a39bf4705bd8e39d18cd5d05</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1007%2Fs00775-006-0103-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-006-0103-z%26sid%3Dliteratum%253Aachs%26aulast%3DTalib%26aufirst%3DJ.%26aulast%3DBeck%26aufirst%3DJ.%2BL.%26aulast%3DRalph%26aufirst%3DS.%2BF.%26atitle%3DA%2520mass%2520spectrometric%2520investigation%2520of%2520the%2520binding%2520of%2520gold%2520antiarthritic%2520agents%2520and%2520the%2520metabolite%2520%255BAu%2528CN%25292%255D%25E2%2588%2592%2520to%2520human%2520serum%2520albumin%26jtitle%3DJ.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2006%26volume%3D11%26spage%3D559%26epage%3D570%26doi%3D10.1007%2Fs00775-006-0103-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Wallin, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCafferty, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godschmidt, M. S.</span><span> </span><span class="NLM_article-title">Incidence and management of diarrhea during longterm auranofin therapy</span> <span class="citation_source-journal">J. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1755</span><span class="NLM_x">–</span> <span class="NLM_lpage">1758</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=3265956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADyaL1M7lslCltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1988&pages=1755-1758&author=B.+A.+Wallinauthor=J.+P.+McCaffertyauthor=M.+J.+Foxauthor=D.+R.+Cooperauthor=M.+S.+Godschmidt&title=Incidence+and+management+of+diarrhea+during+longterm+auranofin+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Incidence and management of diarrhea during longterm auranofin therapy</span></div><div class="casAuthors">Wallin B A; McCafferty J P; Fox M J; Cooper D R; Goldschmidt M S</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of rheumatology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1755-8</span>
        ISSN:<span class="NLM_cas:issn">0315-162X</span>.
    </div><div class="casAbstract">The incidence, severity, and management of diarrhea during longterm administration of auranofin (AF)--up to 33 months--were evaluated prospectively in 137 patients with active rheumatoid arthritis.  At least 1 episode of diarrhea was reported in 101 patients (74%), but the rate of occurrence/patient-months of therapy was 24% (569 events/2,370 patient-months of treatment).  The monthly prevalence declined from a range of 30-40% during the initial 6 months to about 10% for patients treated for 18-24 months.  Most diarrhea was intermittent and mild; only 11 patients (8%) discontinued treatment because of diarrheal symptoms.  No intervention was required in 46 of the 101 patients affected.  In 44 others, loose stools were successfully managed with antidiarrheal medications, a reduction in dosage, or both.  Although diarrhea is a common event during AF administration, particularly early in therapy, for most patients it usually does not significantly interfere with treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSaUyrCkp1Jdlf1XRtfYM0dfW6udTcc2ebXncohvveLZrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M7lslCltQ%253D%253D&md5=6468f1dba43043d9c1cdd5fd9650422e</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWallin%26aufirst%3DB.%2BA.%26aulast%3DMcCafferty%26aufirst%3DJ.%2BP.%26aulast%3DFox%26aufirst%3DM.%2BJ.%26aulast%3DCooper%26aufirst%3DD.%2BR.%26aulast%3DGodschmidt%26aufirst%3DM.%2BS.%26atitle%3DIncidence%2520and%2520management%2520of%2520diarrhea%2520during%2520longterm%2520auranofin%2520therapy%26jtitle%3DJ.%2520Rheumatol.%26date%3D1988%26volume%3D15%26spage%3D1755%26epage%3D1758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Juliana, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes-Alnemri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Datta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solorzano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quong, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E. S.</span><span> </span><span class="NLM_article-title">Anti-inflammatory compounds parthenolide and bay 11–7082 are direct inhibitors of the inflammasome</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">9792</span><span class="NLM_x">–</span> <span class="NLM_lpage">9802</span><span class="refDoi"> DOI: 10.1074/jbc.M109.082305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M109.082305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20093358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjsFehtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=9792-9802&author=C.+Julianaauthor=T.+Fernandes-Alnemriauthor=J.+Wuauthor=P.+Dattaauthor=L.+Solorzanoauthor=J.+W.+Yuauthor=R.+Mengauthor=A.+A.+Quongauthor=E.+Latzauthor=C.+P.+Scottauthor=E.+S.+Alnemri&title=Anti-inflammatory+compounds+parthenolide+and+bay+11%E2%80%937082+are+direct+inhibitors+of+the+inflammasome&doi=10.1074%2Fjbc.M109.082305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome</span></div><div class="casAuthors">Juliana, Christine; Fernandes-Alnemri, Teresa; Wu, Jianghong; Datta, Pinaki; Solorzano, Leobaldo; Yu, Je-Wook; Meng, Rong; Quong, Andrew A.; Latz, Eicke; Scott, Charles P.; Alnemri, Emad S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">9792-9802</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Activation of the inflammasome generates the pro-inflammatory cytokines interleukin-1β and -18, which are important mediators of inflammation.  Abnormal activation of the inflammasome leads to many inflammatory diseases, including gout, silicosis, neurodegeneration, and genetically inherited periodic fever syndromes.  Therefore, identification of small mol. inhibitors that target the inflammasome is an important step toward developing effective therapeutics for the treatment of inflammation.  Here, we show that the herbal NF-κB inhibitory compd. parthenolide inhibits the activity of multiple inflammasomes in macrophages by directly inhibiting the protease activity of caspase-1.  Addnl. investigations of other NF-κB inhibitors revealed that the synthetic IκB kinase-β inhibitor Bay 11-7082 and structurally related vinyl sulfone compds. selectively inhibit NLRP3 inflammasome activity in macrophages independent of their inhibitory effect on NF-κB activity.  In vitro assays of the effect of parthenolide and Bay 11-7082 on the ATPase activity of NLRP3 demonstrated that both compds. inhibit the ATPase activity of NLRP3, suggesting that the inhibitory effect of these compds. on inflammasome activity could be mediated in part through their effect on the ATPase activity of NLRP3.  Our results thus elucidate the mol. mechanism for the therapeutic anti-inflammatory activity of parthenolide and identify vinyl sulfones as a new class of potential therapeutics that target the NLRP3 inflammasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUzn3dZTa4nLVg90H21EOLACvtfcHk0lghGD4Ac9F8pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjsFehtLk%253D&md5=d834b6cd4977c3a46df0cf075e3fa6df</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.082305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.082305%26sid%3Dliteratum%253Aachs%26aulast%3DJuliana%26aufirst%3DC.%26aulast%3DFernandes-Alnemri%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DDatta%26aufirst%3DP.%26aulast%3DSolorzano%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DJ.%2BW.%26aulast%3DMeng%26aufirst%3DR.%26aulast%3DQuong%26aufirst%3DA.%2BA.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DScott%26aufirst%3DC.%2BP.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26atitle%3DAnti-inflammatory%2520compounds%2520parthenolide%2520and%2520bay%252011%25E2%2580%25937082%2520are%2520direct%2520inhibitors%2520of%2520the%2520inflammasome%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D9792%26epage%3D9802%26doi%3D10.1074%2Fjbc.M109.082305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span> </span><span class="NLM_article-title">Parthenolide inhibits LPS-induced inflammatory cytokines through the toll-like receptor 4 signal pathway in THP-1 cells</span> <span class="citation_source-journal">Acta Biochim. Biophys. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span><span class="refDoi"> DOI: 10.1093/abbs/gmv019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1093%2Fabbs%2Fgmv019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=25841439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADC%252BC2MjhtVemsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2015&pages=368-375&author=S.+Liauthor=X.+Gaoauthor=X.+Wuauthor=Z.+Wuauthor=L.+Chengauthor=L.+Zhuauthor=D.+Shenauthor=X.+Tong&title=Parthenolide+inhibits+LPS-induced+inflammatory+cytokines+through+the+toll-like+receptor+4+signal+pathway+in+THP-1+cells&doi=10.1093%2Fabbs%2Fgmv019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide inhibits LPS-induced inflammatory cytokines through the toll-like receptor 4 signal pathway in THP-1 cells</span></div><div class="casAuthors">Li Shuangshuang; Tong Xiangmin; Gao Xiangli; Zhu Lifen; Shen Dan; Wu Xiaoxin; Wu Zhigang; Cheng Linfang</div><div class="citationInfo"><span class="NLM_cas:title">Acta biochimica et biophysica Sinica</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">368-75</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Parthenolide (PTL) shows potent anti-inflammatory and anti-cancer activities.  In the present study, the molecular mechanisms of PTL's activities were explored in lipopolysaccharide (LPS)-induced human leukemia monocytic THP-1 cells and human primary monocytes.  The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt (MTS) assay was used to analyze the effect of PTL on THP-1 cell viability.  Enzyme-linked immunosorbent assay was used to determine the effect of PTL on LPS-induced inflammatory cytokine secretion.  Flow cytometry and quantitative real-time polymerase chain reaction were used to assess the effect of PTL on LPS-induced toll-like receptor 4 (TLR4) expression.  Phosphorylation levels of signaling molecules were determined by western blot analysis.  Results showed that PTL <12.5 μM did not significantly affect THP-1 cells viability.  LPS treatment led to a marked up-regulation of interleukin (IL)-6, IL-1β, IL-8, IL-12p40, tumor necrosis factor-α, IL-18, and NO in THP-1 cells.  However, PTL inhibited the expression of these cytokines in a dose-dependent manner, with IC50 values of 1.091-2.620 μM.  PTL blocked TLR4 expression with an IC50 value of 1.373 μM as determined by the flow cytometry analysis, and this blocking effect was verified at both protein and mRNA levels.  Up-regulation of phosphorylation levels of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, p38, nuclear factor κB (NF-κB) p65, and IκBα and up-regulation of expressions of other molecules (inducible nitric oxide synthase, TLR4, and TNF receptor-associated factor 6) induced by LPS were abolished by PTL in a dose-dependent manner.  The anti-inflammatory mechanisms of PTL operate partly through the TLR4-mediated mitogen-activated protein kinase and NF-κB signaling pathways.  Therefore, TLR4 may be a new target for anti-inflammation therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAm875nepcNi6Ufuk_1xoTfW6udTcc2ebXncohvveLZrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjhtVemsA%253D%253D&md5=ad7811239d8c643a23c0fd726a2a29cb</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1093%2Fabbs%2Fgmv019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fabbs%252Fgmv019%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DD.%26aulast%3DTong%26aufirst%3DX.%26atitle%3DParthenolide%2520inhibits%2520LPS-induced%2520inflammatory%2520cytokines%2520through%2520the%2520toll-like%2520receptor%25204%2520signal%2520pathway%2520in%2520THP-1%2520cells%26jtitle%3DActa%2520Biochim.%2520Biophys.%2520Sin.%26date%3D2015%26volume%3D47%26spage%3D368%26epage%3D375%26doi%3D10.1093%2Fabbs%2Fgmv019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Strickson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmerich, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knebel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plater, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritorto, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shpiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The anti-inflammatory drug bay 11–7082 suppresses the MyD88-dependent signalling network by targeting the ubiquitin system</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">451</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span><span class="refDoi"> DOI: 10.1042/BJ20121651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1042%2FBJ20121651" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=451&publication_year=2013&pages=427-437&author=S.+Stricksonauthor=D.+G.+Campbellauthor=C.+H.+Emmerichauthor=A.+Knebelauthor=L.+Platerauthor=M.+S.+Ritortoauthor=N.+Shpiroauthor=P.+Cohen&title=The+anti-inflammatory+drug+bay+11%E2%80%937082+suppresses+the+MyD88-dependent+signalling+network+by+targeting+the+ubiquitin+system&doi=10.1042%2FBJ20121651"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1042%2FBJ20121651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20121651%26sid%3Dliteratum%253Aachs%26aulast%3DStrickson%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DD.%2BG.%26aulast%3DEmmerich%26aufirst%3DC.%2BH.%26aulast%3DKnebel%26aufirst%3DA.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DRitorto%26aufirst%3DM.%2BS.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520anti-inflammatory%2520drug%2520bay%252011%25E2%2580%25937082%2520suppresses%2520the%2520MyD88-dependent%2520signalling%2520network%2520by%2520targeting%2520the%2520ubiquitin%2520system%26jtitle%3DBiochem.%2520J.%26date%3D2013%26volume%3D451%26spage%3D427%26epage%3D437%26doi%3D10.1042%2FBJ20121651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Avonto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taglialatela-Scafati, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minassi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Petrocellis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appendino, G.</span><span> </span><span class="NLM_article-title">An NMR spectroscopic method to identify and classify thiol-trapping agents: revival of michael acceptors for drug discovery?</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span><span class="refDoi"> DOI: 10.1002/anie.201005959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1002%2Fanie.201005959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitlGiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=467-471&author=C.+Avontoauthor=O.+Taglialatela-Scafatiauthor=F.+Pollastroauthor=A.+Minassiauthor=V.+Di+Marzoauthor=L.+De+Petrocellisauthor=G.+Appendino&title=An+NMR+spectroscopic+method+to+identify+and+classify+thiol-trapping+agents%3A+revival+of+michael+acceptors+for+drug+discovery%3F&doi=10.1002%2Fanie.201005959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">An NMR Spectroscopic Method to Identify and Classify Thiol-Trapping Agents: Revival of Michael Acceptors for Drug Discovery?</span></div><div class="casAuthors">Avonto, Cristina; Taglialatela-Scafati, Orazio; Pollastro, Federica; Minassi, Alberto; Di Marzo, Vincenzo; De Petrocellis, Luciano; Appendino, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">467-471, S467/1-S467/30</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We have developed a simple and quick NMR spectroscopic method to identify Michael acceptor sites in complex multifunctional compds.  The method sorts them out in reversible and irreversible thiol sinks, and predicts their potential to modify proteins, as validated by the identification of several new chemotypes of TRPA1 activators.  These include well-known anti-inflammatory agents, such as curcumin and parthenolide, which had been overlooked as ligands for this druggable end point of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt8t1J015hqbVg90H21EOLACvtfcHk0lhkLlObFkKJNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitlGiuw%253D%253D&md5=8fd61bce5e0dfeb9209a6572516fd583</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1002%2Fanie.201005959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201005959%26sid%3Dliteratum%253Aachs%26aulast%3DAvonto%26aufirst%3DC.%26aulast%3DTaglialatela-Scafati%26aufirst%3DO.%26aulast%3DPollastro%26aufirst%3DF.%26aulast%3DMinassi%26aufirst%3DA.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26aulast%3DAppendino%26aufirst%3DG.%26atitle%3DAn%2520NMR%2520spectroscopic%2520method%2520to%2520identify%2520and%2520classify%2520thiol-trapping%2520agents%253A%2520revival%2520of%2520michael%2520acceptors%2520for%2520drug%2520discovery%253F%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D467%26epage%3D471%26doi%3D10.1002%2Fanie.201005959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Saadane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiDonato, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, M.</span><span> </span><span class="NLM_article-title">Parthenolide inhibits IκB kinase, NF-κB activation, and inflammatory response in cystic fibrosis cells and mice</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">728</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span><span class="refDoi"> DOI: 10.1165/rcmb.2006-0323OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1165%2Frcmb.2006-0323OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=17272824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmslOlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2007&pages=728-736&author=A.+Saadaneauthor=S.+Mastersauthor=J.+DiDonatoauthor=J.+Liauthor=M.+Berger&title=Parthenolide+inhibits+I%CE%BAB+kinase%2C+NF-%CE%BAB+activation%2C+and+inflammatory+response+in+cystic+fibrosis+cells+and+mice&doi=10.1165%2Frcmb.2006-0323OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide inhibits IκB kinase, NF-κB activation, and inflammatory response in cystic fibrosis cells and mice</span></div><div class="casAuthors">Saadane, Aicha; Masters, Sophia; DiDonato, Joseph; Li, Jingfeng; Berger, Melvin</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">728-736</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Cystic fibrosis (CF) is characterized by prolonged and excessive inflammatory responses in the lung and increased activation of NF-κB.  Parthenolide is a sesquiterpene lactone derived from the plant feverfew, which has been used in folk medicine for antiinflammatory activity.  Several studies suggest that this compd. inhibits the NF-κB pathway, but the exact site is controversial.  We hypothesized that parthenolide might ameliorate the excessive inflammatory response in CF models by inhibiting activation of NF-κB.  This was tested in vitro, using two pairs of cell lines with defective vs. normal CF transmembrane conductance regulator (CFTR) (antisense/sense transfected 16 HBE and IB-3/S9), and in vivo, using CFTR-knockout (KO) mice.  All cell lines were pretreated with parthenolide and then stimulated with IL-1β and/or TNF.  Parthenolide significantly inhibited IL-8 secretion induced by these cytokines and prevented NF-κB activation, IκBα degrdn., and IκB Kinase complex activity.  CFTR-KO and wild-type mice were pretreated with parthenolide or vehicle alone then challenged intratracheally with LPS.  Bronchoalveolar lavage was performed 3, 6, and 8 h later.  Parthenolide pretreatment inhibited PMN influx as well as cytokine and chemokine prodn.  This was also assocd. with inhibition of IκBα degrdn. and NF-κB activation.  We thus conclude that parthenolide inhibits IκB kinase, resulting in stabilization of cytoplasmic IκBα, which in turn leads to inhibition of NF-κB translocation and attenuation of subsequent inflammatory responses.  IκB kinase may be a good target, and parthenolide and/or feverfew might be promising treatments for the excessive inflammation in CF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBcSLbwwBaKrVg90H21EOLACvtfcHk0lhkLlObFkKJNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmslOlur0%253D&md5=9123338efa0254ee3d8bf4d4034c7614</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2006-0323OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2006-0323OC%26sid%3Dliteratum%253Aachs%26aulast%3DSaadane%26aufirst%3DA.%26aulast%3DMasters%26aufirst%3DS.%26aulast%3DDiDonato%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBerger%26aufirst%3DM.%26atitle%3DParthenolide%2520inhibits%2520I%25CE%25BAB%2520kinase%252C%2520NF-%25CE%25BAB%2520activation%252C%2520and%2520inflammatory%2520response%2520in%2520cystic%2520fibrosis%2520cells%2520and%2520mice%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2007%26volume%3D36%26spage%3D728%26epage%3D736%26doi%3D10.1165%2Frcmb.2006-0323OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">García-Piñeres, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mora, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strunck, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pahl, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merfort, I.</span><span> </span><span class="NLM_article-title">Cysteine 38 in p65/NF-κB plays a crucial role in DNA binding inhibition by sesquiterpene lactones</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">39713</span><span class="NLM_x">–</span> <span class="NLM_lpage">39720</span><span class="refDoi"> DOI: 10.1074/jbc.M101985200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M101985200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=39713-39720&author=A.+J.+Garc%C3%ADa-Pi%C3%B1eresauthor=V.+Castroauthor=G.+Moraauthor=T.+J.+Schmidtauthor=E.+Strunckauthor=H.+L.+Pahlauthor=I.+Merfort&title=Cysteine+38+in+p65%2FNF-%CE%BAB+plays+a+crucial+role+in+DNA+binding+inhibition+by+sesquiterpene+lactones&doi=10.1074%2Fjbc.M101985200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M101985200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M101985200%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa-Pi%25C3%25B1eres%26aufirst%3DA.%2BJ.%26aulast%3DCastro%26aufirst%3DV.%26aulast%3DMora%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DT.%2BJ.%26aulast%3DStrunck%26aufirst%3DE.%26aulast%3DPahl%26aufirst%3DH.%2BL.%26aulast%3DMerfort%26aufirst%3DI.%26atitle%3DCysteine%252038%2520in%2520p65%252FNF-%25CE%25BAB%2520plays%2520a%2520crucial%2520role%2520in%2520DNA%2520binding%2520inhibition%2520by%2520sesquiterpene%2520lactones%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D39713%26epage%3D39720%26doi%3D10.1074%2Fjbc.M101985200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Meng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond-Stintz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, B. S.</span><span> </span><span class="NLM_article-title">IKK inhibitor bay 11–7082 induces necroptotic cell death in precursor-B acute lymphoblastic leukaemic blasts</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">487</span><span class="NLM_x">–</span> <span class="NLM_lpage">490</span><span class="refDoi"> DOI: 10.1111/j.1365-2141.2009.07988.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1111%2Fj.1365-2141.2009.07988.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=19958360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADC%252BC3c%252FktV2ksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2010&pages=487-490&author=X.+Mengauthor=M.+A.+Martinezauthor=M.+A.+Raymond-Stintzauthor=S.+S.+Winterauthor=B.+S.+Wilson&title=IKK+inhibitor+bay+11%E2%80%937082+induces+necroptotic+cell+death+in+precursor-B+acute+lymphoblastic+leukaemic+blasts&doi=10.1111%2Fj.1365-2141.2009.07988.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">IKK inhibitor bay 11-7082 induces necroptotic cell death in precursor-B acute lymphoblastic leukaemic blasts</span></div><div class="casAuthors">Meng Xiangbing; Martinez Marina A; Raymond-Stintz Mary A; Winter Stuart S; Wilson Bridget S</div><div class="citationInfo"><span class="NLM_cas:title">British journal of haematology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">487-90</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAMyeEv3au04JKJbLTgsvCfW6udTcc2eaYJ7eo0BWcxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c%252FktV2ksQ%253D%253D&md5=6e9eeef37372b6aeb3d033997cf57f06</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.2009.07988.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.2009.07988.x%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DMartinez%26aufirst%3DM.%2BA.%26aulast%3DRaymond-Stintz%26aufirst%3DM.%2BA.%26aulast%3DWinter%26aufirst%3DS.%2BS.%26aulast%3DWilson%26aufirst%3DB.%2BS.%26atitle%3DIKK%2520inhibitor%2520bay%252011%25E2%2580%25937082%2520induces%2520necroptotic%2520cell%2520death%2520in%2520precursor-B%2520acute%2520lymphoblastic%2520leukaemic%2520blasts%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2010%26volume%3D148%26spage%3D487%26epage%3D490%26doi%3D10.1111%2Fj.1365-2141.2009.07988.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Krishnan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bencze, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonks, N. K.</span><span> </span><span class="NLM_article-title">The anti-inflammatory compound bay-11–7082 is a potent inhibitor of protein tyrosine phosphatases</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">2830</span><span class="NLM_x">–</span> <span class="NLM_lpage">2841</span><span class="refDoi"> DOI: 10.1111/febs.12283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1111%2Ffebs.12283" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=2830-2841&author=N.+Krishnanauthor=G.+Benczeauthor=P.+Cohenauthor=N.+K.+Tonks&title=The+anti-inflammatory+compound+bay-11%E2%80%937082+is+a+potent+inhibitor+of+protein+tyrosine+phosphatases&doi=10.1111%2Ffebs.12283"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12283%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnan%26aufirst%3DN.%26aulast%3DBencze%26aufirst%3DG.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DTonks%26aufirst%3DN.%2BK.%26atitle%3DThe%2520anti-inflammatory%2520compound%2520bay-11%25E2%2580%25937082%2520is%2520a%2520potent%2520inhibitor%2520of%2520protein%2520tyrosine%2520phosphatases%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D2830%26epage%3D2841%26doi%3D10.1111%2Ffebs.12283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Kwok, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ndubuisi, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elofsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">The anti-inflammatory natural product parthenolide from the medicinal herb feverfew directly binds to and inhibits IκB kinase</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">766</span><span class="refDoi"> DOI: 10.1016/S1074-5521(01)00049-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2FS1074-5521%2801%2900049-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=11514225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtV2ku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=759-766&author=B.+H.+Kwokauthor=B.+Kohauthor=M.+I.+Ndubuisiauthor=M.+Elofssonauthor=C.+M.+Crews&title=The+anti-inflammatory+natural+product+parthenolide+from+the+medicinal+herb+feverfew+directly+binds+to+and+inhibits+I%CE%BAB+kinase&doi=10.1016%2FS1074-5521%2801%2900049-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IκB kinase</span></div><div class="casAuthors">Kwok, B. H. B.; Koh, B.; Ndubuisi, M. I.; Elofsson, M.; Crews, C. M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">759-766</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Biol. active natural products continue to be useful in the exploration and control of intracellular signaling processes.  For example, the sesquiterpene lactone parthenolide from the anti-inflammatory medicinal herb Feverfew (Tanacetum parthenium) appears to inhibit the pro-inflammatory signaling pathway.  Parthenolide's direct mol. target, however, remains unknown.  We set out to identify the mol. mechanisms of parthenolide's anti-inflammatory activity.  A parthenolide affinity reagent was synthesized and shown to bind directly to and inhibit IB kinase (IKK), the kinase subunit known to play a crit. role in cytokine-mediated signaling.  Mutation of cysteine 179 in the activation loop of IKKβ abolished sensitivity towards parthenolide.  Moreover, we showed that parthenolide's in vitro and in vivo anti-inflammatory activity is mediated through the α-methylene γ-lactone moiety shared by other sesquiterpene lactones.  In recent years, the multi-subunit IKK complex has been shown to be responsible for cytokine-mediated stimulation of genes involved in inflammation and as such represents an attractive target for pharmaceutical intervention.  Our finding that parthenolide targets this kinase complex provides a possible mol. basis for the anti-inflammatory properties of parthenolide.  In addn., these results may be useful in the development of addnl. anti-inflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9wzcv0O9mwrVg90H21EOLACvtfcHk0lj6p73FtRgiNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtV2ku7k%253D&md5=bf8be7acdd42fd794f9ad10df20ffa5d</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2801%2900049-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252801%252900049-7%26sid%3Dliteratum%253Aachs%26aulast%3DKwok%26aufirst%3DB.%2BH.%26aulast%3DKoh%26aufirst%3DB.%26aulast%3DNdubuisi%26aufirst%3DM.%2BI.%26aulast%3DElofsson%26aufirst%3DM.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DThe%2520anti-inflammatory%2520natural%2520product%2520parthenolide%2520from%2520the%2520medicinal%2520herb%2520feverfew%2520directly%2520binds%2520to%2520and%2520inhibits%2520I%25CE%25BAB%2520kinase%26jtitle%3DChem.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D759%26epage%3D766%26doi%3D10.1016%2FS1074-5521%2801%2900049-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Dong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C.</span><span> </span><span class="NLM_article-title">Parthenolide is neuroprotective in rat experimental stroke model: Downregulating NF-κB, phospho-p38MAPK, and caspase-1 and ameliorating BBB permeability</span> <span class="citation_source-journal">Mediators Inflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">370804</span><span class="refDoi"> DOI: 10.1155/2013/370804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1155%2F2013%2F370804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=23935248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADC%252BC3sfoslKquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=370804&author=L.+Dongauthor=H.+Qiaoauthor=X.+Zhangauthor=X.+Zhangauthor=C.+Wangauthor=L.+Wangauthor=L.+Cuiauthor=J.+Zhaoauthor=Y.+Xingauthor=Y.+Liauthor=Z.+Liuauthor=C.+Zhu&title=Parthenolide+is+neuroprotective+in+rat+experimental+stroke+model%3A+Downregulating+NF-%CE%BAB%2C+phospho-p38MAPK%2C+and+caspase-1+and+ameliorating+BBB+permeability&doi=10.1155%2F2013%2F370804"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide is neuroprotective in rat experimental stroke model: downregulating NF-κB, phospho-p38MAPK, and caspase-1 and ameliorating BBB permeability</span></div><div class="casAuthors">Dong Lipeng; Qiao Huimin; Zhang Xiangjian; Zhang Xiaolin; Wang Chaohui; Wang Lina; Cui Lili; Zhao Jingru; Xing Yinxue; Li Yanhua; Liu Zongjie; Zhu Chunhua</div><div class="citationInfo"><span class="NLM_cas:title">Mediators of inflammation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2013</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">370804</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">UNLABELLED:  Inflammatory damage plays an important role in cerebral ischemic pathogenesis and may represent a target for treatment.  Parthenolide (PN) has been proved to elicit a wide range of biological activities through its anti-inflammatory action in the treatment of migraine, arthritis, and atherosclerosis.  To decide whether this effect applies to ischemic injury in brain, we therefore investigate the potential neuroprotective role of PN and the underlying mechanisms.  Male Sprague-Dawley rats were randomly divided into Saline, Vehicle, and PN groups and a permanent middle cerebral artery occlusion (MCAO) model was used.  PN administered intraperitoneally immediately after cerebral ischemia and once daily on the following days.  At time points after MCAO, neurological deficit, infarct volume, and brain water content were measured.  Immunohistochemistry, western blot and RT-PCR were used to analyze the expression of NF- κ B and caspase-1 in ischemic brain tissue.  Phospho-p38MAPK and claudin-5 were detected by western blot.  The results indicated that PN dramatically ameliorated neurological deficit, brain water content, and infarct volume, downregulated NF- κ B, phospho-p38MAPK, and caspase-1 expressions, and upregulated claudin-5 expression in ischemic brain tissue.  CONCLUSIONS:  PN protected the brain from damage caused by MCAO; this effect may be through downregulating NF- κ B, phosho-p38MAPK, and caspase-1 expressions and ameliorating BBB permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRmlADo7JYRJ2HOrQ6qeX-mfW6udTcc2eaYJ7eo0BWcxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfoslKquw%253D%253D&md5=4ec3edab83593452865d28e24f2cf5dc</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1155%2F2013%2F370804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F370804%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DL.%26aulast%3DQiao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DXing%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DC.%26atitle%3DParthenolide%2520is%2520neuroprotective%2520in%2520rat%2520experimental%2520stroke%2520model%253A%2520Downregulating%2520NF-%25CE%25BAB%252C%2520phospho-p38MAPK%252C%2520and%2520caspase-1%2520and%2520ameliorating%2520BBB%2520permeability%26jtitle%3DMediators%2520Inflammation%26date%3D2013%26volume%3D2013%26spage%3D370804%26doi%3D10.1155%2F2013%2F370804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Guzman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelakantan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassane, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachowicz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liesveld, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, C. T.</span><span> </span><span class="NLM_article-title">An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">4427</span><span class="NLM_x">–</span> <span class="NLM_lpage">4435</span><span class="refDoi"> DOI: 10.1182/blood-2007-05-090621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1182%2Fblood-2007-05-090621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=17804695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1Wg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2007&pages=4427-4435&author=M.+L.+Guzmanauthor=R.+M.+Rossiauthor=S.+Neelakantanauthor=X.+Liauthor=C.+A.+Corbettauthor=D.+C.+Hassaneauthor=M.+W.+Beckerauthor=J.+M.+Bennettauthor=E.+Sullivanauthor=J.+L.+Lachowiczauthor=A.+Vaughanauthor=C.+J.+Sweeneyauthor=W.+Matthewsauthor=M.+Carrollauthor=J.+L.+Liesveldauthor=P.+A.+Crooksauthor=C.+T.+Jordan&title=An+orally+bioavailable+parthenolide+analog+selectively+eradicates+acute+myelogenous+leukemia+stem+and+progenitor+cells&doi=10.1182%2Fblood-2007-05-090621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells</span></div><div class="casAuthors">Guzman, Monica L.; Rossi, Randall M.; Neelakantan, Sundar; Li, Xiaojie; Corbett, Cheryl A.; Hassane, Duane C.; Becker, Michael W.; Bennett, John M.; Sullivan, Edmund; Lachowicz, Joshua L.; Vaughan, Andrew; Sweeney, Christopher J.; Matthews, William; Carroll, Martin; Liesveld, Jane L.; Crooks, Peter A.; Jordan, Craig T.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4427-4435</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Leukemia stem cells (LSCs) are thought to play a central role in the pathogenesis of acute leukemia and likely contribute to both disease initiation and relapse.  Therefore, identification of agents that target LSCs is an important consideration for the development of new therapies.  To this end, we have previously demonstrated that the naturally occurring compd. parthenolide (PTL) can induce death of human LSCs in vitro while sparing normal hematopoletic cells.  However, PTL has relatively poor pharmacol. properties that limit its potential clin. use.  Consequently, we generated a family of PTL analogs designed to improve soly. and bioavailability.  These studies identified an analog, dimethylaminoparthenolide (DMAPT), which induces rapid death of primary human LSCs from both myeloid and lymphoid leukemias, and is also highly cytotoxic to bulk leukemic cell populations.  Mol. studies indicate the prevalent activities of DMAPT include induction of oxidative stress responses, inhibition of NF-κB, and activation of p53.  The compd. has approx. 70% oral bioavailability, and pharmacol. studies using both mouse xenograft models and spontaneous acute canine leukemias demonstrate in vivo bioactivity as detd. by functional assays and multiple biomarkers.  Therefore, based on the collective preclin. data, we propose that the novel compd. DMAPT has the potential to target human LSCs in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9EOlsw8KCBbVg90H21EOLACvtfcHk0lilCkmiu0chGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1Wg&md5=921e2df12d1c4084fad14b072c200850</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-05-090621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-05-090621%26sid%3Dliteratum%253Aachs%26aulast%3DGuzman%26aufirst%3DM.%2BL.%26aulast%3DRossi%26aufirst%3DR.%2BM.%26aulast%3DNeelakantan%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DCorbett%26aufirst%3DC.%2BA.%26aulast%3DHassane%26aufirst%3DD.%2BC.%26aulast%3DBecker%26aufirst%3DM.%2BW.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DSullivan%26aufirst%3DE.%26aulast%3DLachowicz%26aufirst%3DJ.%2BL.%26aulast%3DVaughan%26aufirst%3DA.%26aulast%3DSweeney%26aufirst%3DC.%2BJ.%26aulast%3DMatthews%26aufirst%3DW.%26aulast%3DCarroll%26aufirst%3DM.%26aulast%3DLiesveld%26aufirst%3DJ.%2BL.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DJordan%26aufirst%3DC.%2BT.%26atitle%3DAn%2520orally%2520bioavailable%2520parthenolide%2520analog%2520selectively%2520eradicates%2520acute%2520myelogenous%2520leukemia%2520stem%2520and%2520progenitor%2520cells%26jtitle%3DBlood%26date%3D2007%26volume%3D110%26spage%3D4427%26epage%3D4435%26doi%3D10.1182%2Fblood-2007-05-090621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Shanmugam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusumanchi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appaiah, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelakantan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaunig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakshatri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, C. J.</span><span> </span><span class="NLM_article-title">A water soluble parthenolide analog suppresses <i>in vivo</i> tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-κB and generating reactive oxygen species</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">2481</span><span class="NLM_x">–</span> <span class="NLM_lpage">2494</span><span class="refDoi"> DOI: 10.1002/ijc.25587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1002%2Fijc.25587" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20669221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVSktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2011&pages=2481-2494&author=R.+Shanmugamauthor=P.+Kusumanchiauthor=H.+Appaiahauthor=L.+Chengauthor=P.+Crooksauthor=S.+Neelakantanauthor=T.+Peatauthor=J.+Klaunigauthor=W.+Matthewsauthor=H.+Nakshatriauthor=C.+J.+Sweeney&title=A+water+soluble+parthenolide+analog+suppresses+in+vivo+tumor+growth+of+two+tobacco-associated+cancers%2C+lung+and+bladder+cancer%2C+by+targeting+NF-%CE%BAB+and+generating+reactive+oxygen+species&doi=10.1002%2Fijc.25587"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-κB and generating reactive oxygen species</span></div><div class="casAuthors">Shanmugam, Rajasubramaniam; Kusumanchi, Praveen; Appaiah, Hitesh; Cheng, Liang; Crooks, Peter; Neelakantan, Sundar; Peat, Tyler; Klaunig, James; Matthews, William; Nakshatri, Harikrishna; Sweeney, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2481-2494</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Dimethylaminoparthenolide (DMAPT) is a water sol. parthenolide analog with preclin. activity in hematol. malignancies.  Using non-small lung cancer (NSCLC) cell lines (A549 and H522) and an immortalized human bronchial epithelial cell line (BEAS2B) and TCC cell lines (UMUC-3, HT-1197 and HT-1376) and a bladder papilloma (RT-4), we aimed to characterize DMAPT's anticancer activity in tobacco-assocd. neoplasms.  Flow cytometric, electrophoretic mobility gel shift assays (EMSA), and Western blot studies measured generation of reactive oxygen species (ROS), inhibition of NFκB DNA binding, and changes in cell cycle distribution and apoptotic proteins.  DMAPT generated ROS with subsequent JNK activation and also decreased NFκB DNA binding and antiapoptotic proteins, TRAF-2 and XIAP.  DMAPT-induced apoptotic cell death and altered cell cycle distribution with upregulation of p21 and p73 levels in a cell type-dependent manner.  DMAPT suppressed cyclin D1 in BEAS2B.  DMAPT retained NFκB and cell cycle inhibitory activity in the presence of the tobacco carcinogen nitrosamine ketone, 4(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).  Using a BrdU accumulation assay, 5-20 μM of DMAPT was shown to inhibit cellular proliferation of all cell lines by more than 95%.  Oral dosing of DMAPT suppressed in vivo A549 and UMUC-3 s.c. xenograft growth by 54% (p = 0.015) and 63% (p < 0.01), resp., and A549 lung metastatic vol. by 28% (p = 0.043).  In total, this data demonstrates DMAPT's novel anticancer properties in both early and late stage tobacco-assocd. neoplasms as well as its significant in vivo activity.  The data provides support for the conduct of clin. trials in TCC and NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2e1ljnaOlnbVg90H21EOLACvtfcHk0liastU6IoXC5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVSktbc%253D&md5=bea684074cee2e4d1d477d210c3ef60b</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1002%2Fijc.25587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.25587%26sid%3Dliteratum%253Aachs%26aulast%3DShanmugam%26aufirst%3DR.%26aulast%3DKusumanchi%26aufirst%3DP.%26aulast%3DAppaiah%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DCrooks%26aufirst%3DP.%26aulast%3DNeelakantan%26aufirst%3DS.%26aulast%3DPeat%26aufirst%3DT.%26aulast%3DKlaunig%26aufirst%3DJ.%26aulast%3DMatthews%26aufirst%3DW.%26aulast%3DNakshatri%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DC.%2BJ.%26atitle%3DA%2520water%2520soluble%2520parthenolide%2520analog%2520suppresses%2520in%2520vivo%2520tumor%2520growth%2520of%2520two%2520tobacco-associated%2520cancers%252C%2520lung%2520and%2520bladder%2520cancer%252C%2520by%2520targeting%2520NF-%25CE%25BAB%2520and%2520generating%2520reactive%2520oxygen%2520species%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2011%26volume%3D128%26spage%3D2481%26epage%3D2494%26doi%3D10.1002%2Fijc.25587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">D'Anneo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlisi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauricella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puleio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Bella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guercio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vento, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tesoriere, G.</span><span> </span><span class="NLM_article-title">Parthenolide generates reactive oxygen species and autophagy in MDA-MB231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e891</span><span class="refDoi"> DOI: 10.1038/cddis.2013.415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fcddis.2013.415" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=e891&author=A.+D%27Anneoauthor=D.+Carlisiauthor=M.+Lauricellaauthor=R.+Puleioauthor=R.+Martinezauthor=S.+Di+Bellaauthor=P.+Di+Marcoauthor=S.+Emanueleauthor=R.+Di+Fioreauthor=A.+Guercioauthor=R.+Ventoauthor=G.+Tesoriere&title=Parthenolide+generates+reactive+oxygen+species+and+autophagy+in+MDA-MB231+cells.+A+soluble+parthenolide+analogue+inhibits+tumour+growth+and+metastasis+in+a+xenograft+model+of+breast+cancer&doi=10.1038%2Fcddis.2013.415"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.415%26sid%3Dliteratum%253Aachs%26aulast%3DD%2527Anneo%26aufirst%3DA.%26aulast%3DCarlisi%26aufirst%3DD.%26aulast%3DLauricella%26aufirst%3DM.%26aulast%3DPuleio%26aufirst%3DR.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DDi%2BBella%26aufirst%3DS.%26aulast%3DDi%2BMarco%26aufirst%3DP.%26aulast%3DEmanuele%26aufirst%3DS.%26aulast%3DDi%2BFiore%26aufirst%3DR.%26aulast%3DGuercio%26aufirst%3DA.%26aulast%3DVento%26aufirst%3DR.%26aulast%3DTesoriere%26aufirst%3DG.%26atitle%3DParthenolide%2520generates%2520reactive%2520oxygen%2520species%2520and%2520autophagy%2520in%2520MDA-MB231%2520cells.%2520A%2520soluble%2520parthenolide%2520analogue%2520inhibits%2520tumour%2520growth%2520and%2520metastasis%2520in%2520a%2520xenograft%2520model%2520of%2520breast%2520cancer%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26spage%3De891%26doi%3D10.1038%2Fcddis.2013.415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Siedle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Pineres, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte-Monting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rungeler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaas, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Costa, F. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisiel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merfort, I.</span><span> </span><span class="NLM_article-title">Quantitative structure-activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-κB</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6042</span><span class="NLM_x">–</span> <span class="NLM_lpage">6054</span><span class="refDoi"> DOI: 10.1021/jm049937r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049937r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6042-6054&author=B.+Siedleauthor=A.+J.+Garcia-Pineresauthor=R.+Murilloauthor=J.+Schulte-Montingauthor=V.+Castroauthor=P.+Rungelerauthor=C.+A.+Klaasauthor=F.+B.+Da+Costaauthor=W.+Kisielauthor=I.+Merfort&title=Quantitative+structure-activity+relationship+of+sesquiterpene+lactones+as+inhibitors+of+the+transcription+factor+NF-%CE%BAB&doi=10.1021%2Fjm049937r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm049937r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049937r%26sid%3Dliteratum%253Aachs%26aulast%3DSiedle%26aufirst%3DB.%26aulast%3DGarcia-Pineres%26aufirst%3DA.%2BJ.%26aulast%3DMurillo%26aufirst%3DR.%26aulast%3DSchulte-Monting%26aufirst%3DJ.%26aulast%3DCastro%26aufirst%3DV.%26aulast%3DRungeler%26aufirst%3DP.%26aulast%3DKlaas%26aufirst%3DC.%2BA.%26aulast%3DDa%2BCosta%26aufirst%3DF.%2BB.%26aulast%3DKisiel%26aufirst%3DW.%26aulast%3DMerfort%26aufirst%3DI.%26atitle%3DQuantitative%2520structure-activity%2520relationship%2520of%2520sesquiterpene%2520lactones%2520as%2520inhibitors%2520of%2520the%2520transcription%2520factor%2520NF-%25CE%25BAB%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6042%26epage%3D6054%26doi%3D10.1021%2Fjm049937r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Kerr, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farady, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marion, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sajid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caffrey, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legac, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKerrow, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinen, L. S.</span><span> </span><span class="NLM_article-title">Vinyl sulfones as antiparasitic agents and a structural basis for drug design</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">25697</span><span class="NLM_x">–</span> <span class="NLM_lpage">25703</span><span class="refDoi"> DOI: 10.1074/jbc.M109.014340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M109.014340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=19620707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWhsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=25697-25703&author=I.+D.+Kerrauthor=J.+H.+Leeauthor=C.+J.+Faradyauthor=R.+Marionauthor=M.+Rickertauthor=M.+Sajidauthor=K.+C.+Pandeyauthor=C.+R.+Caffreyauthor=J.+Legacauthor=E.+Hansellauthor=J.+H.+McKerrowauthor=C.+S.+Craikauthor=P.+J.+Rosenthalauthor=L.+S.+Brinen&title=Vinyl+sulfones+as+antiparasitic+agents+and+a+structural+basis+for+drug+design&doi=10.1074%2Fjbc.M109.014340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design</span></div><div class="casAuthors">Kerr, Iain D.; Lee, Ji H.; Farady, Christopher J.; Marion, Rachael; Rickert, Mathias; Sajid, Mohammed; Pandey, Kailash C.; Caffrey, Conor R.; Legac, Jennifer; Hansell, Elizabeth; McKerrow, James H.; Craik, Charles S.; Rosenthal, Philip J.; Brinen, Linda S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">25697-25703</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cysteine proteases of the papain superfamily are implicated in a no. of cellular processes and are important virulence factors in the pathogenesis of parasitic disease.  These enzymes have therefore emerged as promising targets for antiparasitic drugs.  We report the crystal structures of three major parasite cysteine proteases, cruzain, falcipain-3, and the first reported structure of rhodesain, in complex with a class of potent, small mol., cysteine protease inhibitors, the vinyl sulfones.  These data, in conjunction with comparative inhibition kinetics, provide insight into the mol. mechanisms that drive cysteine protease inhibition by vinyl sulfones, the binding specificity of these important proteases and the potential of vinyl sulfones as antiparasitic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolV0DUxF0YFbVg90H21EOLACvtfcHk0liastU6IoXC5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWhsbbK&md5=c0bed13d912846fdcb4c2ba7f31954cb</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.014340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.014340%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DFarady%26aufirst%3DC.%2BJ.%26aulast%3DMarion%26aufirst%3DR.%26aulast%3DRickert%26aufirst%3DM.%26aulast%3DSajid%26aufirst%3DM.%26aulast%3DPandey%26aufirst%3DK.%2BC.%26aulast%3DCaffrey%26aufirst%3DC.%2BR.%26aulast%3DLegac%26aufirst%3DJ.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DBrinen%26aufirst%3DL.%2BS.%26atitle%3DVinyl%2520sulfones%2520as%2520antiparasitic%2520agents%2520and%2520a%2520structural%2520basis%2520for%2520drug%2520design%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D25697%26epage%3D25703%26doi%3D10.1074%2Fjbc.M109.014340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Youm, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodogai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D'Agostino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planavsky, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupfer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanneganti, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahmy, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biragyn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, V. D.</span><span> </span><span class="NLM_article-title">The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1038/nm.3804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnm.3804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=25686106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVSit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=263-269&author=Y.+H.+Youmauthor=K.+Y.+Nguyenauthor=R.+W.+Grantauthor=E.+L.+Goldbergauthor=M.+Bodogaiauthor=D.+Kimauthor=D.+D%27Agostinoauthor=N.+Planavskyauthor=C.+Lupferauthor=T.+D.+Kannegantiauthor=S.+Kangauthor=T.+L.+Horvathauthor=T.+M.+Fahmyauthor=P.+A.+Crawfordauthor=A.+Biragynauthor=E.+Alnemriauthor=V.+D.+Dixit&title=The+ketone+metabolite+%CE%B2-hydroxybutyrate+blocks+NLRP3+inflammasome-mediated+inflammatory+disease&doi=10.1038%2Fnm.3804"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease</span></div><div class="casAuthors">Youm, Yun-Hee; Nguyen, Kim Y.; Grant, Ryan W.; Goldberg, Emily L.; Bodogai, Monica; Kim, Dongin; D'Agostino, Dominic; Planavsky, Noah; Lupfer, Christopher; Kanneganti, Thirumala D.; Kang, Seokwon; Horvath, Tamas L.; Fahmy, Tarek M.; Crawford, Peter A.; Biragyn, Arya; Alnemri, Emad; Dixit, Vishwa Deep</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">263-269</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The ketone bodies β-hydroxybutyrate (BHB) and acetoacetate (AcAc) support mammalian survival during states of energy deficit by serving as alternative sources of ATP.  BHB levels are elevated by starvation, caloric restriction, high-intensity exercise, or the low-carbohydrate ketogenic diet.  Prolonged fasting reduces inflammation; however, the impact that ketones and other alternative metabolic fuels produced during energy deficits have on the innate immune response is unknown.  We report that BHB, but neither AcAc nor the structurally related short-chain fatty acids butyrate and acetate, suppresses activation of the NLRP3 inflammasome in response to urate crystals, ATP and lipotoxic fatty acids.  BHB did not inhibit caspase-1 activation in response to pathogens that activate the NLR family, CARD domain contg. 4 (NLRC4) or absent in melanoma 2 (AIM2) inflammasome and did not affect non-canonical caspase-11, inflammasome activation.  Mechanistically, BHB inhibits the NLRP3 inflammasome by preventing K+ efflux and reducing ASC oligomerization and speck formation.  The inhibitory effects of BHB on NLRP3 are not dependent on chirality or starvation-regulated mechanisms like AMP-activated protein kinase (AMPK), reactive oxygen species (ROS), autophagy or glycolytic inhibition.  BHB blocks the NLRP3 inflammasome without undergoing oxidn. in the TCA cycle, and independently of uncoupling protein-2 (UCP2), sirtuin-2 (SIRT2), the G protein-coupled receptor GPR109A or hydrocarboxylic acid receptor 2 (HCAR2).  BHB reduces NLRP3 inflammasome-mediated interleukin (IL)-1β and IL-18 prodn. in human monocytes.  In vivo, BHB or a ketogenic diet attenuates caspase-1 activation and IL-1β secretion in mouse models of NLRP3-mediated diseases such as Muckle-Wells syndrome, familial cold autoinflammatory syndrome and urate crystal-induced peritonitis.  Our findings suggest that the anti-inflammatory effects of caloric restriction or ketogenic diets may be linked to BHB-mediated inhibition of the NLRP3 inflammasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiJJ1p9GsaxrVg90H21EOLACvtfcHk0lhGhLPTYcYaoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVSit7s%253D&md5=954f5298fa8cf263cf05174f05270e3a</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1038%2Fnm.3804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3804%26sid%3Dliteratum%253Aachs%26aulast%3DYoum%26aufirst%3DY.%2BH.%26aulast%3DNguyen%26aufirst%3DK.%2BY.%26aulast%3DGrant%26aufirst%3DR.%2BW.%26aulast%3DGoldberg%26aufirst%3DE.%2BL.%26aulast%3DBodogai%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DD%2527Agostino%26aufirst%3DD.%26aulast%3DPlanavsky%26aufirst%3DN.%26aulast%3DLupfer%26aufirst%3DC.%26aulast%3DKanneganti%26aufirst%3DT.%2BD.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DHorvath%26aufirst%3DT.%2BL.%26aulast%3DFahmy%26aufirst%3DT.%2BM.%26aulast%3DCrawford%26aufirst%3DP.%2BA.%26aulast%3DBiragyn%26aufirst%3DA.%26aulast%3DAlnemri%26aufirst%3DE.%26aulast%3DDixit%26aufirst%3DV.%2BD.%26atitle%3DThe%2520ketone%2520metabolite%2520%25CE%25B2-hydroxybutyrate%2520blocks%2520NLRP3%2520inflammasome-mediated%2520inflammatory%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2015%26volume%3D21%26spage%3D263%26epage%3D269%26doi%3D10.1038%2Fnm.3804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span> </span><span class="NLM_article-title">A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1504</span><span class="NLM_x">–</span> <span class="NLM_lpage">1512</span><span class="refDoi"> DOI: 10.1016/j.bcp.2013.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.bcp.2013.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=23506741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1ejs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=1504-1512&author=W.+Liuauthor=W.+Guoauthor=J.+Wuauthor=Q.+Luoauthor=F.+Taoauthor=Y.+Guauthor=Y.+Shenauthor=J.+Liauthor=R.+Tanauthor=Q.+Xuauthor=Y.+Sun&title=A+novel+benzo%5Bd%5Dimidazole+derivate+prevents+the+development+of+dextran+sulfate+sodium-induced+murine+experimental+colitis+via+inhibition+of+NLRP3+inflammasome&doi=10.1016%2Fj.bcp.2013.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome</span></div><div class="casAuthors">Liu, Wen; Guo, Wenjie; Wu, Jing; Luo, Qiong; Tao, Feifei; Gu, Yanhong; Shen, Yan; Li, Jianxin; Tan, Renxiang; Xu, Qiang; Sun, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1504-1512</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">NLRP3 inflammasome has been reported to be assocd. with various kinds of immunol. diseases including colitis.  However, there are few drug candidates targeting inflammasomes for the treatment of colitis.  In the present study, we aimed at examg. the effect of 1-ethyl-5-methyl-2-phenyl-1H-benzo[d]imidazole, a synthetic small mol. compd. also named Fc11a-2, for the treatment of dextran sulfate sodium (DSS)-induced exptl. colitis in mice via targeting NLRP3 inflammasome.  Treatment with Fc11a-2 dose-dependently attenuated the loss of body wt. and shortening of colon length induced by DSS.  In addn., the disease activity index, histopathol. scores and myeloperoxidase activity were also significantly reduced by Fc11a-2 treatment.  Moreover, protein and mRNA levels of DSS-induced proinflammatory cytokines in colon, including TNF-α, IL-1β, IL-18, IL-17A and IFN-γ, were markedly suppressed by Fc11a-2.  Furthermore, a decreased CD11c+ macrophage infiltration in colons and inactivation of caspase-1 in peritoneal macrophages were detected in Fc11a-2-treated mice.  The mechanism of action of Fc11a-2 was related to the inhibition of the cleavage of pro-caspase-1, pro-IL-1β and pro-IL-18 which in turn suppressed the activation of NLRP3 inflammasome.  Taken together, our results demonstrate the ability of Fc11a-2 to inhibit NLRP3 inflammasome activation and its potential use in the treatment of inflammatory bowel diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC4yBlq18j1bVg90H21EOLACvtfcHk0lhGhLPTYcYaoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1ejs7s%253D&md5=28fe5ced430f1f103df5b34d7c5b0306</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DTao%26aufirst%3DF.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DY.%26atitle%3DA%2520novel%2520benzo%255Bd%255Dimidazole%2520derivate%2520prevents%2520the%2520development%2520of%2520dextran%2520sulfate%2520sodium-induced%2520murine%2520experimental%2520colitis%2520via%2520inhibition%2520of%2520NLRP3%2520inflammasome%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D85%26spage%3D1504%26epage%3D1512%26doi%3D10.1016%2Fj.bcp.2013.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varadarajan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Planillon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burberry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Núñez, G.</span><span> </span><span class="NLM_article-title">3,4-Methylenedioxy-β-nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">1142</span><span class="NLM_x">–</span> <span class="NLM_lpage">1150</span><span class="refDoi"> DOI: 10.1074/jbc.M113.515080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M113.515080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=24265316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFOjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=1142-1150&author=Y.+Heauthor=S.+Varadarajanauthor=R.+Mu%C3%B1oz-Planillonauthor=A.+Burberryauthor=Y.+Nakamuraauthor=G.+N%C3%BA%C3%B1ez&title=3%2C4-Methylenedioxy-%CE%B2-nitrostyrene+inhibits+NLRP3+inflammasome+activation+by+blocking+assembly+of+the+inflammasome&doi=10.1074%2Fjbc.M113.515080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">3,4-Methylenedioxy-β-nitrostyrene Inhibits NLRP3 Inflammasome Activation by Blocking Assembly of the Inflammasome</span></div><div class="casAuthors">He, Yuan; Varadarajan, Saranyaraajan; Munoz-Planillo, Raul; Burberry, Aaron; Nakamura, Yuumi; Nunez, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1142-1150</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The NLRP3 inflammasome is a crit. component of the innate immune system.  NLRP3 activation is induced by diverse stimuli assocd. with bacterial infection or tissue damage, but its inappropriate activation is involved in the pathogenesis of inherited and acquired inflammatory diseases.  However, the mechanism by which NLRP3 is activated remains poorly understood.  In this study, we explored the role of kinases in NLRP3 inflammasome activation by screening a kinase inhibitor library and identified 3,4-methylenedioxy-β-nitrostyrene (MNS) as an inhibitor for NLRP3 inflammasome activation.  Notably, MNS did not affect the activation of the NLRC4 or AIM2 (absent in melanoma 2) inflammasome.  Mechanistically, MNS specifically prevented NLRP3-mediated ASC speck formation and oligomerization without blocking potassium efflux induced by NLRP3 agonists.  Surprisingly, Syk kinase, the reported target of MNS, did not mediate the inhibitory activity of MNS on NLRP3 inflammasome activation.  We also found that the nitrovinyl group of MNS is essential for the inhibitory activity of MNS.  Immunopptn., mass spectrometry, and mutation studies suggest that both the nucleotide binding oligomerization domain and the leucine-rich repeat domain of NLRP3 were the intracellular targets of MNS.  Administration of MNS also inhibited NLRP3 ATPase activity in vitro, suggesting that MNS blocks the NLRP3 inflammasome by directly targeting NLRP3 or NLRP3-assocd. complexes.  These studies identified a novel chem. probe for studying the mol. mechanism of NLRP3 inflammasome activation which may advance the development of novel strategies to treat diseases assocd. with abnormal activation of NLRP3 inflammasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9jDGHS4OBurVg90H21EOLACvtfcHk0lgBJ0bfUW6Bhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFOjsA%253D%253D&md5=e22d775cc6ffe38a7e0b4ea3772f8b32</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.515080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.515080%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DVaradarajan%26aufirst%3DS.%26aulast%3DMu%25C3%25B1oz-Planillon%26aufirst%3DR.%26aulast%3DBurberry%26aufirst%3DA.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DG.%26atitle%3D3%252C4-Methylenedioxy-%25CE%25B2-nitrostyrene%2520inhibits%2520NLRP3%2520inflammasome%2520activation%2520by%2520blocking%2520assembly%2520of%2520the%2520inflammasome%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D1142%26epage%3D1150%26doi%3D10.1074%2Fjbc.M113.515080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Wang, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. C.</span><span> </span><span class="NLM_article-title">Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-β-nitrostyrene, a novel tyrosine kinase inhibitor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1380</span><span class="NLM_x">–</span> <span class="NLM_lpage">1389</span><span class="refDoi"> DOI: 10.1124/mol.106.023986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1124%2Fmol.106.023986" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1380-1389&author=W.+Y.+Wangauthor=Y.+C.+Wuauthor=C.+C.+Wu&title=Prevention+of+platelet+glycoprotein+IIb%2FIIIa+activation+by+3%2C4-methylenedioxy-%CE%B2-nitrostyrene%2C+a+novel+tyrosine+kinase+inhibitor&doi=10.1124%2Fmol.106.023986"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.023986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.023986%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%2BY.%26aulast%3DWu%26aufirst%3DY.%2BC.%26aulast%3DWu%26aufirst%3DC.%2BC.%26atitle%3DPrevention%2520of%2520platelet%2520glycoprotein%2520IIb%252FIIIa%2520activation%2520by%25203%252C4-methylenedioxy-%25CE%25B2-nitrostyrene%252C%2520a%2520novel%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D1380%26epage%3D1389%26doi%3D10.1124%2Fmol.106.023986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Wang, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. C.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of novel β-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span><span class="refDoi"> DOI: 10.1016/j.bcp.2007.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.bcp.2007.06.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=601-611&author=W.+Y.+Wangauthor=P.+W.+Hsiehauthor=Y.+C.+Wuauthor=C.+C.+Wu&title=Synthesis+and+pharmacological+evaluation+of+novel+%CE%B2-nitrostyrene+derivatives+as+tyrosine+kinase+inhibitors+with+potent+antiplatelet+activity&doi=10.1016%2Fj.bcp.2007.06.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2007.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2007.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%2BY.%26aulast%3DHsieh%26aufirst%3DP.%2BW.%26aulast%3DWu%26aufirst%3DY.%2BC.%26aulast%3DWu%26aufirst%3DC.%2BC.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520novel%2520%25CE%25B2-nitrostyrene%2520derivatives%2520as%2520tyrosine%2520kinase%2520inhibitors%2520with%2520potent%2520antiplatelet%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D74%26spage%3D601%26epage%3D611%26doi%3D10.1016%2Fj.bcp.2007.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Hsieh, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. C.</span><span> </span><span class="NLM_article-title">The synthesis and biologic evaluation of anti-platelet and cytotoxic β-nitrostyrenes</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">7621</span><span class="NLM_x">–</span> <span class="NLM_lpage">7627</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.08.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.bmc.2010.08.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=7621-7627&author=P.+W.+Hsiehauthor=Y.+T.+Changauthor=W.+Y.+Chuangauthor=H.+C.+Shihauthor=S.+Z.+Chiangauthor=C.+C.+Wu&title=The+synthesis+and+biologic+evaluation+of+anti-platelet+and+cytotoxic+%CE%B2-nitrostyrenes&doi=10.1016%2Fj.bmc.2010.08.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.08.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.08.039%26sid%3Dliteratum%253Aachs%26aulast%3DHsieh%26aufirst%3DP.%2BW.%26aulast%3DChang%26aufirst%3DY.%2BT.%26aulast%3DChuang%26aufirst%3DW.%2BY.%26aulast%3DShih%26aufirst%3DH.%2BC.%26aulast%3DChiang%26aufirst%3DS.%2BZ.%26aulast%3DWu%26aufirst%3DC.%2BC.%26atitle%3DThe%2520synthesis%2520and%2520biologic%2520evaluation%2520of%2520anti-platelet%2520and%2520cytotoxic%2520%25CE%25B2-nitrostyrenes%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D7621%26epage%3D7627%26doi%3D10.1016%2Fj.bmc.2010.08.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Kast, R. E.</span><span> </span><span class="NLM_article-title">Ritonavir and disulfiram may be synergistic in lowering active interleukin-18 levels in acute pancreatitis, and thereby hasten recovery</span> <span class="citation_source-journal">J. Pancreas</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span><span class="refDoi"> DOI: 10.1186/s40880-015-0010-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1186%2Fs40880-015-0010-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=18469453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADC%252BD1czgslGhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=350-353&author=R.+E.+Kast&title=Ritonavir+and+disulfiram+may+be+synergistic+in+lowering+active+interleukin-18+levels+in+acute+pancreatitis%2C+and+thereby+hasten+recovery&doi=10.1186%2Fs40880-015-0010-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Ritonavir and disulfiram may be synergistic in lowering active interleukin-18 levels in acute pancreatitis, and thereby hasten recovery</span></div><div class="casAuthors">Kast Richard Eric</div><div class="citationInfo"><span class="NLM_cas:title">JOP : Journal of the pancreas</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">350-3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Interleukin-18 (IL-18) is one of the mediators of both pancreas damage and systemic complications like hypotension and multi-organ dysfunction during acute pancreatitis.  IL-18 is generated intracellularly from pro-IL-18 by caspase-1 mediated proteolysis.  Active caspase-1 itself is generated intracellularly by the action of the inflammasome, autocatalysis and other stimuli.  The anti-retroviral drug ritonavir inhibits conversion of inactive pro-caspase-1 to active caspase-1.  Since ritonavir is well tolerated in short-term use it may therefore prove useful in treating acute pancreatitis by lowering caspase-1 mediated IL-18 formation and the many inflammatory mediators downstream from that.  The alcoholism treatment drug disulfiram has been in continuous use since the 1950s.  It likewise has a low risk profile.  Disulfiram inhibits several human proteases, among them caspase-1.  Given the current morbidity and mortality of pancreatitis, research should be directed to ritonavir and disulfiram as treatment options for illnesses like pancreatitis where excessive IL-18 contributes to pathology.  The first clinically used angiotensin converting enzyme inhibitor, captopril, has shown potent caspase-1 inhibiting activity as well and should be investigated in rodent models of human pancreatitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtIh8z4lKke-2mnZh2OgS0fW6udTcc2eaRev0rNM3cu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czgslGhtA%253D%253D&md5=8e4cf13ef53f54accf6c3b53e0ee00ef</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1186%2Fs40880-015-0010-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40880-015-0010-1%26sid%3Dliteratum%253Aachs%26aulast%3DKast%26aufirst%3DR.%2BE.%26atitle%3DRitonavir%2520and%2520disulfiram%2520may%2520be%2520synergistic%2520in%2520lowering%2520active%2520interleukin-18%2520levels%2520in%2520acute%2520pancreatitis%252C%2520and%2520thereby%2520hasten%2520recovery%26jtitle%3DJ.%2520Pancreas%26date%3D2008%26volume%3D9%26spage%3D350%26epage%3D353%26doi%3D10.1186%2Fs40880-015-0010-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Rudolphi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerwin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verzijl, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Kraan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Berg, W.</span><span> </span><span class="NLM_article-title">Pralnacasan, an inhibitor of interleukin-1β converting enzyme, reduces joint damage in two murine models of osteoarthritis</span> <span class="citation_source-journal">Osteoarthr. Cartilage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">738</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span><span class="refDoi"> DOI: 10.1016/S1063-4584(03)00153-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2FS1063-4584%2803%2900153-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=13129693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADC%252BD3svjsFOhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=738-746&author=K.+Rudolphiauthor=N.+Gerwinauthor=N.+Verzijlauthor=P.+van+der+Kraanauthor=W.+van+den+Berg&title=Pralnacasan%2C+an+inhibitor+of+interleukin-1%CE%B2+converting+enzyme%2C+reduces+joint+damage+in+two+murine+models+of+osteoarthritis&doi=10.1016%2FS1063-4584%2803%2900153-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis</span></div><div class="casAuthors">Rudolphi K; Gerwin N; Verzijl N; van der Kraan P; van den Berg W</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">738-46</span>
        ISSN:<span class="NLM_cas:issn">1063-4584</span>.
    </div><div class="casAbstract">OBJECTIVE:  To study the effect of pralnacasan, the orally bioavailable pro-drug of a potent, non-peptide inhibitor of interleukin-1beta converting enzyme (ICE), RU 36384/VRT-18858, on joint damage in two mouse models of knee osteoarthritis (OA).  DESIGN:  In a collagenase-induced OA model, pralnacasan was given orally by gavage to female Balb/c mice at 0, 12.5, 25 and 50 mg/kg twice a day.  In the second study, pralnacasan was tested in male STR/1N mice, which develop OA spontaneously, by administering food-drug mixtures ad libitum at concentrations of 0, 700 and 4200 ppm (mg/kg food).  OA joint damage was assessed by a semi-quantitative histopathological score in both studies.  In the STR/1N mouse study, urinary levels of collagen cross-links hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP) were determined by high-pressure liquid chromatography at baseline, after 3 and 6 weeks of treatment and RU 36384/VRT-18858 plasma concentrations was measured after 6 weeks.  RESULTS:  In both studies, the mice developed moderate to severe knee joint OA in the medial joint compartments (tibial plateau and femoral condyle), the non-treated control groups showing median histopathological scores from 18 to 21 of a maximal score of 32.  Pralnacasan was well tolerated.  At the doses of 12.5 and 50 mg/kg in collagenase-induced OA and at the high dose of 4200 ppm in STR/1N mice pralnacasan treatment significantly reduced OA by 13-22%.  In the STR/1N mice, urinary levels of HP cross-links and the ratio of HP/LP, which are indicators of joint damage in OA, were significantly reduced in the high dose group by 59 and 84%, respectively.  CONCLUSIONS:  The ICE inhibitor pralnacasan reduced joint damage in two experimental models of OA and has the potential to become a disease-modifying drug for the treatment of OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS00eZqsMAAocjl5L8hwNX0fW6udTcc2ebb4ng94FCJPbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svjsFOhtg%253D%253D&md5=ec8e69c841b711bb5c56cb1f9ac983c3</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2FS1063-4584%2803%2900153-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1063-4584%252803%252900153-5%26sid%3Dliteratum%253Aachs%26aulast%3DRudolphi%26aufirst%3DK.%26aulast%3DGerwin%26aufirst%3DN.%26aulast%3DVerzijl%26aufirst%3DN.%26aulast%3Dvan%2Bder%2BKraan%26aufirst%3DP.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DW.%26atitle%3DPralnacasan%252C%2520an%2520inhibitor%2520of%2520interleukin-1%25CE%25B2%2520converting%2520enzyme%252C%2520reduces%2520joint%2520damage%2520in%2520two%2520murine%2520models%2520of%2520osteoarthritis%26jtitle%3DOsteoarthr.%2520Cartilage%26date%3D2003%26volume%3D11%26spage%3D738%26epage%3D746%26doi%3D10.1016%2FS1063-4584%2803%2900153-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Wannamaker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namchuk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germann, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randle, J. C.</span><span> </span><span class="NLM_article-title">(S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1β and IL-18</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span><span class="refDoi"> DOI: 10.1124/jpet.106.111344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1124%2Fjpet.106.111344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=17289835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFehtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=509-516&author=W.+Wannamakerauthor=R.+Daviesauthor=M.+Namchukauthor=J.+Pollardauthor=P.+Fordauthor=G.+Kuauthor=C.+Deckerauthor=P.+Charifsonauthor=P.+Weberauthor=U.+A.+Germannauthor=K.+Kuidaauthor=J.+C.+Randle&title=%28S%29-1-%28%28S%29-2-%7B%5B1-%284-amino-3-chloro-phenyl%29-methanoyl%5D-amino%7D-3%2C3-dimethyl-butanoyl%29-pyrrolidine-2-carboxylic+acid+%28%282R%2C3S%29-2-ethoxy-5-oxo-tetrahydro-furan-3-yl%29-amide+%28VX-765%29%2C+an+orally+available+selective+interleukin+%28IL%29-converting+enzyme%2Fcaspase-1+inhibitor%2C+exhibits+potent+anti-inflammatory+activities+by+inhibiting+the+release+of+IL-1%CE%B2+and+IL-18&doi=10.1124%2Fjpet.106.111344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">(S)-1-((S)-2-{[1-(4-Amino-3-chlorophenyl)methanoyl]amino}-3,3-dimethylbutanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1β and IL-18</span></div><div class="casAuthors">Wannamaker, Woods; Davies, Robert; Namchuk, Mark; Pollard, John; Ford, Pamella; Ku, George; Decker, Caroline; Charifson, Paul; Weber, Peter; Germann, Ursula A.; Kuida, Keisuke; Randle, John C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">509-516</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">VX-765 is an orally absorbed prodrug of (S)-3-({1-[(S)-1-((S)-2-{[1-(4-amino-3-chlorophenyl)methanoyl]amino}-3,3-dimethyl-butanoyl)pyrrolidin-2-yl]-methanoyl}amino)-4-oxobutyric acid (VRT-043198), a potent and selective inhibitor of interleukin-converting enzyme/caspase-1 subfamily caspases.  VRT-043198 exhibits 100- to 10,000-fold selectivity against other caspase-3 and -6 to -9.  The therapeutic potential of VX-765 was assessed by detg. the effects of VRT-043198 on cytokine release by monocytes in vitro and of orally administered VX-765 in several animal models in vivo.  In cultures of peripheral blood mononuclear cells and whole blood from healthy subjects stimulated with bacterial products, VRT-043198 inhibited the release of interleukin (IL)-1β and IL-18, but it had little effect on the release of several other cytokines, including IL-1α, tumor necrosis factor-α, IL-6 and IL-8.  In contrast, VRT-043198 had little or no demonstrable activity in cellular models of apoptosis, and it did not affect the proliferation of activated primary T cells or T-cell lines.  VX-765 was efficiently converted to VRT-043198 when administered orally to mice, and it inhibited lipopolysaccharide-induced cytokine secretion.  In addn., VX-765 reduced disease severity and the expression of inflammatory mediators in models of rheumatoid arthritis and skin inflammation.  These data suggest that VX-765 is a novel cytokine inhibitor useful for treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUYnZtQc6cNrVg90H21EOLACvtfcHk0lgscKyfDqih1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFehtLY%253D&md5=f310c20314ee44357acd3027105a8b6a</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.111344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.111344%26sid%3Dliteratum%253Aachs%26aulast%3DWannamaker%26aufirst%3DW.%26aulast%3DDavies%26aufirst%3DR.%26aulast%3DNamchuk%26aufirst%3DM.%26aulast%3DPollard%26aufirst%3DJ.%26aulast%3DFord%26aufirst%3DP.%26aulast%3DKu%26aufirst%3DG.%26aulast%3DDecker%26aufirst%3DC.%26aulast%3DCharifson%26aufirst%3DP.%26aulast%3DWeber%26aufirst%3DP.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DKuida%26aufirst%3DK.%26aulast%3DRandle%26aufirst%3DJ.%2BC.%26atitle%3D%2528S%2529-1-%2528%2528S%2529-2-%257B%255B1-%25284-amino-3-chloro-phenyl%2529-methanoyl%255D-amino%257D-3%252C3-dimethyl-butanoyl%2529-pyrrolidine-2-carboxylic%2520acid%2520%2528%25282R%252C3S%2529-2-ethoxy-5-oxo-tetrahydro-furan-3-yl%2529-amide%2520%2528VX-765%2529%252C%2520an%2520orally%2520available%2520selective%2520interleukin%2520%2528IL%2529-converting%2520enzyme%252Fcaspase-1%2520inhibitor%252C%2520exhibits%2520potent%2520anti-inflammatory%2520activities%2520by%2520inhibiting%2520the%2520release%2520of%2520IL-1%25CE%25B2%2520and%2520IL-18%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D509%26epage%3D516%26doi%3D10.1124%2Fjpet.106.111344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Maroso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balosso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravizza, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vezzani, A.</span><span> </span><span class="NLM_article-title">Interleukin-1 type 1 receptor/toll-like receptor signalling in epilepsy: the importance of IL-1β and high-mobility group box 1</span> <span class="citation_source-journal">J. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span><span class="refDoi"> DOI: 10.1111/j.1365-2796.2011.02431.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1111%2Fj.1365-2796.2011.02431.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=21793950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlClt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=2011&pages=319-326&author=M.+Marosoauthor=S.+Balossoauthor=T.+Ravizzaauthor=J.+Liuauthor=M.+E.+Bianchiauthor=A.+Vezzani&title=Interleukin-1+type+1+receptor%2Ftoll-like+receptor+signalling+in+epilepsy%3A+the+importance+of+IL-1%CE%B2+and+high-mobility+group+box+1&doi=10.1111%2Fj.1365-2796.2011.02431.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1</span></div><div class="casAuthors">Maroso, M.; Balosso, S.; Ravizza, T.; Liu, J.; Bianchi, M. E.; Vezzani, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Internal Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">319-326</span>CODEN:
                <span class="NLM_cas:coden">JINMEO</span>;
        ISSN:<span class="NLM_cas:issn">0954-6820</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Inflammatory processes in brain tissue have been described in human epilepsy of various etiologies and in exptl. models of seizures.  This, together with the anticonvulsant properties of anti-inflammatory therapies both in clin. and in exptl. settings, highlights the important role of brain inflammation in the aetiopathogenesis of seizures.  Preclin. investigations in exptl. models using pharmacol. and genetic tools have identified a significant contribution of interleukin-1 (IL-1) type 1 receptor/Toll-like receptor (IL-1R/TLR) signalling to seizure activity.  This signalling can be activated by ligands assocd. with infections (pathogen-assocd. mol. patterns) or by endogenous mols., such as proinflammatory cytokines (e.g. IL-1beta) or danger signals [damage-assocd. mol. patterns, e.g. high-mobility group box 1 (HMGB1)].  IL-1beta and HMGB1 are synthesized and released by astrocytes and microglia in the rodent brain during seizures.  Notably, a rapid release of HMGB1 from neurons appears to be triggered by proconvulsant drugs even before seizure occurrence and is involved in their pptn. of seizures.  The activation of IL-1R/TLR signalling mediates rapid post-translational changes in N-methyl-D-aspartate-gated ion channels in neurons.  A long-term decrease in seizure threshold has also been obsd., possibly mediated by transcriptional activation of genes contributing to mol. and cellular plasticity.  This emerging evidence identifies specific targets with potential anticonvulsant effects in drug-resistant forms of epilepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI4SQ8Peg2tbVg90H21EOLACvtfcHk0lgscKyfDqih1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlClt73P&md5=1623a46927cddaa75877139f0b730334</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2796.2011.02431.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2796.2011.02431.x%26sid%3Dliteratum%253Aachs%26aulast%3DMaroso%26aufirst%3DM.%26aulast%3DBalosso%26aufirst%3DS.%26aulast%3DRavizza%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26aulast%3DVezzani%26aufirst%3DA.%26atitle%3DInterleukin-1%2520type%25201%2520receptor%252Ftoll-like%2520receptor%2520signalling%2520in%2520epilepsy%253A%2520the%2520importance%2520of%2520IL-1%25CE%25B2%2520and%2520high-mobility%2520group%2520box%25201%26jtitle%3DJ.%2520Intern.%2520Med.%26date%3D2011%26volume%3D270%26spage%3D319%26epage%3D326%26doi%3D10.1111%2Fj.1365-2796.2011.02431.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">MacKenzie, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schipper, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. C.</span><span> </span><span class="NLM_article-title">The potential for caspases in drug discovery</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=568-576&author=S.+H.+MacKenzieauthor=J.+L.+Schipperauthor=A.+C.+Clark&title=The+potential+for+caspases+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacKenzie%26aufirst%3DS.%2BH.%26aulast%3DSchipper%26aufirst%3DJ.%2BL.%26aulast%3DClark%26aufirst%3DA.%2BC.%26atitle%3DThe%2520potential%2520for%2520caspases%2520in%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26spage%3D568%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Gong, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, F.</span><span> </span><span class="NLM_article-title">Chemical probing reveals insights into the signaling mechanism of inflammasome activation</span> <span class="citation_source-journal">Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1289</span><span class="NLM_x">–</span> <span class="NLM_lpage">1305</span><span class="refDoi"> DOI: 10.1038/cr.2010.135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fcr.2010.135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20856264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWqu7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1289-1305&author=Y.+N.+Gongauthor=X.+Wangauthor=J.+Wangauthor=Z.+Yangauthor=S.+Liauthor=J.+Yangauthor=L.+Liuauthor=X.+Leiauthor=F.+Shao&title=Chemical+probing+reveals+insights+into+the+signaling+mechanism+of+inflammasome+activation&doi=10.1038%2Fcr.2010.135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical probing reveals insights into the signaling mechanism of inflammasome activation</span></div><div class="casAuthors">Gong, Yi-Nan; Wang, Xiaoming; Wang, Jiayi; Yang, Zhenxiao; Li, Shan; Yang, Jieling; Liu, Liping; Lei, Xiaoguang; Shao, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1289-1305</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Caspase-1-mediated IL-1β prodn. is generally controlled by two pathways.  Toll-like receptors (TLRs) recognize pathogen-derived products and induce NF-κB-dependent pro-IL-1β transcription; NOD-like receptors (NLRs) assemble caspase-1-activating inflammasome complexes that sense bacterial products/danger signals.  Through a targeted chem. screen, we identify bromoxone, a marine natural product, as a specific and potent inhibitor of the caspase-1 pathway.  Bromoxone is effective over diverse inflammatory stimuli including TLR ligands plus ATP/nigericin, cytosolic DNA, flagellin and Bacillus anthracis lethal toxin.  Bromoxone also efficiently suppresses caspase-1 activation triggered by several types of bacterial infection.  Bromoxone acts upstream or at the level of the inflammasome in a transcription-independent manner.  Bromoxone also inhibits pro-IL-1β expression by targeting components upstream of IKK in the TLR-NF-κB pathway.  The unique dual activities of bromoxone are shared by the known TAK1 inhibitor that specifically blocks Nalp3 inflammasome activation.  Hinted from the mechanistic and pharmacol. properties of bromoxone, we further discover that several known NF-κB inhibitors that act upstream of IKK, but not those targeting IKK or IKK downstream, are potent blockers of different NLRs-mediated caspase-1 activation.  Our study uncovers a possible non-transcriptional mol. link between the NLR (Nalp3)-mediated inflammasome pathway and TLR-NF-κB signaling, and suggests a potential strategy to develop new anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppjC16zIWsMbVg90H21EOLACvtfcHk0lim3c8BR69WUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWqu7nP&md5=efe3462264b2a58c9d54fd8fee8a06b1</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1038%2Fcr.2010.135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2010.135%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DY.%2BN.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DShao%26aufirst%3DF.%26atitle%3DChemical%2520probing%2520reveals%2520insights%2520into%2520the%2520signaling%2520mechanism%2520of%2520inflammasome%2520activation%26jtitle%3DCell%2520Res.%26date%3D2010%26volume%3D20%26spage%3D1289%26epage%3D1305%26doi%3D10.1038%2Fcr.2010.135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Matsunaga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchimori, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ii, M.</span><span> </span><span class="NLM_article-title">TAK-242 (resatorvid), a small-molecule inhibitor of toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1124/mol.110.068064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1124%2Fmol.110.068064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20881006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1ehuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=34-41&author=N.+Matsunagaauthor=N.+Tsuchimoriauthor=T.+Matsumotoauthor=M.+Ii&title=TAK-242+%28resatorvid%29%2C+a+small-molecule+inhibitor+of+toll-like+receptor+%28TLR%29+4+signaling%2C+binds+selectively+to+TLR4+and+interferes+with+interactions+between+TLR4+and+its+adaptor+molecules&doi=10.1124%2Fmol.110.068064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules</span></div><div class="casAuthors">Matsunaga, Naoko; Tsuchimori, Noboru; Matsumoto, Tatsumi; Ii, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-41</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">TAK-242 (resatorvid), a small-mol.-specific inhibitor of Toll-like receptor (TLR) 4 signaling, inhibits the prodn. of lipopolysaccharide-induced inflammatory mediators by binding to the intracellular domain of TLR4.  Cys747 in TLR4 has been identified previously as the binding site of TAK-242.  However, the mechanism by which TAK-242 inhibits TLR4 signaling after binding to TLR4 remains unknown.  The present study demonstrated, using coimmunopptn., that TAK-242 interferes with protein-protein interactions between TLR4 and its adaptor mols.  Among 10 different human TLRs, TAK-242 selectively bound to TLR4.  The time course of the inhibitory effect of TAK-242 on inflammatory mediator prodn. corresponded to that of the binding of TAK-242 to TLR4.  TAK-242 inhibited the assocn. of TLR4 with Toll/interleukin-1 receptor domain-contg. adaptor protein (TIRAP) or Toll/interleukin-1 receptor domain-contg. adaptor protein inducing interferon-β-related adaptor mol. (TRAM) in human embryonic kidney (HEK) 293 cells overexpressing TLR4, MD-2, and TIRAP or TRAM, resp.  TAK-242 inhibited the TIRAP-mediated activation of nuclear factor βB (NF-κB) and the TRAM-mediated activation of NF-κB and interferon-sensitive response element in HEK293 cells stably expressing TLR4, MD-2, and CD14.  The activation of endogenous interleukin-1 receptor-assocd. kinase in RAW264.7 cells was also inhibited by TAK-242 treatment.  These findings suggest that TAK-242 binds selectively to TLR4 and subsequently disrupts the interaction of TLR4 with adaptor mols., thereby inhibiting TLR4 signal transduction and its downstream signaling events.  This work proposes a novel paradigm of a small mol. capable of disrupting protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEHy_7WltDNbVg90H21EOLACvtfcHk0lim3c8BR69WUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1ehuw%253D%253D&md5=c3ce97a9ab69101a59117c80c8f01044</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.068064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.068064%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DN.%26aulast%3DTsuchimori%26aufirst%3DN.%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DIi%26aufirst%3DM.%26atitle%3DTAK-242%2520%2528resatorvid%2529%252C%2520a%2520small-molecule%2520inhibitor%2520of%2520toll-like%2520receptor%2520%2528TLR%2529%25204%2520signaling%252C%2520binds%2520selectively%2520to%2520TLR4%2520and%2520interferes%2520with%2520interactions%2520between%2520TLR4%2520and%2520its%2520adaptor%2520molecules%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D79%26spage%3D34%26epage%3D41%26doi%3D10.1124%2Fmol.110.068064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Takashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimatsu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazeki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaisho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uekata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazeki, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iizawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ii, M.</span><span> </span><span class="NLM_article-title">Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">1250</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2009.00297.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1111%2Fj.1476-5381.2009.00297.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=19563534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVelt7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2009&pages=1250-1262&author=K.+Takashimaauthor=N.+Matsunagaauthor=M.+Yoshimatsuauthor=K.+Hazekiauthor=T.+Kaishoauthor=M.+Uekataauthor=O.+Hazekiauthor=S.+Akiraauthor=Y.+Iizawaauthor=M.+Ii&title=Analysis+of+binding+site+for+the+novel+small-molecule+TLR4+signal+transduction+inhibitor+TAK-242+and+its+therapeutic+effect+on+mouse+sepsis+model&doi=10.1111%2Fj.1476-5381.2009.00297.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model</span></div><div class="casAuthors">Takashima, K.; Matsunaga, N.; Yoshimatsu, M.; Hazeki, K.; Kaisho, T.; Uekata, M.; Hazeki, O.; Akira, S.; Iizawa, Y.; Ii, M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1250-1262</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">TAK-242, a novel synthetic small-mol., suppresses prodn. of multiple cytokines by inhibiting Toll-like receptor (TLR) 4 signalling.  In this study, we investigated the target mol. of TAK-242 and examd. its therapeutic effect in a mouse sepsis model.  Binding assay with [3H]-TAK-242 and nuclear factor-κB reporter assay were used to identify the target mol. and binding site of TAK-242.  Bacillus calmette guerin (BCG)-primed mouse sepsis model using live Escherichia coli was used to est. the efficacy of TAK-242 in sepsis.  TAK-242 strongly bound to TLR4, but binding to TLR2, 3, 5, 9, TLR-related adaptor mols. and MD-2 was either not obsd. or marginal.  Mutational anal. using TLR4 mutants indicated that TAK-242 inhibits TLR4 signalling by binding to Cys747 in the intracellular domain of TLR4.  TAK-242 inhibited MyD88-independent pathway as well as MyD88-dependent pathway and its inhibitory effect was largely unaffected by lipopolysaccharide (LPS) concn. and types of TLR4 ligands.  TAK-242 had no effect on the LPS-induced conformational change of TLR4-MD-2 and TLR4 homodimerization.  In mouse sepsis model, although TAK-242 alone did not affect bacterial counts in blood, if co-administered with ceftazidime it inhibited the increases in serum cytokine levels and improved survival of mice.  TAK-242 suppressed TLR4 signalling by binding directly to a specific amino acid Cys747 in the intracellular domain of TLR4.  When co-administered with antibiotics, TAK-242 showed potent therapeutic effects in an E. coli-induced sepsis model using BCG-primed mice.  Thus, TAK-242 may be a promising therapeutic agent for sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrjFTRtcT0z7Vg90H21EOLACvtfcHk0lim3c8BR69WUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVelt7bL&md5=c3e6334f557e868f0246f51857b62f19</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00297.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00297.x%26sid%3Dliteratum%253Aachs%26aulast%3DTakashima%26aufirst%3DK.%26aulast%3DMatsunaga%26aufirst%3DN.%26aulast%3DYoshimatsu%26aufirst%3DM.%26aulast%3DHazeki%26aufirst%3DK.%26aulast%3DKaisho%26aufirst%3DT.%26aulast%3DUekata%26aufirst%3DM.%26aulast%3DHazeki%26aufirst%3DO.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DIizawa%26aufirst%3DY.%26aulast%3DIi%26aufirst%3DM.%26atitle%3DAnalysis%2520of%2520binding%2520site%2520for%2520the%2520novel%2520small-molecule%2520TLR4%2520signal%2520transduction%2520inhibitor%2520TAK-242%2520and%2520its%2520therapeutic%2520effect%2520on%2520mouse%2520sepsis%2520model%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D157%26spage%3D1250%26epage%3D1262%26doi%3D10.1111%2Fj.1476-5381.2009.00297.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">de Seny, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobraiville, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esser, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaise, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaise, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, F. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Relic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaise, M. G.</span><span> </span><span class="NLM_article-title">Acute-phase serum amyloid A in osteoarthritis: regulatory mechanism and proinflammatory properties</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e66769</span><span class="refDoi"> DOI: 10.1371/journal.pone.0066769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1371%2Fjournal.pone.0066769" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e66769&author=D.+de+Senyauthor=G.+Cobraivilleauthor=E.+Charlierauthor=S.+Neuvilleauthor=N.+Esserauthor=D.+Malaiseauthor=O.+Malaiseauthor=F.+Q.+Calvoauthor=B.+Relicauthor=M.+G.+Malaise&title=Acute-phase+serum+amyloid+A+in+osteoarthritis%3A+regulatory+mechanism+and+proinflammatory+properties&doi=10.1371%2Fjournal.pone.0066769"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0066769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0066769%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BSeny%26aufirst%3DD.%26aulast%3DCobraiville%26aufirst%3DG.%26aulast%3DCharlier%26aufirst%3DE.%26aulast%3DNeuville%26aufirst%3DS.%26aulast%3DEsser%26aufirst%3DN.%26aulast%3DMalaise%26aufirst%3DD.%26aulast%3DMalaise%26aufirst%3DO.%26aulast%3DCalvo%26aufirst%3DF.%2BQ.%26aulast%3DRelic%26aufirst%3DB.%26aulast%3DMalaise%26aufirst%3DM.%2BG.%26atitle%3DAcute-phase%2520serum%2520amyloid%2520A%2520in%2520osteoarthritis%253A%2520regulatory%2520mechanism%2520and%2520proinflammatory%2520properties%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De66769%26doi%3D10.1371%2Fjournal.pone.0066769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Glushkova, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parfenyuk, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khrenov, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novoselova, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunin, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesenko, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novoselova, E. G.</span><span> </span><span class="NLM_article-title">Inhibitors of TLR-4, NF-kappaB, and SAPK/JNK signaling reduce the toxic effect of lipopolysaccharide on RAW 264.7 cells</span> <span class="citation_source-journal">J. Immunotoxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span><span class="refDoi"> DOI: 10.3109/1547691X.2012.700652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.3109%2F1547691X.2012.700652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22830990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1antr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=133-140&author=O.+V.+Glushkovaauthor=S.+B.+Parfenyukauthor=M.+O.+Khrenovauthor=T.+V.+Novoselovaauthor=S.+M.+Luninauthor=E.+E.+Fesenkoauthor=E.+G.+Novoselova&title=Inhibitors+of+TLR-4%2C+NF-kappaB%2C+and+SAPK%2FJNK+signaling+reduce+the+toxic+effect+of+lipopolysaccharide+on+RAW+264.7+cells&doi=10.3109%2F1547691X.2012.700652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of TLR-4, NF-κB, and SAPK/JNK signaling reduce the toxic effect of lipopolysaccharide on RAW 264.7 cells</span></div><div class="casAuthors">Glushkova, Olga V.; Parfenyuk, Svetlana B.; Khrenov, Maxim O.; Novoselova, Tatyana V.; Lunin, Sergey M.; Fesenko, Eugeny E.; Novoselova, Elena G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunotoxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-140</span>CODEN:
                <span class="NLM_cas:coden">JIOMAP</span>;
        ISSN:<span class="NLM_cas:issn">1547-691X</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The present study was designed to examine and compare the effects of three suppressors on the cytokine response in tandem with examg.: the synthesis of inducible forms of heat shock proteins; HSP72 and HSP90α; activities of NF-κB and SAPK/JNK signaling pathways; and TLR4 expression.  Pre-treatment with inhibitors offers promise as protective means to lower the activity of these cascades, thereby circumventing the formation of excessive amts. of pro-inflammatory mols.  Three inhibitors of TLR4, SAPK/JNK, and NF-κB signaling, namely CLI-095, SP600125, and IKK Inhibitor XII, resp., were added to cultured RAW 264.7 macrophages before the Escherichia coli lipopolysaccharide (LPS) application.  Treatments of RAW 264.7 cells with each of the inhibitors resulted in a reduced response to LPS as was visualized by a decrease of TNF-α, IL-1, and IFN-γ prodn.  In addn., inhibitors of the NF-κB and SAPK/JNK signaling reduced IL-6 prodn. in LPS-treated cells, whereas the IKK inhibitor XII also decreased IL-10 prodn.  Further, the NO prodn. in LPS-stimulated macrophages was significantly reduced following application of CLI-095 or IKK inhibitor XII.  The results also showed that the inhibitors suppressed TLR4 prodn. and decreased phosphorylation of NF-κB and SAPK/JNK proteins, thereby preventing the activation NF-κB and SAPK/JNK signaling pathways in LPS-activated cells.  In addn., the prodn. of inducible heat shock proteins, HSP72 and HSP90-α, was reduced in LPS-stimulated RAW 264.7 cells pre-treated with inhibitors.  These results suggest that inhibitors CLI-095, SP600125, and IKK inhibitor XII demonstrate potential effectiveness in the redn. of the inflammatory response by mechanisms involving both the cellular defense system and cellular signaling.  In conclusion, suppressor of NF-κB cascade, IKK inhibitor XII, seems to be the most effective anti-toxic agent among studied inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXplXs6EStjrVg90H21EOLACvtfcHk0lhVajBnSEniZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1antr4%253D&md5=a50c14270c6f551eb23ff0b5402fedbe</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.3109%2F1547691X.2012.700652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F1547691X.2012.700652%26sid%3Dliteratum%253Aachs%26aulast%3DGlushkova%26aufirst%3DO.%2BV.%26aulast%3DParfenyuk%26aufirst%3DS.%2BB.%26aulast%3DKhrenov%26aufirst%3DM.%2BO.%26aulast%3DNovoselova%26aufirst%3DT.%2BV.%26aulast%3DLunin%26aufirst%3DS.%2BM.%26aulast%3DFesenko%26aufirst%3DE.%2BE.%26aulast%3DNovoselova%26aufirst%3DE.%2BG.%26atitle%3DInhibitors%2520of%2520TLR-4%252C%2520NF-kappaB%252C%2520and%2520SAPK%252FJNK%2520signaling%2520reduce%2520the%2520toxic%2520effect%2520of%2520lipopolysaccharide%2520on%2520RAW%2520264.7%2520cells%26jtitle%3DJ.%2520Immunotoxicol.%26date%3D2013%26volume%3D10%26spage%3D133%26epage%3D140%26doi%3D10.3109%2F1547691X.2012.700652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Ii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazeki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazeki, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iizawa, Y.</span><span> </span><span class="NLM_article-title">A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1288</span><span class="NLM_x">–</span> <span class="NLM_lpage">1295</span><span class="refDoi"> DOI: 10.1124/mol.105.019695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1124%2Fmol.105.019695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=16373689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtlKntLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=1288-1295&author=M.+Iiauthor=N.+Matsunagaauthor=K.+Hazekiauthor=K.+Nakamuraauthor=K.+Takashimaauthor=T.+Seyaauthor=O.+Hazekiauthor=T.+Kitazakiauthor=Y.+Iizawa&title=A+novel+cyclohexene+derivative%2C+ethyl+%286R%29-6-%5BN-%282-chloro-4-fluorophenyl%29sulfamoyl%5Dcyclohex-1-ene-1-carboxylate+%28TAK-242%29%2C+selectively+inhibits+toll-like+receptor+4-mediated+cytokine+production+through+suppression+of+intracellular+signaling&doi=10.1124%2Fmol.105.019695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling</span></div><div class="casAuthors">Ii, Masayuki; Matsunaga, Naoko; Hazeki, Kaoru; Nakamura, Kazuyo; Takashima, Katsunori; Seya, Tsukasa; Hazeki, Osamu; Kitazaki, Tomoyuki; Iizawa, Yuji</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1288-1295</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Proinflammatory mediators such as cytokines and NO play pivotal roles in various inflammatory diseases.  To combat inflammatory diseases successfully, regulation of proinflammatory mediator prodn. would be a crit. process.  In the present study, we investigated the in vitro effects of Et (6R)-6-[N-(2-chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), a novel small mol. cytokine prodn. inhibitor, and its mechanism of action.  In RAW264.7 cells and mouse peritoneal macrophages, TAK-242 suppressed lipopolysaccharide (LPS)-induced prodn. of NO, tumor necrosis factor-α (TNF-α), and interleukin (IL)-6, with 50% inhibitory concn. (IC50) of 1.1 to 11 nM.  TAK-242 also suppressed the prodn. of these cytokines from LPS-stimulated human peripheral blood mononuclear cells (PBMCs) at IC50 values from 11 to 33 nM.  In addn., the inhibitory effects on the LPS-induced IL-6 and IL-12 prodn. were similar in human PBMCs, monocytes, and macrophages.  TAK-242 inhibited mRNA expression of IL-6 and TNF-α induced by LPS and interferon-γ in RAW264.7 cells.  The phosphorylation of mitogen-activated protein kinases induced by LPS was also inhibited in a concn.-dependent manner.  However, TAK-242 did not antagonize the binding of LPS to the cells.  It is noteworthy that TAK-242 suppressed the cytokine prodn. induced by Toll-like receptor (TLR) 4 ligands, but not by ligands for TLR2, -3, and -9.  In addn., IL-1 β-induced IL-8 prodn. from human PBMCs was not markedly affected by TAK-242.  These data suggest that TAK-242 suppresses the prodn. of multiple cytokines by selectively inhibiting TLR4 intracellular signaling.  Finally, TAK-242 is a novel small mol. TLR4 signaling inhibitor and could be a promising therapeutic agent for inflammatory diseases, whose pathogenesis involves TLR4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw9_-xuGrPUbVg90H21EOLACvtfcHk0lhVajBnSEniZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtlKntLs%253D&md5=c8ad6248fc504e71aafd9e3f3ad7a546</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.019695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.019695%26sid%3Dliteratum%253Aachs%26aulast%3DIi%26aufirst%3DM.%26aulast%3DMatsunaga%26aufirst%3DN.%26aulast%3DHazeki%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DTakashima%26aufirst%3DK.%26aulast%3DSeya%26aufirst%3DT.%26aulast%3DHazeki%26aufirst%3DO.%26aulast%3DKitazaki%26aufirst%3DT.%26aulast%3DIizawa%26aufirst%3DY.%26atitle%3DA%2520novel%2520cyclohexene%2520derivative%252C%2520ethyl%2520%25286R%2529-6-%255BN-%25282-chloro-4-fluorophenyl%2529sulfamoyl%255Dcyclohex-1-ene-1-carboxylate%2520%2528TAK-242%2529%252C%2520selectively%2520inhibits%2520toll-like%2520receptor%25204-mediated%2520cytokine%2520production%2520through%2520suppression%2520of%2520intracellular%2520signaling%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D69%26spage%3D1288%26epage%3D1295%26doi%3D10.1124%2Fmol.105.019695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Sha, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iizawa, Y.</span><span> </span><span class="NLM_article-title">Therapeutic effects of TAK-242, a novel selective toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">571</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2007.06.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.ejphar.2007.06.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=17632100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCitrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=571&publication_year=2007&pages=231-239&author=T.+Shaauthor=M.+Sunamotoauthor=T.+Kitazakiauthor=J.+Satoauthor=M.+Iiauthor=Y.+Iizawa&title=Therapeutic+effects+of+TAK-242%2C+a+novel+selective+toll-like+receptor+4+signal+transduction+inhibitor%2C+in+mouse+endotoxin+shock+model&doi=10.1016%2Fj.ejphar.2007.06.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model</span></div><div class="casAuthors">Sha, Takukyu; Sunamoto, Mie; Kitazaki, Tomoyuki; Sato, Jun; Ii, Masayuki; Iizawa, Yuji</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">571</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">231-239</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Et (6R)-6-[N-(2-chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), a novel small mol. that selectively inhibits Toll-like receptor 4-mediated signaling, inhibits various kinds of inflammatory mediators such as nitric oxide (NO), tumor necrosis factor (TNF)-α, interleukin (IL)-1, IL-6, IL-10, macrophage inhibitory protein (MIP)-2 and prostaglandin E2 from lipopolysaccharide (LPS)-stimulated macrophages.  The effects of TAK-242 were evaluated in a mouse model of endotoxin shock.  I.v. administration of TAK-242 to mice 1 h before LPS challenge dose-dependently inhibited LPS-induced increases in serum levels of TNF-α, IL-1β, IL-6, IL-10, MIP-2, and NO metabolites.  TAK-242 protected mice from LPS-induced lethality in a similar dose-dependent manner, and rescued 100% of mice at a dose of 1 mg/kg.  Interestingly, TAK-242 worked quickly, and showed beneficial effects even when administered after LPS challenge.  Even though increases in serum levels of IL-6 and hypothermia were already evident 2 h after LPS challenge, TAK-242 administration inhibited further increase in IL-6 levels and decrease in body temp.  LPS-induced increases in serum levels of organ dysfunction markers, such as alanine aminotransferase, total bilirubin, and blood urea nitrogen, were also significantly suppressed by post-treatment as well as pre-treatment.  Furthermore, administration of 3 mg/kg TAK-242 significantly increased survival of mice, even when given 4 h after LPS challenge.  These results suggest that TAK-242 protects mice against LPS-induced lethality by inhibiting prodn. of multiple cytokines and NO.  TAK-242 has a quick onset of action and provides significant benefits by post-treatment, suggesting that it may be a promising drug candidate for the treatment of sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUWvZqAlZpt7Vg90H21EOLACvtfcHk0liev5ffwjj4uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCitrrL&md5=f7d6a1f73a905d9757ef7de3e4ad0b30</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.06.027%26sid%3Dliteratum%253Aachs%26aulast%3DSha%26aufirst%3DT.%26aulast%3DSunamoto%26aufirst%3DM.%26aulast%3DKitazaki%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DJ.%26aulast%3DIi%26aufirst%3DM.%26aulast%3DIizawa%26aufirst%3DY.%26atitle%3DTherapeutic%2520effects%2520of%2520TAK-242%252C%2520a%2520novel%2520selective%2520toll-like%2520receptor%25204%2520signal%2520transduction%2520inhibitor%252C%2520in%2520mouse%2520endotoxin%2520shock%2520model%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D571%26spage%3D231%26epage%3D239%26doi%3D10.1016%2Fj.ejphar.2007.06.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Sha, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iizawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ii, M.</span><span> </span><span class="NLM_article-title">Combination of imipenem and TAK-242, a toll-like receptor 4 signal transduction inhibitor, improves survival in a murine model of polymicrobial sepsis</span> <span class="citation_source-journal">Shock</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span><span class="refDoi"> DOI: 10.1097/SHK.0b013e3181f48942</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1097%2FSHK.0b013e3181f48942" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2011&pages=205-209&author=T.+Shaauthor=Y.+Iizawaauthor=M.+Ii&title=Combination+of+imipenem+and+TAK-242%2C+a+toll-like+receptor+4+signal+transduction+inhibitor%2C+improves+survival+in+a+murine+model+of+polymicrobial+sepsis&doi=10.1097%2FSHK.0b013e3181f48942"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1097%2FSHK.0b013e3181f48942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FSHK.0b013e3181f48942%26sid%3Dliteratum%253Aachs%26aulast%3DSha%26aufirst%3DT.%26aulast%3DIizawa%26aufirst%3DY.%26aulast%3DIi%26aufirst%3DM.%26atitle%3DCombination%2520of%2520imipenem%2520and%2520TAK-242%252C%2520a%2520toll-like%2520receptor%25204%2520signal%2520transduction%2520inhibitor%252C%2520improves%2520survival%2520in%2520a%2520murine%2520model%2520of%2520polymicrobial%2520sepsis%26jtitle%3DShock%26date%3D2011%26volume%3D35%26spage%3D205%26epage%3D209%26doi%3D10.1097%2FSHK.0b013e3181f48942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Goldfarb, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortegel, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrillo, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanotti-Cavazzoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casey, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dellinger, R. P.</span><span> </span><span class="NLM_article-title">TAKEDA-143242 increased survival via reduced cytokines in porcine peritonitis</span> <span class="citation_source-journal">J. Surg. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">e165</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span><span class="refDoi"> DOI: 10.1016/j.jss.2010.09.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.jss.2010.09.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2011&pages=e165-173&author=R.+D.+Goldfarbauthor=J.+W.+Ortegelauthor=J.+E.+Parrilloauthor=S.+Zanotti-Cavazzoniauthor=L.+C.+Caseyauthor=R.+P.+Dellinger&title=TAKEDA-143242+increased+survival+via+reduced+cytokines+in+porcine+peritonitis&doi=10.1016%2Fj.jss.2010.09.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.jss.2010.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jss.2010.09.031%26sid%3Dliteratum%253Aachs%26aulast%3DGoldfarb%26aufirst%3DR.%2BD.%26aulast%3DOrtegel%26aufirst%3DJ.%2BW.%26aulast%3DParrillo%26aufirst%3DJ.%2BE.%26aulast%3DZanotti-Cavazzoni%26aufirst%3DS.%26aulast%3DCasey%26aufirst%3DL.%2BC.%26aulast%3DDellinger%26aufirst%3DR.%2BP.%26atitle%3DTAKEDA-143242%2520increased%2520survival%2520via%2520reduced%2520cytokines%2520in%2520porcine%2520peritonitis%26jtitle%3DJ.%2520Surg.%2520Res.%26date%3D2011%26volume%3D166%26spage%3De165%26epage%3D173%26doi%3D10.1016%2Fj.jss.2010.09.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Hua, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prunty, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayeed, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, D. G.</span><span> </span><span class="NLM_article-title">TAK-242, an antagonist for toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span><span class="refDoi"> DOI: 10.1038/jcbfm.2014.240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fjcbfm.2014.240" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=25586141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGrsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=536-542&author=F.+Huaauthor=H.+Tangauthor=J.+Wangauthor=M.+C.+Pruntyauthor=X.+Huaauthor=I.+Sayeedauthor=D.+G.+Stein&title=TAK-242%2C+an+antagonist+for+toll-like+receptor+4%2C+protects+against+acute+cerebral+ischemia%2Freperfusion+injury+in+mice&doi=10.1038%2Fjcbfm.2014.240"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice</span></div><div class="casAuthors">Hua, Fang; Tang, Huiling; Wang, Jun; Prunty, Megan C.; Hua, Xiaodong; Sayeed, Iqbal; Stein, Donald G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">536-542</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Toll-like receptor 4 (TLR4) contributes to cerebral ischemia/reperfusion (I/R) injury and is a potential target for the treatment of ischemic stroke.  This expt. is to evaluate the effect of an exogenous TLR4 antagonist, TAK-242, against acute cerebral I/R injury.  A mouse model of cerebral I/R was induced by transient middle cerebral artery occlusion.  TAK-242 (3 mg/kg body wt.) was injected i.p. 1 h after ischemia.  Our results showed that the concn. of TAK-242 in plasma increased to 52.0 ng/mL 3 h after injection, was maintained at 54.1 ng/mL 8 h after injection, and decreased to 22.6 ng/mL 24 h after injection.  The concn. of TAK-242 in brain tissue increased to 26.1 ng/mL in ischemic hemisphere and 14.2 ng/mL in nonischemic hemisphere 3 h after injection, and was maintained at the similar levels 24 h after injection.  We found that TAK-242 significantly reduced cerebral infarction compared with vehicle control, improved neurol. function, inhibited the phosphorylation of downstream protein kinases in TLR4 signaling pathway, and downregulated the expression of inflammatory cytokines.  We conclude that TAK-242 is able to cross blood-brain barrier, blocks TLR4 signaling, mediates the expression of inflammatory cytokines, and protects the brain from acute damage induced by I/R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-M4XQgqpBY7Vg90H21EOLACvtfcHk0liev5ffwjj4uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGrsr0%253D&md5=a3383c2162301b44b7cb5697ca060470</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2014.240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2014.240%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DF.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPrunty%26aufirst%3DM.%2BC.%26aulast%3DHua%26aufirst%3DX.%26aulast%3DSayeed%26aufirst%3DI.%26aulast%3DStein%26aufirst%3DD.%2BG.%26atitle%3DTAK-242%252C%2520an%2520antagonist%2520for%2520toll-like%2520receptor%25204%252C%2520protects%2520against%2520acute%2520cerebral%2520ischemia%252Freperfusion%2520injury%2520in%2520mice%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2015%26volume%3D35%26spage%3D536%26epage%3D542%26doi%3D10.1038%2Fjcbfm.2014.240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byth, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toader, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span> </span><span class="NLM_article-title">Mechanism and <i>in vitro</i> pharmacology of TAK1 inhibition by (5Z)-7-oxozeaenol</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span><span class="refDoi"> DOI: 10.1021/cb3005897</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb3005897" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslSg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=643-650&author=J.+Wuauthor=F.+Powellauthor=N.+A.+Larsenauthor=Z.+Laiauthor=K.+F.+Bythauthor=J.+Readauthor=R.+F.+Guauthor=M.+Rothauthor=D.+Toaderauthor=J.+C.+Saehauthor=H.+Chen&title=Mechanism+and+in+vitro+pharmacology+of+TAK1+inhibition+by+%285Z%29-7-oxozeaenol&doi=10.1021%2Fcb3005897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism and In Vitro Pharmacology of TAK1 Inhibition by (5Z)-7-Oxozeaenol</span></div><div class="casAuthors">Wu, Jiaquan; Powell, Francoise; Larsen, Nicholas A.; Lai, Zhongwu; Byth, Kate F.; Read, Jon; Gu, Rong-Fang; Roth, Mark; Toader, Dorin; Saeh, Jamal Carlos; Chen, Huawei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">643-650</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Transforming growth factor-β activated kinase-1 (TAK1) is a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family that regulates several signaling pathways including NF-κB signal transduction and p38 activation.  TAK1 deregulation has been implicated in human diseases including cancer and inflammation.  Here, we show that, in addn. to its kinase activity, TAK1 has intrinsic ATPase activity, that (5Z)-7-Oxozeaenol irreversibly inhibits TAK1, and that sensitivity to (5Z)-7-Oxozeaenol inhibition in hematol. cancer cell lines is NRAS mutation status and TAK1 pathway dependent.  X-ray crystallog. and mass spectrometric studies showed that (5Z)-7-Oxozeaenol forms a covalent complex with TAK1.  Detailed biochem. characterization revealed that (5Z)-7-Oxozeaenol inhibited both the kinase and the ATPase activity of TAK1 following a bi-phase kinetics, consistent with the irreversible inhibition mechanism.  In DoHH2 cells, (5Z)-7-Oxozeaenol potently inhibited the p38 phosphorylation driven by TAK1, and the inhibition lasted over 6 h after withdrawal of (5Z)-7-Oxozeaenol.  Profiling (5Z)-7-Oxozeaenol in a panel of hematol. cancer cells showed that sensitive cell lines tended to carry NRAS mutations and that genes in TAK1 regulated pathways were enriched in sensitive cell lines.  Taken together, we have elucidated the mol. mechanism of a TAK1 irreversible inhibitor and laid the foundation for designing next generation TAK1 irreversible inhibitors.  The NRAS-TAK1-Wnt signaling network discerned in our study may prove to be useful in patient selection for TAK1 targeted agents in hematol. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQoK3PzlpHObVg90H21EOLACvtfcHk0ljjuqtOjkp8NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslSg&md5=4bd8a0667c6eeddbf9f81153ab4ffbe5</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fcb3005897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb3005897%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DPowell%26aufirst%3DF.%26aulast%3DLarsen%26aufirst%3DN.%2BA.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DByth%26aufirst%3DK.%2BF.%26aulast%3DRead%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DR.%2BF.%26aulast%3DRoth%26aufirst%3DM.%26aulast%3DToader%26aufirst%3DD.%26aulast%3DSaeh%26aufirst%3DJ.%2BC.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DMechanism%2520and%2520in%2520vitro%2520pharmacology%2520of%2520TAK1%2520inhibition%2520by%2520%25285Z%2529-7-oxozeaenol%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D643%26epage%3D650%26doi%3D10.1021%2Fcb3005897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Hett, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slater, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawate, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, D. T.</span><span> </span><span class="NLM_article-title">Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">398</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span><span class="refDoi"> DOI: 10.1038/nchembio.1236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnchembio.1236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=23603659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Sls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=398-405&author=E.+C.+Hettauthor=L.+H.+Slaterauthor=K.+G.+Markauthor=T.+Kawateauthor=B.+G.+Monksauthor=A.+Stutzauthor=E.+Latzauthor=D.+T.+Hung&title=Chemical+genetics+reveals+a+kinase-independent+role+for+protein+kinase+R+in+pyroptosis&doi=10.1038%2Fnchembio.1236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis</span></div><div class="casAuthors">Hett, Erik C.; Slater, Louise H.; Mark, Kevin G.; Kawate, Tomohiko; Monks, Brian G.; Stutz, Andrea; Latz, Eicke; Hung, Deborah T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">398-405</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Formation of the inflammasome, a scaffolding complex that activates caspase-1, is important in numerous diseases.  Pyroptotic cell death induced by anthrax lethal toxin (LT) is a model for inflammasome-mediated caspase-1 activation.  We discovered 7-desacetoxy-6,7-dehydrogedunin (7DG) in a phenotypic screen as a small mol. that protects macrophages from LT-induced death.  Using chem. proteomics, we identified protein kinase R (PKR) as the target of 7DG and show that RNAi knockdown of PKR phenocopies treatment with 7DG.  Further, we show that PKR's role in ASC assembly and caspase-1 activation induced by several different inflammasome stimuli is independent of PKR's kinase activity, demonstrating that PKR has a previously uncharacterized role in caspase-1 activation and pyroptosis that is distinct from its reported kinase-dependent roles in apoptosis and inflammasome formation in lipopolysaccharide-primed cells.  Remarkably, PKR has different roles in two distinct cell death pathways and has a broad role in inflammasome function relevant in other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXeyfUICrnXLVg90H21EOLACvtfcHk0ljjuqtOjkp8NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Sls7s%253D&md5=ea43350c90efab90469218bf30e4b11d</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1236%26sid%3Dliteratum%253Aachs%26aulast%3DHett%26aufirst%3DE.%2BC.%26aulast%3DSlater%26aufirst%3DL.%2BH.%26aulast%3DMark%26aufirst%3DK.%2BG.%26aulast%3DKawate%26aufirst%3DT.%26aulast%3DMonks%26aufirst%3DB.%2BG.%26aulast%3DStutz%26aufirst%3DA.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DHung%26aufirst%3DD.%2BT.%26atitle%3DChemical%2520genetics%2520reveals%2520a%2520kinase-independent%2520role%2520for%2520protein%2520kinase%2520R%2520in%2520pyroptosis%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D398%26epage%3D405%26doi%3D10.1038%2Fnchembio.1236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Lu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inouye, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundbäck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdes-Ferrer, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olofsson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalb, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlandsson-Harris, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ting, J. P.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antoine, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavan, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotamisligil, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, K. J.</span><span> </span><span class="NLM_article-title">Novel role of PKR in inflammasome activation and HMGB1 release</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">670</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1038/nature11290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnature11290" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=670-674&author=B.+Luauthor=T.+Nakamuraauthor=K.+Inouyeauthor=J.+Liauthor=Y.+Tangauthor=P.+Lundb%C3%A4ckauthor=S.+I.+Valdes-Ferrerauthor=P.+S.+Olofssonauthor=T.+Kalbauthor=J.+Rothauthor=Y.+Zouauthor=H.+Erlandsson-Harrisauthor=H.+Yangauthor=J.+P.-Y.+Tingauthor=H.+Wangauthor=U.+Anderssonauthor=D.+J.+Antoineauthor=S.+S.+Chavanauthor=G.+S.+Hotamisligilauthor=K.+J.+Tracey&title=Novel+role+of+PKR+in+inflammasome+activation+and+HMGB1+release&doi=10.1038%2Fnature11290"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1038%2Fnature11290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11290%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DB.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DInouye%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DLundb%25C3%25A4ck%26aufirst%3DP.%26aulast%3DValdes-Ferrer%26aufirst%3DS.%2BI.%26aulast%3DOlofsson%26aufirst%3DP.%2BS.%26aulast%3DKalb%26aufirst%3DT.%26aulast%3DRoth%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DErlandsson-Harris%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DTing%26aufirst%3DJ.%2BP.-Y.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DAntoine%26aufirst%3DD.%2BJ.%26aulast%3DChavan%26aufirst%3DS.%2BS.%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DNovel%2520role%2520of%2520PKR%2520in%2520inflammasome%2520activation%2520and%2520HMGB1%2520release%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D670%26epage%3D674%26doi%3D10.1038%2Fnature11290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Bonnet, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weil, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dam, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hovanessian, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meurs, E. F.</span><span> </span><span class="NLM_article-title">PKR stimulates NF-κB irrespective of its kinase function by interacting with the IκB kinase complex</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4532</span><span class="NLM_x">–</span> <span class="NLM_lpage">4542</span><span class="refDoi"> DOI: 10.1128/MCB.20.13.4532-4542.2000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1128%2FMCB.20.13.4532-4542.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10848580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksVOjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=4532-4542&author=M.+C.+Bonnetauthor=R.+Weilauthor=E.+Damauthor=A.+G.+Hovanessianauthor=E.+F.+Meurs&title=PKR+stimulates+NF-%CE%BAB+irrespective+of+its+kinase+function+by+interacting+with+the+I%CE%BAB+kinase+complex&doi=10.1128%2FMCB.20.13.4532-4542.2000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">PKR stimulates NF-κB irrespective of its kinase function by interacting with the IκB kinase complex</span></div><div class="casAuthors">Bonnet, Marion C.; Weil, Robert; Dam, Elisabeth; Hovanessian, Ara G.; Meurs, Eliane F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4532-4542</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The interferon (IFN)-induced double-stranded RNA-activated protein kinase PKR mediates inhibition of protein synthesis through phosphorylation of the α subunit of eukaryotic initiation factor 2 (eIF2α) and is also involved in the induction of the IFN gene through the activation of the transcription factor NF-κB.  NF-κB is retained in the cytoplasm through binding to its inhibitor IκBα.  The crit. step in NF-κB activation is the phosphorylation of IκBα by the IκB kinase (IKK) complex.  This activity releases NF-κB from IκBα and allows its translocation to the nucleus.  Here, we have studied the ability of PKR to activate NF-κB in a reporter assay and have shown for the first time that two catalytically inactive PKR mutants, PKR/KR296 and a deletion mutant (PKR/Del42) which lacks the potential eIF2α-binding domain, can also activate NF-κB.  This result indicated that NF-κB activation by PKR does not require its kinase activity and that it is independent of the PKR-eIF2α relationship.  Transfection of either wild-type PKR or catalytically inactive PKR in PKR0/0 mouse embryo fibroblasts resulted in the activation of the IKK complex.  By using a glutathione S-transferase pull-down assay, we showed that PKR interacts with the IKKβ subunit of the IKK complex.  This interaction apparently does not require the integrity of the IKK complex, as it was found to occur with exts. from cells deficient in the NF-κB essential modulator, one of the components of the IKK complex.  Therefore, our results reveal a novel pathway by which PKR can modulate the NF-κB signaling pathway without using its kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqankUHDyrgHrVg90H21EOLACvtfcHk0ljjuqtOjkp8NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksVOjtLc%253D&md5=e4043f71ec7f431dc6c55d6efffeb02b</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1128%2FMCB.20.13.4532-4542.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.20.13.4532-4542.2000%26sid%3Dliteratum%253Aachs%26aulast%3DBonnet%26aufirst%3DM.%2BC.%26aulast%3DWeil%26aufirst%3DR.%26aulast%3DDam%26aufirst%3DE.%26aulast%3DHovanessian%26aufirst%3DA.%2BG.%26aulast%3DMeurs%26aufirst%3DE.%2BF.%26atitle%3DPKR%2520stimulates%2520NF-%25CE%25BAB%2520irrespective%2520of%2520its%2520kinase%2520function%2520by%2520interacting%2520with%2520the%2520I%25CE%25BAB%2520kinase%2520complex%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2000%26volume%3D20%26spage%3D4532%26epage%3D4542%26doi%3D10.1128%2FMCB.20.13.4532-4542.2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Juliana, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes-Alnemri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farias, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E. S.</span><span> </span><span class="NLM_article-title">Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">36617</span><span class="NLM_x">–</span> <span class="NLM_lpage">36622</span><span class="refDoi"> DOI: 10.1074/jbc.M112.407130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M112.407130" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=36617-36622&author=C.+Julianaauthor=T.+Fernandes-Alnemriauthor=S.+Kangauthor=A.+Fariasauthor=F.+Qinauthor=E.+S.+Alnemri&title=Non-transcriptional+priming+and+deubiquitination+regulate+NLRP3+inflammasome+activation&doi=10.1074%2Fjbc.M112.407130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.407130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.407130%26sid%3Dliteratum%253Aachs%26aulast%3DJuliana%26aufirst%3DC.%26aulast%3DFernandes-Alnemri%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DFarias%26aufirst%3DA.%26aulast%3DQin%26aufirst%3DF.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26atitle%3DNon-transcriptional%2520priming%2520and%2520deubiquitination%2520regulate%2520NLRP3%2520inflammasome%2520activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D36617%26epage%3D36622%26doi%3D10.1074%2Fjbc.M112.407130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Lopez-Castejon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luheshi, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">High, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehead, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flitsch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudovsky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, D.</span><span> </span><span class="NLM_article-title">Deubiquitinases regulate the activity of caspase-1 and interleukin-1β secretion via assembly of the inflammasome</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">2721</span><span class="NLM_x">–</span> <span class="NLM_lpage">2733</span><span class="refDoi"> DOI: 10.1074/jbc.M112.422238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M112.422238" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=2721-2733&author=G.+Lopez-Castejonauthor=N.+M.+Luheshiauthor=V.+Companauthor=S.+Highauthor=R.+C.+Whiteheadauthor=S.+Flitschauthor=A.+Kirovauthor=I.+Prudovskyauthor=E.+Swantonauthor=D.+Brough&title=Deubiquitinases+regulate+the+activity+of+caspase-1+and+interleukin-1%CE%B2+secretion+via+assembly+of+the+inflammasome&doi=10.1074%2Fjbc.M112.422238"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.422238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.422238%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Castejon%26aufirst%3DG.%26aulast%3DLuheshi%26aufirst%3DN.%2BM.%26aulast%3DCompan%26aufirst%3DV.%26aulast%3DHigh%26aufirst%3DS.%26aulast%3DWhitehead%26aufirst%3DR.%2BC.%26aulast%3DFlitsch%26aufirst%3DS.%26aulast%3DKirov%26aufirst%3DA.%26aulast%3DPrudovsky%26aufirst%3DI.%26aulast%3DSwanton%26aufirst%3DE.%26aulast%3DBrough%26aufirst%3DD.%26atitle%3DDeubiquitinases%2520regulate%2520the%2520activity%2520of%2520caspase-1%2520and%2520interleukin-1%25CE%25B2%2520secretion%2520via%2520assembly%2520of%2520the%2520inflammasome%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D2721%26epage%3D2733%26doi%3D10.1074%2Fjbc.M112.422238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Shi, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenderov, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abu-Asab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehrl, J. H.</span><span> </span><span class="NLM_article-title">Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span><span class="refDoi"> DOI: 10.1038/ni.2215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fni.2215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22286270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlOlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=255-263&author=C.+S.+Shiauthor=K.+Shenderovauthor=N.+N.+Huangauthor=J.+Kabatauthor=M.+Abu-Asabauthor=K.+A.+Fitzgeraldauthor=A.+Sherauthor=J.+H.+Kehrl&title=Activation+of+autophagy+by+inflammatory+signals+limits+IL-1%CE%B2+production+by+targeting+ubiquitinated+inflammasomes+for+destruction&doi=10.1038%2Fni.2215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction</span></div><div class="casAuthors">Shi, Chong-Shan; Shenderov, Kevin; Huang, Ning-Na; Kabat, Juraj; Abu-Asab, Mones; Fitzgerald, Katherine A.; Sher, Alan; Kehrl, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-263</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autophagosomes delivers cytoplasmic constituents to lysosomes for degrdn., whereas inflammasomes are mol. platforms activated by infection or stress that regulate the activity of caspase-1 and the maturation of interleukin 1β (IL-1β) and IL-18.  Here we show that the induction of AIM2 or NLRP3 inflammasomes in macrophages triggered activation of the G protein RalB and autophagosome formation.  The induction of autophagy did not depend on the adaptor ASC or capase-1 but was dependent on the presence of the inflammasome sensor.  Blocking autophagy potentiated inflammasome activity, whereas stimulating autophagy limited it.  Assembled inflammasomes underwent ubiquitination and recruited the autophagic adaptor p62, which assisted their delivery to autophagosomes.  Our data indicate that autophagy accompanies inflammasome activation to temper inflammation by eliminating active inflammasomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqosogK1NAUALVg90H21EOLACvtfcHk0lj2rb2PZrQSog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlOlsb0%253D&md5=55ed59af5cd9f38066ff8d9a1f40f4ba</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1038%2Fni.2215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.2215%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DC.%2BS.%26aulast%3DShenderov%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DN.%2BN.%26aulast%3DKabat%26aufirst%3DJ.%26aulast%3DAbu-Asab%26aufirst%3DM.%26aulast%3DFitzgerald%26aufirst%3DK.%2BA.%26aulast%3DSher%26aufirst%3DA.%26aulast%3DKehrl%26aufirst%3DJ.%2BH.%26atitle%3DActivation%2520of%2520autophagy%2520by%2520inflammatory%2520signals%2520limits%2520IL-1%25CE%25B2%2520production%2520by%2520targeting%2520ubiquitinated%2520inflammasomes%2520for%2520destruction%26jtitle%3DNat.%2520Immunol.%26date%3D2012%26volume%3D13%26spage%3D255%26epage%3D263%26doi%3D10.1038%2Fni.2215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Ferrari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiozzi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falzoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Susino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baricordi, O. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Virgilio, F.</span><span> </span><span class="NLM_article-title">Extracellular ATP triggers IL-1β release by activating the purinergic P2Z receptor of human macrophages</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">1451</span><span class="NLM_x">–</span> <span class="NLM_lpage">1458</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=9233643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADyaK2sXkslKrtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=1997&pages=1451-1458&author=D.+Ferrariauthor=P.+Chiozziauthor=S.+Falzoniauthor=M.+Dal+Susinoauthor=L.+Melchiorriauthor=O.+R.+Baricordiauthor=F.+Di+Virgilio&title=Extracellular+ATP+triggers+IL-1%CE%B2+release+by+activating+the+purinergic+P2Z+receptor+of+human+macrophages"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular ATP triggers IL-1β release by activating the purinergic P2Z receptor of human macrophages</span></div><div class="casAuthors">Ferrari, Davide; Chiozzi, Paola; Falzoni, Simonetta; Dal Susino, Monica; Melchiorri, Loredana; Baricordi, Olavio R.; Di Virgilio, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1451-1458</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Extracellular ATP (ATPe) is known to cause release of processed IL-1β from LPS-treated macrophages and microglial cells.  IL-1β release is fast and thought to be assocd. with cell death.  The authors have reinvestigated this process to identify (1) the purinergic receptor involved; (2) the relation to cell death; and (3) pharmacol. agonists or antagonists able to modulate IL-1β release.  The data confirm that ATPe is a powerful stimulus for IL-1β release from LPS-treated human macrophages; however, the authors also show that IL-1β release is not necessarily assocd. with cell death, as it occurs at lower ATP concns. and much earlier than leakage of cytoplasmic markers.  The selective purinergic P2Z receptor agonist benzoylbenzoyl ATP was at least one order of magnitude more powerful than ATP, but also had a strong cytotoxic effect.  Methylthio-ATP was equipotent as ATPe at the optimal concn. of 1 mM, but markedly inhibitory at higher concns.  The irreversible P2Z blocker-oxidized ATP completely inhibited ATPe-induced IL-1β release.  IL-1β release also was inhibited by increasing the K+ concn. of the incubation medium.  These data suggest that ATPe triggers IL-1β via the purinergic P2Z receptor recently shown to be expressed by human macrophages and identified as a new member of the P2X family (P2X7), and provide pharmacol. tools for the modulation of IL-1β release in vitro and, possibly, in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2liwcW09JWrVg90H21EOLACvtfcHk0lj2rb2PZrQSog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslKrtLo%253D&md5=188ea739b2440fc90fefded2c486c764</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DD.%26aulast%3DChiozzi%26aufirst%3DP.%26aulast%3DFalzoni%26aufirst%3DS.%26aulast%3DDal%2BSusino%26aufirst%3DM.%26aulast%3DMelchiorri%26aufirst%3DL.%26aulast%3DBaricordi%26aufirst%3DO.%2BR.%26aulast%3DDi%2BVirgilio%26aufirst%3DF.%26atitle%3DExtracellular%2520ATP%2520triggers%2520IL-1%25CE%25B2%2520release%2520by%2520activating%2520the%2520purinergic%2520P2Z%2520receptor%2520of%2520human%2520macrophages%26jtitle%3DJ.%2520Immunol.%26date%3D1997%26volume%3D159%26spage%3D1451%26epage%3D1458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Solle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labasi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perregaux, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stam, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrushova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koller, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span> </span><span class="NLM_article-title">Altered cytokine production in mice lacking P2X<sub>7</sub> receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1074/jbc.M006781200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M006781200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=11016935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtFSjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=125-132&author=M.+Solleauthor=J.+Labasiauthor=D.+G.+Perregauxauthor=E.+Stamauthor=N.+Petrushovaauthor=B.+H.+Kollerauthor=R.+J.+Griffithsauthor=C.+A.+Gabel&title=Altered+cytokine+production+in+mice+lacking+P2X7+receptors&doi=10.1074%2Fjbc.M006781200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Altered cytokine production in mice lacking P2X7 receptors</span></div><div class="casAuthors">Solle, Mike; Labasi, Jeff; Perregaux, David G.; Stam, Ethan; Petrushova, Nina; Koller, Beverly H.; Griffiths, Richard J.; Gabel, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The P2X7 receptor (P2X7R) is an ATP-gated ion channel expressed by monocytes and macrophages.  To directly address the role of this receptor in interleukin (IL)-1β post-translational processing, the authors have generated a P2X7R-deficient mouse line.  P2X7R-/- macrophages respond to lipopolysaccharide and produce levels of cyclooxygenase-2 and pro-IL-1β comparable with those generated by wild-type cells.  In response to ATP, however, pro-IL-1β produced by the P2X7R-/- cells is not externalized or activated by caspase-1.  Nigericin, an alternate secretion stimulus, promotes release of 17-kDa IL-1β from P2X7R-/- macrophages.  In response to in vivo lipopolysaccharide injection, both wild-type and P2X7R-/- animals display increases in peritoneal lavage IL-6 levels but no detectable IL-1.  Subsequent ATP injection to wild-type animals promotes an increase in IL-1, which in turn leads to addnl. IL-6 prodn.; similar increases did not occur in ATP-treated, LPS-primed P2X7R-/- animals.  Absence of the P2X7R thus leads to an inability of peritoneal macrophages to release IL-1 in response to ATP.  As a result of the IL-1 deficiency, in vivo cytokine signaling cascades are impaired in P2X7R-deficient animals.  Together these results demonstrate that P2X7R activation can provide a signal that leads to maturation and release of IL-1β and initiation of a cytokine cascade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplWJDl5YjMEbVg90H21EOLACvtfcHk0lh7RiWjX6DBUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtFSjug%253D%253D&md5=cbbd35688998cce33e72e3b835d0f9c3</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M006781200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M006781200%26sid%3Dliteratum%253Aachs%26aulast%3DSolle%26aufirst%3DM.%26aulast%3DLabasi%26aufirst%3DJ.%26aulast%3DPerregaux%26aufirst%3DD.%2BG.%26aulast%3DStam%26aufirst%3DE.%26aulast%3DPetrushova%26aufirst%3DN.%26aulast%3DKoller%26aufirst%3DB.%2BH.%26aulast%3DGriffiths%26aufirst%3DR.%2BJ.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26atitle%3DAltered%2520cytokine%2520production%2520in%2520mice%2520lacking%2520P2X7%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D125%26epage%3D132%26doi%3D10.1074%2Fjbc.M006781200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Chessell, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatcher, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egerton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murfin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peck, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grahames, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casula, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yiangou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buell, G. N.</span><span> </span><span class="NLM_article-title">Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span><span class="refDoi"> DOI: 10.1016/j.pain.2005.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.pain.2005.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=15777864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlCiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2005&pages=386-396&author=I.+P.+Chessellauthor=J.+P.+Hatcherauthor=C.+Bountraauthor=A.+D.+Michelauthor=J.+P.+Hughesauthor=P.+Greenauthor=J.+Egertonauthor=M.+Murfinauthor=J.+Richardsonauthor=W.+L.+Peckauthor=C.+B.+Grahamesauthor=M.+A.+Casulaauthor=Y.+Yiangouauthor=R.+Birchauthor=P.+Anandauthor=G.+N.+Buell&title=Disruption+of+the+P2X7+purinoceptor+gene+abolishes+chronic+inflammatory+and+neuropathic+pain&doi=10.1016%2Fj.pain.2005.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain</span></div><div class="casAuthors">Chessell, Iain P.; Hatcher, Jonathan P.; Bountra, Chas; Michel, Anton D.; Hughes, Jane P.; Green, Paula; Egerton, Julie; Murfin, Melanie; Richardson, Jill; Peck, Wendy L.; Grahames, Caroline B. A.; Casula, Maria Anna; Yiangou, Yiangos; Birch, Rolfe; Anand, Praveen; Buell, Gary N.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">386-396</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The P2X7 purinoceptor is a ligand-gated cation channel, expressed predominantly by cells of immune origin, with a unique phenotype which includes release of biol. active inflammatory cytokine, interleukin (IL)-1β following activation, and unique ion channel biophysics obsd. only in this receptor family.  In mice lacking this receptor, inflammatory (in an adjuvant-induced model) and neuropathic (in a partial nerve ligation model) hypersensitivity is completely absent to both mech. and thermal stimuli, while normal nociceptive processing is preserved.  The knockout animals were unimpaired in their ability to produce mRNA for pro-IL-1β, and cytometric anal. of paw and systemic cytokines from knockout and wild-type animals following adjuvant insult suggests a selective effect of the gene deletion on release of IL-1β and IL-10, with systemic redns. in adjuvant-induced increases in IL-6 and MCP-1.  In addn., the authors show that this receptor is upregulated in human dorsal root ganglia and injured nerves obtained from chronic neuropathic pain patients.  The authors hypothesize that the P2X7 receptor, via regulation of mature IL-1β prodn., plays a common upstream transductional role in the development of pain of neuropathic and inflammatory origin.  Drugs which block this target may have the potential to deliver broad-spectrum analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-BHrUu6ak17Vg90H21EOLACvtfcHk0lh7RiWjX6DBUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlCiu78%253D&md5=883f5bdb9b8950fa97d5a69a7325b026</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2005.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2005.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DChessell%26aufirst%3DI.%2BP.%26aulast%3DHatcher%26aufirst%3DJ.%2BP.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DMichel%26aufirst%3DA.%2BD.%26aulast%3DHughes%26aufirst%3DJ.%2BP.%26aulast%3DGreen%26aufirst%3DP.%26aulast%3DEgerton%26aufirst%3DJ.%26aulast%3DMurfin%26aufirst%3DM.%26aulast%3DRichardson%26aufirst%3DJ.%26aulast%3DPeck%26aufirst%3DW.%2BL.%26aulast%3DGrahames%26aufirst%3DC.%2BB.%26aulast%3DCasula%26aufirst%3DM.%2BA.%26aulast%3DYiangou%26aufirst%3DY.%26aulast%3DBirch%26aufirst%3DR.%26aulast%3DAnand%26aufirst%3DP.%26aulast%3DBuell%26aufirst%3DG.%2BN.%26atitle%3DDisruption%2520of%2520the%2520P2X7%2520purinoceptor%2520gene%2520abolishes%2520chronic%2520inflammatory%2520and%2520neuropathic%2520pain%26jtitle%3DPain%26date%3D2005%26volume%3D114%26spage%3D386%26epage%3D396%26doi%3D10.1016%2Fj.pain.2005.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Labasi, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrushova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donovan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payette, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brissette, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wicks, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audoly, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span> </span><span class="NLM_article-title">Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">6436</span><span class="NLM_x">–</span> <span class="NLM_lpage">6445</span><span class="refDoi"> DOI: 10.4049/jimmunol.168.12.6436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.168.12.6436" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2002&pages=6436-6445&author=J.+M.+Labasiauthor=N.+Petrushovaauthor=C.+Donovanauthor=S.+McCurdyauthor=P.+Liraauthor=M.+M.+Payetteauthor=W.+Brissetteauthor=J.+R.+Wicksauthor=L.+Audolyauthor=C.+A.+Gabel&title=Absence+of+the+P2X7+receptor+alters+leukocyte+function+and+attenuates+an+inflammatory+response&doi=10.4049%2Fjimmunol.168.12.6436"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.168.12.6436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.168.12.6436%26sid%3Dliteratum%253Aachs%26aulast%3DLabasi%26aufirst%3DJ.%2BM.%26aulast%3DPetrushova%26aufirst%3DN.%26aulast%3DDonovan%26aufirst%3DC.%26aulast%3DMcCurdy%26aufirst%3DS.%26aulast%3DLira%26aufirst%3DP.%26aulast%3DPayette%26aufirst%3DM.%2BM.%26aulast%3DBrissette%26aufirst%3DW.%26aulast%3DWicks%26aufirst%3DJ.%2BR.%26aulast%3DAudoly%26aufirst%3DL.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26atitle%3DAbsence%2520of%2520the%2520P2X7%2520receptor%2520alters%2520leukocyte%2520function%2520and%2520attenuates%2520an%2520inflammatory%2520response%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D168%26spage%3D6436%26epage%3D6445%26doi%3D10.4049%2Fjimmunol.168.12.6436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Kanneganti, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamkanfi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenabeele, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunez, G.</span><span> </span><span class="NLM_article-title">Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of toll-like receptor signaling</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span><span class="refDoi"> DOI: 10.1016/j.immuni.2007.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.immuni.2007.03.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=433-443&author=T.+D.+Kannegantiauthor=M.+Lamkanfiauthor=Y.+G.+Kimauthor=G.+Chenauthor=J.+H.+Parkauthor=L.+Franchiauthor=P.+Vandenabeeleauthor=G.+Nunez&title=Pannexin-1-mediated+recognition+of+bacterial+molecules+activates+the+cryopyrin+inflammasome+independent+of+toll-like+receptor+signaling&doi=10.1016%2Fj.immuni.2007.03.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2007.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2007.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DKanneganti%26aufirst%3DT.%2BD.%26aulast%3DLamkanfi%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DY.%2BG.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DFranchi%26aufirst%3DL.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DNunez%26aufirst%3DG.%26atitle%3DPannexin-1-mediated%2520recognition%2520of%2520bacterial%2520molecules%2520activates%2520the%2520cryopyrin%2520inflammasome%2520independent%2520of%2520toll-like%2520receptor%2520signaling%26jtitle%3DImmunity%26date%3D2007%26volume%3D26%26spage%3D433%26epage%3D443%26doi%3D10.1016%2Fj.immuni.2007.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Park, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hien, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span> </span><span class="NLM_article-title">Discovery of novel 2,5-dioxoimidazolidine-based P2X<sub>7</sub> receptor antagonists as constrained analogues of KN62</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2114</span><span class="NLM_x">–</span> <span class="NLM_lpage">2134</span><span class="refDoi"> DOI: 10.1021/jm500324g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500324g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVCht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2114-2134&author=J.+H.+Parkauthor=G.+E.+Leeauthor=S.+D.+Leeauthor=T.+T.+Hienauthor=S.+Kimauthor=J.+W.+Yangauthor=J.+H.+Choauthor=H.+Koauthor=S.+C.+Limauthor=Y.+G.+Kimauthor=K.+W.+Kangauthor=Y.+C.+Kim&title=Discovery+of+novel+2%2C5-dioxoimidazolidine-based+P2X7+receptor+antagonists+as+constrained+analogues+of+KN62&doi=10.1021%2Fjm500324g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel 2,5-Dioxoimidazolidine-Based P2X7 Receptor Antagonists as Constrained Analogues of KN62</span></div><div class="casAuthors">Park, Jin-Hee; Lee, Ga-Eun; Lee, So-Deok; Hien, Tran Thi; Kim, Sujin; Yang, Jin Won; Cho, Joong-Heui; Ko, Hyojin; Lim, Sung-Chul; Kim, Yoon-Gyoon; Kang, Keon-Wook; Kim, Yong-Chul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2114-2134</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel 2,5-dioxoimidazolidine-based conformationally constrained analogs of KN62 were developed as P2X7 receptor (P2X7R) antagonists using a rigidification strategy of the tyrosine backbone of KN62.  SAR anal. of the 2,5-dioxoimidazolidine scaffold indicated that piperidine substitution at the N3 position and no substitution at N1 position were preferable.  Further optimization of the substituents at the piperidine nitrogen and the spacer around the skeleton resulted in several superior antagonists to KN62, including 1-adamantanecarbonyl analog I (IC50 = 23 nM in ethidium uptake assay; IC50 = 14 nM in IL-1β ELISA assay) and (3-CF3-4-Cl)benzoyl analog (-)-II (54 nM in ethidium uptake assay; 9 nM in IL-1β ELISA assay), which was more potent than the corresponding (+) isomer.  Compd. II displayed potent inhibitory activity in an ex vivo model of LTP-induced pain signaling in the spinal cord and significant anti-inflammatory activity in in vivo models of carrageenan-induced paw edema and type II collagen-induced joint arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3crY7yQxKLVg90H21EOLACvtfcHk0lg7_j29oMtLMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVCht7g%253D&md5=a54d0b90676aa34ab80f5b1750a48ff5</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm500324g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500324g%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DG.%2BE.%26aulast%3DLee%26aufirst%3DS.%2BD.%26aulast%3DHien%26aufirst%3DT.%2BT.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DJ.%2BW.%26aulast%3DCho%26aufirst%3DJ.%2BH.%26aulast%3DKo%26aufirst%3DH.%26aulast%3DLim%26aufirst%3DS.%2BC.%26aulast%3DKim%26aufirst%3DY.%2BG.%26aulast%3DKang%26aufirst%3DK.%2BW.%26aulast%3DKim%26aufirst%3DY.%2BC.%26atitle%3DDiscovery%2520of%2520novel%25202%252C5-dioxoimidazolidine-based%2520P2X7%2520receptor%2520antagonists%2520as%2520constrained%2520analogues%2520of%2520KN62%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2114%26epage%3D2134%26doi%3D10.1021%2Fjm500324g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Keystone, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInnes, I. B.</span><span> </span><span class="NLM_article-title">Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1630</span><span class="NLM_x">–</span> <span class="NLM_lpage">1635</span><span class="refDoi"> DOI: 10.1136/annrheumdis-2011-143578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1136%2Fannrheumdis-2011-143578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22966146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1SqurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=1630-1635&author=E.+C.+Keystoneauthor=M.+M.+Wangauthor=M.+Laytonauthor=S.+Hollisauthor=I.+B.+McInnes&title=Clinical+evaluation+of+the+efficacy+of+the+P2X7+purinergic+receptor+antagonist+AZD9056+on+the+signs+and+symptoms+of+rheumatoid+arthritis+in+patients+with+active+disease+despite+treatment+with+methotrexate+or+sulphasalazine&doi=10.1136%2Fannrheumdis-2011-143578"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine</span></div><div class="casAuthors">Keystone, Edward C.; Wang, Millie M.; Layton, Mark; Hollis, Sally; McInnes, Iain B.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1630-1635</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objectives: The P2X7 purinergic receptor antagonist AZD9056 was evaluated in a phase IIa study and subsequently in a phase IIb study to assess the effects of orally administered AZD9056 on the signs/symptoms of rheumatoid arthritis (RA), with American College of Rheumatol. 20% response criteria (ACR20) as the primary outcome.  Methods: Both studies were randomized, double-blind, placebo-controlled, parallel-group studies in patients with RA receiving methotrexate or sulphasalazine.  Phase IIa was an ascending-dose trial in two cohorts (n=75) using AZD9056 administered daily over 4 wk.  Phase IIb included an open-label etanercept treatment group.  Patients were randomized to receive treatment for 6 mo with 50, 100, 200 or 400 mg AZD9056 (oral, once a day) or matching placebo (oral, once a day), or s.c. etanercept (50 mg once a week).  Results: In phase IIa, 65% of AZD9056 recipients at 400 mg/day responded at the ACR20 level compared with 27% of placebo-treated patients.  A significant redn. in swollen and tender joint count was obsd. in the actively treated group compared with placebo, whereas no effect on acute-phase response was obsd.  Of 385 randomized patients in the phase IIb study, 383 received treatment.  AZD9056 (all doses) had no clin. or statistically significant effect on RA relative to placebo as measured by the proportion of patients meeting the ACR20 criteria at 6 mo and further supported by secondary end points.  In both studies AZD9056 was well tolerated up to 400 mg/day.  Conclusions: AZD9056 does not have significant efficacy in the treatment of RA, and the P2X7 receptor does not appear to be a therapeutically useful target in RA.  Trial registration no. ClinicalTrials.gov NCT00520572.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzCebkc5d0gLVg90H21EOLACvtfcHk0lg7_j29oMtLMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1SqurzL&md5=97ca48663327aa8578f11001fa96d8c0</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2011-143578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2011-143578%26sid%3Dliteratum%253Aachs%26aulast%3DKeystone%26aufirst%3DE.%2BC.%26aulast%3DWang%26aufirst%3DM.%2BM.%26aulast%3DLayton%26aufirst%3DM.%26aulast%3DHollis%26aufirst%3DS.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26atitle%3DClinical%2520evaluation%2520of%2520the%2520efficacy%2520of%2520the%2520P2X7%2520purinergic%2520receptor%2520antagonist%2520AZD9056%2520on%2520the%2520signs%2520and%2520symptoms%2520of%2520rheumatoid%2520arthritis%2520in%2520patients%2520with%2520active%2520disease%2520despite%2520treatment%2520with%2520methotrexate%2520or%2520sulphasalazine%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2012%26volume%3D71%26spage%3D1630%26epage%3D1635%26doi%3D10.1136%2Fannrheumdis-2011-143578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Stock, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishaq, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mebus, C. A.</span><span> </span><span class="NLM_article-title">Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate</span> <span class="citation_source-journal">J. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">720</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span><span class="refDoi"> DOI: 10.3899/jrheum.110874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.3899%2Fjrheum.110874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22382341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVOnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=720-727&author=T.+C.+Stockauthor=B.+J.+Bloomauthor=N.+Weiauthor=S.+Ishaqauthor=W.+Parkauthor=X.+Wangauthor=P.+Guptaauthor=C.+A.+Mebus&title=Efficacy+and+safety+of+CE-224%2C535%2C+an+antagonist+of+P2X7+receptor%2C+in+treatment+of+patients+with+rheumatoid+arthritis+inadequately+controlled+by+methotrexate&doi=10.3899%2Fjrheum.110874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate</span></div><div class="casAuthors">Stock, Thomas C.; Bloom, Bradley J.; Wei, Nathan; Ishaq, Saliha; Park, Won; Wang, Xin; Gupta, Pankaj; Mebus, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Rheumatology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">720-727</span>CODEN:
                <span class="NLM_cas:coden">JRHUA9</span>;
        ISSN:<span class="NLM_cas:issn">0315-162X</span>.
    
            (<span class="NLM_cas:orgname">Journal of Rheumatology Publishing Co. Ltd.</span>)
        </div><div class="casAbstract">To evaluate efficacy and safety of CE-224,535, a selective P2X7 receptor antagonist, vs. placebo, in patients with active rheumatoid arthritis (RA) and inadequate response to methotrexate (MTX).  In our phase IIA study (ClinicalTrials.gov no. NCT00628095; A6341009), patients aged ≥ 18 years with active RA were randomized to receive either CE-224,535 (500 mg bid) or placebo for 12 wk; all patients continued a stable background dose of ≥ 7.5 mg MTX.  The American College of Rheumatol. 20% (ACR20) response rate (primary efficacy endpoint) was not significantly different from placebo for CE-224,535 (34.0% vs 36.2%; p = 0.591) at Week 12, or at any timepoint over the 12-wk treatment period.  There was no significant difference at Week 12 for the ACR20 response rate following subgroup analyses by age, sex, baseline disease activity, baseline duration of disease, geog. region, or concomitant use of steroids.  ACR50/ACR70 response rates and change from baseline in Disease Activity Score 28-joint C-reactive protein (DAS28-3-CRP) and Health Assessment Questionnaire-Disability Index for CE-224,535 were not significant at Week 12 vs. placebo.  Treatment-emergent adverse events (AE) were reported by 62.3% (CE-224,535) and 55.3% (placebo) of patients; the most common AE were nausea (11.3%, CE-224,535; 4.3%, placebo) and diarrhea (7.5%, CE-224,535; 4.3%, placebo).  The proportion of patients discontinuing due to an AE was 9.4% (CE-224,535) and 6.4% (placebo); no deaths were reported.  Serious AE occurred in 3.8% (CE-224,535) and 2.1% (placebo) of patients; none was considered treatment-related.  CE-224,535 was not efficacious, compared with placebo, for the treatment of RA in patients with an inadequate response to MTX.  CE-224,535 demonstrated an acceptable safety and tolerability profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorblWg-aNBNLVg90H21EOLACvtfcHk0lg7_j29oMtLMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVOnsro%253D&md5=dc919436c3c6e7f3f624c57b77c5dbb2</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.3899%2Fjrheum.110874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3899%252Fjrheum.110874%26sid%3Dliteratum%253Aachs%26aulast%3DStock%26aufirst%3DT.%2BC.%26aulast%3DBloom%26aufirst%3DB.%2BJ.%26aulast%3DWei%26aufirst%3DN.%26aulast%3DIshaq%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DGupta%26aufirst%3DP.%26aulast%3DMebus%26aufirst%3DC.%2BA.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520CE-224%252C535%252C%2520an%2520antagonist%2520of%2520P2X7%2520receptor%252C%2520in%2520treatment%2520of%2520patients%2520with%2520rheumatoid%2520arthritis%2520inadequately%2520controlled%2520by%2520methotrexate%26jtitle%3DJ.%2520Rheumatol.%26date%3D2012%26volume%3D39%26spage%3D720%26epage%3D727%26doi%3D10.3899%2Fjrheum.110874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Ali, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurijssens, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostenfeld, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stylianou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott-Stevens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosking, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewit, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span> </span><span class="NLM_article-title">Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><span class="refDoi"> DOI: 10.1111/j.1365-2125.2012.04320.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1111%2Fj.1365-2125.2012.04320.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22568863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVGmsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2013&pages=197-207&author=Z.+Aliauthor=B.+Laurijssensauthor=T.+Ostenfeldauthor=S.+McHughauthor=A.+Stylianouauthor=P.+Scott-Stevensauthor=L.+Hoskingauthor=O.+Dewitauthor=J.+C.+Richardsonauthor=C.+Chen&title=Pharmacokinetic+and+pharmacodynamic+profiling+of+a+P2X7+receptor+allosteric+modulator+GSK1482160+in+healthy+human+subjects&doi=10.1111%2Fj.1365-2125.2012.04320.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects</span></div><div class="casAuthors">Ali, Zahid; Laurijssens, Bart; Ostenfeld, Thor; McHugh, Simon; Stylianou, Anastasia; Scott-Stevens, Paul; Hosking, Louise; Dewit, Odile; Richardson, Jill C.; Chen, Chao</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">197-207</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • P2X7 receptors are involved in the prodn. of pro-inflammatory cytokines, such as Il-1β, by central and peripheral immune cells.  Il-1β has been implicated as an important mediator of inflammation.  Therefore, the P2X7 receptor is an attractive therapeutic target for inflammatory diseases.  WHAT THIS STUDY ADDS • Findings in pharmacokinetics, pharmacodynamics, safety and tolerability of a P2X7 receptor modulator, GSK1482160, from the first human study for the mol. are described.  A pharmacokinetic/pharmacodynamic model for LPS-stimulated ATP-induced Il-1β prodn. in blood allowed the integration of all relevant data and provided in vivo evidence of the nature of the drug-receptor interaction.  The model has the potential to be used to simulate future trials.  AIMS This paper describes findings from the first-in-human study for GSK1482160, an orally available allosteric P2X7 receptor modulator.  The study aimed to assess the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of the compd. in healthy subjects.  METHODS Escalating single doses of up to 1 g were administered to healthy subjects in a single-blind and placebo-controlled fashion.  Safety, tolerability, blood drug concns. and ex vivo Il-1β prodn. in blood were evaluated.  RESULTS. Drug concn. peaked within 3.5 h of dosing under fasting conditions and declined thereafter with a relatively short half-life of less than 4.5 h.  Exposure was proportional to dose with between subject variability of less than 60%.  A PK/PD model quantified Il-1β as a function of drug exposure.  The model allowed simulation of in vivo pharmacol. for various untested dose levels and regimens.  Furthermore, the mechanistic model supported the hypothesis that the compd. reduces the efficacy of ATP at the P2X7 receptor without affecting its affinity.  No major safety or tolerability concerns were identified in this small study (n= 29), except for one case of asymptomatic accelerated idioventricular rhythm at the top dose.  CONCLUSION. The model-based approach maximized anal. power by integrating all biomarker data and revealed mechanistic insight into the pharmacol. of P2X7 modulation by GSK1482160.  Simulations by this model ultimately led to the discontinuation of the development of this compd.  The therapeutic relevance of the P2X7 receptor remains to be tested in patients.  The mechanistic-model-based approach can be applied widely to drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr41Bz54gV-qLVg90H21EOLACvtfcHk0lj5-K674-fZog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVGmsbnF&md5=835023636e0c5b039245344c2a9a207a</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2012.04320.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2012.04320.x%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DZ.%26aulast%3DLaurijssens%26aufirst%3DB.%26aulast%3DOstenfeld%26aufirst%3DT.%26aulast%3DMcHugh%26aufirst%3DS.%26aulast%3DStylianou%26aufirst%3DA.%26aulast%3DScott-Stevens%26aufirst%3DP.%26aulast%3DHosking%26aufirst%3DL.%26aulast%3DDewit%26aufirst%3DO.%26aulast%3DRichardson%26aufirst%3DJ.%2BC.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DPharmacokinetic%2520and%2520pharmacodynamic%2520profiling%2520of%2520a%2520P2X7%2520receptor%2520allosteric%2520modulator%2520GSK1482160%2520in%2520healthy%2520human%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2013%26volume%3D75%26spage%3D197%26epage%3D207%26doi%3D10.1111%2Fj.1365-2125.2012.04320.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Ferrari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzirani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adinolfi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoli, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idzko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panther, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Virgilio, F.</span><span> </span><span class="NLM_article-title">The P2X7 receptor: a key player in IL-1 processing and release</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">3877</span><span class="NLM_x">–</span> <span class="NLM_lpage">3883</span><span class="refDoi"> DOI: 10.4049/jimmunol.176.7.3877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.176.7.3877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=16547218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1ertL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=3877-3883&author=D.+Ferrariauthor=C.+Pizziraniauthor=E.+Adinolfiauthor=R.+M.+Lemoliauthor=A.+Curtiauthor=M.+Idzkoauthor=E.+Pantherauthor=F.+Di+Virgilio&title=The+P2X7+receptor%3A+a+key+player+in+IL-1+processing+and+release&doi=10.4049%2Fjimmunol.176.7.3877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">The P2X7 Receptor: A Key Player in IL-1 Processing and Release</span></div><div class="casAuthors">Ferrari, Davide; Pizzirani, Cinzia; Adinolfi, Elena; Lemoli, Roberto M.; Curti, Antonio; Idzko, Marco; Panther, Elisabeth; Di Virgilio, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3877-3883</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">A review.  Human interleukin 1 (IL-1) family proteins are key mediators of the host response to infections, injury, and immunol. challenges.  The mechanism by which IL-1 activates proinflammatory responses in target cells, and the plasma membrane receptors involved, are fairly well known.  This has led to the development of innovative drugs that block IL-1 downstream to its synthesis and secretion.  On the contrary, the mechanism of IL-1 and other IL-1 family members (e.g., IL-18) maturation and release is incompletely understood.  Accruing evidence points to a plasma membrane receptor for extracellular ATP, the P2X7 receptor, as a key player in both processes.  A deeper understanding of the mechanism by which the P2X7 receptor triggers IL-1 maturation and exteriorization may suggest novel avenues for the treatment of inflammatory diseases and provide a deeper insight in the fundamental mechanism of protease activation and cellular export of proteins lacking a leader sequence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_AAKnLXk6DbVg90H21EOLACvtfcHk0lj5-K674-fZog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1ertL4%253D&md5=c64da9cb2a04420486b508cc6afd3a03</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.176.7.3877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.176.7.3877%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DD.%26aulast%3DPizzirani%26aufirst%3DC.%26aulast%3DAdinolfi%26aufirst%3DE.%26aulast%3DLemoli%26aufirst%3DR.%2BM.%26aulast%3DCurti%26aufirst%3DA.%26aulast%3DIdzko%26aufirst%3DM.%26aulast%3DPanther%26aufirst%3DE.%26aulast%3DDi%2BVirgilio%26aufirst%3DF.%26atitle%3DThe%2520P2X7%2520receptor%253A%2520a%2520key%2520player%2520in%2520IL-1%2520processing%2520and%2520release%26jtitle%3DJ.%2520Immunol.%26date%3D2006%26volume%3D176%26spage%3D3877%26epage%3D3883%26doi%3D10.4049%2Fjimmunol.176.7.3877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Sorge, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorfman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beggs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaykin, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vander Meulen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costigan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarkoni-Abitbul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tichauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livneh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peltz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maixner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diatchenko, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seltzer, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mogil, J. S.</span><span> </span><span class="NLM_article-title">Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span><span class="refDoi"> DOI: 10.1038/nm.2710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnm.2710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22447075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVemsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=595-599&author=R.+E.+Sorgeauthor=T.+Trangauthor=R.+Dorfmanauthor=S.+B.+Smithauthor=S.+Beggsauthor=J.+Ritchieauthor=J.+S.+Austinauthor=D.+V.+Zaykinauthor=H.+Vander+Meulenauthor=M.+Costiganauthor=T.+A.+Herbertauthor=M.+Yarkoni-Abitbulauthor=D.+Tichauerauthor=J.+Livnehauthor=E.+Gershonauthor=M.+Zhengauthor=K.+Tanauthor=S.+L.+Johnauthor=G.+D.+Sladeauthor=J.+Jordanauthor=C.+J.+Woolfauthor=G.+Peltzauthor=W.+Maixnerauthor=L.+Diatchenkoauthor=Z.+Seltzerauthor=M.+W.+Salterauthor=J.+S.+Mogil&title=Genetically+determined+P2X7+receptor+pore+formation+regulates+variability+in+chronic+pain+sensitivity&doi=10.1038%2Fnm.2710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity</span></div><div class="casAuthors">Sorge, Robert E.; Trang, Tuan; Dorfman, Ruslan; Smith, Shad B.; Beggs, Simon; Ritchie, Jennifer; Austin, Jean-Sebastien; Zaykin, Dmitri V.; Vander Meulen, Heather; Costigan, Michael; Herbert, Teri A.; Yarkoni-Abitbul, Merav; Tichauer, David; Livneh, Jessica; Gershon, Edith; Zheng, Ming; Tan, Keith; John, Sally L.; Slade, Gary D.; Jordan, Joanne; Woolf, Clifford J.; Peltz, Gary; Maixner, William; Diatchenko, Luda; Seltzer, Ze'ev; Salter, Michael W.; Mogil, Jeffrey S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">595-599</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chronic pain is highly variable between individuals, as is the response to analgesics.  Although much of the variability in chronic pain and analgesic response is heritable, an understanding of the genetic determinants underlying this variability is rudimentary.  Here we show that variation within the coding sequence of the gene encoding the P2X7 receptor (P2X7R) affects chronic pain sensitivity in both mice and humans.  P2X7Rs, which are members of the family of ionotropic ATP-gated receptors, have two distinct modes of function: they can function through their intrinsic cationic channel or by forming nonselective pores that are permeable to mols. with a mass of up to 900 Da.  Using genome-wide linkage analyses, we discovered an assocn. between nerve-injury-induced pain behavior (mech. allodynia) and the P451L mutation of the mouse P2rx7 gene, such that mice in which P2X7Rs have impaired pore formation as a result of this mutation showed less allodynia than mice with the pore-forming P2rx7 allele.  Administration of a peptide corresponding to the P2X7R C-terminal domain, which blocked pore formation but not cation channel activity, selectively reduced nerve injury and inflammatory allodynia only in mice with the pore-forming P2rx7 allele.  Moreover, in two independent human chronic pain cohorts, a cohort with pain after mastectomy and a cohort with osteoarthritis, we obsd. a genetic assocn. between lower pain intensity and the hypofunctional His270 (rs7958311) allele of P2RX7.  Our findings suggest that selectively targeting P2X7R pore formation may be a new strategy for individualizing the treatment of chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZLBa24xQIrrVg90H21EOLACvtfcHk0lj5-K674-fZog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVemsLc%253D&md5=1981fc416df0a25f45c4cfd72c5f64ce</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1038%2Fnm.2710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2710%26sid%3Dliteratum%253Aachs%26aulast%3DSorge%26aufirst%3DR.%2BE.%26aulast%3DTrang%26aufirst%3DT.%26aulast%3DDorfman%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DS.%2BB.%26aulast%3DBeggs%26aufirst%3DS.%26aulast%3DRitchie%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DJ.%2BS.%26aulast%3DZaykin%26aufirst%3DD.%2BV.%26aulast%3DVander%2BMeulen%26aufirst%3DH.%26aulast%3DCostigan%26aufirst%3DM.%26aulast%3DHerbert%26aufirst%3DT.%2BA.%26aulast%3DYarkoni-Abitbul%26aufirst%3DM.%26aulast%3DTichauer%26aufirst%3DD.%26aulast%3DLivneh%26aufirst%3DJ.%26aulast%3DGershon%26aufirst%3DE.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DK.%26aulast%3DJohn%26aufirst%3DS.%2BL.%26aulast%3DSlade%26aufirst%3DG.%2BD.%26aulast%3DJordan%26aufirst%3DJ.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26aulast%3DPeltz%26aufirst%3DG.%26aulast%3DMaixner%26aufirst%3DW.%26aulast%3DDiatchenko%26aufirst%3DL.%26aulast%3DSeltzer%26aufirst%3DZ.%26aulast%3DSalter%26aufirst%3DM.%2BW.%26aulast%3DMogil%26aufirst%3DJ.%2BS.%26atitle%3DGenetically%2520determined%2520P2X7%2520receptor%2520pore%2520formation%2520regulates%2520variability%2520in%2520chronic%2520pain%2520sensitivity%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D595%26epage%3D599%26doi%3D10.1038%2Fnm.2710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Chen, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leng, R. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, D. Q.</span><span> </span><span class="NLM_article-title">Association of P2X7R gene polymorphisms with systemic lupus erythematosus in a Chinese population</span> <span class="citation_source-journal">Mutagenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><span class="refDoi"> DOI: 10.1093/mutage/get007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1093%2Fmutage%2Fget007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=351-355&author=G.+M.+Chenauthor=C.+C.+Fengauthor=Q.+L.+Yeauthor=J.+H.+Taoauthor=R.+Liauthor=H.+Pengauthor=M.+Zhouauthor=R.+X.+Lengauthor=J.+Liauthor=H.+Cenauthor=Y.+G.+Fanauthor=H.+F.+Panauthor=D.+Q.+Ye&title=Association+of+P2X7R+gene+polymorphisms+with+systemic+lupus+erythematosus+in+a+Chinese+population&doi=10.1093%2Fmutage%2Fget007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1093%2Fmutage%2Fget007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fmutage%252Fget007%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%2BM.%26aulast%3DFeng%26aufirst%3DC.%2BC.%26aulast%3DYe%26aufirst%3DQ.%2BL.%26aulast%3DTao%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DLeng%26aufirst%3DR.%2BX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCen%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DY.%2BG.%26aulast%3DPan%26aufirst%3DH.%2BF.%26aulast%3DYe%26aufirst%3DD.%2BQ.%26atitle%3DAssociation%2520of%2520P2X7R%2520gene%2520polymorphisms%2520with%2520systemic%2520lupus%2520erythematosus%2520in%2520a%2520Chinese%2520population%26jtitle%3DMutagenesis%26date%3D2013%26volume%3D28%26spage%3D351%26epage%3D355%26doi%3D10.1093%2Fmutage%2Fget007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Robinson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalbeth, N.</span><span> </span><span class="NLM_article-title">Advances in pharmacotherapy for the treatment of gout</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span><span class="refDoi"> DOI: 10.1517/14656566.2015.997213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1517%2F14656566.2015.997213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=25547991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisl2msbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=533-546&author=P.+C.+Robinsonauthor=N.+Dalbeth&title=Advances+in+pharmacotherapy+for+the+treatment+of+gout&doi=10.1517%2F14656566.2015.997213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in pharmacotherapy for the treatment of gout</span></div><div class="casAuthors">Robinson, Philip C.; Dalbeth, Nicola</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">533-546</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction:Gout is a common inflammatory arthritis affecting almost 6% of US males and 2% of US females.  The central cause of gout is deposition of monosodium urate crystals, and the focus of treatment is aimed at crystal dissoln. using urate-lowering therapy.  Areas covered:The review describes the current treatments for urate-lowering therapy including allopurinol, febuxostat, probenecid, benzbromarone and pegloticase.  Anti-inflammatory treatment of acute flares and prophylaxis of flares with NSAIDs, colchicine, corticosteroids and anti-IL-1 agents is also reviewed.  In addn., drugs in Phase III clin. trials for gout indications are reviewed.  Expert opinion:In the last decade, there has been major progress in the pharmacotherapy of gout.  Management guidelines have emphasized the importance of a therapeutic serum urate target for effective gout management.  Studies have identified the safe and effective dosing strategies for 'old' drugs such as allopurinol and colchicine.  New therapeutic agents have been developed and approved for both urate-lowering therapy and anti-inflammatory treatment of acute flares.  However, quality of care remains a major challenge in gout management, and strategies to ensure best practice require further focus to ensure that the progress of the last decade translates into clin. benefit for people with gout.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvCyFOETsPyrVg90H21EOLACvtfcHk0liPE_frKNXRwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisl2msbs%253D&md5=0f8b9ec6198edd9ff6876b549524f70c</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1517%2F14656566.2015.997213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2015.997213%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DP.%2BC.%26aulast%3DDalbeth%26aufirst%3DN.%26atitle%3DAdvances%2520in%2520pharmacotherapy%2520for%2520the%2520treatment%2520of%2520gout%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2015%26volume%3D16%26spage%3D533%26epage%3D546%26doi%3D10.1517%2F14656566.2015.997213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Gutman, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, T. F.</span><span> </span><span class="NLM_article-title">Benemid (p-di-n-propylsulfamyl)-benzoic acid) as uricosuric agent in chronic gouty arthritis</span> <span class="citation_source-journal">Trans. Assoc. Am. Physicians</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1951</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1951&pages=279-288&author=A.+B.+Gutmanauthor=T.+F.+Yu&title=Benemid+%28p-di-n-propylsulfamyl%29-benzoic+acid%29+as+uricosuric+agent+in+chronic+gouty+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGutman%26aufirst%3DA.%2BB.%26aulast%3DYu%26aufirst%3DT.%2BF.%26atitle%3DBenemid%2520%2528p-di-n-propylsulfamyl%2529-benzoic%2520acid%2529%2520as%2520uricosuric%2520agent%2520in%2520chronic%2520gouty%2520arthritis%26jtitle%3DTrans.%2520Assoc.%2520Am.%2520Physicians%26date%3D1951%26volume%3D64%26spage%3D279%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Silverman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locovei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, G.</span><span> </span><span class="NLM_article-title">Probenecid, a gout remedy, inhibits pannexin 1 channels</span> <span class="citation_source-journal">Am. J. Physiol. Cell Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">C761</span><span class="NLM_x">–</span> <span class="NLM_lpage">767</span><span class="refDoi"> DOI: 10.1152/ajpcell.00227.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1152%2Fajpcell.00227.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=18596212" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2008&pages=C761-767&author=W.+Silvermanauthor=S.+Locoveiauthor=G.+Dahl&title=Probenecid%2C+a+gout+remedy%2C+inhibits+pannexin+1+channels&doi=10.1152%2Fajpcell.00227.2008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00227.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00227.2008%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DW.%26aulast%3DLocovei%26aufirst%3DS.%26aulast%3DDahl%26aufirst%3DG.%26atitle%3DProbenecid%252C%2520a%2520gout%2520remedy%252C%2520inhibits%2520pannexin%25201%2520channels%26jtitle%3DAm.%2520J.%2520Physiol.%2520Cell%2520Physiol.%26date%3D2008%26volume%3D295%26spage%3DC761%26epage%3D767%26doi%3D10.1152%2Fajpcell.00227.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelegrin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surprenant, A.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of pannexin-1 currents expressed in mammalian cells</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span><span class="refDoi"> DOI: 10.1124/jpet.108.146365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1124%2Fjpet.108.146365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=19023039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Khurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2009&pages=409-418&author=W.+Maauthor=H.+Huiauthor=P.+Pelegrinauthor=A.+Surprenant&title=Pharmacological+characterization+of+pannexin-1+currents+expressed+in+mammalian+cells&doi=10.1124%2Fjpet.108.146365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of pannexin-1 currents expressed in mammalian cells</span></div><div class="casAuthors">Ma, Weihong; Hui, Hui; Pelegrin, Pablo; Surprenant, Annmarie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">409-418</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Pannexin (Panx) 1 is a widely expressed protein that shares structural, but not amino acid, homol. with gap junction proteins, the connexins.  Panx1 does not form gap junctions in mammalian cells, but it may function as a plasma membrane hemichannel.  Little is known of the pharmacol. properties of panx1 expression in mammalian cells.  Here, we identify three variants in the human PANX1 gene.  We expressed these variants and mouse Panx1 in mammalian cells and compared Panx1-induced currents.  All human Panx1 variants and the mouse Panx1 showed identical protein expression levels, localization patterns, and functional properties; although, the frequency of functional expression was species-dependent.  Panx1 currents were independent of changes in extracellular or intracellular calcium or phospholipase C transduction.  We found compds. that inhibited Panx1 currents with a rank order of potency: carbenoxolone > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) ≈ disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate ≈ 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> probenecid >> flufenamic acid = niflumic acid.  Triphosphate nucleotides (ATP, GTP, and UTP) rapidly and reversibly inhibited Panx1 currents via mechanism(s) independent of purine receptors.  When Panx1 was coexpressed with purinergic P2X7 receptor (P2X7R), DIDS was found to act as a P2X7R antagonist to inhibit ATP-evoked currents, but none of the other compds. inhibited P2X7R currents.  This is the first detailed pharmacol. characterization of Panx1-mediated currents in mammalian cells and sheds new, although contradictory, light on the hypothesis that Panx1 acts as a hemichannel to allow passage of large mols. in response to P2X7R activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNwXaPFJzlfLVg90H21EOLACvtfcHk0liPE_frKNXRwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Khurs%253D&md5=39cd0d5ea254b48e3a6015f67c67a14f</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.146365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.146365%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%26aulast%3DHui%26aufirst%3DH.%26aulast%3DPelegrin%26aufirst%3DP.%26aulast%3DSurprenant%26aufirst%3DA.%26atitle%3DPharmacological%2520characterization%2520of%2520pannexin-1%2520currents%2520expressed%2520in%2520mammalian%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D328%26spage%3D409%26epage%3D418%26doi%3D10.1124%2Fjpet.108.146365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Silverman, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Rivero Vaccari, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locovei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scemes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keane, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, G.</span><span> </span><span class="NLM_article-title">The pannexin 1 channel activates the inflammasome in neurons and astrocytes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">18143</span><span class="NLM_x">–</span> <span class="NLM_lpage">18151</span><span class="refDoi"> DOI: 10.1074/jbc.M109.004804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M109.004804" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=18143-18151&author=W.+R.+Silvermanauthor=J.+P.+de+Rivero+Vaccariauthor=S.+Locoveiauthor=F.+Qiuauthor=S.+K.+Carlssonauthor=E.+Scemesauthor=R.+W.+Keaneauthor=G.+Dahl&title=The+pannexin+1+channel+activates+the+inflammasome+in+neurons+and+astrocytes&doi=10.1074%2Fjbc.M109.004804"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.004804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.004804%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DW.%2BR.%26aulast%3Dde%2BRivero%2BVaccari%26aufirst%3DJ.%2BP.%26aulast%3DLocovei%26aufirst%3DS.%26aulast%3DQiu%26aufirst%3DF.%26aulast%3DCarlsson%26aufirst%3DS.%2BK.%26aulast%3DScemes%26aufirst%3DE.%26aulast%3DKeane%26aufirst%3DR.%2BW.%26aulast%3DDahl%26aufirst%3DG.%26atitle%3DThe%2520pannexin%25201%2520channel%2520activates%2520the%2520inflammasome%2520in%2520neurons%2520and%2520astrocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D18143%26epage%3D18151%26doi%3D10.1074%2Fjbc.M109.004804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Selen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amidon, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welling, P. G.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of probenecid following oral doses to human volunteers</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1238</span><span class="NLM_x">–</span> <span class="NLM_lpage">1242</span><span class="refDoi"> DOI: 10.1002/jps.2600711114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1002%2Fjps.2600711114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1982&pages=1238-1242&author=A.+Selenauthor=G.+L.+Amidonauthor=P.+G.+Welling&title=Pharmacokinetics+of+probenecid+following+oral+doses+to+human+volunteers&doi=10.1002%2Fjps.2600711114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600711114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600711114%26sid%3Dliteratum%253Aachs%26aulast%3DSelen%26aufirst%3DA.%26aulast%3DAmidon%26aufirst%3DG.%2BL.%26aulast%3DWelling%26aufirst%3DP.%2BG.%26atitle%3DPharmacokinetics%2520of%2520probenecid%2520following%2520oral%2520doses%2520to%2520human%2520volunteers%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1982%26volume%3D71%26spage%3D1238%26epage%3D1242%26doi%3D10.1002%2Fjps.2600711114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Mawhinney, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Rivero Vaccari, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keane, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bramlett, H. M.</span><span> </span><span class="NLM_article-title">Heightened inflammasome activation is linked to age-related cognitive impairment in fischer 344 rats</span> <span class="citation_source-journal">BMC Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="refDoi"> DOI: 10.1186/1471-2202-12-123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1186%2F1471-2202-12-123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22133203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38XitFyrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=123&author=L.+J.+Mawhinneyauthor=J.+P.+de+Rivero+Vaccariauthor=G.+A.+Daleauthor=R.+W.+Keaneauthor=H.+M.+Bramlett&title=Heightened+inflammasome+activation+is+linked+to+age-related+cognitive+impairment+in+fischer+344+rats&doi=10.1186%2F1471-2202-12-123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Heightened inflammasome activation is linked to age-related cognitive impairment in Fischer 344 rats</span></div><div class="casAuthors">Mawhinney, Lana J.; Vaccari, Juan Pablo de Rivero; Dale, Gordon A.; Keane, Robert W.; Bramlett, Helen M.</div><div class="citationInfo"><span class="NLM_cas:title">BMC Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">123</span>CODEN:
                <span class="NLM_cas:coden">BNMEA6</span>;
        ISSN:<span class="NLM_cas:issn">1471-2202</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Members of the mammalian nucleotide binding domain, leucine-rich repeat (LRR)-contg. receptor (NLR) family of proteins are key modulators of innate immunity regulating inflammation.  Our previous work has shown that among the members of this family, NLRP1/NALP1, present in neurons, plays a crucial role in inflammasome formation and the prodn. of the inflammatory cytokines interleukin (IL)-1β and IL-18 after various types of central nervous system injury.  Results: We investigated whether age-related cognitive decline may involve a heightened inflammatory response assocd. with activation of the NLRP1 inflammasome in the hippocampus.  Young (3 mo) and aged (18 mo) male Fischer 344 rats were tested in a spatial acquisition task via Morris water maze.  Following behavioral testing, hippocampal lysates were assayed for expression of NLRP1 inflammasome components and inflammatory cytokines.  Hippocampal lysates from aged rats showed significantly higher levels of NLRP1 inflammasome constituents, caspase-1, caspase-11, the purinergic receptor P2X7, pannexin-1 and X-linked inhibitor of apoptosis (XIAP) than lysates from younger animals.  Following treatment with probenecid, an inhibitor or pannexin-1, aged animals demonstrated redn. in inflammasome activation and improvement in spatial learning performance.  Conclusions: Our behavioral findings are consistent with increases in IL-1β and IL-18 that have been previously shown to correlate with spatial learning deficits.  Probenecid reduced activated caspase-1 and ameliorated spatial learning deficits in aged rats.  Thus, aging processes stimulate activation of the NLRP1 inflammasome and secretion of IL-1β and IL-18 that may contribute to age-related cognitive decline in the growing elderly population.  Moreover, probenecid may be potentially useful as a therapy to improve cognitive outcomes in the aging population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox8G5rh-06TrVg90H21EOLACvtfcHk0liFvAdpUWf1ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitFyrsL0%253D&md5=9afff98dac8e36aa15d945fce4ee3b9e</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1186%2F1471-2202-12-123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2202-12-123%26sid%3Dliteratum%253Aachs%26aulast%3DMawhinney%26aufirst%3DL.%2BJ.%26aulast%3Dde%2BRivero%2BVaccari%26aufirst%3DJ.%2BP.%26aulast%3DDale%26aufirst%3DG.%2BA.%26aulast%3DKeane%26aufirst%3DR.%2BW.%26aulast%3DBramlett%26aufirst%3DH.%2BM.%26atitle%3DHeightened%2520inflammasome%2520activation%2520is%2520linked%2520to%2520age-related%2520cognitive%2520impairment%2520in%2520fischer%2520344%2520rats%26jtitle%3DBMC%2520Neurosci.%26date%3D2011%26volume%3D12%26spage%3D123%26doi%3D10.1186%2F1471-2202-12-123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Minkiewicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Rivero Vaccari, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keane, R. W.</span><span> </span><span class="NLM_article-title">Human astrocytes express a novel NLRP2 inflammasome</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1113</span><span class="NLM_x">–</span> <span class="NLM_lpage">1121</span><span class="refDoi"> DOI: 10.1002/glia.22499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1002%2Fglia.22499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=23625868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADC%252BC3srovFyksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2013&pages=1113-1121&author=J.+Minkiewiczauthor=J.+P.+de+Rivero+Vaccariauthor=R.+W.+Keane&title=Human+astrocytes+express+a+novel+NLRP2+inflammasome&doi=10.1002%2Fglia.22499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Human astrocytes express a novel NLRP2 inflammasome</span></div><div class="casAuthors">Minkiewicz Julia; de Rivero Vaccari Juan Pablo; Keane Robert W</div><div class="citationInfo"><span class="NLM_cas:title">Glia</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1113-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Central nervous system (CNS) trauma involves extensive cellular damage that is due, in part, to an innate inflammatory response induced by extracellular ATP.  The innate immune response is regulated by pattern recognition receptors (PRRs), which include NOD-like receptors (NLRs).  The PRRs and signaling cascades that regulate innate glial responses to CNS injury remain largely undefined.  In this report, we show that human astrocytes express the NLR protein 2 (NLRP2) inflammasome that is activated by the danger associated molecular pattern (DAMP) ATP.  The NLRP2 inflammasome is a multiprotein complex that consists of NLRP2, the adaptor protein apoptosis-speck-like protein containing a caspase recruitment domain (ASC) and caspase-1.  NLRP2 also interacts with the P2X7 receptor and the pannexin 1 channel.  Stimulation of human astrocytes with ATP resulted in activation of the NLRP2 inflammasome leading to the processing of inflammatory caspase-1 and interleukin-1β (IL-1β).  ATP-induced activation of the NLRP2 inflammasome was inhibited by the pannexin 1 inhibitor probenecid and by the P2X7 receptor antagonist Brilliant Blue G (BBG). siRNA knockdown of NLRP2 significantly decreased NLRP2 levels and caspase-1 processing in human astrocytes in response to ATP.  Our findings suggest that the astrocytic NLRP2 inflammasome is an important component of the CNS inflammatory response and that the NLRP2 inflammasome may be a therapeutic target to inhibit inflammation induced by CNS injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSu_HAA0wsQupw7prLlxLOzfW6udTcc2eZuayJlVBg_Irntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srovFyksw%253D%253D&md5=5fe2673fc9581d2d3f004af73713ac1b</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1002%2Fglia.22499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.22499%26sid%3Dliteratum%253Aachs%26aulast%3DMinkiewicz%26aufirst%3DJ.%26aulast%3Dde%2BRivero%2BVaccari%26aufirst%3DJ.%2BP.%26aulast%3DKeane%26aufirst%3DR.%2BW.%26atitle%3DHuman%2520astrocytes%2520express%2520a%2520novel%2520NLRP2%2520inflammasome%26jtitle%3DGlia%26date%3D2013%26volume%3D61%26spage%3D1113%26epage%3D1121%26doi%3D10.1002%2Fglia.22499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Lamkanfi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malireddi, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanneganti, T. D.</span><span> </span><span class="NLM_article-title">Fungal zymosan and mannan activate the cryopyrin inflammasome</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">20574</span><span class="NLM_x">–</span> <span class="NLM_lpage">20581</span><span class="refDoi"> DOI: 10.1074/jbc.M109.023689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M109.023689" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=20574-20581&author=M.+Lamkanfiauthor=R.+K.+Malireddiauthor=T.+D.+Kanneganti&title=Fungal+zymosan+and+mannan+activate+the+cryopyrin+inflammasome&doi=10.1074%2Fjbc.M109.023689"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.023689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.023689%26sid%3Dliteratum%253Aachs%26aulast%3DLamkanfi%26aufirst%3DM.%26aulast%3DMalireddi%26aufirst%3DR.%2BK.%26aulast%3DKanneganti%26aufirst%3DT.%2BD.%26atitle%3DFungal%2520zymosan%2520and%2520mannan%2520activate%2520the%2520cryopyrin%2520inflammasome%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D20574%26epage%3D20581%26doi%3D10.1074%2Fjbc.M109.023689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Bhaskaracharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dao-Ung, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalilian, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spildrejorde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skarratt, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sluyter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, L.</span><span> </span><span class="NLM_article-title">Probenecid blocks human P2X7 receptor-induced dye uptake via a pannexin-1 independent mechanism</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e93058</span><span class="refDoi"> DOI: 10.1371/journal.pone.0093058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1371%2Fjournal.pone.0093058" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e93058&author=A.+Bhaskaracharyaauthor=P.+Dao-Ungauthor=I.+Jalilianauthor=M.+Spildrejordeauthor=K.+K.+Skarrattauthor=S.+J.+Fullerauthor=R.+Sluyterauthor=L.+Stokes&title=Probenecid+blocks+human+P2X7+receptor-induced+dye+uptake+via+a+pannexin-1+independent+mechanism&doi=10.1371%2Fjournal.pone.0093058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0093058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0093058%26sid%3Dliteratum%253Aachs%26aulast%3DBhaskaracharya%26aufirst%3DA.%26aulast%3DDao-Ung%26aufirst%3DP.%26aulast%3DJalilian%26aufirst%3DI.%26aulast%3DSpildrejorde%26aufirst%3DM.%26aulast%3DSkarratt%26aufirst%3DK.%2BK.%26aulast%3DFuller%26aufirst%3DS.%2BJ.%26aulast%3DSluyter%26aufirst%3DR.%26aulast%3DStokes%26aufirst%3DL.%26atitle%3DProbenecid%2520blocks%2520human%2520P2X7%2520receptor-induced%2520dye%2520uptake%2520via%2520a%2520pannexin-1%2520independent%2520mechanism%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De93058%26doi%3D10.1371%2Fjournal.pone.0093058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Qu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misaghi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmour, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cupp, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubyak, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, V. M.</span><span> </span><span class="NLM_article-title">Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">6553</span><span class="NLM_x">–</span> <span class="NLM_lpage">6561</span><span class="refDoi"> DOI: 10.4049/jimmunol.1100478</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.1100478" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=6553-6561&author=Y.+Quauthor=S.+Misaghiauthor=K.+Newtonauthor=L.+L.+Gilmourauthor=S.+Louieauthor=J.+E.+Cuppauthor=G.+R.+Dubyakauthor=D.+Hackosauthor=V.+M.+Dixit&title=Pannexin-1+is+required+for+ATP+release+during+apoptosis+but+not+for+inflammasome+activation&doi=10.4049%2Fjimmunol.1100478"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1100478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1100478%26sid%3Dliteratum%253Aachs%26aulast%3DQu%26aufirst%3DY.%26aulast%3DMisaghi%26aufirst%3DS.%26aulast%3DNewton%26aufirst%3DK.%26aulast%3DGilmour%26aufirst%3DL.%2BL.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DCupp%26aufirst%3DJ.%2BE.%26aulast%3DDubyak%26aufirst%3DG.%2BR.%26aulast%3DHackos%26aufirst%3DD.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DPannexin-1%2520is%2520required%2520for%2520ATP%2520release%2520during%2520apoptosis%2520but%2520not%2520for%2520inflammasome%2520activation%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26spage%3D6553%26epage%3D6561%26doi%3D10.4049%2Fjimmunol.1100478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Laliberte, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perregaux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazoles, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span> </span><span class="NLM_article-title">Tenidap modulates cytoplasmic pH and inhibits anion transport <i>in vitro</i></span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">2168</span><span class="NLM_x">–</span> <span class="NLM_lpage">2179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=1994&pages=2168-2179&author=R.+Laliberteauthor=D.+Perregauxauthor=L.+Svenssonauthor=C.+J.+Pazolesauthor=C.+A.+Gabel&title=Tenidap+modulates+cytoplasmic+pH+and+inhibits+anion+transport+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaliberte%26aufirst%3DR.%26aulast%3DPerregaux%26aufirst%3DD.%26aulast%3DSvensson%26aufirst%3DL.%26aulast%3DPazoles%26aufirst%3DC.%2BJ.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26atitle%3DTenidap%2520modulates%2520cytoplasmic%2520pH%2520and%2520inhibits%2520anion%2520transport%2520in%2520vitro%26jtitle%3DJ.%2520Immunol.%26date%3D1994%26volume%3D153%26spage%3D2168%26epage%3D2179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Sanz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiozzi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colaianna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zotti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabace, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuliani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Virgilio, F.</span><span> </span><span class="NLM_article-title">Nimodipine inhibits IL-1β release stimulated by amyloid β from microglia</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">1702</span><span class="NLM_x">–</span> <span class="NLM_lpage">1711</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02112.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1111%2Fj.1476-5381.2012.02112.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22831460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVWns7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=1702-1711&author=J.+M.+Sanzauthor=P.+Chiozziauthor=M.+Colaiannaauthor=M.+Zottiauthor=D.+Ferrariauthor=L.+Trabaceauthor=G.+Zulianiauthor=F.+Di+Virgilio&title=Nimodipine+inhibits+IL-1%CE%B2+release+stimulated+by+amyloid+%CE%B2+from+microglia&doi=10.1111%2Fj.1476-5381.2012.02112.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Nimodipine inhibits IL-1β release stimulated by amyloid β from microglia</span></div><div class="casAuthors">Sanz, J. M.; Chiozzi, P.; Colaianna, M.; Zotti, M.; Ferrari, D.; Trabace, L.; Zuliani, G.; Di Virgilio, F.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1702-1711</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose: There is growing evidence that inflammation plays a major role in the pathogenesis of neural damage caused by deposition of amyloid β (Aβ) in the brain.  Nimodipine has received attention as a drug that might improve learning and reduce cognitive deficits in Alzheimer's disease, but the mechanism of action is poorly known.  In this study, we tested the hypothesis that nimodipine inhibited Aβ-stimulated IL-1β release from microglia.  Exptl. Approach: Cultures of N13 microglia cells or primary mouse microglia were treated with nimodipine, and intracellular accumulation and release of IL-1β in response to Aβ or to the P2 receptor agonists ATP and benzoyl ATP (BzATP) were measured.  Accumulation of IL-1β was measured in vivo after intrahippocampal inoculation of Aβ in the absence or presence of nimodipine.  The effect of nimodipine on Aβ-triggered cytotoxicity was also investigated.  Key Results: We show here that nimodipine dose-dependently inhibited Aβ-stimulated IL-1β synthesis and release from primary microglia and microglia cell lines.  Furthermore, nimodipine also inhibited Aβ-induced IL-1β in vivo accumulation at concns. known to be reached in the CNS.  Finally, nimodipine protected microglia from Aβ-dependent cytotoxicity.  Conclusion and Implications: These data suggest that alleviation of symptoms of Alzheimer's disease following nimodipine administration might be due to an anti-inflammatory effect and point to a novel role for nimodipine as a centrally acting anti-inflammatory drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnS4pLJbEKILVg90H21EOLACvtfcHk0ljG_d1dQuOYqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVWns7jO&md5=d6c53c83ef5a8dd466926fbd2f638d4e</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02112.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02112.x%26sid%3Dliteratum%253Aachs%26aulast%3DSanz%26aufirst%3DJ.%2BM.%26aulast%3DChiozzi%26aufirst%3DP.%26aulast%3DColaianna%26aufirst%3DM.%26aulast%3DZotti%26aufirst%3DM.%26aulast%3DFerrari%26aufirst%3DD.%26aulast%3DTrabace%26aufirst%3DL.%26aulast%3DZuliani%26aufirst%3DG.%26aulast%3DDi%2BVirgilio%26aufirst%3DF.%26atitle%3DNimodipine%2520inhibits%2520IL-1%25CE%25B2%2520release%2520stimulated%2520by%2520amyloid%2520%25CE%25B2%2520from%2520microglia%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26spage%3D1702%26epage%3D1711%26doi%3D10.1111%2Fj.1476-5381.2012.02112.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">van de Veerdonk, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeekens, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joosten, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kullberg, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinarello, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Meer, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Netea, M. G.</span><span> </span><span class="NLM_article-title">Reactive oxygen species-independent activation of the IL-1β inflammasome in cells from patients with chronic granulomatous disease</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">3030</span><span class="NLM_x">–</span> <span class="NLM_lpage">3033</span><span class="refDoi"> DOI: 10.1073/pnas.0914795107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1073%2Fpnas.0914795107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=3030-3033&author=F.+L.+van+de+Veerdonkauthor=S.+P.+Smeekensauthor=L.+A.+Joostenauthor=B.+J.+Kullbergauthor=C.+A.+Dinarelloauthor=J.+W.+van+der+Meerauthor=M.+G.+Netea&title=Reactive+oxygen+species-independent+activation+of+the+IL-1%CE%B2+inflammasome+in+cells+from+patients+with+chronic+granulomatous+disease&doi=10.1073%2Fpnas.0914795107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0914795107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0914795107%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bde%2BVeerdonk%26aufirst%3DF.%2BL.%26aulast%3DSmeekens%26aufirst%3DS.%2BP.%26aulast%3DJoosten%26aufirst%3DL.%2BA.%26aulast%3DKullberg%26aufirst%3DB.%2BJ.%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26aulast%3Dvan%2Bder%2BMeer%26aufirst%3DJ.%2BW.%26aulast%3DNetea%26aufirst%3DM.%2BG.%26atitle%3DReactive%2520oxygen%2520species-independent%2520activation%2520of%2520the%2520IL-1%25CE%25B2%2520inflammasome%2520in%2520cells%2520from%2520patients%2520with%2520chronic%2520granulomatous%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D3030%26epage%3D3033%26doi%3D10.1073%2Fpnas.0914795107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Meissner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seger, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moshous, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichenbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zychlinsky, A.</span><span> </span><span class="NLM_article-title">Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">1570</span><span class="NLM_x">–</span> <span class="NLM_lpage">1573</span><span class="refDoi"> DOI: 10.1182/blood-2010-01-264218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1182%2Fblood-2010-01-264218" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2010&pages=1570-1573&author=F.+Meissnerauthor=R.+A.+Segerauthor=D.+Moshousauthor=A.+Fischerauthor=J.+Reichenbachauthor=A.+Zychlinsky&title=Inflammasome+activation+in+NADPH+oxidase+defective+mononuclear+phagocytes+from+patients+with+chronic+granulomatous+disease&doi=10.1182%2Fblood-2010-01-264218"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1182%2Fblood-2010-01-264218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2010-01-264218%26sid%3Dliteratum%253Aachs%26aulast%3DMeissner%26aufirst%3DF.%26aulast%3DSeger%26aufirst%3DR.%2BA.%26aulast%3DMoshous%26aufirst%3DD.%26aulast%3DFischer%26aufirst%3DA.%26aulast%3DReichenbach%26aufirst%3DJ.%26aulast%3DZychlinsky%26aufirst%3DA.%26atitle%3DInflammasome%2520activation%2520in%2520NADPH%2520oxidase%2520defective%2520mononuclear%2520phagocytes%2520from%2520patients%2520with%2520chronic%2520granulomatous%2520disease%26jtitle%3DBlood%26date%3D2010%26volume%3D116%26spage%3D1570%26epage%3D1573%26doi%3D10.1182%2Fblood-2010-01-264218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">van Bruggen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koker, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Houdt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuijpers, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Berg, T. K.</span><span> </span><span class="NLM_article-title">Human NLRP3 inflammasome activation is Nox1–4 independent</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">5398</span><span class="NLM_x">–</span> <span class="NLM_lpage">5400</span><span class="refDoi"> DOI: 10.1182/blood-2009-10-250803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1182%2Fblood-2009-10-250803" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=5398-5400&author=R.+van+Bruggenauthor=M.+Y.+Kokerauthor=M.+Jansenauthor=M.+van+Houdtauthor=D.+Roosauthor=T.+W.+Kuijpersauthor=T.+K.+van+den+Berg&title=Human+NLRP3+inflammasome+activation+is+Nox1%E2%80%934+independent&doi=10.1182%2Fblood-2009-10-250803"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-10-250803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-10-250803%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BBruggen%26aufirst%3DR.%26aulast%3DKoker%26aufirst%3DM.%2BY.%26aulast%3DJansen%26aufirst%3DM.%26aulast%3Dvan%2BHoudt%26aufirst%3DM.%26aulast%3DRoos%26aufirst%3DD.%26aulast%3DKuijpers%26aufirst%3DT.%2BW.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DT.%2BK.%26atitle%3DHuman%2520NLRP3%2520inflammasome%2520activation%2520is%2520Nox1%25E2%2580%25934%2520independent%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D5398%26epage%3D5400%26doi%3D10.1182%2Fblood-2009-10-250803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Alvarez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Fernandez, M. A.</span><span> </span><span class="NLM_article-title">TNF-α may mediate inflammasome activation in the absence of bacterial infection in more than one way</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e71477</span><span class="refDoi"> DOI: 10.1371/journal.pone.0071477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1371%2Fjournal.pone.0071477" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e71477&author=S.+Alvarezauthor=M.+A.+Munoz-Fernandez&title=TNF-%CE%B1+may+mediate+inflammasome+activation+in+the+absence+of+bacterial+infection+in+more+than+one+way&doi=10.1371%2Fjournal.pone.0071477"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0071477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0071477%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez%26aufirst%3DS.%26aulast%3DMunoz-Fernandez%26aufirst%3DM.%2BA.%26atitle%3DTNF-%25CE%25B1%2520may%2520mediate%2520inflammasome%2520activation%2520in%2520the%2520absence%2520of%2520bacterial%2520infection%2520in%2520more%2520than%2520one%2520way%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De71477%26doi%3D10.1371%2Fjournal.pone.0071477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Liao, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ka, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, K. F.</span><span> </span><span class="NLM_article-title">Lipopolysaccharide/adenosine triphosphate-mediated signal transduction in the regulation of NLRP3 protein expression and caspase-1-mediated interleukin-1β secretion</span> <span class="citation_source-journal">Inflammation Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span><span class="refDoi"> DOI: 10.1007/s00011-012-0555-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1007%2Fs00011-012-0555-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22986467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVeqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=89-96&author=P.+C.+Liaoauthor=L.+K.+Chaoauthor=J.+C.+Chouauthor=W.+C.+Dongauthor=C.+N.+Linauthor=C.+Y.+Linauthor=A.+Chenauthor=S.+M.+Kaauthor=C.+L.+Hoauthor=K.+F.+Hua&title=Lipopolysaccharide%2Fadenosine+triphosphate-mediated+signal+transduction+in+the+regulation+of+NLRP3+protein+expression+and+caspase-1-mediated+interleukin-1%CE%B2+secretion&doi=10.1007%2Fs00011-012-0555-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Lipopolysaccharide/adenosine triphosphate-mediated signal transduction in the regulation of NLRP3 protein expression and caspase-1-mediated interleukin-1β secretion</span></div><div class="casAuthors">Liao, Pei-Chun; Chao, Louis Kuoping; Chou, Ju-Ching; Dong, Wei-Chih; Lin, Chien-Nan; Lin, Chai-Yi; Chen, Ann; Ka, Shuk-Man; Ho, Chen-Lung; Hua, Kuo-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-96</span>CODEN:
                <span class="NLM_cas:coden">INREFB</span>;
        ISSN:<span class="NLM_cas:issn">1023-3830</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Objective: Reactive oxygen species (ROS) plays a crit. role in the regulation of NLRP3 inflammasome activation.  However, the ROS-mediated signaling pathways controlling NLRP3 inflammasome activation are not well defined.  Methods: Using lipopolysaccharide (LPS) and ATP (ATP) activated murine macrophages as the testing model, cytokine release and protein expression were quantified by ELISA and Western blot, resp.  ROS was scavenged by N-acetyl cysteine; NADPH oxidase, the major source of ROS, was inhibited by diphenyliodonium, apocynin or gp91-phox siRNA transfection; and protein kinase was inhibited by its specific inhibitor.  Results: LPS-induced NLRP3 protein expression was regulated through the NADPH oxidase/ROS/NF-κB-dependent, JAK2/PI3-kinase/AKT/NF-κB-dependent, and MAPK-dependent pathways, while ATP-induced caspase-1 activation was regulated through the NADPH oxidase/ROS-dependent pathway.  Conclusions: These results demonstrate that ROS regulates not only the priming stage, but also the activation stage, of NLRP3 inflammasome activation in LPS + ATP-activated macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFOSgjDrCW07Vg90H21EOLACvtfcHk0lgR1EF2khRTJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVeqsA%253D%253D&md5=0233c591b70a4a04f6a96a8b1a7c4e8f</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1007%2Fs00011-012-0555-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00011-012-0555-2%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DP.%2BC.%26aulast%3DChao%26aufirst%3DL.%2BK.%26aulast%3DChou%26aufirst%3DJ.%2BC.%26aulast%3DDong%26aufirst%3DW.%2BC.%26aulast%3DLin%26aufirst%3DC.%2BN.%26aulast%3DLin%26aufirst%3DC.%2BY.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DKa%26aufirst%3DS.%2BM.%26aulast%3DHo%26aufirst%3DC.%2BL.%26aulast%3DHua%26aufirst%3DK.%2BF.%26atitle%3DLipopolysaccharide%252Fadenosine%2520triphosphate-mediated%2520signal%2520transduction%2520in%2520the%2520regulation%2520of%2520NLRP3%2520protein%2520expression%2520and%2520caspase-1-mediated%2520interleukin-1%25CE%25B2%2520secretion%26jtitle%3DInflammation%2520Res.%26date%3D2013%26volume%3D62%26spage%3D89%26epage%3D96%26doi%3D10.1007%2Fs00011-012-0555-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Dostert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrilli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Bruggen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mossman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, J.</span><span> </span><span class="NLM_article-title">Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">674</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span><span class="refDoi"> DOI: 10.1126/science.1156995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1126%2Fscience.1156995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=18403674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFyis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2008&pages=674-677&author=C.+Dostertauthor=V.+Petrilliauthor=R.+Van+Bruggenauthor=C.+Steeleauthor=B.+T.+Mossmanauthor=J.+Tschopp&title=Innate+immune+activation+through+Nalp3+inflammasome+sensing+of+asbestos+and+silica&doi=10.1126%2Fscience.1156995"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica</span></div><div class="casAuthors">Dostert, Catherine; Petrilli, Virginie; Van Bruggen, Robin; Steele, Chad; Mossman, Brooke T.; Tschopp, Juerg</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">5876</span>),
    <span class="NLM_cas:pages">674-677</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The inhalation of airborne pollutants, such as asbestos or silica, is linked to inflammation of the lung, fibrosis, and lung cancer.  How the presence of pathogenic dust is recognized and how chronic inflammatory diseases are triggered are poorly understood.  Asbestos and silica are sensed by the Nalp3 inflammasome, whose subsequent activation leads to interleukin-1β secretion.  Inflammasome activation is triggered by reactive oxygen species, which are generated by a NADPH oxidase upon particle phagocytosis.  (NADPH is the reduced form of NADP.).  In a model of asbestos inhalation, Nalp3-/- mice showed diminished recruitment of inflammatory cells to the lungs, paralleled by lower cytokine prodn.  The authors' findings implicate the Nalp3 inflammasome in particulate matter-related pulmonary diseases and support its role as a major proinflammatory "danger" receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0IlhnfJR5DLVg90H21EOLACvtfcHk0lgR1EF2khRTJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFyis7c%253D&md5=551595f3d70002b0ec9b891a0852db57</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1126%2Fscience.1156995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1156995%26sid%3Dliteratum%253Aachs%26aulast%3DDostert%26aufirst%3DC.%26aulast%3DPetrilli%26aufirst%3DV.%26aulast%3DVan%2BBruggen%26aufirst%3DR.%26aulast%3DSteele%26aufirst%3DC.%26aulast%3DMossman%26aufirst%3DB.%2BT.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DInnate%2520immune%2520activation%2520through%2520Nalp3%2520inflammasome%2520sensing%2520of%2520asbestos%2520and%2520silica%26jtitle%3DScience%26date%3D2008%26volume%3D320%26spage%3D674%26epage%3D677%26doi%3D10.1126%2Fscience.1156995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Jabaut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ather, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taracanova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poynter, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ckless, K.</span><span> </span><span class="NLM_article-title">Mitochondria-targeted drugs enhance Nlrp3 inflammasome-dependent IL-1β secretion in association with alterations in cellular redox and energy status</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2013.01.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.freeradbiomed.2013.01.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=23376234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFSltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2013&pages=233-245&author=J.+Jabautauthor=J.+L.+Atherauthor=A.+Taracanovaauthor=M.+E.+Poynterauthor=K.+Ckless&title=Mitochondria-targeted+drugs+enhance+Nlrp3+inflammasome-dependent+IL-1%CE%B2+secretion+in+association+with+alterations+in+cellular+redox+and+energy+status&doi=10.1016%2Fj.freeradbiomed.2013.01.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-targeted drugs enhance Nlrp3 inflammasome-dependent IL-1β secretion in association with alterations in cellular redox and energy status</span></div><div class="casAuthors">Jabaut, Joshua; Ather, Jennifer L.; Taracanova, Alexandra; Poynter, Matthew E.; Ckless, Karina</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">233-245</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Nlrp3 inflammasome is activated in response to an array of environmental and endogenous mols. leading to caspase-1-dependent IL-1β processing and secretion by myeloid cells.  Several identified Nlrp3 inflammasome activators also trigger reactive oxygen species (ROS) prodn.  However, the initial concept that NADPH oxidases are the primary source of ROS prodn. during inflammasome activation is becoming less accepted.  Therefore, the importance of mitochondria-derived ROS has been recently explored.  In this study, the authors explore the impact of mitochondria dysfunction and ROS prodn. on Nlrp3 inflammasome stimulation and IL-1β secretion induced by serum amyloid A (SAA) in primary mouse peritoneal macrophages.  To induce mitochondrial dysfunction, the authors utilized antimycin A, which blocks electron flow at complex III, and carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP), a mitochondrial oxidative phosphorylation uncoupler.  The authors also utilized a superoxide dismutase mimetic, MnTBAP, which targets the mitochondria, as well as the broad-spectrum antioxidants DPI (diphenyleneiodonium chloride) and ebselen.  The authors' findings demonstrate that SAA alone induces mitochondrial ROS in a time-dependent manner.  The authors obsd. that MnTBAP and ebselen blocked IL-1β secretion caused by SAA only when added before stimulation, and DPI augmented IL-1β secretion.  Surprisingly, these effects were not directly related to intracellular or mitochondrial ROS levels.  The authors also found that mitochondria-targeted drugs increased IL-1β secretion regardless of their impact on mitochondrial function and ROS levels, suggesting that mitochondrial ROS-dependent and -independent mechanisms play a role in the Nlrp3 inflammasome/IL-1β secretion axis in SAA-stimulated cells.  Finally, the authors found that FCCP significantly sustained the assocn. of the Nlrp3 inflammasome complex, which could explain the most robust effect among the drugs tested in enhancing IL-1β secretion in SAA-treated cells.  Overall, the authors' data suggest that the Nlrp3 inflammasome/IL-1β secretion axis is a very highly regulated inflammatory pathway that is susceptible not only to changes in mitochondrial or intracellular ROS, but also to changes in overall mitochondrial function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo17bZqXX6B1rVg90H21EOLACvtfcHk0lj7KptSwQD_Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFSltrc%253D&md5=d3a2b3bb3bc9abf167cd3bfc8b4ceef3</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2013.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2013.01.025%26sid%3Dliteratum%253Aachs%26aulast%3DJabaut%26aufirst%3DJ.%26aulast%3DAther%26aufirst%3DJ.%2BL.%26aulast%3DTaracanova%26aufirst%3DA.%26aulast%3DPoynter%26aufirst%3DM.%2BE.%26aulast%3DCkless%26aufirst%3DK.%26atitle%3DMitochondria-targeted%2520drugs%2520enhance%2520Nlrp3%2520inflammasome-dependent%2520IL-1%25CE%25B2%2520secretion%2520in%2520association%2520with%2520alterations%2520in%2520cellular%2520redox%2520and%2520energy%2520status%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2013%26volume%3D60%26spage%3D233%26epage%3D245%26doi%3D10.1016%2Fj.freeradbiomed.2013.01.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Rajamaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lappalainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oorni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valimaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matikainen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovanen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eklund, K. K.</span><span> </span><span class="NLM_article-title">Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e11765</span><span class="refDoi"> DOI: 10.1371/journal.pone.0011765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1371%2Fjournal.pone.0011765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20668705" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e11765&author=K.+Rajamakiauthor=J.+Lappalainenauthor=K.+Oorniauthor=E.+Valimakiauthor=S.+Matikainenauthor=P.+T.+Kovanenauthor=K.+K.+Eklund&title=Cholesterol+crystals+activate+the+NLRP3+inflammasome+in+human+macrophages%3A+a+novel+link+between+cholesterol+metabolism+and+inflammation&doi=10.1371%2Fjournal.pone.0011765"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0011765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0011765%26sid%3Dliteratum%253Aachs%26aulast%3DRajamaki%26aufirst%3DK.%26aulast%3DLappalainen%26aufirst%3DJ.%26aulast%3DOorni%26aufirst%3DK.%26aulast%3DValimaki%26aufirst%3DE.%26aulast%3DMatikainen%26aufirst%3DS.%26aulast%3DKovanen%26aufirst%3DP.%2BT.%26aulast%3DEklund%26aufirst%3DK.%2BK.%26atitle%3DCholesterol%2520crystals%2520activate%2520the%2520NLRP3%2520inflammasome%2520in%2520human%2520macrophages%253A%2520a%2520novel%2520link%2520between%2520cholesterol%2520metabolism%2520and%2520inflammation%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De11765%26doi%3D10.1371%2Fjournal.pone.0011765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Schroder, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, J.</span><span> </span><span class="NLM_article-title">The inflammasomes</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">832</span><span class="refDoi"> DOI: 10.1016/j.cell.2010.01.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.cell.2010.01.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20303873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2010&pages=821-832&author=K.+Schroderauthor=J.+Tschopp&title=The+inflammasomes&doi=10.1016%2Fj.cell.2010.01.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">The inflammasomes</span></div><div class="casAuthors">Schroder, Kate; Tschopp, Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">821-832</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Inflammasomes are mol. platforms activated upon cellular infection or stress that trigger the maturation of proinflammatory cytokines such as interleukin-1β to engage innate immune defenses.  Strong assocns. between dysregulated inflammasome activity and human heritable and acquired inflammatory diseases highlight the importance this pathway in tailoring immune responses.  Here, the authors comprehensively review mechanisms directing normal inflammasome function and its dysregulation in disease.  Agonists and activation mechanisms of the NLRP1, NLRP3, IPAF, and AIM2 inflammasomes are discussed.  Regulatory mechanisms that potentiate or limit inflammasome activation are examd., as well as emerging links between the inflammasome and pyroptosis and autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkn9iIPQld9bVg90H21EOLACvtfcHk0lj7KptSwQD_Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSgu78%253D&md5=6a94a8c8cbae8e360f7b918524fc8d40</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.01.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.01.040%26sid%3Dliteratum%253Aachs%26aulast%3DSchroder%26aufirst%3DK.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DThe%2520inflammasomes%26jtitle%3DCell%26date%3D2010%26volume%3D140%26spage%3D821%26epage%3D832%26doi%3D10.1016%2Fj.cell.2010.01.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Heid, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keyel, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, R. D.</span><span> </span><span class="NLM_article-title">Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">5230</span><span class="NLM_x">–</span> <span class="NLM_lpage">5238</span><span class="refDoi"> DOI: 10.4049/jimmunol.1301490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.1301490" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2013&pages=5230-5238&author=M.+E.+Heidauthor=P.+A.+Keyelauthor=C.+Kamgaauthor=S.+Shivaauthor=S.+C.+Watkinsauthor=R.+D.+Salter&title=Mitochondrial+reactive+oxygen+species+induces+NLRP3-dependent+lysosomal+damage+and+inflammasome+activation&doi=10.4049%2Fjimmunol.1301490"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1301490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1301490%26sid%3Dliteratum%253Aachs%26aulast%3DHeid%26aufirst%3DM.%2BE.%26aulast%3DKeyel%26aufirst%3DP.%2BA.%26aulast%3DKamga%26aufirst%3DC.%26aulast%3DShiva%26aufirst%3DS.%26aulast%3DWatkins%26aufirst%3DS.%2BC.%26aulast%3DSalter%26aufirst%3DR.%2BD.%26atitle%3DMitochondrial%2520reactive%2520oxygen%2520species%2520induces%2520NLRP3-dependent%2520lysosomal%2520damage%2520and%2520inflammasome%2520activation%26jtitle%3DJ.%2520Immunol.%26date%3D2013%26volume%3D191%26spage%3D5230%26epage%3D5238%26doi%3D10.4049%2Fjimmunol.1301490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Niemi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teirila, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lappalainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oorni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovanen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matikainen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eklund, K. K.</span><span> </span><span class="NLM_article-title">Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">6119</span><span class="NLM_x">–</span> <span class="NLM_lpage">6128</span><span class="refDoi"> DOI: 10.4049/jimmunol.1002843</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.1002843" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=6119-6128&author=K.+Niemiauthor=L.+Teirilaauthor=J.+Lappalainenauthor=K.+Rajamakiauthor=M.+H.+Baumannauthor=K.+Oorniauthor=H.+Wolffauthor=P.+T.+Kovanenauthor=S.+Matikainenauthor=K.+K.+Eklund&title=Serum+amyloid+A+activates+the+NLRP3+inflammasome+via+P2X7+receptor+and+a+cathepsin+B-sensitive+pathway&doi=10.4049%2Fjimmunol.1002843"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1002843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1002843%26sid%3Dliteratum%253Aachs%26aulast%3DNiemi%26aufirst%3DK.%26aulast%3DTeirila%26aufirst%3DL.%26aulast%3DLappalainen%26aufirst%3DJ.%26aulast%3DRajamaki%26aufirst%3DK.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DOorni%26aufirst%3DK.%26aulast%3DWolff%26aufirst%3DH.%26aulast%3DKovanen%26aufirst%3DP.%2BT.%26aulast%3DMatikainen%26aufirst%3DS.%26aulast%3DEklund%26aufirst%3DK.%2BK.%26atitle%3DSerum%2520amyloid%2520A%2520activates%2520the%2520NLRP3%2520inflammasome%2520via%2520P2X7%2520receptor%2520and%2520a%2520cathepsin%2520B-sensitive%2520pathway%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26spage%3D6119%26epage%3D6128%26doi%3D10.4049%2Fjimmunol.1002843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Biswas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, R. F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holian, A.</span><span> </span><span class="NLM_article-title">Role of lysosomes in silica-induced inflammasome activation and inflammation in absence of MARCO</span> <span class="citation_source-journal">J. Immunol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2014</span><span class="NLM_x">, </span> <span class="NLM_fpage">304180</span><span class="refDoi"> DOI: 10.1155/2014/304180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1155%2F2014%2F304180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=25054161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADC%252BC2cblsFWguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=304180&author=R.+Biswasauthor=R.+F.+Hamiltonauthor=A.+Holian&title=Role+of+lysosomes+in+silica-induced+inflammasome+activation+and+inflammation+in+absence+of+MARCO&doi=10.1155%2F2014%2F304180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Role of lysosomes in silica-induced inflammasome activation and inflammation in absence of MARCO</span></div><div class="casAuthors">Biswas Rupa; Hamilton Raymond F Jr; Holian Andrij</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunology research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2014</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">304180</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MARCO is the predominant scavenger receptor for recognition and binding of silica particles by alveolar macrophages (AM).  Previously, it was shown that mice null for MARCO have a greater inflammatory response to silica, but the mechanism was not described.  The aim of this study was to determine the relationship between MARCO and NLRP3 inflammasome activity.  Silica increased NLRP3 inflammasome activation and release of the proinflammatory cytokine, IL-1β, to a greater extent in MARCO(-/-) AM compared to wild type (WT) AM.  Furthermore, in MARCO(-/-) AM there was greater cathepsin B release from phagolysosomes, Caspase-1 activation, and acid sphingomyelinase activity compared to WT AM, supporting the critical role played by lysosomal membrane permeabilization (LMP) in triggering silica-induced inflammation.  The difference in sensitivity to LMP appears to be in cholesterol recycling since increasing cholesterol in AM by treatment with U18666A decreased silica-induced NLRP3 inflammasome activation, and cells lacking MARCO were less able to sequester cholesterol following silica treatment.  Taken together, these results demonstrate that MARCO contributes to normal cholesterol uptake in macrophages; therefore, in the absence of MARCO, macrophages are more susceptible to a greater inflammatory response by particulates known to cause NLRP3 inflammasome activation and the effect is due to increased LMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT3HeveT8EGok2yPDyEFiigfW6udTcc2eZ0cwIKm54zY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cblsFWguw%253D%253D&md5=8d93360a8d28f2e64fefab04fc213ec0</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1155%2F2014%2F304180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F304180%26sid%3Dliteratum%253Aachs%26aulast%3DBiswas%26aufirst%3DR.%26aulast%3DHamilton%26aufirst%3DR.%2BF.%26aulast%3DHolian%26aufirst%3DA.%26atitle%3DRole%2520of%2520lysosomes%2520in%2520silica-induced%2520inflammasome%2520activation%2520and%2520inflammation%2520in%2520absence%2520of%2520MARCO%26jtitle%3DJ.%2520Immunol.%2520Res.%26date%3D2014%26volume%3D2014%26spage%3D304180%26doi%3D10.1155%2F2014%2F304180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Hentze, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, A. G.</span><span> </span><span class="NLM_article-title">Critical role for cathepsin B in mediating caspase-1-dependent interleukin-18 maturation and caspase-1-independent necrosis triggered by the microbial toxin nigericin</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">956</span><span class="NLM_x">–</span> <span class="NLM_lpage">968</span><span class="refDoi"> DOI: 10.1038/sj.cdd.4401264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fsj.cdd.4401264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=12934070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFeju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=956-968&author=H.+Hentzeauthor=X.+Y.+Linauthor=M.+S.+Choiauthor=A.+G.+Porter&title=Critical+role+for+cathepsin+B+in+mediating+caspase-1-dependent+interleukin-18+maturation+and+caspase-1-independent+necrosis+triggered+by+the+microbial+toxin+nigericin&doi=10.1038%2Fsj.cdd.4401264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Critical role for cathepsin B in mediating caspase-1-dependent interleukin-18 maturation and caspase-1-independent necrosis triggered by the microbial toxin nigericin</span></div><div class="casAuthors">Hentze, H.; Lin, X. Y.; Choi, M. S. K.; Porter, A. G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">956-968</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The potassium ionophore nigericin induces cell death and promotes the maturation and release of IL-1β in lipopolysaccharide (LPS)-primed monocytes and macrophages, the latter depending on caspase-1 activation by an unknown mechanism.  Here, we investigate the pathway that triggers cell death and activates caspase-1.  We show that without LPS priming, nigericin alone triggered caspase-1 activation and IL-18 generation in THP-1 monocytic cells.  Simultaneously, nigericin induced caspase-1-independent necrotic cell death, which was blocked by the cathepsin B inhibitor CA-074-Me and other cathepsin inhibitors.  Cathepsin B activation after nigericin treatment was detd. biochem. and corroborated by rapid lysosomal leakage and translocation of cathepsin B to the cytoplasm.  IL-18 maturation was prevented by both caspase-1 and cathepsin B inhibitors in THP-1 cells, primary mouse macrophages and human blood monocytes.  Moreover, IL-18 generation was reduced in THP-1 cells stably transformed either with cystatin A (an endogenous cathepsin inhibitor) or antisense cathepsin B cDNA.  Collectively, our study establishes a crit. role for cathepsin B in nigericin-induced caspase-1-dependent IL-18 maturation and caspase-1-independent necrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxqDtsvRNxl7Vg90H21EOLACvtfcHk0ljMbSoZg9HyUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFeju74%253D&md5=0a791211cca0b2dcc17f156fd2c08910</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401264%26sid%3Dliteratum%253Aachs%26aulast%3DHentze%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DX.%2BY.%26aulast%3DChoi%26aufirst%3DM.%2BS.%26aulast%3DPorter%26aufirst%3DA.%2BG.%26atitle%3DCritical%2520role%2520for%2520cathepsin%2520B%2520in%2520mediating%2520caspase-1-dependent%2520interleukin-18%2520maturation%2520and%2520caspase-1-independent%2520necrosis%2520triggered%2520by%2520the%2520microbial%2520toxin%2520nigericin%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2003%26volume%3D10%26spage%3D956%26epage%3D968%26doi%3D10.1038%2Fsj.cdd.4401264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Newman, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppla, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moayeri, M.</span><span> </span><span class="NLM_article-title">CA-074Me protection against anthrax lethal toxin</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">4327</span><span class="NLM_x">–</span> <span class="NLM_lpage">4336</span><span class="refDoi"> DOI: 10.1128/IAI.00730-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1128%2FIAI.00730-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=19635822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Ghu73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2009&pages=4327-4336&author=Z.+L.+Newmanauthor=S.+H.+Lepplaauthor=M.+Moayeri&title=CA-074Me+protection+against+anthrax+lethal+toxin&doi=10.1128%2FIAI.00730-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">CA-074Me protection against anthrax lethal toxin</span></div><div class="casAuthors">Newman, Zachary L.; Leppla, Stephen H.; Moayeri, Mahtab</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4327-4336</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Anthrax lethal toxin (LT) activates the NLRP1b (NALP1b) inflammasome and caspase-1 in macrophages from certain inbred mouse strains, but the mechanism by which this occurs is poorly understood.  The authors report here that similar to several NLRP3 (NALP3, cryopyrin)-activating stimuli, LT activation of the NLRP1b inflammasome involves lysosomal membrane permeabilization (LMP) and subsequent cytoplasmic cathepsin B activity.  CA-074Me, a potent cathepsin B inhibitor, protects LT-sensitive macrophages from cell death and prevents the activation of caspase-1.  RNA interference knockdown of cathepsin B expression, however, cannot prevent LT-mediated cell death, suggesting that CA-074Me may also act on other cellular proteases released during LMP.  CA-074Me appears to function downstream of LT translocation to the cytosol (as assessed by mitogen-activated protein kinase kinase cleavage), K+ effluxes, and proteasome activity.  The initial increase in cytoplasmic activity of cathepsin B occurs at the same time or shortly before caspase-1 activation but precedes a larger-scale lysosomal destabilization correlated closely with cytolysis.  The authors present results suggesting that LMP may be involved in the activation of the NLRP1b inflammasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC_dn4VijRO7Vg90H21EOLACvtfcHk0ljMbSoZg9HyUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Ghu73F&md5=6681a78216494c6029865c213875ae6b</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1128%2FIAI.00730-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00730-09%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DZ.%2BL.%26aulast%3DLeppla%26aufirst%3DS.%2BH.%26aulast%3DMoayeri%26aufirst%3DM.%26atitle%3DCA-074Me%2520protection%2520against%2520anthrax%2520lethal%2520toxin%26jtitle%3DInfect.%2520Immun.%26date%3D2009%26volume%3D77%26spage%3D4327%26epage%3D4336%26doi%3D10.1128%2FIAI.00730-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Gross, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poeck, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bscheider, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dostert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannesschlager, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endres, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardivel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweighoffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocsai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruland, J.</span><span> </span><span class="NLM_article-title">Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">459</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">436</span><span class="refDoi"> DOI: 10.1038/nature07965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnature07965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=19339971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvV2ksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=459&publication_year=2009&pages=433-436&author=O.+Grossauthor=H.+Poeckauthor=M.+Bscheiderauthor=C.+Dostertauthor=N.+Hannesschlagerauthor=S.+Endresauthor=G.+Hartmannauthor=A.+Tardivelauthor=E.+Schweighofferauthor=V.+Tybulewiczauthor=A.+Mocsaiauthor=J.+Tschoppauthor=J.+Ruland&title=Syk+kinase+signalling+couples+to+the+Nlrp3+inflammasome+for+anti-fungal+host+defence&doi=10.1038%2Fnature07965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence</span></div><div class="casAuthors">Gross, Olaf; Poeck, Hendrik; Bscheider, Michael; Dostert, Catherine; Hannesschlaeger, Nicole; Endres, Stefan; Hartmann, Gunther; Tardivel, Aubry; Schweighoffer, Edina; Tybulewicz, Victor; Mocsai, Attila; Tschopp, Juerg; Ruland, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">459</span>
        (<span class="NLM_cas:issue">7245</span>),
    <span class="NLM_cas:pages">433-436</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Fungal infections represent a serious threat, particularly in immunocompromised patients.  Interleukin-1β (IL-1β) is a key pro-inflammatory factor in innate antifungal immunity.  The mechanism by which the mammalian immune system regulates IL-1β prodn. after fungal recognition is unclear.  Two signals are generally required for IL-1β prodn.: an NF-κB-dependent signal that induces the synthesis of pro-IL-1β (p35), and a second signal that triggers proteolytic pro-IL-1β processing to produce bioactive IL-1β (p17) via Caspase-1-contg. multiprotein complexes called inflammasomes.  Here we demonstrate that the tyrosine kinase Syk, operating downstream of several immunoreceptor tyrosine-based activation motif (ITAM)-coupled fungal pattern recognition receptors, controls both pro-IL-1β synthesis and inflammasome activation after cell stimulation with Candida albicans.  Whereas Syk signalling for pro-IL-1β synthesis selectively uses the Card9 pathway, inflammasome activation by the fungus involves reactive oxygen species prodn. and potassium efflux.  Genetic deletion or pharmalogical inhibition of Syk selectively abrogated inflammasome activation by C. albicans but not by inflammasome activators such as Salmonella typhimurium or the bacterial toxin nigericin.  Nlrp3 (also known as NALP3) was identified as the crit. NOD-like receptor family member that transduces the fungal recognition signal to the inflammasome adaptor Asc (Pycard) for Caspase-1 (Casp1) activation and pro-IL-1β processing.  Consistent with an essential role for Nlrp3 inflammasomes in antifungal immunity, we show that Nlrp3-deficient mice are hypersusceptible to Candida albicans infection.  Thus, our results demonstrate the mol. basis for IL-1β prodn. after fungal infection and identify a crucial function for the Nlrp3 inflammasome in mammalian host defense in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK4a_GDL8lrrVg90H21EOLACvtfcHk0ljPULVmSCxg0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvV2ksLs%253D&md5=7a8d5d412df3bcd7e34dc5e6affe7a42</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1038%2Fnature07965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07965%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DO.%26aulast%3DPoeck%26aufirst%3DH.%26aulast%3DBscheider%26aufirst%3DM.%26aulast%3DDostert%26aufirst%3DC.%26aulast%3DHannesschlager%26aufirst%3DN.%26aulast%3DEndres%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DG.%26aulast%3DTardivel%26aufirst%3DA.%26aulast%3DSchweighoffer%26aufirst%3DE.%26aulast%3DTybulewicz%26aufirst%3DV.%26aulast%3DMocsai%26aufirst%3DA.%26aulast%3DTschopp%26aufirst%3DJ.%26aulast%3DRuland%26aufirst%3DJ.%26atitle%3DSyk%2520kinase%2520signalling%2520couples%2520to%2520the%2520Nlrp3%2520inflammasome%2520for%2520anti-fungal%2520host%2520defence%26jtitle%3DNature%26date%3D2009%26volume%3D459%26spage%3D433%26epage%3D436%26doi%3D10.1038%2Fnature07965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Shio, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenbarth, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savaria, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinet, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellemare, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harder, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutterwala, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohle, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Descoteaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flavell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, M.</span><span> </span><span class="NLM_article-title">Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1000559</span><span class="refDoi"> DOI: 10.1371/journal.ppat.1000559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1371%2Fjournal.ppat.1000559" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=e1000559&author=M.+T.+Shioauthor=S.+C.+Eisenbarthauthor=M.+Savariaauthor=A.+F.+Vinetauthor=M.+J.+Bellemareauthor=K.+W.+Harderauthor=F.+S.+Sutterwalaauthor=D.+S.+Bohleauthor=A.+Descoteauxauthor=R.+A.+Flavellauthor=M.+Olivier&title=Malarial+hemozoin+activates+the+NLRP3+inflammasome+through+Lyn+and+Syk+kinases&doi=10.1371%2Fjournal.ppat.1000559"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1000559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1000559%26sid%3Dliteratum%253Aachs%26aulast%3DShio%26aufirst%3DM.%2BT.%26aulast%3DEisenbarth%26aufirst%3DS.%2BC.%26aulast%3DSavaria%26aufirst%3DM.%26aulast%3DVinet%26aufirst%3DA.%2BF.%26aulast%3DBellemare%26aufirst%3DM.%2BJ.%26aulast%3DHarder%26aufirst%3DK.%2BW.%26aulast%3DSutterwala%26aufirst%3DF.%2BS.%26aulast%3DBohle%26aufirst%3DD.%2BS.%26aulast%3DDescoteaux%26aufirst%3DA.%26aulast%3DFlavell%26aufirst%3DR.%2BA.%26aulast%3DOlivier%26aufirst%3DM.%26atitle%3DMalarial%2520hemozoin%2520activates%2520the%2520NLRP3%2520inflammasome%2520through%2520Lyn%2520and%2520Syk%2520kinases%26jtitle%3DPLoS%2520Pathog.%26date%3D2009%26volume%3D5%26spage%3De1000559%26doi%3D10.1371%2Fjournal.ppat.1000559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Lin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, W. W.</span><span> </span><span class="NLM_article-title">Syk is involved in NLRP3 inflammasome-mediated caspase-1 activation through adaptor ASC phosphorylation and enhanced oligomerization</span> <span class="citation_source-journal">J. Leukocyte Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">835</span><span class="refDoi"> DOI: 10.1189/jlb.3HI0814-371RR</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1189%2Fjlb.3HI0814-371RR" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovVyisLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=825-835&author=Y.+C.+Linauthor=D.+Y.+Huangauthor=J.+S.+Wangauthor=Y.+L.+Linauthor=S.+L.+Hsiehauthor=K.+C.+Huangauthor=W.+W.+Lin&title=Syk+is+involved+in+NLRP3+inflammasome-mediated+caspase-1+activation+through+adaptor+ASC+phosphorylation+and+enhanced+oligomerization&doi=10.1189%2Fjlb.3HI0814-371RR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Syk is involved in NLRP3 inflammasome-mediated caspase-1 activation through adaptor ASC phosphorylation and enhanced oligomerization</span></div><div class="casAuthors">Lin, Ying-Cing; Huang, Duen-Yi; Wang, Jang-Shiun; Lin, Yi-Ling; Hsieh, Shie-Liang; Huang, Kuo-Chin; Lin, Wan-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">825-835</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Society for Leucocyte Biology</span>)
        </div><div class="casAbstract">NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived mols. assocd. with cellular damage.  Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases.  Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear.  In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1.  Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells.  The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1.  Herein, we find that Syk can assoc. directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1.  Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is crit. to enhance ASC oligomerization and the recruitment of procaspase-1.  Together, our results reveal a new mol. pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC.  Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlnXzcOq-TvrVg90H21EOLACvtfcHk0ljPULVmSCxg0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovVyisLw%253D&md5=2bcf6ff04d8e32a1d516e39dcf395fc5</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1189%2Fjlb.3HI0814-371RR&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.3HI0814-371RR%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DY.%2BC.%26aulast%3DHuang%26aufirst%3DD.%2BY.%26aulast%3DWang%26aufirst%3DJ.%2BS.%26aulast%3DLin%26aufirst%3DY.%2BL.%26aulast%3DHsieh%26aufirst%3DS.%2BL.%26aulast%3DHuang%26aufirst%3DK.%2BC.%26aulast%3DLin%26aufirst%3DW.%2BW.%26atitle%3DSyk%2520is%2520involved%2520in%2520NLRP3%2520inflammasome-mediated%2520caspase-1%2520activation%2520through%2520adaptor%2520ASC%2520phosphorylation%2520and%2520enhanced%2520oligomerization%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2015%26volume%3D97%26spage%3D825%26epage%3D835%26doi%3D10.1189%2Fjlb.3HI0814-371RR" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Pine, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoettler, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banquerigo, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brahn, E.</span><span> </span><span class="NLM_article-title">Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor</span> <span class="citation_source-journal">Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span><span class="refDoi"> DOI: 10.1016/j.clim.2007.03.543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.clim.2007.03.543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=17537677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1eltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2007&pages=244-257&author=P.+R.+Pineauthor=B.+Changauthor=N.+Schoettlerauthor=M.+L.+Banquerigoauthor=S.+Wangauthor=A.+Lauauthor=F.+Zhaoauthor=E.+B.+Grossbardauthor=D.+G.+Payanauthor=E.+Brahn&title=Inflammation+and+bone+erosion+are+suppressed+in+models+of+rheumatoid+arthritis+following+treatment+with+a+novel+Syk+inhibitor&doi=10.1016%2Fj.clim.2007.03.543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor</span></div><div class="casAuthors">Pine, Polly R.; Chang, Betty; Schoettler, Nathan; Banquerigo, Mona L.; Wang, Su; Lau, Angela; Zhao, Feifei; Grossbard, Elliott B.; Payan, Donald G.; Brahn, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Immunology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">244-257</span>CODEN:
                <span class="NLM_cas:coden">CLIIFY</span>;
        ISSN:<span class="NLM_cas:issn">1521-6616</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk), a key mediator of immunoreceptor signaling in inflammatory cells, is essential for immune complex-mediated signal transduction initiated by activated receptors for IgG.  In collagen-induced arthritis, R788/R406, a novel and potent small mol. Syk inhibitor suppressed clin. arthritis, bone erosions, pannus formation, and synovitis.  Serum anti-collagen type II antibody levels were unaltered, while the half-life of exogenous antibody was extended when co-administered with R406.  Expression of the targeted kinase (Syk) in synovial tissue correlated with the joint level of inflammatory cell infiltrates and was virtually undetectable in treated rats.  Syk inhibition suppressed synovial cytokines and cartilage oligomeric matrix protein (COMP) in serum, suggesting a sensitive and reliable biomarker for R406 activity.  These results highlight the role of activating Fcgamma receptors in inflammatory synovitis and suggest that interruption of the signaling cascade with a novel Syk inhibitor may be a useful addn. to immunosuppressive disease-modifying anti-rheumatic drugs currently used in the treatment of human autoimmune diseases such as rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Nm2XObIb37Vg90H21EOLACvtfcHk0ljPULVmSCxg0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1eltb0%253D&md5=98b5020fb23cc209e5b7c322024748fb</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.clim.2007.03.543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clim.2007.03.543%26sid%3Dliteratum%253Aachs%26aulast%3DPine%26aufirst%3DP.%2BR.%26aulast%3DChang%26aufirst%3DB.%26aulast%3DSchoettler%26aufirst%3DN.%26aulast%3DBanquerigo%26aufirst%3DM.%2BL.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DBrahn%26aufirst%3DE.%26atitle%3DInflammation%2520and%2520bone%2520erosion%2520are%2520suppressed%2520in%2520models%2520of%2520rheumatoid%2520arthritis%2520following%2520treatment%2520with%2520a%2520novel%2520Syk%2520inhibitor%26jtitle%3DClin.%2520Immunol.%26date%3D2007%26volume%3D124%26spage%3D244%26epage%3D257%26doi%3D10.1016%2Fj.clim.2007.03.543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Weinblatt, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgos-Vargas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikranian, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medrano-Ramirez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales-Torres, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musser, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straniero, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente-Gonzales, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E.</span><span> </span><span class="NLM_article-title">Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3309</span><span class="NLM_x">–</span> <span class="NLM_lpage">3318</span><span class="refDoi"> DOI: 10.1002/art.23992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1002%2Fart.23992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=18975322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2hs7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=3309-3318&author=M.+E.+Weinblattauthor=A.+Kavanaughauthor=R.+Burgos-Vargasauthor=A.+H.+Dikranianauthor=G.+Medrano-Ramirezauthor=J.+L.+Morales-Torresauthor=F.+T.+Murphyauthor=T.+K.+Musserauthor=N.+Stranieroauthor=A.+V.+Vicente-Gonzalesauthor=E.+Grossbard&title=Treatment+of+rheumatoid+arthritis+with+a+Syk+kinase+inhibitor%3A+a+twelve-week%2C+randomized%2C+placebo-controlled+trial&doi=10.1002%2Fart.23992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial</span></div><div class="casAuthors">Weinblatt, Michael E.; Kavanaugh, Arthur; Burgos-Vargas, Ruben; Dikranian, Ara H.; Medrano-Ramirez, Gabriel; Morales-Torres, Jorge L.; Murphy, Frederick T.; Musser, Theresa Kane; Straniero, Nicholas; Vicente-Gonzales, Angela V.; Grossbard, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3309-3318</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: Spleen tyrosine kinase (Syk) has been identified as an important modulator of immune signaling in B cells and cells bearing Fcγ-activating receptors.  R788, a prodrug of active metabolite R406, has been shown to be an inhibitor of Syk kinase, active in a variety of in vitro and in vivo models, suggesting potential activity in the treatment of rheumatoid arthritis (RA).  Methods: We enrolled 189 patients with active RA despite methotrexate therapy in a 3-mo, multicenter, ascending-dose, double-blind, placebo-controlled trial.  The primary end point was the American College of Rheumatol. 20% improvement criteria (ACR20) response rate at week 12.  Results: Twice-daily oral doses of 100 mg and 150 mg of R788 were significantly superior to placebo or twice-daily oral doses of 50 mg at week 12 (ACR20 achieved in 65% and 72% vs. 38% and 32% of patients, resp. [P < 0.01]).  ACR50 (achieved in 49% and 57% vs. 19% and 17% of patients, resp.) and ACR70 (achieved in 33% and 40% vs. 4% and 2% of patients, resp.) scores showed a similar pattern.  Clin. effect was noted as early as 1 wk after initiation of therapy.  Redns. in serum interleukin-6 and matrix metalloproteinase 3 levels also occurred as early as week 1 in the groups receiving 100 mg and 150 mg R788.  The major adverse effects were gastrointestinal side effects (predominantly diarrhea) and neutropenia (<1,500/mm3), both of which were dose related.  Conclusion: These results indicate that an inhibitor of Syk kinase produces significant clin. benefits at 12 wk in a population of patients with active RA receiving methotrexate therapy.  Syk kinase may be an important new therapeutic target in RA and related autoimmune conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqomUu-KV6uvbVg90H21EOLACvtfcHk0lgSvy94_ituAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2hs7jF&md5=a49db998eb1a011d8ae59580f4c868c6</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1002%2Fart.23992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.23992%26sid%3Dliteratum%253Aachs%26aulast%3DWeinblatt%26aufirst%3DM.%2BE.%26aulast%3DKavanaugh%26aufirst%3DA.%26aulast%3DBurgos-Vargas%26aufirst%3DR.%26aulast%3DDikranian%26aufirst%3DA.%2BH.%26aulast%3DMedrano-Ramirez%26aufirst%3DG.%26aulast%3DMorales-Torres%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DF.%2BT.%26aulast%3DMusser%26aufirst%3DT.%2BK.%26aulast%3DStraniero%26aufirst%3DN.%26aulast%3DVicente-Gonzales%26aufirst%3DA.%2BV.%26aulast%3DGrossbard%26aufirst%3DE.%26atitle%3DTreatment%2520of%2520rheumatoid%2520arthritis%2520with%2520a%2520Syk%2520kinase%2520inhibitor%253A%2520a%2520twelve-week%252C%2520randomized%252C%2520placebo-controlled%2520trial%26jtitle%3DArthritis%2520Rheum.%26date%3D2008%26volume%3D58%26spage%3D3309%26epage%3D3318%26doi%3D10.1002%2Fart.23992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Currie, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kropf, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomgren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallion, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitney, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansdon, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciejewski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macaluso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Paolo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, S. A.</span><span> </span><span class="NLM_article-title">Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3856</span><span class="NLM_x">–</span> <span class="NLM_lpage">3873</span><span class="refDoi"> DOI: 10.1021/jm500228a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500228a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1CrsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3856-3873&author=K.+S.+Currieauthor=J.+E.+Kropfauthor=T.+Leeauthor=P.+Blomgrenauthor=J.+Xuauthor=Z.+Zhaoauthor=S.+Gallionauthor=J.+A.+Whitneyauthor=D.+Maclinauthor=E.+B.+Lansdonauthor=P.+Maciejewskiauthor=A.+M.+Rossiauthor=H.+Rongauthor=J.+Macalusoauthor=J.+Barbosaauthor=J.+A.+Di+Paoloauthor=S.+A.+Mitchell&title=Discovery+of+GS-9973%2C+a+selective+and+orally+efficacious+inhibitor+of+spleen+tyrosine+kinase&doi=10.1021%2Fjm500228a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine Kinase</span></div><div class="casAuthors">Currie, Kevin S.; Kropf, Jeffrey E.; Lee, Tony; Blomgren, Peter; Xu, Jianjun; Zhao, Zhongdong; Gallion, Steve; Whitney, J. Andrew; Maclin, Deborah; Lansdon, Eric B.; Maciejewski, Patricia; Rossi, Ann Marie; Rong, Hong; Macaluso, Jennifer; Barbosa, James; Di Paolo, Julie A.; Mitchell, Scott A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3856-3873</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk) is an attractive drug target in autoimmune, inflammatory, and oncol. disease indications.  The most advanced Syk inhibitor, R406, (or its prodrug form fostamatinib), has shown efficacy in multiple therapeutic indications, but its clin. progress has been hampered by dose-limiting adverse effects that have been attributed, at least in part, to the off-target activities of R406.  It is expected that a more selective Syk inhibitor would provide a greater therapeutic window.  Herein the authors report the discovery and optimization of a novel series of imidazo[1,2-a]pyrazine Syk inhibitors.  This work culminated in the identification of GS-9973, a highly selective and orally efficacious Syk inhibitor which is currently undergoing clin. evaluation for autoimmune and oncol. indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRyEcx9jKxCbVg90H21EOLACvtfcHk0lgSvy94_ituAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1CrsL4%253D&md5=fc53448de1f5416f2c6600876f8c6385</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1021%2Fjm500228a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500228a%26sid%3Dliteratum%253Aachs%26aulast%3DCurrie%26aufirst%3DK.%2BS.%26aulast%3DKropf%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DBlomgren%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DGallion%26aufirst%3DS.%26aulast%3DWhitney%26aufirst%3DJ.%2BA.%26aulast%3DMaclin%26aufirst%3DD.%26aulast%3DLansdon%26aufirst%3DE.%2BB.%26aulast%3DMaciejewski%26aufirst%3DP.%26aulast%3DRossi%26aufirst%3DA.%2BM.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DMacaluso%26aufirst%3DJ.%26aulast%3DBarbosa%26aufirst%3DJ.%26aulast%3DDi%2BPaolo%26aufirst%3DJ.%2BA.%26aulast%3DMitchell%26aufirst%3DS.%2BA.%26atitle%3DDiscovery%2520of%2520GS-9973%252C%2520a%2520selective%2520and%2520orally%2520efficacious%2520inhibitor%2520of%2520spleen%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3856%26epage%3D3873%26doi%3D10.1021%2Fjm500228a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Fernandes-Alnemri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E. S.</span><span> </span><span class="NLM_article-title">Cutting edge: TLR signaling licenses IRAK1 for rapid activation of the NLRP3 inflammasome</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">3995</span><span class="NLM_x">–</span> <span class="NLM_lpage">3999</span><span class="refDoi"> DOI: 10.4049/jimmunol.1301681</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.1301681" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2013&pages=3995-3999&author=T.+Fernandes-Alnemriauthor=S.+Kangauthor=C.+Andersonauthor=J.+Sagaraauthor=K.+A.+Fitzgeraldauthor=E.+S.+Alnemri&title=Cutting+edge%3A+TLR+signaling+licenses+IRAK1+for+rapid+activation+of+the+NLRP3+inflammasome&doi=10.4049%2Fjimmunol.1301681"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1301681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1301681%26sid%3Dliteratum%253Aachs%26aulast%3DFernandes-Alnemri%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DC.%26aulast%3DSagara%26aufirst%3DJ.%26aulast%3DFitzgerald%26aufirst%3DK.%2BA.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26atitle%3DCutting%2520edge%253A%2520TLR%2520signaling%2520licenses%2520IRAK1%2520for%2520rapid%2520activation%2520of%2520the%2520NLRP3%2520inflammasome%26jtitle%3DJ.%2520Immunol.%26date%3D2013%26volume%3D191%26spage%3D3995%26epage%3D3999%26doi%3D10.4049%2Fjimmunol.1301681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Lin, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasare, C.</span><span> </span><span class="NLM_article-title">IRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span><span class="refDoi"> DOI: 10.1073/pnas.1320294111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1073%2Fpnas.1320294111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=775-780&author=K.+M.+Linauthor=W.+Huauthor=T.+D.+Troutmanauthor=M.+Jenningsauthor=T.+Brewerauthor=X.+Liauthor=S.+Nandaauthor=P.+Cohenauthor=J.+A.+Thomasauthor=C.+Pasare&title=IRAK-1+bypasses+priming+and+directly+links+TLRs+to+rapid+NLRP3+inflammasome+activation&doi=10.1073%2Fpnas.1320294111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1320294111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1320294111%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DK.%2BM.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DTroutman%26aufirst%3DT.%2BD.%26aulast%3DJennings%26aufirst%3DM.%26aulast%3DBrewer%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DNanda%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DThomas%26aufirst%3DJ.%2BA.%26aulast%3DPasare%26aufirst%3DC.%26atitle%3DIRAK-1%2520bypasses%2520priming%2520and%2520directly%2520links%2520TLRs%2520to%2520rapid%2520NLRP3%2520inflammasome%2520activation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D775%26epage%3D780%26doi%3D10.1073%2Fpnas.1320294111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Chaudhary, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, D. L.</span><span> </span><span class="NLM_article-title">Recent advances in the discovery of small molecule inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4) as a therapeutic target for inflammation and oncology disorders</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1021/jm5016044</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5016044" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVCjsLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=96-110&author=D.+Chaudharyauthor=S.+Robinsonauthor=D.+L.+Romero&title=Recent+advances+in+the+discovery+of+small+molecule+inhibitors+of+interleukin-1+receptor-associated+kinase+4+%28IRAK4%29+as+a+therapeutic+target+for+inflammation+and+oncology+disorders&doi=10.1021%2Fjm5016044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Discovery of Small Molecule Inhibitors of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) as a Therapeutic Target for Inflammation and Oncology Disorders</span></div><div class="casAuthors">Chaudhary, Divya; Robinson, Shaughnessy; Romero, Donna L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-110</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  IRAK4, a serine/threonine kinase, plays a key role in both inflammation and oncol. diseases.  Herein, we summarize the compelling biol. surrounding the IRAK4 signaling node in disease, review key structural features of IRAK4 including selectivity challenges, and describe efforts to discover clin. viable IRAK4 inhibitors.  Finally, a view of knowledge gained and remaining challenges is provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1K6ExwztfCLVg90H21EOLACvtfcHk0lhb9f-gAArqxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVCjsLzL&md5=795797f7f3f07597ecd0b5899498804b</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fjm5016044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5016044%26sid%3Dliteratum%253Aachs%26aulast%3DChaudhary%26aufirst%3DD.%26aulast%3DRobinson%26aufirst%3DS.%26aulast%3DRomero%26aufirst%3DD.%2BL.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520of%2520small%2520molecule%2520inhibitors%2520of%2520interleukin-1%2520receptor-associated%2520kinase%25204%2520%2528IRAK4%2529%2520as%2520a%2520therapeutic%2520target%2520for%2520inflammation%2520and%2520oncology%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D96%26epage%3D110%26doi%3D10.1021%2Fjm5016044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Martinon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, J.</span><span> </span><span class="NLM_article-title">The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-1β</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span><span class="refDoi"> DOI: 10.1016/S1097-2765(02)00599-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2FS1097-2765%2802%2900599-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=417-426&author=F.+Martinonauthor=K.+Burnsauthor=J.+Tschopp&title=The+inflammasome%3A+a+molecular+platform+triggering+activation+of+inflammatory+caspases+and+processing+of+proIL-1%CE%B2&doi=10.1016%2FS1097-2765%2802%2900599-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2802%2900599-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252802%252900599-3%26sid%3Dliteratum%253Aachs%26aulast%3DMartinon%26aufirst%3DF.%26aulast%3DBurns%26aufirst%3DK.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DThe%2520inflammasome%253A%2520a%2520molecular%2520platform%2520triggering%2520activation%2520of%2520inflammatory%2520caspases%2520and%2520processing%2520of%2520proIL-1%25CE%25B2%26jtitle%3DMol.%2520Cell%26date%3D2002%26volume%3D10%26spage%3D417%26epage%3D426%26doi%3D10.1016%2FS1097-2765%2802%2900599-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Brydges, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeough, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misaghi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putnam, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestein, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horner, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soroosh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watford, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastner, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, H. M.</span><span> </span><span class="NLM_article-title">Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">875</span><span class="NLM_x">–</span> <span class="NLM_lpage">887</span><span class="refDoi"> DOI: 10.1016/j.immuni.2009.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.immuni.2009.05.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=875-887&author=S.+D.+Brydgesauthor=J.+L.+Muellerauthor=M.+D.+McGeoughauthor=C.+A.+Penaauthor=A.+Misaghiauthor=C.+Gandhiauthor=C.+D.+Putnamauthor=D.+L.+Boyleauthor=G.+S.+Firesteinauthor=A.+A.+Hornerauthor=P.+Sorooshauthor=W.+T.+Watfordauthor=J.+J.+O%27Sheaauthor=D.+L.+Kastnerauthor=H.+M.+Hoffman&title=Inflammasome-mediated+disease+animal+models+reveal+roles+for+innate+but+not+adaptive+immunity&doi=10.1016%2Fj.immuni.2009.05.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2009.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2009.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DBrydges%26aufirst%3DS.%2BD.%26aulast%3DMueller%26aufirst%3DJ.%2BL.%26aulast%3DMcGeough%26aufirst%3DM.%2BD.%26aulast%3DPena%26aufirst%3DC.%2BA.%26aulast%3DMisaghi%26aufirst%3DA.%26aulast%3DGandhi%26aufirst%3DC.%26aulast%3DPutnam%26aufirst%3DC.%2BD.%26aulast%3DBoyle%26aufirst%3DD.%2BL.%26aulast%3DFirestein%26aufirst%3DG.%2BS.%26aulast%3DHorner%26aufirst%3DA.%2BA.%26aulast%3DSoroosh%26aufirst%3DP.%26aulast%3DWatford%26aufirst%3DW.%2BT.%26aulast%3DO%2527Shea%26aufirst%3DJ.%2BJ.%26aulast%3DKastner%26aufirst%3DD.%2BL.%26aulast%3DHoffman%26aufirst%3DH.%2BM.%26atitle%3DInflammasome-mediated%2520disease%2520animal%2520models%2520reveal%2520roles%2520for%2520innate%2520but%2520not%2520adaptive%2520immunity%26jtitle%3DImmunity%26date%3D2009%26volume%3D30%26spage%3D875%26epage%3D887%26doi%3D10.1016%2Fj.immuni.2009.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Cogswell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godlevski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisely, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clay, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leesnitzer, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ways, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. G.</span><span> </span><span class="NLM_article-title">NF-κB regulates IL-1β transcription through a consensus NF-κB binding site and a nonconsensus CRE-like site</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=1994&pages=712-723&author=J.+P.+Cogswellauthor=M.+M.+Godlevskiauthor=G.+B.+Wiselyauthor=W.+C.+Clayauthor=L.+M.+Leesnitzerauthor=J.+P.+Waysauthor=J.+G.+Gray&title=NF-%CE%BAB+regulates+IL-1%CE%B2+transcription+through+a+consensus+NF-%CE%BAB+binding+site+and+a+nonconsensus+CRE-like+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCogswell%26aufirst%3DJ.%2BP.%26aulast%3DGodlevski%26aufirst%3DM.%2BM.%26aulast%3DWisely%26aufirst%3DG.%2BB.%26aulast%3DClay%26aufirst%3DW.%2BC.%26aulast%3DLeesnitzer%26aufirst%3DL.%2BM.%26aulast%3DWays%26aufirst%3DJ.%2BP.%26aulast%3DGray%26aufirst%3DJ.%2BG.%26atitle%3DNF-%25CE%25BAB%2520regulates%2520IL-1%25CE%25B2%2520transcription%2520through%2520a%2520consensus%2520NF-%25CE%25BAB%2520binding%2520site%2520and%2520a%2520nonconsensus%2520CRE-like%2520site%26jtitle%3DJ.%2520Immunol.%26date%3D1994%26volume%3D153%26spage%3D712%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Small, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McColl, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allmendinger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pahle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Castejon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothwell, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knowles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kell, D. B.</span><span> </span><span class="NLM_article-title">Efficient discovery of anti-inflammatory small-molecule combinations using evolutionary computing</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">902</span><span class="NLM_x">–</span> <span class="NLM_lpage">908</span><span class="refDoi"> DOI: 10.1038/nchembio.689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnchembio.689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22020553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=902-908&author=B.+G.+Smallauthor=B.+W.+McCollauthor=R.+Allmendingerauthor=J.+Pahleauthor=G.+Lopez-Castejonauthor=N.+J.+Rothwellauthor=J.+Knowlesauthor=P.+Mendesauthor=D.+Broughauthor=D.+B.+Kell&title=Efficient+discovery+of+anti-inflammatory+small-molecule+combinations+using+evolutionary+computing&doi=10.1038%2Fnchembio.689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient discovery of anti-inflammatory small-molecule combinations using evolutionary computing</span></div><div class="casAuthors">Small, Ben G.; McColl, Barry W.; Allmendinger, Richard; Pahle, Juergen; Lopez-Castejon, Gloria; Rothwell, Nancy J.; Knowles, Joshua; Mendes, Pedro; Brough, David; Kell, Douglas B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">902-908</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The control of biochem. fluxes is distributed, and to perturb complex intracellular networks effectively it is often necessary to modulate several steps simultaneously.  However, the no. of possible permutations leads to a combinatorial explosion in the no. of expts. that would have to be performed in a complete anal.  We used a multiobjective evolutionary algorithm to optimize reagent combinations from a dynamic chem. library of 33 compds. with established or predicted targets in the regulatory network controlling IL-1β expression.  The evolutionary algorithm converged on excellent solns. within 11 generations, during which we studied just 550 combinations out of the potential search space of ∼9 billion.  The top five reagents with the greatest contribution to combinatorial effects throughout the evolutionary algorithm were then optimized pairwise.  A p38 MAPK inhibitor together with either an inhibitor of IκB kinase or a chelator of poorly liganded iron yielded synergistic inhibition of macrophage IL-1β expression.  Evolutionary searches provide a powerful and general approach to the discovery of new combinations of pharmacol. agents with therapeutic indexes potentially greater than those of single drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo7fSr1-34EbVg90H21EOLACvtfcHk0lh8-NTklbsVkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7nK&md5=5b36a491c9331206abef4903daf932a8</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.689%26sid%3Dliteratum%253Aachs%26aulast%3DSmall%26aufirst%3DB.%2BG.%26aulast%3DMcColl%26aufirst%3DB.%2BW.%26aulast%3DAllmendinger%26aufirst%3DR.%26aulast%3DPahle%26aufirst%3DJ.%26aulast%3DLopez-Castejon%26aufirst%3DG.%26aulast%3DRothwell%26aufirst%3DN.%2BJ.%26aulast%3DKnowles%26aufirst%3DJ.%26aulast%3DMendes%26aufirst%3DP.%26aulast%3DBrough%26aufirst%3DD.%26aulast%3DKell%26aufirst%3DD.%2BB.%26atitle%3DEfficient%2520discovery%2520of%2520anti-inflammatory%2520small-molecule%2520combinations%2520using%2520evolutionary%2520computing%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D902%26epage%3D908%26doi%3D10.1038%2Fnchembio.689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Cocco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Stilo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borretto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevanato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantozzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miglio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertinaria, M.</span><span> </span><span class="NLM_article-title">Electrophilic warhead-based design of compounds preventing NLRP3 inflammasome-dependent pyroptosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10366</span><span class="NLM_x">–</span> <span class="NLM_lpage">10382</span><span class="refDoi"> DOI: 10.1021/jm501072b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501072b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10366-10382&author=M.+Coccoauthor=D.+Garellaauthor=A.+Di+Stiloauthor=E.+Borrettoauthor=L.+Stevanatoauthor=M.+Giorgisauthor=E.+Mariniauthor=R.+Fantozziauthor=G.+Miglioauthor=M.+Bertinaria&title=Electrophilic+warhead-based+design+of+compounds+preventing+NLRP3+inflammasome-dependent+pyroptosis&doi=10.1021%2Fjm501072b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Fjm501072b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501072b%26sid%3Dliteratum%253Aachs%26aulast%3DCocco%26aufirst%3DM.%26aulast%3DGarella%26aufirst%3DD.%26aulast%3DDi%2BStilo%26aufirst%3DA.%26aulast%3DBorretto%26aufirst%3DE.%26aulast%3DStevanato%26aufirst%3DL.%26aulast%3DGiorgis%26aufirst%3DM.%26aulast%3DMarini%26aufirst%3DE.%26aulast%3DFantozzi%26aufirst%3DR.%26aulast%3DMiglio%26aufirst%3DG.%26aulast%3DBertinaria%26aufirst%3DM.%26atitle%3DElectrophilic%2520warhead-based%2520design%2520of%2520compounds%2520preventing%2520NLRP3%2520inflammasome-dependent%2520pyroptosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10366%26epage%3D10382%26doi%3D10.1021%2Fjm501072b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Bae, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. H.</span><span> </span><span class="NLM_article-title">Crystal structure of NALP3 protein pyrin domain (PYD) and its implications in inflammasome assembly</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">39528</span><span class="NLM_x">–</span> <span class="NLM_lpage">39536</span><span class="refDoi"> DOI: 10.1074/jbc.M111.278812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M111.278812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=21880711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSqtLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=39528-39536&author=J.+Y.+Baeauthor=H.+H.+Park&title=Crystal+structure+of+NALP3+protein+pyrin+domain+%28PYD%29+and+its+implications+in+inflammasome+assembly&doi=10.1074%2Fjbc.M111.278812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of NALP3 Protein Pyrin Domain (PYD) and Its Implications in Inflammasome Assembly</span></div><div class="casAuthors">Bae, Ju Young; Park, Hyun Ho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">39528-39536, S39528/1-S39528/2</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">NALP3 inflammasome, composed of the three proteins NALP3, ASC, and Caspase-1, is a macromol. complex responsible for the innate immune response against infection with bacterial and viral pathogens.  Formation of the inflammasome can lead to the activation of inflammatory caspases, such as Caspase-1, which then activate pro-inflammatory cytokines by proteolytic cleavage.  The assembly of the NALP3 inflammasome depends on the protein-interacting domain known as the death domain superfamily.  NALP3 inflammasome is assembled via a pyrin domain (PYD)/PYD interaction between ASC and NALP3 and a caspase recruitment domain/caspase recruitment domain interaction between ASC and Caspase-1.  As a first step toward elucidating the mol. mechanisms of inflammatory caspase activation by formation of inflammasome, the authors report the crystal structure of the PYD from NALP3 at 1.7-Å resoln.  Although NALP3 PYD has the canonical six-helical bundle structural fold similar to other PYDs, the high resoln. structure reveals the possible biol. important homodimeric interface and the dynamic properties of the fold.  Comparison with other PYD structures shows both similarities and differences that may be functionally relevant.  Structural and sequence analyses further implicate conserved surface residues in NALP3 PYD for ASC interaction and inflammasome assembly.  The most interesting aspect of the structure was the unexpected disulfide bond between Cys-8 and Cys-108, which might be important for regulation of the activity of NALP3 by redox potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHEyUe6A6AKrVg90H21EOLACvtfcHk0lh8-NTklbsVkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSqtLzL&md5=9a9fdbd99a3e8aba9fcba7f2c8b48902</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.278812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.278812%26sid%3Dliteratum%253Aachs%26aulast%3DBae%26aufirst%3DJ.%2BY.%26aulast%3DPark%26aufirst%3DH.%2BH.%26atitle%3DCrystal%2520structure%2520of%2520NALP3%2520protein%2520pyrin%2520domain%2520%2528PYD%2529%2520and%2520its%2520implications%2520in%2520inflammasome%2520assembly%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D39528%26epage%3D39536%26doi%3D10.1074%2Fjbc.M111.278812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Nobel, C. S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orrenius, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slater, A. F. G.</span><span> </span><span class="NLM_article-title">Disulfiram is a potent inhibitor of proteases of the caspase family</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1319</span><span class="NLM_x">–</span> <span class="NLM_lpage">1324</span><span class="refDoi"> DOI: 10.1021/tx970131m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx970131m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1997&pages=1319-1324&author=C.+S.+I.+Nobelauthor=M.+Kimlandauthor=D.+W.+Nicholsonauthor=S.+Orreniusauthor=A.+F.+G.+Slater&title=Disulfiram+is+a+potent+inhibitor+of+proteases+of+the+caspase+family&doi=10.1021%2Ftx970131m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Ftx970131m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx970131m%26sid%3Dliteratum%253Aachs%26aulast%3DNobel%26aufirst%3DC.%2BS.%2BI.%26aulast%3DKimland%26aufirst%3DM.%26aulast%3DNicholson%26aufirst%3DD.%2BW.%26aulast%3DOrrenius%26aufirst%3DS.%26aulast%3DSlater%26aufirst%3DA.%2BF.%2BG.%26atitle%3DDisulfiram%2520is%2520a%2520potent%2520inhibitor%2520of%2520proteases%2520of%2520the%2520caspase%2520family%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D1997%26volume%3D10%26spage%3D1319%26epage%3D1324%26doi%3D10.1021%2Ftx970131m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Haddad, J. J.</span><span> </span><span class="NLM_article-title">A redox microenvironment is essential for MAPK-dependent secretion of pro-inflammatory cytokines: modulation by glutathione (GSH/GSSG) biosynthesis and equilibrium in the alveolar epithelium</span> <span class="citation_source-journal">Cell. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span><span class="refDoi"> DOI: 10.1016/j.cellimm.2011.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.cellimm.2011.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=21550026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlygtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=2011&pages=53-61&author=J.+J.+Haddad&title=A+redox+microenvironment+is+essential+for+MAPK-dependent+secretion+of+pro-inflammatory+cytokines%3A+modulation+by+glutathione+%28GSH%2FGSSG%29+biosynthesis+and+equilibrium+in+the+alveolar+epithelium&doi=10.1016%2Fj.cellimm.2011.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">A redox microenvironment is essential for MAPK-dependent secretion of pro-inflammatory cytokines: Modulation by glutathione (GSH/GSSG) biosynthesis and equilibrium in the alveolar epithelium</span></div><div class="casAuthors">Haddad, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-61</span>CODEN:
                <span class="NLM_cas:coden">CLIMB8</span>;
        ISSN:<span class="NLM_cas:issn">0008-8749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The characterization of oxidant (glutathione)-dependent regulation of MAPKp38/RK-mediated TNF-α secretion was undertaken in vitro, and the ramifications of the influence of a redox microenvironment were unraveled.  Intermittent exposure of alveolar epithelial cells (FATEII) to LPS (endotoxin) transiently and temporally induced the expression of MAPKp38/RK.  This upregulation was assocd. with the activation of MAPKAP-K2, manifested by the specific phosphorylation of the downstream heat-shock protein (Hsp)-27.  Selective blockading of the MAPKp38/RK pathway using the pyridinyl imidazole SB-203580 abrogated the LPS-dependent release of TNF-α.  N-acetyl-L-cysteine (NAC), a precursor of glutathione, reduced TNF-α secretion and increased [GSH].  Conversely, L-buthionine-(S,R)-sulfoximine (BSO), an irreversible inhibitor of γ-glutamylcysteine synthetase (γ-GCS), the rate-limiting enzyme in the pathway mediating GSH biosynthesis, augmented the secretion of TNF-α and [GSSG] accumulation.  Whereas NAC abrogated the phosphorylation of MAPKp38/RK, BSO reversibly amplified this effect.  Furthermore, intermittent exposure of FATEII cells to the exogenous oxidants X/XO and H2O2 upregulated the secretion of pro-inflammatory cytokines IL-1β, IL-6 and TNF-α; this upregulation was correlated with increasing activity of key glutathione-related enzymes, closely involved with maintaining the cyclic GSH/GSSG equil.  These results indicate that a redox microenvironment plays a major role in regulating MAPK-dependent prodn. of cytokines in the alveolar epithelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbDh0qzWNlC7Vg90H21EOLACvtfcHk0lhxy-UaxPa-5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlygtbk%253D&md5=bf407b714443461b527b70a69f762579</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1016%2Fj.cellimm.2011.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellimm.2011.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DHaddad%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520redox%2520microenvironment%2520is%2520essential%2520for%2520MAPK-dependent%2520secretion%2520of%2520pro-inflammatory%2520cytokines%253A%2520modulation%2520by%2520glutathione%2520%2528GSH%252FGSSG%2529%2520biosynthesis%2520and%2520equilibrium%2520in%2520the%2520alveolar%2520epithelium%26jtitle%3DCell.%2520Immunol.%26date%3D2011%26volume%3D270%26spage%3D53%26epage%3D61%26doi%3D10.1016%2Fj.cellimm.2011.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Rider, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guttman, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braiman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voronov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinarello, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apte, R. N.</span><span> </span><span class="NLM_article-title">IL-1α and IL-1β recruit different myeloid cells and promote different stages of sterile inflammation</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">187</span><span class="NLM_x">, </span> <span class="NLM_fpage">4835</span><span class="NLM_x">–</span> <span class="NLM_lpage">4843</span><span class="refDoi"> DOI: 10.4049/jimmunol.1102048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.1102048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2011&pages=4835-4843&author=P.+Riderauthor=Y.+Carmiauthor=O.+Guttmanauthor=A.+Braimanauthor=I.+Cohenauthor=E.+Voronovauthor=M.+R.+Whiteauthor=C.+A.+Dinarelloauthor=R.+N.+Apte&title=IL-1%CE%B1+and+IL-1%CE%B2+recruit+different+myeloid+cells+and+promote+different+stages+of+sterile+inflammation&doi=10.4049%2Fjimmunol.1102048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1102048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1102048%26sid%3Dliteratum%253Aachs%26aulast%3DRider%26aufirst%3DP.%26aulast%3DCarmi%26aufirst%3DY.%26aulast%3DGuttman%26aufirst%3DO.%26aulast%3DBraiman%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DI.%26aulast%3DVoronov%26aufirst%3DE.%26aulast%3DWhite%26aufirst%3DM.%2BR.%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26aulast%3DApte%26aufirst%3DR.%2BN.%26atitle%3DIL-1%25CE%25B1%2520and%2520IL-1%25CE%25B2%2520recruit%2520different%2520myeloid%2520cells%2520and%2520promote%2520different%2520stages%2520of%2520sterile%2520inflammation%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D187%26spage%3D4835%26epage%3D4843%26doi%3D10.4049%2Fjimmunol.1102048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Miller, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Connell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietras, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahangian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thirumala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modlin, R. L.</span><span> </span><span class="NLM_article-title">MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against <i>Staphylococcus aureus</i></span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">91</span><span class="refDoi"> DOI: 10.1016/j.immuni.2005.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.immuni.2005.11.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=79-91&author=L.+S.+Millerauthor=R.+M.+O%27Connellauthor=M.+A.+Gutierrezauthor=E.+M.+Pietrasauthor=A.+Shahangianauthor=C.+E.+Grossauthor=A.+Thirumalaauthor=A.+L.+Cheungauthor=G.+Chengauthor=R.+L.+Modlin&title=MyD88+mediates+neutrophil+recruitment+initiated+by+IL-1R+but+not+TLR2+activation+in+immunity+against+Staphylococcus+aureus&doi=10.1016%2Fj.immuni.2005.11.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2005.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2005.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DL.%2BS.%26aulast%3DO%2527Connell%26aufirst%3DR.%2BM.%26aulast%3DGutierrez%26aufirst%3DM.%2BA.%26aulast%3DPietras%26aufirst%3DE.%2BM.%26aulast%3DShahangian%26aufirst%3DA.%26aulast%3DGross%26aufirst%3DC.%2BE.%26aulast%3DThirumala%26aufirst%3DA.%26aulast%3DCheung%26aufirst%3DA.%2BL.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DModlin%26aufirst%3DR.%2BL.%26atitle%3DMyD88%2520mediates%2520neutrophil%2520recruitment%2520initiated%2520by%2520IL-1R%2520but%2520not%2520TLR2%2520activation%2520in%2520immunity%2520against%2520Staphylococcus%2520aureus%26jtitle%3DImmunity%26date%3D2006%26volume%3D24%26spage%3D79%26epage%3D91%26doi%3D10.1016%2Fj.immuni.2005.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Miller, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietras, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uricchio, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Connell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modlin, R. L.</span><span> </span><span class="NLM_article-title">Inflammasome-mediated production of IL-1β is required for neutrophil recruitment against <i>Staphylococcus aureus</i> in vivo</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">6933</span><span class="NLM_x">–</span> <span class="NLM_lpage">6942</span><span class="refDoi"> DOI: 10.4049/jimmunol.179.10.6933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.179.10.6933" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2007&pages=6933-6942&author=L.+S.+Millerauthor=E.+M.+Pietrasauthor=L.+H.+Uricchioauthor=K.+Hiranoauthor=S.+Raoauthor=H.+Linauthor=R.+M.+O%27Connellauthor=Y.+Iwakuraauthor=A.+L.+Cheungauthor=G.+Chengauthor=R.+L.+Modlin&title=Inflammasome-mediated+production+of+IL-1%CE%B2+is+required+for+neutrophil+recruitment+against+Staphylococcus+aureus+in+vivo&doi=10.4049%2Fjimmunol.179.10.6933"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.179.10.6933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.179.10.6933%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DL.%2BS.%26aulast%3DPietras%26aufirst%3DE.%2BM.%26aulast%3DUricchio%26aufirst%3DL.%2BH.%26aulast%3DHirano%26aufirst%3DK.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DO%2527Connell%26aufirst%3DR.%2BM.%26aulast%3DIwakura%26aufirst%3DY.%26aulast%3DCheung%26aufirst%3DA.%2BL.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DModlin%26aufirst%3DR.%2BL.%26atitle%3DInflammasome-mediated%2520production%2520of%2520IL-1%25CE%25B2%2520is%2520required%2520for%2520neutrophil%2520recruitment%2520against%2520Staphylococcus%2520aureus%2520in%2520vivo%26jtitle%3DJ.%2520Immunol.%26date%3D2007%26volume%3D179%26spage%3D6933%26epage%3D6942%26doi%3D10.4049%2Fjimmunol.179.10.6933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group">Galloway, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyrich, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BSRBR Control Centre Consortium</span><span class="NLM_x">; </span><span class="NLM_contrib-group">British Society for Rheumatology Biologics Register</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symmons, D. P. M.</span><span> </span><span class="NLM_article-title">BSRBR Control Centre Consortium; Symmons, D. P.; on behalf of the British Society for Rheumatology Biologics Register. The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register</span> <span class="citation_source-journal">Rheumatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1341</span><span class="NLM_x">–</span> <span class="NLM_lpage">1342</span><span class="refDoi"> DOI: 10.1093/rheumatology/ker146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1093%2Frheumatology%2Fker146" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=1341-1342&author=J.+B.+Gallowayauthor=K.+L.+Hyrichauthor=L.+K.+Mercerauthor=W.+G.+Dixonauthor=K.+D.+Watsonauthor=M.+Luntauthor=BSRBR+Control+Centre+Consortiumauthor=British+Society+for+Rheumatology+Biologics+Registerauthor=D.+P.+M.+Symmons&title=BSRBR+Control+Centre+Consortium%3B+Symmons%2C+D.+P.%3B+on+behalf+of+the+British+Society+for+Rheumatology+Biologics+Register.+The+risk+of+serious+infections+in+patients+receiving+anakinra+for+rheumatoid+arthritis%3A+results+from+the+British+Society+for+Rheumatology+Biologics+Register&doi=10.1093%2Frheumatology%2Fker146"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fker146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fker146%26sid%3Dliteratum%253Aachs%26aulast%3DGalloway%26aufirst%3DJ.%2BB.%26aulast%3DHyrich%26aufirst%3DK.%2BL.%26aulast%3DMercer%26aufirst%3DL.%2BK.%26aulast%3DDixon%26aufirst%3DW.%2BG.%26aulast%3DWatson%26aufirst%3DK.%2BD.%26aulast%3DLunt%26aufirst%3DM.%26aulast%3D%26aulast%3D%26aulast%3DSymmons%26aufirst%3DD.%2BP.%2BM.%26atitle%3DBSRBR%2520Control%2520Centre%2520Consortium%253B%2520Symmons%252C%2520D.%2520P.%253B%2520on%2520behalf%2520of%2520the%2520British%2520Society%2520for%2520Rheumatology%2520Biologics%2520Register.%2520The%2520risk%2520of%2520serious%2520infections%2520in%2520patients%2520receiving%2520anakinra%2520for%2520rheumatoid%2520arthritis%253A%2520results%2520from%2520the%2520British%2520Society%2520for%2520Rheumatology%2520Biologics%2520Register%26jtitle%3DRheumatology%26date%3D2011%26volume%3D50%26spage%3D1341%26epage%3D1342%26doi%3D10.1093%2Frheumatology%2Fker146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group">Brassard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kezouh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suissa, S.</span><span> </span><span class="NLM_article-title">Antirheumatic drugs and the risk of tuberculosis</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">722</span><span class="refDoi"> DOI: 10.1086/506935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1086%2F506935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=16912945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFSktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2006&pages=717-722&author=P.+Brassardauthor=A.+Kezouhauthor=S.+Suissa&title=Antirheumatic+drugs+and+the+risk+of+tuberculosis&doi=10.1086%2F506935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Antirheumatic drugs and the risk of tuberculosis</span></div><div class="casAuthors">Brassard, Paul; Kezouh, Abbas; Suissa, Samy</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">717-722</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">The study aimed to quantify the rate of Mycobacterium tuberculosis disease (TB) among a cohort of patients with rheumatoid arthritis (RA) and to assess whether the independent use of disease-modifying antirheumatic drugs (DMARDs) is assocd. with the risk of developing TB.  The study was performed using the PharMetrics Patient-Centric database.  The cohort consisted of all subjects with ≥1 occurrence of a diagnosis of RA during an inpatient or outpatient visit during the period of Sept. 1998 through Dec. 2003.  Conditional logistic regression was used in a nested case-control anal. to est. the rate ratio (RR) of TB with any use of biol. or traditional DMARDs during the year before the index date.  The interaction between DMARDs and the current use of corticosteroids was also assessed.  The cohort consisted of 112,300 patients with RA.  A total of 386 cases of TB were identified, which resulted in an overall rate of 2.19 cases per 1000 person-years.  The adjusted RR of TB for biol. DMARD use is 1.5 (95% Cl, 1.1-1.9).  Use of traditional DMARDs was also independently assocd. with TB (RR, 1.2; 95% Cl, 1.0-1.5).  RRs of developing TB disease with the use of biol. or traditional DMARD were lower among current users of corticosteroids than among noncurrent users of corticosteroids.  The use of biol. and traditional DMARDs is assocd. with an increased risk of developing TB in patients with RA, mainly among noncurrent users of corticosteroids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC44D8LIIlkbVg90H21EOLACvtfcHk0ljwYRR0_5NkYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFSktrw%253D&md5=92c28359aa1cc923f7e8293e1cc4ab27</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1086%2F506935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F506935%26sid%3Dliteratum%253Aachs%26aulast%3DBrassard%26aufirst%3DP.%26aulast%3DKezouh%26aufirst%3DA.%26aulast%3DSuissa%26aufirst%3DS.%26atitle%3DAntirheumatic%2520drugs%2520and%2520the%2520risk%2520of%2520tuberculosis%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2006%26volume%3D43%26spage%3D717%26epage%3D722%26doi%3D10.1086%2F506935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group">Salliot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougados, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossec, L.</span><span> </span><span class="NLM_article-title">Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span><span class="refDoi"> DOI: 10.1136/ard.2007.083188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1136%2Fard.2007.083188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=18203761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FhtlOrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2009&pages=25-32&author=C.+Salliotauthor=M.+Dougadosauthor=L.+Gossec&title=Risk+of+serious+infections+during+rituximab%2C+abatacept+and+anakinra+treatments+for+rheumatoid+arthritis%3A+meta-analyses+of+randomised+placebo-controlled+trials&doi=10.1136%2Fard.2007.083188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials</span></div><div class="casAuthors">Salliot C; Dougados M; Gossec L</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the rheumatic diseases</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Tumour necrosis factor alpha blockers in rheumatoid arthritis are known to increase the risk of serious infections defined as life-threatening, requiring hospitalisation or intravenous antibiotics.  Recently, new biological agents have become available.  Their safety is an important issue.  PURPOSE:  To assess if biological agents, ie rituximab, abatacept and anakinra increase the risk of serious infections in patients with rheumatoid arthritis in published randomised controlled trials.  DATA SOURCE:  A systematic review of the literature using PUBMED, EMBASE, Cochrane library and abstracts databases (American College of Rheumatology and European League Against Rheumatism annual meetings) was performed up to October 2007.  This search was completed with data from the Food and Drug Administration, the European Agency for the Evaluation of Medicinal Products and manufacturers.  DATA EXTRACTION:  Three fixed-effect meta-analyses were performed to compare serious infection rates between each biological agent and placebo.  Pooled odds ratios (ORs) were calculated, using the Mantel-Haenszel method with a continuity correction.  DATA SYNTHESIS:  Twelve randomised controlled trials with data concerning serious infections were analysed (three for rituximab, five for abatacept and four for anakinra).  They included 745 patients, 1960 patients, 2062 patients and 2112 patients treated by rituximab, abatacept, anakinra and placebo respectively.  The overall pooled ORs did not reveal a statistically significant increased risk of serious infection for abatacept and rituximab; this risk was increased for high doses of anakinra (> or =100 mg daily) versus low dose and placebo (ORs = 9.63 (95% CI, 1.31 to 70.91) and 3.40 (95% CI, 1.11 to 10.46) respectively).  CONCLUSIONS:  These meta-analyses did not reveal a significant increase in the risk of serious infections during rituximab or abatacept treatments in patients with rheumatoid arthritis; however, high doses of anakinra may increase this risk, especially when patients have comorbidity factors.  Large studies must be performed to confirm this safety profile in daily practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-ty7EjBoZkxjv2lLSLOxFfW6udTcc2eYd7KU-Wa6skbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FhtlOrsg%253D%253D&md5=968211a7838fb14f3a329c2c27a49c4c</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1136%2Fard.2007.083188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fard.2007.083188%26sid%3Dliteratum%253Aachs%26aulast%3DSalliot%26aufirst%3DC.%26aulast%3DDougados%26aufirst%3DM.%26aulast%3DGossec%26aufirst%3DL.%26atitle%3DRisk%2520of%2520serious%2520infections%2520during%2520rituximab%252C%2520abatacept%2520and%2520anakinra%2520treatments%2520for%2520rheumatoid%2520arthritis%253A%2520meta-analyses%2520of%2520randomised%2520placebo-controlled%2520trials%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2009%26volume%3D68%26spage%3D25%26epage%3D32%26doi%3D10.1136%2Fard.2007.083188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group">Monteleone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stow, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, K.</span><span> </span><span class="NLM_article-title">Mechanisms of unconventional secretion of IL-1 family cytokines</span> <span class="citation_source-journal">Cytokine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span><span class="refDoi"> DOI: 10.1016/j.cyto.2015.03.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.cyto.2015.03.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2015&pages=213-218&author=M.+Monteleoneauthor=J.+L.+Stowauthor=K.+Schroder&title=Mechanisms+of+unconventional+secretion+of+IL-1+family+cytokines&doi=10.1016%2Fj.cyto.2015.03.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1016%2Fj.cyto.2015.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cyto.2015.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DMonteleone%26aufirst%3DM.%26aulast%3DStow%26aufirst%3DJ.%2BL.%26aulast%3DSchroder%26aufirst%3DK.%26atitle%3DMechanisms%2520of%2520unconventional%2520secretion%2520of%2520IL-1%2520family%2520cytokines%26jtitle%3DCytokine%26date%3D2015%26volume%3D74%26spage%3D213%26epage%3D218%26doi%3D10.1016%2Fj.cyto.2015.03.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group">Sweeny, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clough, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhamidipati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baluom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, D. T.</span><span> </span><span class="NLM_article-title">Metabolism of fostamatinib, the oral methylene phosphate prodrug of the spleen tyrosine kinase inhibitor R406 in humans: contribution of hepatic and gut bacterial processes to the overall biotransformation</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1166</span><span class="NLM_x">–</span> <span class="NLM_lpage">1176</span><span class="refDoi"> DOI: 10.1124/dmd.110.032151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1124%2Fdmd.110.032151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20371637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Klsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1166-1176&author=D.+J.+Sweenyauthor=W.+Liauthor=J.+Cloughauthor=S.+Bhamidipatiauthor=R.+Singhauthor=G.+Parkauthor=M.+Baluomauthor=E.+Grossbardauthor=D.+T.+Lau&title=Metabolism+of+fostamatinib%2C+the+oral+methylene+phosphate+prodrug+of+the+spleen+tyrosine+kinase+inhibitor+R406+in+humans%3A+contribution+of+hepatic+and+gut+bacterial+processes+to+the+overall+biotransformation&doi=10.1124%2Fdmd.110.032151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of fostamatinib, the oral methylene phosphate prodrug of the spleen tyrosine kinase inhibitor R406 in humans: Contribution of hepatic and gut bacterial processes to the overall biotransformation</span></div><div class="casAuthors">Sweeny, David J.; Li, Weiqun; Clough, Jeffrey; Bhamidipati, Somasekhar; Singh, Rajinder; Park, Gary; Baluom, Muhammad; Grossbard, Elliott; Lau, David T.-W.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1166-1176</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The metab. of the spleen tyrosine kinase inhibitor N4-(2,2-dimethyl-3-oxo-4-pyrid[1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethyoxyphenyl)-2,4-pyrimidinediamine (R406) and its oral prodrug N4-(2,2-dimethyl-4-[(dihydrogenphosphonoxy)methyl]-3-oxo-5-pyrid[1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethyoxyphenyl)-2,4-pyrimidinediamine disodium hexahydrate (R788, fostamatinib) was detd. in vitro and in humans.  R788 was rapidly converted to R406 by human intestinal microsomes, and only low levels of R788 were obsd. in plasma of human subjects after oral administration of 14C-R788.  R406 was the major drug-related compd. in plasma from human subjects, and only low levels of metabolites were obsd. in plasma.  The plasma metabolites of R406 were identified as a sulfate conjugate and glucuronide conjugate of the para-O-demethylated metabolite of R406 (R529) and a direct N-glucuronide conjugate of R406.  Elimination of drug-related material into the urine accounted for 19% of the administered dose, and the major metabolite in urine from all the human subjects was the lactam N-glucuronide of R406.  On av., 80% of the total drug was recovered in feces.  Two drug-related peaks were obsd.; one peak was identified as R406, and the other peak was identified as a unique 3,5-benzene diol metabolite of R406.  The 3,5-benzene diol metabolite appeared to result from the subsequent O-demethylations and dehydroxylation of R529 by anaerobic gut bacteria because only R529 was converted to this metabolite after the in vitro incubation with human fecal samples.  These data indicate that the major fecal metabolite of R406 obsd. in humans is a product of a hepatic cytochrome P 450-mediated O-demethylation and subsequent O-demethylations and dehydroxylation by gut bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjYey4HpvXGbVg90H21EOLACvtfcHk0ljwYRR0_5NkYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Klsb0%253D&md5=391fda31851968948d538f70319979e1</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.032151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.032151%26sid%3Dliteratum%253Aachs%26aulast%3DSweeny%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DClough%26aufirst%3DJ.%26aulast%3DBhamidipati%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DG.%26aulast%3DBaluom%26aufirst%3DM.%26aulast%3DGrossbard%26aufirst%3DE.%26aulast%3DLau%26aufirst%3DD.%2BT.%26atitle%3DMetabolism%2520of%2520fostamatinib%252C%2520the%2520oral%2520methylene%2520phosphate%2520prodrug%2520of%2520the%2520spleen%2520tyrosine%2520kinase%2520inhibitor%2520R406%2520in%2520humans%253A%2520contribution%2520of%2520hepatic%2520and%2520gut%2520bacterial%2520processes%2520to%2520the%2520overall%2520biotransformation%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D1166%26epage%3D1176%26doi%3D10.1124%2Fdmd.110.032151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 80 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Huihui Ti, Yang Zhou, Xue Liang, Runfeng Li, Ke Ding, <span class="NLM_string-name hlFld-ContribAuthor">Xin Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (13)
                                     , 5944-5978. <a href="https://doi.org/10.1021/acs.jmedchem.8b01520" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01520%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeted%252BTreatments%252Bfor%252BChronic%252BObstructive%252BPulmonary%252BDisease%252B%252528COPD%252529%252BUsing%252BLow-Molecular-Weight%252BDrugs%252B%252528LMWDs%252529%26aulast%3DTi%26aufirst%3DHuihui%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D30092018%26date%3D12022019%26date%3D25012019%26volume%3D62%26issue%3D13%26spage%3D5944%26epage%3D5978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mohd Abdullaha, Shabber Mohammed, Mehboob Ali, Ajay Kumar, Ram A. Vishwakarma, <span class="NLM_string-name hlFld-ContribAuthor">Sandip B. Bharate</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Quinazolin-4(3H)-ones as NLRP3 Inflammasome Inhibitors: Computational Design, Metal-Free Synthesis, and in Vitro Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (9)
                                     , 5129-5140. <a href="https://doi.org/10.1021/acs.joc.9b00138" title="DOI URL">https://doi.org/10.1021/acs.joc.9b00138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b00138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b00138%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDiscovery%252Bof%252BQuinazolin-4%2525283H%252529-ones%252Bas%252BNLRP3%252BInflammasome%252BInhibitors%25253A%252BComputational%252BDesign%25252C%252BMetal-Free%252BSynthesis%25252C%252Band%252Bin%252BVitro%252BBiological%252BEvaluation%26aulast%3DAbdullaha%26aufirst%3DMohd%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15012019%26date%3D02042019%26date%3D21032019%26volume%3D84%26issue%3D9%26spage%3D5129%26epage%3D5140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sonali
S. Bharate, Vikas Kumar, Gurdarshan Singh, Amarinder Singh, Mehak Gupta, Deepika Singh, Ajay Kumar, Ram A. Vishwakarma, <span class="NLM_string-name hlFld-ContribAuthor">Sandip B. Bharate</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Development of Crocus sativus-Based Botanical Lead IIIM-141 for Alzheimer’s Disease: Chemical Standardization, Efficacy, Formulation Development, Pharmacokinetics, and Safety Pharmacology. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (8)
                                     , 9572-9585. <a href="https://doi.org/10.1021/acsomega.8b00841" title="DOI URL">https://doi.org/10.1021/acsomega.8b00841</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b00841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b00841%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DPreclinical%252BDevelopment%252Bof%252BCrocus%252Bsativus-Based%252BBotanical%252BLead%252BIIIM-141%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BChemical%252BStandardization%25252C%252BEfficacy%25252C%252BFormulation%252BDevelopment%25252C%252BPharmacokinetics%25252C%252Band%252BSafety%252BPharmacology%26aulast%3DBharate%26aufirst%3DSonali%2BS.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27042018%26date%3D03082018%26volume%3D3%26issue%3D8%26spage%3D9572%26epage%3D9585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jacob Fulp, Liu He, Stefano Toldo, Yuqi Jiang, Ashley Boice, Chunqing Guo, Xia Li, Andrew Rolfe, Dong Sun, Antonio Abbate, Xiang-Yang Wang, <span class="NLM_string-name hlFld-ContribAuthor">Shijun Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Insights of Benzenesulfonamide Analogues as NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (12)
                                     , 5412-5423. <a href="https://doi.org/10.1021/acs.jmedchem.8b00733" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00733</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00733%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BInsights%252Bof%252BBenzenesulfonamide%252BAnalogues%252Bas%252BNLRP3%252BInflammasome%252BInhibitors%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BCharacterization%26aulast%3DFulp%26aufirst%3DJacob%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D07052018%26date%3D18062018%26date%3D07062018%26volume%3D61%26issue%3D12%26spage%3D5412%26epage%3D5423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mattia  Cocco</span>, <span class="hlFld-ContribAuthor ">Carolina  Pellegrini</span>, <span class="hlFld-ContribAuthor ">Helios  Martínez-Banaclocha</span>, <span class="hlFld-ContribAuthor ">Marta  Giorgis</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Marini</span>, <span class="hlFld-ContribAuthor ">Annalisa  Costale</span>, <span class="hlFld-ContribAuthor ">Gianluca  Miglio</span>, <span class="hlFld-ContribAuthor ">Matteo  Fornai</span>, <span class="hlFld-ContribAuthor ">Luca  Antonioli</span>, <span class="hlFld-ContribAuthor ">Gloria  López-Castejón</span>, <span class="hlFld-ContribAuthor ">Ana  Tapia-Abellán</span>, <span class="hlFld-ContribAuthor ">Diego  Angosto</span>, <span class="hlFld-ContribAuthor ">Iva  Hafner-Bratkovič</span>, <span class="hlFld-ContribAuthor ">Luca  Regazzoni</span>, <span class="hlFld-ContribAuthor ">Corrado  Blandizzi</span>, <span class="hlFld-ContribAuthor ">Pablo  Pelegrín</span>, and <span class="hlFld-ContribAuthor ">Massimo  Bertinaria</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 3656-3671. <a href="https://doi.org/10.1021/acs.jmedchem.6b01624" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01624%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Ban%252BAcrylate%252BDerivative%252BTargeting%252Bthe%252BNLRP3%252BInflammasome%252Bfor%252Bthe%252BTreatment%252Bof%252BInflammatory%252BBowel%252BDisease%26aulast%3DCocco%26aufirst%3DMattia%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D02112016%26date%3D24042017%26date%3D11052017%26date%3D14042017%26volume%3D60%26issue%3D9%26spage%3D3656%26epage%3D3671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ai Hua  Zhang</span>, <span class="hlFld-ContribAuthor ">Wen  Liu</span>, <span class="hlFld-ContribAuthor ">Nan  Jiang</span>, <span class="hlFld-ContribAuthor ">Qiang  Xu</span>, and <span class="hlFld-ContribAuthor ">Ren Xiang  Tan</span>  . </span><span class="cited-content_cbyCitation_article-title">Spirodalesol, an NLRP3 Inflammasome Activation Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (24)
                                     , 6496-6499. <a href="https://doi.org/10.1021/acs.orglett.6b03435" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b03435</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b03435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b03435%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSpirodalesol%25252C%252Ban%252BNLRP3%252BInflammasome%252BActivation%252BInhibitor%26aulast%3DZhang%26aufirst%3DAi%2BHua%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D17112016%26date%3D07122016%26date%3D16122016%26volume%3D18%26issue%3D24%26spage%3D6496%26epage%3D6499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Swarna L.  Vijayaraj</span>, <span class="hlFld-ContribAuthor ">Rebecca  Feltham</span>, <span class="hlFld-ContribAuthor ">Maryam  Rashidi</span>, <span class="hlFld-ContribAuthor ">Daniel  Frank</span>, <span class="hlFld-ContribAuthor ">Zhengyang  Liu</span>, <span class="hlFld-ContribAuthor ">Daniel S.  Simpson</span>, <span class="hlFld-ContribAuthor ">Gregor  Ebert</span>, <span class="hlFld-ContribAuthor ">Angelina  Vince</span>, <span class="hlFld-ContribAuthor ">Marco J.  Herold</span>, <span class="hlFld-ContribAuthor ">Andrew  Kueh</span>, <span class="hlFld-ContribAuthor ">Jaclyn S.  Pearson</span>, <span class="hlFld-ContribAuthor ">Laura F.  Dagley</span>, <span class="hlFld-ContribAuthor ">James M.  Murphy</span>, <span class="hlFld-ContribAuthor ">Andrew I.  Webb</span>, <span class="hlFld-ContribAuthor ">Kate E.  Lawlor</span>, <span class="hlFld-ContribAuthor ">James E.  Vince</span>. </span><span class="cited-content_cbyCitation_article-title">The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it for proteasomal degradation. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-021-22979-3" title="DOI URL">https://doi.org/10.1038/s41467-021-22979-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-021-22979-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-021-22979-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DThe%252Bubiquitylation%252Bof%252BIL-1%2525CE%2525B2%252Blimits%252Bits%252Bcleavage%252Bby%252Bcaspase-1%252Band%252Btargets%252Bit%252Bfor%252Bproteasomal%252Bdegradation%26aulast%3DVijayaraj%26aufirst%3DSwarna%2BL.%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wanwan  Li</span>, <span class="hlFld-ContribAuthor ">Zhongqiang  Cao</span>, <span class="hlFld-ContribAuthor ">Junjie  Cheng</span>, <span class="hlFld-ContribAuthor ">Feiyu  Chen</span>, <span class="hlFld-ContribAuthor ">Shuai  Li</span>, <span class="hlFld-ContribAuthor ">Yiwei  Huang</span>, <span class="hlFld-ContribAuthor ">Long Tai  Zheng</span>, <span class="hlFld-ContribAuthor ">Na  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-phenyl-1-(phenylsulfonamido)cyclopropane-1-carboxamide analogs as NLRP3 inflammasome inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (6)
                                     , 1294-1308. <a href="https://doi.org/10.1007/s00044-021-02740-7" title="DOI URL">https://doi.org/10.1007/s00044-021-02740-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-021-02740-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-021-02740-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDiscovery%252Bof%252BN-phenyl-1-%252528phenylsulfonamido%252529cyclopropane-1-carboxamide%252Banalogs%252Bas%252BNLRP3%252Binflammasome%252Binhibitors%26aulast%3DLi%26aufirst%3DWanwan%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D6%26spage%3D1294%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tim  Keuler</span>, <span class="hlFld-ContribAuthor ">Karl  Gatterdam</span>, <span class="hlFld-ContribAuthor ">Anil  Akbal</span>, <span class="hlFld-ContribAuthor ">Marta  Lovotti</span>, <span class="hlFld-ContribAuthor ">Michael  Marleaux</span>, <span class="hlFld-ContribAuthor ">Matthias  Geyer</span>, <span class="hlFld-ContribAuthor ">Eicke  Latz</span>, <span class="hlFld-ContribAuthor ">Michael  Gütschow</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Fluorescent and Biotin Probes Targeting NLRP3. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fchem.2021.642273" title="DOI URL">https://doi.org/10.3389/fchem.2021.642273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2021.642273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2021.642273%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DDevelopment%252Bof%252BFluorescent%252Band%252BBiotin%252BProbes%252BTargeting%252BNLRP3%26aulast%3DKeuler%26aufirst%3DTim%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianhua  Li</span>, <span class="hlFld-ContribAuthor ">Jiamin  Ma</span>, <span class="hlFld-ContribAuthor ">Mengyu  Li</span>, <span class="hlFld-ContribAuthor ">Jing  Tao</span>, <span class="hlFld-ContribAuthor ">Jiayi  Chen</span>, <span class="hlFld-ContribAuthor ">Chengye  Yao</span>, <span class="hlFld-ContribAuthor ">Shanglong  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">GYY4137 alleviates sepsis-induced acute lung injury in mice by inhibiting the PDGFRβ/Akt/NF-κB/NLRP3 pathway. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2021,</strong> <em>271 </em>, 119192. <a href="https://doi.org/10.1016/j.lfs.2021.119192" title="DOI URL">https://doi.org/10.1016/j.lfs.2021.119192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2021.119192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2021.119192%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DGYY4137%252Balleviates%252Bsepsis-induced%252Bacute%252Blung%252Binjury%252Bin%252Bmice%252Bby%252Binhibiting%252Bthe%252BPDGFR%2525CE%2525B2%25252FAkt%25252FNF-%2525CE%2525BAB%25252FNLRP3%252Bpathway%26aulast%3DLi%26aufirst%3DJianhua%26date%3D2021%26volume%3D271%26spage%3D119192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hellida Larissa  Sousa‐Brito</span>, <span class="hlFld-ContribAuthor ">Loeste  Arruda‐Barbosa</span>, <span class="hlFld-ContribAuthor ">Alfredo Augusto  Vasconcelos‐Silva</span>, <span class="hlFld-ContribAuthor ">Karoline  Gonzaga‐Costa</span>, <span class="hlFld-ContribAuthor ">Gloria Pinto  Duarte</span>, <span class="hlFld-ContribAuthor ">Rosivaldo Santos  Borges</span>, <span class="hlFld-ContribAuthor ">Pedro Jorge Caldas  Magalhães</span>, <span class="hlFld-ContribAuthor ">Saad  Lahlou</span>. </span><span class="cited-content_cbyCitation_article-title">Vasorelaxant effect of trans‐4‐chloro‐β‐nitrostyrene, a synthetic nitroderivative, in rat thoracic aorta. </span><span class="cited-content_cbyCitation_journal-name">Fundamental & Clinical Pharmacology</span><span> <strong>2021,</strong> <em>35 </em>
                                    (2)
                                     , 331-340. <a href="https://doi.org/10.1111/fcp.12624" title="DOI URL">https://doi.org/10.1111/fcp.12624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/fcp.12624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ffcp.12624%26sid%3Dliteratum%253Aachs%26jtitle%3DFundamental%2520%2526%2520Clinical%2520Pharmacology%26atitle%3DVasorelaxant%252Beffect%252Bof%252Btrans%2525E2%252580%2525904%2525E2%252580%252590chloro%2525E2%252580%252590%2525CE%2525B2%2525E2%252580%252590nitrostyrene%25252C%252Ba%252Bsynthetic%252Bnitroderivative%25252C%252Bin%252Brat%252Bthoracic%252Baorta%26aulast%3DSousa%25E2%2580%2590Brito%26aufirst%3DHellida%2BLarissa%26date%3D2021%26date%3D2020%26volume%3D35%26issue%3D2%26spage%3D331%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria T.  Proetto</span>, <span class="hlFld-ContribAuthor ">Kelsey  Alexander</span>, <span class="hlFld-ContribAuthor ">Mohand  Melaimi</span>, <span class="hlFld-ContribAuthor ">Guy  Bertrand</span>, <span class="hlFld-ContribAuthor ">Nathan C.  Gianneschi</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclic (Alkyl)(Amino)Carbene (CAAC) Gold(I) Complexes as Chemotherapeutic Agents. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>27 </em>
                                    (11)
                                     , 3772-3778. <a href="https://doi.org/10.1002/chem.202004317" title="DOI URL">https://doi.org/10.1002/chem.202004317</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202004317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202004317%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DCyclic%252B%252528Alkyl%252529%252528Amino%252529Carbene%252B%252528CAAC%252529%252BGold%252528I%252529%252BComplexes%252Bas%252BChemotherapeutic%252BAgents%26aulast%3DProetto%26aufirst%3DMaria%2BT.%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D11%26spage%3D3772%26epage%3D3778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haizhou  Zhu</span>, <span class="hlFld-ContribAuthor ">Venkateshwara  Dronamraju</span>, <span class="hlFld-ContribAuthor ">Wei  Xie</span>, <span class="hlFld-ContribAuthor ">Swati S.  More</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur-containing therapeutics in the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 305-352. <a href="https://doi.org/10.1007/s00044-020-02687-1" title="DOI URL">https://doi.org/10.1007/s00044-020-02687-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02687-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02687-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSulfur-containing%252Btherapeutics%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhu%26aufirst%3DHaizhou%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D2%26spage%3D305%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carmelo  Gurnari</span>, <span class="hlFld-ContribAuthor ">Emiliano  Fabiani</span>, <span class="hlFld-ContribAuthor ">Giulia  Falconi</span>, <span class="hlFld-ContribAuthor ">Serena  Travaglini</span>, <span class="hlFld-ContribAuthor ">Tiziana  Ottone</span>, <span class="hlFld-ContribAuthor ">Antonio  Cristiano</span>, <span class="hlFld-ContribAuthor ">Maria Teresa  Voso</span>. </span><span class="cited-content_cbyCitation_article-title">From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression. </span><span class="cited-content_cbyCitation_journal-name">Biology</span><span> <strong>2021,</strong> <em>10 </em>
                                    (2)
                                     , 128. <a href="https://doi.org/10.3390/biology10020128" title="DOI URL">https://doi.org/10.3390/biology10020128</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biology10020128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiology10020128%26sid%3Dliteratum%253Aachs%26jtitle%3DBiology%26atitle%3DFrom%252BClonal%252BHematopoiesis%252Bto%252BTherapy-Related%252BMyeloid%252BNeoplasms%25253A%252BThe%252BSilent%252BWay%252Bof%252BCancer%252BProgression%26aulast%3DGurnari%26aufirst%3DCarmelo%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D2%26spage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anil K.  Singh</span>, <span class="hlFld-ContribAuthor ">Mahamudul  Haque</span>, <span class="hlFld-ContribAuthor ">Kayla  O’Sullivan</span>, <span class="hlFld-ContribAuthor ">Mukesh  Chourasia</span>, <span class="hlFld-ContribAuthor ">Madhu M.  Ouseph</span>, <span class="hlFld-ContribAuthor ">Salahuddin  Ahmed</span>. </span><span class="cited-content_cbyCitation_article-title">Suppression of monosodium urate crystal-induced inflammation by inhibiting TGF-β-activated kinase 1-dependent signaling: role of the ubiquitin proteasome system. </span><span class="cited-content_cbyCitation_journal-name">Cellular & Molecular Immunology</span><span> <strong>2021,</strong> <em>18 </em>
                                    (1)
                                     , 162-170. <a href="https://doi.org/10.1038/s41423-019-0284-3" title="DOI URL">https://doi.org/10.1038/s41423-019-0284-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41423-019-0284-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41423-019-0284-3%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520%2526%2520Molecular%2520Immunology%26atitle%3DSuppression%252Bof%252Bmonosodium%252Burate%252Bcrystal-induced%252Binflammation%252Bby%252Binhibiting%252BTGF-%2525CE%2525B2-activated%252Bkinase%252B1-dependent%252Bsignaling%25253A%252Brole%252Bof%252Bthe%252Bubiquitin%252Bproteasome%252Bsystem%26aulast%3DSingh%26aufirst%3DAnil%2BK.%26date%3D2021%26date%3D2019%26volume%3D18%26issue%3D1%26spage%3D162%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sohaib  Nizami</span>, <span class="hlFld-ContribAuthor ">Kanisa  Arunasalam</span>, <span class="hlFld-ContribAuthor ">Jack  Green</span>, <span class="hlFld-ContribAuthor ">James  Cook</span>, <span class="hlFld-ContribAuthor ">Catherine B.  Lawrence</span>, <span class="hlFld-ContribAuthor ">Tryfon  Zarganes‐Tzitzikas</span>, <span class="hlFld-ContribAuthor ">John B.  Davis</span>, <span class="hlFld-ContribAuthor ">Elena  Di Daniel</span>, <span class="hlFld-ContribAuthor ">David  Brough</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of the NLRP3 inflammasome by HSP90 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Immunology</span><span> <strong>2021,</strong> <em>162 </em>
                                    (1)
                                     , 84-91. <a href="https://doi.org/10.1111/imm.13267" title="DOI URL">https://doi.org/10.1111/imm.13267</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/imm.13267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fimm.13267%26sid%3Dliteratum%253Aachs%26jtitle%3DImmunology%26atitle%3DInhibition%252Bof%252Bthe%252BNLRP3%252Binflammasome%252Bby%252BHSP90%252Binhibitors%26aulast%3DNizami%26aufirst%3DSohaib%26date%3D2021%26date%3D2020%26volume%3D162%26issue%3D1%26spage%3D84%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalie  Arnold</span>, <span class="hlFld-ContribAuthor ">Katharina  Lechner</span>, <span class="hlFld-ContribAuthor ">Christoph  Waldeyer</span>, <span class="hlFld-ContribAuthor ">Michael D  Shapiro</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Koenig</span>. </span><span class="cited-content_cbyCitation_article-title">Inflammation and Cardiovascular Disease: The Future. </span><span class="cited-content_cbyCitation_journal-name">European Cardiology Review</span><span> <strong>2021,</strong> <em>16 </em><a href="https://doi.org/10.15420/ecr.2020.50" title="DOI URL">https://doi.org/10.15420/ecr.2020.50</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15420/ecr.2020.50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15420%2Fecr.2020.50%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Cardiology%2520Review%26atitle%3DInflammation%252Band%252BCardiovascular%252BDisease%25253A%252BThe%252BFuture%26aulast%3DArnold%26aufirst%3DNatalie%26date%3D2021%26date%3D2021%26volume%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anqi  Ye</span>, <span class="hlFld-ContribAuthor ">Wanting  Li</span>, <span class="hlFld-ContribAuthor ">Lin  Zhou</span>, <span class="hlFld-ContribAuthor ">Luyao  Ao</span>, <span class="hlFld-ContribAuthor ">Weirong  Fang</span>, <span class="hlFld-ContribAuthor ">Yunman  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting pyroptosis to regulate ischemic stroke injury: Molecular mechanisms and preclinical evidences. </span><span class="cited-content_cbyCitation_journal-name">Brain Research Bulletin</span><span> <strong>2020,</strong> <em>165 </em>, 146-160. <a href="https://doi.org/10.1016/j.brainresbull.2020.10.009" title="DOI URL">https://doi.org/10.1016/j.brainresbull.2020.10.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.brainresbull.2020.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.brainresbull.2020.10.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Research%2520Bulletin%26atitle%3DTargeting%252Bpyroptosis%252Bto%252Bregulate%252Bischemic%252Bstroke%252Binjury%25253A%252BMolecular%252Bmechanisms%252Band%252Bpreclinical%252Bevidences%26aulast%3DYe%26aufirst%3DAnqi%26date%3D2020%26volume%3D165%26spage%3D146%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lina Y.  El-Sharkawy</span>, <span class="hlFld-ContribAuthor ">David  Brough</span>, <span class="hlFld-ContribAuthor ">Sally  Freeman</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibiting the NLRP3 Inflammasome. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (23)
                                     , 5533. <a href="https://doi.org/10.3390/molecules25235533" title="DOI URL">https://doi.org/10.3390/molecules25235533</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25235533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25235533%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DInhibiting%252Bthe%252BNLRP3%252BInflammasome%26aulast%3DEl-Sharkawy%26aufirst%3DLina%2BY.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D23%26spage%3D5533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anca  Grivei</span>, <span class="hlFld-ContribAuthor ">Kurt T.K.  Giuliani</span>, <span class="hlFld-ContribAuthor ">Xiangju  Wang</span>, <span class="hlFld-ContribAuthor ">Jacobus  Ungerer</span>, <span class="hlFld-ContribAuthor ">Leo  Francis</span>, <span class="hlFld-ContribAuthor ">Kirsten  Hepburn</span>, <span class="hlFld-ContribAuthor ">George T.  John</span>, <span class="hlFld-ContribAuthor ">Pedro F.H.  Gois</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Kassianos</span>, <span class="hlFld-ContribAuthor ">Helen  Healy</span>. </span><span class="cited-content_cbyCitation_article-title">Oxidative stress and inflammasome activation in human rhabdomyolysis-induced acute kidney injury. </span><span class="cited-content_cbyCitation_journal-name">Free Radical Biology and Medicine</span><span> <strong>2020,</strong> <em>160 </em>, 690-695. <a href="https://doi.org/10.1016/j.freeradbiomed.2020.09.011" title="DOI URL">https://doi.org/10.1016/j.freeradbiomed.2020.09.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.freeradbiomed.2020.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.freeradbiomed.2020.09.011%26sid%3Dliteratum%253Aachs%26jtitle%3DFree%2520Radical%2520Biology%2520and%2520Medicine%26atitle%3DOxidative%252Bstress%252Band%252Binflammasome%252Bactivation%252Bin%252Bhuman%252Brhabdomyolysis-induced%252Bacute%252Bkidney%252Binjury%26aulast%3DGrivei%26aufirst%3DAnca%26date%3D2020%26volume%3D160%26spage%3D690%26epage%3D695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hery  Poerwosusanta</span>, <span class="hlFld-ContribAuthor ">Gunadi</span>, <span class="hlFld-ContribAuthor ">Ika Kustiyah  Oktaviyanti</span>, <span class="hlFld-ContribAuthor ">Nia  Kania</span>, <span class="hlFld-ContribAuthor ">Zairin  Noor</span>. </span><span class="cited-content_cbyCitation_article-title">Laparoscopic procedures impact on mast cell mediators, extracellular matrix and adhesion scoring system in rats. </span><span class="cited-content_cbyCitation_journal-name">Annals of Medicine and Surgery</span><span> <strong>2020,</strong> <em>58 </em>, 102-106. <a href="https://doi.org/10.1016/j.amsu.2020.08.043" title="DOI URL">https://doi.org/10.1016/j.amsu.2020.08.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.amsu.2020.08.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.amsu.2020.08.043%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520Medicine%2520and%2520Surgery%26atitle%3DLaparoscopic%252Bprocedures%252Bimpact%252Bon%252Bmast%252Bcell%252Bmediators%25252C%252Bextracellular%252Bmatrix%252Band%252Badhesion%252Bscoring%252Bsystem%252Bin%252Brats%26aulast%3DPoerwosusanta%26aufirst%3DHery%26date%3D2020%26volume%3D58%26spage%3D102%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Silva</span>, <span class="hlFld-ContribAuthor ">Marta  Pereira</span>, <span class="hlFld-ContribAuthor ">Mylène A.  Carrascal</span>, <span class="hlFld-ContribAuthor ">Gonçalo  Brites</span>, <span class="hlFld-ContribAuthor ">Bruno  Neves</span>, <span class="hlFld-ContribAuthor ">Patrícia  Moreira</span>, <span class="hlFld-ContribAuthor ">Rosa  Resende</span>, <span class="hlFld-ContribAuthor ">Maria Manuel  Silva</span>, <span class="hlFld-ContribAuthor ">Armanda E.  Santos</span>, <span class="hlFld-ContribAuthor ">Cláudia  Pereira</span>, <span class="hlFld-ContribAuthor ">Maria Teresa  Cruz</span>. </span><span class="cited-content_cbyCitation_article-title">Calcium Modulation, Anti-Oxidant and Anti-Inflammatory Effect of Skin Allergens Targeting the Nrf2 Signaling Pathway in Alzheimer’s Disease Cellular Models. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (20)
                                     , 7791. <a href="https://doi.org/10.3390/ijms21207791" title="DOI URL">https://doi.org/10.3390/ijms21207791</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21207791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21207791%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DCalcium%252BModulation%25252C%252BAnti-Oxidant%252Band%252BAnti-Inflammatory%252BEffect%252Bof%252BSkin%252BAllergens%252BTargeting%252Bthe%252BNrf2%252BSignaling%252BPathway%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BCellular%252BModels%26aulast%3DSilva%26aufirst%3DAna%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D20%26spage%3D7791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Piesche</span>, <span class="hlFld-ContribAuthor ">Jessica  Roos</span>, <span class="hlFld-ContribAuthor ">Benjamin  Kühn</span>, <span class="hlFld-ContribAuthor ">Jasmin  Fettel</span>, <span class="hlFld-ContribAuthor ">Nadine  Hellmuth</span>, <span class="hlFld-ContribAuthor ">Camilla  Brat</span>, <span class="hlFld-ContribAuthor ">Isabelle V.  Maucher</span>, <span class="hlFld-ContribAuthor ">Omar  Awad</span>, <span class="hlFld-ContribAuthor ">Carmela  Matrone</span>, <span class="hlFld-ContribAuthor ">Simon Gabriel  Comerma Steffensen</span>, <span class="hlFld-ContribAuthor ">Georg  Manolikakes</span>, <span class="hlFld-ContribAuthor ">Ulrike  Heinicke</span>, <span class="hlFld-ContribAuthor ">Kai D.  Zacharowski</span>, <span class="hlFld-ContribAuthor ">Dieter  Steinhilber</span>, <span class="hlFld-ContribAuthor ">Thorsten J.  Maier</span>. </span><span class="cited-content_cbyCitation_article-title">The Emerging Therapeutic Potential of Nitro Fatty Acids and Other Michael Acceptor-Containing Drugs for the Treatment of Inflammation and Cancer. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.01297" title="DOI URL">https://doi.org/10.3389/fphar.2020.01297</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.01297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.01297%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DThe%252BEmerging%252BTherapeutic%252BPotential%252Bof%252BNitro%252BFatty%252BAcids%252Band%252BOther%252BMichael%252BAcceptor-Containing%252BDrugs%252Bfor%252Bthe%252BTreatment%252Bof%252BInflammation%252Band%252BCancer%26aulast%3DPiesche%26aufirst%3DMatthias%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daan F.  van den Berg</span>, <span class="hlFld-ContribAuthor ">Anje A.  te Velde</span>. </span><span class="cited-content_cbyCitation_article-title">Severe COVID-19: NLRP3 Inflammasome Dysregulated. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fimmu.2020.01580" title="DOI URL">https://doi.org/10.3389/fimmu.2020.01580</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2020.01580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2020.01580%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DSevere%252BCOVID-19%25253A%252BNLRP3%252BInflammasome%252BDysregulated%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DDaan%2BF.%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patrick P.  Lowe</span>, <span class="hlFld-ContribAuthor ">Yeonhee  Cho</span>, <span class="hlFld-ContribAuthor ">David  Tornai</span>, <span class="hlFld-ContribAuthor ">Sahin  Coban</span>, <span class="hlFld-ContribAuthor ">Donna  Catalano</span>, <span class="hlFld-ContribAuthor ">Gyongyi  Szabo</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of the Inflammasome Signaling Cascade Reduces Alcohol Consumption in Female But Not Male Mice. </span><span class="cited-content_cbyCitation_journal-name">Alcoholism: Clinical and Experimental Research</span><span> <strong>2020,</strong> <em>44 </em>
                                    (2)
                                     , 567-578. <a href="https://doi.org/10.1111/acer.14272" title="DOI URL">https://doi.org/10.1111/acer.14272</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/acer.14272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Facer.14272%26sid%3Dliteratum%253Aachs%26jtitle%3DAlcoholism%253A%2520Clinical%2520and%2520Experimental%2520Research%26atitle%3DInhibition%252Bof%252Bthe%252BInflammasome%252BSignaling%252BCascade%252BReduces%252BAlcohol%252BConsumption%252Bin%252BFemale%252BBut%252BNot%252BMale%252BMice%26aulast%3DLowe%26aufirst%3DPatrick%2BP.%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D2%26spage%3D567%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohd  Abdullaha</span>, <span class="hlFld-ContribAuthor ">Mehboob  Ali</span>, <span class="hlFld-ContribAuthor ">Dilpreet  Kour</span>, <span class="hlFld-ContribAuthor ">Ajay  Kumar</span>, <span class="hlFld-ContribAuthor ">Sandip B.  Bharate</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of benzo[cd]indol-2-one and benzylidene-thiazolidine-2,4-dione as new classes of NLRP3 inflammasome inhibitors via ER-β structure based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>95 </em>, 103500. <a href="https://doi.org/10.1016/j.bioorg.2019.103500" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103500</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103500%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bbenzo%25255Bcd%25255Dindol-2-one%252Band%252Bbenzylidene-thiazolidine-2%25252C4-dione%252Bas%252Bnew%252Bclasses%252Bof%252BNLRP3%252Binflammasome%252Binhibitors%252Bvia%252BER-%2525CE%2525B2%252Bstructure%252Bbased%252Bvirtual%252Bscreening%26aulast%3DAbdullaha%26aufirst%3DMohd%26date%3D2020%26volume%3D95%26spage%3D103500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangna  Zhang</span>, <span class="hlFld-ContribAuthor ">Ana  Xu</span>, <span class="hlFld-ContribAuthor ">Jiahui  Lv</span>, <span class="hlFld-ContribAuthor ">Qiuqiong  Zhang</span>, <span class="hlFld-ContribAuthor ">Yingying  Ran</span>, <span class="hlFld-ContribAuthor ">Chao  Wei</span>, <span class="hlFld-ContribAuthor ">Jingde  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111822. <a href="https://doi.org/10.1016/j.ejmech.2019.111822" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111822</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111822%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Bsmall%252Bmolecule%252Binhibitors%252Btargeting%252BNLRP3%252Binflammasome%252Bpathway%252Bfor%252Binflammatory%252Bdiseases%26aulast%3DZhang%26aufirst%3DXiangna%26date%3D2020%26volume%3D185%26spage%3D111822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yunyuan  Huang</span>, <span class="hlFld-ContribAuthor ">Lin  Wei</span>, <span class="hlFld-ContribAuthor ">Xinya  Han</span>, <span class="hlFld-ContribAuthor ">Haifeng  Chen</span>, <span class="hlFld-ContribAuthor ">Yanliang  Ren</span>, <span class="hlFld-ContribAuthor ">Yanhong  Xu</span>, <span class="hlFld-ContribAuthor ">Rongrong  Song</span>, <span class="hlFld-ContribAuthor ">Li  Rao</span>, <span class="hlFld-ContribAuthor ">Chen  Su</span>, <span class="hlFld-ContribAuthor ">Chao  Peng</span>, <span class="hlFld-ContribAuthor ">Lingling  Feng</span>, <span class="hlFld-ContribAuthor ">Jian  Wan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel allosteric site and covalent inhibitors of FBPase with potent hypoglycemic effects. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>184 </em>, 111749. <a href="https://doi.org/10.1016/j.ejmech.2019.111749" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111749</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111749%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Ballosteric%252Bsite%252Band%252Bcovalent%252Binhibitors%252Bof%252BFBPase%252Bwith%252Bpotent%252Bhypoglycemic%252Beffects%26aulast%3DHuang%26aufirst%3DYunyuan%26date%3D2019%26volume%3D184%26spage%3D111749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ram  Kuwar</span>, <span class="hlFld-ContribAuthor ">Andrew  Rolfe</span>, <span class="hlFld-ContribAuthor ">Long  Di</span>, <span class="hlFld-ContribAuthor ">Hongyu  Xu</span>, <span class="hlFld-ContribAuthor ">Liu  He</span>, <span class="hlFld-ContribAuthor ">Yuqi  Jiang</span>, <span class="hlFld-ContribAuthor ">Shijun  Zhang</span>, <span class="hlFld-ContribAuthor ">Dong  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroinflammation</span><span> <strong>2019,</strong> <em>16 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12974-019-1471-y" title="DOI URL">https://doi.org/10.1186/s12974-019-1471-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12974-019-1471-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12974-019-1471-y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroinflammation%26atitle%3DA%252Bnovel%252Bsmall%252Bmolecular%252BNLRP3%252Binflammasome%252Binhibitor%252Balleviates%252Bneuroinflammatory%252Bresponse%252Bfollowing%252Btraumatic%252Bbrain%252Binjury%26aulast%3DKuwar%26aufirst%3DRam%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pu  Hong</span>, <span class="hlFld-ContribAuthor ">Ruo-Nan  Gu</span>, <span class="hlFld-ContribAuthor ">Feng-Xian  Li</span>, <span class="hlFld-ContribAuthor ">Xiao-Xing  Xiong</span>, <span class="hlFld-ContribAuthor ">Wen-Bin  Liang</span>, <span class="hlFld-ContribAuthor ">Zhi-Jian  You</span>, <span class="hlFld-ContribAuthor ">Hong-Fei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroinflammation</span><span> <strong>2019,</strong> <em>16 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12974-019-1498-0" title="DOI URL">https://doi.org/10.1186/s12974-019-1498-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12974-019-1498-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12974-019-1498-0%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroinflammation%26atitle%3DNLRP3%252Binflammasome%252Bas%252Ba%252Bpotential%252Btreatment%252Bin%252Bischemic%252Bstroke%252Bconcomitant%252Bwith%252Bdiabetes%26aulast%3DHong%26aufirst%3DPu%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carlo  Marchetti</span>. </span><span class="cited-content_cbyCitation_article-title">The NLRP3 Inflammasome as a Pharmacological Target. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cardiovascular Pharmacology</span><span> <strong>2019,</strong> <em>74 </em>
                                    (4)
                                     , 285-296. <a href="https://doi.org/10.1097/FJC.0000000000000718" title="DOI URL">https://doi.org/10.1097/FJC.0000000000000718</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/FJC.0000000000000718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FFJC.0000000000000718%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cardiovascular%2520Pharmacology%26atitle%3DThe%252BNLRP3%252BInflammasome%252Bas%252Ba%252BPharmacological%252BTarget%26aulast%3DMarchetti%26aufirst%3DCarlo%26date%3D2019%26volume%3D74%26issue%3D4%26spage%3D285%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Sun</span>, <span class="hlFld-ContribAuthor ">Lumei  Chi</span>, <span class="hlFld-ContribAuthor ">Zhidong  He</span>, <span class="hlFld-ContribAuthor ">Yu  Gao</span>, <span class="hlFld-ContribAuthor ">Yufei  Gao</span>, <span class="hlFld-ContribAuthor ">Yujing  Huang</span>, <span class="hlFld-ContribAuthor ">Guangxian  Nan</span>. </span><span class="cited-content_cbyCitation_article-title">NLRP3 inflammasome contributes to neurovascular unit damage in stroke. </span><span class="cited-content_cbyCitation_journal-name">Journal of Drug Targeting</span><span> <strong>2019,</strong> <em>27 </em>
                                    (8)
                                     , 866-875. <a href="https://doi.org/10.1080/1061186X.2018.1564925" title="DOI URL">https://doi.org/10.1080/1061186X.2018.1564925</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1061186X.2018.1564925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1061186X.2018.1564925%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Drug%2520Targeting%26atitle%3DNLRP3%252Binflammasome%252Bcontributes%252Bto%252Bneurovascular%252Bunit%252Bdamage%252Bin%252Bstroke%26aulast%3DSun%26aufirst%3DJing%26date%3D2019%26date%3D2019%26volume%3D27%26issue%3D8%26spage%3D866%26epage%3D875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Man  Wang</span>, <span class="hlFld-ContribAuthor ">Shuai  Jiang</span>, <span class="hlFld-ContribAuthor ">Yinfeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Peifeng  Li</span>, <span class="hlFld-ContribAuthor ">Kun  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">The Multifaceted Roles of Pyroptotic Cell Death Pathways in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (9)
                                     , 1313. <a href="https://doi.org/10.3390/cancers11091313" title="DOI URL">https://doi.org/10.3390/cancers11091313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11091313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11091313%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BMultifaceted%252BRoles%252Bof%252BPyroptotic%252BCell%252BDeath%252BPathways%252Bin%252BCancer%26aulast%3DWang%26aufirst%3DMan%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D9%26spage%3D1313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chaelin  Lee</span>, <span class="hlFld-ContribAuthor ">Hien Thi Thu  Do</span>, <span class="hlFld-ContribAuthor ">Junhyeok  Her</span>, <span class="hlFld-ContribAuthor ">Yeonjae  Kim</span>, <span class="hlFld-ContribAuthor ">Dongkyu  Seo</span>, <span class="hlFld-ContribAuthor ">Inmoo  Rhee</span>. </span><span class="cited-content_cbyCitation_article-title">Inflammasome as a promising therapeutic target for cancer. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2019,</strong> <em>231 </em>, 116593. <a href="https://doi.org/10.1016/j.lfs.2019.116593" title="DOI URL">https://doi.org/10.1016/j.lfs.2019.116593</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2019.116593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2019.116593%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DInflammasome%252Bas%252Ba%252Bpromising%252Btherapeutic%252Btarget%252Bfor%252Bcancer%26aulast%3DLee%26aufirst%3DChaelin%26date%3D2019%26volume%3D231%26spage%3D116593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Massimo  Bertinaria</span>, <span class="hlFld-ContribAuthor ">Simone  Gastaldi</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Marini</span>, <span class="hlFld-ContribAuthor ">Marta  Giorgis</span>. </span><span class="cited-content_cbyCitation_article-title">Development of covalent NLRP3 inflammasome inhibitors: Chemistry and biological activity. </span><span class="cited-content_cbyCitation_journal-name">Archives of Biochemistry and Biophysics</span><span> <strong>2019,</strong> <em>670 </em>, 116-139. <a href="https://doi.org/10.1016/j.abb.2018.11.013" title="DOI URL">https://doi.org/10.1016/j.abb.2018.11.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.abb.2018.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.abb.2018.11.013%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Biochemistry%2520and%2520Biophysics%26atitle%3DDevelopment%252Bof%252Bcovalent%252BNLRP3%252Binflammasome%252Binhibitors%25253A%252BChemistry%252Band%252Bbiological%252Bactivity%26aulast%3DBertinaria%26aufirst%3DMassimo%26date%3D2019%26volume%3D670%26spage%3D116%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Jin</span>, <span class="hlFld-ContribAuthor ">Jian  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Insights Into the NLRP3 Inflammasome in Atherosclerosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Heart Association</span><span> <strong>2019,</strong> <em>8 </em>
                                    (12)
                                     <a href="https://doi.org/10.1161/JAHA.119.012219" title="DOI URL">https://doi.org/10.1161/JAHA.119.012219</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1161/JAHA.119.012219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1161%2FJAHA.119.012219%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Heart%2520Association%26atitle%3DNovel%252BInsights%252BInto%252Bthe%252BNLRP3%252BInflammasome%252Bin%252BAtherosclerosis%26aulast%3DJin%26aufirst%3DYing%26date%3D2019%26volume%3D8%26issue%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sofie  Voet</span>, <span class="hlFld-ContribAuthor ">Sahana  Srinivasan</span>, <span class="hlFld-ContribAuthor ">Mohamed  Lamkanfi</span>, <span class="hlFld-ContribAuthor ">Geert  Loo</span>. </span><span class="cited-content_cbyCitation_article-title">Inflammasomes in neuroinflammatory and neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">EMBO Molecular Medicine</span><span> <strong>2019,</strong> <em>11 </em>
                                    (6)
                                     <a href="https://doi.org/10.15252/emmm.201810248" title="DOI URL">https://doi.org/10.15252/emmm.201810248</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15252/emmm.201810248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15252%2Femmm.201810248%26sid%3Dliteratum%253Aachs%26jtitle%3DEMBO%2520Molecular%2520Medicine%26atitle%3DInflammasomes%252Bin%252Bneuroinflammatory%252Band%252Bneurodegenerative%252Bdiseases%26aulast%3DVoet%26aufirst%3DSofie%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paolo  Ruggeri</span>, <span class="hlFld-ContribAuthor ">Gaetano  Caramori</span>. </span><span class="cited-content_cbyCitation_article-title">Functional Role of Inflammasome Activation in a Subset of Obese Nonsmoking Patients with Severe Asthma. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Respiratory and Critical Care Medicine</span><span> <strong>2019,</strong> <em>199 </em>
                                    (9)
                                     , 1045-1047. <a href="https://doi.org/10.1164/rccm.201903-0667ED" title="DOI URL">https://doi.org/10.1164/rccm.201903-0667ED</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1164/rccm.201903-0667ED&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1164%2Frccm.201903-0667ED%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Respiratory%2520and%2520Critical%2520Care%2520Medicine%26atitle%3DFunctional%252BRole%252Bof%252BInflammasome%252BActivation%252Bin%252Ba%252BSubset%252Bof%252BObese%252BNonsmoking%252BPatients%252Bwith%252BSevere%252BAsthma%26aulast%3DRuggeri%26aufirst%3DPaolo%26date%3D2019%26volume%3D199%26issue%3D9%26spage%3D1045%26epage%3D1047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dejia  Kong</span>, <span class="hlFld-ContribAuthor ">Ping  Fu</span>, <span class="hlFld-ContribAuthor ">Qin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xian  Ma</span>, <span class="hlFld-ContribAuthor ">Ping  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Protective effects of Asiatic acid against pelvic inflammatory disease in rats. </span><span class="cited-content_cbyCitation_journal-name">Experimental and Therapeutic Medicine</span><span> <strong>2019,</strong> <em> </em><a href="https://doi.org/10.3892/etm.2019.7498" title="DOI URL">https://doi.org/10.3892/etm.2019.7498</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/etm.2019.7498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fetm.2019.7498%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520and%2520Therapeutic%2520Medicine%26atitle%3DProtective%252Beffects%252Bof%252BAsiatic%252Bacid%252Bagainst%252Bpelvic%252Binflammatory%252Bdisease%252Bin%252Brats%26aulast%3DKong%26aufirst%3DDejia%26date%3D2019%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taylena Maria  Teófilo</span>, <span class="hlFld-ContribAuthor ">Glória Pinto  Duarte</span>, <span class="hlFld-ContribAuthor ">Rosivaldo Santos  Borges</span>, <span class="hlFld-ContribAuthor ">Armênio Aguiar  Santos</span>, <span class="hlFld-ContribAuthor ">Pedro Jorge Caldas  Magalhães</span>, <span class="hlFld-ContribAuthor ">Saad  Lahlou</span>. </span><span class="cited-content_cbyCitation_article-title">Stimulation of pulmonary vagal C-fibers by trans-4-methyl-β-nitrostyrene induces bradycardiac and depressor reflex in rats: Role of vanilloid TRPV1 receptors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2019,</strong> <em>849 </em>, 154-159. <a href="https://doi.org/10.1016/j.ejphar.2019.01.063" title="DOI URL">https://doi.org/10.1016/j.ejphar.2019.01.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2019.01.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2019.01.063%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DStimulation%252Bof%252Bpulmonary%252Bvagal%252BC-fibers%252Bby%252Btrans-4-methyl-%2525CE%2525B2-nitrostyrene%252Binduces%252Bbradycardiac%252Band%252Bdepressor%252Breflex%252Bin%252Brats%25253A%252BRole%252Bof%252Bvanilloid%252BTRPV1%252Breceptors%26aulast%3DTe%25C3%25B3filo%26aufirst%3DTaylena%2BMaria%26date%3D2019%26volume%3D849%26spage%3D154%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rebecca  Ward</span>, <span class="hlFld-ContribAuthor ">Weiguo  Li</span>, <span class="hlFld-ContribAuthor ">Yasir  Abdul</span>, <span class="hlFld-ContribAuthor ">LaDonya  Jackson</span>, <span class="hlFld-ContribAuthor ">Guangkuo  Dong</span>, <span class="hlFld-ContribAuthor ">Sarah  Jamil</span>, <span class="hlFld-ContribAuthor ">Jessica  Filosa</span>, <span class="hlFld-ContribAuthor ">Susan C.  Fagan</span>, <span class="hlFld-ContribAuthor ">Adviye  Ergul</span>. </span><span class="cited-content_cbyCitation_article-title">NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2019,</strong> <em>142 </em>, 237-250. <a href="https://doi.org/10.1016/j.phrs.2019.01.035" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.01.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.01.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.01.035%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DNLRP3%252Binflammasome%252Binhibition%252Bwith%252BMCC950%252Bimproves%252Bdiabetes-mediated%252Bcognitive%252Bimpairment%252Band%252Bvasoneuronal%252Bremodeling%252Bafter%252Bischemia%26aulast%3DWard%26aufirst%3DRebecca%26date%3D2019%26volume%3D142%26spage%3D237%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajendra  Karki</span>, <span class="hlFld-ContribAuthor ">Thirumala-Devi  Kanneganti</span>. </span><span class="cited-content_cbyCitation_article-title">Diverging inflammasome signals in tumorigenesis and potential targeting. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Cancer</span><span> <strong>2019,</strong> <em>19 </em>
                                    (4)
                                     , 197-214. <a href="https://doi.org/10.1038/s41568-019-0123-y" title="DOI URL">https://doi.org/10.1038/s41568-019-0123-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41568-019-0123-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41568-019-0123-y%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Cancer%26atitle%3DDiverging%252Binflammasome%252Bsignals%252Bin%252Btumorigenesis%252Band%252Bpotential%252Btargeting%26aulast%3DKarki%26aufirst%3DRajendra%26date%3D2019%26date%3D2019%26volume%3D19%26issue%3D4%26spage%3D197%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kurt T. K.  Giuliani</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Kassianos</span>, <span class="hlFld-ContribAuthor ">Helen  Healy</span>, <span class="hlFld-ContribAuthor ">Pedro H. F.  Gois</span>. </span><span class="cited-content_cbyCitation_article-title">Pigment Nephropathy: Novel Insights into Inflammasome-Mediated Pathogenesis. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (8)
                                     , 1997. <a href="https://doi.org/10.3390/ijms20081997" title="DOI URL">https://doi.org/10.3390/ijms20081997</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20081997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20081997%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DPigment%252BNephropathy%25253A%252BNovel%252BInsights%252Binto%252BInflammasome-Mediated%252BPathogenesis%26aulast%3DGiuliani%26aufirst%3DKurt%2BT.%2BK.%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D8%26spage%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernando  Lopez-Caamal</span>, <span class="hlFld-ContribAuthor ">Heinrich J.  Huber</span>. </span><span class="cited-content_cbyCitation_article-title">Stable IL-1-Activation in an Inflammasome Signalling Model Depends on Positive and Negative Feedbacks and Tight Regulation of Protein Production. </span><span class="cited-content_cbyCitation_journal-name">IEEE/ACM Transactions on Computational Biology and Bioinformatics</span><span> <strong>2019,</strong> <em>16 </em>
                                    (2)
                                     , 627-637. <a href="https://doi.org/10.1109/TCBB.2018.2794971" title="DOI URL">https://doi.org/10.1109/TCBB.2018.2794971</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1109/TCBB.2018.2794971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1109%2FTCBB.2018.2794971%26sid%3Dliteratum%253Aachs%26jtitle%3DIEEE%252FACM%2520Transactions%2520on%2520Computational%2520Biology%2520and%2520Bioinformatics%26atitle%3DStable%252BIL-1-Activation%252Bin%252Ban%252BInflammasome%252BSignalling%252BModel%252BDepends%252Bon%252BPositive%252Band%252BNegative%252BFeedbacks%252Band%252BTight%252BRegulation%252Bof%252BProtein%252BProduction%26aulast%3DLopez-Caamal%26aufirst%3DFernando%26date%3D2019%26volume%3D16%26issue%3D2%26spage%3D627%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena  Redondo-Castro</span>, <span class="hlFld-ContribAuthor ">Dorte  Faust</span>, <span class="hlFld-ContribAuthor ">Simon  Fox</span>, <span class="hlFld-ContribAuthor ">Alex G.  Baldwin</span>, <span class="hlFld-ContribAuthor ">Simon  Osborne</span>, <span class="hlFld-ContribAuthor ">Michael J.  Haley</span>, <span class="hlFld-ContribAuthor ">Eric  Karran</span>, <span class="hlFld-ContribAuthor ">Hugh  Nuthall</span>, <span class="hlFld-ContribAuthor ">Peter J.  Atkinson</span>, <span class="hlFld-ContribAuthor ">Lee A.  Dawson</span>, <span class="hlFld-ContribAuthor ">Carol  Routledge</span>, <span class="hlFld-ContribAuthor ">Stuart M.  Allan</span>, <span class="hlFld-ContribAuthor ">Sally  Freeman</span>, <span class="hlFld-ContribAuthor ">Janet  Brownlees</span>, <span class="hlFld-ContribAuthor ">David  Brough</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a characterised tool kit for the interrogation of NLRP3 inflammasome-dependent responses. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-24029-3" title="DOI URL">https://doi.org/10.1038/s41598-018-24029-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-24029-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-24029-3%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDevelopment%252Bof%252Ba%252Bcharacterised%252Btool%252Bkit%252Bfor%252Bthe%252Binterrogation%252Bof%252BNLRP3%252Binflammasome-dependent%252Bresponses%26aulast%3DRedondo-Castro%26aufirst%3DElena%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tessa  Swanton</span>, <span class="hlFld-ContribAuthor ">James  Cook</span>, <span class="hlFld-ContribAuthor ">James A.  Beswick</span>, <span class="hlFld-ContribAuthor ">Sally  Freeman</span>, <span class="hlFld-ContribAuthor ">Catherine B.  Lawrence</span>, <span class="hlFld-ContribAuthor ">David  Brough</span>. </span><span class="cited-content_cbyCitation_article-title">Is Targeting the Inflammasome a Way Forward for Neuroscience Drug Discovery?. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2018,</strong> <em>23 </em>
                                    (10)
                                     , 991-1017. <a href="https://doi.org/10.1177/2472555218786210" title="DOI URL">https://doi.org/10.1177/2472555218786210</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2472555218786210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2472555218786210%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DIs%252BTargeting%252Bthe%252BInflammasome%252Ba%252BWay%252BForward%252Bfor%252BNeuroscience%252BDrug%252BDiscovery%25253F%26aulast%3DSwanton%26aufirst%3DTessa%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D10%26spage%3D991%26epage%3D1017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taiki  Miyazawa</span>, <span class="hlFld-ContribAuthor ">Kiyotaka  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Sharon H.  Kim</span>, <span class="hlFld-ContribAuthor ">Michael J.  Thomas</span>, <span class="hlFld-ContribAuthor ">Ligi  Paul</span>, <span class="hlFld-ContribAuthor ">Jean-Marc  Zingg</span>, <span class="hlFld-ContribAuthor ">Gregory G.  Dolnikowski</span>, <span class="hlFld-ContribAuthor ">Susan B.  Roberts</span>, <span class="hlFld-ContribAuthor ">Fumiko  Kimura</span>, <span class="hlFld-ContribAuthor ">Teruo  Miyazawa</span>, <span class="hlFld-ContribAuthor ">Angelo  Azzi</span>, <span class="hlFld-ContribAuthor ">Mohsen  Meydani</span>. </span><span class="cited-content_cbyCitation_article-title">Curcumin and piperine supplementation of obese mice under caloric restriction modulates body fat and interleukin-1β. </span><span class="cited-content_cbyCitation_journal-name">Nutrition & Metabolism</span><span> <strong>2018,</strong> <em>15 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12986-018-0250-6" title="DOI URL">https://doi.org/10.1186/s12986-018-0250-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12986-018-0250-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12986-018-0250-6%26sid%3Dliteratum%253Aachs%26jtitle%3DNutrition%2520%2526%2520Metabolism%26atitle%3DCurcumin%252Band%252Bpiperine%252Bsupplementation%252Bof%252Bobese%252Bmice%252Bunder%252Bcaloric%252Brestriction%252Bmodulates%252Bbody%252Bfat%252Band%252Binterleukin-1%2525CE%2525B2%26aulast%3DMiyazawa%26aufirst%3DTaiki%26date%3D2018%26date%3D2018%26volume%3D15%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Su-Chen  Ho</span>, <span class="hlFld-ContribAuthor ">Yi-Huang  Chang</span>, <span class="hlFld-ContribAuthor ">Ku-Shang  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Moieties Required for Cinnamaldehyde-Related Compounds to Inhibit Canonical IL-1β Secretion. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (12)
                                     , 3241. <a href="https://doi.org/10.3390/molecules23123241" title="DOI URL">https://doi.org/10.3390/molecules23123241</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23123241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23123241%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStructural%252BMoieties%252BRequired%252Bfor%252BCinnamaldehyde-Related%252BCompounds%252Bto%252BInhibit%252BCanonical%252BIL-1%2525CE%2525B2%252BSecretion%26aulast%3DHo%26aufirst%3DSu-Chen%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D12%26spage%3D3241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francis J.  Herman</span>, <span class="hlFld-ContribAuthor ">Giulio Maria  Pasinetti</span>. </span><span class="cited-content_cbyCitation_article-title">Principles of inflammasome priming and inhibition: Implications for psychiatric disorders. </span><span class="cited-content_cbyCitation_journal-name">Brain, Behavior, and Immunity</span><span> <strong>2018,</strong> <em>73 </em>, 66-84. <a href="https://doi.org/10.1016/j.bbi.2018.06.010" title="DOI URL">https://doi.org/10.1016/j.bbi.2018.06.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbi.2018.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbi.2018.06.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%252C%2520Behavior%252C%2520and%2520Immunity%26atitle%3DPrinciples%252Bof%252Binflammasome%252Bpriming%252Band%252Binhibition%25253A%252BImplications%252Bfor%252Bpsychiatric%252Bdisorders%26aulast%3DHerman%26aufirst%3DFrancis%2BJ.%26date%3D2018%26volume%3D73%26spage%3D66%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susana  Rovira-Llopis</span>, <span class="hlFld-ContribAuthor ">Nadezda  Apostolova</span>, <span class="hlFld-ContribAuthor ">Celia  Bañuls</span>, <span class="hlFld-ContribAuthor ">Jordi  Muntané</span>, <span class="hlFld-ContribAuthor ">Milagros  Rocha</span>, <span class="hlFld-ContribAuthor ">Victor M.  Victor</span>. </span><span class="cited-content_cbyCitation_article-title">Mitochondria, the NLRP3 Inflammasome, and Sirtuins in Type 2 Diabetes: New Therapeutic TargetsReviewing Editors:
              Markus Bachschmid, Dylan Burger, Vittorio Calabrese, Amadou Camara, Lukas Kubala, Giuseppe Poli, and Chandan K. Sen. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants & Redox Signaling</span><span> <strong>2018,</strong> <em>29 </em>
                                    (8)
                                     , 749-791. <a href="https://doi.org/10.1089/ars.2017.7313" title="DOI URL">https://doi.org/10.1089/ars.2017.7313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/ars.2017.7313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fars.2017.7313%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%2520%2526%2520Redox%2520Signaling%26atitle%3DMitochondria%25252C%252Bthe%252BNLRP3%252BInflammasome%25252C%252Band%252BSirtuins%252Bin%252BType%252B2%252BDiabetes%25253A%252BNew%252BTherapeutic%252BTargetsReviewing%252BEditors%25253A%252BMarkus%252BBachschmid%25252C%252BDylan%252BBurger%25252C%252BVittorio%252BCalabrese%25252C%252BAmadou%252BCamara%25252C%252BLukas%252BKubala%25252C%252BGiuseppe%252BPoli%25252C%252Band%252BChandan%252BK.%252BSen%26aulast%3DRovira-Llopis%26aufirst%3DSusana%26date%3D2018%26volume%3D29%26issue%3D8%26spage%3D749%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David P.  Steensma</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical Implications of Clonal Hematopoiesis. </span><span class="cited-content_cbyCitation_journal-name">Mayo Clinic Proceedings</span><span> <strong>2018,</strong> <em>93 </em>
                                    (8)
                                     , 1122-1130. <a href="https://doi.org/10.1016/j.mayocp.2018.04.002" title="DOI URL">https://doi.org/10.1016/j.mayocp.2018.04.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mayocp.2018.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mayocp.2018.04.002%26sid%3Dliteratum%253Aachs%26jtitle%3DMayo%2520Clinic%2520Proceedings%26atitle%3DClinical%252BImplications%252Bof%252BClonal%252BHematopoiesis%26aulast%3DSteensma%26aufirst%3DDavid%2BP.%26date%3D2018%26volume%3D93%26issue%3D8%26spage%3D1122%26epage%3D1130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew S. J.  Mangan</span>, <span class="hlFld-ContribAuthor ">Edward J.  Olhava</span>, <span class="hlFld-ContribAuthor ">William R.  Roush</span>, <span class="hlFld-ContribAuthor ">H. Martin  Seidel</span>, <span class="hlFld-ContribAuthor ">Gary D.  Glick</span>, <span class="hlFld-ContribAuthor ">Eicke  Latz</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the NLRP3 inflammasome in inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2018,</strong> <em>17 </em>
                                    (8)
                                     , 588-606. <a href="https://doi.org/10.1038/nrd.2018.97" title="DOI URL">https://doi.org/10.1038/nrd.2018.97</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd.2018.97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd.2018.97%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DTargeting%252Bthe%252BNLRP3%252Binflammasome%252Bin%252Binflammatory%252Bdiseases%26aulast%3DMangan%26aufirst%3DMatthew%2BS.%2BJ.%26date%3D2018%26date%3D2018%26volume%3D17%26issue%3D8%26spage%3D588%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kohtaro  Goto</span>, <span class="hlFld-ContribAuthor ">Hiroko  Ideo</span>, <span class="hlFld-ContribAuthor ">Akiko  Tsuchida</span>, <span class="hlFld-ContribAuthor ">Yuriko  Hirose</span>, <span class="hlFld-ContribAuthor ">Ikuro  Maruyama</span>, <span class="hlFld-ContribAuthor ">Satoshi  Noma</span>, <span class="hlFld-ContribAuthor ">Takashi  Shirai</span>, <span class="hlFld-ContribAuthor ">Junko  Amano</span>, <span class="hlFld-ContribAuthor ">Mamoru  Mizuno</span>, <span class="hlFld-ContribAuthor ">Akio  Matsuda</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 1,5-Anhydro- d -fructose derivatives and evaluation of their inflammasome inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (13)
                                     , 3763-3772. <a href="https://doi.org/10.1016/j.bmc.2017.11.041" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.11.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.11.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.11.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252B1%25252C5-Anhydro-%252Bd%252B-fructose%252Bderivatives%252Band%252Bevaluation%252Bof%252Btheir%252Binflammasome%252Binhibitors%26aulast%3DGoto%26aufirst%3DKohtaro%26date%3D2018%26volume%3D26%26issue%3D13%26spage%3D3763%26epage%3D3772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alena  Grebe</span>, <span class="hlFld-ContribAuthor ">Florian  Hoss</span>, <span class="hlFld-ContribAuthor ">Eicke  Latz</span>. </span><span class="cited-content_cbyCitation_article-title">NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis. </span><span class="cited-content_cbyCitation_journal-name">Circulation Research</span><span> <strong>2018,</strong> <em>122 </em>
                                    (12)
                                     , 1722-1740. <a href="https://doi.org/10.1161/CIRCRESAHA.118.311362" title="DOI URL">https://doi.org/10.1161/CIRCRESAHA.118.311362</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1161/CIRCRESAHA.118.311362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1161%2FCIRCRESAHA.118.311362%26sid%3Dliteratum%253Aachs%26jtitle%3DCirculation%2520Research%26atitle%3DNLRP3%252BInflammasome%252Band%252Bthe%252BIL-1%252BPathway%252Bin%252BAtherosclerosis%26aulast%3DGrebe%26aufirst%3DAlena%26date%3D2018%26volume%3D122%26issue%3D12%26spage%3D1722%26epage%3D1740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alaa  Alhazmi</span>. </span><span class="cited-content_cbyCitation_article-title">NOD-like receptor(s) and host immune responses with Pseudomonas aeruginosa infection. </span><span class="cited-content_cbyCitation_journal-name">Inflammation Research</span><span> <strong>2018,</strong> <em>67 </em>
                                    (6)
                                     , 479-493. <a href="https://doi.org/10.1007/s00011-018-1132-0" title="DOI URL">https://doi.org/10.1007/s00011-018-1132-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00011-018-1132-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00011-018-1132-0%26sid%3Dliteratum%253Aachs%26jtitle%3DInflammation%2520Research%26atitle%3DNOD-like%252Breceptor%252528s%252529%252Band%252Bhost%252Bimmune%252Bresponses%252Bwith%252BPseudomonas%252Baeruginosa%252Binfection%26aulast%3DAlhazmi%26aufirst%3DAlaa%26date%3D2018%26date%3D2018%26volume%3D67%26issue%3D6%26spage%3D479%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristen  Davies</span>, <span class="hlFld-ContribAuthor ">Marwan A S  Bukhari</span>. </span><span class="cited-content_cbyCitation_article-title">Recent pharmacological advances in the management of gout. </span><span class="cited-content_cbyCitation_journal-name">Rheumatology</span><span> <strong>2018,</strong> <em>57 </em>
                                    (6)
                                     , 951-958. <a href="https://doi.org/10.1093/rheumatology/kex343" title="DOI URL">https://doi.org/10.1093/rheumatology/kex343</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/rheumatology/kex343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Frheumatology%2Fkex343%26sid%3Dliteratum%253Aachs%26jtitle%3DRheumatology%26atitle%3DRecent%252Bpharmacological%252Badvances%252Bin%252Bthe%252Bmanagement%252Bof%252Bgout%26aulast%3DDavies%26aufirst%3DKristen%26date%3D2018%26date%3D2017%26volume%3D57%26issue%3D6%26spage%3D951%26epage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cira  Dansokho</span>, <span class="hlFld-ContribAuthor ">Michael Thomas  Heneka</span>. </span><span class="cited-content_cbyCitation_article-title">Neuroinflammatory responses in Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neural Transmission</span><span> <strong>2018,</strong> <em>125 </em>
                                    (5)
                                     , 771-779. <a href="https://doi.org/10.1007/s00702-017-1831-7" title="DOI URL">https://doi.org/10.1007/s00702-017-1831-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00702-017-1831-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00702-017-1831-7%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neural%2520Transmission%26atitle%3DNeuroinflammatory%252Bresponses%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DDansokho%26aufirst%3DCira%26date%3D2018%26date%3D2017%26volume%3D125%26issue%3D5%26spage%3D771%26epage%3D779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alex G.  Baldwin</span>, <span class="hlFld-ContribAuthor ">Victor S.  Tapia</span>, <span class="hlFld-ContribAuthor ">Tessa  Swanton</span>, <span class="hlFld-ContribAuthor ">Claire S.  White</span>, <span class="hlFld-ContribAuthor ">James A.  Beswick</span>, <span class="hlFld-ContribAuthor ">David  Brough</span>, <span class="hlFld-ContribAuthor ">Sally  Freeman</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Evaluation of Oxazaborine Inhibitors of the NLRP3 Inflammasome. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (4)
                                     , 312-320. <a href="https://doi.org/10.1002/cmdc.201700731" title="DOI URL">https://doi.org/10.1002/cmdc.201700731</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700731%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BEvaluation%252Bof%252BOxazaborine%252BInhibitors%252Bof%252Bthe%252BNLRP3%252BInflammasome%26aulast%3DBaldwin%26aufirst%3DAlex%2BG.%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D4%26spage%3D312%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carlo  Marchetti</span>, <span class="hlFld-ContribAuthor ">Benjamin  Swartzwelter</span>, <span class="hlFld-ContribAuthor ">Fabia  Gamboni</span>, <span class="hlFld-ContribAuthor ">Charles P.  Neff</span>, <span class="hlFld-ContribAuthor ">Katrin  Richter</span>, <span class="hlFld-ContribAuthor ">Tania  Azam</span>, <span class="hlFld-ContribAuthor ">Sonia  Carta</span>, <span class="hlFld-ContribAuthor ">Isak  Tengesdal</span>, <span class="hlFld-ContribAuthor ">Travis  Nemkov</span>, <span class="hlFld-ContribAuthor ">Angelo  D’Alessandro</span>, <span class="hlFld-ContribAuthor ">Curtis  Henry</span>, <span class="hlFld-ContribAuthor ">Gerald S.  Jones</span>, <span class="hlFld-ContribAuthor ">Scott A.  Goodrich</span>, <span class="hlFld-ContribAuthor ">Joseph P.  St. Laurent</span>, <span class="hlFld-ContribAuthor ">Terry M.  Jones</span>, <span class="hlFld-ContribAuthor ">Curtis L.  Scribner</span>, <span class="hlFld-ContribAuthor ">Robert B.  Barrow</span>, <span class="hlFld-ContribAuthor ">Roy D.  Altman</span>, <span class="hlFld-ContribAuthor ">Damaris B.  Skouras</span>, <span class="hlFld-ContribAuthor ">Marco  Gattorno</span>, <span class="hlFld-ContribAuthor ">Veronika  Grau</span>, <span class="hlFld-ContribAuthor ">Sabina  Janciauskiene</span>, <span class="hlFld-ContribAuthor ">Anna  Rubartelli</span>, <span class="hlFld-ContribAuthor ">Leo A. B.  Joosten</span>, <span class="hlFld-ContribAuthor ">Charles A.  Dinarello</span>. </span><span class="cited-content_cbyCitation_article-title">OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2018,</strong> <em>115 </em>
                                    (7)
                                     , E1530-E1539. <a href="https://doi.org/10.1073/pnas.1716095115" title="DOI URL">https://doi.org/10.1073/pnas.1716095115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1716095115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1716095115%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DOLT1177%25252C%252Ba%252B%2525CE%2525B2-sulfonyl%252Bnitrile%252Bcompound%25252C%252Bsafe%252Bin%252Bhumans%25252C%252Binhibits%252Bthe%252BNLRP3%252Binflammasome%252Band%252Breverses%252Bthe%252Bmetabolic%252Bcost%252Bof%252Binflammation%26aulast%3DMarchetti%26aufirst%3DCarlo%26date%3D2018%26date%3D2018%26volume%3D115%26issue%3D7%26spage%3DE1530%26epage%3DE1539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew A.  Sherman</span>, <span class="hlFld-ContribAuthor ">Madathilparambil V.  Suresh</span>, <span class="hlFld-ContribAuthor ">Vladislav A.  Dolgachev</span>, <span class="hlFld-ContribAuthor ">Lane K.  McCandless</span>, <span class="hlFld-ContribAuthor ">Xiang  Xue</span>, <span class="hlFld-ContribAuthor ">Li  Ziru</span>, <span class="hlFld-ContribAuthor ">David  Machado-Aranda</span>, <span class="hlFld-ContribAuthor ">Yatrik M.  Shah</span>, <span class="hlFld-ContribAuthor ">Krishnan  Raghavendran</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Characterization of Hypoxic Alveolar Epithelial Cells After Lung Contusion Indicates an Important Role for HIF-1α. </span><span class="cited-content_cbyCitation_journal-name">Annals of Surgery</span><span> <strong>2018,</strong> <em>267 </em>
                                    (2)
                                     , 382-391. <a href="https://doi.org/10.1097/SLA.0000000000002070" title="DOI URL">https://doi.org/10.1097/SLA.0000000000002070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/SLA.0000000000002070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FSLA.0000000000002070%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520Surgery%26atitle%3DMolecular%252BCharacterization%252Bof%252BHypoxic%252BAlveolar%252BEpithelial%252BCells%252BAfter%252BLung%252BContusion%252BIndicates%252Ban%252BImportant%252BRole%252Bfor%252BHIF-1%2525CE%2525B1%26aulast%3DSherman%26aufirst%3DMatthew%2BA.%26date%3D2018%26volume%3D267%26issue%3D2%26spage%3D382%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Su-Chen  Ho</span>, <span class="hlFld-ContribAuthor ">Yi-Huang  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of Inhibitory Capacities of 6-, 8- and 10-Gingerols/Shogaols on the Canonical NLRP3 Inflammasome-Mediated IL-1β Secretion. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (2)
                                     , 466. <a href="https://doi.org/10.3390/molecules23020466" title="DOI URL">https://doi.org/10.3390/molecules23020466</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23020466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23020466%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DComparison%252Bof%252BInhibitory%252BCapacities%252Bof%252B6-%25252C%252B8-%252Band%252B10-Gingerols%25252FShogaols%252Bon%252Bthe%252BCanonical%252BNLRP3%252BInflammasome-Mediated%252BIL-1%2525CE%2525B2%252BSecretion%26aulast%3DHo%26aufirst%3DSu-Chen%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D2%26spage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Divyesh  Patel</span>, <span class="hlFld-ContribAuthor ">Sagar  Gaikwad</span>, <span class="hlFld-ContribAuthor ">Naveen  Challagundla</span>, <span class="hlFld-ContribAuthor ">Manish  Nivsarkar</span>, <span class="hlFld-ContribAuthor ">Reena  Agrawal-Rajput</span>. </span><span class="cited-content_cbyCitation_article-title">Spleen tyrosine kinase inhibition ameliorates airway inflammation through modulation of NLRP3 inflammosome and Th17/Treg axis. </span><span class="cited-content_cbyCitation_journal-name">International Immunopharmacology</span><span> <strong>2018,</strong> <em>54 </em>, 375-384. <a href="https://doi.org/10.1016/j.intimp.2017.11.026" title="DOI URL">https://doi.org/10.1016/j.intimp.2017.11.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.intimp.2017.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.intimp.2017.11.026%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Immunopharmacology%26atitle%3DSpleen%252Btyrosine%252Bkinase%252Binhibition%252Bameliorates%252Bairway%252Binflammation%252Bthrough%252Bmodulation%252Bof%252BNLRP3%252Binflammosome%252Band%252BTh17%25252FTreg%252Baxis%26aulast%3DPatel%26aufirst%3DDivyesh%26date%3D2018%26volume%3D54%26spage%3D375%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alex G.  Baldwin</span>, <span class="hlFld-ContribAuthor ">Jack  Rivers-Auty</span>, <span class="hlFld-ContribAuthor ">Michael J.D.  Daniels</span>, <span class="hlFld-ContribAuthor ">Claire S.  White</span>, <span class="hlFld-ContribAuthor ">Carl H.  Schwalbe</span>, <span class="hlFld-ContribAuthor ">Tom  Schilling</span>, <span class="hlFld-ContribAuthor ">Halah  Hammadi</span>, <span class="hlFld-ContribAuthor ">Panichakorn  Jaiyong</span>, <span class="hlFld-ContribAuthor ">Nicholas G.  Spencer</span>, <span class="hlFld-ContribAuthor ">Hazel  England</span>, <span class="hlFld-ContribAuthor ">Nadia M.  Luheshi</span>, <span class="hlFld-ContribAuthor ">Manikandan  Kadirvel</span>, <span class="hlFld-ContribAuthor ">Catherine B.  Lawrence</span>, <span class="hlFld-ContribAuthor ">Nancy J.  Rothwell</span>, <span class="hlFld-ContribAuthor ">Michael K.  Harte</span>, <span class="hlFld-ContribAuthor ">Richard A.  Bryce</span>, <span class="hlFld-ContribAuthor ">Stuart M.  Allan</span>, <span class="hlFld-ContribAuthor ">Claudia  Eder</span>, <span class="hlFld-ContribAuthor ">Sally  Freeman</span>, <span class="hlFld-ContribAuthor ">David  Brough</span>. </span><span class="cited-content_cbyCitation_article-title">Boron-Based Inhibitors of the NLRP3 Inflammasome. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2017,</strong> <em>24 </em>
                                    (11)
                                     , 1321-1335.e5. <a href="https://doi.org/10.1016/j.chembiol.2017.08.011" title="DOI URL">https://doi.org/10.1016/j.chembiol.2017.08.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2017.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2017.08.011%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DBoron-Based%252BInhibitors%252Bof%252Bthe%252BNLRP3%252BInflammasome%26aulast%3DBaldwin%26aufirst%3DAlex%2BG.%26date%3D2017%26volume%3D24%26issue%3D11%26spage%3D1321%26epage%3D1335.e5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James R.  Hill</span>, <span class="hlFld-ContribAuthor ">Rebecca C.  Coll</span>, <span class="hlFld-ContribAuthor ">Nancy  Sue</span>, <span class="hlFld-ContribAuthor ">Janet C.  Reid</span>, <span class="hlFld-ContribAuthor ">Jennifer  Dou</span>, <span class="hlFld-ContribAuthor ">Caroline L.  Holley</span>, <span class="hlFld-ContribAuthor ">Ruby  Pelingon</span>, <span class="hlFld-ContribAuthor ">Joshua B.  Dickinson</span>, <span class="hlFld-ContribAuthor ">Trevor J.  Biden</span>, <span class="hlFld-ContribAuthor ">Kate  Schroder</span>, <span class="hlFld-ContribAuthor ">Matthew A.  Cooper</span>, <span class="hlFld-ContribAuthor ">Avril A. B.  Robertson</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfonylureas as Concomitant Insulin Secretagogues and NLRP3 Inflammasome Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (17)
                                     , 1449-1457. <a href="https://doi.org/10.1002/cmdc.201700270" title="DOI URL">https://doi.org/10.1002/cmdc.201700270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700270%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSulfonylureas%252Bas%252BConcomitant%252BInsulin%252BSecretagogues%252Band%252BNLRP3%252BInflammasome%252BInhibitors%26aulast%3DHill%26aufirst%3DJames%2BR.%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D17%26spage%3D1449%26epage%3D1457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jorge H.  Tabares-Guevara</span>, <span class="hlFld-ContribAuthor ">Oscar J.  Lara-Guzmán</span>, <span class="hlFld-ContribAuthor ">Julian A.  Londoño-Londoño</span>, <span class="hlFld-ContribAuthor ">Jelver A.  Sierra</span>, <span class="hlFld-ContribAuthor ">Yudy M.  León-Varela</span>, <span class="hlFld-ContribAuthor ">Rafael M.  Álvarez-Quintero</span>, <span class="hlFld-ContribAuthor ">Edison J.  Osorio</span>, <span class="hlFld-ContribAuthor ">José R.  Ramirez-Pineda</span>. </span><span class="cited-content_cbyCitation_article-title">Natural Biflavonoids Modulate Macrophage–Oxidized LDL Interaction In Vitro and Promote Atheroprotection In Vivo. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2017,</strong> <em>8 </em><a href="https://doi.org/10.3389/fimmu.2017.00923" title="DOI URL">https://doi.org/10.3389/fimmu.2017.00923</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2017.00923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2017.00923%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DNatural%252BBiflavonoids%252BModulate%252BMacrophage%2525E2%252580%252593Oxidized%252BLDL%252BInteraction%252BIn%252BVitro%252Band%252BPromote%252BAtheroprotection%252BIn%252BVivo%26aulast%3DTabares-Guevara%26aufirst%3DJorge%2BH.%26date%3D2017%26date%3D2017%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy E  Nielsen</span>, <span class="hlFld-ContribAuthor ">Joseph D  Hantho</span>, <span class="hlFld-ContribAuthor ">Rock J  Mancini</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic agonists of NOD-like, RIG-I-like, and C-type lectin receptors for probing the inflammatory immune response. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (12)
                                     , 1345-1360. <a href="https://doi.org/10.4155/fmc-2017-0101" title="DOI URL">https://doi.org/10.4155/fmc-2017-0101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0101%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252Bagonists%252Bof%252BNOD-like%25252C%252BRIG-I-like%25252C%252Band%252BC-type%252Blectin%252Breceptors%252Bfor%252Bprobing%252Bthe%252Binflammatory%252Bimmune%252Bresponse%26aulast%3DNielsen%26aufirst%3DAmy%2BE%26date%3D2017%26volume%3D9%26issue%3D12%26spage%3D1345%26epage%3D1360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taylena Maria  Teófilo</span>, <span class="hlFld-ContribAuthor ">Loeste  Arruda-Barbosa</span>, <span class="hlFld-ContribAuthor ">Jussara Mathyelle  Rodrigues-Silva</span>, <span class="hlFld-ContribAuthor ">Joyce Karen Lima  Vale</span>, <span class="hlFld-ContribAuthor ">Rosivaldo Santos  Borges</span>, <span class="hlFld-ContribAuthor ">Gloria Pinto  Duarte</span>, <span class="hlFld-ContribAuthor ">Pedro Jorge Caldas  Magalhães</span>, <span class="hlFld-ContribAuthor ">Saad  Lahlou</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanism of the vasorelaxant effect induced by trans-4-methyl-β-nitrostyrene, a synthetic nitroderivative, in rat thoracic aorta. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Experimental Pharmacology and Physiology</span><span> <strong>2017,</strong> <em>44 </em>
                                    (7)
                                     , 787-794. <a href="https://doi.org/10.1111/1440-1681.12771" title="DOI URL">https://doi.org/10.1111/1440-1681.12771</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/1440-1681.12771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2F1440-1681.12771%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Experimental%2520Pharmacology%2520and%2520Physiology%26atitle%3DMechanism%252Bof%252Bthe%252Bvasorelaxant%252Beffect%252Binduced%252Bby%252Btrans-4-methyl-%2525CE%2525B2-nitrostyrene%25252C%252Ba%252Bsynthetic%252Bnitroderivative%25252C%252Bin%252Brat%252Bthoracic%252Baorta%26aulast%3DTe%25C3%25B3filo%26aufirst%3DTaylena%2BMaria%26date%3D2017%26date%3D2017%26volume%3D44%26issue%3D7%26spage%3D787%26epage%3D794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hazel H.  Szeto</span>, <span class="hlFld-ContribAuthor ">Shaoyi  Liu</span>, <span class="hlFld-ContribAuthor ">Yi  Soong</span>, <span class="hlFld-ContribAuthor ">Surya V.  Seshan</span>, <span class="hlFld-ContribAuthor ">Leona  Cohen-Gould</span>, <span class="hlFld-ContribAuthor ">Viacheslav  Manichev</span>, <span class="hlFld-ContribAuthor ">Leonard C.  Feldman</span>, <span class="hlFld-ContribAuthor ">Torgny  Gustafsson</span>. </span><span class="cited-content_cbyCitation_article-title">Mitochondria Protection after Acute Ischemia Prevents Prolonged Upregulation of IL-1
              β
              and IL-18 and Arrests CKD. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Society of Nephrology</span><span> <strong>2017,</strong> <em>28 </em>
                                    (5)
                                     , 1437-1449. <a href="https://doi.org/10.1681/ASN.2016070761" title="DOI URL">https://doi.org/10.1681/ASN.2016070761</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1681/ASN.2016070761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1681%2FASN.2016070761%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Society%2520of%2520Nephrology%26atitle%3DMitochondria%252BProtection%252Bafter%252BAcute%252BIschemia%252BPrevents%252BProlonged%252BUpregulation%252Bof%252BIL-1%252B%2525CE%2525B2%252Band%252BIL-18%252Band%252BArrests%252BCKD%26aulast%3DSzeto%26aufirst%3DHazel%2BH.%26date%3D2017%26date%3D2016%26volume%3D28%26issue%3D5%26spage%3D1437%26epage%3D1449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claire S.  White</span>, <span class="hlFld-ContribAuthor ">Catherine B.  Lawrence</span>, <span class="hlFld-ContribAuthor ">David  Brough</span>, <span class="hlFld-ContribAuthor ">Jack  Rivers-Auty</span>. </span><span class="cited-content_cbyCitation_article-title">Inflammasomes as therapeutic targets for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Brain Pathology</span><span> <strong>2017,</strong> <em>27 </em>
                                    (2)
                                     , 223-234. <a href="https://doi.org/10.1111/bpa.12478" title="DOI URL">https://doi.org/10.1111/bpa.12478</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bpa.12478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbpa.12478%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Pathology%26atitle%3DInflammasomes%252Bas%252Btherapeutic%252Btargets%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DWhite%26aufirst%3DClaire%2BS.%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D2%26spage%3D223%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kajal  Hamidzadeh</span>, <span class="hlFld-ContribAuthor ">Stephen M.  Christensen</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Dalby</span>, <span class="hlFld-ContribAuthor ">Prabha  Chandrasekaran</span>, <span class="hlFld-ContribAuthor ">David M.  Mosser</span>. </span><span class="cited-content_cbyCitation_article-title">Macrophages and the Recovery from Acute and Chronic Inflammation. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Physiology</span><span> <strong>2017,</strong> <em>79 </em>
                                    (1)
                                     , 567-592. <a href="https://doi.org/10.1146/annurev-physiol-022516-034348" title="DOI URL">https://doi.org/10.1146/annurev-physiol-022516-034348</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-physiol-022516-034348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-physiol-022516-034348%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Physiology%26atitle%3DMacrophages%252Band%252Bthe%252BRecovery%252Bfrom%252BAcute%252Band%252BChronic%252BInflammation%26aulast%3DHamidzadeh%26aufirst%3DKajal%26date%3D2017%26volume%3D79%26issue%3D1%26spage%3D567%26epage%3D592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isabelle V.  Maucher</span>, <span class="hlFld-ContribAuthor ">Michael  Rühl</span>, <span class="hlFld-ContribAuthor ">Simon B.M.  Kretschmer</span>, <span class="hlFld-ContribAuthor ">Bettina  Hofmann</span>, <span class="hlFld-ContribAuthor ">Benjamin  Kühn</span>, <span class="hlFld-ContribAuthor ">Jasmin  Fettel</span>, <span class="hlFld-ContribAuthor ">Anja  Vogel</span>, <span class="hlFld-ContribAuthor ">Karsten T.  Flügel</span>, <span class="hlFld-ContribAuthor ">Georg  Manolikakes</span>, <span class="hlFld-ContribAuthor ">Nadine  Hellmuth</span>, <span class="hlFld-ContribAuthor ">Ann-Kathrin  Häfner</span>, <span class="hlFld-ContribAuthor ">Vahid  Golghalyani</span>, <span class="hlFld-ContribAuthor ">Ann-Katrin  Ball</span>, <span class="hlFld-ContribAuthor ">Matthias  Piesche</span>, <span class="hlFld-ContribAuthor ">Carmela  Matrone</span>, <span class="hlFld-ContribAuthor ">Gerd  Geisslinger</span>, <span class="hlFld-ContribAuthor ">Michael J.  Parnham</span>, <span class="hlFld-ContribAuthor ">Michael  Karas</span>, <span class="hlFld-ContribAuthor ">Dieter  Steinhilber</span>, <span class="hlFld-ContribAuthor ">Jessica  Roos</span>, <span class="hlFld-ContribAuthor ">Thorsten J.  Maier</span>. </span><span class="cited-content_cbyCitation_article-title">Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2017,</strong> <em>125 </em>, 55-74. <a href="https://doi.org/10.1016/j.bcp.2016.11.004" title="DOI URL">https://doi.org/10.1016/j.bcp.2016.11.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2016.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2016.11.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DMichael%252Bacceptor%252Bcontaining%252Bdrugs%252Bare%252Ba%252Bnovel%252Bclass%252Bof%252B5-lipoxygenase%252Binhibitor%252Btargeting%252Bthe%252Bsurface%252Bcysteines%252BC416%252Band%252BC418%26aulast%3DMaucher%26aufirst%3DIsabelle%2BV.%26date%3D2017%26volume%3D125%26spage%3D55%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takao  Kataoka</span>. </span><span class="cited-content_cbyCitation_article-title">Adaptive and Innate Immune Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 115-147. <a href="https://doi.org/10.1007/978-4-431-56529-1_5" title="DOI URL">https://doi.org/10.1007/978-4-431-56529-1_5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-4-431-56529-1_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-4-431-56529-1_5%26sid%3Dliteratum%253Aachs%26atitle%3DAdaptive%252Band%252BInnate%252BImmune%252BSystems%26aulast%3DKataoka%26aufirst%3DTakao%26date%3D2017%26date%3D2017%26spage%3D115%26epage%3D147%26pub%3DSpringer%2520Japan%26atitle%3DBioprobes%26aulast%3DOsada%26aufirst%3DHiroyuki%26date%3D2017%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Daniels</span>, <span class="hlFld-ContribAuthor ">David  Brough</span>. </span><span class="cited-content_cbyCitation_article-title">Unconventional Pathways of Secretion Contribute to Inflammation. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2017,</strong> <em>18 </em>
                                    (1)
                                     , 102. <a href="https://doi.org/10.3390/ijms18010102" title="DOI URL">https://doi.org/10.3390/ijms18010102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms18010102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms18010102%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DUnconventional%252BPathways%252Bof%252BSecretion%252BContribute%252Bto%252BInflammation%26aulast%3DDaniels%26aufirst%3DMichael%26date%3D2017%26date%3D2017%26volume%3D18%26issue%3D1%26spage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christina J.  Groß</span>, <span class="hlFld-ContribAuthor ">Ritu  Mishra</span>, <span class="hlFld-ContribAuthor ">Katharina S.  Schneider</span>, <span class="hlFld-ContribAuthor ">Guillaume  Médard</span>, <span class="hlFld-ContribAuthor ">Jennifer  Wettmarshausen</span>, <span class="hlFld-ContribAuthor ">Daniela C.  Dittlein</span>, <span class="hlFld-ContribAuthor ">Hexin  Shi</span>, <span class="hlFld-ContribAuthor ">Oliver  Gorka</span>, <span class="hlFld-ContribAuthor ">Paul-Albert  Koenig</span>, <span class="hlFld-ContribAuthor ">Stephan  Fromm</span>, <span class="hlFld-ContribAuthor ">Giovanni  Magnani</span>, <span class="hlFld-ContribAuthor ">Tamara  Ćiković</span>, <span class="hlFld-ContribAuthor ">Lara  Hartjes</span>, <span class="hlFld-ContribAuthor ">Joachim  Smollich</span>, <span class="hlFld-ContribAuthor ">Avril A.B.  Robertson</span>, <span class="hlFld-ContribAuthor ">Matthew A.  Cooper</span>, <span class="hlFld-ContribAuthor ">Marc  Schmidt-Supprian</span>, <span class="hlFld-ContribAuthor ">Michael  Schuster</span>, <span class="hlFld-ContribAuthor ">Kate  Schroder</span>, <span class="hlFld-ContribAuthor ">Petr  Broz</span>, <span class="hlFld-ContribAuthor ">Claudia  Traidl-Hoffmann</span>, <span class="hlFld-ContribAuthor ">Bruce  Beutler</span>, <span class="hlFld-ContribAuthor ">Bernhard  Kuster</span>, <span class="hlFld-ContribAuthor ">Jürgen  Ruland</span>, <span class="hlFld-ContribAuthor ">Sabine  Schneider</span>, <span class="hlFld-ContribAuthor ">Fabiana  Perocchi</span>, <span class="hlFld-ContribAuthor ">Olaf  Groß</span>. </span><span class="cited-content_cbyCitation_article-title">K + Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria. </span><span class="cited-content_cbyCitation_journal-name">Immunity</span><span> <strong>2016,</strong> <em>45 </em>
                                    (4)
                                     , 761-773. <a href="https://doi.org/10.1016/j.immuni.2016.08.010" title="DOI URL">https://doi.org/10.1016/j.immuni.2016.08.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.immuni.2016.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.immuni.2016.08.010%26sid%3Dliteratum%253Aachs%26jtitle%3DImmunity%26atitle%3DK%252B%25252B%252BEfflux-Independent%252BNLRP3%252BInflammasome%252BActivation%252Bby%252BSmall%252BMolecules%252BTargeting%252BMitochondria%26aulast%3DGro%25C3%259F%26aufirst%3DChristina%25C2%25A0J.%26date%3D2016%26volume%3D45%26issue%3D4%26spage%3D761%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolett  Lénárt</span>, <span class="hlFld-ContribAuthor ">David  Brough</span>, <span class="hlFld-ContribAuthor ">Ádám  Dénes</span>. </span><span class="cited-content_cbyCitation_article-title">Inflammasomes link vascular disease with neuroinflammation and brain disorders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cerebral Blood Flow & Metabolism</span><span> <strong>2016,</strong> <em>36 </em>
                                    (10)
                                     , 1668-1685. <a href="https://doi.org/10.1177/0271678X16662043" title="DOI URL">https://doi.org/10.1177/0271678X16662043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0271678X16662043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0271678X16662043%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cerebral%2520Blood%2520Flow%2520%2526%2520Metabolism%26atitle%3DInflammasomes%252Blink%252Bvascular%252Bdisease%252Bwith%252Bneuroinflammation%252Band%252Bbrain%252Bdisorders%26aulast%3DL%25C3%25A9n%25C3%25A1rt%26aufirst%3DNikolett%26date%3D2016%26date%3D2016%26volume%3D36%26issue%3D10%26spage%3D1668%26epage%3D1685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael J.  Primiano</span>, <span class="hlFld-ContribAuthor ">Bruce A.  Lefker</span>, <span class="hlFld-ContribAuthor ">Michael R.  Bowman</span>, <span class="hlFld-ContribAuthor ">Andrea G.  Bree</span>, <span class="hlFld-ContribAuthor ">Cedric  Hubeau</span>, <span class="hlFld-ContribAuthor ">Paul D.  Bonin</span>, <span class="hlFld-ContribAuthor ">Matthew  Mangan</span>, <span class="hlFld-ContribAuthor ">Ken  Dower</span>, <span class="hlFld-ContribAuthor ">Brian G.  Monks</span>, <span class="hlFld-ContribAuthor ">Leah  Cushing</span>, <span class="hlFld-ContribAuthor ">Stephen  Wang</span>, <span class="hlFld-ContribAuthor ">Julia  Guzova</span>, <span class="hlFld-ContribAuthor ">Aiping  Jiao</span>, <span class="hlFld-ContribAuthor ">Lih-Ling  Lin</span>, <span class="hlFld-ContribAuthor ">Eicke  Latz</span>, <span class="hlFld-ContribAuthor ">David  Hepworth</span>, <span class="hlFld-ContribAuthor ">J. Perry  Hall</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Immunology</span><span> <strong>2016,</strong> <em>197 </em>
                                    (6)
                                     , 2421-2433. <a href="https://doi.org/10.4049/jimmunol.1600035" title="DOI URL">https://doi.org/10.4049/jimmunol.1600035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4049/jimmunol.1600035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4049%2Fjimmunol.1600035%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Immunology%26atitle%3DEfficacy%252Band%252BPharmacology%252Bof%252Bthe%252BNLRP3%252BInflammasome%252BInhibitor%252BCP-456%25252C773%252B%252528CRID3%252529%252Bin%252BMurine%252BModels%252Bof%252BDermal%252Band%252BPulmonary%252BInflammation%26aulast%3DPrimiano%26aufirst%3DMichael%2BJ.%26date%3D2016%26date%3D2016%26volume%3D197%26issue%3D6%26spage%3D2421%26epage%3D2433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isis  Ludwig-Portugall</span>, <span class="hlFld-ContribAuthor ">Eva  Bartok</span>, <span class="hlFld-ContribAuthor ">Ermanila  Dhana</span>, <span class="hlFld-ContribAuthor ">Beatrix D.G.  Evers</span>, <span class="hlFld-ContribAuthor ">Michael J.  Primiano</span>, <span class="hlFld-ContribAuthor ">J. Perry  Hall</span>, <span class="hlFld-ContribAuthor ">Bernardo S.  Franklin</span>, <span class="hlFld-ContribAuthor ">Percy A.  Knolle</span>, <span class="hlFld-ContribAuthor ">Veit  Hornung</span>, <span class="hlFld-ContribAuthor ">Gunther  Hartmann</span>, <span class="hlFld-ContribAuthor ">Peter  Boor</span>, <span class="hlFld-ContribAuthor ">Eicke  Latz</span>, <span class="hlFld-ContribAuthor ">Christian  Kurts</span>. </span><span class="cited-content_cbyCitation_article-title">An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice. </span><span class="cited-content_cbyCitation_journal-name">Kidney International</span><span> <strong>2016,</strong> <em>90 </em>
                                    (3)
                                     , 525-539. <a href="https://doi.org/10.1016/j.kint.2016.03.035" title="DOI URL">https://doi.org/10.1016/j.kint.2016.03.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.kint.2016.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.kint.2016.03.035%26sid%3Dliteratum%253Aachs%26jtitle%3DKidney%2520International%26atitle%3DAn%252BNLRP3-specific%252Binflammasome%252Binhibitor%252Battenuates%252Bcrystal-induced%252Bkidney%252Bfibrosis%252Bin%2525C2%2525A0mice%26aulast%3DLudwig-Portugall%26aufirst%3DIsis%26date%3D2016%26volume%3D90%26issue%3D3%26spage%3D525%26epage%3D539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. E.  Castañeda-Lopez</span>, <span class="hlFld-ContribAuthor ">I.  Garza-Veloz</span>, <span class="hlFld-ContribAuthor ">Y.  Lopez-Hernandez</span>, <span class="hlFld-ContribAuthor ">O. Y.  Barbosa-Cisneros</span>, <span class="hlFld-ContribAuthor ">M. L.  Martinez-Fierro</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-Inflammatory Effects of Modified Adenoviral Vectors for Gene Therapy: A View through Animal Models Tested. </span><span class="cited-content_cbyCitation_journal-name">Immunological Investigations</span><span> <strong>2016,</strong> <em>45 </em>
                                    (5)
                                     , 450-470. <a href="https://doi.org/10.3109/08820139.2016.1168831" title="DOI URL">https://doi.org/10.3109/08820139.2016.1168831</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/08820139.2016.1168831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F08820139.2016.1168831%26sid%3Dliteratum%253Aachs%26jtitle%3DImmunological%2520Investigations%26atitle%3DAnti-Inflammatory%252BEffects%252Bof%252BModified%252BAdenoviral%252BVectors%252Bfor%252BGene%252BTherapy%25253A%252BA%252BView%252Bthrough%252BAnimal%252BModels%252BTested%26aulast%3DCasta%25C3%25B1eda-Lopez%26aufirst%3DM.%2BE.%26date%3D2016%26date%3D2016%26volume%3D45%26issue%3D5%26spage%3D450%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefano  Toldo</span>, <span class="hlFld-ContribAuthor ">Mohammed  Quader</span>, <span class="hlFld-ContribAuthor ">Fadi  Salloum</span>, <span class="hlFld-ContribAuthor ">Eleonora  Mezzaroma</span>, <span class="hlFld-ContribAuthor ">Antonio  Abbate</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the Innate Immune Response to Improve Cardiac Graft Recovery after Heart Transplantation: Implications for the Donation after Cardiac Death. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2016,</strong> <em>17 </em>
                                    (6)
                                     , 958. <a href="https://doi.org/10.3390/ijms17060958" title="DOI URL">https://doi.org/10.3390/ijms17060958</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms17060958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms17060958%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DTargeting%252Bthe%252BInnate%252BImmune%252BResponse%252Bto%252BImprove%252BCardiac%252BGraft%252BRecovery%252Bafter%252BHeart%252BTransplantation%25253A%252BImplications%252Bfor%252Bthe%252BDonation%252Bafter%252BCardiac%252BDeath%26aulast%3DToldo%26aufirst%3DStefano%26date%3D2016%26date%3D2016%26volume%3D17%26issue%3D6%26spage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiru  Li</span>, <span class="hlFld-ContribAuthor ">Jamison J.  Grailer</span>, <span class="hlFld-ContribAuthor ">Na  Wang</span>, <span class="hlFld-ContribAuthor ">Mingming  Wang</span>, <span class="hlFld-ContribAuthor ">Jianfei  Yao</span>, <span class="hlFld-ContribAuthor ">Rui  Zhong</span>, <span class="hlFld-ContribAuthor ">George F.  Gao</span>, <span class="hlFld-ContribAuthor ">Peter A.  Ward</span>, <span class="hlFld-ContribAuthor ">Dun-Xian  Tan</span>, <span class="hlFld-ContribAuthor ">Xiangdong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Melatonin alleviates acute lung injury through inhibiting the NLRP3 inflammasome. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pineal Research</span><span> <strong>2016,</strong> <em>60 </em>
                                    (4)
                                     , 405-414. <a href="https://doi.org/10.1111/jpi.12322" title="DOI URL">https://doi.org/10.1111/jpi.12322</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jpi.12322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjpi.12322%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pineal%2520Research%26atitle%3DMelatonin%252Balleviates%252Bacute%252Blung%252Binjury%252Bthrough%252Binhibiting%252Bthe%252BNLRP3%252Binflammasome%26aulast%3DZhang%26aufirst%3DYong%26date%3D2016%26date%3D2016%26volume%3D60%26issue%3D4%26spage%3D405%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0026.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. NLRP3 priming through the TLR4-MyD88 signaling pathway. Macrophages/microglia are primed by PAMP/DAMP stimulation of a Toll-like receptor (TLR) to express pro-IL-1β and NLRP3 in an inactive state.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. NLRP3-dependent IL-1β release during sterile inflammation. (1) A DAMP signal induces recruitment of ASC and procaspase-1. (2) Recruitment causes oligomerization and NLRP3 inflammasome formation. (3) Autoactivation induces procaspase-1 cleavage and caspase-1 release. (4) Activated caspase-1 cleaves pro-IL-1β into mature IL-1β. (5) IL-1β is secreted in a caspase-1-dependent manner extracellularly through an as yet agreed mechanism.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of NLRP3 inhibitors <b>1</b>/<b>3</b> and anion exchange inhibitor <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of IL-1β processing inhibitors <b>4</b>–<b>7</b> and NLRP3 inhibitor <b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0006.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structure of NLRP1/NLRP3 inhibitor <b>9</b> and <i>N</i>6-benzyladenine analogues <b>10</b>–<b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0019.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Mechanism of Action of NLRP1/NLRP3 Inhibitor <b>12</b> via Michael Addition<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0020.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Mechanism of Action of NLRP3 Inhibitor <b>13</b> via Michael Addition<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0007.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. SAR summary of <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0008.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures of NLRP3 inhibitors <b>14</b>–<b>15</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0021.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Proposed Mechanism of Action of NLRP3 Inhibitor <b>16</b> via Michael Addition</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0009.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. SAR summary of <b>16</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0022.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Metabolism of Caspase-1 Prodrugs (A) <b>19</b> into <b>20</b> and (B) <b>21</b> into <b>22</b><a onclick="showRef(event, 'ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref99 ref100">(99, 100)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0010.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of caspase-1 inhibitors <b>17</b>–<b>18</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0011.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structure of TLR4 antagonist <b>23</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0012.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. SAR summary of <b>24</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0023.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Mechanism of Action of TAK1 Inhibitor <b>25</b> via Michael Addition<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0013.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structure of IKK inhibitor <b>30</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0014.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structures of DUB inhibitors <b>31</b>–<b>35</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0015.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Structures of P2X7R antagonists <b>36</b>–<b>39</b> and pannexin-1 inhibitor <b>40</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0016.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structures of ABC anion transporter inhibitors <b>41</b>–<b>43</b>, Ca<sup>2+</sup> channel blockers <b>44</b>–<b>45</b>, Cl<sup>–</sup> channel blocker <b>46</b>, and intracellular Ca<sup>2+</sup> chelator prodrug <b>47</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0017.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Structures of ROS inhibitors <b>48</b>–<b>49</b> and cathepsin B inhibitor <b>50</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0024.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Metabolism of Syk Prodrug <b>52</b> into <b>51</b><a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/medium/jm-2015-010915_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0018.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Structures of selective Syk inhibitor <b>53</b> and IRAK1/4 inhibitor <b>54</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01091/20160310/images/large/jm-2015-010915_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01091&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53251" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53251" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 183 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Koizumi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakasone, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span> </span><span class="NLM_article-title">Inflammasome activation via intracellular NLRs triggered by bacterial infection</span> <span class="citation_source-journal">Cell. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span><span class="refDoi"> DOI: 10.1111/j.1462-5822.2011.01707.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1111%2Fj.1462-5822.2011.01707.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=21995284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFGqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=149-154&author=Y.+Koizumiauthor=C.+Tomaauthor=N.+Higaauthor=T.+Noharaauthor=N.+Nakasoneauthor=T.+Suzuki&title=Inflammasome+activation+via+intracellular+NLRs+triggered+by+bacterial+infection&doi=10.1111%2Fj.1462-5822.2011.01707.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammasome activation via intracellular NLRs triggered by bacterial infection</span></div><div class="casAuthors">Koizumi, Yukiko; Toma, Claudia; Higa, Naomi; Nohara, Toshitsugu; Nakasone, Noboru; Suzuki, Toshihiko</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-154</span>CODEN:
                <span class="NLM_cas:coden">CEMIF5</span>;
        ISSN:<span class="NLM_cas:issn">1462-5814</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Members of the nucleotide-binding, oligomerization domain (NOD)-like receptor (NLR) proteins assemble into a multiprotein platform, known as the inflammasome, to induce caspase-1 activation followed by the subsequent secretion of IL-1β and IL-18.  In this review, we focus on the role of NLRs in inflammasome activation as part of the host defense against bacterial pathogens.  One of activators of the NLRC4 inflammasome is bacterial flagellin secreted through type III or IV secretion systems, which are important for the pathogenicity of many Gram-neg. bacteria.  The NLRP3 inflammasome is mainly activated by a large no. of bacterial pore-forming toxins.  Despite our knowledge of inflammasome activation upon bacterial infection, the function of antibacterial defense under in vivo conditions remains to be elucidated.  Further understanding of NLR function should provide new insights into the mechanisms of host pro-inflammatory responses and the pathogenesis of bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosZd8f_hk8KrVg90H21EOLACvtfcHk0li1V1NX6SCmTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFGqsrY%253D&md5=5e9065827392d3138cb5b6ed1cd843df</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1462-5822.2011.01707.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1462-5822.2011.01707.x%26sid%3Dliteratum%253Aachs%26aulast%3DKoizumi%26aufirst%3DY.%26aulast%3DToma%26aufirst%3DC.%26aulast%3DHiga%26aufirst%3DN.%26aulast%3DNohara%26aufirst%3DT.%26aulast%3DNakasone%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DT.%26atitle%3DInflammasome%2520activation%2520via%2520intracellular%2520NLRs%2520triggered%2520by%2520bacterial%2520infection%26jtitle%3DCell.%2520Microbiol.%26date%3D2012%26volume%3D14%26spage%3D149%26epage%3D154%26doi%3D10.1111%2Fj.1462-5822.2011.01707.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Dinarello, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Meer, J. W.</span><span> </span><span class="NLM_article-title">Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">652</span><span class="refDoi"> DOI: 10.1038/nrd3800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnrd3800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22850787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=633-652&author=C.+A.+Dinarelloauthor=A.+Simonauthor=J.+W.+van+der+Meer&title=Treating+inflammation+by+blocking+interleukin-1+in+a+broad+spectrum+of+diseases&doi=10.1038%2Fnrd3800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases</span></div><div class="casAuthors">Dinarello, Charles A.; Simon, Anna; van der Meer, Jos W. M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">633-652</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Interleukin-1 (IL-1) is a highly active pro-inflammatory cytokine that lowers pain thresholds and damages tissues.  Monotherapy blocking IL-1 activity in autoinflammatory syndromes results in a rapid and sustained redn. in disease severity, including reversal of inflammation-mediated loss of sight, hearing and organ function.  This approach can therefore be effective in treating common conditions such as post-infarction heart failure, and trials targeting a broad spectrum of new indications are underway.  So far, three IL-1-targeted agents have been approved: the IL-1 receptor antagonist anakinra, the sol. decoy receptor rilonacept and the neutralizing monoclonal anti-IL-1β antibody canakinumab.  In addn., a monoclonal antibody directed against the IL-1 receptor and a neutralizing anti-IL-1α antibody are in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6wcqDUVKRhLVg90H21EOLACvtfcHk0lj1KANCG3OnPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmtrfJ&md5=9297c8530f9d2c75da0880a7df7c1fe2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd3800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3800%26sid%3Dliteratum%253Aachs%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BMeer%26aufirst%3DJ.%2BW.%26atitle%3DTreating%2520inflammation%2520by%2520blocking%2520interleukin-1%2520in%2520a%2520broad%2520spectrum%2520of%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D633%26epage%3D652%26doi%3D10.1038%2Fnrd3800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Chen, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuñez, G.</span><span> </span><span class="NLM_article-title">Sterile inflammation: sensing and reacting to damage</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">826</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span><span class="refDoi"> DOI: 10.1038/nri2873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnri2873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=21088683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVersLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=826-837&author=G.+Y.+Chenauthor=G.+Nu%C3%B1ez&title=Sterile+inflammation%3A+sensing+and+reacting+to+damage&doi=10.1038%2Fnri2873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Sterile inflammation: sensing and reacting to damage</span></div><div class="casAuthors">Chen, Grace Y.; Nunez, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">826-837</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Over the past several decades, much has been revealed about the nature of the host innate immune response to microorganisms, with the identification of pattern recognition receptors (PRRs) and pathogen-assocd. mol. patterns, which are the conserved microbial motifs sensed by these receptors.  It is now apparent that these same PRRs can also be activated by non-microbial signals, many of which are considered as damage-assocd. mol. patterns.  The sterile inflammation that ensues either resolves the initial insult or leads to disease.  Here, we review the triggers and receptor pathways that result in sterile inflammation and its impact on human health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosJXKQoxN6sbVg90H21EOLACvtfcHk0lj1KANCG3OnPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVersLnM&md5=f77022de4a28f73f0e7a4255dfe013fd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnri2873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2873%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%2BY.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26atitle%3DSterile%2520inflammation%253A%2520sensing%2520and%2520reacting%2520to%2520damage%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D10%26spage%3D826%26epage%3D837%26doi%3D10.1038%2Fnri2873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Takeuchi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akira, S.</span><span> </span><span class="NLM_article-title">Pattern recognition receptors and inflammation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">–</span> <span class="NLM_lpage">820</span><span class="refDoi"> DOI: 10.1016/j.cell.2010.01.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.cell.2010.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20303872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2010&pages=805-820&author=O.+Takeuchiauthor=S.+Akira&title=Pattern+recognition+receptors+and+inflammation&doi=10.1016%2Fj.cell.2010.01.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Pattern recognition receptors and inflammation</span></div><div class="casAuthors">Takeuchi, Osamu; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">805-820</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Infection of cells by microorganisms activates the inflammatory response.  The initial sensing of infection is mediated by innate pattern recognition receptors (PRRs), which include Toll-like receptors, RIG-I-like receptors, NOD-like receptors, and C-type lectin receptors.  The intracellular signaling cascades triggered by these PRRs lead to transcriptional expression of inflammatory mediators that coordinate the elimination of pathogens and infected cells.  However, aberrant activation of this system leads to immunodeficiency, septic shock, or induction of autoimmunity.  In this Review, the authors discuss the role of PRRs, their signaling pathways, and how they control inflammatory responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0N2xgJRnA2bVg90H21EOLACvtfcHk0liiUm8HKHF6FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSgu74%253D&md5=b0b11ee0ff10f679cea981997796fe6d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DO.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DPattern%2520recognition%2520receptors%2520and%2520inflammation%26jtitle%3DCell%26date%3D2010%26volume%3D140%26spage%3D805%26epage%3D820%26doi%3D10.1016%2Fj.cell.2010.01.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Rock, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ontiveros, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kono, H.</span><span> </span><span class="NLM_article-title">The sterile inflammatory response</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span><span class="refDoi"> DOI: 10.1146/annurev-immunol-030409-101311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1146%2Fannurev-immunol-030409-101311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20307211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=321-342&author=K.+L.+Rockauthor=E.+Latzauthor=F.+Ontiverosauthor=H.+Kono&title=The+sterile+inflammatory+response&doi=10.1146%2Fannurev-immunol-030409-101311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The sterile inflammatory response</span></div><div class="casAuthors">Rock, Kenneth L.; Latz, Eicke; Ontiveros, Fernando; Kono, Hajime</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">321-342</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The acute inflammatory response is a double-edged sword.  On the one hand, it plays a key role in initial host defense, particularly against many infections.  On the other hand, its aim is imprecise, and as a consequence, when it is drawn into battle, it can cause collateral damage in tissues.  In situations where the inciting stimulus is sterile, the cost-benefit ratio may be high; because of this, sterile inflammation underlies the pathogenesis of a no. of diseases.  Although there have been major advances in our understanding of how microbes trigger inflammation, much less has been learned about this process in sterile situations.  This review focuses on a subset of the many sterile stimuli that can induce inflammation-specifically dead cells and a variety of irritant particles, including crystals, minerals, and protein aggregates.  Although this subset of stimuli is structurally very diverse and might appear to be unrelated, there is accumulating evidence that the innate immune system may recognize them in similar ways and stimulate the sterile inflammatory response via common pathways.  Here we review established and emerging data about these responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoigSou6cTWKbVg90H21EOLACvtfcHk0liiUm8HKHF6FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSms7s%253D&md5=506769335b2c6835d674d8791c2d67f6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1146%2Fannurev-immunol-030409-101311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-immunol-030409-101311%26sid%3Dliteratum%253Aachs%26aulast%3DRock%26aufirst%3DK.%2BL.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DOntiveros%26aufirst%3DF.%26aulast%3DKono%26aufirst%3DH.%26atitle%3DThe%2520sterile%2520inflammatory%2520response%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D28%26spage%3D321%26epage%3D342%26doi%3D10.1146%2Fannurev-immunol-030409-101311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Cassel, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutterwala, F. S.</span><span> </span><span class="NLM_article-title">Sterile inflammatory responses mediated by the NLRP3 inflammasome</span> <span class="citation_source-journal">Eur. J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span><span class="refDoi"> DOI: 10.1002/eji.200940207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1002%2Feji.200940207" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2010&pages=607-611&author=S.+L.+Casselauthor=F.+S.+Sutterwala&title=Sterile+inflammatory+responses+mediated+by+the+NLRP3+inflammasome&doi=10.1002%2Feji.200940207"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Feji.200940207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.200940207%26sid%3Dliteratum%253Aachs%26aulast%3DCassel%26aufirst%3DS.%2BL.%26aulast%3DSutterwala%26aufirst%3DF.%2BS.%26atitle%3DSterile%2520inflammatory%2520responses%2520mediated%2520by%2520the%2520NLRP3%2520inflammasome%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D2010%26volume%3D40%26spage%3D607%26epage%3D611%26doi%3D10.1002%2Feji.200940207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Latz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, A.</span><span> </span><span class="NLM_article-title">Activation and regulation of the inflammasomes</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span><span class="refDoi"> DOI: 10.1038/nri3452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnri3452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=23702978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFSgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=397-411&author=E.+Latzauthor=T.+S.+Xiaoauthor=A.+Stutz&title=Activation+and+regulation+of+the+inflammasomes&doi=10.1038%2Fnri3452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Activation and regulation of the inflammasomes</span></div><div class="casAuthors">Latz, Eicke; Xiao, T. Sam; Stutz, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">397-411</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Inflammasomes are key signalling platforms that detect pathogenic microorganisms and sterile stressors, and that activate the highly pro-inflammatory cytokines interleukin-1β (IL-1β) and IL-18.  In this Review, we discuss the complex regulatory mechanisms that facilitate a balanced but effective inflammasome-mediated immune response, and we highlight the similarities to another mol. signalling platform - the apoptosome - that monitors cellular health.  Extracellular regulatory mechanisms are discussed, as well as the intracellular control of inflammasome assembly, for example, via ion fluxes, free radicals and autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom16nKHEVN3bVg90H21EOLACvtfcHk0liwUodDz9X1TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFSgsLw%253D&md5=86c377fdd6dc6759679f4e410fad96af</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnri3452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3452%26sid%3Dliteratum%253Aachs%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DXiao%26aufirst%3DT.%2BS.%26aulast%3DStutz%26aufirst%3DA.%26atitle%3DActivation%2520and%2520regulation%2520of%2520the%2520inflammasomes%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2013%26volume%3D13%26spage%3D397%26epage%3D411%26doi%3D10.1038%2Fnri3452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Pelegrin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surprenant, A.</span><span> </span><span class="NLM_article-title">Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5071</span><span class="NLM_x">–</span> <span class="NLM_lpage">5082</span><span class="refDoi"> DOI: 10.1038/sj.emboj.7601378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fsj.emboj.7601378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=17036048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFChsrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=5071-5082&author=P.+Pelegrinauthor=A.+Surprenant&title=Pannexin-1+mediates+large+pore+formation+and+interleukin-1%CE%B2+release+by+the+ATP-gated+P2X7+receptor&doi=10.1038%2Fsj.emboj.7601378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor</span></div><div class="casAuthors">Pelegrin, Pablo; Surprenant, Annmarie</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5071-5082</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">P2X7 receptors are ATP-gated cation channels; their activation in macrophage also leads to rapid opening of a membrane pore permeable to dyes such as ethidium, and to release of the pro-inflammatory cytokine, interleukin-1β (IL-1β).  It has not been known what this dye-uptake path is, or whether it is involved in downstream signaling to IL-1β release.  Here, we identify pannexin-1, a recently described mammalian protein that functions as a hemichannel when ectopically expressed, as this dye-uptake pathway and show that signaling through pannexin-1 is required for processing of caspase-1 and release of mature IL-1β induced by P2X7 receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgKvoL27FfqbVg90H21EOLACvtfcHk0liwUodDz9X1TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFChsrzM&md5=9b4bb218bde9ee4145bd3f70d900012c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601378%26sid%3Dliteratum%253Aachs%26aulast%3DPelegrin%26aufirst%3DP.%26aulast%3DSurprenant%26aufirst%3DA.%26atitle%3DPannexin-1%2520mediates%2520large%2520pore%2520formation%2520and%2520interleukin-1%25CE%25B2%2520release%2520by%2520the%2520ATP-gated%2520P2X7%2520receptor%26jtitle%3DEMBO%2520J.%26date%3D2006%26volume%3D25%26spage%3D5071%26epage%3D5082%26doi%3D10.1038%2Fsj.emboj.7601378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Locovei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scemes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spray, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, G.</span><span> </span><span class="NLM_article-title">Pannexin1 is part of the pore forming unit of the P2X<sub>7</sub> receptor death complex</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">581</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span><span class="refDoi"> DOI: 10.1016/j.febslet.2006.12.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.febslet.2006.12.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2007&pages=483-488&author=S.+Locoveiauthor=E.+Scemesauthor=F.+Qiuauthor=D.+C.+Sprayauthor=G.+Dahl&title=Pannexin1+is+part+of+the+pore+forming+unit+of+the+P2X7+receptor+death+complex&doi=10.1016%2Fj.febslet.2006.12.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2006.12.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2006.12.056%26sid%3Dliteratum%253Aachs%26aulast%3DLocovei%26aufirst%3DS.%26aulast%3DScemes%26aufirst%3DE.%26aulast%3DQiu%26aufirst%3DF.%26aulast%3DSpray%26aufirst%3DD.%2BC.%26aulast%3DDahl%26aufirst%3DG.%26atitle%3DPannexin1%2520is%2520part%2520of%2520the%2520pore%2520forming%2520unit%2520of%2520the%2520P2X7%2520receptor%2520death%2520complex%26jtitle%3DFEBS%2520Lett.%26date%3D2007%26volume%3D581%26spage%3D483%26epage%3D488%26doi%3D10.1016%2Fj.febslet.2006.12.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Martinon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pétrilli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardivel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, J.</span><span> </span><span class="NLM_article-title">Gout-associated uric acid crystals activate the NALP3 inflammasome</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span><span class="refDoi"> DOI: 10.1038/nature04516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnature04516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=16407889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD28XitFGitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=237-241&author=F.+Martinonauthor=V.+P%C3%A9trilliauthor=A.+Mayorauthor=A.+Tardivelauthor=J.+Tschopp&title=Gout-associated+uric+acid+crystals+activate+the+NALP3+inflammasome&doi=10.1038%2Fnature04516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Gout-associated uric acid crystals activate the NALP3 inflammasome</span></div><div class="casAuthors">Martinon, Fabio; Petrilli, Virginie; Mayor, Annick; Tardivel, Aubry; Tschopp, Juerg</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7081</span>),
    <span class="NLM_cas:pages">237-241</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Development of the acute and chronic inflammatory responses known as gout and pseudogout are assocd. with the deposition of monosodium urate (MSU) or calcium pyrophosphate dihydrate (CPPD) crystals, resp., in joints and periarticular tissues.  Although MSU crystals were first identified as the etiol. agent of gout in the eighteenth century and more recently as a danger signal' released from dying cells, little is known about the mol. mechanisms underlying MSU- or CPPD-induced inflammation.  Here we show that MSU and CPPD engage the caspase-1-activating NALP3 (also called cryopyrin) inflammasome, resulting in the prodn. of active interleukin (IL)-1β and IL-18.  Macrophages from mice deficient in various components of the inflammasome such as caspase-1, ASC and NALP3 are defective in crystal-induced IL-1β activation.  Moreover, an impaired neutrophil influx is found in an in vivo model of crystal-induced peritonitis in inflammasome-deficient mice or mice deficient in the IL-1β receptor (IL-1R).  These findings provide insight into the mol. processes underlying the inflammatory conditions of gout and pseudogout, and further support a pivotal role of the inflammasome in several autoinflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Z0Lgw8VSWLVg90H21EOLACvtfcHk0ljJOuHG898ZuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitFGitLg%253D&md5=e8694a6dc4096b44f07442df6feb791f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature04516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04516%26sid%3Dliteratum%253Aachs%26aulast%3DMartinon%26aufirst%3DF.%26aulast%3DP%25C3%25A9trilli%26aufirst%3DV.%26aulast%3DMayor%26aufirst%3DA.%26aulast%3DTardivel%26aufirst%3DA.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DGout-associated%2520uric%2520acid%2520crystals%2520activate%2520the%2520NALP3%2520inflammasome%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D237%26epage%3D241%26doi%3D10.1038%2Fnature04516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Halle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornung, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinheckel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golenbock, D. T.</span><span> </span><span class="NLM_article-title">The NALP3 inflammasome is involved in the innate immune response to amyloid-beta</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">865</span><span class="refDoi"> DOI: 10.1038/ni.1636</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fni.1636" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=18604209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=857-865&author=A.+Halleauthor=V.+Hornungauthor=G.+C.+Petzoldauthor=C.+R.+Stewartauthor=B.+G.+Monksauthor=T.+Reinheckelauthor=K.+A.+Fitzgeraldauthor=E.+Latzauthor=K.+J.+Mooreauthor=D.+T.+Golenbock&title=The+NALP3+inflammasome+is+involved+in+the+innate+immune+response+to+amyloid-beta&doi=10.1038%2Fni.1636"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The NALP3 inflammasome is involved in the innate immune response to amyloid-β</span></div><div class="casAuthors">Halle, Annett; Hornung, Veit; Petzold, Gabor C.; Stewart, Cameron R.; Monks, Brian G.; Reinheckel, Thomas; Fitzgerald, Katherine A.; Latz, Eicke; Moore, Kathryn J.; Golenbock, Douglas T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">857-865</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The fibrillar peptide amyloid-β (Aβ) has a chief function in the pathogenesis of Alzheimer's disease.  Interleukin 1β (IL-1β) is a key cytokine in the inflammatory response to Aβ.  Insol. materials such as crystals activate the inflammasome formed by the cytoplasmic receptor NALP3, which results in the release of IL-1β.  Here we identify the NALP3 inflammasome as a sensor of Aβ in a process involving the phagocytosis of Aβ and subsequent lysosomal damage and release of cathepsin B.  Furthermore, the IL-1β pathway was essential for the microglial synthesis of proinflammatory and neurotoxic factors, and the inflammasome, caspase-1 and IL-1β were crit. for the recruitment of microglia to exogenous Aβ in the brain.  Our findings suggest that activation of the NALP3 inflammasome is important for inflammation and tissue damage in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-KTzVDnDlb7Vg90H21EOLACvtfcHk0ljJOuHG898ZuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCmu74%253D&md5=49eaff7db252ca630e801c6ea015f77f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fni.1636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1636%26sid%3Dliteratum%253Aachs%26aulast%3DHalle%26aufirst%3DA.%26aulast%3DHornung%26aufirst%3DV.%26aulast%3DPetzold%26aufirst%3DG.%2BC.%26aulast%3DStewart%26aufirst%3DC.%2BR.%26aulast%3DMonks%26aufirst%3DB.%2BG.%26aulast%3DReinheckel%26aufirst%3DT.%26aulast%3DFitzgerald%26aufirst%3DK.%2BA.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DMoore%26aufirst%3DK.%2BJ.%26aulast%3DGolenbock%26aufirst%3DD.%2BT.%26atitle%3DThe%2520NALP3%2520inflammasome%2520is%2520involved%2520in%2520the%2520innate%2520immune%2520response%2520to%2520amyloid-beta%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D857%26epage%3D865%26doi%3D10.1038%2Fni.1636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Luheshi, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Castejon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, D.</span><span> </span><span class="NLM_article-title">Sphingosine regulates the NLRP3-inflammasome and IL-1β release from macrophages</span> <span class="citation_source-journal">Eur. J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">716</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span><span class="refDoi"> DOI: 10.1002/eji.201142079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1002%2Feji.201142079" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=716-725&author=N.+M.+Luheshiauthor=J.+A.+Gilesauthor=G.+Lopez-Castejonauthor=D.+Brough&title=Sphingosine+regulates+the+NLRP3-inflammasome+and+IL-1%CE%B2+release+from+macrophages&doi=10.1002%2Feji.201142079"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Feji.201142079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.201142079%26sid%3Dliteratum%253Aachs%26aulast%3DLuheshi%26aufirst%3DN.%2BM.%26aulast%3DGiles%26aufirst%3DJ.%2BA.%26aulast%3DLopez-Castejon%26aufirst%3DG.%26aulast%3DBrough%26aufirst%3DD.%26atitle%3DSphingosine%2520regulates%2520the%2520NLRP3-inflammasome%2520and%2520IL-1%25CE%25B2%2520release%2520from%2520macrophages%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D2012%26volume%3D42%26spage%3D716%26epage%3D725%26doi%3D10.1002%2Feji.201142079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Compan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroja-Mazo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Castejon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angosto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montero, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herranz, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelegrin, P.</span><span> </span><span class="NLM_article-title">Cell volume regulation modulates NLRP3 inflammasome activation</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">487</span><span class="NLM_x">–</span> <span class="NLM_lpage">500</span><span class="refDoi"> DOI: 10.1016/j.immuni.2012.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.immuni.2012.06.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=487-500&author=V.+Companauthor=A.+Baroja-Mazoauthor=G.+Lopez-Castejonauthor=A.+I.+Gomezauthor=C.+M.+Martinezauthor=D.+Angostoauthor=M.+T.+Monteroauthor=A.+S.+Herranzauthor=E.+Bazanauthor=D.+Reimersauthor=V.+Muleroauthor=P.+Pelegrin&title=Cell+volume+regulation+modulates+NLRP3+inflammasome+activation&doi=10.1016%2Fj.immuni.2012.06.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2012.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2012.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DCompan%26aufirst%3DV.%26aulast%3DBaroja-Mazo%26aufirst%3DA.%26aulast%3DLopez-Castejon%26aufirst%3DG.%26aulast%3DGomez%26aufirst%3DA.%2BI.%26aulast%3DMartinez%26aufirst%3DC.%2BM.%26aulast%3DAngosto%26aufirst%3DD.%26aulast%3DMontero%26aufirst%3DM.%2BT.%26aulast%3DHerranz%26aufirst%3DA.%2BS.%26aulast%3DBazan%26aufirst%3DE.%26aulast%3DReimers%26aufirst%3DD.%26aulast%3DMulero%26aufirst%3DV.%26aulast%3DPelegrin%26aufirst%3DP.%26atitle%3DCell%2520volume%2520regulation%2520modulates%2520NLRP3%2520inflammasome%2520activation%26jtitle%3DImmunity%26date%3D2012%26volume%3D37%26spage%3D487%26epage%3D500%26doi%3D10.1016%2Fj.immuni.2012.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Munoz-Planillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuffa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Colon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajendiran, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunez, G.</span><span> </span><span class="NLM_article-title">K<sup>+</sup> efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1142</span><span class="NLM_x">–</span> <span class="NLM_lpage">1153</span><span class="refDoi"> DOI: 10.1016/j.immuni.2013.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.immuni.2013.05.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=1142-1153&author=R.+Munoz-Planilloauthor=P.+Kuffaauthor=G.+Martinez-Colonauthor=B.+L.+Smithauthor=T.+M.+Rajendiranauthor=G.+Nunez&title=K%2B+efflux+is+the+common+trigger+of+NLRP3+inflammasome+activation+by+bacterial+toxins+and+particulate+matter&doi=10.1016%2Fj.immuni.2013.05.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2013.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2013.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz-Planillo%26aufirst%3DR.%26aulast%3DKuffa%26aufirst%3DP.%26aulast%3DMartinez-Colon%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DB.%2BL.%26aulast%3DRajendiran%26aufirst%3DT.%2BM.%26aulast%3DNunez%26aufirst%3DG.%26atitle%3DK%252B%2520efflux%2520is%2520the%2520common%2520trigger%2520of%2520NLRP3%2520inflammasome%2520activation%2520by%2520bacterial%2520toxins%2520and%2520particulate%2520matter%26jtitle%3DImmunity%26date%3D2013%26volume%3D38%26spage%3D1142%26epage%3D1153%26doi%3D10.1016%2Fj.immuni.2013.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Hornung, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauernfeind, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samstad, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kono, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rock, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span> </span><span class="NLM_article-title">Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">856</span><span class="refDoi"> DOI: 10.1038/ni.1631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fni.1631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=18604214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCmurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=847-856&author=V.+Hornungauthor=F.+Bauernfeindauthor=A.+Halleauthor=E.+O.+Samstadauthor=H.+Konoauthor=K.+L.+Rockauthor=K.+A.+Fitzgeraldauthor=E.+Latz&title=Silica+crystals+and+aluminum+salts+activate+the+NALP3+inflammasome+through+phagosomal+destabilization&doi=10.1038%2Fni.1631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization</span></div><div class="casAuthors">Hornung, Veit; Bauernfeind, Franz; Halle, Annett; Samstad, Eivind O.; Kono, Hajime; Rock, Kenneth L.; Fitzgerald, Katherine A.; Latz, Eicke</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">847-856</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhalation of silica crystals causes inflammation in the alveolar space.  Prolonged exposure to silica can lead to the development of silicosis, an irreversible, fibrotic pulmonary disease.  The mechanisms by which silica and other crystals activate immune cells are not well understood.  Here we demonstrate that silica and aluminum salt crystals activated inflammasomes formed by the cytoplasmic receptor NALP3.  NALP3 activation required phagocytosis of crystals, and this uptake subsequently led to lysosomal damage and rupture. 'Sterile' lysosomal damage (without crystals) also induced NALP3 activation, and inhibition of either phagosomal acidification or cathepsin B activity impaired NALP3 activation.  Our results indicate that the NALP3 inflammasome senses lysosomal damage as an endogenous 'danger' signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp4tZdMdqXM7Vg90H21EOLACvtfcHk0ljjE62ZfyIfjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCmurs%253D&md5=af9db69a6d9d8aed2f8119e6f9c22f49</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fni.1631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1631%26sid%3Dliteratum%253Aachs%26aulast%3DHornung%26aufirst%3DV.%26aulast%3DBauernfeind%26aufirst%3DF.%26aulast%3DHalle%26aufirst%3DA.%26aulast%3DSamstad%26aufirst%3DE.%2BO.%26aulast%3DKono%26aufirst%3DH.%26aulast%3DRock%26aufirst%3DK.%2BL.%26aulast%3DFitzgerald%26aufirst%3DK.%2BA.%26aulast%3DLatz%26aufirst%3DE.%26atitle%3DSilica%2520crystals%2520and%2520aluminum%2520salts%2520activate%2520the%2520NALP3%2520inflammasome%2520through%2520phagosomal%2520destabilization%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D847%26epage%3D856%26doi%3D10.1038%2Fni.1631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Zhou, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yazdi, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, J.</span><span> </span><span class="NLM_article-title">A role for mitochondria in NLRP3 inflammasome activation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">469</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span><span class="refDoi"> DOI: 10.1038/nature09663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnature09663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=21124315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2nsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=469&publication_year=2011&pages=221-225&author=R.+Zhouauthor=A.+S.+Yazdiauthor=P.+Menuauthor=J.+Tschopp&title=A+role+for+mitochondria+in+NLRP3+inflammasome+activation&doi=10.1038%2Fnature09663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A role for mitochondria in NLRP3 inflammasome activation</span></div><div class="casAuthors">Zhou, Rong-Bin; Yazdi, Amir S.; Menu, Philippe; Tschopp, Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">469</span>
        (<span class="NLM_cas:issue">7329</span>),
    <span class="NLM_cas:pages">221-225</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">An inflammatory response initiated by the NLRP3 inflammasome is triggered by a variety of situations of host 'danger', including infection and metabolic dysregulation.  Previous studies suggested that NLRP3 inflammasome activity is neg. regulated by autophagy and pos. regulated by reactive oxygen species (ROS) derived from an uncharacterized organelle.  Here we show that mitophagy/autophagy blockade leads to the accumulation of damaged, ROS-generating mitochondria, and this in turn activates the NLRP3 inflammasome.  Resting NLRP3 localizes to endoplasmic reticulum structures, whereas on inflammasome activation both NLRP3 and its adaptor ASC redistribute to the perinuclear space where they colocalize with endoplasmic reticulum and mitochondria organelle clusters.  Notably, both ROS generation and inflammasome activation are suppressed when mitochondrial activity is dysregulated by inhibition of the voltage-dependent anion channel.  This indicates that NLRP3 inflammasome senses mitochondrial dysfunction and may explain the frequent assocn. of mitochondrial damage with inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2S_8r04FZELVg90H21EOLACvtfcHk0lg77aaDf29knA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2nsLrE&md5=f1a13fa2ad8568fbd6c9467121aa1d9d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnature09663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09663%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DYazdi%26aufirst%3DA.%2BS.%26aulast%3DMenu%26aufirst%3DP.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DA%2520role%2520for%2520mitochondria%2520in%2520NLRP3%2520inflammasome%2520activation%26jtitle%3DNature%26date%3D2011%26volume%3D469%26spage%3D221%26epage%3D225%26doi%3D10.1038%2Fnature09663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Py, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vakifahmetoglu-Norberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span> </span><span class="NLM_article-title">Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span><span class="refDoi"> DOI: 10.1016/j.molcel.2012.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.molcel.2012.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=23246432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCku7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=331-338&author=B.+F.+Pyauthor=M.+S.+Kimauthor=H.+Vakifahmetoglu-Norbergauthor=J.+Yuan&title=Deubiquitination+of+NLRP3+by+BRCC3+critically+regulates+inflammasome+activity&doi=10.1016%2Fj.molcel.2012.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Deubiquitination of NLRP3 by BRCC3 Critically Regulates Inflammasome Activity</span></div><div class="casAuthors">Py, Benedicte F.; Kim, Mi-Sung; Vakifahmetoglu-Norberg, Helin; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">331-338</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">NLRP3 is an important pattern recognition receptor involved in mediating inflammasome activation in response to viral and bacterial infections as well as various proinflammatory stimuli assocd. with tissue damage or malfunction.  Upon activation, NLRP3 assembles a multimeric inflammasome complex comprising the adaptor ASC and the effector pro-caspase-1 to mediate the activation of caspase-1.  Although NLRP3 expression is induced by the NF-κB pathway, the posttranscriptional mol. mechanism controlling the activation of NLRP3 remains elusive.  Using both pharmacol. and mol. approaches, we show that the activation of NLRP3 inflammasome is regulated by a deubiquitination mechanism.  We further identify the deubiquitinating enzyme, BRCC3, as a crit. regulator of NLRP3 activity by promoting its deubiquitination and characterizing NLRP3 as a substrate for the cytosolic BRCC3-contg. BRISC complex.  Our results elucidate a regulatory mechanism involving BRCC3-dependent NLRP3 regulation and highlight NLRP3 ubiquitination as a potential therapeutic target for inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4BbAkb645obVg90H21EOLACvtfcHk0lg77aaDf29knA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCku7nL&md5=b84aeaec7e762a36b39abd55d705b30b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2012.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2012.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DPy%26aufirst%3DB.%2BF.%26aulast%3DKim%26aufirst%3DM.%2BS.%26aulast%3DVakifahmetoglu-Norberg%26aufirst%3DH.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DDeubiquitination%2520of%2520NLRP3%2520by%2520BRCC3%2520critically%2520regulates%2520inflammasome%2520activity%26jtitle%3DMol.%2520Cell%26date%3D2013%26volume%3D49%26spage%3D331%26epage%3D338%26doi%3D10.1016%2Fj.molcel.2012.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Duewell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kono, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rayner, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirois, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vladimer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauernfeind, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abela, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuñez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnurr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espevik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lien, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rock, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornung, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span> </span><span class="NLM_article-title">NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">464</span><span class="NLM_x">, </span> <span class="NLM_fpage">1357</span><span class="NLM_x">–</span> <span class="NLM_lpage">1361</span><span class="refDoi"> DOI: 10.1038/nature08938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnature08938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20428172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltl2mu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=464&publication_year=2010&pages=1357-1361&author=P.+Duewellauthor=H.+Konoauthor=K.+J.+Raynerauthor=C.+M.+Siroisauthor=G.+Vladimerauthor=F.+G.+Bauernfeindauthor=G.+S.+Abelaauthor=L.+Franchiauthor=G.+Nu%C3%B1ezauthor=M.+Schnurrauthor=T.+Espevikauthor=E.+Lienauthor=K.+A.+Fitzgeraldauthor=K.+L.+Rockauthor=K.+J.+Mooreauthor=S.+D.+Wrightauthor=V.+Hornungauthor=E.+Latz&title=NLRP3+inflammasomes+are+required+for+atherogenesis+and+activated+by+cholesterol+crystals&doi=10.1038%2Fnature08938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals</span></div><div class="casAuthors">Duewell, Peter; Kono, Hajime; Rayner, Katey J.; Sirois, Cherilyn M.; Vladimer, Gregory; Bauernfeind, Franz G.; Abela, George S.; Franchi, Luigi; Nunez, Gabriel; Schnurr, Max; Espevik, Terje; Lien, Egil; Fitzgerald, Katherine A.; Rock, Kenneth L.; Moore, Kathryn J.; Wright, Samuel D.; Hornung, Veit; Latz, Eicke</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">464</span>
        (<span class="NLM_cas:issue">7293</span>),
    <span class="NLM_cas:pages">1357-1361</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The inflammatory nature of atherosclerosis is well established but the agent(s) that incite inflammation in the artery wall remain largely unknown.  Germ-free animals are susceptible to atherosclerosis, suggesting that endogenous substances initiate the inflammation.  Mature atherosclerotic lesions contain macroscopic deposits of cholesterol crystals in the necrotic core, but their appearance late in atherogenesis had been thought to disqualify them as primary inflammatory stimuli.  However, using a new microscopic technique, the authors revealed that minute cholesterol crystals are present in early diet-induced atherosclerotic lesions and that their appearance in mice coincides with the first appearance of inflammatory cells.  Other cryst. substances can induce inflammation by stimulating the caspase-1-activating NLRP3 (NALP3 or cryopyrin) inflammasome, which results in cleavage and secretion of interleukin (IL)-1 family cytokines.  Here the authors show that cholesterol crystals activate the NLRP3 inflammasome in phagocytes in vitro in a process that involves phagolysosomal damage.  Similarly, when injected i.p., cholesterol crystals induce acute inflammation, which is impaired in mice deficient in components of the NLRP3 inflammasome, cathepsin B, cathepsin L or IL-1 mols.  Moreover, when mice deficient in low-d. lipoprotein receptor (LDLR) were bone-marrow transplanted with NLRP3-deficient, ASC (also known as PYCARD)-deficient or IL-1α/β-deficient bone marrow and fed on a high-cholesterol diet, they had markedly decreased early atherosclerosis and inflammasome-dependent IL-18 levels.  Minimally modified LDL can lead to cholesterol crystn. concomitant with NLRP3 inflammasome priming and activation in macrophages.  Although there is the possibility that oxidized LDL activates the NLRP3 inflammasome in vivo, the results demonstrate that cryst. cholesterol acts as an endogenous danger signal and its deposition in arteries or elsewhere is an early cause rather than a late consequence of inflammation.  These findings provide new insights into the pathogenesis of atherosclerosis and indicate new potential mol. targets for the therapy of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRFmxeie_MGrVg90H21EOLACvtfcHk0lg77aaDf29knA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltl2mu7w%253D&md5=593ac5b735c8d1151ae4f4b7861a3591</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnature08938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08938%26sid%3Dliteratum%253Aachs%26aulast%3DDuewell%26aufirst%3DP.%26aulast%3DKono%26aufirst%3DH.%26aulast%3DRayner%26aufirst%3DK.%2BJ.%26aulast%3DSirois%26aufirst%3DC.%2BM.%26aulast%3DVladimer%26aufirst%3DG.%26aulast%3DBauernfeind%26aufirst%3DF.%2BG.%26aulast%3DAbela%26aufirst%3DG.%2BS.%26aulast%3DFranchi%26aufirst%3DL.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26aulast%3DSchnurr%26aufirst%3DM.%26aulast%3DEspevik%26aufirst%3DT.%26aulast%3DLien%26aufirst%3DE.%26aulast%3DFitzgerald%26aufirst%3DK.%2BA.%26aulast%3DRock%26aufirst%3DK.%2BL.%26aulast%3DMoore%26aufirst%3DK.%2BJ.%26aulast%3DWright%26aufirst%3DS.%2BD.%26aulast%3DHornung%26aufirst%3DV.%26aulast%3DLatz%26aufirst%3DE.%26atitle%3DNLRP3%2520inflammasomes%2520are%2520required%2520for%2520atherogenesis%2520and%2520activated%2520by%2520cholesterol%2520crystals%26jtitle%3DNature%26date%3D2010%26volume%3D464%26spage%3D1357%26epage%3D1361%26doi%3D10.1038%2Fnature08938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Lee, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E. K.</span><span> </span><span class="NLM_article-title">Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.2337/db12-0420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.2337%2Fdb12-0420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=23086037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Grtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=194-204&author=H.+M.+Leeauthor=J.+J.+Kimauthor=H.+J.+Kimauthor=M.+Shongauthor=B.+J.+Kuauthor=E.+K.+Jo&title=Upregulated+NLRP3+inflammasome+activation+in+patients+with+type+2+diabetes&doi=10.2337%2Fdb12-0420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes</span></div><div class="casAuthors">Lee, Hye-Mi; Kim, Jwa-Jin; Kim, Hyun Jin; Shong, Minho; Ku, Bon Jeong; Jo, Eun-Kyeong</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">194-204</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Despite the recent attention focused on the roles of the nucleotide binding and oligomerization domain-like receptor family pyrin domain-contg. 3 (NLRP3) inflammasome in the pathogenesis of type 2 diabetes, little is known about the ex vivo profile of inflammasome activation in type 2 diabetic patients.  In this study, we investigated patterns of NLRP3 inflammasome activation in monocyte-derived macrophages (MDMs) from drug-naive patients with newly diagnosed type 2 diabetes.  Type 2 diabetic subjects had significantly increased mRNA and protein expression of NLRP3, apoptosis-assocd. speck-like protein contg. a CARD (ASC), and proinflammatory cytokines in MDMs cultured with autologous sera compared with healthy controls.  Upregulated interleukin (IL)-1β maturation, IL-18 secretion, and caspase-1 cleavage were obsd. in MDMs from type 2 diabetic patients after stimulation with various danger mols. (ATP, high-mobility group protein B1, free fatty acids, islet amyloid polypeptide, and monosodium uric acid crystals).  Mitochondrial reactive oxygen species and NLRP3 were required for IL-1β synthesis in MDMs.  Finally, 2 mo of therapy with the antidiabetic drug metformin significantly inhibited the maturation of IL-1β in MDMs from patients with type 2 diabetes through AMP-activated protein kinase (AMPK) activation.  Taken together, these data suggest that NLRP3 inflammasome activation is elevated in myeloid cells from type 2 diabetic patients and that antidiabetic treatment with metformin contributes to modulation of inflammasome activation in type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWj-f4MOH8DLVg90H21EOLACvtfcHk0lh1ezPKTlKtIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Grtg%253D%253D&md5=01921ee3ed7f038c650e8d339bd2e54f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2337%2Fdb12-0420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb12-0420%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BM.%26aulast%3DKim%26aufirst%3DJ.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DShong%26aufirst%3DM.%26aulast%3DKu%26aufirst%3DB.%2BJ.%26aulast%3DJo%26aufirst%3DE.%2BK.%26atitle%3DUpregulated%2520NLRP3%2520inflammasome%2520activation%2520in%2520patients%2520with%2520type%25202%2520diabetes%26jtitle%3DDiabetes%26date%3D2013%26volume%3D62%26spage%3D194%26epage%3D204%26doi%3D10.2337%2Fdb12-0420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Heneka, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kummer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delekate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira-Saecker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griep, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzeng, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelpi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golenbock, D. T.</span><span> </span><span class="NLM_article-title">NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">493</span><span class="NLM_x">, </span> <span class="NLM_fpage">674</span><span class="NLM_x">–</span> <span class="NLM_lpage">678</span><span class="refDoi"> DOI: 10.1038/nature11729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnature11729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=23254930" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=493&publication_year=2012&pages=674-678&author=M.+T.+Henekaauthor=M.+P.+Kummerauthor=A.+Stutzauthor=A.+Delekateauthor=S.+Schwartzauthor=A.+Vieira-Saeckerauthor=A.+Griepauthor=D.+Axtauthor=A.+Remusauthor=T.+C.+Tzengauthor=E.+Gelpiauthor=A.+Halleauthor=M.+Korteauthor=E.+Latzauthor=D.+T.+Golenbock&title=NLRP3+is+activated+in+Alzheimer%E2%80%99s+disease+and+contributes+to+pathology+in+APP%2FPS1+mice&doi=10.1038%2Fnature11729"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature11729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11729%26sid%3Dliteratum%253Aachs%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26aulast%3DKummer%26aufirst%3DM.%2BP.%26aulast%3DStutz%26aufirst%3DA.%26aulast%3DDelekate%26aufirst%3DA.%26aulast%3DSchwartz%26aufirst%3DS.%26aulast%3DVieira-Saecker%26aufirst%3DA.%26aulast%3DGriep%26aufirst%3DA.%26aulast%3DAxt%26aufirst%3DD.%26aulast%3DRemus%26aufirst%3DA.%26aulast%3DTzeng%26aufirst%3DT.%2BC.%26aulast%3DGelpi%26aufirst%3DE.%26aulast%3DHalle%26aufirst%3DA.%26aulast%3DKorte%26aufirst%3DM.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DGolenbock%26aufirst%3DD.%2BT.%26atitle%3DNLRP3%2520is%2520activated%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520contributes%2520to%2520pathology%2520in%2520APP%252FPS1%2520mice%26jtitle%3DNature%26date%3D2012%26volume%3D493%26spage%3D674%26epage%3D678%26doi%3D10.1038%2Fnature11729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Masters, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aksentijevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastner, D. L.</span><span> </span><span class="NLM_article-title">Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span><span class="refDoi"> DOI: 10.1146/annurev.immunol.25.022106.141627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1146%2Fannurev.immunol.25.022106.141627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=19302049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFSlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=621-668&author=S.+L.+Mastersauthor=A.+Simonauthor=I.+Aksentijevichauthor=D.+L.+Kastner&title=Horror+autoinflammaticus%3A+the+molecular+pathophysiology+of+autoinflammatory+disease&doi=10.1146%2Fannurev.immunol.25.022106.141627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Horror Autoinflammaticus: the molecular pathophysiology of autoinflammatory disease</span></div><div class="casAuthors">Masters, Seth L.; Simon, Anna; Aksentijevich, Ivona; Kastner, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">621-668</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The autoinflammatory diseases are characterized by seemingly unprovoked episodes of inflammation, without high-titer autoantibodies or antigen-specific T cells.  The concept was proposed ten years ago with the identification of the genes underlying hereditary periodic fever syndromes.  This nosol. has taken root because of the dramatic advances in our knowledge of the genetic basis of both mendelian and complex autoinflammatory diseases, and with the recognition that these illnesses derive from genetic variants of the innate immune system.  Herein we propose an updated classification scheme based on the mol. insights garnered over the past decade, supplanting a clin. classification that has served well but is opaque to the genetic, immunol., and therapeutic interrelationships now before us.  We define six categories of autoinflammatory disease: IL-1β activation disorders (inflammasomopathies), NF-κB activation syndromes, protein misfolding disorders, complement regulatory diseases, disturbances in cytokine signaling, and macrophage activation syndromes.  A system based on mol. pathophysiol. will bring greater clarity to our discourse while catalyzing new hypotheses both at the bench and at the beside.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodovOVe3sfuLVg90H21EOLACvtfcHk0lh1ezPKTlKtIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFSlt7w%253D&md5=9d5c2608de4e9c56630bc3197e5cf019</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.25.022106.141627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.25.022106.141627%26sid%3Dliteratum%253Aachs%26aulast%3DMasters%26aufirst%3DS.%2BL.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3DAksentijevich%26aufirst%3DI.%26aulast%3DKastner%26aufirst%3DD.%2BL.%26atitle%3DHorror%2520autoinflammaticus%253A%2520the%2520molecular%2520pathophysiology%2520of%2520autoinflammatory%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D27%26spage%3D621%26epage%3D668%26doi%3D10.1146%2Fannurev.immunol.25.022106.141627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Mitroulis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skendros, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritis, K.</span><span> </span><span class="NLM_article-title">Targeting IL-1β in disease; the expanding role of NLRP3 inflammasome</span> <span class="citation_source-journal">Eur. J. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span><span class="refDoi"> DOI: 10.1016/j.ejim.2010.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.ejim.2010.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20493414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVemt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=157-163&author=I.+Mitroulisauthor=P.+Skendrosauthor=K.+Ritis&title=Targeting+IL-1%CE%B2+in+disease%3B+the+expanding+role+of+NLRP3+inflammasome&doi=10.1016%2Fj.ejim.2010.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting IL-1β in disease; the expanding role of NLRP3 inflammasome</span></div><div class="casAuthors">Mitroulis, Ioannis; Skendros, Panagiotis; Ritis, Konstantinos</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Internal Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-163</span>CODEN:
                <span class="NLM_cas:coden">EJIMEJ</span>;
        ISSN:<span class="NLM_cas:issn">0953-6205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  NLRP3 inflammasome activation and IL-1β secretion have recently emerged as a central mechanism in the pathogenesis of disease.  Genetically defined syndromes like cryopyrin-assocd. periodic syndromes (CAPS, cryopyrinopathies) and familial Mediterranean fever (FMF) or diseases assocd. with NLRP3 activation by danger signals like gout, pseudogout, Alzheimer's disease or type 2 diabetes are included in this group of diseases.  The contribution of anakinra, a recombinant, nonglycosylated human IL-1 receptor antagonist, in both the identification and treatment of such syndromes was considerable.  Recently, rilonacept, a long-acting IL-1 receptor fusion protein, and canakinumab, a fully humanized anti-IL-1β monoclonal antibody, have been developed, with the intention to further extent IL-1β inhibition treatment strategies to a broader spectrum of disorders beyond the characterized autoinflammatory syndromes, offering a more favorable administration profile.  On the other hand, the developed caspase-1 inhibitors, even though effective in exptl. models, were not proven efficient in the treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyqt3vJqN3YLVg90H21EOLACvtfcHk0lh1ezPKTlKtIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVemt78%253D&md5=17e671744de78aa115234f4e7b11ef16</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejim.2010.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejim.2010.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DMitroulis%26aufirst%3DI.%26aulast%3DSkendros%26aufirst%3DP.%26aulast%3DRitis%26aufirst%3DK.%26atitle%3DTargeting%2520IL-1%25CE%25B2%2520in%2520disease%253B%2520the%2520expanding%2520role%2520of%2520NLRP3%2520inflammasome%26jtitle%3DEur.%2520J.%2520Intern.%2520Med.%26date%3D2010%26volume%3D21%26spage%3D157%26epage%3D163%26doi%3D10.1016%2Fj.ejim.2010.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Dubois, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rissmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, A. F.</span><span> </span><span class="NLM_article-title">Rilonacept and canakinumab</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">639</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span><span class="refDoi"> DOI: 10.1111/j.1365-2125.2011.03958.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1111%2Fj.1365-2125.2011.03958.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=21375570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVSktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=639-641&author=E.+A.+Duboisauthor=R.+Rissmannauthor=A.+F.+Cohen&title=Rilonacept+and+canakinumab&doi=10.1111%2Fj.1365-2125.2011.03958.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">New drug mechanisms</span></div><div class="casAuthors">Dubois, Eline A.; Rissmann, Robert; Cohen, Adam F.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">639-641</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  In this series we draw attention to medicines that have entered the European market with an entirely new mechanism of action.  Publication is not to be confused with endorsement of use in clin. practice.  Copyright to the images belongs to Leiden University, but use of the images (also available at http://coo.lumc.nl/trc) is free.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVS8lZQg8-RLVg90H21EOLACvtfcHk0ljyuAQkm_dP-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVSktrc%253D&md5=73bb0a428bbb5dac7fbddd83e09b4b4e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2011.03958.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2011.03958.x%26sid%3Dliteratum%253Aachs%26aulast%3DDubois%26aufirst%3DE.%2BA.%26aulast%3DRissmann%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DA.%2BF.%26atitle%3DRilonacept%2520and%2520canakinumab%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D71%26spage%3D639%26epage%3D641%26doi%3D10.1111%2Fj.1365-2125.2011.03958.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Kotz, J.</span><span> </span><span class="NLM_article-title">The gout pipeline crystallizes</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span><span class="refDoi"> DOI: 10.1038/nrd3748</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnrd3748" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=425-426&author=J.+Kotz&title=The+gout+pipeline+crystallizes&doi=10.1038%2Fnrd3748"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnrd3748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3748%26sid%3Dliteratum%253Aachs%26aulast%3DKotz%26aufirst%3DJ.%26atitle%3DThe%2520gout%2520pipeline%2520crystallizes%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D425%26epage%3D426%26doi%3D10.1038%2Fnrd3748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Galea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogungbenro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulme, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenhalgh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aarons, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grainger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothwell, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, P.</span><span> </span><span class="NLM_article-title">Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span><span class="refDoi"> DOI: 10.1038/jcbfm.2010.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fjcbfm.2010.103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20628399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=439-447&author=J.+Galeaauthor=K.+Ogungbenroauthor=S.+Hulmeauthor=A.+Greenhalghauthor=L.+Aaronsauthor=S.+Scarthauthor=P.+Hutchinsonauthor=S.+Graingerauthor=A.+Kingauthor=S.+J.+Hopkinsauthor=N.+Rothwellauthor=P.+Tyrrell&title=Intravenous+anakinra+can+achieve+experimentally+effective+concentrations+in+the+central+nervous+system+within+a+therapeutic+time+window%3A+results+of+a+dose-ranging+study&doi=10.1038%2Fjcbfm.2010.103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study</span></div><div class="casAuthors">Galea, James; Ogungbenro, Kayode; Hulme, Sharon; Greenhalgh, Andrew; Aarons, Leon; Scarth, Sylvia; Hutchinson, Peter; Grainger, Samantha; King, Andrew; Hopkins, Stephen J.; Rothwell, Nancy; Tyrrell, Pippa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">439-447</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The naturally occurring antagonist of interleukin-1, IL-1RA, is highly neuroprotective exptl., shows few adverse effects, and inhibits the systemic acute phase response to stroke.  A single regime pilot study showed slow penetration into cerebrospinal fluid (CSF) at exptl. therapeutic concns.  Twenty-five patients with subarachnoid hemorrhage (SAH) and external ventricular drains were sequentially allocated to five administration regimes, using i.v. bolus doses of 100 to 500 mg and 4 h i.v. infusions of IL-1RA ranging from 1 to 10 mg per kg per h.  Choice of regimes and timing of plasma and CSF sampling was informed by pharmacometric anal. of pilot study data.  Data were analyzed using nonlinear mixed effects modeling.  Plasma and CSF concns. of IL-1RA in all regimes were within the predicted intervals.  A 500-mg bolus followed by an i.v. infusion of IL-1RA at 10 mg per kg per h achieved exptl. therapeutic CSF concns. of IL-1RA within 45 min.  Exptl., neuroprotective CSF concns. in patients with SAH can be safely achieved within a therapeutic time window.  Pharmacokinetic anal. suggests that IL-1RA transport across the blood-CSF barrier in SAH is passive.  Identification of the practicality of this delivery regime allows further studies of efficacy of IL-1RA in acute cerebrovascular disease.  Journal of Cerebral Blood Flow & Metab. (2011) 31, 439-447; doi:10.1038/jcbfm.2010.103; published online 14 July 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBuGm9TEo7FrVg90H21EOLACvtfcHk0ljyuAQkm_dP-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOmt7g%253D&md5=009f226842530db3e2425f432ac34bf6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2010.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2010.103%26sid%3Dliteratum%253Aachs%26aulast%3DGalea%26aufirst%3DJ.%26aulast%3DOgungbenro%26aufirst%3DK.%26aulast%3DHulme%26aufirst%3DS.%26aulast%3DGreenhalgh%26aufirst%3DA.%26aulast%3DAarons%26aufirst%3DL.%26aulast%3DScarth%26aufirst%3DS.%26aulast%3DHutchinson%26aufirst%3DP.%26aulast%3DGrainger%26aufirst%3DS.%26aulast%3DKing%26aufirst%3DA.%26aulast%3DHopkins%26aufirst%3DS.%2BJ.%26aulast%3DRothwell%26aufirst%3DN.%26aulast%3DTyrrell%26aufirst%3DP.%26atitle%3DIntravenous%2520anakinra%2520can%2520achieve%2520experimentally%2520effective%2520concentrations%2520in%2520the%2520central%2520nervous%2520system%2520within%2520a%2520therapeutic%2520time%2520window%253A%2520results%2520of%2520a%2520dose-ranging%2520study%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2011%26volume%3D31%26spage%3D439%26epage%3D447%26doi%3D10.1038%2Fjcbfm.2010.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">So, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Smedt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revaz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, J.</span><span> </span><span class="NLM_article-title">A pilot study of IL-1 inhibition by anakinra in acute gout</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">R28</span><span class="refDoi"> DOI: 10.1186/ar2143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1186%2Far2143" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=R28&author=A.+Soauthor=T.+De+Smedtauthor=S.+Revazauthor=J.+Tschopp&title=A+pilot+study+of+IL-1+inhibition+by+anakinra+in+acute+gout&doi=10.1186%2Far2143"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1186%2Far2143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far2143%26sid%3Dliteratum%253Aachs%26aulast%3DSo%26aufirst%3DA.%26aulast%3DDe%2BSmedt%26aufirst%3DT.%26aulast%3DRevaz%26aufirst%3DS.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DA%2520pilot%2520study%2520of%2520IL-1%2520inhibition%2520by%2520anakinra%2520in%2520acute%2520gout%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2007%26volume%3D9%26spage%3DR28%26doi%3D10.1186%2Far2143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Fleishmann, R. M.</span><span> </span><span class="NLM_article-title">Safety of anakinra, a recombinant interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis and comparison to anti-TNF-α agents</span> <span class="citation_source-journal">Clin. Exp. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 27</span><span class="NLM_x">) </span> <span class="NLM_fpage">S35</span><span class="NLM_x">–</span> <span class="NLM_lpage">S41</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=S35-S41&issue=Suppl+27&author=R.+M.+Fleishmann&title=Safety+of+anakinra%2C+a+recombinant+interleukin-1+receptor+antagonist+%28r-metHuIL-1ra%29%2C+in+patients+with+rheumatoid+arthritis+and+comparison+to+anti-TNF-%CE%B1+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFleishmann%26aufirst%3DR.%2BM.%26atitle%3DSafety%2520of%2520anakinra%252C%2520a%2520recombinant%2520interleukin-1%2520receptor%2520antagonist%2520%2528r-metHuIL-1ra%2529%252C%2520in%2520patients%2520with%2520rheumatoid%2520arthritis%2520and%2520comparison%2520to%2520anti-TNF-%25CE%25B1%2520agents%26jtitle%3DClin.%2520Exp.%2520Rheumatol.%26date%3D2002%26volume%3D20%26issue%3DSuppl%252027%26spage%3DS35%26epage%3DS41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Hoffman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Throne, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amar, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kivitz, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belomestnov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yancopoulos, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellis, S. J.</span><span> </span><span class="NLM_article-title">Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2443</span><span class="NLM_x">–</span> <span class="NLM_lpage">2452</span><span class="refDoi"> DOI: 10.1002/art.23687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1002%2Fart.23687" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=18668535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCjtbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=2443-2452&author=H.+M.+Hoffmanauthor=M.+L.+Throneauthor=N.+J.+Amarauthor=M.+Sebaiauthor=A.+J.+Kivitzauthor=A.+Kavanaughauthor=S.+P.+Weinsteinauthor=P.+Belomestnovauthor=G.+D.+Yancopoulosauthor=N.+Stahlauthor=S.+J.+Mellis&title=Efficacy+and+safety+of+rilonacept+%28interleukin-1+Trap%29+in+patients+with+cryopyrin-associated+periodic+syndromes%3A+results+from+two+sequential+placebo-controlled+studies&doi=10.1002%2Fart.23687"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies</span></div><div class="casAuthors">Hoffman, Hal M.; Throne, Martin L.; Amar, N. J.; Sebai, Mohamed; Kivitz, Alan J.; Kavanaugh, Arthur; Weinstein, Steven P.; Belomestnov, Pavel; Yancopoulos, George D.; Stahl, Neil; Mellis, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2443-2452</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To assess the efficacy and safety of rilonacept (Interleukin-1 [IL-1] Trap), a long-acting and potent inhibitor of IL-1, in patients with cryopyrin-assocd. periodic syndromes (CAPS), including familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS).  Forty-seven adult patients with CAPS, as defined by mutations in the causative NLRP3 (CIAS1) gene and pathognomonic symptoms, were enrolled in 2 consecutive phase III studies.  Study 1 involved a 6-wk randomized double-blind comparison of weekly s.c. injections of rilonacept (160 mg) vs. placebo.  Study 2 consisted of 9 wk of single-blind treatment with rilonacept (part A), followed by a 9-wk, randomized, double-blind, placebo-controlled withdrawal procedure (part B).  Primary efficacy was evaluated using a validated composite key symptom score.  Forty-four patients completed both studies.  In study 1, rilonacept therapy reduced the group mean composite symptom score by 84%, compared with 13% with placebo therapy (primary end point; P < 0.0001 vs. placebo).  Rilonacept also significantly improved all other efficacy end points in study 1 (nos. of multisymptom and single-symptom disease flare days, single-symptom scores, physician's and patient's global assessments of disease activity, limitations in daily activities, and C-reactive protein and serum amyloid A [SAA] levels).  In study 2 part B, rilonacept was superior to placebo for maintaining the improvements seen with rilonacept therapy, as shown by all efficacy parameters (primary end point; P < 0.0001 vs. placebo).  Rilonacept was generally well tolerated; the most common adverse events were injection site reactions.  Treatment with weekly rilonacept provided marked and lasting improvement in the clin. signs and symptoms of CAPS, and normalized the levels of SAA from those assocd. with risk of developing amyloidosis.  Rilonacept exhibited a generally favorable safety and tolerability profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB7wpZXXBmmbVg90H21EOLACvtfcHk0lij44l69Bxhfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCjtbfL&md5=7fe18f2d56d72bc94656d1c524951d1c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fart.23687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.23687%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DH.%2BM.%26aulast%3DThrone%26aufirst%3DM.%2BL.%26aulast%3DAmar%26aufirst%3DN.%2BJ.%26aulast%3DSebai%26aufirst%3DM.%26aulast%3DKivitz%26aufirst%3DA.%2BJ.%26aulast%3DKavanaugh%26aufirst%3DA.%26aulast%3DWeinstein%26aufirst%3DS.%2BP.%26aulast%3DBelomestnov%26aufirst%3DP.%26aulast%3DYancopoulos%26aufirst%3DG.%2BD.%26aulast%3DStahl%26aufirst%3DN.%26aulast%3DMellis%26aufirst%3DS.%2BJ.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520rilonacept%2520%2528interleukin-1%2520Trap%2529%2520in%2520patients%2520with%2520cryopyrin-associated%2520periodic%2520syndromes%253A%2520results%2520from%2520two%2520sequential%2520placebo-controlled%2520studies%26jtitle%3DArthritis%2520Rheum.%26date%3D2008%26volume%3D58%26spage%3D2443%26epage%3D2452%26doi%3D10.1002%2Fart.23687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Fox, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaprakash, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCully, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldbach-Mansky, R.</span><span> </span><span class="NLM_article-title">The serum and cerebrospinal fluid pharmacokinetics of anakinra after intravenous administration to non-human primates</span> <span class="citation_source-journal">J. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">223</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span><span class="refDoi"> DOI: 10.1016/j.jneuroim.2010.03.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.jneuroim.2010.03.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20421138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVanu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2010&pages=138-140&author=E.+Foxauthor=N.+Jayaprakashauthor=T.+H.+Phamauthor=A.+Rowleyauthor=C.+L.+McCullyauthor=F.+Pucinoauthor=R.+Goldbach-Mansky&title=The+serum+and+cerebrospinal+fluid+pharmacokinetics+of+anakinra+after+intravenous+administration+to+non-human+primates&doi=10.1016%2Fj.jneuroim.2010.03.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The serum and cerebrospinal fluid pharmacokinetics of anakinra after intravenous administration to non-human primates</span></div><div class="casAuthors">Fox, Elizabeth; Jayaprakash, Nalini; Pham, Tuyet-Hang; Rowley, Ayana; McCully, Cynthia L.; Pucino, Frank; Goldbach-Mansky, Raphaela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">138-140</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Anakinra improves the central nervous system manifestations of neonatal-onset multisystem inflammatory disease, which is mediated by IL-1ss oversecretion.  The cerebrospinal fluid (CSF) penetration of the IL-1 receptor antagonist anakinra was studied in rhesus monkeys after i.v. doses of 3 and 10 mg/kg.  Drug exposure (area under concn.-time curve) in CSF was 0.28% of that in serum.  The av. CSF concn. at 3 mg/kg was 1.8 ng/mL, which is 30-fold higher than endogenous CSF levels of IL-1Ra.  The CSF penetration was not dose-dependent, indicating that the CSF penetration was not satd. in the 3 to 10 mg/kg dose range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF26EOHDXCGrVg90H21EOLACvtfcHk0lij44l69Bxhfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVanu7w%253D&md5=f05ea8e7c5c53b8a77d1fbce9cc27e2a</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2010.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2010.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DE.%26aulast%3DJayaprakash%26aufirst%3DN.%26aulast%3DPham%26aufirst%3DT.%2BH.%26aulast%3DRowley%26aufirst%3DA.%26aulast%3DMcCully%26aufirst%3DC.%2BL.%26aulast%3DPucino%26aufirst%3DF.%26aulast%3DGoldbach-Mansky%26aufirst%3DR.%26atitle%3DThe%2520serum%2520and%2520cerebrospinal%2520fluid%2520pharmacokinetics%2520of%2520anakinra%2520after%2520intravenous%2520administration%2520to%2520non-human%2520primates%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2010%26volume%3D223%26spage%3D138%26epage%3D140%26doi%3D10.1016%2Fj.jneuroim.2010.03.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Fautrel, B.</span><span> </span><span class="NLM_article-title">Economic benefits of optimizing anchor therapy for rheumatoid arthritis</span> <span class="citation_source-journal">Rheumatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">iv21</span><span class="NLM_x">–</span> <span class="NLM_lpage">iv26</span><span class="refDoi"> DOI: 10.1093/rheumatology/kes088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1093%2Frheumatology%2Fkes088" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=iv21-iv26&issue=Suppl+4&author=B.+Fautrel&title=Economic+benefits+of+optimizing+anchor+therapy+for+rheumatoid+arthritis&doi=10.1093%2Frheumatology%2Fkes088"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fkes088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fkes088%26sid%3Dliteratum%253Aachs%26aulast%3DFautrel%26aufirst%3DB.%26atitle%3DEconomic%2520benefits%2520of%2520optimizing%2520anchor%2520therapy%2520for%2520rheumatoid%2520arthritis%26jtitle%3DRheumatology%26date%3D2012%26volume%3D51%26issue%3DSuppl%25204%26spage%3Div21%26epage%3Div26%26doi%3D10.1093%2Frheumatology%2Fkes088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Brydges, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broderick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeough, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, H. M.</span><span> </span><span class="NLM_article-title">Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">4695</span><span class="NLM_x">–</span> <span class="NLM_lpage">4705</span><span class="refDoi"> DOI: 10.1172/JCI71543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1172%2FJCI71543" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=4695-4705&author=S.+D.+Brydgesauthor=L.+Broderickauthor=M.+D.+McGeoughauthor=C.+A.+Penaauthor=J.+L.+Muellerauthor=H.+M.+Hoffman&title=Divergence+of+IL-1%2C+IL-18%2C+and+cell+death+in+NLRP3+inflammasomopathies&doi=10.1172%2FJCI71543"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1172%2FJCI71543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI71543%26sid%3Dliteratum%253Aachs%26aulast%3DBrydges%26aufirst%3DS.%2BD.%26aulast%3DBroderick%26aufirst%3DL.%26aulast%3DMcGeough%26aufirst%3DM.%2BD.%26aulast%3DPena%26aufirst%3DC.%2BA.%26aulast%3DMueller%26aufirst%3DJ.%2BL.%26aulast%3DHoffman%26aufirst%3DH.%2BM.%26atitle%3DDivergence%2520of%2520IL-1%252C%2520IL-18%252C%2520and%2520cell%2520death%2520in%2520NLRP3%2520inflammasomopathies%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D4695%26epage%3D4705%26doi%3D10.1172%2FJCI71543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Chuang, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J. Y.</span><span> </span><span class="NLM_article-title">Natural compounds and aging: between autophagy and inflammasome</span> <span class="citation_source-journal">BioMed Res. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2014</span><span class="NLM_x">, </span> <span class="NLM_fpage">297293</span><span class="refDoi"> DOI: 10.1155/2014/297293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1155%2F2014%2F297293" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=297293&author=S.+Y.+Chuangauthor=C.+H.+Linauthor=J.+Y.+Fang&title=Natural+compounds+and+aging%3A+between+autophagy+and+inflammasome&doi=10.1155%2F2014%2F297293"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1155%2F2014%2F297293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F297293%26sid%3Dliteratum%253Aachs%26aulast%3DChuang%26aufirst%3DS.%2BY.%26aulast%3DLin%26aufirst%3DC.%2BH.%26aulast%3DFang%26aufirst%3DJ.%2BY.%26atitle%3DNatural%2520compounds%2520and%2520aging%253A%2520between%2520autophagy%2520and%2520inflammasome%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2014%26volume%3D2014%26spage%3D297293%26doi%3D10.1155%2F2014%2F297293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Riddle, M. C.</span><span> </span><span class="NLM_article-title">Editorial: sulfonylureas differ in effects on ischemic preconditioning--is it time to retire glyburide?</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span><span class="refDoi"> DOI: 10.1210/jc.2002-021971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1210%2Fjc.2002-021971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=12574174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252FmtlKrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2003&pages=528-530&author=M.+C.+Riddle&title=Editorial%3A+sulfonylureas+differ+in+effects+on+ischemic+preconditioning%2D%2Dis+it+time+to+retire+glyburide%3F&doi=10.1210%2Fjc.2002-021971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Editorial: sulfonylureas differ in effects on ischemic preconditioning--is it time to retire glyburide?</span></div><div class="casAuthors">Riddle Matthew C</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical endocrinology and metabolism</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">528-30</span>
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAe95u6G0R1E2yPDyEFiigfW6udTcc2ebXKUl91FLBn7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252FmtlKrsQ%253D%253D&md5=f24cbcb4e560bd943758819b115dce92</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1210%2Fjc.2002-021971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2002-021971%26sid%3Dliteratum%253Aachs%26aulast%3DRiddle%26aufirst%3DM.%2BC.%26atitle%3DEditorial%253A%2520sulfonylureas%2520differ%2520in%2520effects%2520on%2520ischemic%2520preconditioning--is%2520it%2520time%2520to%2520retire%2520glyburide%253F%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2003%26volume%3D88%26spage%3D528%26epage%3D530%26doi%3D10.1210%2Fjc.2002-021971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Kinard, T. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satin, L. S.</span><span> </span><span class="NLM_article-title">An ATP-sensitive Cl<sup>–</sup> channel current that is activated by cell swelling, cAMP, and glyburide in insulin-secreting cells</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1461</span><span class="NLM_x">–</span> <span class="NLM_lpage">1466</span><span class="refDoi"> DOI: 10.2337/diab.44.12.1461</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.2337%2Fdiab.44.12.1461" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1995&pages=1461-1466&author=T.+A.+S.+Kinardauthor=L.+S.+Satin&title=An+ATP-sensitive+Cl%E2%80%93+channel+current+that+is+activated+by+cell+swelling%2C+cAMP%2C+and+glyburide+in+insulin-secreting+cells&doi=10.2337%2Fdiab.44.12.1461"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2337%2Fdiab.44.12.1461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiab.44.12.1461%26sid%3Dliteratum%253Aachs%26aulast%3DKinard%26aufirst%3DT.%2BA.%2BS.%26aulast%3DSatin%26aufirst%3DL.%2BS.%26atitle%3DAn%2520ATP-sensitive%2520Cl%25E2%2580%2593%2520channel%2520current%2520that%2520is%2520activated%2520by%2520cell%2520swelling%252C%2520cAMP%252C%2520and%2520glyburide%2520in%2520insulin-secreting%2520cells%26jtitle%3DDiabetes%26date%3D1995%26volume%3D44%26spage%3D1461%26epage%3D1466%26doi%3D10.2337%2Fdiab.44.12.1461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Ashcroft, F. M.</span><span> </span><span class="NLM_article-title">ATP-sensitive potassium channelopathies: focus on insulin secretion</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">2047</span><span class="NLM_x">–</span> <span class="NLM_lpage">2058</span><span class="refDoi"> DOI: 10.1172/JCI25495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1172%2FJCI25495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=16075046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntFCmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=2047-2058&author=F.+M.+Ashcroft&title=ATP-sensitive+potassium+channelopathies%3A+focus+on+insulin+secretion&doi=10.1172%2FJCI25495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">ATP-sensitive potassium channelopathies: Focus on insulin secretion</span></div><div class="casAuthors">Ashcroft, Frances M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2047-2058</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  ATP-sensitive potassium (KATP) channels, so named because they are inhibited by intracellular ATP, play key physiol. roles in many tissues.  In pancreatic β cells, these channels regulate glucose-dependent insulin secretion and serve as the target for sulfonylurea drugs used to treat type 2 diabetes.  This review focuses on insulin secretory disorders, such as congenital hyperinsulinemia and neonatal diabetes, that result from mutations in KATP channel genes.  It also considers the extent to which defective regulation of KATP channel activity contributes to the etiol. of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfwlNV6Q4l6LVg90H21EOLACvtfcHk0li-DnsB4zNvZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntFCmt7s%253D&md5=6e46d4abf33b4364182d98aace1000ad</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1172%2FJCI25495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI25495%26sid%3Dliteratum%253Aachs%26aulast%3DAshcroft%26aufirst%3DF.%2BM.%26atitle%3DATP-sensitive%2520potassium%2520channelopathies%253A%2520focus%2520on%2520insulin%2520secretion%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26spage%3D2047%26epage%3D2058%26doi%3D10.1172%2FJCI25495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Perregaux, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNiff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laliberte, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawryluk, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peurano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stam, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffths, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombroski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span> </span><span class="NLM_article-title">Identification and characterization of a novel class of interleukin-1 post-translational processing inhibitors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=11561079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFWltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=187-197&author=D.+G.+Perregauxauthor=P.+McNiffauthor=R.+Laliberteauthor=N.+Hawrylukauthor=H.+Peuranoauthor=E.+Stamauthor=J.+Egglerauthor=R.+Griffthsauthor=M.+A.+Dombroskiauthor=C.+A.+Gabel&title=Identification+and+characterization+of+a+novel+class+of+interleukin-1+post-translational+processing+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of a novel class of interleukin-1 post-translational processing inhibitors</span></div><div class="casAuthors">Perregaux, David G.; McNiff, Patricia; Laliberte, Ronald; Hawryluk, Natalie; Peurano, Heather; Stam, Ethan; Eggler, Jim; Griffiths, Richard; Dombroski, Mark A.; Gabel, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">187-197</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Lipopolysaccharide (LPS)-activated monocytes and macrophages produce large quantities of pro-interleukin (IL)-1β but externalize little mature cytokine.  Efficient post-translational processing of the pro-cytokine occurs in vitro when these cells encounter a secretion stimulus such as ATP, cytolytic T cells, or hypotonic stress.  Each of these stimuli promotes rapid conversion of 31-kDa pro-IL-1β to its mature 17-kDa species and release of the 17-kDa cytokine.  In this study, two novel pharmacol. agents, CP-424,174 and CP-412,245, are identified as potent inhibitors of stimulus-coupled IL-1β post-translational processing.  These agents, both diarylsulfonylureas, block formation of mature IL-1β without increasing the amt. of pro-cytokine that is released extracellularly, and they inhibit independently of the secretion stimulus used.  Conditioned medium derived from LPS-activated/ATP-treated human monocytes maintained in the absence and presence of CP-424,174 contained comparable quantities of IL-6, tumor necrosis factor-α (TNFα), and IL-1RA, but 30-fold less IL-1β was generated in the test agent's presence.  As a result of this decrease, monocyte conditioned medium prepd. in the presence of CP-424,174 demonstrated a greatly diminished capacity to promote an IL-1-dependent response (induction of serum amyloid A synthesis by Hep3B cells).  Oral administration of CP-424,174 to mice resulted in inhibition of IL-1 in the absence of an effect on IL-6 and TNFα.  These novel agents, therefore, act as selective cytokine release inhibitors and define a new therapeutic approach for controlling IL-1 prodn. in inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnTnmtD12hMrVg90H21EOLACvtfcHk0li-DnsB4zNvZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFWltL8%253D&md5=5da5f7fd4689c1dd7dc8e187a8f9d02f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerregaux%26aufirst%3DD.%2BG.%26aulast%3DMcNiff%26aufirst%3DP.%26aulast%3DLaliberte%26aufirst%3DR.%26aulast%3DHawryluk%26aufirst%3DN.%26aulast%3DPeurano%26aufirst%3DH.%26aulast%3DStam%26aufirst%3DE.%26aulast%3DEggler%26aufirst%3DJ.%26aulast%3DGriffths%26aufirst%3DR.%26aulast%3DDombroski%26aufirst%3DM.%2BA.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520novel%2520class%2520of%2520interleukin-1%2520post-translational%2520processing%2520inhibitors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D187%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Hamon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luciani, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becq, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verrier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubartelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimini, G.</span><span> </span><span class="NLM_article-title">Interleukin-1β secretion is impaired by inhibitors of the atp binding cassette transporter, ABC1</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">2911</span><span class="NLM_x">–</span> <span class="NLM_lpage">2915</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1997&pages=2911-2915&author=Y.+Hamonauthor=M.+F.+Lucianiauthor=F.+Becqauthor=B.+Verrierauthor=A.+Rubartelliauthor=G.+Chimini&title=Interleukin-1%CE%B2+secretion+is+impaired+by+inhibitors+of+the+atp+binding+cassette+transporter%2C+ABC1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHamon%26aufirst%3DY.%26aulast%3DLuciani%26aufirst%3DM.%2BF.%26aulast%3DBecq%26aufirst%3DF.%26aulast%3DVerrier%26aufirst%3DB.%26aulast%3DRubartelli%26aufirst%3DA.%26aulast%3DChimini%26aufirst%3DG.%26atitle%3DInterleukin-1%25CE%25B2%2520secretion%2520is%2520impaired%2520by%2520inhibitors%2520of%2520the%2520atp%2520binding%2520cassette%2520transporter%252C%2520ABC1%26jtitle%3DBlood%26date%3D1997%26volume%3D90%26spage%3D2911%26epage%3D2915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Pétrilli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dostert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, J.</span><span> </span><span class="NLM_article-title">Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1583</span><span class="NLM_x">–</span> <span class="NLM_lpage">1589</span><span class="refDoi"> DOI: 10.1038/sj.cdd.4402195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fsj.cdd.4402195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=17599094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptFymurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=1583-1589&author=V.+P%C3%A9trilliauthor=S.+Papinauthor=C.+Dostertauthor=A.+Mayorauthor=F.+Martinonauthor=J.+Tschopp&title=Activation+of+the+NALP3+inflammasome+is+triggered+by+low+intracellular+potassium+concentration&doi=10.1038%2Fsj.cdd.4402195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration</span></div><div class="casAuthors">Petrilli, V.; Papin, S.; Dostert, C.; Mayor, A.; Martinon, F.; Tschopp, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1583-1589</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inflammasomes are Nod-like receptor(NLR)- and caspase-1-contg. cytoplasmic multiprotein complexes, which upon their assembly, process and activate the proinflammatory cytokines interleukin (IL)-1β and IL-18.  The inflammasomes harboring the NLR members NALP1, NALP3 and IPAF have been best characterized.  While the IPAF inflammasome is activated by bacterial flagellin, activation of the NALP3 inflammasome is triggered not only by several microbial components, but also by a plethora of danger-assocd. host mols. such as uric acid.  How NALP3 senses these chem. unrelated activators is not known.  Here, we provide evidence that activation of NALP3, but not of the IPAF inflammasome, is blocked by inhibiting K+ efflux from cells.  Low intracellular K+ is also a requirement for NALP1 inflammasome activation by lethal toxin of Bacillus anthracis.  In vitro, NALP inflammasome assembly and caspase-1 recruitment occurs spontaneously at K+ concns. below 90 mM, but is prevented at higher concns.  Thus, low intracellular K+ may be the least common trigger of NALP-inflammasome activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_dQ8Ub0nztrVg90H21EOLACvtfcHk0lgntfDDd2jeOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptFymurg%253D&md5=2bfb251f0e7b7d90ebed564cbd63c90f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4402195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4402195%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9trilli%26aufirst%3DV.%26aulast%3DPapin%26aufirst%3DS.%26aulast%3DDostert%26aufirst%3DC.%26aulast%3DMayor%26aufirst%3DA.%26aulast%3DMartinon%26aufirst%3DF.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DActivation%2520of%2520the%2520NALP3%2520inflammasome%2520is%2520triggered%2520by%2520low%2520intracellular%2520potassium%2520concentration%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2007%26volume%3D14%26spage%3D1583%26epage%3D1589%26doi%3D10.1038%2Fsj.cdd.4402195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Coelho, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavriani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixeira, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, P. C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudo-Hayashi, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muscará, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira-Filho, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargaftig, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taveres-de-Lima, W.</span><span> </span><span class="NLM_article-title">Lymphatic-borne IL-1β and the inducible isoform of nitric oxide synthase trigger the bronchial hyporesponsiveness after intestinal ischema/reperfusion in rats</span> <span class="citation_source-journal">Shock</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">694</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span><span class="refDoi"> DOI: 10.1097/shk.0b013e318053621d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1097%2Fshk.0b013e318053621d" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=694-699&author=F.+R.+Coelhoauthor=G.+Cavrianiauthor=A.+L.+Soaresauthor=S.+A.+Teixeiraauthor=P.+C.+L.+Almeidaauthor=L.+S.+Sudo-Hayashiauthor=M.+N.+Muscar%C3%A1author=R.+M.+Oliveira-Filhoauthor=B.+B.+Vargaftigauthor=W.+Taveres-de-Lima&title=Lymphatic-borne+IL-1%CE%B2+and+the+inducible+isoform+of+nitric+oxide+synthase+trigger+the+bronchial+hyporesponsiveness+after+intestinal+ischema%2Freperfusion+in+rats&doi=10.1097%2Fshk.0b013e318053621d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1097%2Fshk.0b013e318053621d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fshk.0b013e318053621d%26sid%3Dliteratum%253Aachs%26aulast%3DCoelho%26aufirst%3DF.%2BR.%26aulast%3DCavriani%26aufirst%3DG.%26aulast%3DSoares%26aufirst%3DA.%2BL.%26aulast%3DTeixeira%26aufirst%3DS.%2BA.%26aulast%3DAlmeida%26aufirst%3DP.%2BC.%2BL.%26aulast%3DSudo-Hayashi%26aufirst%3DL.%2BS.%26aulast%3DMuscar%25C3%25A1%26aufirst%3DM.%2BN.%26aulast%3DOliveira-Filho%26aufirst%3DR.%2BM.%26aulast%3DVargaftig%26aufirst%3DB.%2BB.%26aulast%3DTaveres-de-Lima%26aufirst%3DW.%26atitle%3DLymphatic-borne%2520IL-1%25CE%25B2%2520and%2520the%2520inducible%2520isoform%2520of%2520nitric%2520oxide%2520synthase%2520trigger%2520the%2520bronchial%2520hyporesponsiveness%2520after%2520intestinal%2520ischema%252Freperfusion%2520in%2520rats%26jtitle%3DShock%26date%3D2007%26volume%3D28%26spage%3D694%26epage%3D699%26doi%3D10.1097%2Fshk.0b013e318053621d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Lamkanfi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitari, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misaghi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, V. M.</span><span> </span><span class="NLM_article-title">Glyburide inhibits the Cryopyrin/Nalp3 inflammasome</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">187</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1083/jcb.200903124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1083%2Fjcb.200903124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=19805629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KrsrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2009&pages=61-70&author=M.+Lamkanfiauthor=J.+L.+Muellerauthor=A.+C.+Vitariauthor=S.+Misaghiauthor=A.+Fedorovaauthor=K.+Deshayesauthor=W.+P.+Leeauthor=H.+M.+Hoffmanauthor=V.+M.+Dixit&title=Glyburide+inhibits+the+Cryopyrin%2FNalp3+inflammasome&doi=10.1083%2Fjcb.200903124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Glyburide inhibits the Cryopyrin/Nalp3 inflammasome</span></div><div class="casAuthors">Lamkanfi, Mohamed; Mueller, James L.; Vitari, Alberto C.; Misaghi, Shahram; Fedorova, Anna; Deshayes, Kurt; Lee, Wyne P.; Hoffman, Hal M.; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-70</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Inflammasomes activate caspase-1 for processing and secretion of the cytokines interleukin-1β (IL-1β) and IL-18.  Cryopyrin/NALP3/NLRP3 is an essential component of inflammasomes triggered by microbial ligands, danger-assocd. mol. patterns (DAMPs), and crystals.  Inappropriate Cryopyrin activity has been incriminated in the pathogenesis of gouty arthritis, Alzheimer's, and silicosis.  Therefore, inhibitors of the Nalp3 inflammasome offer considerable therapeutic promise.  In this study, we show that the type 2 diabetes drug glyburide prevented activation of the Cryopyrin inflammasome.  Glyburide's cyclohexylurea group, which binds to ATPase (ATP)-sensitive K+ (KATP) channels for insulin secretion, is dispensable for inflammasome inhibition.  Macrophages lacking KATP subunits or ATP-binding cassette transporters also activate the Cryopyrin inflammasome normally.  Glyburide analogs inhibit ATP- but not hypothermia-induced IL-1β secretion from human monocytes expressing familial cold-assocd. autoinflammatory syndrome-assocd. Cryopyrin mutations, thus suggesting that inhibition occurs upstream of Cryopyrin.  Concurrent with the role of Cryopyrin in endotoxemia, glyburide significantly delays lipopolysaccharide-induced lethality in mice.  Therefore, glyburide is the first identified compd. to prevent Cryopyrin activation and microbial ligand-, DAMP-, and crystal-induced IL-1β secretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo-tgw9HwK8bVg90H21EOLACvtfcHk0lgntfDDd2jeOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KrsrjK&md5=00481f501e14377c75031ca5af6aad12</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200903124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200903124%26sid%3Dliteratum%253Aachs%26aulast%3DLamkanfi%26aufirst%3DM.%26aulast%3DMueller%26aufirst%3DJ.%2BL.%26aulast%3DVitari%26aufirst%3DA.%2BC.%26aulast%3DMisaghi%26aufirst%3DS.%26aulast%3DFedorova%26aufirst%3DA.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DW.%2BP.%26aulast%3DHoffman%26aufirst%3DH.%2BM.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DGlyburide%2520inhibits%2520the%2520Cryopyrin%252FNalp3%2520inflammasome%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2009%26volume%3D187%26spage%3D61%26epage%3D70%26doi%3D10.1083%2Fjcb.200903124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Coll, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, L. A. J.</span><span> </span><span class="NLM_article-title">The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e29539</span><span class="refDoi"> DOI: 10.1371/journal.pone.0029539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1371%2Fjournal.pone.0029539" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e29539&author=R.+C.+Collauthor=L.+A.+J.+O%E2%80%99Neill&title=The+cytokine+release+inhibitory+drug+CRID3+targets+ASC+oligomerisation+in+the+NLRP3+and+AIM2+inflammasomes&doi=10.1371%2Fjournal.pone.0029539"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0029539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0029539%26sid%3Dliteratum%253Aachs%26aulast%3DColl%26aufirst%3DR.%2BC.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%2BJ.%26atitle%3DThe%2520cytokine%2520release%2520inhibitory%2520drug%2520CRID3%2520targets%2520ASC%2520oligomerisation%2520in%2520the%2520NLRP3%2520and%2520AIM2%2520inflammasomes%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De29539%26doi%3D10.1371%2Fjournal.pone.0029539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Lottaz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beleznay, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickel, M.</span><span> </span><span class="NLM_article-title">Inhibition of ATP-binding cassette transporter downregulates interleukin-1β-mediated autocrine activation of human dermal fibroblasts</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span><span class="refDoi"> DOI: 10.1046/j.0022-202x.2001.01451.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1046%2Fj.0022-202x.2001.01451.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2001&pages=871-876&author=D.+Lottazauthor=Z.+Beleznayauthor=M.+Bickel&title=Inhibition+of+ATP-binding+cassette+transporter+downregulates+interleukin-1%CE%B2-mediated+autocrine+activation+of+human+dermal+fibroblasts&doi=10.1046%2Fj.0022-202x.2001.01451.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1046%2Fj.0022-202x.2001.01451.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0022-202x.2001.01451.x%26sid%3Dliteratum%253Aachs%26aulast%3DLottaz%26aufirst%3DD.%26aulast%3DBeleznay%26aufirst%3DZ.%26aulast%3DBickel%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520ATP-binding%2520cassette%2520transporter%2520downregulates%2520interleukin-1%25CE%25B2-mediated%2520autocrine%2520activation%2520of%2520human%2520dermal%2520fibroblasts%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2001%26volume%3D117%26spage%3D871%26epage%3D876%26doi%3D10.1046%2Fj.0022-202x.2001.01451.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Kuipers, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janczy, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Sluijs, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlaar, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolthuis, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roelofs, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flavell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutterwala, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bresser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leemans, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Poll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieland, C. W.</span><span> </span><span class="NLM_article-title">Ventilator-induced lung injury is mediated by the NLRP3 inflammasome</span> <span class="citation_source-journal">Anesthesiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">1104</span><span class="NLM_x">–</span> <span class="NLM_lpage">1115</span><span class="refDoi"> DOI: 10.1097/ALN.0b013e3182518bc0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1097%2FALN.0b013e3182518bc0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2012&pages=1104-1115&author=M.+T.+Kuipersauthor=H.+Aslamiauthor=J.+R.+Janczyauthor=K.+F.+van+der+Sluijsauthor=A.+P.+Vlaarauthor=E.+K.+Wolthuisauthor=G.+Choiauthor=J.+J.+Roelofsauthor=R.+A.+Flavellauthor=F.+S.+Sutterwalaauthor=P.+Bresserauthor=J.+C.+Leemansauthor=T.+van+der+Pollauthor=M.+J.+Schultzauthor=C.+W.+Wieland&title=Ventilator-induced+lung+injury+is+mediated+by+the+NLRP3+inflammasome&doi=10.1097%2FALN.0b013e3182518bc0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1097%2FALN.0b013e3182518bc0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FALN.0b013e3182518bc0%26sid%3Dliteratum%253Aachs%26aulast%3DKuipers%26aufirst%3DM.%2BT.%26aulast%3DAslami%26aufirst%3DH.%26aulast%3DJanczy%26aufirst%3DJ.%2BR.%26aulast%3Dvan%2Bder%2BSluijs%26aufirst%3DK.%2BF.%26aulast%3DVlaar%26aufirst%3DA.%2BP.%26aulast%3DWolthuis%26aufirst%3DE.%2BK.%26aulast%3DChoi%26aufirst%3DG.%26aulast%3DRoelofs%26aufirst%3DJ.%2BJ.%26aulast%3DFlavell%26aufirst%3DR.%2BA.%26aulast%3DSutterwala%26aufirst%3DF.%2BS.%26aulast%3DBresser%26aufirst%3DP.%26aulast%3DLeemans%26aufirst%3DJ.%2BC.%26aulast%3Dvan%2Bder%2BPoll%26aufirst%3DT.%26aulast%3DSchultz%26aufirst%3DM.%2BJ.%26aulast%3DWieland%26aufirst%3DC.%2BW.%26atitle%3DVentilator-induced%2520lung%2520injury%2520is%2520mediated%2520by%2520the%2520NLRP3%2520inflammasome%26jtitle%3DAnesthesiology%26date%3D2012%26volume%3D116%26spage%3D1104%26epage%3D1115%26doi%3D10.1097%2FALN.0b013e3182518bc0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Kerur, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarallo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastos-Carvalho, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschning, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelfand, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambati, J.</span><span> </span><span class="NLM_article-title">TLR-independent and P2X7-dependent signaling mediate Alu RNA-induced NLRP3 inflammasome activation in geographic atrophy</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7395</span><span class="NLM_x">–</span> <span class="NLM_lpage">7401</span><span class="refDoi"> DOI: 10.1167/iovs.13-12500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1167%2Fiovs.13-12500" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=7395-7401&author=N.+Kerurauthor=Y.+Hiranoauthor=V.+Taralloauthor=B.+J.+Fowlerauthor=A.+Bastos-Carvalhoauthor=T.+Yasumaauthor=R.+Yasumaauthor=Y.+Kimauthor=D.+R.+Hintonauthor=C.+J.+Kirschningauthor=B.+D.+Gelfandauthor=J.+Ambati&title=TLR-independent+and+P2X7-dependent+signaling+mediate+Alu+RNA-induced+NLRP3+inflammasome+activation+in+geographic+atrophy&doi=10.1167%2Fiovs.13-12500"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1167%2Fiovs.13-12500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.13-12500%26sid%3Dliteratum%253Aachs%26aulast%3DKerur%26aufirst%3DN.%26aulast%3DHirano%26aufirst%3DY.%26aulast%3DTarallo%26aufirst%3DV.%26aulast%3DFowler%26aufirst%3DB.%2BJ.%26aulast%3DBastos-Carvalho%26aufirst%3DA.%26aulast%3DYasuma%26aufirst%3DT.%26aulast%3DYasuma%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DHinton%26aufirst%3DD.%2BR.%26aulast%3DKirschning%26aufirst%3DC.%2BJ.%26aulast%3DGelfand%26aufirst%3DB.%2BD.%26aulast%3DAmbati%26aufirst%3DJ.%26atitle%3DTLR-independent%2520and%2520P2X7-dependent%2520signaling%2520mediate%2520Alu%2520RNA-induced%2520NLRP3%2520inflammasome%2520activation%2520in%2520geographic%2520atrophy%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2013%26volume%3D54%26spage%3D7395%26epage%3D7401%26doi%3D10.1167%2Fiovs.13-12500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Masters, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanian, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hull, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tannahill, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshihara, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullooly, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mielke, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coll, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, K. H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mok, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newsholme, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuñez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yodoi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavelle, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Neill, L. A. J.</span><span> </span><span class="NLM_article-title">Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span><span class="refDoi"> DOI: 10.1038/ni.1935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fni.1935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20835230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFCnsbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=897-904&author=S.+L.+Mastersauthor=A.+Dunneauthor=S.+L.+Subramanianauthor=R.+L.+Hullauthor=G.+M.+Tannahillauthor=F.+A.+Sharpauthor=C.+Beckerauthor=L.+Franchiauthor=E.+Yoshiharaauthor=Z.+Chenauthor=N.+Mulloolyauthor=L.+A.+Mielkeauthor=J.+Harrisauthor=R.+C.+Collauthor=K.+H.+G.+Millsauthor=K.+H.+Mokauthor=P.+Newsholmeauthor=G.+Nu%C3%B1ezauthor=J.+Yodoiauthor=S.+E.+Kahnauthor=E.+D.+Lavelleauthor=L.+A.+J.+O%27Neill&title=Activation+of+the+NLRP3+inflammasome+by+islet+amyloid+polypeptide+provides+a+mechanism+for+enhanced+IL-1%CE%B2+in+type+2+diabetes&doi=10.1038%2Fni.1935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes</span></div><div class="casAuthors">Masters, Seth L.; Dunne, Aisling; Subramanian, Shoba L.; Hull, Rebecca L.; Tannahill, Gillian M.; Sharp, Fiona A.; Becker, Christine; Franchi, Luigi; Yoshihara, Eiji; Chen, Zhe; Mullooly, Niamh; Mielke, Lisa A.; Harris, James; Coll, Rebecca C.; Mills, Kingston H. G.; Mok, K. Hun; Newsholme, Philip; Nunez, Gabriel; Yodoi, Junji; Kahn, Steven E.; Lavelle, Ed C.; O'Neill, Luke A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">897-904</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Interleukin 1β (IL-1β) is an important inflammatory mediator of type 2 diabetes.  Here we show that oligomers of islet amyloid polypeptide (IAPP), a protein that forms amyloid deposits in the pancreas during type 2 diabetes, triggered the NLRP3 inflammasome and generated mature IL-1β.  One therapy for type 2 diabetes, glyburide, suppressed IAPP-mediated IL-1β prodn. in vitro.  Processing of IL-1β initiated by IAPP first required priming, a process that involved glucose metab. and was facilitated by minimally oxidized low-d. lipoprotein.  Finally, mice transgenic for human IAPP had more IL-1β in pancreatic islets, which localized together with amyloid and macrophages.  Our findings identify previously unknown mechanisms in the pathogenesis of type 2 diabetes and treatment of pathol. caused by IAPP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj6D_CKHz2ILVg90H21EOLACvtfcHk0lisXR4hoLXtMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFCnsbzF&md5=bcd5b8d8afdbc3f0cf850dbe9fb029a0</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fni.1935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1935%26sid%3Dliteratum%253Aachs%26aulast%3DMasters%26aufirst%3DS.%2BL.%26aulast%3DDunne%26aufirst%3DA.%26aulast%3DSubramanian%26aufirst%3DS.%2BL.%26aulast%3DHull%26aufirst%3DR.%2BL.%26aulast%3DTannahill%26aufirst%3DG.%2BM.%26aulast%3DSharp%26aufirst%3DF.%2BA.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DFranchi%26aufirst%3DL.%26aulast%3DYoshihara%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DMullooly%26aufirst%3DN.%26aulast%3DMielke%26aufirst%3DL.%2BA.%26aulast%3DHarris%26aufirst%3DJ.%26aulast%3DColl%26aufirst%3DR.%2BC.%26aulast%3DMills%26aufirst%3DK.%2BH.%2BG.%26aulast%3DMok%26aufirst%3DK.%2BH.%26aulast%3DNewsholme%26aufirst%3DP.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26aulast%3DYodoi%26aufirst%3DJ.%26aulast%3DKahn%26aufirst%3DS.%2BE.%26aulast%3DLavelle%26aufirst%3DE.%2BD.%26aulast%3DO%2527Neill%26aufirst%3DL.%2BA.%2BJ.%26atitle%3DActivation%2520of%2520the%2520NLRP3%2520inflammasome%2520by%2520islet%2520amyloid%2520polypeptide%2520provides%2520a%2520mechanism%2520for%2520enhanced%2520IL-1%25CE%25B2%2520in%2520type%25202%2520diabetes%26jtitle%3DNat.%2520Immunol.%26date%3D2010%26volume%3D11%26spage%3D897%26epage%3D904%26doi%3D10.1038%2Fni.1935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Koh, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weehuizen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kager, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoogendijk, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bast, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peacock, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Poll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmetz, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiersinga, W. J.</span><span> </span><span class="NLM_article-title">Glyburide reduces bacterial dissemination in a mouse model of melioidosis</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e2500</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0002500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1371%2Fjournal.pntd.0002500" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=e2500&author=G.+C.+Kohauthor=T.+A.+Weehuizenauthor=K.+Breitbachauthor=K.+Krauseauthor=H.+K.+de+Jongauthor=L.+M.+Kagerauthor=A.+J.+Hoogendijkauthor=A.+Bastauthor=S.+J.+Peacockauthor=T.+van+der+Pollauthor=I.+Steinmetzauthor=W.+J.+Wiersinga&title=Glyburide+reduces+bacterial+dissemination+in+a+mouse+model+of+melioidosis&doi=10.1371%2Fjournal.pntd.0002500"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0002500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0002500%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DG.%2BC.%26aulast%3DWeehuizen%26aufirst%3DT.%2BA.%26aulast%3DBreitbach%26aufirst%3DK.%26aulast%3DKrause%26aufirst%3DK.%26aulast%3Dde%2BJong%26aufirst%3DH.%2BK.%26aulast%3DKager%26aufirst%3DL.%2BM.%26aulast%3DHoogendijk%26aufirst%3DA.%2BJ.%26aulast%3DBast%26aufirst%3DA.%26aulast%3DPeacock%26aufirst%3DS.%2BJ.%26aulast%3Dvan%2Bder%2BPoll%26aufirst%3DT.%26aulast%3DSteinmetz%26aufirst%3DI.%26aulast%3DWiersinga%26aufirst%3DW.%2BJ.%26atitle%3DGlyburide%2520reduces%2520bacterial%2520dissemination%2520in%2520a%2520mouse%2520model%2520of%2520melioidosis%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2013%26volume%3D7%26spage%3De2500%26doi%3D10.1371%2Fjournal.pntd.0002500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Hughes, F. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivar, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennis, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt-Thomas, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaner, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nietert, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spruill, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purves, J. T.</span><span> </span><span class="NLM_article-title">Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation</span> <span class="citation_source-journal">Am. J. Physiol. Renal Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">F299</span><span class="NLM_x">–</span> <span class="NLM_lpage">F308</span><span class="refDoi"> DOI: 10.1152/ajprenal.00297.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1152%2Fajprenal.00297.2013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2014&pages=F299-F308&author=F.+M.+J.+Hughesauthor=N.+P.+Vivarauthor=J.+G.+Kennisauthor=J.+D.+Pratt-Thomasauthor=D.+W.+Loweauthor=B.+E.+Shanerauthor=P.+J.+Nietertauthor=L.+S.+Spruillauthor=J.+T.+Purves&title=Inflammasomes+are+important+mediators+of+cyclophosphamide-induced+bladder+inflammation&doi=10.1152%2Fajprenal.00297.2013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1152%2Fajprenal.00297.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajprenal.00297.2013%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DF.%2BM.%2BJ.%26aulast%3DVivar%26aufirst%3DN.%2BP.%26aulast%3DKennis%26aufirst%3DJ.%2BG.%26aulast%3DPratt-Thomas%26aufirst%3DJ.%2BD.%26aulast%3DLowe%26aufirst%3DD.%2BW.%26aulast%3DShaner%26aufirst%3DB.%2BE.%26aulast%3DNietert%26aufirst%3DP.%2BJ.%26aulast%3DSpruill%26aufirst%3DL.%2BS.%26aulast%3DPurves%26aufirst%3DJ.%2BT.%26atitle%3DInflammasomes%2520are%2520important%2520mediators%2520of%2520cyclophosphamide-induced%2520bladder%2520inflammation%26jtitle%3DAm.%2520J.%2520Physiol.%2520Renal%2520Physiol.%26date%3D2014%26volume%3D306%26spage%3DF299%26epage%3DF308%26doi%3D10.1152%2Fajprenal.00297.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">York, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellanos, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabay, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantuzzi, G.</span><span> </span><span class="NLM_article-title">Inhibition of the nucleotide-binding domain, leucine-rich containing family, pyrin-domain containing 3 inflammasome reduces the severity of experimentally induced acute pancreatitis in obese mice</span> <span class="citation_source-journal">Transl. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1016/j.trsl.2014.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.trsl.2014.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=25152324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2ltrjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2014&pages=259-269&author=J.+M.+Yorkauthor=K.+J.+Castellanosauthor=R.+J.+Cabayauthor=G.+Fantuzzi&title=Inhibition+of+the+nucleotide-binding+domain%2C+leucine-rich+containing+family%2C+pyrin-domain+containing+3+inflammasome+reduces+the+severity+of+experimentally+induced+acute+pancreatitis+in+obese+mice&doi=10.1016%2Fj.trsl.2014.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the nucleotide-binding domain, leucine-rich containing family, pyrin-domain containing 3 inflammasome reduces the severity of experimentally induced acute pancreatitis in obese mice</span></div><div class="casAuthors">York, Jason M.; Castellanos, Karla J.; Cabay, Robert J.; Fantuzzi, Giamila</div><div class="citationInfo"><span class="NLM_cas:title">Translational Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">259-269</span>CODEN:
                <span class="NLM_cas:coden">TRRECL</span>;
        ISSN:<span class="NLM_cas:issn">1878-1810</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Acute pancreatitis (AP), although most often a mild and self-limiting inflammatory disease, worsens to a characteristically necrotic severe acute pancreatitis (SAP) in about 20% of cases.  Obesity, affecting more than one-third of American adults, is a risk factor for the development of SAP, but the exact mechanism of this assocn. has not been identified.  Coincidental with chronic low-grade inflammation, activation of the nucleotide-binding domain, leucine-rich contg. family, pyrin-domain contg. 3 (NLRP3) inflammasome increases with obesity.  Lean mice genetically deficient in specific components of the NLRP3 inflammasome are protected from exptl. induced AP, indicating a direct involvement of this pathway in AP pathophysiol.  We hypothesized that inhibition of the NLRP3 inflammasome with the sulfonylurea drug glyburide would reduce disease severity in obese mice with caerulein-induced SAP.  Treatment with glyburide led to significantly reduced relative pancreatic mass and water content and less pancreatic damage and cell death in genetically obese ob/ob mice with SAP compared with vehicle-treated obese SAP mice.  Glyburide administration in ob/ob mice with caerulein-induced SAP also resulted in significantly reduced serum levels of interleukin 6, lipase, and amylase and led to lower prodn. of lipopolysaccharide-stimulated interleukin 1β release in cultured peritoneal cells, compared with vehicle-treated ob/ob mice with SAP.  Together, these data indicate involvement of the NLRP3 inflammasome in obesity-assocd. SAP and expose the possible utility of its inhibition in prevention or treatment of SAP in obese individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps95hySoHMRrVg90H21EOLACvtfcHk0ljcvGXCNosyOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2ltrjO&md5=99de8ca21e7210f66446cd9ded64dc31</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.trsl.2014.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trsl.2014.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DYork%26aufirst%3DJ.%2BM.%26aulast%3DCastellanos%26aufirst%3DK.%2BJ.%26aulast%3DCabay%26aufirst%3DR.%2BJ.%26aulast%3DFantuzzi%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520the%2520nucleotide-binding%2520domain%252C%2520leucine-rich%2520containing%2520family%252C%2520pyrin-domain%2520containing%25203%2520inflammasome%2520reduces%2520the%2520severity%2520of%2520experimentally%2520induced%2520acute%2520pancreatitis%2520in%2520obese%2520mice%26jtitle%3DTransl.%2520Res.%26date%3D2014%26volume%3D164%26spage%3D259%26epage%3D269%26doi%3D10.1016%2Fj.trsl.2014.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Zeller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danchin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vahanian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorgis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueret, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyart, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deturck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabone, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machecourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leclercq, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drouet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bataille, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cambou, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrieres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, T.</span><span> </span><span class="NLM_article-title">Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">4993</span><span class="NLM_x">–</span> <span class="NLM_lpage">5002</span><span class="refDoi"> DOI: 10.1210/jc.2010-0449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1210%2Fjc.2010-0449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20702526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2nsbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2010&pages=4993-5002&author=M.+Zellerauthor=N.+Danchinauthor=D.+Simonauthor=A.+Vahanianauthor=L.+Lorgisauthor=Y.+Cottinauthor=J.+Berlandauthor=P.+Gueretauthor=P.+Wyartauthor=R.+Deturckauthor=X.+Taboneauthor=J.+Machecourtauthor=F.+Leclercqauthor=E.+Drouetauthor=G.+Mulakauthor=V.+Batailleauthor=J.+P.+Cambouauthor=J.+Ferrieresauthor=T.+Simon&title=Impact+of+type+of+preadmission+sulfonylureas+on+mortality+and+cardiovascular+outcomes+in+diabetic+patients+with+acute+myocardial+infarction&doi=10.1210%2Fjc.2010-0449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction</span></div><div class="casAuthors">Zeller, Marianne; Danchin, Nicolas; Simon, Dominique; Vahanian, Alec; Lorgis, Luc; Cottin, Yves; Berland, Jacques; Gueret, Pascal; Wyart, Pascal; Deturck, Regis; Tabone, Xavier; Machecourt, Jacques; Leclercq, Florence; Drouet, Elodie; Mulak, Genevieve; Bataille, Vincent; Cambou, Jean-Pierre; Ferrieres, Jean; Simon, Tabassome</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4993-5002</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The impact of antidiabetic medications on clin. outcomes in patients developing acute myocardial infarction (MI) is controversial.  We sought to det. whether in-hospital outcomes in patients who were on sulfonylureas (SUs) when they developed their MIs differed from that of diabetic patients not receiving SUs and whether clin. outcomes were related to the pancreatic cells specificity of SUs.  We analyzed the outcomes of the 1310 diabetic patients included in the nationwide French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction in 2005.  Medications used before the acute episode were recorded.  In-hospital complications were analyzed according to prior antidiabetic treatment.  Mortality was lower in patients previously treated with SUs (3.9%) vs. those on other oral medications (6.4%), insulin (9.4%), or no medication (8.4%) (P = 0.014).  Among SU-treated patients, in-hospital mortality was lower in patients receiving pancreatic cells-specific SUs (gliclazide or glimepiride) (2.7%), compared with glibenclamide (7.5%) (P = 0.019).  Arrhythmias and ischemic complications were also less frequent in patients receiving gliclazide/glimepiride.  The lower risk in patients receiving gliclazide/glimepiride vs. glibenclamide persisted after multivariate adjustment (odds ratio 0.15; 95% confidence interval 0.04-0.56) and in propensity score-matched cohorts.  In this nationwide registry of patients hospitalized for acute MI, no hazard was assocd. with the use of SUs before the acute episode.  In addn., patients previously receiving gliclazide/glimepiride had improved in-hospital outcomes, compared with those on glibenclamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiBAG9nO7Pv7Vg90H21EOLACvtfcHk0ljcvGXCNosyOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2nsbjK&md5=b3da8cef05b488df056b574a164953a5</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1210%2Fjc.2010-0449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2010-0449%26sid%3Dliteratum%253Aachs%26aulast%3DZeller%26aufirst%3DM.%26aulast%3DDanchin%26aufirst%3DN.%26aulast%3DSimon%26aufirst%3DD.%26aulast%3DVahanian%26aufirst%3DA.%26aulast%3DLorgis%26aufirst%3DL.%26aulast%3DCottin%26aufirst%3DY.%26aulast%3DBerland%26aufirst%3DJ.%26aulast%3DGueret%26aufirst%3DP.%26aulast%3DWyart%26aufirst%3DP.%26aulast%3DDeturck%26aufirst%3DR.%26aulast%3DTabone%26aufirst%3DX.%26aulast%3DMachecourt%26aufirst%3DJ.%26aulast%3DLeclercq%26aufirst%3DF.%26aulast%3DDrouet%26aufirst%3DE.%26aulast%3DMulak%26aufirst%3DG.%26aulast%3DBataille%26aufirst%3DV.%26aulast%3DCambou%26aufirst%3DJ.%2BP.%26aulast%3DFerrieres%26aufirst%3DJ.%26aulast%3DSimon%26aufirst%3DT.%26atitle%3DImpact%2520of%2520type%2520of%2520preadmission%2520sulfonylureas%2520on%2520mortality%2520and%2520cardiovascular%2520outcomes%2520in%2520diabetic%2520patients%2520with%2520acute%2520myocardial%2520infarction%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2010%26volume%3D95%26spage%3D4993%26epage%3D5002%26doi%3D10.1210%2Fjc.2010-0449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Marchetti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chojnacki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toldo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezzaroma, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tranchida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Tassell, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbate, A.</span><span> </span><span class="NLM_article-title">A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span><span class="refDoi"> DOI: 10.1097/FJC.0000000000000053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1097%2FFJC.0000000000000053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=316-322&author=C.+Marchettiauthor=J.+Chojnackiauthor=S.+Toldoauthor=E.+Mezzaromaauthor=N.+Tranchidaauthor=S.+W.+Roseauthor=M.+Federiciauthor=B.+W.+Van+Tassellauthor=S.+Zhangauthor=A.+Abbate&title=A+novel+pharmacologic+inhibitor+of+the+NLRP3+inflammasome+limits+myocardial+injury+after+ischemia-reperfusion+in+the+mouse&doi=10.1097%2FFJC.0000000000000053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1097%2FFJC.0000000000000053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFJC.0000000000000053%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetti%26aufirst%3DC.%26aulast%3DChojnacki%26aufirst%3DJ.%26aulast%3DToldo%26aufirst%3DS.%26aulast%3DMezzaroma%26aufirst%3DE.%26aulast%3DTranchida%26aufirst%3DN.%26aulast%3DRose%26aufirst%3DS.%2BW.%26aulast%3DFederici%26aufirst%3DM.%26aulast%3DVan%2BTassell%26aufirst%3DB.%2BW.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DAbbate%26aufirst%3DA.%26atitle%3DA%2520novel%2520pharmacologic%2520inhibitor%2520of%2520the%2520NLRP3%2520inflammasome%2520limits%2520myocardial%2520injury%2520after%2520ischemia-reperfusion%2520in%2520the%2520mouse%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2014%26volume%3D63%26spage%3D316%26epage%3D322%26doi%3D10.1097%2FFJC.0000000000000053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Marchetti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toldo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chojnacki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezzaroma, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salloum, F. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauro, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalavadia, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halquist, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Tassell, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbate, A.</span><span> </span><span class="NLM_article-title">Pharmacologic inhibition of the NLRP3 inflammasome preserves cardiac function after ischemic and non-ischemic injury in the mouse</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1097/FJC.0000000000000247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1097%2FFJC.0000000000000247" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2015&pages=1-8&author=C.+Marchettiauthor=S.+Toldoauthor=J.+Chojnackiauthor=E.+Mezzaromaauthor=K.+Liuauthor=F.+N.+Salloumauthor=A.+Nordioauthor=S.+Carboneauthor=A.+G.+Mauroauthor=A.+Dasauthor=A.+A.+Zalavadiaauthor=M.+S.+Halquistauthor=M.+Federiciauthor=B.+W.+Van+Tassellauthor=S.+Zhangauthor=A.+Abbate&title=Pharmacologic+inhibition+of+the+NLRP3+inflammasome+preserves+cardiac+function+after+ischemic+and+non-ischemic+injury+in+the+mouse&doi=10.1097%2FFJC.0000000000000247"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1097%2FFJC.0000000000000247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFJC.0000000000000247%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetti%26aufirst%3DC.%26aulast%3DToldo%26aufirst%3DS.%26aulast%3DChojnacki%26aufirst%3DJ.%26aulast%3DMezzaroma%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DSalloum%26aufirst%3DF.%2BN.%26aulast%3DNordio%26aufirst%3DA.%26aulast%3DCarbone%26aufirst%3DS.%26aulast%3DMauro%26aufirst%3DA.%2BG.%26aulast%3DDas%26aufirst%3DA.%26aulast%3DZalavadia%26aufirst%3DA.%2BA.%26aulast%3DHalquist%26aufirst%3DM.%2BS.%26aulast%3DFederici%26aufirst%3DM.%26aulast%3DVan%2BTassell%26aufirst%3DB.%2BW.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DAbbate%26aufirst%3DA.%26atitle%3DPharmacologic%2520inhibition%2520of%2520the%2520NLRP3%2520inflammasome%2520preserves%2520cardiac%2520function%2520after%2520ischemic%2520and%2520non-ischemic%2520injury%2520in%2520the%2520mouse%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2015%26volume%3D66%26spage%3D1%26epage%3D8%26doi%3D10.1097%2FFJC.0000000000000247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Laliberte, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perregaux, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoth, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peese, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombroski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span> </span><span class="NLM_article-title">Glutathione <i>S</i>-transferase omega 1–1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1β posttranslational processing</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">16567</span><span class="NLM_x">–</span> <span class="NLM_lpage">16578</span><span class="refDoi"> DOI: 10.1074/jbc.M211596200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M211596200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=16567-16578&author=R.+E.+Laliberteauthor=D.+G.+Perregauxauthor=L.+R.+Hothauthor=P.+J.+Rosnerauthor=C.+K.+Jordanauthor=K.+M.+Peeseauthor=J.+F.+Egglerauthor=M.+A.+Dombroskiauthor=K.+F.+Geogheganauthor=C.+A.+Gabel&title=Glutathione+S-transferase+omega+1%E2%80%931+is+a+target+of+cytokine+release+inhibitory+drugs+and+may+be+responsible+for+their+effect+on+interleukin-1%CE%B2+posttranslational+processing&doi=10.1074%2Fjbc.M211596200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M211596200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M211596200%26sid%3Dliteratum%253Aachs%26aulast%3DLaliberte%26aufirst%3DR.%2BE.%26aulast%3DPerregaux%26aufirst%3DD.%2BG.%26aulast%3DHoth%26aufirst%3DL.%2BR.%26aulast%3DRosner%26aufirst%3DP.%2BJ.%26aulast%3DJordan%26aufirst%3DC.%2BK.%26aulast%3DPeese%26aufirst%3DK.%2BM.%26aulast%3DEggler%26aufirst%3DJ.%2BF.%26aulast%3DDombroski%26aufirst%3DM.%2BA.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26atitle%3DGlutathione%2520S-transferase%2520omega%25201%25E2%2580%25931%2520is%2520a%2520target%2520of%2520cytokine%2520release%2520inhibitory%2520drugs%2520and%2520may%2520be%2520responsible%2520for%2520their%2520effect%2520on%2520interleukin-1%25CE%25B2%2520posttranslational%2520processing%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D16567%26epage%3D16578%26doi%3D10.1074%2Fjbc.M211596200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Coll, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chae, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Planillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inserra, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dungan, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croker, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haneklaus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastner, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Neill, L. A.</span><span> </span><span class="NLM_article-title">A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1038/nm.3806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnm.3806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=25686105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVSit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=248-255&author=R.+C.+Collauthor=A.+A.+Robertsonauthor=J.+J.+Chaeauthor=S.+C.+Higginsauthor=R.+Munoz-Planilloauthor=M.+C.+Inserraauthor=I.+Vetterauthor=L.+S.+Dunganauthor=B.+G.+Monksauthor=A.+Stutzauthor=D.+E.+Crokerauthor=M.+S.+Butlerauthor=M.+Haneklausauthor=C.+E.+Suttonauthor=G.+Nunezauthor=E.+Latzauthor=D.+L.+Kastnerauthor=K.+H.+Millsauthor=S.+L.+Mastersauthor=K.+Schroderauthor=M.+A.+Cooperauthor=L.+A.+O%27Neill&title=A+small-molecule+inhibitor+of+the+NLRP3+inflammasome+for+the+treatment+of+inflammatory+diseases&doi=10.1038%2Fnm.3806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases</span></div><div class="casAuthors">Coll, Rebecca C.; Robertson, Avril A. B.; Chae, Jae Jin; Higgins, Sarah C.; Munoz-Planillo, Raul; Inserra, Marco C.; Vetter, Irina; Dungan, Lara S.; Monks, Brian G.; Stutz, Andrea; Croker, Daniel E.; Butler, Mark S.; Haneklaus, Moritz; Sutton, Caroline E.; Nunez, Gabriel; Latz, Eicke; Kastner, Daniel L.; Mills, Kingston H. G.; Masters, Seth L.; Schroder, Kate; Cooper, Matthew A.; O'Neill, Luke A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">248-255</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The NOD-like receptor (NLR) family, pyrin domain-contg. protein 3 (NLRP3) inflammasome is a component of the inflammatory process, and its aberrant activation is pathogenic in inherited disorders such as cryopyrin-assocd. periodic syndrome (CAPS) and complex diseases such as multiple sclerosis, type 2 diabetes, Alzheimer's disease and atherosclerosis.  We describe the development of MCC950, a potent, selective, small-mol. inhibitor of NLRP3.  MCC950 blocked canonical and noncanonical NLRP3 activation at nanomolar concns.  MCC950 specifically inhibited activation of NLRP3 but not the AIM2, NLRC4 or NLRP1 inflammasomes.  MCC950 reduced interleukin-1β (IL-1β) prodn. in vivo and attenuated the severity of exptl. autoimmune encephalomyelitis (EAE), a disease model of multiple sclerosis.  Furthermore, MCC950 treatment rescued neonatal lethality in a mouse model of CAPS and was active in ex vivo samples from individuals with Muckle-Wells syndrome.  MCC950 is thus a potential therapeutic for NLRP3-assocd. syndromes, including autoinflammatory and autoimmune diseases, and a tool for further study of the NLRP3 inflammasome in human health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBPny7QJdNA7Vg90H21EOLACvtfcHk0liPDM-19TYLnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVSit7g%253D&md5=5ffe3683cc33ded3c3b18421e987cac5</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fnm.3806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3806%26sid%3Dliteratum%253Aachs%26aulast%3DColl%26aufirst%3DR.%2BC.%26aulast%3DRobertson%26aufirst%3DA.%2BA.%26aulast%3DChae%26aufirst%3DJ.%2BJ.%26aulast%3DHiggins%26aufirst%3DS.%2BC.%26aulast%3DMunoz-Planillo%26aufirst%3DR.%26aulast%3DInserra%26aufirst%3DM.%2BC.%26aulast%3DVetter%26aufirst%3DI.%26aulast%3DDungan%26aufirst%3DL.%2BS.%26aulast%3DMonks%26aufirst%3DB.%2BG.%26aulast%3DStutz%26aufirst%3DA.%26aulast%3DCroker%26aufirst%3DD.%2BE.%26aulast%3DButler%26aufirst%3DM.%2BS.%26aulast%3DHaneklaus%26aufirst%3DM.%26aulast%3DSutton%26aufirst%3DC.%2BE.%26aulast%3DNunez%26aufirst%3DG.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DKastner%26aufirst%3DD.%2BL.%26aulast%3DMills%26aufirst%3DK.%2BH.%26aulast%3DMasters%26aufirst%3DS.%2BL.%26aulast%3DSchroder%26aufirst%3DK.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26aulast%3DO%2527Neill%26aufirst%3DL.%2BA.%26atitle%3DA%2520small-molecule%2520inhibitor%2520of%2520the%2520NLRP3%2520inflammasome%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DNat.%2520Med.%26date%3D2015%26volume%3D21%26spage%3D248%26epage%3D255%26doi%3D10.1038%2Fnm.3806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Kean, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, W. W.</span><span> </span><span class="NLM_article-title">Auranofin</span> <span class="citation_source-journal">Rheumatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span><span class="refDoi"> DOI: 10.1093/rheumatology/36.5.560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1093%2Frheumatology%2F36.5.560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADyaK2sXkt1ert70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=560-572&author=W.+F.+Keanauthor=L.+Hartauthor=W.+W.+Buchanan&title=Auranofin&doi=10.1093%2Frheumatology%2F36.5.560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Auranofin</span></div><div class="casAuthors">Kean, W. F.; Hart, L.; Buchanan, W. W.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Rheumatology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">560-572</span>CODEN:
                <span class="NLM_cas:coden">BJRHDF</span>;
        ISSN:<span class="NLM_cas:issn">0263-7103</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 110 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDkbAGdbOko7Vg90H21EOLACvtfcHk0lhbpMpkXxZZ_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkt1ert70%253D&md5=988732af6d9cd13a33abb16114550422</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2F36.5.560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252F36.5.560%26sid%3Dliteratum%253Aachs%26aulast%3DKean%26aufirst%3DW.%2BF.%26aulast%3DHart%26aufirst%3DL.%26aulast%3DBuchanan%26aufirst%3DW.%2BW.%26atitle%3DAuranofin%26jtitle%3DRheumatology%26date%3D1997%26volume%3D36%26spage%3D560%26epage%3D572%26doi%3D10.1093%2Frheumatology%2F36.5.560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span> </span><span class="NLM_article-title">Auranofin inhibits overproduction of pro-inflammatory cytokines, cyclooxygenase expression and PGE2 production in macrophages</span> <span class="citation_source-journal">Arch. Pharmacal Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span><span class="refDoi"> DOI: 10.1007/s12272-008-1122-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1007%2Fs12272-008-1122-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=18277610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlyitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=67-74&author=S.+Hanauthor=K.+Kimauthor=H.+Kimauthor=J.+Kwonauthor=Y.+H.+Leeauthor=C.+K.+Leeauthor=Y.+Songauthor=S.+J.+Leeauthor=N.+Haauthor=K.+Kim&title=Auranofin+inhibits+overproduction+of+pro-inflammatory+cytokines%2C+cyclooxygenase+expression+and+PGE2+production+in+macrophages&doi=10.1007%2Fs12272-008-1122-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Auranofin inhibits overproduction of pro-inflammatory cytokines, cyclooxygenase expression and PGE2 production in macrophages</span></div><div class="casAuthors">Han, Shinha; Kim, Kwanghee; Kim, Hyunyul; Kwon, Jeunghak; Lee, Young-Hee; Lee, Chong-Kil; Song, Youngcheon; Lee, Sang-Jin; Ha, Namjoo; Kim, Kyungjae</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-74</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">Auranofin (AF), a gold compd., is an orally active therapeutic agent used to treat rheumatoid arthritis (RA), a self-perpetuating inflammatory disease.  RA is characterized by autoimmune-mediated proliferation of synovial cells that leads to inflammation, pain, and swelling in most major joints.  However, the mechanism as to how AF relieves RA symptoms has not been fully elucidated.  The object of this study was to examine the ability of AF to immunomodulate macrophages as antigen presenting cells (APCs).  Macrophages are recognized as playing an important role in the pathogenesis of RA, in that there is a relative abundance of macrophage-derived cytokines, such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and interleukin-6 (IL-6) in rheumatoid synovium.  In this work, we tested whether AF (2.5-20 mM) could inhibit inflammatory activity in the macrophage cell line RAW 264.7.  AF decreased prodn. of nitric oxide (NO) and the pro-inflammatory cytokines, TNF-α, IL-1β and IL-6 in macrophages.  Furthermore, AF inhibited cyclooxygenase-2 (COX-2)-dependent prostaglandin E2 (PGE2) prodn. in a concn.-dependent manner.  In conclusion, these findings may provide an explanation for the clin. effects of AF in patients with RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOHN1I7ymmfbVg90H21EOLACvtfcHk0lhbpMpkXxZZ_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlyitLo%253D&md5=d050c6b43efddff06983e01e1652354a</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1007%2Fs12272-008-1122-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-008-1122-9%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DKwon%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DC.%2BK.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DHa%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DK.%26atitle%3DAuranofin%2520inhibits%2520overproduction%2520of%2520pro-inflammatory%2520cytokines%252C%2520cyclooxygenase%2520expression%2520and%2520PGE2%2520production%2520in%2520macrophages%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2008%26volume%3D31%26spage%3D67%26epage%3D74%26doi%3D10.1007%2Fs12272-008-1122-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Yamada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashiramoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukui, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsubouchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, M.</span><span> </span><span class="NLM_article-title">Auranofin inhibits interleukin-1β-induced transcript of cyclooxygenase-2 on cultured human synoviocytes</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span><span class="refDoi"> DOI: 10.1016/S0014-2999(99)00707-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2FS0014-2999%2899%2900707-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10594346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADyaK1MXnslGqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=1999&pages=71-79&author=R.+Yamadaauthor=H.+Sanoauthor=T.+Hlaauthor=A.+Hashiramotoauthor=W.+Fukuiauthor=S.+Miyazakiauthor=M.+Kohnoauthor=Y.+Tsubouchiauthor=Y.+Kusakaauthor=M.+Kondo&title=Auranofin+inhibits+interleukin-1%CE%B2-induced+transcript+of+cyclooxygenase-2+on+cultured+human+synoviocytes&doi=10.1016%2FS0014-2999%2899%2900707-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Auranofin inhibits interleukin-1β-induced transcript of cyclooxygenase-2 on cultured human synoviocytes</span></div><div class="casAuthors">Yamada, R.; Sano, H.; Hla, T.; Hashiramoto, A.; Fukui, W.; Miyazaki, S.; Kohno, M.; Tsubouchi, Y.; Kusaka, Y.; Kondo, M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-79</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The aim of this study was to characterize the effects of auranofin (2,3,4,6-tetra-O-acetyl-l-thio-β-D-glucopyranosato-S) on cyclooxygenase expression and prostaglandin E2 synthesis on cultured human synovial fibroblast-like cells (synoviocytes).  Synoviocytes were treated with auranofin in the presence or absence of interleukin-1β.  Cultured supernatants were harvested for prostaglandin E2 synthesis.  Cyclooxygenase-1 and -2 expression was analyzed with Western and Northern blotting.  Translocation of nuclear factor-κ B p65 was detd. by immunostaining.  Cytotoxicity was measured with 51Cr release assay.  Auranofin attenuated interleukin-1β-induced prostaglandin E2 prodn. of the cells in a dose-dependent fashion.  Auranofin selectively suppressed interleukin-1β-induced cyclooxygenase-2 mRNA and protein expression of the cells without alteration of cyclooxygenase-1 expression.  Also, auranofin interfered with interleukin-1β-induced translocation of nuclear factor-κ B.  These inhibitory effects did not originate in the cytotoxicity of the agent.  Our data indicate that auranofin inhibits interleukin-1β-induced prostaglandin E2 synthesis and cyclooxygenase-2 expression via suppression of nuclear factor-κ B activation on synoviocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbI7AOUCPL6rVg90H21EOLACvtfcHk0lhbpMpkXxZZ_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslGqtL0%253D&md5=afc6721348429fb0108257e750995631</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2899%2900707-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252899%252900707-4%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DR.%26aulast%3DSano%26aufirst%3DH.%26aulast%3DHla%26aufirst%3DT.%26aulast%3DHashiramoto%26aufirst%3DA.%26aulast%3DFukui%26aufirst%3DW.%26aulast%3DMiyazaki%26aufirst%3DS.%26aulast%3DKohno%26aufirst%3DM.%26aulast%3DTsubouchi%26aufirst%3DY.%26aulast%3DKusaka%26aufirst%3DY.%26aulast%3DKondo%26aufirst%3DM.%26atitle%3DAuranofin%2520inhibits%2520interleukin-1%25CE%25B2-induced%2520transcript%2520of%2520cyclooxygenase-2%2520on%2520cultured%2520human%2520synoviocytes%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D385%26spage%3D71%26epage%3D79%26doi%3D10.1016%2FS0014-2999%2899%2900707-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Bondeson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundler, R.</span><span> </span><span class="NLM_article-title">Auranofin inhibits the induction of interleukin 1β and tumor necrosis factor α mRNA in macrophages</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1753</span><span class="NLM_x">–</span> <span class="NLM_lpage">1759</span><span class="refDoi"> DOI: 10.1016/0006-2952(95)02030-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2F0006-2952%2895%2902030-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1995&pages=1753-1759&author=J.+S.+Bondesonauthor=R.+Sundler&title=Auranofin+inhibits+the+induction+of+interleukin+1%CE%B2+and+tumor+necrosis+factor+%CE%B1+mRNA+in+macrophages&doi=10.1016%2F0006-2952%2895%2902030-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2895%2902030-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252895%252902030-6%26sid%3Dliteratum%253Aachs%26aulast%3DBondeson%26aufirst%3DJ.%2BS.%26aulast%3DSundler%26aufirst%3DR.%26atitle%3DAuranofin%2520inhibits%2520the%2520induction%2520of%2520interleukin%25201%25CE%25B2%2520and%2520tumor%2520necrosis%2520factor%2520%25CE%25B1%2520mRNA%2520in%2520macrophages%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D50%26spage%3D1753%26epage%3D1759%26doi%3D10.1016%2F0006-2952%2895%2902030-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Isakov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisman-Shomer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhar, M.</span><span> </span><span class="NLM_article-title">Suppression of the pro-inflammatory NLRP3/interleukin-1β pathway in macrophages by the thioredoxin reductase inhibitor auranofin</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Gen. Subj.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1840</span><span class="NLM_x">, </span> <span class="NLM_fpage">3153</span><span class="NLM_x">–</span> <span class="NLM_lpage">3161</span><span class="refDoi"> DOI: 10.1016/j.bbagen.2014.07.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.bbagen.2014.07.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=25065288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1KisLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1840&publication_year=2014&pages=3153-3161&author=E.+Isakovauthor=P.+Weisman-Shomerauthor=M.+Benhar&title=Suppression+of+the+pro-inflammatory+NLRP3%2Finterleukin-1%CE%B2+pathway+in+macrophages+by+the+thioredoxin+reductase+inhibitor+auranofin&doi=10.1016%2Fj.bbagen.2014.07.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of the pro-inflammatory NLRP3/interleukin-1β pathway in macrophages by the thioredoxin reductase inhibitor auranofin</span></div><div class="casAuthors">Isakov, Elina; Weisman-Shomer, Pnina; Benhar, Moran</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1840</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3153-3161</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The thioredoxin/thioredoxin reductase system, which is best known for its essential role in antioxidant defense and redox homeostasis, is increasingly implicated in the regulation of multiple cellular signaling pathways.  In the present study, we asked if the thioredoxin system in macrophages might regulate toll-like receptor 4 (TLR4)-dependent gene expression and consequent responses.Using microarray anal. we analyzed the effect of auranofin, a highly potent and specific inhibitor of thioredoxin reductase, on the transcriptional program activated in J774 macrophages by the TLR4 agonist, lipopolysaccharide (LPS).  We used quant. real-time PCR (qPCR), Western blotting, ELISA and cytotoxicity assays to confirm and extend the microarray results.  Global transcriptional profiling revealed that macrophage treatment with auranofin exerted a selective effect on LPS-induced gene expression, suppressing the induction of a small no. of genes.  Interestingly, among these suppressed genes were three members of the interleukin-1 (IL-1) family of genes, among which IL-1β was most affected.  QPCR analyses confirmed the repressive effects of auranofin on IL-1 genes.  In addn., qPCR and Western blot analyses showed that auranofin impaired TLR4-dependent induction of the inflammasome receptor NLRP3, which plays a crit. role in IL-1β processing.  Consistent with these findings, inflammasome-dependent release of IL-1β from stimulated macrophages was suppressed by auranofin as was inflammasome-mediated cell death.  Our findings suggest a regulatory role for the thioredoxin system in macrophage inflammatory signaling.  Inhibition of the thioredoxin system in macrophages exerts an anti-inflammatory effect by repressing the activation of the NLRP3/IL-1β pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV5WxiA-pLjbVg90H21EOLACvtfcHk0ljPtHmPhjLEIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1KisLbF&md5=bbd3a0041aaea5bf89f8099612db4b95</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2014.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2014.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DIsakov%26aufirst%3DE.%26aulast%3DWeisman-Shomer%26aufirst%3DP.%26aulast%3DBenhar%26aufirst%3DM.%26atitle%3DSuppression%2520of%2520the%2520pro-inflammatory%2520NLRP3%252Finterleukin-1%25CE%25B2%2520pathway%2520in%2520macrophages%2520by%2520the%2520thioredoxin%2520reductase%2520inhibitor%2520auranofin%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2014%26volume%3D1840%26spage%3D3153%26epage%3D3161%26doi%3D10.1016%2Fj.bbagen.2014.07.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Jeon, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jue, D. M.</span><span> </span><span class="NLM_article-title">Thiol-reactive metal compounds inhibit NF-κB activation by blocking IκB kinase</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">5981</span><span class="NLM_x">–</span> <span class="NLM_lpage">5989</span><span class="refDoi"> DOI: 10.4049/jimmunol.164.11.5981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.164.11.5981" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2000&pages=5981-5989&author=K.+I.+Jeonauthor=J.+Y.+Jeongauthor=D.+M.+Jue&title=Thiol-reactive+metal+compounds+inhibit+NF-%CE%BAB+activation+by+blocking+I%CE%BAB+kinase&doi=10.4049%2Fjimmunol.164.11.5981"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.164.11.5981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.164.11.5981%26sid%3Dliteratum%253Aachs%26aulast%3DJeon%26aufirst%3DK.%2BI.%26aulast%3DJeong%26aufirst%3DJ.%2BY.%26aulast%3DJue%26aufirst%3DD.%2BM.%26atitle%3DThiol-reactive%2520metal%2520compounds%2520inhibit%2520NF-%25CE%25BAB%2520activation%2520by%2520blocking%2520I%25CE%25BAB%2520kinase%26jtitle%3DJ.%2520Immunol.%26date%3D2000%26volume%3D164%26spage%3D5981%26epage%3D5989%26doi%3D10.4049%2Fjimmunol.164.11.5981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Bauernfeind, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes-Alnemri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornung, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span> </span><span class="NLM_article-title">Cutting edge: NF-κB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">183</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span><span class="refDoi"> DOI: 10.4049/jimmunol.0901363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.0901363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=19570822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFWgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2009&pages=787-791&author=F.+G.+Bauernfeindauthor=G.+Horvathauthor=A.+Stutzauthor=E.+S.+Alnemriauthor=K.+MacDonaldauthor=D.+Speertauthor=T.+Fernandes-Alnemriauthor=J.+Wuauthor=B.+G.+Monksauthor=K.+A.+Fitzgeraldauthor=V.+Hornungauthor=E.+Latz&title=Cutting+edge%3A+NF-%CE%BAB+activating+pattern+recognition+and+cytokine+receptors+license+NLRP3+inflammasome+activation+by+regulating+NLRP3+expression&doi=10.4049%2Fjimmunol.0901363"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression</span></div><div class="casAuthors">Bauernfeind, Franz G.; Horvath, Gabor; Stutz, Andrea; Alnemri, Emad S.; MacDonald, Kelly; Speert, David; Fernandes-Alnemri, Teresa; Wu, Jianghong; Monks, Brian G.; Fitzgerald, Katherine A.; Hornung, Veit; Latz, Eicke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">787-791</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The IL-1 family cytokines are regulated on transcriptional and posttranscriptional levels.  Pattern recognition and cytokine receptors control pro-IL-1β transcription whereas inflammasomes regulate the proteolytic processing of pro-IL-1β.  The NLRP3 inflammasome, however, assembles in response to extracellular ATP, pore-forming toxins, or crystals only in the presence of proinflammatory stimuli.  How the activation of gene transcription by signaling receptors enables NLRP3 activation remains elusive and controversial.  In this study, the authors show that cell priming through multiple signaling receptors induces NLRP3 expression, which the authors identified to be a crit. checkpoint for NLRP3 activation.  Signals provided by NF-κB activators are necessary but not sufficient for NLRP3 activation, and a second stimulus such as ATP or crystal-induced damage is required for NLRP3 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQUf4OrrejQ7Vg90H21EOLACvtfcHk0ljPtHmPhjLEIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFWgt78%253D&md5=1b04c9f756bb70d6292bd8bd5507ee1f</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0901363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0901363%26sid%3Dliteratum%253Aachs%26aulast%3DBauernfeind%26aufirst%3DF.%2BG.%26aulast%3DHorvath%26aufirst%3DG.%26aulast%3DStutz%26aufirst%3DA.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26aulast%3DMacDonald%26aufirst%3DK.%26aulast%3DSpeert%26aufirst%3DD.%26aulast%3DFernandes-Alnemri%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DMonks%26aufirst%3DB.%2BG.%26aulast%3DFitzgerald%26aufirst%3DK.%2BA.%26aulast%3DHornung%26aufirst%3DV.%26aulast%3DLatz%26aufirst%3DE.%26atitle%3DCutting%2520edge%253A%2520NF-%25CE%25BAB%2520activating%2520pattern%2520recognition%2520and%2520cytokine%2520receptors%2520license%2520NLRP3%2520inflammasome%2520activation%2520by%2520regulating%2520NLRP3%2520expression%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D183%26spage%3D787%26epage%3D791%26doi%3D10.4049%2Fjimmunol.0901363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Handel, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deFazio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherland, R. L.</span><span> </span><span class="NLM_article-title">Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">4497</span><span class="NLM_x">–</span> <span class="NLM_lpage">4501</span><span class="refDoi"> DOI: 10.1073/pnas.92.10.4497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1073%2Fpnas.92.10.4497" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=4497-4501&author=M.+L.+Handelauthor=C.+K.+Wattsauthor=A.+deFazioauthor=R.+O.+Dayauthor=R.+L.+Sutherland&title=Inhibition+of+AP-1+binding+and+transcription+by+gold+and+selenium+involving+conserved+cysteine+residues+in+Jun+and+Fos&doi=10.1073%2Fpnas.92.10.4497"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.10.4497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.10.4497%26sid%3Dliteratum%253Aachs%26aulast%3DHandel%26aufirst%3DM.%2BL.%26aulast%3DWatts%26aufirst%3DC.%2BK.%26aulast%3DdeFazio%26aufirst%3DA.%26aulast%3DDay%26aufirst%3DR.%2BO.%26aulast%3DSutherland%26aufirst%3DR.%2BL.%26atitle%3DInhibition%2520of%2520AP-1%2520binding%2520and%2520transcription%2520by%2520gold%2520and%2520selenium%2520involving%2520conserved%2520cysteine%2520residues%2520in%2520Jun%2520and%2520Fos%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1995%26volume%3D92%26spage%3D4497%26epage%3D4501%26doi%3D10.1073%2Fpnas.92.10.4497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Kataoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishizawa, M.</span><span> </span><span class="NLM_article-title">Induction of cellular antioxidative stress genes through heterodimeric transcription factor Nrf2/small Maf by antirheumatic gold(I) compounds</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">34074</span><span class="NLM_x">–</span> <span class="NLM_lpage">34081</span><span class="refDoi"> DOI: 10.1074/jbc.M105383200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M105383200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=34074-34081&author=K.+Kataokaauthor=H.+Handaauthor=M.+Nishizawa&title=Induction+of+cellular+antioxidative+stress+genes+through+heterodimeric+transcription+factor+Nrf2%2Fsmall+Maf+by+antirheumatic+gold%28I%29+compounds&doi=10.1074%2Fjbc.M105383200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M105383200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M105383200%26sid%3Dliteratum%253Aachs%26aulast%3DKataoka%26aufirst%3DK.%26aulast%3DHanda%26aufirst%3DH.%26aulast%3DNishizawa%26aufirst%3DM.%26atitle%3DInduction%2520of%2520cellular%2520antioxidative%2520stress%2520genes%2520through%2520heterodimeric%2520transcription%2520factor%2520Nrf2%252Fsmall%2520Maf%2520by%2520antirheumatic%2520gold%2528I%2529%2520compounds%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D34074%26epage%3D34081%26doi%3D10.1074%2Fjbc.M105383200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Youn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saitoh, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, D. H.</span><span> </span><span class="NLM_article-title">Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">866</span><span class="NLM_x">–</span> <span class="NLM_lpage">871</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2006.09.097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.bbrc.2006.09.097" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2006&pages=866-871&author=H.+S.+Younauthor=J.+Y.+Leeauthor=S.+I.+Saitohauthor=K.+Miyakeauthor=D.+H.+Hwang&title=Auranofin%2C+as+an+anti-rheumatic+gold+compound%2C+suppresses+LPS-induced+homodimerization+of+TLR4&doi=10.1016%2Fj.bbrc.2006.09.097"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2006.09.097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2006.09.097%26sid%3Dliteratum%253Aachs%26aulast%3DYoun%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DSaitoh%26aufirst%3DS.%2BI.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DHwang%26aufirst%3DD.%2BH.%26atitle%3DAuranofin%252C%2520as%2520an%2520anti-rheumatic%2520gold%2520compound%252C%2520suppresses%2520LPS-induced%2520homodimerization%2520of%2520TLR4%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D350%26spage%3D866%26epage%3D871%26doi%3D10.1016%2Fj.bbrc.2006.09.097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Newman, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirianni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mawhinney, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppla, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moayeri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, L. M.</span><span> </span><span class="NLM_article-title">Auranofin protects against anthrax lethal toxin-induced activation of the Nlrp1b inflammasome</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1028</span><span class="NLM_x">–</span> <span class="NLM_lpage">1035</span><span class="refDoi"> DOI: 10.1128/AAC.00772-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1128%2FAAC.00772-10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=1028-1035&author=Z.+L.+Newmanauthor=N.+Sirianniauthor=C.+Mawhinneyauthor=M.+S.+Leeauthor=S.+H.+Lepplaauthor=M.+Moayeriauthor=L.+M.+Johansen&title=Auranofin+protects+against+anthrax+lethal+toxin-induced+activation+of+the+Nlrp1b+inflammasome&doi=10.1128%2FAAC.00772-10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1128%2FAAC.00772-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00772-10%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DZ.%2BL.%26aulast%3DSirianni%26aufirst%3DN.%26aulast%3DMawhinney%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DLeppla%26aufirst%3DS.%2BH.%26aulast%3DMoayeri%26aufirst%3DM.%26aulast%3DJohansen%26aufirst%3DL.%2BM.%26atitle%3DAuranofin%2520protects%2520against%2520anthrax%2520lethal%2520toxin-induced%2520activation%2520of%2520the%2520Nlrp1b%2520inflammasome%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2011%26volume%3D55%26spage%3D1028%26epage%3D1035%26doi%3D10.1128%2FAAC.00772-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Gunatilleke, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrios, A. M.</span><span> </span><span class="NLM_article-title">Inhibition of lysosomal cysteine proteases by a series of Au(I) complexes: a detailed mechanistic investigation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3933</span><span class="NLM_x">–</span> <span class="NLM_lpage">3937</span><span class="refDoi"> DOI: 10.1021/jm060158f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060158f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3933-3937&author=S.+S.+Gunatillekeauthor=A.+M.+Barrios&title=Inhibition+of+lysosomal+cysteine+proteases+by+a+series+of+Au%28I%29+complexes%3A+a+detailed+mechanistic+investigation&doi=10.1021%2Fjm060158f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm060158f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060158f%26sid%3Dliteratum%253Aachs%26aulast%3DGunatilleke%26aufirst%3DS.%2BS.%26aulast%3DBarrios%26aufirst%3DA.%2BM.%26atitle%3DInhibition%2520of%2520lysosomal%2520cysteine%2520proteases%2520by%2520a%2520series%2520of%2520Au%2528I%2529%2520complexes%253A%2520a%2520detailed%2520mechanistic%2520investigation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3933%26epage%3D3937%26doi%3D10.1021%2Fjm060158f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Lopez-Sanchez, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrales, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Pedrera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aranda, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Ariza, A.</span><span> </span><span class="NLM_article-title">Pharmacological impairment of <i>S</i>-nitrosoglutathione or thioredoxin reductases augments protein <i>S</i>-Nitrosation in human hepatocarcinoma cells</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20332448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFCru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=415-421&author=L.+M.+Lopez-Sanchezauthor=F.+J.+Corralesauthor=C.+Lopez-Pedreraauthor=E.+Arandaauthor=A.+Rodriguez-Ariza&title=Pharmacological+impairment+of+S-nitrosoglutathione+or+thioredoxin+reductases+augments+protein+S-Nitrosation+in+human+hepatocarcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological impairment of S-Nitrosoglutathione or thioredoxin reductases augments protein S-nitrosation in human hepatocarcinoma cells</span></div><div class="casAuthors">Lopez-Sanchez, Laura M.; Corrales, Fernando J.; Lopez-Pedrera, Chary; Aranda, Enrique; Rodriguez-Ariza, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">415-422</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background/Aim: S-Nitrosoglutathione reductase (GSNOR) and thioredoxin enzyme systems participate in cellular defense against nitrosative stress.  Pharmacol. interventions against these enzyme systems might represent valuable strategies to impair S-nitrosothiol (SNO) homeostasis in tumor cells.  Materials and Methods: Human HepG2 cells were pre-treated with mithramycin A or auranofin and exposed to S-nitroso-L-cysteine.  GSNOR mRNA levels were analyzed by quant. real-time reverse transcriptase-polymerase chain reaction and S-nitrosated proteins were detected and purified using the biotin-switch approach.  Proteins were identified using electrospray ionization tandem mass spectrometry.  Results: Mithramycin interfered with GSNOR induction resulting in an increased cellular sensitivity to protein S-nitrosation.  Moreover, the thioredoxin reductase inhibitor auranofin also increased cellular susceptibility to S-nitrosoprotein formation.  The impairment of these two cellular defense systems against nitrosative stress resulted in different sets of S-nitrosated proteins, as revealed by the proteomics approach.  Conclusion: Our results suggest that pharmacol. intervention with mithramycin or auranofin may constitute promising tools for altering SNO homeostasis in tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0ysmmz7dON7Vg90H21EOLACvtfcHk0lgRCO68lucb-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFCru74%253D&md5=432b3df332768edccc448145dd62adc3</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Sanchez%26aufirst%3DL.%2BM.%26aulast%3DCorrales%26aufirst%3DF.%2BJ.%26aulast%3DLopez-Pedrera%26aufirst%3DC.%26aulast%3DAranda%26aufirst%3DE.%26aulast%3DRodriguez-Ariza%26aufirst%3DA.%26atitle%3DPharmacological%2520impairment%2520of%2520S-nitrosoglutathione%2520or%2520thioredoxin%2520reductases%2520augments%2520protein%2520S-Nitrosation%2520in%2520human%2520hepatocarcinoma%2520cells%26jtitle%3DAnticancer%2520Res.%26date%3D2010%26volume%3D30%26spage%3D415%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Krikavova, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutyra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travnicek, Z.</span><span> </span><span class="NLM_article-title">Gold(I)-triphenylphosphine complexes with hypoxanthine-derived ligands: in vitro evaluations of anticancer and anti-inflammatory activities</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e107373</span><span class="refDoi"> DOI: 10.1371/journal.pone.0107373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1371%2Fjournal.pone.0107373" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e107373&author=R.+Krikavovaauthor=J.+Hosekauthor=J.+Vancoauthor=J.+Hutyraauthor=Z.+Dvorakauthor=Z.+Travnicek&title=Gold%28I%29-triphenylphosphine+complexes+with+hypoxanthine-derived+ligands%3A+in+vitro+evaluations+of+anticancer+and+anti-inflammatory+activities&doi=10.1371%2Fjournal.pone.0107373"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0107373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0107373%26sid%3Dliteratum%253Aachs%26aulast%3DKrikavova%26aufirst%3DR.%26aulast%3DHosek%26aufirst%3DJ.%26aulast%3DVanco%26aufirst%3DJ.%26aulast%3DHutyra%26aufirst%3DJ.%26aulast%3DDvorak%26aufirst%3DZ.%26aulast%3DTravnicek%26aufirst%3DZ.%26atitle%3DGold%2528I%2529-triphenylphosphine%2520complexes%2520with%2520hypoxanthine-derived%2520ligands%253A%2520in%2520vitro%2520evaluations%2520of%2520anticancer%2520and%2520anti-inflammatory%2520activities%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De107373%26doi%3D10.1371%2Fjournal.pone.0107373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Seitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valbracht, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotz, M.</span><span> </span><span class="NLM_article-title">Gold sodium thiomalate and chloroquine inhibit cytokine production in monocytic THP-1 cells through distinct transcriptional and posttranslational mechanisms</span> <span class="citation_source-journal">J. Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">484</span><span class="refDoi"> DOI: 10.1023/B:JOCI.0000010424.41475.17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1023%2FB%3AJOCI.0000010424.41475.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=15031635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsF2n" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=477-484&author=M.+Seitzauthor=J.+Valbrachtauthor=J.+Quachauthor=M.+Lotz&title=Gold+sodium+thiomalate+and+chloroquine+inhibit+cytokine+production+in+monocytic+THP-1+cells+through+distinct+transcriptional+and+posttranslational+mechanisms&doi=10.1023%2FB%3AJOCI.0000010424.41475.17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Gold sodium thiomalate and chloroquine inhibit cytokine production in monocytic THP-1 cells through distinct transcriptional and posttranslational mechanisms</span></div><div class="casAuthors">Seitz, Michael; Valbracht, Jean; Quach, Jacqueline; Lotz, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">477-484</span>CODEN:
                <span class="NLM_cas:coden">JCIMDO</span>;
        ISSN:<span class="NLM_cas:issn">0271-9142</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Gold sodium thiomalate (GST), chloroquine (CQ), and methotrexate have been widely used in the therapy of rheumatoid arthritis and other inflammatory conditions.  Using the human monocytic cell line THP-1 we have analyzed effects of these drugs on cytokine prodn. and intracellular signaling.  GST and CQ were equally effective in reducing lipopolysaccharide (LPS)-induced IL-1β release while CQ was a more effective inhibitor of TNF-α prodn. than GST.  Methotrexate did not effect prodn. of these cytokines.  CQ reduced IL-1β mRNA expression and strongly inhibited phosphorylation of mitogen-activated protein kinase (MAPK) p38, and to a lesser extent c-Jun N-terminal kinase and extracellular signal-regulated kinase 1/2.  In contrast, GST did not effect cytokine mRNA expression or MAPK activation.  However, GST selectively inhibited the activity of the interleukin-1 converting enzyme (ICE)/caspase-1.  These data demonstrate that CQ inhibits IL-1β release from monocytes by interfering with pretranscriptional signaling and TNF-α release by posttranslational events whereas GST down-regulates IL-1β secretion by interfering with posttranslational IL-1β processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp36o-oRPxw4bVg90H21EOLACvtfcHk0lhdzIM60ajOnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsF2n&md5=cf7995559e48562c010b4d05a3d255d2</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1023%2FB%3AJOCI.0000010424.41475.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253AJOCI.0000010424.41475.17%26sid%3Dliteratum%253Aachs%26aulast%3DSeitz%26aufirst%3DM.%26aulast%3DValbracht%26aufirst%3DJ.%26aulast%3DQuach%26aufirst%3DJ.%26aulast%3DLotz%26aufirst%3DM.%26atitle%3DGold%2520sodium%2520thiomalate%2520and%2520chloroquine%2520inhibit%2520cytokine%2520production%2520in%2520monocytic%2520THP-1%2520cells%2520through%2520distinct%2520transcriptional%2520and%2520posttranslational%2520mechanisms%26jtitle%3DJ.%2520Clin.%2520Immunol.%26date%3D2003%26volume%3D23%26spage%3D477%26epage%3D484%26doi%3D10.1023%2FB%3AJOCI.0000010424.41475.17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Jeon, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jue, D. M.</span><span> </span><span class="NLM_article-title">Gold compound auranofin inhibits IκB kinase (IKK) by modifying Cys-179 of IKKβ subunit</span> <span class="citation_source-journal">Exp. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><span class="refDoi"> DOI: 10.1038/emm.2003.9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Femm.2003.9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=12754408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktV2gsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=61-66&author=K.+I.+Jeonauthor=M.+S.+Byunauthor=D.+M.+Jue&title=Gold+compound+auranofin+inhibits+I%CE%BAB+kinase+%28IKK%29+by+modifying+Cys-179+of+IKK%CE%B2+subunit&doi=10.1038%2Femm.2003.9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Gold compound auranofin inhibits IκB kinase (IKK) by modifying Cys-179 of IKKβ subunit</span></div><div class="casAuthors">Jeon, Kye-Im; Byun, Mi-Sun; Jue, Dae-Myung</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Molecular Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">61-66</span>CODEN:
                <span class="NLM_cas:coden">EMMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1226-3613</span>.
    
            (<span class="NLM_cas:orgname">Korean Society of Medical Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Antirheumatic gold compds. have been shown to inhibit NF-κB activation by blocking IκB kinase (IKK) activity.  To examine the possible inhibitory mechanism of gold compds., we expressed wild type and mutant forms of IKKα and β subunits in COS-7 cells and detd. the effect of gold on the activity of these enzymes both in vivo and in vitro.  Substitution of Cys-179 of IKKβ with alanine (C179A) rendered the enzyme to become resistant to inhibition by a gold compd. auranofin, however, similar protective effect was not obsd. with an equiv. level of IKKα (C178A) mutant expressed in the cells.  Auranofin inhibited constitutively active IKKα and β and variants; IKKα (S176E, S180E) or IKKβ (S177E, S181E), suggesting that gold directly cause inhibition of activated enzyme.  The different inhibitory effect of auranofin on IKKα (C178A) and IKKβ (C179A) mutants indicates that gold could inhibit the two subunits of IKK in a different mode, and the inhibition of NF-κB and IKK activation induced by inflammatory signals in gold-treated cells appears through its interaction with Cys-179 of IKKβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqtYQQpMEm37Vg90H21EOLACvtfcHk0lhdzIM60ajOnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktV2gsLY%253D&md5=d78da3e625a7137227e25e91c7e00d64</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Femm.2003.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femm.2003.9%26sid%3Dliteratum%253Aachs%26aulast%3DJeon%26aufirst%3DK.%2BI.%26aulast%3DByun%26aufirst%3DM.%2BS.%26aulast%3DJue%26aufirst%3DD.%2BM.%26atitle%3DGold%2520compound%2520auranofin%2520inhibits%2520I%25CE%25BAB%2520kinase%2520%2528IKK%2529%2520by%2520modifying%2520Cys-179%2520of%2520IKK%25CE%25B2%2520subunit%26jtitle%3DExp.%2520Mol.%2520Med.%26date%3D2003%26volume%3D35%26spage%3D61%26epage%3D66%26doi%3D10.1038%2Femm.2003.9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Travnicek, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starha, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silha, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchy, P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prazanova, G.</span><span> </span><span class="NLM_article-title">Anti-inflammatory active gold(I) complexes involving 6-substituted-purine derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4568</span><span class="NLM_x">–</span> <span class="NLM_lpage">4579</span><span class="refDoi"> DOI: 10.1021/jm201416p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201416p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4568-4579&author=Z.+Travnicekauthor=P.+Starhaauthor=J.+Vancoauthor=T.+Silhaauthor=J.+Hosekauthor=P.+Suchyauthor=G.+Prazanova&title=Anti-inflammatory+active+gold%28I%29+complexes+involving+6-substituted-purine+derivatives&doi=10.1021%2Fjm201416p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm201416p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201416p%26sid%3Dliteratum%253Aachs%26aulast%3DTravnicek%26aufirst%3DZ.%26aulast%3DStarha%26aufirst%3DP.%26aulast%3DVanco%26aufirst%3DJ.%26aulast%3DSilha%26aufirst%3DT.%26aulast%3DHosek%26aufirst%3DJ.%26aulast%3DSuchy%26aufirst%3DP.%26aulast%3DPrazanova%26aufirst%3DG.%26atitle%3DAnti-inflammatory%2520active%2520gold%2528I%2529%2520complexes%2520involving%25206-substituted-purine%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4568%26epage%3D4579%26doi%3D10.1021%2Fjm201416p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Shoeib, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, B. L.</span><span> </span><span class="NLM_article-title">Structural analysis of the anti-arthritic drug auranofin: its complexes with cysteine, selenocysteine and their fragmentation products</span> <span class="citation_source-journal">Inorg. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span><span class="refDoi"> DOI: 10.1016/j.ica.2009.08.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.ica.2009.08.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsV2js7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=184-192&author=T.+Shoeibauthor=D.+W.+Atkinsonauthor=B.+L.+Sharp&title=Structural+analysis+of+the+anti-arthritic+drug+auranofin%3A+its+complexes+with+cysteine%2C+selenocysteine+and+their+fragmentation+products&doi=10.1016%2Fj.ica.2009.08.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Structural analysis of the anti-arthritic drug Auranofin: Its complexes with cysteine, selenocysteine and their fragmentation products</span></div><div class="casAuthors">Shoeib, Tamer; Atkinson, Duncan W.; Sharp, Barry L.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganica Chimica Acta</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">184-192</span>CODEN:
                <span class="NLM_cas:coden">ICHAA3</span>;
        ISSN:<span class="NLM_cas:issn">0020-1693</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fragmentation of chloro(triethylphosphine)gold and the anti-arthritic agent Auranofin, [1-(thio-κS)-β-D-glucopyranose-2,3,4,6-tetraacetato](triethylphosphine)gold (1) in pos. mode MS electrospray conditions was studied in the presence of cysteine and Se-methylselenocysteine; relevant structures were calcd. at DFT B3LYP level of theory.  Evidence for all the complexes, with the exception of the Auranofin-selenocysteine complex, was obtained.  Several fragmentation products were examd. and their proposed structures reported.  Structural details of many exptl. obsd. ions including [Auranofin + H]+, [(Et3P)Au-cysteine]+ and [(Et3P)-Au-methylselenocysteine]+ were examd. by means of hybrid d. functional theory at the B3LYP/DZVP level.  Structural information and relative free energies are presented for several isomers of each ion considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow61KQUt_mgbVg90H21EOLACvtfcHk0ljJxtQWowm8wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2js7fF&md5=cc443cf99701fb551747dcc179571179</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.ica.2009.08.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ica.2009.08.034%26sid%3Dliteratum%253Aachs%26aulast%3DShoeib%26aufirst%3DT.%26aulast%3DAtkinson%26aufirst%3DD.%2BW.%26aulast%3DSharp%26aufirst%3DB.%2BL.%26atitle%3DStructural%2520analysis%2520of%2520the%2520anti-arthritic%2520drug%2520auranofin%253A%2520its%2520complexes%2520with%2520cysteine%252C%2520selenocysteine%2520and%2520their%2520fragmentation%2520products%26jtitle%3DInorg.%2520Chim.%2520Acta%26date%3D2010%26volume%3D363%26spage%3D184%26epage%3D192%26doi%3D10.1016%2Fj.ica.2009.08.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Krikavova, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchy, P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travnicek, Z.</span><span> </span><span class="NLM_article-title">Diverse in vitro and in vivo anti-inflammatory effects of trichlorido-gold(III) complexes with N6-benzyladenine derivatives</span> <span class="citation_source-journal">J. Inorg. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1016/j.jinorgbio.2014.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.jinorgbio.2014.02.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2014&pages=92-99&author=R.+Krikavovaauthor=J.+Hosekauthor=P.+Suchyauthor=J.+Vancoauthor=Z.+Travnicek&title=Diverse+in+vitro+and+in+vivo+anti-inflammatory+effects+of+trichlorido-gold%28III%29+complexes+with+N6-benzyladenine+derivatives&doi=10.1016%2Fj.jinorgbio.2014.02.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2014.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2014.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DKrikavova%26aufirst%3DR.%26aulast%3DHosek%26aufirst%3DJ.%26aulast%3DSuchy%26aufirst%3DP.%26aulast%3DVanco%26aufirst%3DJ.%26aulast%3DTravnicek%26aufirst%3DZ.%26atitle%3DDiverse%2520in%2520vitro%2520and%2520in%2520vivo%2520anti-inflammatory%2520effects%2520of%2520trichlorido-gold%2528III%2529%2520complexes%2520with%2520N6-benzyladenine%2520derivatives%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2014%26volume%3D134%26spage%3D92%26epage%3D99%26doi%3D10.1016%2Fj.jinorgbio.2014.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Tett, S. E.</span><span> </span><span class="NLM_article-title">Clinical pharmacokinetics of slow-acting antirheumatic drugs</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span><span class="refDoi"> DOI: 10.2165/00003088-199325050-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.2165%2F00003088-199325050-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=7904547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADyaK2c7hs1amtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1993&pages=392-407&author=S.+E.+Tett&title=Clinical+pharmacokinetics+of+slow-acting+antirheumatic+drugs&doi=10.2165%2F00003088-199325050-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacokinetics of slow-acting antirheumatic drugs</span></div><div class="casAuthors">Tett S E</div><div class="citationInfo"><span class="NLM_cas:title">Clinical pharmacokinetics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">392-407</span>
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    </div><div class="casAbstract">The pharmacokinetics of the slow acting antirheumatic drugs (SAARDs), hydroxychloroquine, chloroquine, penicillamine, the gold complexes and sulphasalazine, in humans have been studied.  For all these drugs, both in controlled clinical trials and in empirical observations from rheumatological practice, delays of several months are reported before full clinical effects are achieved.  Variability in response is also characteristic of these agents.  Pharmacokinetic factors may partially explain these clinical observations.  Delays in the achievement of steady-state concentrations or of concentrations likely to have a therapeutic benefit may occur because of slow drug accumulation.  Variable concentrations may arise after standard administered doses because of interindividual pharmacokinetic variability.  These factors are likely to contribute to the delay in response and the variable response, respectively.  Pharmacokinetics of the antimalarials, hydroxychloroquine and chloroquine, are characterised by extensive tissue sequestration with reported volumes of distribution in the thousands of litres.  Both drugs have reported elimination half-lives of greater than 1 month.  A 2- to 3-fold range occurs in the fraction of an oral dose absorbed from a tablet formulation.  Variable interindividual clearance is also reported.  Hydroxychloroquine and chloroquine are administered as racemates.  Enantioselective disposition of both compounds occurs, again with notable interindividual variability.  Sulphasalazine is split in the large intestine into sulphapyridine, proposed to be the active compound in rheumatoid arthritis, and mesalazine (5-aminosalicylic acid).  Sulphapyridine is metabolised partly by acetylation, the rate of which is under genetic control.  A wide range of sulphapyridine steady-state concentrations are reported after standard doses of sulphasalazine.  The gold complexes are administered either intramuscularly or in an oral form (auranofin).  Gold is widely distributed in the body.  Very long terminal elimination half-lives and slow accumulation rates are reported.  Penicillamine is administered orally.  Its bioavailability is variable and may decrease by as much as 70% in the presence of food, antacids and iron salts.  Penicillamine forms disulphide bonds with many proteins in the blood and tissues, creating potential slow release reservoirs of the drug.  Like the other SAARDs, gold complexes and penicillamine are found in a wide range of blood concentrations after administration in standard doses to different individuals.  More research must be conducted into the concentration-effect relationships of the SAARDs before the pharmacokinetic characteristics of these drugs can be used effectively to optimise patient therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQUav1UOXD0MINpW7w2tapOfW6udTcc2ebwCkCyJgOF6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7hs1amtA%253D%253D&md5=8298ec9857970d6578b0382c757474ad</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.2165%2F00003088-199325050-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-199325050-00005%26sid%3Dliteratum%253Aachs%26aulast%3DTett%26aufirst%3DS.%2BE.%26atitle%3DClinical%2520pharmacokinetics%2520of%2520slow-acting%2520antirheumatic%2520drugs%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D1993%26volume%3D25%26spage%3D392%26epage%3D407%26doi%3D10.2165%2F00003088-199325050-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Roberts, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schliesman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, C. F.,  3rd.</span><span> </span><span class="NLM_article-title">Kinetics and mechanism of the reaction between serum albumin and auranofin (and its isopropyl analogue) in vitro</span> <span class="citation_source-journal">Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">424</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span><span class="refDoi"> DOI: 10.1021/ic9414280</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic9414280" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1996&pages=424-433&author=J.+R.+Robertsauthor=J.+Xiaoauthor=B.+Schliesmanauthor=D.+J.+Parsonsauthor=C.+F.+Shaw&title=Kinetics+and+mechanism+of+the+reaction+between+serum+albumin+and+auranofin+%28and+its+isopropyl+analogue%29+in+vitro&doi=10.1021%2Fic9414280"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fic9414280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic9414280%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DJ.%2BR.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DSchliesman%26aufirst%3DB.%26aulast%3DParsons%26aufirst%3DD.%2BJ.%26aulast%3DShaw%26aufirst%3DC.%2BF.%26atitle%3DKinetics%2520and%2520mechanism%2520of%2520the%2520reaction%2520between%2520serum%2520albumin%2520and%2520auranofin%2520%2528and%2520its%2520isopropyl%2520analogue%2529%2520in%2520vitro%26jtitle%3DInorg.%2520Chem.%26date%3D1996%26volume%3D35%26spage%3D424%26epage%3D433%26doi%3D10.1021%2Fic9414280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Talib, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, S. F.</span><span> </span><span class="NLM_article-title">A mass spectrometric investigation of the binding of gold antiarthritic agents and the metabolite [Au(CN)2]<sup>−</sup> to human serum albumin</span> <span class="citation_source-journal">J. Biol. Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span><span class="refDoi"> DOI: 10.1007/s00775-006-0103-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1007%2Fs00775-006-0103-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=16791640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVyjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=559-570&author=J.+Talibauthor=J.+L.+Beckauthor=S.+F.+Ralph&title=A+mass+spectrometric+investigation+of+the+binding+of+gold+antiarthritic+agents+and+the+metabolite+%5BAu%28CN%292%5D%E2%88%92+to+human+serum+albumin&doi=10.1007%2Fs00775-006-0103-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">A mass spectrometric investigation of the binding of gold antiarthritic agents and the metabolite [Au(CN)2]- to human serum albumin</span></div><div class="casAuthors">Talib, Jihan; Beck, Jennifer L.; Ralph, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">559-570</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Electrospray ionization (ESI) mass spectrometry was used to examine the reactions of the clin. used antiarthritic agent [Au(S2O3)2]3-, and AuPEt3Cl, a deriv. of another clin. used agent auranofin, with human serum albumin (HSA) obtained from a human volunteer.  Both compds. reacted readily with HSA to form complexes contg. one or more covalently attached gold fragments.  In the case of AuPEt3Cl, binding was accompanied by the loss of the chloride ligand, while for [Au(S2O3)2]3- the mass spectral data indicated binding of Au(S2O3) groups.  Expts. performed using HSA with Cys34 blocked by reaction with iodoacetamide were consistent with reaction of both gold compds. with this amino acid.  Sep. blocking expts. using diethylpyrocarbonate and AuPEt3Cl also provided evidence for histidine residues acting as lower-affinity binding sites for this gold compd.  ESI mass spectra of solns. contg. [Au(S2O3)2]3- or [Au(CN)2]-, and HSA, provided evidence for the formation of protein complexes in which intact gold mols. were noncovalently bound.  In the case of [Au(S2O3)2]3-, these noncovalent complexes proved to be transitory in nature.  However, for [Au(CN)2]- a noncovalent complex contg. a single gold mol. bound to HSA was found to be stable, and constituted the main adduct formed in solns. contg. low-to-medium Au-to-HSA ratios.  Evidence was also obtained for the formation of a covalent adduct in which a single Au(CN) moiety was bonded to Cys34 of the protein.  AuPEt3Cl reacted to a much lower extent with HSA that had Cys34 modified by formation of a disulfide bond to added cysteine, than with unmodified HSA.  This suggests that the extent of modification of the protein in vivo may have an important influence on the transport and bioavailability of gold antiarthritic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsi-NRWEcW0rVg90H21EOLACvtfcHk0ljJxtQWowm8wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVyjtbo%253D&md5=5f4e5fd0a39bf4705bd8e39d18cd5d05</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1007%2Fs00775-006-0103-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-006-0103-z%26sid%3Dliteratum%253Aachs%26aulast%3DTalib%26aufirst%3DJ.%26aulast%3DBeck%26aufirst%3DJ.%2BL.%26aulast%3DRalph%26aufirst%3DS.%2BF.%26atitle%3DA%2520mass%2520spectrometric%2520investigation%2520of%2520the%2520binding%2520of%2520gold%2520antiarthritic%2520agents%2520and%2520the%2520metabolite%2520%255BAu%2528CN%25292%255D%25E2%2588%2592%2520to%2520human%2520serum%2520albumin%26jtitle%3DJ.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2006%26volume%3D11%26spage%3D559%26epage%3D570%26doi%3D10.1007%2Fs00775-006-0103-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Wallin, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCafferty, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godschmidt, M. S.</span><span> </span><span class="NLM_article-title">Incidence and management of diarrhea during longterm auranofin therapy</span> <span class="citation_source-journal">J. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1755</span><span class="NLM_x">–</span> <span class="NLM_lpage">1758</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=3265956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADyaL1M7lslCltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1988&pages=1755-1758&author=B.+A.+Wallinauthor=J.+P.+McCaffertyauthor=M.+J.+Foxauthor=D.+R.+Cooperauthor=M.+S.+Godschmidt&title=Incidence+and+management+of+diarrhea+during+longterm+auranofin+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Incidence and management of diarrhea during longterm auranofin therapy</span></div><div class="casAuthors">Wallin B A; McCafferty J P; Fox M J; Cooper D R; Goldschmidt M S</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of rheumatology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1755-8</span>
        ISSN:<span class="NLM_cas:issn">0315-162X</span>.
    </div><div class="casAbstract">The incidence, severity, and management of diarrhea during longterm administration of auranofin (AF)--up to 33 months--were evaluated prospectively in 137 patients with active rheumatoid arthritis.  At least 1 episode of diarrhea was reported in 101 patients (74%), but the rate of occurrence/patient-months of therapy was 24% (569 events/2,370 patient-months of treatment).  The monthly prevalence declined from a range of 30-40% during the initial 6 months to about 10% for patients treated for 18-24 months.  Most diarrhea was intermittent and mild; only 11 patients (8%) discontinued treatment because of diarrheal symptoms.  No intervention was required in 46 of the 101 patients affected.  In 44 others, loose stools were successfully managed with antidiarrheal medications, a reduction in dosage, or both.  Although diarrhea is a common event during AF administration, particularly early in therapy, for most patients it usually does not significantly interfere with treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSaUyrCkp1Jdlf1XRtfYM0dfW6udTcc2eY0aWqEYoCfN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M7lslCltQ%253D%253D&md5=6468f1dba43043d9c1cdd5fd9650422e</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWallin%26aufirst%3DB.%2BA.%26aulast%3DMcCafferty%26aufirst%3DJ.%2BP.%26aulast%3DFox%26aufirst%3DM.%2BJ.%26aulast%3DCooper%26aufirst%3DD.%2BR.%26aulast%3DGodschmidt%26aufirst%3DM.%2BS.%26atitle%3DIncidence%2520and%2520management%2520of%2520diarrhea%2520during%2520longterm%2520auranofin%2520therapy%26jtitle%3DJ.%2520Rheumatol.%26date%3D1988%26volume%3D15%26spage%3D1755%26epage%3D1758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Juliana, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes-Alnemri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Datta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solorzano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quong, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E. S.</span><span> </span><span class="NLM_article-title">Anti-inflammatory compounds parthenolide and bay 11–7082 are direct inhibitors of the inflammasome</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">9792</span><span class="NLM_x">–</span> <span class="NLM_lpage">9802</span><span class="refDoi"> DOI: 10.1074/jbc.M109.082305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M109.082305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20093358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjsFehtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=9792-9802&author=C.+Julianaauthor=T.+Fernandes-Alnemriauthor=J.+Wuauthor=P.+Dattaauthor=L.+Solorzanoauthor=J.+W.+Yuauthor=R.+Mengauthor=A.+A.+Quongauthor=E.+Latzauthor=C.+P.+Scottauthor=E.+S.+Alnemri&title=Anti-inflammatory+compounds+parthenolide+and+bay+11%E2%80%937082+are+direct+inhibitors+of+the+inflammasome&doi=10.1074%2Fjbc.M109.082305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome</span></div><div class="casAuthors">Juliana, Christine; Fernandes-Alnemri, Teresa; Wu, Jianghong; Datta, Pinaki; Solorzano, Leobaldo; Yu, Je-Wook; Meng, Rong; Quong, Andrew A.; Latz, Eicke; Scott, Charles P.; Alnemri, Emad S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">9792-9802</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Activation of the inflammasome generates the pro-inflammatory cytokines interleukin-1β and -18, which are important mediators of inflammation.  Abnormal activation of the inflammasome leads to many inflammatory diseases, including gout, silicosis, neurodegeneration, and genetically inherited periodic fever syndromes.  Therefore, identification of small mol. inhibitors that target the inflammasome is an important step toward developing effective therapeutics for the treatment of inflammation.  Here, we show that the herbal NF-κB inhibitory compd. parthenolide inhibits the activity of multiple inflammasomes in macrophages by directly inhibiting the protease activity of caspase-1.  Addnl. investigations of other NF-κB inhibitors revealed that the synthetic IκB kinase-β inhibitor Bay 11-7082 and structurally related vinyl sulfone compds. selectively inhibit NLRP3 inflammasome activity in macrophages independent of their inhibitory effect on NF-κB activity.  In vitro assays of the effect of parthenolide and Bay 11-7082 on the ATPase activity of NLRP3 demonstrated that both compds. inhibit the ATPase activity of NLRP3, suggesting that the inhibitory effect of these compds. on inflammasome activity could be mediated in part through their effect on the ATPase activity of NLRP3.  Our results thus elucidate the mol. mechanism for the therapeutic anti-inflammatory activity of parthenolide and identify vinyl sulfones as a new class of potential therapeutics that target the NLRP3 inflammasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUzn3dZTa4nLVg90H21EOLACvtfcHk0lh7a2oioywFRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjsFehtLk%253D&md5=d834b6cd4977c3a46df0cf075e3fa6df</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.082305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.082305%26sid%3Dliteratum%253Aachs%26aulast%3DJuliana%26aufirst%3DC.%26aulast%3DFernandes-Alnemri%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DDatta%26aufirst%3DP.%26aulast%3DSolorzano%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DJ.%2BW.%26aulast%3DMeng%26aufirst%3DR.%26aulast%3DQuong%26aufirst%3DA.%2BA.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DScott%26aufirst%3DC.%2BP.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26atitle%3DAnti-inflammatory%2520compounds%2520parthenolide%2520and%2520bay%252011%25E2%2580%25937082%2520are%2520direct%2520inhibitors%2520of%2520the%2520inflammasome%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D9792%26epage%3D9802%26doi%3D10.1074%2Fjbc.M109.082305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span> </span><span class="NLM_article-title">Parthenolide inhibits LPS-induced inflammatory cytokines through the toll-like receptor 4 signal pathway in THP-1 cells</span> <span class="citation_source-journal">Acta Biochim. Biophys. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span><span class="refDoi"> DOI: 10.1093/abbs/gmv019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1093%2Fabbs%2Fgmv019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=25841439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADC%252BC2MjhtVemsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2015&pages=368-375&author=S.+Liauthor=X.+Gaoauthor=X.+Wuauthor=Z.+Wuauthor=L.+Chengauthor=L.+Zhuauthor=D.+Shenauthor=X.+Tong&title=Parthenolide+inhibits+LPS-induced+inflammatory+cytokines+through+the+toll-like+receptor+4+signal+pathway+in+THP-1+cells&doi=10.1093%2Fabbs%2Fgmv019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide inhibits LPS-induced inflammatory cytokines through the toll-like receptor 4 signal pathway in THP-1 cells</span></div><div class="casAuthors">Li Shuangshuang; Tong Xiangmin; Gao Xiangli; Zhu Lifen; Shen Dan; Wu Xiaoxin; Wu Zhigang; Cheng Linfang</div><div class="citationInfo"><span class="NLM_cas:title">Acta biochimica et biophysica Sinica</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">368-75</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Parthenolide (PTL) shows potent anti-inflammatory and anti-cancer activities.  In the present study, the molecular mechanisms of PTL's activities were explored in lipopolysaccharide (LPS)-induced human leukemia monocytic THP-1 cells and human primary monocytes.  The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt (MTS) assay was used to analyze the effect of PTL on THP-1 cell viability.  Enzyme-linked immunosorbent assay was used to determine the effect of PTL on LPS-induced inflammatory cytokine secretion.  Flow cytometry and quantitative real-time polymerase chain reaction were used to assess the effect of PTL on LPS-induced toll-like receptor 4 (TLR4) expression.  Phosphorylation levels of signaling molecules were determined by western blot analysis.  Results showed that PTL <12.5 μM did not significantly affect THP-1 cells viability.  LPS treatment led to a marked up-regulation of interleukin (IL)-6, IL-1β, IL-8, IL-12p40, tumor necrosis factor-α, IL-18, and NO in THP-1 cells.  However, PTL inhibited the expression of these cytokines in a dose-dependent manner, with IC50 values of 1.091-2.620 μM.  PTL blocked TLR4 expression with an IC50 value of 1.373 μM as determined by the flow cytometry analysis, and this blocking effect was verified at both protein and mRNA levels.  Up-regulation of phosphorylation levels of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, p38, nuclear factor κB (NF-κB) p65, and IκBα and up-regulation of expressions of other molecules (inducible nitric oxide synthase, TLR4, and TNF receptor-associated factor 6) induced by LPS were abolished by PTL in a dose-dependent manner.  The anti-inflammatory mechanisms of PTL operate partly through the TLR4-mediated mitogen-activated protein kinase and NF-κB signaling pathways.  Therefore, TLR4 may be a new target for anti-inflammation therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAm875nepcNi6Ufuk_1xoTfW6udTcc2eY0aWqEYoCfN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjhtVemsA%253D%253D&md5=ad7811239d8c643a23c0fd726a2a29cb</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1093%2Fabbs%2Fgmv019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fabbs%252Fgmv019%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DD.%26aulast%3DTong%26aufirst%3DX.%26atitle%3DParthenolide%2520inhibits%2520LPS-induced%2520inflammatory%2520cytokines%2520through%2520the%2520toll-like%2520receptor%25204%2520signal%2520pathway%2520in%2520THP-1%2520cells%26jtitle%3DActa%2520Biochim.%2520Biophys.%2520Sin.%26date%3D2015%26volume%3D47%26spage%3D368%26epage%3D375%26doi%3D10.1093%2Fabbs%2Fgmv019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Strickson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmerich, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knebel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plater, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritorto, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shpiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The anti-inflammatory drug bay 11–7082 suppresses the MyD88-dependent signalling network by targeting the ubiquitin system</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">451</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span><span class="refDoi"> DOI: 10.1042/BJ20121651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1042%2FBJ20121651" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=451&publication_year=2013&pages=427-437&author=S.+Stricksonauthor=D.+G.+Campbellauthor=C.+H.+Emmerichauthor=A.+Knebelauthor=L.+Platerauthor=M.+S.+Ritortoauthor=N.+Shpiroauthor=P.+Cohen&title=The+anti-inflammatory+drug+bay+11%E2%80%937082+suppresses+the+MyD88-dependent+signalling+network+by+targeting+the+ubiquitin+system&doi=10.1042%2FBJ20121651"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1042%2FBJ20121651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20121651%26sid%3Dliteratum%253Aachs%26aulast%3DStrickson%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DD.%2BG.%26aulast%3DEmmerich%26aufirst%3DC.%2BH.%26aulast%3DKnebel%26aufirst%3DA.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DRitorto%26aufirst%3DM.%2BS.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520anti-inflammatory%2520drug%2520bay%252011%25E2%2580%25937082%2520suppresses%2520the%2520MyD88-dependent%2520signalling%2520network%2520by%2520targeting%2520the%2520ubiquitin%2520system%26jtitle%3DBiochem.%2520J.%26date%3D2013%26volume%3D451%26spage%3D427%26epage%3D437%26doi%3D10.1042%2FBJ20121651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Avonto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taglialatela-Scafati, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minassi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Petrocellis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appendino, G.</span><span> </span><span class="NLM_article-title">An NMR spectroscopic method to identify and classify thiol-trapping agents: revival of michael acceptors for drug discovery?</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span><span class="refDoi"> DOI: 10.1002/anie.201005959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1002%2Fanie.201005959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitlGiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=467-471&author=C.+Avontoauthor=O.+Taglialatela-Scafatiauthor=F.+Pollastroauthor=A.+Minassiauthor=V.+Di+Marzoauthor=L.+De+Petrocellisauthor=G.+Appendino&title=An+NMR+spectroscopic+method+to+identify+and+classify+thiol-trapping+agents%3A+revival+of+michael+acceptors+for+drug+discovery%3F&doi=10.1002%2Fanie.201005959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">An NMR Spectroscopic Method to Identify and Classify Thiol-Trapping Agents: Revival of Michael Acceptors for Drug Discovery?</span></div><div class="casAuthors">Avonto, Cristina; Taglialatela-Scafati, Orazio; Pollastro, Federica; Minassi, Alberto; Di Marzo, Vincenzo; De Petrocellis, Luciano; Appendino, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">467-471, S467/1-S467/30</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We have developed a simple and quick NMR spectroscopic method to identify Michael acceptor sites in complex multifunctional compds.  The method sorts them out in reversible and irreversible thiol sinks, and predicts their potential to modify proteins, as validated by the identification of several new chemotypes of TRPA1 activators.  These include well-known anti-inflammatory agents, such as curcumin and parthenolide, which had been overlooked as ligands for this druggable end point of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt8t1J015hqbVg90H21EOLACvtfcHk0lgVnE6scjE3VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitlGiuw%253D%253D&md5=8fd61bce5e0dfeb9209a6572516fd583</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1002%2Fanie.201005959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201005959%26sid%3Dliteratum%253Aachs%26aulast%3DAvonto%26aufirst%3DC.%26aulast%3DTaglialatela-Scafati%26aufirst%3DO.%26aulast%3DPollastro%26aufirst%3DF.%26aulast%3DMinassi%26aufirst%3DA.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26aulast%3DAppendino%26aufirst%3DG.%26atitle%3DAn%2520NMR%2520spectroscopic%2520method%2520to%2520identify%2520and%2520classify%2520thiol-trapping%2520agents%253A%2520revival%2520of%2520michael%2520acceptors%2520for%2520drug%2520discovery%253F%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D467%26epage%3D471%26doi%3D10.1002%2Fanie.201005959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Saadane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiDonato, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, M.</span><span> </span><span class="NLM_article-title">Parthenolide inhibits IκB kinase, NF-κB activation, and inflammatory response in cystic fibrosis cells and mice</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">728</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span><span class="refDoi"> DOI: 10.1165/rcmb.2006-0323OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1165%2Frcmb.2006-0323OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=17272824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmslOlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2007&pages=728-736&author=A.+Saadaneauthor=S.+Mastersauthor=J.+DiDonatoauthor=J.+Liauthor=M.+Berger&title=Parthenolide+inhibits+I%CE%BAB+kinase%2C+NF-%CE%BAB+activation%2C+and+inflammatory+response+in+cystic+fibrosis+cells+and+mice&doi=10.1165%2Frcmb.2006-0323OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide inhibits IκB kinase, NF-κB activation, and inflammatory response in cystic fibrosis cells and mice</span></div><div class="casAuthors">Saadane, Aicha; Masters, Sophia; DiDonato, Joseph; Li, Jingfeng; Berger, Melvin</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">728-736</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Cystic fibrosis (CF) is characterized by prolonged and excessive inflammatory responses in the lung and increased activation of NF-κB.  Parthenolide is a sesquiterpene lactone derived from the plant feverfew, which has been used in folk medicine for antiinflammatory activity.  Several studies suggest that this compd. inhibits the NF-κB pathway, but the exact site is controversial.  We hypothesized that parthenolide might ameliorate the excessive inflammatory response in CF models by inhibiting activation of NF-κB.  This was tested in vitro, using two pairs of cell lines with defective vs. normal CF transmembrane conductance regulator (CFTR) (antisense/sense transfected 16 HBE and IB-3/S9), and in vivo, using CFTR-knockout (KO) mice.  All cell lines were pretreated with parthenolide and then stimulated with IL-1β and/or TNF.  Parthenolide significantly inhibited IL-8 secretion induced by these cytokines and prevented NF-κB activation, IκBα degrdn., and IκB Kinase complex activity.  CFTR-KO and wild-type mice were pretreated with parthenolide or vehicle alone then challenged intratracheally with LPS.  Bronchoalveolar lavage was performed 3, 6, and 8 h later.  Parthenolide pretreatment inhibited PMN influx as well as cytokine and chemokine prodn.  This was also assocd. with inhibition of IκBα degrdn. and NF-κB activation.  We thus conclude that parthenolide inhibits IκB kinase, resulting in stabilization of cytoplasmic IκBα, which in turn leads to inhibition of NF-κB translocation and attenuation of subsequent inflammatory responses.  IκB kinase may be a good target, and parthenolide and/or feverfew might be promising treatments for the excessive inflammation in CF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBcSLbwwBaKrVg90H21EOLACvtfcHk0lgVnE6scjE3VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmslOlur0%253D&md5=9123338efa0254ee3d8bf4d4034c7614</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2006-0323OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2006-0323OC%26sid%3Dliteratum%253Aachs%26aulast%3DSaadane%26aufirst%3DA.%26aulast%3DMasters%26aufirst%3DS.%26aulast%3DDiDonato%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBerger%26aufirst%3DM.%26atitle%3DParthenolide%2520inhibits%2520I%25CE%25BAB%2520kinase%252C%2520NF-%25CE%25BAB%2520activation%252C%2520and%2520inflammatory%2520response%2520in%2520cystic%2520fibrosis%2520cells%2520and%2520mice%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2007%26volume%3D36%26spage%3D728%26epage%3D736%26doi%3D10.1165%2Frcmb.2006-0323OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">García-Piñeres, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mora, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strunck, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pahl, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merfort, I.</span><span> </span><span class="NLM_article-title">Cysteine 38 in p65/NF-κB plays a crucial role in DNA binding inhibition by sesquiterpene lactones</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">39713</span><span class="NLM_x">–</span> <span class="NLM_lpage">39720</span><span class="refDoi"> DOI: 10.1074/jbc.M101985200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M101985200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=39713-39720&author=A.+J.+Garc%C3%ADa-Pi%C3%B1eresauthor=V.+Castroauthor=G.+Moraauthor=T.+J.+Schmidtauthor=E.+Strunckauthor=H.+L.+Pahlauthor=I.+Merfort&title=Cysteine+38+in+p65%2FNF-%CE%BAB+plays+a+crucial+role+in+DNA+binding+inhibition+by+sesquiterpene+lactones&doi=10.1074%2Fjbc.M101985200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M101985200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M101985200%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa-Pi%25C3%25B1eres%26aufirst%3DA.%2BJ.%26aulast%3DCastro%26aufirst%3DV.%26aulast%3DMora%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DT.%2BJ.%26aulast%3DStrunck%26aufirst%3DE.%26aulast%3DPahl%26aufirst%3DH.%2BL.%26aulast%3DMerfort%26aufirst%3DI.%26atitle%3DCysteine%252038%2520in%2520p65%252FNF-%25CE%25BAB%2520plays%2520a%2520crucial%2520role%2520in%2520DNA%2520binding%2520inhibition%2520by%2520sesquiterpene%2520lactones%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D39713%26epage%3D39720%26doi%3D10.1074%2Fjbc.M101985200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Meng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond-Stintz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, B. S.</span><span> </span><span class="NLM_article-title">IKK inhibitor bay 11–7082 induces necroptotic cell death in precursor-B acute lymphoblastic leukaemic blasts</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">487</span><span class="NLM_x">–</span> <span class="NLM_lpage">490</span><span class="refDoi"> DOI: 10.1111/j.1365-2141.2009.07988.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1111%2Fj.1365-2141.2009.07988.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=19958360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADC%252BC3c%252FktV2ksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2010&pages=487-490&author=X.+Mengauthor=M.+A.+Martinezauthor=M.+A.+Raymond-Stintzauthor=S.+S.+Winterauthor=B.+S.+Wilson&title=IKK+inhibitor+bay+11%E2%80%937082+induces+necroptotic+cell+death+in+precursor-B+acute+lymphoblastic+leukaemic+blasts&doi=10.1111%2Fj.1365-2141.2009.07988.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">IKK inhibitor bay 11-7082 induces necroptotic cell death in precursor-B acute lymphoblastic leukaemic blasts</span></div><div class="casAuthors">Meng Xiangbing; Martinez Marina A; Raymond-Stintz Mary A; Winter Stuart S; Wilson Bridget S</div><div class="citationInfo"><span class="NLM_cas:title">British journal of haematology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">487-90</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAMyeEv3au04JKJbLTgsvCfW6udTcc2eaCw6LhsjEEcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c%252FktV2ksQ%253D%253D&md5=6e9eeef37372b6aeb3d033997cf57f06</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.2009.07988.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.2009.07988.x%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DMartinez%26aufirst%3DM.%2BA.%26aulast%3DRaymond-Stintz%26aufirst%3DM.%2BA.%26aulast%3DWinter%26aufirst%3DS.%2BS.%26aulast%3DWilson%26aufirst%3DB.%2BS.%26atitle%3DIKK%2520inhibitor%2520bay%252011%25E2%2580%25937082%2520induces%2520necroptotic%2520cell%2520death%2520in%2520precursor-B%2520acute%2520lymphoblastic%2520leukaemic%2520blasts%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2010%26volume%3D148%26spage%3D487%26epage%3D490%26doi%3D10.1111%2Fj.1365-2141.2009.07988.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Krishnan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bencze, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonks, N. K.</span><span> </span><span class="NLM_article-title">The anti-inflammatory compound bay-11–7082 is a potent inhibitor of protein tyrosine phosphatases</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">2830</span><span class="NLM_x">–</span> <span class="NLM_lpage">2841</span><span class="refDoi"> DOI: 10.1111/febs.12283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1111%2Ffebs.12283" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=2830-2841&author=N.+Krishnanauthor=G.+Benczeauthor=P.+Cohenauthor=N.+K.+Tonks&title=The+anti-inflammatory+compound+bay-11%E2%80%937082+is+a+potent+inhibitor+of+protein+tyrosine+phosphatases&doi=10.1111%2Ffebs.12283"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12283%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnan%26aufirst%3DN.%26aulast%3DBencze%26aufirst%3DG.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DTonks%26aufirst%3DN.%2BK.%26atitle%3DThe%2520anti-inflammatory%2520compound%2520bay-11%25E2%2580%25937082%2520is%2520a%2520potent%2520inhibitor%2520of%2520protein%2520tyrosine%2520phosphatases%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D2830%26epage%3D2841%26doi%3D10.1111%2Ffebs.12283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Kwok, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ndubuisi, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elofsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">The anti-inflammatory natural product parthenolide from the medicinal herb feverfew directly binds to and inhibits IκB kinase</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">766</span><span class="refDoi"> DOI: 10.1016/S1074-5521(01)00049-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2FS1074-5521%2801%2900049-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=11514225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtV2ku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=759-766&author=B.+H.+Kwokauthor=B.+Kohauthor=M.+I.+Ndubuisiauthor=M.+Elofssonauthor=C.+M.+Crews&title=The+anti-inflammatory+natural+product+parthenolide+from+the+medicinal+herb+feverfew+directly+binds+to+and+inhibits+I%CE%BAB+kinase&doi=10.1016%2FS1074-5521%2801%2900049-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IκB kinase</span></div><div class="casAuthors">Kwok, B. H. B.; Koh, B.; Ndubuisi, M. I.; Elofsson, M.; Crews, C. M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">759-766</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Biol. active natural products continue to be useful in the exploration and control of intracellular signaling processes.  For example, the sesquiterpene lactone parthenolide from the anti-inflammatory medicinal herb Feverfew (Tanacetum parthenium) appears to inhibit the pro-inflammatory signaling pathway.  Parthenolide's direct mol. target, however, remains unknown.  We set out to identify the mol. mechanisms of parthenolide's anti-inflammatory activity.  A parthenolide affinity reagent was synthesized and shown to bind directly to and inhibit IB kinase (IKK), the kinase subunit known to play a crit. role in cytokine-mediated signaling.  Mutation of cysteine 179 in the activation loop of IKKβ abolished sensitivity towards parthenolide.  Moreover, we showed that parthenolide's in vitro and in vivo anti-inflammatory activity is mediated through the α-methylene γ-lactone moiety shared by other sesquiterpene lactones.  In recent years, the multi-subunit IKK complex has been shown to be responsible for cytokine-mediated stimulation of genes involved in inflammation and as such represents an attractive target for pharmaceutical intervention.  Our finding that parthenolide targets this kinase complex provides a possible mol. basis for the anti-inflammatory properties of parthenolide.  In addn., these results may be useful in the development of addnl. anti-inflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9wzcv0O9mwrVg90H21EOLACvtfcHk0li7afSdd4M0XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtV2ku7k%253D&md5=bf8be7acdd42fd794f9ad10df20ffa5d</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2801%2900049-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252801%252900049-7%26sid%3Dliteratum%253Aachs%26aulast%3DKwok%26aufirst%3DB.%2BH.%26aulast%3DKoh%26aufirst%3DB.%26aulast%3DNdubuisi%26aufirst%3DM.%2BI.%26aulast%3DElofsson%26aufirst%3DM.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DThe%2520anti-inflammatory%2520natural%2520product%2520parthenolide%2520from%2520the%2520medicinal%2520herb%2520feverfew%2520directly%2520binds%2520to%2520and%2520inhibits%2520I%25CE%25BAB%2520kinase%26jtitle%3DChem.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D759%26epage%3D766%26doi%3D10.1016%2FS1074-5521%2801%2900049-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Dong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C.</span><span> </span><span class="NLM_article-title">Parthenolide is neuroprotective in rat experimental stroke model: Downregulating NF-κB, phospho-p38MAPK, and caspase-1 and ameliorating BBB permeability</span> <span class="citation_source-journal">Mediators Inflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">370804</span><span class="refDoi"> DOI: 10.1155/2013/370804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1155%2F2013%2F370804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=23935248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADC%252BC3sfoslKquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=370804&author=L.+Dongauthor=H.+Qiaoauthor=X.+Zhangauthor=X.+Zhangauthor=C.+Wangauthor=L.+Wangauthor=L.+Cuiauthor=J.+Zhaoauthor=Y.+Xingauthor=Y.+Liauthor=Z.+Liuauthor=C.+Zhu&title=Parthenolide+is+neuroprotective+in+rat+experimental+stroke+model%3A+Downregulating+NF-%CE%BAB%2C+phospho-p38MAPK%2C+and+caspase-1+and+ameliorating+BBB+permeability&doi=10.1155%2F2013%2F370804"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide is neuroprotective in rat experimental stroke model: downregulating NF-κB, phospho-p38MAPK, and caspase-1 and ameliorating BBB permeability</span></div><div class="casAuthors">Dong Lipeng; Qiao Huimin; Zhang Xiangjian; Zhang Xiaolin; Wang Chaohui; Wang Lina; Cui Lili; Zhao Jingru; Xing Yinxue; Li Yanhua; Liu Zongjie; Zhu Chunhua</div><div class="citationInfo"><span class="NLM_cas:title">Mediators of inflammation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2013</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">370804</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">UNLABELLED:  Inflammatory damage plays an important role in cerebral ischemic pathogenesis and may represent a target for treatment.  Parthenolide (PN) has been proved to elicit a wide range of biological activities through its anti-inflammatory action in the treatment of migraine, arthritis, and atherosclerosis.  To decide whether this effect applies to ischemic injury in brain, we therefore investigate the potential neuroprotective role of PN and the underlying mechanisms.  Male Sprague-Dawley rats were randomly divided into Saline, Vehicle, and PN groups and a permanent middle cerebral artery occlusion (MCAO) model was used.  PN administered intraperitoneally immediately after cerebral ischemia and once daily on the following days.  At time points after MCAO, neurological deficit, infarct volume, and brain water content were measured.  Immunohistochemistry, western blot and RT-PCR were used to analyze the expression of NF- κ B and caspase-1 in ischemic brain tissue.  Phospho-p38MAPK and claudin-5 were detected by western blot.  The results indicated that PN dramatically ameliorated neurological deficit, brain water content, and infarct volume, downregulated NF- κ B, phospho-p38MAPK, and caspase-1 expressions, and upregulated claudin-5 expression in ischemic brain tissue.  CONCLUSIONS:  PN protected the brain from damage caused by MCAO; this effect may be through downregulating NF- κ B, phosho-p38MAPK, and caspase-1 expressions and ameliorating BBB permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRmlADo7JYRJ2HOrQ6qeX-mfW6udTcc2eaCw6LhsjEEcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfoslKquw%253D%253D&md5=4ec3edab83593452865d28e24f2cf5dc</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1155%2F2013%2F370804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F370804%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DL.%26aulast%3DQiao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DXing%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DC.%26atitle%3DParthenolide%2520is%2520neuroprotective%2520in%2520rat%2520experimental%2520stroke%2520model%253A%2520Downregulating%2520NF-%25CE%25BAB%252C%2520phospho-p38MAPK%252C%2520and%2520caspase-1%2520and%2520ameliorating%2520BBB%2520permeability%26jtitle%3DMediators%2520Inflammation%26date%3D2013%26volume%3D2013%26spage%3D370804%26doi%3D10.1155%2F2013%2F370804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Guzman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelakantan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassane, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachowicz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liesveld, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, C. T.</span><span> </span><span class="NLM_article-title">An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">4427</span><span class="NLM_x">–</span> <span class="NLM_lpage">4435</span><span class="refDoi"> DOI: 10.1182/blood-2007-05-090621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1182%2Fblood-2007-05-090621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=17804695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1Wg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2007&pages=4427-4435&author=M.+L.+Guzmanauthor=R.+M.+Rossiauthor=S.+Neelakantanauthor=X.+Liauthor=C.+A.+Corbettauthor=D.+C.+Hassaneauthor=M.+W.+Beckerauthor=J.+M.+Bennettauthor=E.+Sullivanauthor=J.+L.+Lachowiczauthor=A.+Vaughanauthor=C.+J.+Sweeneyauthor=W.+Matthewsauthor=M.+Carrollauthor=J.+L.+Liesveldauthor=P.+A.+Crooksauthor=C.+T.+Jordan&title=An+orally+bioavailable+parthenolide+analog+selectively+eradicates+acute+myelogenous+leukemia+stem+and+progenitor+cells&doi=10.1182%2Fblood-2007-05-090621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells</span></div><div class="casAuthors">Guzman, Monica L.; Rossi, Randall M.; Neelakantan, Sundar; Li, Xiaojie; Corbett, Cheryl A.; Hassane, Duane C.; Becker, Michael W.; Bennett, John M.; Sullivan, Edmund; Lachowicz, Joshua L.; Vaughan, Andrew; Sweeney, Christopher J.; Matthews, William; Carroll, Martin; Liesveld, Jane L.; Crooks, Peter A.; Jordan, Craig T.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4427-4435</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Leukemia stem cells (LSCs) are thought to play a central role in the pathogenesis of acute leukemia and likely contribute to both disease initiation and relapse.  Therefore, identification of agents that target LSCs is an important consideration for the development of new therapies.  To this end, we have previously demonstrated that the naturally occurring compd. parthenolide (PTL) can induce death of human LSCs in vitro while sparing normal hematopoletic cells.  However, PTL has relatively poor pharmacol. properties that limit its potential clin. use.  Consequently, we generated a family of PTL analogs designed to improve soly. and bioavailability.  These studies identified an analog, dimethylaminoparthenolide (DMAPT), which induces rapid death of primary human LSCs from both myeloid and lymphoid leukemias, and is also highly cytotoxic to bulk leukemic cell populations.  Mol. studies indicate the prevalent activities of DMAPT include induction of oxidative stress responses, inhibition of NF-κB, and activation of p53.  The compd. has approx. 70% oral bioavailability, and pharmacol. studies using both mouse xenograft models and spontaneous acute canine leukemias demonstrate in vivo bioactivity as detd. by functional assays and multiple biomarkers.  Therefore, based on the collective preclin. data, we propose that the novel compd. DMAPT has the potential to target human LSCs in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9EOlsw8KCBbVg90H21EOLACvtfcHk0lj3SU2axAHuFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1Wg&md5=921e2df12d1c4084fad14b072c200850</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-05-090621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-05-090621%26sid%3Dliteratum%253Aachs%26aulast%3DGuzman%26aufirst%3DM.%2BL.%26aulast%3DRossi%26aufirst%3DR.%2BM.%26aulast%3DNeelakantan%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DCorbett%26aufirst%3DC.%2BA.%26aulast%3DHassane%26aufirst%3DD.%2BC.%26aulast%3DBecker%26aufirst%3DM.%2BW.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DSullivan%26aufirst%3DE.%26aulast%3DLachowicz%26aufirst%3DJ.%2BL.%26aulast%3DVaughan%26aufirst%3DA.%26aulast%3DSweeney%26aufirst%3DC.%2BJ.%26aulast%3DMatthews%26aufirst%3DW.%26aulast%3DCarroll%26aufirst%3DM.%26aulast%3DLiesveld%26aufirst%3DJ.%2BL.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DJordan%26aufirst%3DC.%2BT.%26atitle%3DAn%2520orally%2520bioavailable%2520parthenolide%2520analog%2520selectively%2520eradicates%2520acute%2520myelogenous%2520leukemia%2520stem%2520and%2520progenitor%2520cells%26jtitle%3DBlood%26date%3D2007%26volume%3D110%26spage%3D4427%26epage%3D4435%26doi%3D10.1182%2Fblood-2007-05-090621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Shanmugam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusumanchi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appaiah, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelakantan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaunig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakshatri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, C. J.</span><span> </span><span class="NLM_article-title">A water soluble parthenolide analog suppresses <i>in vivo</i> tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-κB and generating reactive oxygen species</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">2481</span><span class="NLM_x">–</span> <span class="NLM_lpage">2494</span><span class="refDoi"> DOI: 10.1002/ijc.25587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1002%2Fijc.25587" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20669221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVSktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2011&pages=2481-2494&author=R.+Shanmugamauthor=P.+Kusumanchiauthor=H.+Appaiahauthor=L.+Chengauthor=P.+Crooksauthor=S.+Neelakantanauthor=T.+Peatauthor=J.+Klaunigauthor=W.+Matthewsauthor=H.+Nakshatriauthor=C.+J.+Sweeney&title=A+water+soluble+parthenolide+analog+suppresses+in+vivo+tumor+growth+of+two+tobacco-associated+cancers%2C+lung+and+bladder+cancer%2C+by+targeting+NF-%CE%BAB+and+generating+reactive+oxygen+species&doi=10.1002%2Fijc.25587"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-κB and generating reactive oxygen species</span></div><div class="casAuthors">Shanmugam, Rajasubramaniam; Kusumanchi, Praveen; Appaiah, Hitesh; Cheng, Liang; Crooks, Peter; Neelakantan, Sundar; Peat, Tyler; Klaunig, James; Matthews, William; Nakshatri, Harikrishna; Sweeney, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2481-2494</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Dimethylaminoparthenolide (DMAPT) is a water sol. parthenolide analog with preclin. activity in hematol. malignancies.  Using non-small lung cancer (NSCLC) cell lines (A549 and H522) and an immortalized human bronchial epithelial cell line (BEAS2B) and TCC cell lines (UMUC-3, HT-1197 and HT-1376) and a bladder papilloma (RT-4), we aimed to characterize DMAPT's anticancer activity in tobacco-assocd. neoplasms.  Flow cytometric, electrophoretic mobility gel shift assays (EMSA), and Western blot studies measured generation of reactive oxygen species (ROS), inhibition of NFκB DNA binding, and changes in cell cycle distribution and apoptotic proteins.  DMAPT generated ROS with subsequent JNK activation and also decreased NFκB DNA binding and antiapoptotic proteins, TRAF-2 and XIAP.  DMAPT-induced apoptotic cell death and altered cell cycle distribution with upregulation of p21 and p73 levels in a cell type-dependent manner.  DMAPT suppressed cyclin D1 in BEAS2B.  DMAPT retained NFκB and cell cycle inhibitory activity in the presence of the tobacco carcinogen nitrosamine ketone, 4(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).  Using a BrdU accumulation assay, 5-20 μM of DMAPT was shown to inhibit cellular proliferation of all cell lines by more than 95%.  Oral dosing of DMAPT suppressed in vivo A549 and UMUC-3 s.c. xenograft growth by 54% (p = 0.015) and 63% (p < 0.01), resp., and A549 lung metastatic vol. by 28% (p = 0.043).  In total, this data demonstrates DMAPT's novel anticancer properties in both early and late stage tobacco-assocd. neoplasms as well as its significant in vivo activity.  The data provides support for the conduct of clin. trials in TCC and NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2e1ljnaOlnbVg90H21EOLACvtfcHk0lj3SU2axAHuFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVSktbc%253D&md5=bea684074cee2e4d1d477d210c3ef60b</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1002%2Fijc.25587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.25587%26sid%3Dliteratum%253Aachs%26aulast%3DShanmugam%26aufirst%3DR.%26aulast%3DKusumanchi%26aufirst%3DP.%26aulast%3DAppaiah%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DCrooks%26aufirst%3DP.%26aulast%3DNeelakantan%26aufirst%3DS.%26aulast%3DPeat%26aufirst%3DT.%26aulast%3DKlaunig%26aufirst%3DJ.%26aulast%3DMatthews%26aufirst%3DW.%26aulast%3DNakshatri%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DC.%2BJ.%26atitle%3DA%2520water%2520soluble%2520parthenolide%2520analog%2520suppresses%2520in%2520vivo%2520tumor%2520growth%2520of%2520two%2520tobacco-associated%2520cancers%252C%2520lung%2520and%2520bladder%2520cancer%252C%2520by%2520targeting%2520NF-%25CE%25BAB%2520and%2520generating%2520reactive%2520oxygen%2520species%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2011%26volume%3D128%26spage%3D2481%26epage%3D2494%26doi%3D10.1002%2Fijc.25587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">D'Anneo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlisi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauricella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puleio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Bella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guercio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vento, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tesoriere, G.</span><span> </span><span class="NLM_article-title">Parthenolide generates reactive oxygen species and autophagy in MDA-MB231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e891</span><span class="refDoi"> DOI: 10.1038/cddis.2013.415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fcddis.2013.415" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=e891&author=A.+D%27Anneoauthor=D.+Carlisiauthor=M.+Lauricellaauthor=R.+Puleioauthor=R.+Martinezauthor=S.+Di+Bellaauthor=P.+Di+Marcoauthor=S.+Emanueleauthor=R.+Di+Fioreauthor=A.+Guercioauthor=R.+Ventoauthor=G.+Tesoriere&title=Parthenolide+generates+reactive+oxygen+species+and+autophagy+in+MDA-MB231+cells.+A+soluble+parthenolide+analogue+inhibits+tumour+growth+and+metastasis+in+a+xenograft+model+of+breast+cancer&doi=10.1038%2Fcddis.2013.415"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.415%26sid%3Dliteratum%253Aachs%26aulast%3DD%2527Anneo%26aufirst%3DA.%26aulast%3DCarlisi%26aufirst%3DD.%26aulast%3DLauricella%26aufirst%3DM.%26aulast%3DPuleio%26aufirst%3DR.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DDi%2BBella%26aufirst%3DS.%26aulast%3DDi%2BMarco%26aufirst%3DP.%26aulast%3DEmanuele%26aufirst%3DS.%26aulast%3DDi%2BFiore%26aufirst%3DR.%26aulast%3DGuercio%26aufirst%3DA.%26aulast%3DVento%26aufirst%3DR.%26aulast%3DTesoriere%26aufirst%3DG.%26atitle%3DParthenolide%2520generates%2520reactive%2520oxygen%2520species%2520and%2520autophagy%2520in%2520MDA-MB231%2520cells.%2520A%2520soluble%2520parthenolide%2520analogue%2520inhibits%2520tumour%2520growth%2520and%2520metastasis%2520in%2520a%2520xenograft%2520model%2520of%2520breast%2520cancer%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26spage%3De891%26doi%3D10.1038%2Fcddis.2013.415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Siedle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Pineres, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte-Monting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rungeler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaas, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Costa, F. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisiel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merfort, I.</span><span> </span><span class="NLM_article-title">Quantitative structure-activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-κB</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6042</span><span class="NLM_x">–</span> <span class="NLM_lpage">6054</span><span class="refDoi"> DOI: 10.1021/jm049937r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049937r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6042-6054&author=B.+Siedleauthor=A.+J.+Garcia-Pineresauthor=R.+Murilloauthor=J.+Schulte-Montingauthor=V.+Castroauthor=P.+Rungelerauthor=C.+A.+Klaasauthor=F.+B.+Da+Costaauthor=W.+Kisielauthor=I.+Merfort&title=Quantitative+structure-activity+relationship+of+sesquiterpene+lactones+as+inhibitors+of+the+transcription+factor+NF-%CE%BAB&doi=10.1021%2Fjm049937r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm049937r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049937r%26sid%3Dliteratum%253Aachs%26aulast%3DSiedle%26aufirst%3DB.%26aulast%3DGarcia-Pineres%26aufirst%3DA.%2BJ.%26aulast%3DMurillo%26aufirst%3DR.%26aulast%3DSchulte-Monting%26aufirst%3DJ.%26aulast%3DCastro%26aufirst%3DV.%26aulast%3DRungeler%26aufirst%3DP.%26aulast%3DKlaas%26aufirst%3DC.%2BA.%26aulast%3DDa%2BCosta%26aufirst%3DF.%2BB.%26aulast%3DKisiel%26aufirst%3DW.%26aulast%3DMerfort%26aufirst%3DI.%26atitle%3DQuantitative%2520structure-activity%2520relationship%2520of%2520sesquiterpene%2520lactones%2520as%2520inhibitors%2520of%2520the%2520transcription%2520factor%2520NF-%25CE%25BAB%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6042%26epage%3D6054%26doi%3D10.1021%2Fjm049937r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Kerr, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farady, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marion, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sajid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caffrey, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legac, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKerrow, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinen, L. S.</span><span> </span><span class="NLM_article-title">Vinyl sulfones as antiparasitic agents and a structural basis for drug design</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">25697</span><span class="NLM_x">–</span> <span class="NLM_lpage">25703</span><span class="refDoi"> DOI: 10.1074/jbc.M109.014340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M109.014340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=19620707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWhsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=25697-25703&author=I.+D.+Kerrauthor=J.+H.+Leeauthor=C.+J.+Faradyauthor=R.+Marionauthor=M.+Rickertauthor=M.+Sajidauthor=K.+C.+Pandeyauthor=C.+R.+Caffreyauthor=J.+Legacauthor=E.+Hansellauthor=J.+H.+McKerrowauthor=C.+S.+Craikauthor=P.+J.+Rosenthalauthor=L.+S.+Brinen&title=Vinyl+sulfones+as+antiparasitic+agents+and+a+structural+basis+for+drug+design&doi=10.1074%2Fjbc.M109.014340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design</span></div><div class="casAuthors">Kerr, Iain D.; Lee, Ji H.; Farady, Christopher J.; Marion, Rachael; Rickert, Mathias; Sajid, Mohammed; Pandey, Kailash C.; Caffrey, Conor R.; Legac, Jennifer; Hansell, Elizabeth; McKerrow, James H.; Craik, Charles S.; Rosenthal, Philip J.; Brinen, Linda S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">25697-25703</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cysteine proteases of the papain superfamily are implicated in a no. of cellular processes and are important virulence factors in the pathogenesis of parasitic disease.  These enzymes have therefore emerged as promising targets for antiparasitic drugs.  We report the crystal structures of three major parasite cysteine proteases, cruzain, falcipain-3, and the first reported structure of rhodesain, in complex with a class of potent, small mol., cysteine protease inhibitors, the vinyl sulfones.  These data, in conjunction with comparative inhibition kinetics, provide insight into the mol. mechanisms that drive cysteine protease inhibition by vinyl sulfones, the binding specificity of these important proteases and the potential of vinyl sulfones as antiparasitic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolV0DUxF0YFbVg90H21EOLACvtfcHk0lhB3w2iRsIsBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWhsbbK&md5=c0bed13d912846fdcb4c2ba7f31954cb</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.014340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.014340%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DFarady%26aufirst%3DC.%2BJ.%26aulast%3DMarion%26aufirst%3DR.%26aulast%3DRickert%26aufirst%3DM.%26aulast%3DSajid%26aufirst%3DM.%26aulast%3DPandey%26aufirst%3DK.%2BC.%26aulast%3DCaffrey%26aufirst%3DC.%2BR.%26aulast%3DLegac%26aufirst%3DJ.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DBrinen%26aufirst%3DL.%2BS.%26atitle%3DVinyl%2520sulfones%2520as%2520antiparasitic%2520agents%2520and%2520a%2520structural%2520basis%2520for%2520drug%2520design%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D25697%26epage%3D25703%26doi%3D10.1074%2Fjbc.M109.014340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Youm, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodogai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D'Agostino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planavsky, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupfer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanneganti, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahmy, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biragyn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, V. D.</span><span> </span><span class="NLM_article-title">The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1038/nm.3804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnm.3804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=25686106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVSit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=263-269&author=Y.+H.+Youmauthor=K.+Y.+Nguyenauthor=R.+W.+Grantauthor=E.+L.+Goldbergauthor=M.+Bodogaiauthor=D.+Kimauthor=D.+D%27Agostinoauthor=N.+Planavskyauthor=C.+Lupferauthor=T.+D.+Kannegantiauthor=S.+Kangauthor=T.+L.+Horvathauthor=T.+M.+Fahmyauthor=P.+A.+Crawfordauthor=A.+Biragynauthor=E.+Alnemriauthor=V.+D.+Dixit&title=The+ketone+metabolite+%CE%B2-hydroxybutyrate+blocks+NLRP3+inflammasome-mediated+inflammatory+disease&doi=10.1038%2Fnm.3804"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease</span></div><div class="casAuthors">Youm, Yun-Hee; Nguyen, Kim Y.; Grant, Ryan W.; Goldberg, Emily L.; Bodogai, Monica; Kim, Dongin; D'Agostino, Dominic; Planavsky, Noah; Lupfer, Christopher; Kanneganti, Thirumala D.; Kang, Seokwon; Horvath, Tamas L.; Fahmy, Tarek M.; Crawford, Peter A.; Biragyn, Arya; Alnemri, Emad; Dixit, Vishwa Deep</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">263-269</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The ketone bodies β-hydroxybutyrate (BHB) and acetoacetate (AcAc) support mammalian survival during states of energy deficit by serving as alternative sources of ATP.  BHB levels are elevated by starvation, caloric restriction, high-intensity exercise, or the low-carbohydrate ketogenic diet.  Prolonged fasting reduces inflammation; however, the impact that ketones and other alternative metabolic fuels produced during energy deficits have on the innate immune response is unknown.  We report that BHB, but neither AcAc nor the structurally related short-chain fatty acids butyrate and acetate, suppresses activation of the NLRP3 inflammasome in response to urate crystals, ATP and lipotoxic fatty acids.  BHB did not inhibit caspase-1 activation in response to pathogens that activate the NLR family, CARD domain contg. 4 (NLRC4) or absent in melanoma 2 (AIM2) inflammasome and did not affect non-canonical caspase-11, inflammasome activation.  Mechanistically, BHB inhibits the NLRP3 inflammasome by preventing K+ efflux and reducing ASC oligomerization and speck formation.  The inhibitory effects of BHB on NLRP3 are not dependent on chirality or starvation-regulated mechanisms like AMP-activated protein kinase (AMPK), reactive oxygen species (ROS), autophagy or glycolytic inhibition.  BHB blocks the NLRP3 inflammasome without undergoing oxidn. in the TCA cycle, and independently of uncoupling protein-2 (UCP2), sirtuin-2 (SIRT2), the G protein-coupled receptor GPR109A or hydrocarboxylic acid receptor 2 (HCAR2).  BHB reduces NLRP3 inflammasome-mediated interleukin (IL)-1β and IL-18 prodn. in human monocytes.  In vivo, BHB or a ketogenic diet attenuates caspase-1 activation and IL-1β secretion in mouse models of NLRP3-mediated diseases such as Muckle-Wells syndrome, familial cold autoinflammatory syndrome and urate crystal-induced peritonitis.  Our findings suggest that the anti-inflammatory effects of caloric restriction or ketogenic diets may be linked to BHB-mediated inhibition of the NLRP3 inflammasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiJJ1p9GsaxrVg90H21EOLACvtfcHk0lhB3w2iRsIsBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVSit7s%253D&md5=954f5298fa8cf263cf05174f05270e3a</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1038%2Fnm.3804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3804%26sid%3Dliteratum%253Aachs%26aulast%3DYoum%26aufirst%3DY.%2BH.%26aulast%3DNguyen%26aufirst%3DK.%2BY.%26aulast%3DGrant%26aufirst%3DR.%2BW.%26aulast%3DGoldberg%26aufirst%3DE.%2BL.%26aulast%3DBodogai%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DD%2527Agostino%26aufirst%3DD.%26aulast%3DPlanavsky%26aufirst%3DN.%26aulast%3DLupfer%26aufirst%3DC.%26aulast%3DKanneganti%26aufirst%3DT.%2BD.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DHorvath%26aufirst%3DT.%2BL.%26aulast%3DFahmy%26aufirst%3DT.%2BM.%26aulast%3DCrawford%26aufirst%3DP.%2BA.%26aulast%3DBiragyn%26aufirst%3DA.%26aulast%3DAlnemri%26aufirst%3DE.%26aulast%3DDixit%26aufirst%3DV.%2BD.%26atitle%3DThe%2520ketone%2520metabolite%2520%25CE%25B2-hydroxybutyrate%2520blocks%2520NLRP3%2520inflammasome-mediated%2520inflammatory%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2015%26volume%3D21%26spage%3D263%26epage%3D269%26doi%3D10.1038%2Fnm.3804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span> </span><span class="NLM_article-title">A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1504</span><span class="NLM_x">–</span> <span class="NLM_lpage">1512</span><span class="refDoi"> DOI: 10.1016/j.bcp.2013.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.bcp.2013.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=23506741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1ejs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=1504-1512&author=W.+Liuauthor=W.+Guoauthor=J.+Wuauthor=Q.+Luoauthor=F.+Taoauthor=Y.+Guauthor=Y.+Shenauthor=J.+Liauthor=R.+Tanauthor=Q.+Xuauthor=Y.+Sun&title=A+novel+benzo%5Bd%5Dimidazole+derivate+prevents+the+development+of+dextran+sulfate+sodium-induced+murine+experimental+colitis+via+inhibition+of+NLRP3+inflammasome&doi=10.1016%2Fj.bcp.2013.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome</span></div><div class="casAuthors">Liu, Wen; Guo, Wenjie; Wu, Jing; Luo, Qiong; Tao, Feifei; Gu, Yanhong; Shen, Yan; Li, Jianxin; Tan, Renxiang; Xu, Qiang; Sun, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1504-1512</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">NLRP3 inflammasome has been reported to be assocd. with various kinds of immunol. diseases including colitis.  However, there are few drug candidates targeting inflammasomes for the treatment of colitis.  In the present study, we aimed at examg. the effect of 1-ethyl-5-methyl-2-phenyl-1H-benzo[d]imidazole, a synthetic small mol. compd. also named Fc11a-2, for the treatment of dextran sulfate sodium (DSS)-induced exptl. colitis in mice via targeting NLRP3 inflammasome.  Treatment with Fc11a-2 dose-dependently attenuated the loss of body wt. and shortening of colon length induced by DSS.  In addn., the disease activity index, histopathol. scores and myeloperoxidase activity were also significantly reduced by Fc11a-2 treatment.  Moreover, protein and mRNA levels of DSS-induced proinflammatory cytokines in colon, including TNF-α, IL-1β, IL-18, IL-17A and IFN-γ, were markedly suppressed by Fc11a-2.  Furthermore, a decreased CD11c+ macrophage infiltration in colons and inactivation of caspase-1 in peritoneal macrophages were detected in Fc11a-2-treated mice.  The mechanism of action of Fc11a-2 was related to the inhibition of the cleavage of pro-caspase-1, pro-IL-1β and pro-IL-18 which in turn suppressed the activation of NLRP3 inflammasome.  Taken together, our results demonstrate the ability of Fc11a-2 to inhibit NLRP3 inflammasome activation and its potential use in the treatment of inflammatory bowel diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC4yBlq18j1bVg90H21EOLACvtfcHk0ljJr1jbElsqaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1ejs7s%253D&md5=28fe5ced430f1f103df5b34d7c5b0306</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DTao%26aufirst%3DF.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DY.%26atitle%3DA%2520novel%2520benzo%255Bd%255Dimidazole%2520derivate%2520prevents%2520the%2520development%2520of%2520dextran%2520sulfate%2520sodium-induced%2520murine%2520experimental%2520colitis%2520via%2520inhibition%2520of%2520NLRP3%2520inflammasome%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D85%26spage%3D1504%26epage%3D1512%26doi%3D10.1016%2Fj.bcp.2013.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varadarajan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Planillon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burberry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Núñez, G.</span><span> </span><span class="NLM_article-title">3,4-Methylenedioxy-β-nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">1142</span><span class="NLM_x">–</span> <span class="NLM_lpage">1150</span><span class="refDoi"> DOI: 10.1074/jbc.M113.515080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M113.515080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=24265316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFOjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=1142-1150&author=Y.+Heauthor=S.+Varadarajanauthor=R.+Mu%C3%B1oz-Planillonauthor=A.+Burberryauthor=Y.+Nakamuraauthor=G.+N%C3%BA%C3%B1ez&title=3%2C4-Methylenedioxy-%CE%B2-nitrostyrene+inhibits+NLRP3+inflammasome+activation+by+blocking+assembly+of+the+inflammasome&doi=10.1074%2Fjbc.M113.515080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">3,4-Methylenedioxy-β-nitrostyrene Inhibits NLRP3 Inflammasome Activation by Blocking Assembly of the Inflammasome</span></div><div class="casAuthors">He, Yuan; Varadarajan, Saranyaraajan; Munoz-Planillo, Raul; Burberry, Aaron; Nakamura, Yuumi; Nunez, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1142-1150</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The NLRP3 inflammasome is a crit. component of the innate immune system.  NLRP3 activation is induced by diverse stimuli assocd. with bacterial infection or tissue damage, but its inappropriate activation is involved in the pathogenesis of inherited and acquired inflammatory diseases.  However, the mechanism by which NLRP3 is activated remains poorly understood.  In this study, we explored the role of kinases in NLRP3 inflammasome activation by screening a kinase inhibitor library and identified 3,4-methylenedioxy-β-nitrostyrene (MNS) as an inhibitor for NLRP3 inflammasome activation.  Notably, MNS did not affect the activation of the NLRC4 or AIM2 (absent in melanoma 2) inflammasome.  Mechanistically, MNS specifically prevented NLRP3-mediated ASC speck formation and oligomerization without blocking potassium efflux induced by NLRP3 agonists.  Surprisingly, Syk kinase, the reported target of MNS, did not mediate the inhibitory activity of MNS on NLRP3 inflammasome activation.  We also found that the nitrovinyl group of MNS is essential for the inhibitory activity of MNS.  Immunopptn., mass spectrometry, and mutation studies suggest that both the nucleotide binding oligomerization domain and the leucine-rich repeat domain of NLRP3 were the intracellular targets of MNS.  Administration of MNS also inhibited NLRP3 ATPase activity in vitro, suggesting that MNS blocks the NLRP3 inflammasome by directly targeting NLRP3 or NLRP3-assocd. complexes.  These studies identified a novel chem. probe for studying the mol. mechanism of NLRP3 inflammasome activation which may advance the development of novel strategies to treat diseases assocd. with abnormal activation of NLRP3 inflammasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9jDGHS4OBurVg90H21EOLACvtfcHk0ljJr1jbElsqaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFOjsA%253D%253D&md5=e22d775cc6ffe38a7e0b4ea3772f8b32</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.515080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.515080%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DVaradarajan%26aufirst%3DS.%26aulast%3DMu%25C3%25B1oz-Planillon%26aufirst%3DR.%26aulast%3DBurberry%26aufirst%3DA.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DG.%26atitle%3D3%252C4-Methylenedioxy-%25CE%25B2-nitrostyrene%2520inhibits%2520NLRP3%2520inflammasome%2520activation%2520by%2520blocking%2520assembly%2520of%2520the%2520inflammasome%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D1142%26epage%3D1150%26doi%3D10.1074%2Fjbc.M113.515080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Wang, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. C.</span><span> </span><span class="NLM_article-title">Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-β-nitrostyrene, a novel tyrosine kinase inhibitor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1380</span><span class="NLM_x">–</span> <span class="NLM_lpage">1389</span><span class="refDoi"> DOI: 10.1124/mol.106.023986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1124%2Fmol.106.023986" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1380-1389&author=W.+Y.+Wangauthor=Y.+C.+Wuauthor=C.+C.+Wu&title=Prevention+of+platelet+glycoprotein+IIb%2FIIIa+activation+by+3%2C4-methylenedioxy-%CE%B2-nitrostyrene%2C+a+novel+tyrosine+kinase+inhibitor&doi=10.1124%2Fmol.106.023986"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.023986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.023986%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%2BY.%26aulast%3DWu%26aufirst%3DY.%2BC.%26aulast%3DWu%26aufirst%3DC.%2BC.%26atitle%3DPrevention%2520of%2520platelet%2520glycoprotein%2520IIb%252FIIIa%2520activation%2520by%25203%252C4-methylenedioxy-%25CE%25B2-nitrostyrene%252C%2520a%2520novel%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D1380%26epage%3D1389%26doi%3D10.1124%2Fmol.106.023986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Wang, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. C.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of novel β-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span><span class="refDoi"> DOI: 10.1016/j.bcp.2007.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.bcp.2007.06.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=601-611&author=W.+Y.+Wangauthor=P.+W.+Hsiehauthor=Y.+C.+Wuauthor=C.+C.+Wu&title=Synthesis+and+pharmacological+evaluation+of+novel+%CE%B2-nitrostyrene+derivatives+as+tyrosine+kinase+inhibitors+with+potent+antiplatelet+activity&doi=10.1016%2Fj.bcp.2007.06.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2007.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2007.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%2BY.%26aulast%3DHsieh%26aufirst%3DP.%2BW.%26aulast%3DWu%26aufirst%3DY.%2BC.%26aulast%3DWu%26aufirst%3DC.%2BC.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520novel%2520%25CE%25B2-nitrostyrene%2520derivatives%2520as%2520tyrosine%2520kinase%2520inhibitors%2520with%2520potent%2520antiplatelet%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D74%26spage%3D601%26epage%3D611%26doi%3D10.1016%2Fj.bcp.2007.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Hsieh, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. C.</span><span> </span><span class="NLM_article-title">The synthesis and biologic evaluation of anti-platelet and cytotoxic β-nitrostyrenes</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">7621</span><span class="NLM_x">–</span> <span class="NLM_lpage">7627</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.08.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.bmc.2010.08.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=7621-7627&author=P.+W.+Hsiehauthor=Y.+T.+Changauthor=W.+Y.+Chuangauthor=H.+C.+Shihauthor=S.+Z.+Chiangauthor=C.+C.+Wu&title=The+synthesis+and+biologic+evaluation+of+anti-platelet+and+cytotoxic+%CE%B2-nitrostyrenes&doi=10.1016%2Fj.bmc.2010.08.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.08.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.08.039%26sid%3Dliteratum%253Aachs%26aulast%3DHsieh%26aufirst%3DP.%2BW.%26aulast%3DChang%26aufirst%3DY.%2BT.%26aulast%3DChuang%26aufirst%3DW.%2BY.%26aulast%3DShih%26aufirst%3DH.%2BC.%26aulast%3DChiang%26aufirst%3DS.%2BZ.%26aulast%3DWu%26aufirst%3DC.%2BC.%26atitle%3DThe%2520synthesis%2520and%2520biologic%2520evaluation%2520of%2520anti-platelet%2520and%2520cytotoxic%2520%25CE%25B2-nitrostyrenes%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D7621%26epage%3D7627%26doi%3D10.1016%2Fj.bmc.2010.08.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Kast, R. E.</span><span> </span><span class="NLM_article-title">Ritonavir and disulfiram may be synergistic in lowering active interleukin-18 levels in acute pancreatitis, and thereby hasten recovery</span> <span class="citation_source-journal">J. Pancreas</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span><span class="refDoi"> DOI: 10.1186/s40880-015-0010-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1186%2Fs40880-015-0010-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=18469453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADC%252BD1czgslGhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=350-353&author=R.+E.+Kast&title=Ritonavir+and+disulfiram+may+be+synergistic+in+lowering+active+interleukin-18+levels+in+acute+pancreatitis%2C+and+thereby+hasten+recovery&doi=10.1186%2Fs40880-015-0010-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Ritonavir and disulfiram may be synergistic in lowering active interleukin-18 levels in acute pancreatitis, and thereby hasten recovery</span></div><div class="casAuthors">Kast Richard Eric</div><div class="citationInfo"><span class="NLM_cas:title">JOP : Journal of the pancreas</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">350-3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Interleukin-18 (IL-18) is one of the mediators of both pancreas damage and systemic complications like hypotension and multi-organ dysfunction during acute pancreatitis.  IL-18 is generated intracellularly from pro-IL-18 by caspase-1 mediated proteolysis.  Active caspase-1 itself is generated intracellularly by the action of the inflammasome, autocatalysis and other stimuli.  The anti-retroviral drug ritonavir inhibits conversion of inactive pro-caspase-1 to active caspase-1.  Since ritonavir is well tolerated in short-term use it may therefore prove useful in treating acute pancreatitis by lowering caspase-1 mediated IL-18 formation and the many inflammatory mediators downstream from that.  The alcoholism treatment drug disulfiram has been in continuous use since the 1950s.  It likewise has a low risk profile.  Disulfiram inhibits several human proteases, among them caspase-1.  Given the current morbidity and mortality of pancreatitis, research should be directed to ritonavir and disulfiram as treatment options for illnesses like pancreatitis where excessive IL-18 contributes to pathology.  The first clinically used angiotensin converting enzyme inhibitor, captopril, has shown potent caspase-1 inhibiting activity as well and should be investigated in rodent models of human pancreatitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtIh8z4lKke-2mnZh2OgS0fW6udTcc2ea-m3BARNRY8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czgslGhtA%253D%253D&md5=8e4cf13ef53f54accf6c3b53e0ee00ef</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1186%2Fs40880-015-0010-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40880-015-0010-1%26sid%3Dliteratum%253Aachs%26aulast%3DKast%26aufirst%3DR.%2BE.%26atitle%3DRitonavir%2520and%2520disulfiram%2520may%2520be%2520synergistic%2520in%2520lowering%2520active%2520interleukin-18%2520levels%2520in%2520acute%2520pancreatitis%252C%2520and%2520thereby%2520hasten%2520recovery%26jtitle%3DJ.%2520Pancreas%26date%3D2008%26volume%3D9%26spage%3D350%26epage%3D353%26doi%3D10.1186%2Fs40880-015-0010-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Rudolphi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerwin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verzijl, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Kraan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Berg, W.</span><span> </span><span class="NLM_article-title">Pralnacasan, an inhibitor of interleukin-1β converting enzyme, reduces joint damage in two murine models of osteoarthritis</span> <span class="citation_source-journal">Osteoarthr. Cartilage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">738</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span><span class="refDoi"> DOI: 10.1016/S1063-4584(03)00153-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2FS1063-4584%2803%2900153-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=13129693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADC%252BD3svjsFOhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=738-746&author=K.+Rudolphiauthor=N.+Gerwinauthor=N.+Verzijlauthor=P.+van+der+Kraanauthor=W.+van+den+Berg&title=Pralnacasan%2C+an+inhibitor+of+interleukin-1%CE%B2+converting+enzyme%2C+reduces+joint+damage+in+two+murine+models+of+osteoarthritis&doi=10.1016%2FS1063-4584%2803%2900153-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis</span></div><div class="casAuthors">Rudolphi K; Gerwin N; Verzijl N; van der Kraan P; van den Berg W</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">738-46</span>
        ISSN:<span class="NLM_cas:issn">1063-4584</span>.
    </div><div class="casAbstract">OBJECTIVE:  To study the effect of pralnacasan, the orally bioavailable pro-drug of a potent, non-peptide inhibitor of interleukin-1beta converting enzyme (ICE), RU 36384/VRT-18858, on joint damage in two mouse models of knee osteoarthritis (OA).  DESIGN:  In a collagenase-induced OA model, pralnacasan was given orally by gavage to female Balb/c mice at 0, 12.5, 25 and 50 mg/kg twice a day.  In the second study, pralnacasan was tested in male STR/1N mice, which develop OA spontaneously, by administering food-drug mixtures ad libitum at concentrations of 0, 700 and 4200 ppm (mg/kg food).  OA joint damage was assessed by a semi-quantitative histopathological score in both studies.  In the STR/1N mouse study, urinary levels of collagen cross-links hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP) were determined by high-pressure liquid chromatography at baseline, after 3 and 6 weeks of treatment and RU 36384/VRT-18858 plasma concentrations was measured after 6 weeks.  RESULTS:  In both studies, the mice developed moderate to severe knee joint OA in the medial joint compartments (tibial plateau and femoral condyle), the non-treated control groups showing median histopathological scores from 18 to 21 of a maximal score of 32.  Pralnacasan was well tolerated.  At the doses of 12.5 and 50 mg/kg in collagenase-induced OA and at the high dose of 4200 ppm in STR/1N mice pralnacasan treatment significantly reduced OA by 13-22%.  In the STR/1N mice, urinary levels of HP cross-links and the ratio of HP/LP, which are indicators of joint damage in OA, were significantly reduced in the high dose group by 59 and 84%, respectively.  CONCLUSIONS:  The ICE inhibitor pralnacasan reduced joint damage in two experimental models of OA and has the potential to become a disease-modifying drug for the treatment of OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS00eZqsMAAocjl5L8hwNX0fW6udTcc2ea-m3BARNRY8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svjsFOhtg%253D%253D&md5=ec8e69c841b711bb5c56cb1f9ac983c3</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2FS1063-4584%2803%2900153-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1063-4584%252803%252900153-5%26sid%3Dliteratum%253Aachs%26aulast%3DRudolphi%26aufirst%3DK.%26aulast%3DGerwin%26aufirst%3DN.%26aulast%3DVerzijl%26aufirst%3DN.%26aulast%3Dvan%2Bder%2BKraan%26aufirst%3DP.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DW.%26atitle%3DPralnacasan%252C%2520an%2520inhibitor%2520of%2520interleukin-1%25CE%25B2%2520converting%2520enzyme%252C%2520reduces%2520joint%2520damage%2520in%2520two%2520murine%2520models%2520of%2520osteoarthritis%26jtitle%3DOsteoarthr.%2520Cartilage%26date%3D2003%26volume%3D11%26spage%3D738%26epage%3D746%26doi%3D10.1016%2FS1063-4584%2803%2900153-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Wannamaker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namchuk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germann, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randle, J. C.</span><span> </span><span class="NLM_article-title">(S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1β and IL-18</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span><span class="refDoi"> DOI: 10.1124/jpet.106.111344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1124%2Fjpet.106.111344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=17289835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFehtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=509-516&author=W.+Wannamakerauthor=R.+Daviesauthor=M.+Namchukauthor=J.+Pollardauthor=P.+Fordauthor=G.+Kuauthor=C.+Deckerauthor=P.+Charifsonauthor=P.+Weberauthor=U.+A.+Germannauthor=K.+Kuidaauthor=J.+C.+Randle&title=%28S%29-1-%28%28S%29-2-%7B%5B1-%284-amino-3-chloro-phenyl%29-methanoyl%5D-amino%7D-3%2C3-dimethyl-butanoyl%29-pyrrolidine-2-carboxylic+acid+%28%282R%2C3S%29-2-ethoxy-5-oxo-tetrahydro-furan-3-yl%29-amide+%28VX-765%29%2C+an+orally+available+selective+interleukin+%28IL%29-converting+enzyme%2Fcaspase-1+inhibitor%2C+exhibits+potent+anti-inflammatory+activities+by+inhibiting+the+release+of+IL-1%CE%B2+and+IL-18&doi=10.1124%2Fjpet.106.111344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">(S)-1-((S)-2-{[1-(4-Amino-3-chlorophenyl)methanoyl]amino}-3,3-dimethylbutanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1β and IL-18</span></div><div class="casAuthors">Wannamaker, Woods; Davies, Robert; Namchuk, Mark; Pollard, John; Ford, Pamella; Ku, George; Decker, Caroline; Charifson, Paul; Weber, Peter; Germann, Ursula A.; Kuida, Keisuke; Randle, John C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">509-516</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">VX-765 is an orally absorbed prodrug of (S)-3-({1-[(S)-1-((S)-2-{[1-(4-amino-3-chlorophenyl)methanoyl]amino}-3,3-dimethyl-butanoyl)pyrrolidin-2-yl]-methanoyl}amino)-4-oxobutyric acid (VRT-043198), a potent and selective inhibitor of interleukin-converting enzyme/caspase-1 subfamily caspases.  VRT-043198 exhibits 100- to 10,000-fold selectivity against other caspase-3 and -6 to -9.  The therapeutic potential of VX-765 was assessed by detg. the effects of VRT-043198 on cytokine release by monocytes in vitro and of orally administered VX-765 in several animal models in vivo.  In cultures of peripheral blood mononuclear cells and whole blood from healthy subjects stimulated with bacterial products, VRT-043198 inhibited the release of interleukin (IL)-1β and IL-18, but it had little effect on the release of several other cytokines, including IL-1α, tumor necrosis factor-α, IL-6 and IL-8.  In contrast, VRT-043198 had little or no demonstrable activity in cellular models of apoptosis, and it did not affect the proliferation of activated primary T cells or T-cell lines.  VX-765 was efficiently converted to VRT-043198 when administered orally to mice, and it inhibited lipopolysaccharide-induced cytokine secretion.  In addn., VX-765 reduced disease severity and the expression of inflammatory mediators in models of rheumatoid arthritis and skin inflammation.  These data suggest that VX-765 is a novel cytokine inhibitor useful for treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUYnZtQc6cNrVg90H21EOLACvtfcHk0lgAzzxg8lhJCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFehtLY%253D&md5=f310c20314ee44357acd3027105a8b6a</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.111344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.111344%26sid%3Dliteratum%253Aachs%26aulast%3DWannamaker%26aufirst%3DW.%26aulast%3DDavies%26aufirst%3DR.%26aulast%3DNamchuk%26aufirst%3DM.%26aulast%3DPollard%26aufirst%3DJ.%26aulast%3DFord%26aufirst%3DP.%26aulast%3DKu%26aufirst%3DG.%26aulast%3DDecker%26aufirst%3DC.%26aulast%3DCharifson%26aufirst%3DP.%26aulast%3DWeber%26aufirst%3DP.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DKuida%26aufirst%3DK.%26aulast%3DRandle%26aufirst%3DJ.%2BC.%26atitle%3D%2528S%2529-1-%2528%2528S%2529-2-%257B%255B1-%25284-amino-3-chloro-phenyl%2529-methanoyl%255D-amino%257D-3%252C3-dimethyl-butanoyl%2529-pyrrolidine-2-carboxylic%2520acid%2520%2528%25282R%252C3S%2529-2-ethoxy-5-oxo-tetrahydro-furan-3-yl%2529-amide%2520%2528VX-765%2529%252C%2520an%2520orally%2520available%2520selective%2520interleukin%2520%2528IL%2529-converting%2520enzyme%252Fcaspase-1%2520inhibitor%252C%2520exhibits%2520potent%2520anti-inflammatory%2520activities%2520by%2520inhibiting%2520the%2520release%2520of%2520IL-1%25CE%25B2%2520and%2520IL-18%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D509%26epage%3D516%26doi%3D10.1124%2Fjpet.106.111344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Maroso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balosso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravizza, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vezzani, A.</span><span> </span><span class="NLM_article-title">Interleukin-1 type 1 receptor/toll-like receptor signalling in epilepsy: the importance of IL-1β and high-mobility group box 1</span> <span class="citation_source-journal">J. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span><span class="refDoi"> DOI: 10.1111/j.1365-2796.2011.02431.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1111%2Fj.1365-2796.2011.02431.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=21793950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlClt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=2011&pages=319-326&author=M.+Marosoauthor=S.+Balossoauthor=T.+Ravizzaauthor=J.+Liuauthor=M.+E.+Bianchiauthor=A.+Vezzani&title=Interleukin-1+type+1+receptor%2Ftoll-like+receptor+signalling+in+epilepsy%3A+the+importance+of+IL-1%CE%B2+and+high-mobility+group+box+1&doi=10.1111%2Fj.1365-2796.2011.02431.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1</span></div><div class="casAuthors">Maroso, M.; Balosso, S.; Ravizza, T.; Liu, J.; Bianchi, M. E.; Vezzani, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Internal Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">319-326</span>CODEN:
                <span class="NLM_cas:coden">JINMEO</span>;
        ISSN:<span class="NLM_cas:issn">0954-6820</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Inflammatory processes in brain tissue have been described in human epilepsy of various etiologies and in exptl. models of seizures.  This, together with the anticonvulsant properties of anti-inflammatory therapies both in clin. and in exptl. settings, highlights the important role of brain inflammation in the aetiopathogenesis of seizures.  Preclin. investigations in exptl. models using pharmacol. and genetic tools have identified a significant contribution of interleukin-1 (IL-1) type 1 receptor/Toll-like receptor (IL-1R/TLR) signalling to seizure activity.  This signalling can be activated by ligands assocd. with infections (pathogen-assocd. mol. patterns) or by endogenous mols., such as proinflammatory cytokines (e.g. IL-1beta) or danger signals [damage-assocd. mol. patterns, e.g. high-mobility group box 1 (HMGB1)].  IL-1beta and HMGB1 are synthesized and released by astrocytes and microglia in the rodent brain during seizures.  Notably, a rapid release of HMGB1 from neurons appears to be triggered by proconvulsant drugs even before seizure occurrence and is involved in their pptn. of seizures.  The activation of IL-1R/TLR signalling mediates rapid post-translational changes in N-methyl-D-aspartate-gated ion channels in neurons.  A long-term decrease in seizure threshold has also been obsd., possibly mediated by transcriptional activation of genes contributing to mol. and cellular plasticity.  This emerging evidence identifies specific targets with potential anticonvulsant effects in drug-resistant forms of epilepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI4SQ8Peg2tbVg90H21EOLACvtfcHk0li-fZjk0dNHvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlClt73P&md5=1623a46927cddaa75877139f0b730334</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2796.2011.02431.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2796.2011.02431.x%26sid%3Dliteratum%253Aachs%26aulast%3DMaroso%26aufirst%3DM.%26aulast%3DBalosso%26aufirst%3DS.%26aulast%3DRavizza%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26aulast%3DVezzani%26aufirst%3DA.%26atitle%3DInterleukin-1%2520type%25201%2520receptor%252Ftoll-like%2520receptor%2520signalling%2520in%2520epilepsy%253A%2520the%2520importance%2520of%2520IL-1%25CE%25B2%2520and%2520high-mobility%2520group%2520box%25201%26jtitle%3DJ.%2520Intern.%2520Med.%26date%3D2011%26volume%3D270%26spage%3D319%26epage%3D326%26doi%3D10.1111%2Fj.1365-2796.2011.02431.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">MacKenzie, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schipper, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. C.</span><span> </span><span class="NLM_article-title">The potential for caspases in drug discovery</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=568-576&author=S.+H.+MacKenzieauthor=J.+L.+Schipperauthor=A.+C.+Clark&title=The+potential+for+caspases+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacKenzie%26aufirst%3DS.%2BH.%26aulast%3DSchipper%26aufirst%3DJ.%2BL.%26aulast%3DClark%26aufirst%3DA.%2BC.%26atitle%3DThe%2520potential%2520for%2520caspases%2520in%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26spage%3D568%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Gong, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, F.</span><span> </span><span class="NLM_article-title">Chemical probing reveals insights into the signaling mechanism of inflammasome activation</span> <span class="citation_source-journal">Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1289</span><span class="NLM_x">–</span> <span class="NLM_lpage">1305</span><span class="refDoi"> DOI: 10.1038/cr.2010.135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fcr.2010.135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20856264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWqu7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1289-1305&author=Y.+N.+Gongauthor=X.+Wangauthor=J.+Wangauthor=Z.+Yangauthor=S.+Liauthor=J.+Yangauthor=L.+Liuauthor=X.+Leiauthor=F.+Shao&title=Chemical+probing+reveals+insights+into+the+signaling+mechanism+of+inflammasome+activation&doi=10.1038%2Fcr.2010.135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical probing reveals insights into the signaling mechanism of inflammasome activation</span></div><div class="casAuthors">Gong, Yi-Nan; Wang, Xiaoming; Wang, Jiayi; Yang, Zhenxiao; Li, Shan; Yang, Jieling; Liu, Liping; Lei, Xiaoguang; Shao, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1289-1305</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Caspase-1-mediated IL-1β prodn. is generally controlled by two pathways.  Toll-like receptors (TLRs) recognize pathogen-derived products and induce NF-κB-dependent pro-IL-1β transcription; NOD-like receptors (NLRs) assemble caspase-1-activating inflammasome complexes that sense bacterial products/danger signals.  Through a targeted chem. screen, we identify bromoxone, a marine natural product, as a specific and potent inhibitor of the caspase-1 pathway.  Bromoxone is effective over diverse inflammatory stimuli including TLR ligands plus ATP/nigericin, cytosolic DNA, flagellin and Bacillus anthracis lethal toxin.  Bromoxone also efficiently suppresses caspase-1 activation triggered by several types of bacterial infection.  Bromoxone acts upstream or at the level of the inflammasome in a transcription-independent manner.  Bromoxone also inhibits pro-IL-1β expression by targeting components upstream of IKK in the TLR-NF-κB pathway.  The unique dual activities of bromoxone are shared by the known TAK1 inhibitor that specifically blocks Nalp3 inflammasome activation.  Hinted from the mechanistic and pharmacol. properties of bromoxone, we further discover that several known NF-κB inhibitors that act upstream of IKK, but not those targeting IKK or IKK downstream, are potent blockers of different NLRs-mediated caspase-1 activation.  Our study uncovers a possible non-transcriptional mol. link between the NLR (Nalp3)-mediated inflammasome pathway and TLR-NF-κB signaling, and suggests a potential strategy to develop new anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppjC16zIWsMbVg90H21EOLACvtfcHk0li-fZjk0dNHvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWqu7nP&md5=efe3462264b2a58c9d54fd8fee8a06b1</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1038%2Fcr.2010.135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2010.135%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DY.%2BN.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DShao%26aufirst%3DF.%26atitle%3DChemical%2520probing%2520reveals%2520insights%2520into%2520the%2520signaling%2520mechanism%2520of%2520inflammasome%2520activation%26jtitle%3DCell%2520Res.%26date%3D2010%26volume%3D20%26spage%3D1289%26epage%3D1305%26doi%3D10.1038%2Fcr.2010.135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Matsunaga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchimori, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ii, M.</span><span> </span><span class="NLM_article-title">TAK-242 (resatorvid), a small-molecule inhibitor of toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1124/mol.110.068064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1124%2Fmol.110.068064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20881006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1ehuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=34-41&author=N.+Matsunagaauthor=N.+Tsuchimoriauthor=T.+Matsumotoauthor=M.+Ii&title=TAK-242+%28resatorvid%29%2C+a+small-molecule+inhibitor+of+toll-like+receptor+%28TLR%29+4+signaling%2C+binds+selectively+to+TLR4+and+interferes+with+interactions+between+TLR4+and+its+adaptor+molecules&doi=10.1124%2Fmol.110.068064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules</span></div><div class="casAuthors">Matsunaga, Naoko; Tsuchimori, Noboru; Matsumoto, Tatsumi; Ii, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-41</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">TAK-242 (resatorvid), a small-mol.-specific inhibitor of Toll-like receptor (TLR) 4 signaling, inhibits the prodn. of lipopolysaccharide-induced inflammatory mediators by binding to the intracellular domain of TLR4.  Cys747 in TLR4 has been identified previously as the binding site of TAK-242.  However, the mechanism by which TAK-242 inhibits TLR4 signaling after binding to TLR4 remains unknown.  The present study demonstrated, using coimmunopptn., that TAK-242 interferes with protein-protein interactions between TLR4 and its adaptor mols.  Among 10 different human TLRs, TAK-242 selectively bound to TLR4.  The time course of the inhibitory effect of TAK-242 on inflammatory mediator prodn. corresponded to that of the binding of TAK-242 to TLR4.  TAK-242 inhibited the assocn. of TLR4 with Toll/interleukin-1 receptor domain-contg. adaptor protein (TIRAP) or Toll/interleukin-1 receptor domain-contg. adaptor protein inducing interferon-β-related adaptor mol. (TRAM) in human embryonic kidney (HEK) 293 cells overexpressing TLR4, MD-2, and TIRAP or TRAM, resp.  TAK-242 inhibited the TIRAP-mediated activation of nuclear factor βB (NF-κB) and the TRAM-mediated activation of NF-κB and interferon-sensitive response element in HEK293 cells stably expressing TLR4, MD-2, and CD14.  The activation of endogenous interleukin-1 receptor-assocd. kinase in RAW264.7 cells was also inhibited by TAK-242 treatment.  These findings suggest that TAK-242 binds selectively to TLR4 and subsequently disrupts the interaction of TLR4 with adaptor mols., thereby inhibiting TLR4 signal transduction and its downstream signaling events.  This work proposes a novel paradigm of a small mol. capable of disrupting protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEHy_7WltDNbVg90H21EOLACvtfcHk0li-fZjk0dNHvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1ehuw%253D%253D&md5=c3ce97a9ab69101a59117c80c8f01044</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.068064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.068064%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DN.%26aulast%3DTsuchimori%26aufirst%3DN.%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DIi%26aufirst%3DM.%26atitle%3DTAK-242%2520%2528resatorvid%2529%252C%2520a%2520small-molecule%2520inhibitor%2520of%2520toll-like%2520receptor%2520%2528TLR%2529%25204%2520signaling%252C%2520binds%2520selectively%2520to%2520TLR4%2520and%2520interferes%2520with%2520interactions%2520between%2520TLR4%2520and%2520its%2520adaptor%2520molecules%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D79%26spage%3D34%26epage%3D41%26doi%3D10.1124%2Fmol.110.068064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Takashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimatsu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazeki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaisho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uekata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazeki, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iizawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ii, M.</span><span> </span><span class="NLM_article-title">Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">1250</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2009.00297.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1111%2Fj.1476-5381.2009.00297.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=19563534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVelt7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2009&pages=1250-1262&author=K.+Takashimaauthor=N.+Matsunagaauthor=M.+Yoshimatsuauthor=K.+Hazekiauthor=T.+Kaishoauthor=M.+Uekataauthor=O.+Hazekiauthor=S.+Akiraauthor=Y.+Iizawaauthor=M.+Ii&title=Analysis+of+binding+site+for+the+novel+small-molecule+TLR4+signal+transduction+inhibitor+TAK-242+and+its+therapeutic+effect+on+mouse+sepsis+model&doi=10.1111%2Fj.1476-5381.2009.00297.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model</span></div><div class="casAuthors">Takashima, K.; Matsunaga, N.; Yoshimatsu, M.; Hazeki, K.; Kaisho, T.; Uekata, M.; Hazeki, O.; Akira, S.; Iizawa, Y.; Ii, M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1250-1262</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">TAK-242, a novel synthetic small-mol., suppresses prodn. of multiple cytokines by inhibiting Toll-like receptor (TLR) 4 signalling.  In this study, we investigated the target mol. of TAK-242 and examd. its therapeutic effect in a mouse sepsis model.  Binding assay with [3H]-TAK-242 and nuclear factor-κB reporter assay were used to identify the target mol. and binding site of TAK-242.  Bacillus calmette guerin (BCG)-primed mouse sepsis model using live Escherichia coli was used to est. the efficacy of TAK-242 in sepsis.  TAK-242 strongly bound to TLR4, but binding to TLR2, 3, 5, 9, TLR-related adaptor mols. and MD-2 was either not obsd. or marginal.  Mutational anal. using TLR4 mutants indicated that TAK-242 inhibits TLR4 signalling by binding to Cys747 in the intracellular domain of TLR4.  TAK-242 inhibited MyD88-independent pathway as well as MyD88-dependent pathway and its inhibitory effect was largely unaffected by lipopolysaccharide (LPS) concn. and types of TLR4 ligands.  TAK-242 had no effect on the LPS-induced conformational change of TLR4-MD-2 and TLR4 homodimerization.  In mouse sepsis model, although TAK-242 alone did not affect bacterial counts in blood, if co-administered with ceftazidime it inhibited the increases in serum cytokine levels and improved survival of mice.  TAK-242 suppressed TLR4 signalling by binding directly to a specific amino acid Cys747 in the intracellular domain of TLR4.  When co-administered with antibiotics, TAK-242 showed potent therapeutic effects in an E. coli-induced sepsis model using BCG-primed mice.  Thus, TAK-242 may be a promising therapeutic agent for sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrjFTRtcT0z7Vg90H21EOLACvtfcHk0lgOUcvdy_RnFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVelt7bL&md5=c3e6334f557e868f0246f51857b62f19</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00297.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00297.x%26sid%3Dliteratum%253Aachs%26aulast%3DTakashima%26aufirst%3DK.%26aulast%3DMatsunaga%26aufirst%3DN.%26aulast%3DYoshimatsu%26aufirst%3DM.%26aulast%3DHazeki%26aufirst%3DK.%26aulast%3DKaisho%26aufirst%3DT.%26aulast%3DUekata%26aufirst%3DM.%26aulast%3DHazeki%26aufirst%3DO.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DIizawa%26aufirst%3DY.%26aulast%3DIi%26aufirst%3DM.%26atitle%3DAnalysis%2520of%2520binding%2520site%2520for%2520the%2520novel%2520small-molecule%2520TLR4%2520signal%2520transduction%2520inhibitor%2520TAK-242%2520and%2520its%2520therapeutic%2520effect%2520on%2520mouse%2520sepsis%2520model%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D157%26spage%3D1250%26epage%3D1262%26doi%3D10.1111%2Fj.1476-5381.2009.00297.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">de Seny, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobraiville, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esser, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaise, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaise, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, F. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Relic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaise, M. G.</span><span> </span><span class="NLM_article-title">Acute-phase serum amyloid A in osteoarthritis: regulatory mechanism and proinflammatory properties</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e66769</span><span class="refDoi"> DOI: 10.1371/journal.pone.0066769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1371%2Fjournal.pone.0066769" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e66769&author=D.+de+Senyauthor=G.+Cobraivilleauthor=E.+Charlierauthor=S.+Neuvilleauthor=N.+Esserauthor=D.+Malaiseauthor=O.+Malaiseauthor=F.+Q.+Calvoauthor=B.+Relicauthor=M.+G.+Malaise&title=Acute-phase+serum+amyloid+A+in+osteoarthritis%3A+regulatory+mechanism+and+proinflammatory+properties&doi=10.1371%2Fjournal.pone.0066769"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0066769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0066769%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BSeny%26aufirst%3DD.%26aulast%3DCobraiville%26aufirst%3DG.%26aulast%3DCharlier%26aufirst%3DE.%26aulast%3DNeuville%26aufirst%3DS.%26aulast%3DEsser%26aufirst%3DN.%26aulast%3DMalaise%26aufirst%3DD.%26aulast%3DMalaise%26aufirst%3DO.%26aulast%3DCalvo%26aufirst%3DF.%2BQ.%26aulast%3DRelic%26aufirst%3DB.%26aulast%3DMalaise%26aufirst%3DM.%2BG.%26atitle%3DAcute-phase%2520serum%2520amyloid%2520A%2520in%2520osteoarthritis%253A%2520regulatory%2520mechanism%2520and%2520proinflammatory%2520properties%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De66769%26doi%3D10.1371%2Fjournal.pone.0066769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Glushkova, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parfenyuk, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khrenov, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novoselova, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunin, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesenko, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novoselova, E. G.</span><span> </span><span class="NLM_article-title">Inhibitors of TLR-4, NF-kappaB, and SAPK/JNK signaling reduce the toxic effect of lipopolysaccharide on RAW 264.7 cells</span> <span class="citation_source-journal">J. Immunotoxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span><span class="refDoi"> DOI: 10.3109/1547691X.2012.700652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.3109%2F1547691X.2012.700652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22830990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1antr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=133-140&author=O.+V.+Glushkovaauthor=S.+B.+Parfenyukauthor=M.+O.+Khrenovauthor=T.+V.+Novoselovaauthor=S.+M.+Luninauthor=E.+E.+Fesenkoauthor=E.+G.+Novoselova&title=Inhibitors+of+TLR-4%2C+NF-kappaB%2C+and+SAPK%2FJNK+signaling+reduce+the+toxic+effect+of+lipopolysaccharide+on+RAW+264.7+cells&doi=10.3109%2F1547691X.2012.700652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of TLR-4, NF-κB, and SAPK/JNK signaling reduce the toxic effect of lipopolysaccharide on RAW 264.7 cells</span></div><div class="casAuthors">Glushkova, Olga V.; Parfenyuk, Svetlana B.; Khrenov, Maxim O.; Novoselova, Tatyana V.; Lunin, Sergey M.; Fesenko, Eugeny E.; Novoselova, Elena G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunotoxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-140</span>CODEN:
                <span class="NLM_cas:coden">JIOMAP</span>;
        ISSN:<span class="NLM_cas:issn">1547-691X</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The present study was designed to examine and compare the effects of three suppressors on the cytokine response in tandem with examg.: the synthesis of inducible forms of heat shock proteins; HSP72 and HSP90α; activities of NF-κB and SAPK/JNK signaling pathways; and TLR4 expression.  Pre-treatment with inhibitors offers promise as protective means to lower the activity of these cascades, thereby circumventing the formation of excessive amts. of pro-inflammatory mols.  Three inhibitors of TLR4, SAPK/JNK, and NF-κB signaling, namely CLI-095, SP600125, and IKK Inhibitor XII, resp., were added to cultured RAW 264.7 macrophages before the Escherichia coli lipopolysaccharide (LPS) application.  Treatments of RAW 264.7 cells with each of the inhibitors resulted in a reduced response to LPS as was visualized by a decrease of TNF-α, IL-1, and IFN-γ prodn.  In addn., inhibitors of the NF-κB and SAPK/JNK signaling reduced IL-6 prodn. in LPS-treated cells, whereas the IKK inhibitor XII also decreased IL-10 prodn.  Further, the NO prodn. in LPS-stimulated macrophages was significantly reduced following application of CLI-095 or IKK inhibitor XII.  The results also showed that the inhibitors suppressed TLR4 prodn. and decreased phosphorylation of NF-κB and SAPK/JNK proteins, thereby preventing the activation NF-κB and SAPK/JNK signaling pathways in LPS-activated cells.  In addn., the prodn. of inducible heat shock proteins, HSP72 and HSP90-α, was reduced in LPS-stimulated RAW 264.7 cells pre-treated with inhibitors.  These results suggest that inhibitors CLI-095, SP600125, and IKK inhibitor XII demonstrate potential effectiveness in the redn. of the inflammatory response by mechanisms involving both the cellular defense system and cellular signaling.  In conclusion, suppressor of NF-κB cascade, IKK inhibitor XII, seems to be the most effective anti-toxic agent among studied inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXplXs6EStjrVg90H21EOLACvtfcHk0lgOUcvdy_RnFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1antr4%253D&md5=a50c14270c6f551eb23ff0b5402fedbe</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.3109%2F1547691X.2012.700652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F1547691X.2012.700652%26sid%3Dliteratum%253Aachs%26aulast%3DGlushkova%26aufirst%3DO.%2BV.%26aulast%3DParfenyuk%26aufirst%3DS.%2BB.%26aulast%3DKhrenov%26aufirst%3DM.%2BO.%26aulast%3DNovoselova%26aufirst%3DT.%2BV.%26aulast%3DLunin%26aufirst%3DS.%2BM.%26aulast%3DFesenko%26aufirst%3DE.%2BE.%26aulast%3DNovoselova%26aufirst%3DE.%2BG.%26atitle%3DInhibitors%2520of%2520TLR-4%252C%2520NF-kappaB%252C%2520and%2520SAPK%252FJNK%2520signaling%2520reduce%2520the%2520toxic%2520effect%2520of%2520lipopolysaccharide%2520on%2520RAW%2520264.7%2520cells%26jtitle%3DJ.%2520Immunotoxicol.%26date%3D2013%26volume%3D10%26spage%3D133%26epage%3D140%26doi%3D10.3109%2F1547691X.2012.700652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Ii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazeki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazeki, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iizawa, Y.</span><span> </span><span class="NLM_article-title">A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1288</span><span class="NLM_x">–</span> <span class="NLM_lpage">1295</span><span class="refDoi"> DOI: 10.1124/mol.105.019695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1124%2Fmol.105.019695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=16373689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtlKntLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=1288-1295&author=M.+Iiauthor=N.+Matsunagaauthor=K.+Hazekiauthor=K.+Nakamuraauthor=K.+Takashimaauthor=T.+Seyaauthor=O.+Hazekiauthor=T.+Kitazakiauthor=Y.+Iizawa&title=A+novel+cyclohexene+derivative%2C+ethyl+%286R%29-6-%5BN-%282-chloro-4-fluorophenyl%29sulfamoyl%5Dcyclohex-1-ene-1-carboxylate+%28TAK-242%29%2C+selectively+inhibits+toll-like+receptor+4-mediated+cytokine+production+through+suppression+of+intracellular+signaling&doi=10.1124%2Fmol.105.019695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling</span></div><div class="casAuthors">Ii, Masayuki; Matsunaga, Naoko; Hazeki, Kaoru; Nakamura, Kazuyo; Takashima, Katsunori; Seya, Tsukasa; Hazeki, Osamu; Kitazaki, Tomoyuki; Iizawa, Yuji</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1288-1295</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Proinflammatory mediators such as cytokines and NO play pivotal roles in various inflammatory diseases.  To combat inflammatory diseases successfully, regulation of proinflammatory mediator prodn. would be a crit. process.  In the present study, we investigated the in vitro effects of Et (6R)-6-[N-(2-chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), a novel small mol. cytokine prodn. inhibitor, and its mechanism of action.  In RAW264.7 cells and mouse peritoneal macrophages, TAK-242 suppressed lipopolysaccharide (LPS)-induced prodn. of NO, tumor necrosis factor-α (TNF-α), and interleukin (IL)-6, with 50% inhibitory concn. (IC50) of 1.1 to 11 nM.  TAK-242 also suppressed the prodn. of these cytokines from LPS-stimulated human peripheral blood mononuclear cells (PBMCs) at IC50 values from 11 to 33 nM.  In addn., the inhibitory effects on the LPS-induced IL-6 and IL-12 prodn. were similar in human PBMCs, monocytes, and macrophages.  TAK-242 inhibited mRNA expression of IL-6 and TNF-α induced by LPS and interferon-γ in RAW264.7 cells.  The phosphorylation of mitogen-activated protein kinases induced by LPS was also inhibited in a concn.-dependent manner.  However, TAK-242 did not antagonize the binding of LPS to the cells.  It is noteworthy that TAK-242 suppressed the cytokine prodn. induced by Toll-like receptor (TLR) 4 ligands, but not by ligands for TLR2, -3, and -9.  In addn., IL-1 β-induced IL-8 prodn. from human PBMCs was not markedly affected by TAK-242.  These data suggest that TAK-242 suppresses the prodn. of multiple cytokines by selectively inhibiting TLR4 intracellular signaling.  Finally, TAK-242 is a novel small mol. TLR4 signaling inhibitor and could be a promising therapeutic agent for inflammatory diseases, whose pathogenesis involves TLR4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw9_-xuGrPUbVg90H21EOLACvtfcHk0liUUVWgNAMK_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtlKntLs%253D&md5=c8ad6248fc504e71aafd9e3f3ad7a546</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.019695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.019695%26sid%3Dliteratum%253Aachs%26aulast%3DIi%26aufirst%3DM.%26aulast%3DMatsunaga%26aufirst%3DN.%26aulast%3DHazeki%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DTakashima%26aufirst%3DK.%26aulast%3DSeya%26aufirst%3DT.%26aulast%3DHazeki%26aufirst%3DO.%26aulast%3DKitazaki%26aufirst%3DT.%26aulast%3DIizawa%26aufirst%3DY.%26atitle%3DA%2520novel%2520cyclohexene%2520derivative%252C%2520ethyl%2520%25286R%2529-6-%255BN-%25282-chloro-4-fluorophenyl%2529sulfamoyl%255Dcyclohex-1-ene-1-carboxylate%2520%2528TAK-242%2529%252C%2520selectively%2520inhibits%2520toll-like%2520receptor%25204-mediated%2520cytokine%2520production%2520through%2520suppression%2520of%2520intracellular%2520signaling%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D69%26spage%3D1288%26epage%3D1295%26doi%3D10.1124%2Fmol.105.019695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Sha, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iizawa, Y.</span><span> </span><span class="NLM_article-title">Therapeutic effects of TAK-242, a novel selective toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">571</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2007.06.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.ejphar.2007.06.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=17632100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCitrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=571&publication_year=2007&pages=231-239&author=T.+Shaauthor=M.+Sunamotoauthor=T.+Kitazakiauthor=J.+Satoauthor=M.+Iiauthor=Y.+Iizawa&title=Therapeutic+effects+of+TAK-242%2C+a+novel+selective+toll-like+receptor+4+signal+transduction+inhibitor%2C+in+mouse+endotoxin+shock+model&doi=10.1016%2Fj.ejphar.2007.06.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model</span></div><div class="casAuthors">Sha, Takukyu; Sunamoto, Mie; Kitazaki, Tomoyuki; Sato, Jun; Ii, Masayuki; Iizawa, Yuji</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">571</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">231-239</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Et (6R)-6-[N-(2-chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), a novel small mol. that selectively inhibits Toll-like receptor 4-mediated signaling, inhibits various kinds of inflammatory mediators such as nitric oxide (NO), tumor necrosis factor (TNF)-α, interleukin (IL)-1, IL-6, IL-10, macrophage inhibitory protein (MIP)-2 and prostaglandin E2 from lipopolysaccharide (LPS)-stimulated macrophages.  The effects of TAK-242 were evaluated in a mouse model of endotoxin shock.  I.v. administration of TAK-242 to mice 1 h before LPS challenge dose-dependently inhibited LPS-induced increases in serum levels of TNF-α, IL-1β, IL-6, IL-10, MIP-2, and NO metabolites.  TAK-242 protected mice from LPS-induced lethality in a similar dose-dependent manner, and rescued 100% of mice at a dose of 1 mg/kg.  Interestingly, TAK-242 worked quickly, and showed beneficial effects even when administered after LPS challenge.  Even though increases in serum levels of IL-6 and hypothermia were already evident 2 h after LPS challenge, TAK-242 administration inhibited further increase in IL-6 levels and decrease in body temp.  LPS-induced increases in serum levels of organ dysfunction markers, such as alanine aminotransferase, total bilirubin, and blood urea nitrogen, were also significantly suppressed by post-treatment as well as pre-treatment.  Furthermore, administration of 3 mg/kg TAK-242 significantly increased survival of mice, even when given 4 h after LPS challenge.  These results suggest that TAK-242 protects mice against LPS-induced lethality by inhibiting prodn. of multiple cytokines and NO.  TAK-242 has a quick onset of action and provides significant benefits by post-treatment, suggesting that it may be a promising drug candidate for the treatment of sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUWvZqAlZpt7Vg90H21EOLACvtfcHk0liUUVWgNAMK_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCitrrL&md5=f7d6a1f73a905d9757ef7de3e4ad0b30</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.06.027%26sid%3Dliteratum%253Aachs%26aulast%3DSha%26aufirst%3DT.%26aulast%3DSunamoto%26aufirst%3DM.%26aulast%3DKitazaki%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DJ.%26aulast%3DIi%26aufirst%3DM.%26aulast%3DIizawa%26aufirst%3DY.%26atitle%3DTherapeutic%2520effects%2520of%2520TAK-242%252C%2520a%2520novel%2520selective%2520toll-like%2520receptor%25204%2520signal%2520transduction%2520inhibitor%252C%2520in%2520mouse%2520endotoxin%2520shock%2520model%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D571%26spage%3D231%26epage%3D239%26doi%3D10.1016%2Fj.ejphar.2007.06.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Sha, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iizawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ii, M.</span><span> </span><span class="NLM_article-title">Combination of imipenem and TAK-242, a toll-like receptor 4 signal transduction inhibitor, improves survival in a murine model of polymicrobial sepsis</span> <span class="citation_source-journal">Shock</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span><span class="refDoi"> DOI: 10.1097/SHK.0b013e3181f48942</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1097%2FSHK.0b013e3181f48942" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2011&pages=205-209&author=T.+Shaauthor=Y.+Iizawaauthor=M.+Ii&title=Combination+of+imipenem+and+TAK-242%2C+a+toll-like+receptor+4+signal+transduction+inhibitor%2C+improves+survival+in+a+murine+model+of+polymicrobial+sepsis&doi=10.1097%2FSHK.0b013e3181f48942"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1097%2FSHK.0b013e3181f48942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FSHK.0b013e3181f48942%26sid%3Dliteratum%253Aachs%26aulast%3DSha%26aufirst%3DT.%26aulast%3DIizawa%26aufirst%3DY.%26aulast%3DIi%26aufirst%3DM.%26atitle%3DCombination%2520of%2520imipenem%2520and%2520TAK-242%252C%2520a%2520toll-like%2520receptor%25204%2520signal%2520transduction%2520inhibitor%252C%2520improves%2520survival%2520in%2520a%2520murine%2520model%2520of%2520polymicrobial%2520sepsis%26jtitle%3DShock%26date%3D2011%26volume%3D35%26spage%3D205%26epage%3D209%26doi%3D10.1097%2FSHK.0b013e3181f48942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Goldfarb, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortegel, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrillo, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanotti-Cavazzoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casey, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dellinger, R. P.</span><span> </span><span class="NLM_article-title">TAKEDA-143242 increased survival via reduced cytokines in porcine peritonitis</span> <span class="citation_source-journal">J. Surg. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">e165</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span><span class="refDoi"> DOI: 10.1016/j.jss.2010.09.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.jss.2010.09.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2011&pages=e165-173&author=R.+D.+Goldfarbauthor=J.+W.+Ortegelauthor=J.+E.+Parrilloauthor=S.+Zanotti-Cavazzoniauthor=L.+C.+Caseyauthor=R.+P.+Dellinger&title=TAKEDA-143242+increased+survival+via+reduced+cytokines+in+porcine+peritonitis&doi=10.1016%2Fj.jss.2010.09.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.jss.2010.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jss.2010.09.031%26sid%3Dliteratum%253Aachs%26aulast%3DGoldfarb%26aufirst%3DR.%2BD.%26aulast%3DOrtegel%26aufirst%3DJ.%2BW.%26aulast%3DParrillo%26aufirst%3DJ.%2BE.%26aulast%3DZanotti-Cavazzoni%26aufirst%3DS.%26aulast%3DCasey%26aufirst%3DL.%2BC.%26aulast%3DDellinger%26aufirst%3DR.%2BP.%26atitle%3DTAKEDA-143242%2520increased%2520survival%2520via%2520reduced%2520cytokines%2520in%2520porcine%2520peritonitis%26jtitle%3DJ.%2520Surg.%2520Res.%26date%3D2011%26volume%3D166%26spage%3De165%26epage%3D173%26doi%3D10.1016%2Fj.jss.2010.09.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Hua, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prunty, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayeed, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, D. G.</span><span> </span><span class="NLM_article-title">TAK-242, an antagonist for toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span><span class="refDoi"> DOI: 10.1038/jcbfm.2014.240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fjcbfm.2014.240" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=25586141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGrsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=536-542&author=F.+Huaauthor=H.+Tangauthor=J.+Wangauthor=M.+C.+Pruntyauthor=X.+Huaauthor=I.+Sayeedauthor=D.+G.+Stein&title=TAK-242%2C+an+antagonist+for+toll-like+receptor+4%2C+protects+against+acute+cerebral+ischemia%2Freperfusion+injury+in+mice&doi=10.1038%2Fjcbfm.2014.240"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice</span></div><div class="casAuthors">Hua, Fang; Tang, Huiling; Wang, Jun; Prunty, Megan C.; Hua, Xiaodong; Sayeed, Iqbal; Stein, Donald G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">536-542</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Toll-like receptor 4 (TLR4) contributes to cerebral ischemia/reperfusion (I/R) injury and is a potential target for the treatment of ischemic stroke.  This expt. is to evaluate the effect of an exogenous TLR4 antagonist, TAK-242, against acute cerebral I/R injury.  A mouse model of cerebral I/R was induced by transient middle cerebral artery occlusion.  TAK-242 (3 mg/kg body wt.) was injected i.p. 1 h after ischemia.  Our results showed that the concn. of TAK-242 in plasma increased to 52.0 ng/mL 3 h after injection, was maintained at 54.1 ng/mL 8 h after injection, and decreased to 22.6 ng/mL 24 h after injection.  The concn. of TAK-242 in brain tissue increased to 26.1 ng/mL in ischemic hemisphere and 14.2 ng/mL in nonischemic hemisphere 3 h after injection, and was maintained at the similar levels 24 h after injection.  We found that TAK-242 significantly reduced cerebral infarction compared with vehicle control, improved neurol. function, inhibited the phosphorylation of downstream protein kinases in TLR4 signaling pathway, and downregulated the expression of inflammatory cytokines.  We conclude that TAK-242 is able to cross blood-brain barrier, blocks TLR4 signaling, mediates the expression of inflammatory cytokines, and protects the brain from acute damage induced by I/R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-M4XQgqpBY7Vg90H21EOLACvtfcHk0lg9ywFdFGkyPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGrsr0%253D&md5=a3383c2162301b44b7cb5697ca060470</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2014.240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2014.240%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DF.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPrunty%26aufirst%3DM.%2BC.%26aulast%3DHua%26aufirst%3DX.%26aulast%3DSayeed%26aufirst%3DI.%26aulast%3DStein%26aufirst%3DD.%2BG.%26atitle%3DTAK-242%252C%2520an%2520antagonist%2520for%2520toll-like%2520receptor%25204%252C%2520protects%2520against%2520acute%2520cerebral%2520ischemia%252Freperfusion%2520injury%2520in%2520mice%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2015%26volume%3D35%26spage%3D536%26epage%3D542%26doi%3D10.1038%2Fjcbfm.2014.240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byth, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toader, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span> </span><span class="NLM_article-title">Mechanism and <i>in vitro</i> pharmacology of TAK1 inhibition by (5Z)-7-oxozeaenol</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span><span class="refDoi"> DOI: 10.1021/cb3005897</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb3005897" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslSg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=643-650&author=J.+Wuauthor=F.+Powellauthor=N.+A.+Larsenauthor=Z.+Laiauthor=K.+F.+Bythauthor=J.+Readauthor=R.+F.+Guauthor=M.+Rothauthor=D.+Toaderauthor=J.+C.+Saehauthor=H.+Chen&title=Mechanism+and+in+vitro+pharmacology+of+TAK1+inhibition+by+%285Z%29-7-oxozeaenol&doi=10.1021%2Fcb3005897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism and In Vitro Pharmacology of TAK1 Inhibition by (5Z)-7-Oxozeaenol</span></div><div class="casAuthors">Wu, Jiaquan; Powell, Francoise; Larsen, Nicholas A.; Lai, Zhongwu; Byth, Kate F.; Read, Jon; Gu, Rong-Fang; Roth, Mark; Toader, Dorin; Saeh, Jamal Carlos; Chen, Huawei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">643-650</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Transforming growth factor-β activated kinase-1 (TAK1) is a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family that regulates several signaling pathways including NF-κB signal transduction and p38 activation.  TAK1 deregulation has been implicated in human diseases including cancer and inflammation.  Here, we show that, in addn. to its kinase activity, TAK1 has intrinsic ATPase activity, that (5Z)-7-Oxozeaenol irreversibly inhibits TAK1, and that sensitivity to (5Z)-7-Oxozeaenol inhibition in hematol. cancer cell lines is NRAS mutation status and TAK1 pathway dependent.  X-ray crystallog. and mass spectrometric studies showed that (5Z)-7-Oxozeaenol forms a covalent complex with TAK1.  Detailed biochem. characterization revealed that (5Z)-7-Oxozeaenol inhibited both the kinase and the ATPase activity of TAK1 following a bi-phase kinetics, consistent with the irreversible inhibition mechanism.  In DoHH2 cells, (5Z)-7-Oxozeaenol potently inhibited the p38 phosphorylation driven by TAK1, and the inhibition lasted over 6 h after withdrawal of (5Z)-7-Oxozeaenol.  Profiling (5Z)-7-Oxozeaenol in a panel of hematol. cancer cells showed that sensitive cell lines tended to carry NRAS mutations and that genes in TAK1 regulated pathways were enriched in sensitive cell lines.  Taken together, we have elucidated the mol. mechanism of a TAK1 irreversible inhibitor and laid the foundation for designing next generation TAK1 irreversible inhibitors.  The NRAS-TAK1-Wnt signaling network discerned in our study may prove to be useful in patient selection for TAK1 targeted agents in hematol. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQoK3PzlpHObVg90H21EOLACvtfcHk0lg9ywFdFGkyPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslSg&md5=4bd8a0667c6eeddbf9f81153ab4ffbe5</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fcb3005897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb3005897%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DPowell%26aufirst%3DF.%26aulast%3DLarsen%26aufirst%3DN.%2BA.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DByth%26aufirst%3DK.%2BF.%26aulast%3DRead%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DR.%2BF.%26aulast%3DRoth%26aufirst%3DM.%26aulast%3DToader%26aufirst%3DD.%26aulast%3DSaeh%26aufirst%3DJ.%2BC.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DMechanism%2520and%2520in%2520vitro%2520pharmacology%2520of%2520TAK1%2520inhibition%2520by%2520%25285Z%2529-7-oxozeaenol%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D643%26epage%3D650%26doi%3D10.1021%2Fcb3005897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Hett, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slater, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawate, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, D. T.</span><span> </span><span class="NLM_article-title">Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">398</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span><span class="refDoi"> DOI: 10.1038/nchembio.1236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnchembio.1236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=23603659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Sls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=398-405&author=E.+C.+Hettauthor=L.+H.+Slaterauthor=K.+G.+Markauthor=T.+Kawateauthor=B.+G.+Monksauthor=A.+Stutzauthor=E.+Latzauthor=D.+T.+Hung&title=Chemical+genetics+reveals+a+kinase-independent+role+for+protein+kinase+R+in+pyroptosis&doi=10.1038%2Fnchembio.1236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis</span></div><div class="casAuthors">Hett, Erik C.; Slater, Louise H.; Mark, Kevin G.; Kawate, Tomohiko; Monks, Brian G.; Stutz, Andrea; Latz, Eicke; Hung, Deborah T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">398-405</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Formation of the inflammasome, a scaffolding complex that activates caspase-1, is important in numerous diseases.  Pyroptotic cell death induced by anthrax lethal toxin (LT) is a model for inflammasome-mediated caspase-1 activation.  We discovered 7-desacetoxy-6,7-dehydrogedunin (7DG) in a phenotypic screen as a small mol. that protects macrophages from LT-induced death.  Using chem. proteomics, we identified protein kinase R (PKR) as the target of 7DG and show that RNAi knockdown of PKR phenocopies treatment with 7DG.  Further, we show that PKR's role in ASC assembly and caspase-1 activation induced by several different inflammasome stimuli is independent of PKR's kinase activity, demonstrating that PKR has a previously uncharacterized role in caspase-1 activation and pyroptosis that is distinct from its reported kinase-dependent roles in apoptosis and inflammasome formation in lipopolysaccharide-primed cells.  Remarkably, PKR has different roles in two distinct cell death pathways and has a broad role in inflammasome function relevant in other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXeyfUICrnXLVg90H21EOLACvtfcHk0lg9ywFdFGkyPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Sls7s%253D&md5=ea43350c90efab90469218bf30e4b11d</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1236%26sid%3Dliteratum%253Aachs%26aulast%3DHett%26aufirst%3DE.%2BC.%26aulast%3DSlater%26aufirst%3DL.%2BH.%26aulast%3DMark%26aufirst%3DK.%2BG.%26aulast%3DKawate%26aufirst%3DT.%26aulast%3DMonks%26aufirst%3DB.%2BG.%26aulast%3DStutz%26aufirst%3DA.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DHung%26aufirst%3DD.%2BT.%26atitle%3DChemical%2520genetics%2520reveals%2520a%2520kinase-independent%2520role%2520for%2520protein%2520kinase%2520R%2520in%2520pyroptosis%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D398%26epage%3D405%26doi%3D10.1038%2Fnchembio.1236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Lu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inouye, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundbäck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdes-Ferrer, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olofsson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalb, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlandsson-Harris, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ting, J. P.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antoine, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavan, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotamisligil, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, K. J.</span><span> </span><span class="NLM_article-title">Novel role of PKR in inflammasome activation and HMGB1 release</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">670</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1038/nature11290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnature11290" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=670-674&author=B.+Luauthor=T.+Nakamuraauthor=K.+Inouyeauthor=J.+Liauthor=Y.+Tangauthor=P.+Lundb%C3%A4ckauthor=S.+I.+Valdes-Ferrerauthor=P.+S.+Olofssonauthor=T.+Kalbauthor=J.+Rothauthor=Y.+Zouauthor=H.+Erlandsson-Harrisauthor=H.+Yangauthor=J.+P.-Y.+Tingauthor=H.+Wangauthor=U.+Anderssonauthor=D.+J.+Antoineauthor=S.+S.+Chavanauthor=G.+S.+Hotamisligilauthor=K.+J.+Tracey&title=Novel+role+of+PKR+in+inflammasome+activation+and+HMGB1+release&doi=10.1038%2Fnature11290"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1038%2Fnature11290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11290%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DB.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DInouye%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DLundb%25C3%25A4ck%26aufirst%3DP.%26aulast%3DValdes-Ferrer%26aufirst%3DS.%2BI.%26aulast%3DOlofsson%26aufirst%3DP.%2BS.%26aulast%3DKalb%26aufirst%3DT.%26aulast%3DRoth%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DErlandsson-Harris%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DTing%26aufirst%3DJ.%2BP.-Y.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DAntoine%26aufirst%3DD.%2BJ.%26aulast%3DChavan%26aufirst%3DS.%2BS.%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DNovel%2520role%2520of%2520PKR%2520in%2520inflammasome%2520activation%2520and%2520HMGB1%2520release%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D670%26epage%3D674%26doi%3D10.1038%2Fnature11290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Bonnet, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weil, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dam, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hovanessian, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meurs, E. F.</span><span> </span><span class="NLM_article-title">PKR stimulates NF-κB irrespective of its kinase function by interacting with the IκB kinase complex</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4532</span><span class="NLM_x">–</span> <span class="NLM_lpage">4542</span><span class="refDoi"> DOI: 10.1128/MCB.20.13.4532-4542.2000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1128%2FMCB.20.13.4532-4542.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10848580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksVOjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=4532-4542&author=M.+C.+Bonnetauthor=R.+Weilauthor=E.+Damauthor=A.+G.+Hovanessianauthor=E.+F.+Meurs&title=PKR+stimulates+NF-%CE%BAB+irrespective+of+its+kinase+function+by+interacting+with+the+I%CE%BAB+kinase+complex&doi=10.1128%2FMCB.20.13.4532-4542.2000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">PKR stimulates NF-κB irrespective of its kinase function by interacting with the IκB kinase complex</span></div><div class="casAuthors">Bonnet, Marion C.; Weil, Robert; Dam, Elisabeth; Hovanessian, Ara G.; Meurs, Eliane F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4532-4542</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The interferon (IFN)-induced double-stranded RNA-activated protein kinase PKR mediates inhibition of protein synthesis through phosphorylation of the α subunit of eukaryotic initiation factor 2 (eIF2α) and is also involved in the induction of the IFN gene through the activation of the transcription factor NF-κB.  NF-κB is retained in the cytoplasm through binding to its inhibitor IκBα.  The crit. step in NF-κB activation is the phosphorylation of IκBα by the IκB kinase (IKK) complex.  This activity releases NF-κB from IκBα and allows its translocation to the nucleus.  Here, we have studied the ability of PKR to activate NF-κB in a reporter assay and have shown for the first time that two catalytically inactive PKR mutants, PKR/KR296 and a deletion mutant (PKR/Del42) which lacks the potential eIF2α-binding domain, can also activate NF-κB.  This result indicated that NF-κB activation by PKR does not require its kinase activity and that it is independent of the PKR-eIF2α relationship.  Transfection of either wild-type PKR or catalytically inactive PKR in PKR0/0 mouse embryo fibroblasts resulted in the activation of the IKK complex.  By using a glutathione S-transferase pull-down assay, we showed that PKR interacts with the IKKβ subunit of the IKK complex.  This interaction apparently does not require the integrity of the IKK complex, as it was found to occur with exts. from cells deficient in the NF-κB essential modulator, one of the components of the IKK complex.  Therefore, our results reveal a novel pathway by which PKR can modulate the NF-κB signaling pathway without using its kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqankUHDyrgHrVg90H21EOLACvtfcHk0li7vcnaDsWwUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksVOjtLc%253D&md5=e4043f71ec7f431dc6c55d6efffeb02b</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1128%2FMCB.20.13.4532-4542.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.20.13.4532-4542.2000%26sid%3Dliteratum%253Aachs%26aulast%3DBonnet%26aufirst%3DM.%2BC.%26aulast%3DWeil%26aufirst%3DR.%26aulast%3DDam%26aufirst%3DE.%26aulast%3DHovanessian%26aufirst%3DA.%2BG.%26aulast%3DMeurs%26aufirst%3DE.%2BF.%26atitle%3DPKR%2520stimulates%2520NF-%25CE%25BAB%2520irrespective%2520of%2520its%2520kinase%2520function%2520by%2520interacting%2520with%2520the%2520I%25CE%25BAB%2520kinase%2520complex%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2000%26volume%3D20%26spage%3D4532%26epage%3D4542%26doi%3D10.1128%2FMCB.20.13.4532-4542.2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Juliana, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes-Alnemri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farias, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E. S.</span><span> </span><span class="NLM_article-title">Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">36617</span><span class="NLM_x">–</span> <span class="NLM_lpage">36622</span><span class="refDoi"> DOI: 10.1074/jbc.M112.407130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M112.407130" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=36617-36622&author=C.+Julianaauthor=T.+Fernandes-Alnemriauthor=S.+Kangauthor=A.+Fariasauthor=F.+Qinauthor=E.+S.+Alnemri&title=Non-transcriptional+priming+and+deubiquitination+regulate+NLRP3+inflammasome+activation&doi=10.1074%2Fjbc.M112.407130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.407130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.407130%26sid%3Dliteratum%253Aachs%26aulast%3DJuliana%26aufirst%3DC.%26aulast%3DFernandes-Alnemri%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DFarias%26aufirst%3DA.%26aulast%3DQin%26aufirst%3DF.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26atitle%3DNon-transcriptional%2520priming%2520and%2520deubiquitination%2520regulate%2520NLRP3%2520inflammasome%2520activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D36617%26epage%3D36622%26doi%3D10.1074%2Fjbc.M112.407130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Lopez-Castejon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luheshi, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">High, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehead, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flitsch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudovsky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, D.</span><span> </span><span class="NLM_article-title">Deubiquitinases regulate the activity of caspase-1 and interleukin-1β secretion via assembly of the inflammasome</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">2721</span><span class="NLM_x">–</span> <span class="NLM_lpage">2733</span><span class="refDoi"> DOI: 10.1074/jbc.M112.422238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M112.422238" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=2721-2733&author=G.+Lopez-Castejonauthor=N.+M.+Luheshiauthor=V.+Companauthor=S.+Highauthor=R.+C.+Whiteheadauthor=S.+Flitschauthor=A.+Kirovauthor=I.+Prudovskyauthor=E.+Swantonauthor=D.+Brough&title=Deubiquitinases+regulate+the+activity+of+caspase-1+and+interleukin-1%CE%B2+secretion+via+assembly+of+the+inflammasome&doi=10.1074%2Fjbc.M112.422238"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.422238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.422238%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Castejon%26aufirst%3DG.%26aulast%3DLuheshi%26aufirst%3DN.%2BM.%26aulast%3DCompan%26aufirst%3DV.%26aulast%3DHigh%26aufirst%3DS.%26aulast%3DWhitehead%26aufirst%3DR.%2BC.%26aulast%3DFlitsch%26aufirst%3DS.%26aulast%3DKirov%26aufirst%3DA.%26aulast%3DPrudovsky%26aufirst%3DI.%26aulast%3DSwanton%26aufirst%3DE.%26aulast%3DBrough%26aufirst%3DD.%26atitle%3DDeubiquitinases%2520regulate%2520the%2520activity%2520of%2520caspase-1%2520and%2520interleukin-1%25CE%25B2%2520secretion%2520via%2520assembly%2520of%2520the%2520inflammasome%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D2721%26epage%3D2733%26doi%3D10.1074%2Fjbc.M112.422238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Shi, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenderov, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abu-Asab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehrl, J. H.</span><span> </span><span class="NLM_article-title">Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span><span class="refDoi"> DOI: 10.1038/ni.2215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fni.2215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22286270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlOlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=255-263&author=C.+S.+Shiauthor=K.+Shenderovauthor=N.+N.+Huangauthor=J.+Kabatauthor=M.+Abu-Asabauthor=K.+A.+Fitzgeraldauthor=A.+Sherauthor=J.+H.+Kehrl&title=Activation+of+autophagy+by+inflammatory+signals+limits+IL-1%CE%B2+production+by+targeting+ubiquitinated+inflammasomes+for+destruction&doi=10.1038%2Fni.2215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction</span></div><div class="casAuthors">Shi, Chong-Shan; Shenderov, Kevin; Huang, Ning-Na; Kabat, Juraj; Abu-Asab, Mones; Fitzgerald, Katherine A.; Sher, Alan; Kehrl, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-263</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autophagosomes delivers cytoplasmic constituents to lysosomes for degrdn., whereas inflammasomes are mol. platforms activated by infection or stress that regulate the activity of caspase-1 and the maturation of interleukin 1β (IL-1β) and IL-18.  Here we show that the induction of AIM2 or NLRP3 inflammasomes in macrophages triggered activation of the G protein RalB and autophagosome formation.  The induction of autophagy did not depend on the adaptor ASC or capase-1 but was dependent on the presence of the inflammasome sensor.  Blocking autophagy potentiated inflammasome activity, whereas stimulating autophagy limited it.  Assembled inflammasomes underwent ubiquitination and recruited the autophagic adaptor p62, which assisted their delivery to autophagosomes.  Our data indicate that autophagy accompanies inflammasome activation to temper inflammation by eliminating active inflammasomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqosogK1NAUALVg90H21EOLACvtfcHk0li7vcnaDsWwUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlOlsb0%253D&md5=55ed59af5cd9f38066ff8d9a1f40f4ba</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1038%2Fni.2215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.2215%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DC.%2BS.%26aulast%3DShenderov%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DN.%2BN.%26aulast%3DKabat%26aufirst%3DJ.%26aulast%3DAbu-Asab%26aufirst%3DM.%26aulast%3DFitzgerald%26aufirst%3DK.%2BA.%26aulast%3DSher%26aufirst%3DA.%26aulast%3DKehrl%26aufirst%3DJ.%2BH.%26atitle%3DActivation%2520of%2520autophagy%2520by%2520inflammatory%2520signals%2520limits%2520IL-1%25CE%25B2%2520production%2520by%2520targeting%2520ubiquitinated%2520inflammasomes%2520for%2520destruction%26jtitle%3DNat.%2520Immunol.%26date%3D2012%26volume%3D13%26spage%3D255%26epage%3D263%26doi%3D10.1038%2Fni.2215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Ferrari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiozzi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falzoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Susino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baricordi, O. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Virgilio, F.</span><span> </span><span class="NLM_article-title">Extracellular ATP triggers IL-1β release by activating the purinergic P2Z receptor of human macrophages</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">1451</span><span class="NLM_x">–</span> <span class="NLM_lpage">1458</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=9233643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADyaK2sXkslKrtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=1997&pages=1451-1458&author=D.+Ferrariauthor=P.+Chiozziauthor=S.+Falzoniauthor=M.+Dal+Susinoauthor=L.+Melchiorriauthor=O.+R.+Baricordiauthor=F.+Di+Virgilio&title=Extracellular+ATP+triggers+IL-1%CE%B2+release+by+activating+the+purinergic+P2Z+receptor+of+human+macrophages"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular ATP triggers IL-1β release by activating the purinergic P2Z receptor of human macrophages</span></div><div class="casAuthors">Ferrari, Davide; Chiozzi, Paola; Falzoni, Simonetta; Dal Susino, Monica; Melchiorri, Loredana; Baricordi, Olavio R.; Di Virgilio, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1451-1458</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Extracellular ATP (ATPe) is known to cause release of processed IL-1β from LPS-treated macrophages and microglial cells.  IL-1β release is fast and thought to be assocd. with cell death.  The authors have reinvestigated this process to identify (1) the purinergic receptor involved; (2) the relation to cell death; and (3) pharmacol. agonists or antagonists able to modulate IL-1β release.  The data confirm that ATPe is a powerful stimulus for IL-1β release from LPS-treated human macrophages; however, the authors also show that IL-1β release is not necessarily assocd. with cell death, as it occurs at lower ATP concns. and much earlier than leakage of cytoplasmic markers.  The selective purinergic P2Z receptor agonist benzoylbenzoyl ATP was at least one order of magnitude more powerful than ATP, but also had a strong cytotoxic effect.  Methylthio-ATP was equipotent as ATPe at the optimal concn. of 1 mM, but markedly inhibitory at higher concns.  The irreversible P2Z blocker-oxidized ATP completely inhibited ATPe-induced IL-1β release.  IL-1β release also was inhibited by increasing the K+ concn. of the incubation medium.  These data suggest that ATPe triggers IL-1β via the purinergic P2Z receptor recently shown to be expressed by human macrophages and identified as a new member of the P2X family (P2X7), and provide pharmacol. tools for the modulation of IL-1β release in vitro and, possibly, in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2liwcW09JWrVg90H21EOLACvtfcHk0ljlM7425yfwLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslKrtLo%253D&md5=188ea739b2440fc90fefded2c486c764</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DD.%26aulast%3DChiozzi%26aufirst%3DP.%26aulast%3DFalzoni%26aufirst%3DS.%26aulast%3DDal%2BSusino%26aufirst%3DM.%26aulast%3DMelchiorri%26aufirst%3DL.%26aulast%3DBaricordi%26aufirst%3DO.%2BR.%26aulast%3DDi%2BVirgilio%26aufirst%3DF.%26atitle%3DExtracellular%2520ATP%2520triggers%2520IL-1%25CE%25B2%2520release%2520by%2520activating%2520the%2520purinergic%2520P2Z%2520receptor%2520of%2520human%2520macrophages%26jtitle%3DJ.%2520Immunol.%26date%3D1997%26volume%3D159%26spage%3D1451%26epage%3D1458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Solle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labasi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perregaux, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stam, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrushova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koller, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span> </span><span class="NLM_article-title">Altered cytokine production in mice lacking P2X<sub>7</sub> receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1074/jbc.M006781200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M006781200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=11016935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtFSjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=125-132&author=M.+Solleauthor=J.+Labasiauthor=D.+G.+Perregauxauthor=E.+Stamauthor=N.+Petrushovaauthor=B.+H.+Kollerauthor=R.+J.+Griffithsauthor=C.+A.+Gabel&title=Altered+cytokine+production+in+mice+lacking+P2X7+receptors&doi=10.1074%2Fjbc.M006781200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Altered cytokine production in mice lacking P2X7 receptors</span></div><div class="casAuthors">Solle, Mike; Labasi, Jeff; Perregaux, David G.; Stam, Ethan; Petrushova, Nina; Koller, Beverly H.; Griffiths, Richard J.; Gabel, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The P2X7 receptor (P2X7R) is an ATP-gated ion channel expressed by monocytes and macrophages.  To directly address the role of this receptor in interleukin (IL)-1β post-translational processing, the authors have generated a P2X7R-deficient mouse line.  P2X7R-/- macrophages respond to lipopolysaccharide and produce levels of cyclooxygenase-2 and pro-IL-1β comparable with those generated by wild-type cells.  In response to ATP, however, pro-IL-1β produced by the P2X7R-/- cells is not externalized or activated by caspase-1.  Nigericin, an alternate secretion stimulus, promotes release of 17-kDa IL-1β from P2X7R-/- macrophages.  In response to in vivo lipopolysaccharide injection, both wild-type and P2X7R-/- animals display increases in peritoneal lavage IL-6 levels but no detectable IL-1.  Subsequent ATP injection to wild-type animals promotes an increase in IL-1, which in turn leads to addnl. IL-6 prodn.; similar increases did not occur in ATP-treated, LPS-primed P2X7R-/- animals.  Absence of the P2X7R thus leads to an inability of peritoneal macrophages to release IL-1 in response to ATP.  As a result of the IL-1 deficiency, in vivo cytokine signaling cascades are impaired in P2X7R-deficient animals.  Together these results demonstrate that P2X7R activation can provide a signal that leads to maturation and release of IL-1β and initiation of a cytokine cascade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplWJDl5YjMEbVg90H21EOLACvtfcHk0ljlM7425yfwLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtFSjug%253D%253D&md5=cbbd35688998cce33e72e3b835d0f9c3</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M006781200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M006781200%26sid%3Dliteratum%253Aachs%26aulast%3DSolle%26aufirst%3DM.%26aulast%3DLabasi%26aufirst%3DJ.%26aulast%3DPerregaux%26aufirst%3DD.%2BG.%26aulast%3DStam%26aufirst%3DE.%26aulast%3DPetrushova%26aufirst%3DN.%26aulast%3DKoller%26aufirst%3DB.%2BH.%26aulast%3DGriffiths%26aufirst%3DR.%2BJ.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26atitle%3DAltered%2520cytokine%2520production%2520in%2520mice%2520lacking%2520P2X7%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D125%26epage%3D132%26doi%3D10.1074%2Fjbc.M006781200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Chessell, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatcher, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egerton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murfin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peck, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grahames, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casula, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yiangou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buell, G. N.</span><span> </span><span class="NLM_article-title">Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span><span class="refDoi"> DOI: 10.1016/j.pain.2005.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.pain.2005.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=15777864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlCiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2005&pages=386-396&author=I.+P.+Chessellauthor=J.+P.+Hatcherauthor=C.+Bountraauthor=A.+D.+Michelauthor=J.+P.+Hughesauthor=P.+Greenauthor=J.+Egertonauthor=M.+Murfinauthor=J.+Richardsonauthor=W.+L.+Peckauthor=C.+B.+Grahamesauthor=M.+A.+Casulaauthor=Y.+Yiangouauthor=R.+Birchauthor=P.+Anandauthor=G.+N.+Buell&title=Disruption+of+the+P2X7+purinoceptor+gene+abolishes+chronic+inflammatory+and+neuropathic+pain&doi=10.1016%2Fj.pain.2005.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain</span></div><div class="casAuthors">Chessell, Iain P.; Hatcher, Jonathan P.; Bountra, Chas; Michel, Anton D.; Hughes, Jane P.; Green, Paula; Egerton, Julie; Murfin, Melanie; Richardson, Jill; Peck, Wendy L.; Grahames, Caroline B. A.; Casula, Maria Anna; Yiangou, Yiangos; Birch, Rolfe; Anand, Praveen; Buell, Gary N.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">386-396</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The P2X7 purinoceptor is a ligand-gated cation channel, expressed predominantly by cells of immune origin, with a unique phenotype which includes release of biol. active inflammatory cytokine, interleukin (IL)-1β following activation, and unique ion channel biophysics obsd. only in this receptor family.  In mice lacking this receptor, inflammatory (in an adjuvant-induced model) and neuropathic (in a partial nerve ligation model) hypersensitivity is completely absent to both mech. and thermal stimuli, while normal nociceptive processing is preserved.  The knockout animals were unimpaired in their ability to produce mRNA for pro-IL-1β, and cytometric anal. of paw and systemic cytokines from knockout and wild-type animals following adjuvant insult suggests a selective effect of the gene deletion on release of IL-1β and IL-10, with systemic redns. in adjuvant-induced increases in IL-6 and MCP-1.  In addn., the authors show that this receptor is upregulated in human dorsal root ganglia and injured nerves obtained from chronic neuropathic pain patients.  The authors hypothesize that the P2X7 receptor, via regulation of mature IL-1β prodn., plays a common upstream transductional role in the development of pain of neuropathic and inflammatory origin.  Drugs which block this target may have the potential to deliver broad-spectrum analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-BHrUu6ak17Vg90H21EOLACvtfcHk0ljlM7425yfwLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlCiu78%253D&md5=883f5bdb9b8950fa97d5a69a7325b026</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2005.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2005.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DChessell%26aufirst%3DI.%2BP.%26aulast%3DHatcher%26aufirst%3DJ.%2BP.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DMichel%26aufirst%3DA.%2BD.%26aulast%3DHughes%26aufirst%3DJ.%2BP.%26aulast%3DGreen%26aufirst%3DP.%26aulast%3DEgerton%26aufirst%3DJ.%26aulast%3DMurfin%26aufirst%3DM.%26aulast%3DRichardson%26aufirst%3DJ.%26aulast%3DPeck%26aufirst%3DW.%2BL.%26aulast%3DGrahames%26aufirst%3DC.%2BB.%26aulast%3DCasula%26aufirst%3DM.%2BA.%26aulast%3DYiangou%26aufirst%3DY.%26aulast%3DBirch%26aufirst%3DR.%26aulast%3DAnand%26aufirst%3DP.%26aulast%3DBuell%26aufirst%3DG.%2BN.%26atitle%3DDisruption%2520of%2520the%2520P2X7%2520purinoceptor%2520gene%2520abolishes%2520chronic%2520inflammatory%2520and%2520neuropathic%2520pain%26jtitle%3DPain%26date%3D2005%26volume%3D114%26spage%3D386%26epage%3D396%26doi%3D10.1016%2Fj.pain.2005.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Labasi, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrushova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donovan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payette, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brissette, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wicks, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audoly, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span> </span><span class="NLM_article-title">Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">6436</span><span class="NLM_x">–</span> <span class="NLM_lpage">6445</span><span class="refDoi"> DOI: 10.4049/jimmunol.168.12.6436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.168.12.6436" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2002&pages=6436-6445&author=J.+M.+Labasiauthor=N.+Petrushovaauthor=C.+Donovanauthor=S.+McCurdyauthor=P.+Liraauthor=M.+M.+Payetteauthor=W.+Brissetteauthor=J.+R.+Wicksauthor=L.+Audolyauthor=C.+A.+Gabel&title=Absence+of+the+P2X7+receptor+alters+leukocyte+function+and+attenuates+an+inflammatory+response&doi=10.4049%2Fjimmunol.168.12.6436"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.168.12.6436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.168.12.6436%26sid%3Dliteratum%253Aachs%26aulast%3DLabasi%26aufirst%3DJ.%2BM.%26aulast%3DPetrushova%26aufirst%3DN.%26aulast%3DDonovan%26aufirst%3DC.%26aulast%3DMcCurdy%26aufirst%3DS.%26aulast%3DLira%26aufirst%3DP.%26aulast%3DPayette%26aufirst%3DM.%2BM.%26aulast%3DBrissette%26aufirst%3DW.%26aulast%3DWicks%26aufirst%3DJ.%2BR.%26aulast%3DAudoly%26aufirst%3DL.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26atitle%3DAbsence%2520of%2520the%2520P2X7%2520receptor%2520alters%2520leukocyte%2520function%2520and%2520attenuates%2520an%2520inflammatory%2520response%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D168%26spage%3D6436%26epage%3D6445%26doi%3D10.4049%2Fjimmunol.168.12.6436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Kanneganti, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamkanfi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenabeele, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunez, G.</span><span> </span><span class="NLM_article-title">Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of toll-like receptor signaling</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span><span class="refDoi"> DOI: 10.1016/j.immuni.2007.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.immuni.2007.03.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=433-443&author=T.+D.+Kannegantiauthor=M.+Lamkanfiauthor=Y.+G.+Kimauthor=G.+Chenauthor=J.+H.+Parkauthor=L.+Franchiauthor=P.+Vandenabeeleauthor=G.+Nunez&title=Pannexin-1-mediated+recognition+of+bacterial+molecules+activates+the+cryopyrin+inflammasome+independent+of+toll-like+receptor+signaling&doi=10.1016%2Fj.immuni.2007.03.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2007.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2007.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DKanneganti%26aufirst%3DT.%2BD.%26aulast%3DLamkanfi%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DY.%2BG.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DFranchi%26aufirst%3DL.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DNunez%26aufirst%3DG.%26atitle%3DPannexin-1-mediated%2520recognition%2520of%2520bacterial%2520molecules%2520activates%2520the%2520cryopyrin%2520inflammasome%2520independent%2520of%2520toll-like%2520receptor%2520signaling%26jtitle%3DImmunity%26date%3D2007%26volume%3D26%26spage%3D433%26epage%3D443%26doi%3D10.1016%2Fj.immuni.2007.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Park, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hien, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span> </span><span class="NLM_article-title">Discovery of novel 2,5-dioxoimidazolidine-based P2X<sub>7</sub> receptor antagonists as constrained analogues of KN62</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2114</span><span class="NLM_x">–</span> <span class="NLM_lpage">2134</span><span class="refDoi"> DOI: 10.1021/jm500324g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500324g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVCht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2114-2134&author=J.+H.+Parkauthor=G.+E.+Leeauthor=S.+D.+Leeauthor=T.+T.+Hienauthor=S.+Kimauthor=J.+W.+Yangauthor=J.+H.+Choauthor=H.+Koauthor=S.+C.+Limauthor=Y.+G.+Kimauthor=K.+W.+Kangauthor=Y.+C.+Kim&title=Discovery+of+novel+2%2C5-dioxoimidazolidine-based+P2X7+receptor+antagonists+as+constrained+analogues+of+KN62&doi=10.1021%2Fjm500324g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel 2,5-Dioxoimidazolidine-Based P2X7 Receptor Antagonists as Constrained Analogues of KN62</span></div><div class="casAuthors">Park, Jin-Hee; Lee, Ga-Eun; Lee, So-Deok; Hien, Tran Thi; Kim, Sujin; Yang, Jin Won; Cho, Joong-Heui; Ko, Hyojin; Lim, Sung-Chul; Kim, Yoon-Gyoon; Kang, Keon-Wook; Kim, Yong-Chul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2114-2134</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel 2,5-dioxoimidazolidine-based conformationally constrained analogs of KN62 were developed as P2X7 receptor (P2X7R) antagonists using a rigidification strategy of the tyrosine backbone of KN62.  SAR anal. of the 2,5-dioxoimidazolidine scaffold indicated that piperidine substitution at the N3 position and no substitution at N1 position were preferable.  Further optimization of the substituents at the piperidine nitrogen and the spacer around the skeleton resulted in several superior antagonists to KN62, including 1-adamantanecarbonyl analog I (IC50 = 23 nM in ethidium uptake assay; IC50 = 14 nM in IL-1β ELISA assay) and (3-CF3-4-Cl)benzoyl analog (-)-II (54 nM in ethidium uptake assay; 9 nM in IL-1β ELISA assay), which was more potent than the corresponding (+) isomer.  Compd. II displayed potent inhibitory activity in an ex vivo model of LTP-induced pain signaling in the spinal cord and significant anti-inflammatory activity in in vivo models of carrageenan-induced paw edema and type II collagen-induced joint arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3crY7yQxKLVg90H21EOLACvtfcHk0lilnXB7K6tMsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVCht7g%253D&md5=a54d0b90676aa34ab80f5b1750a48ff5</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm500324g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500324g%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DG.%2BE.%26aulast%3DLee%26aufirst%3DS.%2BD.%26aulast%3DHien%26aufirst%3DT.%2BT.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DJ.%2BW.%26aulast%3DCho%26aufirst%3DJ.%2BH.%26aulast%3DKo%26aufirst%3DH.%26aulast%3DLim%26aufirst%3DS.%2BC.%26aulast%3DKim%26aufirst%3DY.%2BG.%26aulast%3DKang%26aufirst%3DK.%2BW.%26aulast%3DKim%26aufirst%3DY.%2BC.%26atitle%3DDiscovery%2520of%2520novel%25202%252C5-dioxoimidazolidine-based%2520P2X7%2520receptor%2520antagonists%2520as%2520constrained%2520analogues%2520of%2520KN62%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2114%26epage%3D2134%26doi%3D10.1021%2Fjm500324g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Keystone, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInnes, I. B.</span><span> </span><span class="NLM_article-title">Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1630</span><span class="NLM_x">–</span> <span class="NLM_lpage">1635</span><span class="refDoi"> DOI: 10.1136/annrheumdis-2011-143578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1136%2Fannrheumdis-2011-143578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22966146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1SqurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=1630-1635&author=E.+C.+Keystoneauthor=M.+M.+Wangauthor=M.+Laytonauthor=S.+Hollisauthor=I.+B.+McInnes&title=Clinical+evaluation+of+the+efficacy+of+the+P2X7+purinergic+receptor+antagonist+AZD9056+on+the+signs+and+symptoms+of+rheumatoid+arthritis+in+patients+with+active+disease+despite+treatment+with+methotrexate+or+sulphasalazine&doi=10.1136%2Fannrheumdis-2011-143578"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine</span></div><div class="casAuthors">Keystone, Edward C.; Wang, Millie M.; Layton, Mark; Hollis, Sally; McInnes, Iain B.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1630-1635</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objectives: The P2X7 purinergic receptor antagonist AZD9056 was evaluated in a phase IIa study and subsequently in a phase IIb study to assess the effects of orally administered AZD9056 on the signs/symptoms of rheumatoid arthritis (RA), with American College of Rheumatol. 20% response criteria (ACR20) as the primary outcome.  Methods: Both studies were randomized, double-blind, placebo-controlled, parallel-group studies in patients with RA receiving methotrexate or sulphasalazine.  Phase IIa was an ascending-dose trial in two cohorts (n=75) using AZD9056 administered daily over 4 wk.  Phase IIb included an open-label etanercept treatment group.  Patients were randomized to receive treatment for 6 mo with 50, 100, 200 or 400 mg AZD9056 (oral, once a day) or matching placebo (oral, once a day), or s.c. etanercept (50 mg once a week).  Results: In phase IIa, 65% of AZD9056 recipients at 400 mg/day responded at the ACR20 level compared with 27% of placebo-treated patients.  A significant redn. in swollen and tender joint count was obsd. in the actively treated group compared with placebo, whereas no effect on acute-phase response was obsd.  Of 385 randomized patients in the phase IIb study, 383 received treatment.  AZD9056 (all doses) had no clin. or statistically significant effect on RA relative to placebo as measured by the proportion of patients meeting the ACR20 criteria at 6 mo and further supported by secondary end points.  In both studies AZD9056 was well tolerated up to 400 mg/day.  Conclusions: AZD9056 does not have significant efficacy in the treatment of RA, and the P2X7 receptor does not appear to be a therapeutically useful target in RA.  Trial registration no. ClinicalTrials.gov NCT00520572.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzCebkc5d0gLVg90H21EOLACvtfcHk0ljkzcN8JUc9Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1SqurzL&md5=97ca48663327aa8578f11001fa96d8c0</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2011-143578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2011-143578%26sid%3Dliteratum%253Aachs%26aulast%3DKeystone%26aufirst%3DE.%2BC.%26aulast%3DWang%26aufirst%3DM.%2BM.%26aulast%3DLayton%26aufirst%3DM.%26aulast%3DHollis%26aufirst%3DS.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26atitle%3DClinical%2520evaluation%2520of%2520the%2520efficacy%2520of%2520the%2520P2X7%2520purinergic%2520receptor%2520antagonist%2520AZD9056%2520on%2520the%2520signs%2520and%2520symptoms%2520of%2520rheumatoid%2520arthritis%2520in%2520patients%2520with%2520active%2520disease%2520despite%2520treatment%2520with%2520methotrexate%2520or%2520sulphasalazine%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2012%26volume%3D71%26spage%3D1630%26epage%3D1635%26doi%3D10.1136%2Fannrheumdis-2011-143578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Stock, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishaq, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mebus, C. A.</span><span> </span><span class="NLM_article-title">Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate</span> <span class="citation_source-journal">J. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">720</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span><span class="refDoi"> DOI: 10.3899/jrheum.110874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.3899%2Fjrheum.110874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22382341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVOnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=720-727&author=T.+C.+Stockauthor=B.+J.+Bloomauthor=N.+Weiauthor=S.+Ishaqauthor=W.+Parkauthor=X.+Wangauthor=P.+Guptaauthor=C.+A.+Mebus&title=Efficacy+and+safety+of+CE-224%2C535%2C+an+antagonist+of+P2X7+receptor%2C+in+treatment+of+patients+with+rheumatoid+arthritis+inadequately+controlled+by+methotrexate&doi=10.3899%2Fjrheum.110874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate</span></div><div class="casAuthors">Stock, Thomas C.; Bloom, Bradley J.; Wei, Nathan; Ishaq, Saliha; Park, Won; Wang, Xin; Gupta, Pankaj; Mebus, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Rheumatology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">720-727</span>CODEN:
                <span class="NLM_cas:coden">JRHUA9</span>;
        ISSN:<span class="NLM_cas:issn">0315-162X</span>.
    
            (<span class="NLM_cas:orgname">Journal of Rheumatology Publishing Co. Ltd.</span>)
        </div><div class="casAbstract">To evaluate efficacy and safety of CE-224,535, a selective P2X7 receptor antagonist, vs. placebo, in patients with active rheumatoid arthritis (RA) and inadequate response to methotrexate (MTX).  In our phase IIA study (ClinicalTrials.gov no. NCT00628095; A6341009), patients aged ≥ 18 years with active RA were randomized to receive either CE-224,535 (500 mg bid) or placebo for 12 wk; all patients continued a stable background dose of ≥ 7.5 mg MTX.  The American College of Rheumatol. 20% (ACR20) response rate (primary efficacy endpoint) was not significantly different from placebo for CE-224,535 (34.0% vs 36.2%; p = 0.591) at Week 12, or at any timepoint over the 12-wk treatment period.  There was no significant difference at Week 12 for the ACR20 response rate following subgroup analyses by age, sex, baseline disease activity, baseline duration of disease, geog. region, or concomitant use of steroids.  ACR50/ACR70 response rates and change from baseline in Disease Activity Score 28-joint C-reactive protein (DAS28-3-CRP) and Health Assessment Questionnaire-Disability Index for CE-224,535 were not significant at Week 12 vs. placebo.  Treatment-emergent adverse events (AE) were reported by 62.3% (CE-224,535) and 55.3% (placebo) of patients; the most common AE were nausea (11.3%, CE-224,535; 4.3%, placebo) and diarrhea (7.5%, CE-224,535; 4.3%, placebo).  The proportion of patients discontinuing due to an AE was 9.4% (CE-224,535) and 6.4% (placebo); no deaths were reported.  Serious AE occurred in 3.8% (CE-224,535) and 2.1% (placebo) of patients; none was considered treatment-related.  CE-224,535 was not efficacious, compared with placebo, for the treatment of RA in patients with an inadequate response to MTX.  CE-224,535 demonstrated an acceptable safety and tolerability profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorblWg-aNBNLVg90H21EOLACvtfcHk0ljkzcN8JUc9Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVOnsro%253D&md5=dc919436c3c6e7f3f624c57b77c5dbb2</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.3899%2Fjrheum.110874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3899%252Fjrheum.110874%26sid%3Dliteratum%253Aachs%26aulast%3DStock%26aufirst%3DT.%2BC.%26aulast%3DBloom%26aufirst%3DB.%2BJ.%26aulast%3DWei%26aufirst%3DN.%26aulast%3DIshaq%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DGupta%26aufirst%3DP.%26aulast%3DMebus%26aufirst%3DC.%2BA.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520CE-224%252C535%252C%2520an%2520antagonist%2520of%2520P2X7%2520receptor%252C%2520in%2520treatment%2520of%2520patients%2520with%2520rheumatoid%2520arthritis%2520inadequately%2520controlled%2520by%2520methotrexate%26jtitle%3DJ.%2520Rheumatol.%26date%3D2012%26volume%3D39%26spage%3D720%26epage%3D727%26doi%3D10.3899%2Fjrheum.110874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Ali, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurijssens, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostenfeld, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stylianou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott-Stevens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosking, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewit, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span> </span><span class="NLM_article-title">Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><span class="refDoi"> DOI: 10.1111/j.1365-2125.2012.04320.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1111%2Fj.1365-2125.2012.04320.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22568863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVGmsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2013&pages=197-207&author=Z.+Aliauthor=B.+Laurijssensauthor=T.+Ostenfeldauthor=S.+McHughauthor=A.+Stylianouauthor=P.+Scott-Stevensauthor=L.+Hoskingauthor=O.+Dewitauthor=J.+C.+Richardsonauthor=C.+Chen&title=Pharmacokinetic+and+pharmacodynamic+profiling+of+a+P2X7+receptor+allosteric+modulator+GSK1482160+in+healthy+human+subjects&doi=10.1111%2Fj.1365-2125.2012.04320.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects</span></div><div class="casAuthors">Ali, Zahid; Laurijssens, Bart; Ostenfeld, Thor; McHugh, Simon; Stylianou, Anastasia; Scott-Stevens, Paul; Hosking, Louise; Dewit, Odile; Richardson, Jill C.; Chen, Chao</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">197-207</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • P2X7 receptors are involved in the prodn. of pro-inflammatory cytokines, such as Il-1β, by central and peripheral immune cells.  Il-1β has been implicated as an important mediator of inflammation.  Therefore, the P2X7 receptor is an attractive therapeutic target for inflammatory diseases.  WHAT THIS STUDY ADDS • Findings in pharmacokinetics, pharmacodynamics, safety and tolerability of a P2X7 receptor modulator, GSK1482160, from the first human study for the mol. are described.  A pharmacokinetic/pharmacodynamic model for LPS-stimulated ATP-induced Il-1β prodn. in blood allowed the integration of all relevant data and provided in vivo evidence of the nature of the drug-receptor interaction.  The model has the potential to be used to simulate future trials.  AIMS This paper describes findings from the first-in-human study for GSK1482160, an orally available allosteric P2X7 receptor modulator.  The study aimed to assess the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of the compd. in healthy subjects.  METHODS Escalating single doses of up to 1 g were administered to healthy subjects in a single-blind and placebo-controlled fashion.  Safety, tolerability, blood drug concns. and ex vivo Il-1β prodn. in blood were evaluated.  RESULTS. Drug concn. peaked within 3.5 h of dosing under fasting conditions and declined thereafter with a relatively short half-life of less than 4.5 h.  Exposure was proportional to dose with between subject variability of less than 60%.  A PK/PD model quantified Il-1β as a function of drug exposure.  The model allowed simulation of in vivo pharmacol. for various untested dose levels and regimens.  Furthermore, the mechanistic model supported the hypothesis that the compd. reduces the efficacy of ATP at the P2X7 receptor without affecting its affinity.  No major safety or tolerability concerns were identified in this small study (n= 29), except for one case of asymptomatic accelerated idioventricular rhythm at the top dose.  CONCLUSION. The model-based approach maximized anal. power by integrating all biomarker data and revealed mechanistic insight into the pharmacol. of P2X7 modulation by GSK1482160.  Simulations by this model ultimately led to the discontinuation of the development of this compd.  The therapeutic relevance of the P2X7 receptor remains to be tested in patients.  The mechanistic-model-based approach can be applied widely to drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr41Bz54gV-qLVg90H21EOLACvtfcHk0ljkzcN8JUc9Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVGmsbnF&md5=835023636e0c5b039245344c2a9a207a</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2012.04320.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2012.04320.x%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DZ.%26aulast%3DLaurijssens%26aufirst%3DB.%26aulast%3DOstenfeld%26aufirst%3DT.%26aulast%3DMcHugh%26aufirst%3DS.%26aulast%3DStylianou%26aufirst%3DA.%26aulast%3DScott-Stevens%26aufirst%3DP.%26aulast%3DHosking%26aufirst%3DL.%26aulast%3DDewit%26aufirst%3DO.%26aulast%3DRichardson%26aufirst%3DJ.%2BC.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DPharmacokinetic%2520and%2520pharmacodynamic%2520profiling%2520of%2520a%2520P2X7%2520receptor%2520allosteric%2520modulator%2520GSK1482160%2520in%2520healthy%2520human%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2013%26volume%3D75%26spage%3D197%26epage%3D207%26doi%3D10.1111%2Fj.1365-2125.2012.04320.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Ferrari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzirani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adinolfi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoli, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idzko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panther, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Virgilio, F.</span><span> </span><span class="NLM_article-title">The P2X7 receptor: a key player in IL-1 processing and release</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">3877</span><span class="NLM_x">–</span> <span class="NLM_lpage">3883</span><span class="refDoi"> DOI: 10.4049/jimmunol.176.7.3877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.176.7.3877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=16547218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1ertL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=3877-3883&author=D.+Ferrariauthor=C.+Pizziraniauthor=E.+Adinolfiauthor=R.+M.+Lemoliauthor=A.+Curtiauthor=M.+Idzkoauthor=E.+Pantherauthor=F.+Di+Virgilio&title=The+P2X7+receptor%3A+a+key+player+in+IL-1+processing+and+release&doi=10.4049%2Fjimmunol.176.7.3877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">The P2X7 Receptor: A Key Player in IL-1 Processing and Release</span></div><div class="casAuthors">Ferrari, Davide; Pizzirani, Cinzia; Adinolfi, Elena; Lemoli, Roberto M.; Curti, Antonio; Idzko, Marco; Panther, Elisabeth; Di Virgilio, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3877-3883</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">A review.  Human interleukin 1 (IL-1) family proteins are key mediators of the host response to infections, injury, and immunol. challenges.  The mechanism by which IL-1 activates proinflammatory responses in target cells, and the plasma membrane receptors involved, are fairly well known.  This has led to the development of innovative drugs that block IL-1 downstream to its synthesis and secretion.  On the contrary, the mechanism of IL-1 and other IL-1 family members (e.g., IL-18) maturation and release is incompletely understood.  Accruing evidence points to a plasma membrane receptor for extracellular ATP, the P2X7 receptor, as a key player in both processes.  A deeper understanding of the mechanism by which the P2X7 receptor triggers IL-1 maturation and exteriorization may suggest novel avenues for the treatment of inflammatory diseases and provide a deeper insight in the fundamental mechanism of protease activation and cellular export of proteins lacking a leader sequence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_AAKnLXk6DbVg90H21EOLACvtfcHk0lj8tHLHtlUPEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1ertL4%253D&md5=c64da9cb2a04420486b508cc6afd3a03</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.176.7.3877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.176.7.3877%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DD.%26aulast%3DPizzirani%26aufirst%3DC.%26aulast%3DAdinolfi%26aufirst%3DE.%26aulast%3DLemoli%26aufirst%3DR.%2BM.%26aulast%3DCurti%26aufirst%3DA.%26aulast%3DIdzko%26aufirst%3DM.%26aulast%3DPanther%26aufirst%3DE.%26aulast%3DDi%2BVirgilio%26aufirst%3DF.%26atitle%3DThe%2520P2X7%2520receptor%253A%2520a%2520key%2520player%2520in%2520IL-1%2520processing%2520and%2520release%26jtitle%3DJ.%2520Immunol.%26date%3D2006%26volume%3D176%26spage%3D3877%26epage%3D3883%26doi%3D10.4049%2Fjimmunol.176.7.3877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Sorge, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorfman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beggs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaykin, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vander Meulen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costigan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarkoni-Abitbul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tichauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livneh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peltz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maixner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diatchenko, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seltzer, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mogil, J. S.</span><span> </span><span class="NLM_article-title">Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span><span class="refDoi"> DOI: 10.1038/nm.2710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnm.2710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22447075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVemsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=595-599&author=R.+E.+Sorgeauthor=T.+Trangauthor=R.+Dorfmanauthor=S.+B.+Smithauthor=S.+Beggsauthor=J.+Ritchieauthor=J.+S.+Austinauthor=D.+V.+Zaykinauthor=H.+Vander+Meulenauthor=M.+Costiganauthor=T.+A.+Herbertauthor=M.+Yarkoni-Abitbulauthor=D.+Tichauerauthor=J.+Livnehauthor=E.+Gershonauthor=M.+Zhengauthor=K.+Tanauthor=S.+L.+Johnauthor=G.+D.+Sladeauthor=J.+Jordanauthor=C.+J.+Woolfauthor=G.+Peltzauthor=W.+Maixnerauthor=L.+Diatchenkoauthor=Z.+Seltzerauthor=M.+W.+Salterauthor=J.+S.+Mogil&title=Genetically+determined+P2X7+receptor+pore+formation+regulates+variability+in+chronic+pain+sensitivity&doi=10.1038%2Fnm.2710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity</span></div><div class="casAuthors">Sorge, Robert E.; Trang, Tuan; Dorfman, Ruslan; Smith, Shad B.; Beggs, Simon; Ritchie, Jennifer; Austin, Jean-Sebastien; Zaykin, Dmitri V.; Vander Meulen, Heather; Costigan, Michael; Herbert, Teri A.; Yarkoni-Abitbul, Merav; Tichauer, David; Livneh, Jessica; Gershon, Edith; Zheng, Ming; Tan, Keith; John, Sally L.; Slade, Gary D.; Jordan, Joanne; Woolf, Clifford J.; Peltz, Gary; Maixner, William; Diatchenko, Luda; Seltzer, Ze'ev; Salter, Michael W.; Mogil, Jeffrey S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">595-599</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chronic pain is highly variable between individuals, as is the response to analgesics.  Although much of the variability in chronic pain and analgesic response is heritable, an understanding of the genetic determinants underlying this variability is rudimentary.  Here we show that variation within the coding sequence of the gene encoding the P2X7 receptor (P2X7R) affects chronic pain sensitivity in both mice and humans.  P2X7Rs, which are members of the family of ionotropic ATP-gated receptors, have two distinct modes of function: they can function through their intrinsic cationic channel or by forming nonselective pores that are permeable to mols. with a mass of up to 900 Da.  Using genome-wide linkage analyses, we discovered an assocn. between nerve-injury-induced pain behavior (mech. allodynia) and the P451L mutation of the mouse P2rx7 gene, such that mice in which P2X7Rs have impaired pore formation as a result of this mutation showed less allodynia than mice with the pore-forming P2rx7 allele.  Administration of a peptide corresponding to the P2X7R C-terminal domain, which blocked pore formation but not cation channel activity, selectively reduced nerve injury and inflammatory allodynia only in mice with the pore-forming P2rx7 allele.  Moreover, in two independent human chronic pain cohorts, a cohort with pain after mastectomy and a cohort with osteoarthritis, we obsd. a genetic assocn. between lower pain intensity and the hypofunctional His270 (rs7958311) allele of P2RX7.  Our findings suggest that selectively targeting P2X7R pore formation may be a new strategy for individualizing the treatment of chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZLBa24xQIrrVg90H21EOLACvtfcHk0lj8tHLHtlUPEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVemsLc%253D&md5=1981fc416df0a25f45c4cfd72c5f64ce</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1038%2Fnm.2710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2710%26sid%3Dliteratum%253Aachs%26aulast%3DSorge%26aufirst%3DR.%2BE.%26aulast%3DTrang%26aufirst%3DT.%26aulast%3DDorfman%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DS.%2BB.%26aulast%3DBeggs%26aufirst%3DS.%26aulast%3DRitchie%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DJ.%2BS.%26aulast%3DZaykin%26aufirst%3DD.%2BV.%26aulast%3DVander%2BMeulen%26aufirst%3DH.%26aulast%3DCostigan%26aufirst%3DM.%26aulast%3DHerbert%26aufirst%3DT.%2BA.%26aulast%3DYarkoni-Abitbul%26aufirst%3DM.%26aulast%3DTichauer%26aufirst%3DD.%26aulast%3DLivneh%26aufirst%3DJ.%26aulast%3DGershon%26aufirst%3DE.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DK.%26aulast%3DJohn%26aufirst%3DS.%2BL.%26aulast%3DSlade%26aufirst%3DG.%2BD.%26aulast%3DJordan%26aufirst%3DJ.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26aulast%3DPeltz%26aufirst%3DG.%26aulast%3DMaixner%26aufirst%3DW.%26aulast%3DDiatchenko%26aufirst%3DL.%26aulast%3DSeltzer%26aufirst%3DZ.%26aulast%3DSalter%26aufirst%3DM.%2BW.%26aulast%3DMogil%26aufirst%3DJ.%2BS.%26atitle%3DGenetically%2520determined%2520P2X7%2520receptor%2520pore%2520formation%2520regulates%2520variability%2520in%2520chronic%2520pain%2520sensitivity%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D595%26epage%3D599%26doi%3D10.1038%2Fnm.2710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Chen, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leng, R. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, D. Q.</span><span> </span><span class="NLM_article-title">Association of P2X7R gene polymorphisms with systemic lupus erythematosus in a Chinese population</span> <span class="citation_source-journal">Mutagenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><span class="refDoi"> DOI: 10.1093/mutage/get007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1093%2Fmutage%2Fget007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=351-355&author=G.+M.+Chenauthor=C.+C.+Fengauthor=Q.+L.+Yeauthor=J.+H.+Taoauthor=R.+Liauthor=H.+Pengauthor=M.+Zhouauthor=R.+X.+Lengauthor=J.+Liauthor=H.+Cenauthor=Y.+G.+Fanauthor=H.+F.+Panauthor=D.+Q.+Ye&title=Association+of+P2X7R+gene+polymorphisms+with+systemic+lupus+erythematosus+in+a+Chinese+population&doi=10.1093%2Fmutage%2Fget007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1093%2Fmutage%2Fget007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fmutage%252Fget007%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%2BM.%26aulast%3DFeng%26aufirst%3DC.%2BC.%26aulast%3DYe%26aufirst%3DQ.%2BL.%26aulast%3DTao%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DLeng%26aufirst%3DR.%2BX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCen%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DY.%2BG.%26aulast%3DPan%26aufirst%3DH.%2BF.%26aulast%3DYe%26aufirst%3DD.%2BQ.%26atitle%3DAssociation%2520of%2520P2X7R%2520gene%2520polymorphisms%2520with%2520systemic%2520lupus%2520erythematosus%2520in%2520a%2520Chinese%2520population%26jtitle%3DMutagenesis%26date%3D2013%26volume%3D28%26spage%3D351%26epage%3D355%26doi%3D10.1093%2Fmutage%2Fget007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Robinson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalbeth, N.</span><span> </span><span class="NLM_article-title">Advances in pharmacotherapy for the treatment of gout</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span><span class="refDoi"> DOI: 10.1517/14656566.2015.997213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1517%2F14656566.2015.997213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=25547991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisl2msbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=533-546&author=P.+C.+Robinsonauthor=N.+Dalbeth&title=Advances+in+pharmacotherapy+for+the+treatment+of+gout&doi=10.1517%2F14656566.2015.997213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in pharmacotherapy for the treatment of gout</span></div><div class="casAuthors">Robinson, Philip C.; Dalbeth, Nicola</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">533-546</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction:Gout is a common inflammatory arthritis affecting almost 6% of US males and 2% of US females.  The central cause of gout is deposition of monosodium urate crystals, and the focus of treatment is aimed at crystal dissoln. using urate-lowering therapy.  Areas covered:The review describes the current treatments for urate-lowering therapy including allopurinol, febuxostat, probenecid, benzbromarone and pegloticase.  Anti-inflammatory treatment of acute flares and prophylaxis of flares with NSAIDs, colchicine, corticosteroids and anti-IL-1 agents is also reviewed.  In addn., drugs in Phase III clin. trials for gout indications are reviewed.  Expert opinion:In the last decade, there has been major progress in the pharmacotherapy of gout.  Management guidelines have emphasized the importance of a therapeutic serum urate target for effective gout management.  Studies have identified the safe and effective dosing strategies for 'old' drugs such as allopurinol and colchicine.  New therapeutic agents have been developed and approved for both urate-lowering therapy and anti-inflammatory treatment of acute flares.  However, quality of care remains a major challenge in gout management, and strategies to ensure best practice require further focus to ensure that the progress of the last decade translates into clin. benefit for people with gout.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvCyFOETsPyrVg90H21EOLACvtfcHk0lj8tHLHtlUPEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisl2msbs%253D&md5=0f8b9ec6198edd9ff6876b549524f70c</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1517%2F14656566.2015.997213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2015.997213%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DP.%2BC.%26aulast%3DDalbeth%26aufirst%3DN.%26atitle%3DAdvances%2520in%2520pharmacotherapy%2520for%2520the%2520treatment%2520of%2520gout%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2015%26volume%3D16%26spage%3D533%26epage%3D546%26doi%3D10.1517%2F14656566.2015.997213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Gutman, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, T. F.</span><span> </span><span class="NLM_article-title">Benemid (p-di-n-propylsulfamyl)-benzoic acid) as uricosuric agent in chronic gouty arthritis</span> <span class="citation_source-journal">Trans. Assoc. Am. Physicians</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1951</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1951&pages=279-288&author=A.+B.+Gutmanauthor=T.+F.+Yu&title=Benemid+%28p-di-n-propylsulfamyl%29-benzoic+acid%29+as+uricosuric+agent+in+chronic+gouty+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGutman%26aufirst%3DA.%2BB.%26aulast%3DYu%26aufirst%3DT.%2BF.%26atitle%3DBenemid%2520%2528p-di-n-propylsulfamyl%2529-benzoic%2520acid%2529%2520as%2520uricosuric%2520agent%2520in%2520chronic%2520gouty%2520arthritis%26jtitle%3DTrans.%2520Assoc.%2520Am.%2520Physicians%26date%3D1951%26volume%3D64%26spage%3D279%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Silverman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locovei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, G.</span><span> </span><span class="NLM_article-title">Probenecid, a gout remedy, inhibits pannexin 1 channels</span> <span class="citation_source-journal">Am. J. Physiol. Cell Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">C761</span><span class="NLM_x">–</span> <span class="NLM_lpage">767</span><span class="refDoi"> DOI: 10.1152/ajpcell.00227.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1152%2Fajpcell.00227.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=18596212" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2008&pages=C761-767&author=W.+Silvermanauthor=S.+Locoveiauthor=G.+Dahl&title=Probenecid%2C+a+gout+remedy%2C+inhibits+pannexin+1+channels&doi=10.1152%2Fajpcell.00227.2008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00227.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00227.2008%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DW.%26aulast%3DLocovei%26aufirst%3DS.%26aulast%3DDahl%26aufirst%3DG.%26atitle%3DProbenecid%252C%2520a%2520gout%2520remedy%252C%2520inhibits%2520pannexin%25201%2520channels%26jtitle%3DAm.%2520J.%2520Physiol.%2520Cell%2520Physiol.%26date%3D2008%26volume%3D295%26spage%3DC761%26epage%3D767%26doi%3D10.1152%2Fajpcell.00227.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelegrin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surprenant, A.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of pannexin-1 currents expressed in mammalian cells</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span><span class="refDoi"> DOI: 10.1124/jpet.108.146365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1124%2Fjpet.108.146365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=19023039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Khurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2009&pages=409-418&author=W.+Maauthor=H.+Huiauthor=P.+Pelegrinauthor=A.+Surprenant&title=Pharmacological+characterization+of+pannexin-1+currents+expressed+in+mammalian+cells&doi=10.1124%2Fjpet.108.146365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of pannexin-1 currents expressed in mammalian cells</span></div><div class="casAuthors">Ma, Weihong; Hui, Hui; Pelegrin, Pablo; Surprenant, Annmarie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">409-418</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Pannexin (Panx) 1 is a widely expressed protein that shares structural, but not amino acid, homol. with gap junction proteins, the connexins.  Panx1 does not form gap junctions in mammalian cells, but it may function as a plasma membrane hemichannel.  Little is known of the pharmacol. properties of panx1 expression in mammalian cells.  Here, we identify three variants in the human PANX1 gene.  We expressed these variants and mouse Panx1 in mammalian cells and compared Panx1-induced currents.  All human Panx1 variants and the mouse Panx1 showed identical protein expression levels, localization patterns, and functional properties; although, the frequency of functional expression was species-dependent.  Panx1 currents were independent of changes in extracellular or intracellular calcium or phospholipase C transduction.  We found compds. that inhibited Panx1 currents with a rank order of potency: carbenoxolone > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) ≈ disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate ≈ 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> probenecid >> flufenamic acid = niflumic acid.  Triphosphate nucleotides (ATP, GTP, and UTP) rapidly and reversibly inhibited Panx1 currents via mechanism(s) independent of purine receptors.  When Panx1 was coexpressed with purinergic P2X7 receptor (P2X7R), DIDS was found to act as a P2X7R antagonist to inhibit ATP-evoked currents, but none of the other compds. inhibited P2X7R currents.  This is the first detailed pharmacol. characterization of Panx1-mediated currents in mammalian cells and sheds new, although contradictory, light on the hypothesis that Panx1 acts as a hemichannel to allow passage of large mols. in response to P2X7R activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNwXaPFJzlfLVg90H21EOLACvtfcHk0lisiVH2kmciqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Khurs%253D&md5=39cd0d5ea254b48e3a6015f67c67a14f</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.146365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.146365%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%26aulast%3DHui%26aufirst%3DH.%26aulast%3DPelegrin%26aufirst%3DP.%26aulast%3DSurprenant%26aufirst%3DA.%26atitle%3DPharmacological%2520characterization%2520of%2520pannexin-1%2520currents%2520expressed%2520in%2520mammalian%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D328%26spage%3D409%26epage%3D418%26doi%3D10.1124%2Fjpet.108.146365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Silverman, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Rivero Vaccari, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locovei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scemes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keane, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, G.</span><span> </span><span class="NLM_article-title">The pannexin 1 channel activates the inflammasome in neurons and astrocytes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">18143</span><span class="NLM_x">–</span> <span class="NLM_lpage">18151</span><span class="refDoi"> DOI: 10.1074/jbc.M109.004804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M109.004804" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=18143-18151&author=W.+R.+Silvermanauthor=J.+P.+de+Rivero+Vaccariauthor=S.+Locoveiauthor=F.+Qiuauthor=S.+K.+Carlssonauthor=E.+Scemesauthor=R.+W.+Keaneauthor=G.+Dahl&title=The+pannexin+1+channel+activates+the+inflammasome+in+neurons+and+astrocytes&doi=10.1074%2Fjbc.M109.004804"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.004804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.004804%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DW.%2BR.%26aulast%3Dde%2BRivero%2BVaccari%26aufirst%3DJ.%2BP.%26aulast%3DLocovei%26aufirst%3DS.%26aulast%3DQiu%26aufirst%3DF.%26aulast%3DCarlsson%26aufirst%3DS.%2BK.%26aulast%3DScemes%26aufirst%3DE.%26aulast%3DKeane%26aufirst%3DR.%2BW.%26aulast%3DDahl%26aufirst%3DG.%26atitle%3DThe%2520pannexin%25201%2520channel%2520activates%2520the%2520inflammasome%2520in%2520neurons%2520and%2520astrocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D18143%26epage%3D18151%26doi%3D10.1074%2Fjbc.M109.004804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Selen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amidon, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welling, P. G.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of probenecid following oral doses to human volunteers</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1238</span><span class="NLM_x">–</span> <span class="NLM_lpage">1242</span><span class="refDoi"> DOI: 10.1002/jps.2600711114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1002%2Fjps.2600711114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1982&pages=1238-1242&author=A.+Selenauthor=G.+L.+Amidonauthor=P.+G.+Welling&title=Pharmacokinetics+of+probenecid+following+oral+doses+to+human+volunteers&doi=10.1002%2Fjps.2600711114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600711114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600711114%26sid%3Dliteratum%253Aachs%26aulast%3DSelen%26aufirst%3DA.%26aulast%3DAmidon%26aufirst%3DG.%2BL.%26aulast%3DWelling%26aufirst%3DP.%2BG.%26atitle%3DPharmacokinetics%2520of%2520probenecid%2520following%2520oral%2520doses%2520to%2520human%2520volunteers%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1982%26volume%3D71%26spage%3D1238%26epage%3D1242%26doi%3D10.1002%2Fjps.2600711114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Mawhinney, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Rivero Vaccari, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keane, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bramlett, H. M.</span><span> </span><span class="NLM_article-title">Heightened inflammasome activation is linked to age-related cognitive impairment in fischer 344 rats</span> <span class="citation_source-journal">BMC Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="refDoi"> DOI: 10.1186/1471-2202-12-123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1186%2F1471-2202-12-123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22133203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38XitFyrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=123&author=L.+J.+Mawhinneyauthor=J.+P.+de+Rivero+Vaccariauthor=G.+A.+Daleauthor=R.+W.+Keaneauthor=H.+M.+Bramlett&title=Heightened+inflammasome+activation+is+linked+to+age-related+cognitive+impairment+in+fischer+344+rats&doi=10.1186%2F1471-2202-12-123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Heightened inflammasome activation is linked to age-related cognitive impairment in Fischer 344 rats</span></div><div class="casAuthors">Mawhinney, Lana J.; Vaccari, Juan Pablo de Rivero; Dale, Gordon A.; Keane, Robert W.; Bramlett, Helen M.</div><div class="citationInfo"><span class="NLM_cas:title">BMC Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">123</span>CODEN:
                <span class="NLM_cas:coden">BNMEA6</span>;
        ISSN:<span class="NLM_cas:issn">1471-2202</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Members of the mammalian nucleotide binding domain, leucine-rich repeat (LRR)-contg. receptor (NLR) family of proteins are key modulators of innate immunity regulating inflammation.  Our previous work has shown that among the members of this family, NLRP1/NALP1, present in neurons, plays a crucial role in inflammasome formation and the prodn. of the inflammatory cytokines interleukin (IL)-1β and IL-18 after various types of central nervous system injury.  Results: We investigated whether age-related cognitive decline may involve a heightened inflammatory response assocd. with activation of the NLRP1 inflammasome in the hippocampus.  Young (3 mo) and aged (18 mo) male Fischer 344 rats were tested in a spatial acquisition task via Morris water maze.  Following behavioral testing, hippocampal lysates were assayed for expression of NLRP1 inflammasome components and inflammatory cytokines.  Hippocampal lysates from aged rats showed significantly higher levels of NLRP1 inflammasome constituents, caspase-1, caspase-11, the purinergic receptor P2X7, pannexin-1 and X-linked inhibitor of apoptosis (XIAP) than lysates from younger animals.  Following treatment with probenecid, an inhibitor or pannexin-1, aged animals demonstrated redn. in inflammasome activation and improvement in spatial learning performance.  Conclusions: Our behavioral findings are consistent with increases in IL-1β and IL-18 that have been previously shown to correlate with spatial learning deficits.  Probenecid reduced activated caspase-1 and ameliorated spatial learning deficits in aged rats.  Thus, aging processes stimulate activation of the NLRP1 inflammasome and secretion of IL-1β and IL-18 that may contribute to age-related cognitive decline in the growing elderly population.  Moreover, probenecid may be potentially useful as a therapy to improve cognitive outcomes in the aging population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox8G5rh-06TrVg90H21EOLACvtfcHk0lgGM9G5JUTSCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitFyrsL0%253D&md5=9afff98dac8e36aa15d945fce4ee3b9e</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1186%2F1471-2202-12-123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2202-12-123%26sid%3Dliteratum%253Aachs%26aulast%3DMawhinney%26aufirst%3DL.%2BJ.%26aulast%3Dde%2BRivero%2BVaccari%26aufirst%3DJ.%2BP.%26aulast%3DDale%26aufirst%3DG.%2BA.%26aulast%3DKeane%26aufirst%3DR.%2BW.%26aulast%3DBramlett%26aufirst%3DH.%2BM.%26atitle%3DHeightened%2520inflammasome%2520activation%2520is%2520linked%2520to%2520age-related%2520cognitive%2520impairment%2520in%2520fischer%2520344%2520rats%26jtitle%3DBMC%2520Neurosci.%26date%3D2011%26volume%3D12%26spage%3D123%26doi%3D10.1186%2F1471-2202-12-123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Minkiewicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Rivero Vaccari, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keane, R. W.</span><span> </span><span class="NLM_article-title">Human astrocytes express a novel NLRP2 inflammasome</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1113</span><span class="NLM_x">–</span> <span class="NLM_lpage">1121</span><span class="refDoi"> DOI: 10.1002/glia.22499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1002%2Fglia.22499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=23625868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADC%252BC3srovFyksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2013&pages=1113-1121&author=J.+Minkiewiczauthor=J.+P.+de+Rivero+Vaccariauthor=R.+W.+Keane&title=Human+astrocytes+express+a+novel+NLRP2+inflammasome&doi=10.1002%2Fglia.22499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Human astrocytes express a novel NLRP2 inflammasome</span></div><div class="casAuthors">Minkiewicz Julia; de Rivero Vaccari Juan Pablo; Keane Robert W</div><div class="citationInfo"><span class="NLM_cas:title">Glia</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1113-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Central nervous system (CNS) trauma involves extensive cellular damage that is due, in part, to an innate inflammatory response induced by extracellular ATP.  The innate immune response is regulated by pattern recognition receptors (PRRs), which include NOD-like receptors (NLRs).  The PRRs and signaling cascades that regulate innate glial responses to CNS injury remain largely undefined.  In this report, we show that human astrocytes express the NLR protein 2 (NLRP2) inflammasome that is activated by the danger associated molecular pattern (DAMP) ATP.  The NLRP2 inflammasome is a multiprotein complex that consists of NLRP2, the adaptor protein apoptosis-speck-like protein containing a caspase recruitment domain (ASC) and caspase-1.  NLRP2 also interacts with the P2X7 receptor and the pannexin 1 channel.  Stimulation of human astrocytes with ATP resulted in activation of the NLRP2 inflammasome leading to the processing of inflammatory caspase-1 and interleukin-1β (IL-1β).  ATP-induced activation of the NLRP2 inflammasome was inhibited by the pannexin 1 inhibitor probenecid and by the P2X7 receptor antagonist Brilliant Blue G (BBG). siRNA knockdown of NLRP2 significantly decreased NLRP2 levels and caspase-1 processing in human astrocytes in response to ATP.  Our findings suggest that the astrocytic NLRP2 inflammasome is an important component of the CNS inflammatory response and that the NLRP2 inflammasome may be a therapeutic target to inhibit inflammation induced by CNS injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSu_HAA0wsQupw7prLlxLOzfW6udTcc2eZlKl7C3lL00bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srovFyksw%253D%253D&md5=5fe2673fc9581d2d3f004af73713ac1b</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1002%2Fglia.22499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.22499%26sid%3Dliteratum%253Aachs%26aulast%3DMinkiewicz%26aufirst%3DJ.%26aulast%3Dde%2BRivero%2BVaccari%26aufirst%3DJ.%2BP.%26aulast%3DKeane%26aufirst%3DR.%2BW.%26atitle%3DHuman%2520astrocytes%2520express%2520a%2520novel%2520NLRP2%2520inflammasome%26jtitle%3DGlia%26date%3D2013%26volume%3D61%26spage%3D1113%26epage%3D1121%26doi%3D10.1002%2Fglia.22499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Lamkanfi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malireddi, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanneganti, T. D.</span><span> </span><span class="NLM_article-title">Fungal zymosan and mannan activate the cryopyrin inflammasome</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">20574</span><span class="NLM_x">–</span> <span class="NLM_lpage">20581</span><span class="refDoi"> DOI: 10.1074/jbc.M109.023689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M109.023689" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=20574-20581&author=M.+Lamkanfiauthor=R.+K.+Malireddiauthor=T.+D.+Kanneganti&title=Fungal+zymosan+and+mannan+activate+the+cryopyrin+inflammasome&doi=10.1074%2Fjbc.M109.023689"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.023689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.023689%26sid%3Dliteratum%253Aachs%26aulast%3DLamkanfi%26aufirst%3DM.%26aulast%3DMalireddi%26aufirst%3DR.%2BK.%26aulast%3DKanneganti%26aufirst%3DT.%2BD.%26atitle%3DFungal%2520zymosan%2520and%2520mannan%2520activate%2520the%2520cryopyrin%2520inflammasome%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D20574%26epage%3D20581%26doi%3D10.1074%2Fjbc.M109.023689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Bhaskaracharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dao-Ung, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalilian, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spildrejorde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skarratt, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sluyter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, L.</span><span> </span><span class="NLM_article-title">Probenecid blocks human P2X7 receptor-induced dye uptake via a pannexin-1 independent mechanism</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e93058</span><span class="refDoi"> DOI: 10.1371/journal.pone.0093058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1371%2Fjournal.pone.0093058" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e93058&author=A.+Bhaskaracharyaauthor=P.+Dao-Ungauthor=I.+Jalilianauthor=M.+Spildrejordeauthor=K.+K.+Skarrattauthor=S.+J.+Fullerauthor=R.+Sluyterauthor=L.+Stokes&title=Probenecid+blocks+human+P2X7+receptor-induced+dye+uptake+via+a+pannexin-1+independent+mechanism&doi=10.1371%2Fjournal.pone.0093058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0093058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0093058%26sid%3Dliteratum%253Aachs%26aulast%3DBhaskaracharya%26aufirst%3DA.%26aulast%3DDao-Ung%26aufirst%3DP.%26aulast%3DJalilian%26aufirst%3DI.%26aulast%3DSpildrejorde%26aufirst%3DM.%26aulast%3DSkarratt%26aufirst%3DK.%2BK.%26aulast%3DFuller%26aufirst%3DS.%2BJ.%26aulast%3DSluyter%26aufirst%3DR.%26aulast%3DStokes%26aufirst%3DL.%26atitle%3DProbenecid%2520blocks%2520human%2520P2X7%2520receptor-induced%2520dye%2520uptake%2520via%2520a%2520pannexin-1%2520independent%2520mechanism%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De93058%26doi%3D10.1371%2Fjournal.pone.0093058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Qu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misaghi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmour, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cupp, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubyak, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, V. M.</span><span> </span><span class="NLM_article-title">Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">6553</span><span class="NLM_x">–</span> <span class="NLM_lpage">6561</span><span class="refDoi"> DOI: 10.4049/jimmunol.1100478</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.1100478" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=6553-6561&author=Y.+Quauthor=S.+Misaghiauthor=K.+Newtonauthor=L.+L.+Gilmourauthor=S.+Louieauthor=J.+E.+Cuppauthor=G.+R.+Dubyakauthor=D.+Hackosauthor=V.+M.+Dixit&title=Pannexin-1+is+required+for+ATP+release+during+apoptosis+but+not+for+inflammasome+activation&doi=10.4049%2Fjimmunol.1100478"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1100478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1100478%26sid%3Dliteratum%253Aachs%26aulast%3DQu%26aufirst%3DY.%26aulast%3DMisaghi%26aufirst%3DS.%26aulast%3DNewton%26aufirst%3DK.%26aulast%3DGilmour%26aufirst%3DL.%2BL.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DCupp%26aufirst%3DJ.%2BE.%26aulast%3DDubyak%26aufirst%3DG.%2BR.%26aulast%3DHackos%26aufirst%3DD.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DPannexin-1%2520is%2520required%2520for%2520ATP%2520release%2520during%2520apoptosis%2520but%2520not%2520for%2520inflammasome%2520activation%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26spage%3D6553%26epage%3D6561%26doi%3D10.4049%2Fjimmunol.1100478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Laliberte, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perregaux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazoles, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span> </span><span class="NLM_article-title">Tenidap modulates cytoplasmic pH and inhibits anion transport <i>in vitro</i></span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">2168</span><span class="NLM_x">–</span> <span class="NLM_lpage">2179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=1994&pages=2168-2179&author=R.+Laliberteauthor=D.+Perregauxauthor=L.+Svenssonauthor=C.+J.+Pazolesauthor=C.+A.+Gabel&title=Tenidap+modulates+cytoplasmic+pH+and+inhibits+anion+transport+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaliberte%26aufirst%3DR.%26aulast%3DPerregaux%26aufirst%3DD.%26aulast%3DSvensson%26aufirst%3DL.%26aulast%3DPazoles%26aufirst%3DC.%2BJ.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26atitle%3DTenidap%2520modulates%2520cytoplasmic%2520pH%2520and%2520inhibits%2520anion%2520transport%2520in%2520vitro%26jtitle%3DJ.%2520Immunol.%26date%3D1994%26volume%3D153%26spage%3D2168%26epage%3D2179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Sanz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiozzi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colaianna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zotti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabace, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuliani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Virgilio, F.</span><span> </span><span class="NLM_article-title">Nimodipine inhibits IL-1β release stimulated by amyloid β from microglia</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">1702</span><span class="NLM_x">–</span> <span class="NLM_lpage">1711</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02112.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1111%2Fj.1476-5381.2012.02112.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22831460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVWns7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=1702-1711&author=J.+M.+Sanzauthor=P.+Chiozziauthor=M.+Colaiannaauthor=M.+Zottiauthor=D.+Ferrariauthor=L.+Trabaceauthor=G.+Zulianiauthor=F.+Di+Virgilio&title=Nimodipine+inhibits+IL-1%CE%B2+release+stimulated+by+amyloid+%CE%B2+from+microglia&doi=10.1111%2Fj.1476-5381.2012.02112.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Nimodipine inhibits IL-1β release stimulated by amyloid β from microglia</span></div><div class="casAuthors">Sanz, J. M.; Chiozzi, P.; Colaianna, M.; Zotti, M.; Ferrari, D.; Trabace, L.; Zuliani, G.; Di Virgilio, F.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1702-1711</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose: There is growing evidence that inflammation plays a major role in the pathogenesis of neural damage caused by deposition of amyloid β (Aβ) in the brain.  Nimodipine has received attention as a drug that might improve learning and reduce cognitive deficits in Alzheimer's disease, but the mechanism of action is poorly known.  In this study, we tested the hypothesis that nimodipine inhibited Aβ-stimulated IL-1β release from microglia.  Exptl. Approach: Cultures of N13 microglia cells or primary mouse microglia were treated with nimodipine, and intracellular accumulation and release of IL-1β in response to Aβ or to the P2 receptor agonists ATP and benzoyl ATP (BzATP) were measured.  Accumulation of IL-1β was measured in vivo after intrahippocampal inoculation of Aβ in the absence or presence of nimodipine.  The effect of nimodipine on Aβ-triggered cytotoxicity was also investigated.  Key Results: We show here that nimodipine dose-dependently inhibited Aβ-stimulated IL-1β synthesis and release from primary microglia and microglia cell lines.  Furthermore, nimodipine also inhibited Aβ-induced IL-1β in vivo accumulation at concns. known to be reached in the CNS.  Finally, nimodipine protected microglia from Aβ-dependent cytotoxicity.  Conclusion and Implications: These data suggest that alleviation of symptoms of Alzheimer's disease following nimodipine administration might be due to an anti-inflammatory effect and point to a novel role for nimodipine as a centrally acting anti-inflammatory drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnS4pLJbEKILVg90H21EOLACvtfcHk0liWq3mNjgp-cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVWns7jO&md5=d6c53c83ef5a8dd466926fbd2f638d4e</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02112.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02112.x%26sid%3Dliteratum%253Aachs%26aulast%3DSanz%26aufirst%3DJ.%2BM.%26aulast%3DChiozzi%26aufirst%3DP.%26aulast%3DColaianna%26aufirst%3DM.%26aulast%3DZotti%26aufirst%3DM.%26aulast%3DFerrari%26aufirst%3DD.%26aulast%3DTrabace%26aufirst%3DL.%26aulast%3DZuliani%26aufirst%3DG.%26aulast%3DDi%2BVirgilio%26aufirst%3DF.%26atitle%3DNimodipine%2520inhibits%2520IL-1%25CE%25B2%2520release%2520stimulated%2520by%2520amyloid%2520%25CE%25B2%2520from%2520microglia%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26spage%3D1702%26epage%3D1711%26doi%3D10.1111%2Fj.1476-5381.2012.02112.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">van de Veerdonk, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeekens, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joosten, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kullberg, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinarello, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Meer, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Netea, M. G.</span><span> </span><span class="NLM_article-title">Reactive oxygen species-independent activation of the IL-1β inflammasome in cells from patients with chronic granulomatous disease</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">3030</span><span class="NLM_x">–</span> <span class="NLM_lpage">3033</span><span class="refDoi"> DOI: 10.1073/pnas.0914795107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1073%2Fpnas.0914795107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=3030-3033&author=F.+L.+van+de+Veerdonkauthor=S.+P.+Smeekensauthor=L.+A.+Joostenauthor=B.+J.+Kullbergauthor=C.+A.+Dinarelloauthor=J.+W.+van+der+Meerauthor=M.+G.+Netea&title=Reactive+oxygen+species-independent+activation+of+the+IL-1%CE%B2+inflammasome+in+cells+from+patients+with+chronic+granulomatous+disease&doi=10.1073%2Fpnas.0914795107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0914795107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0914795107%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bde%2BVeerdonk%26aufirst%3DF.%2BL.%26aulast%3DSmeekens%26aufirst%3DS.%2BP.%26aulast%3DJoosten%26aufirst%3DL.%2BA.%26aulast%3DKullberg%26aufirst%3DB.%2BJ.%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26aulast%3Dvan%2Bder%2BMeer%26aufirst%3DJ.%2BW.%26aulast%3DNetea%26aufirst%3DM.%2BG.%26atitle%3DReactive%2520oxygen%2520species-independent%2520activation%2520of%2520the%2520IL-1%25CE%25B2%2520inflammasome%2520in%2520cells%2520from%2520patients%2520with%2520chronic%2520granulomatous%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D3030%26epage%3D3033%26doi%3D10.1073%2Fpnas.0914795107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Meissner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seger, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moshous, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichenbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zychlinsky, A.</span><span> </span><span class="NLM_article-title">Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">1570</span><span class="NLM_x">–</span> <span class="NLM_lpage">1573</span><span class="refDoi"> DOI: 10.1182/blood-2010-01-264218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1182%2Fblood-2010-01-264218" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2010&pages=1570-1573&author=F.+Meissnerauthor=R.+A.+Segerauthor=D.+Moshousauthor=A.+Fischerauthor=J.+Reichenbachauthor=A.+Zychlinsky&title=Inflammasome+activation+in+NADPH+oxidase+defective+mononuclear+phagocytes+from+patients+with+chronic+granulomatous+disease&doi=10.1182%2Fblood-2010-01-264218"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1182%2Fblood-2010-01-264218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2010-01-264218%26sid%3Dliteratum%253Aachs%26aulast%3DMeissner%26aufirst%3DF.%26aulast%3DSeger%26aufirst%3DR.%2BA.%26aulast%3DMoshous%26aufirst%3DD.%26aulast%3DFischer%26aufirst%3DA.%26aulast%3DReichenbach%26aufirst%3DJ.%26aulast%3DZychlinsky%26aufirst%3DA.%26atitle%3DInflammasome%2520activation%2520in%2520NADPH%2520oxidase%2520defective%2520mononuclear%2520phagocytes%2520from%2520patients%2520with%2520chronic%2520granulomatous%2520disease%26jtitle%3DBlood%26date%3D2010%26volume%3D116%26spage%3D1570%26epage%3D1573%26doi%3D10.1182%2Fblood-2010-01-264218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">van Bruggen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koker, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Houdt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuijpers, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Berg, T. K.</span><span> </span><span class="NLM_article-title">Human NLRP3 inflammasome activation is Nox1–4 independent</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">5398</span><span class="NLM_x">–</span> <span class="NLM_lpage">5400</span><span class="refDoi"> DOI: 10.1182/blood-2009-10-250803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1182%2Fblood-2009-10-250803" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=5398-5400&author=R.+van+Bruggenauthor=M.+Y.+Kokerauthor=M.+Jansenauthor=M.+van+Houdtauthor=D.+Roosauthor=T.+W.+Kuijpersauthor=T.+K.+van+den+Berg&title=Human+NLRP3+inflammasome+activation+is+Nox1%E2%80%934+independent&doi=10.1182%2Fblood-2009-10-250803"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-10-250803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-10-250803%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BBruggen%26aufirst%3DR.%26aulast%3DKoker%26aufirst%3DM.%2BY.%26aulast%3DJansen%26aufirst%3DM.%26aulast%3Dvan%2BHoudt%26aufirst%3DM.%26aulast%3DRoos%26aufirst%3DD.%26aulast%3DKuijpers%26aufirst%3DT.%2BW.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DT.%2BK.%26atitle%3DHuman%2520NLRP3%2520inflammasome%2520activation%2520is%2520Nox1%25E2%2580%25934%2520independent%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D5398%26epage%3D5400%26doi%3D10.1182%2Fblood-2009-10-250803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Alvarez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Fernandez, M. A.</span><span> </span><span class="NLM_article-title">TNF-α may mediate inflammasome activation in the absence of bacterial infection in more than one way</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e71477</span><span class="refDoi"> DOI: 10.1371/journal.pone.0071477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1371%2Fjournal.pone.0071477" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e71477&author=S.+Alvarezauthor=M.+A.+Munoz-Fernandez&title=TNF-%CE%B1+may+mediate+inflammasome+activation+in+the+absence+of+bacterial+infection+in+more+than+one+way&doi=10.1371%2Fjournal.pone.0071477"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0071477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0071477%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez%26aufirst%3DS.%26aulast%3DMunoz-Fernandez%26aufirst%3DM.%2BA.%26atitle%3DTNF-%25CE%25B1%2520may%2520mediate%2520inflammasome%2520activation%2520in%2520the%2520absence%2520of%2520bacterial%2520infection%2520in%2520more%2520than%2520one%2520way%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De71477%26doi%3D10.1371%2Fjournal.pone.0071477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Liao, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ka, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, K. F.</span><span> </span><span class="NLM_article-title">Lipopolysaccharide/adenosine triphosphate-mediated signal transduction in the regulation of NLRP3 protein expression and caspase-1-mediated interleukin-1β secretion</span> <span class="citation_source-journal">Inflammation Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span><span class="refDoi"> DOI: 10.1007/s00011-012-0555-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1007%2Fs00011-012-0555-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22986467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVeqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=89-96&author=P.+C.+Liaoauthor=L.+K.+Chaoauthor=J.+C.+Chouauthor=W.+C.+Dongauthor=C.+N.+Linauthor=C.+Y.+Linauthor=A.+Chenauthor=S.+M.+Kaauthor=C.+L.+Hoauthor=K.+F.+Hua&title=Lipopolysaccharide%2Fadenosine+triphosphate-mediated+signal+transduction+in+the+regulation+of+NLRP3+protein+expression+and+caspase-1-mediated+interleukin-1%CE%B2+secretion&doi=10.1007%2Fs00011-012-0555-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Lipopolysaccharide/adenosine triphosphate-mediated signal transduction in the regulation of NLRP3 protein expression and caspase-1-mediated interleukin-1β secretion</span></div><div class="casAuthors">Liao, Pei-Chun; Chao, Louis Kuoping; Chou, Ju-Ching; Dong, Wei-Chih; Lin, Chien-Nan; Lin, Chai-Yi; Chen, Ann; Ka, Shuk-Man; Ho, Chen-Lung; Hua, Kuo-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-96</span>CODEN:
                <span class="NLM_cas:coden">INREFB</span>;
        ISSN:<span class="NLM_cas:issn">1023-3830</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Objective: Reactive oxygen species (ROS) plays a crit. role in the regulation of NLRP3 inflammasome activation.  However, the ROS-mediated signaling pathways controlling NLRP3 inflammasome activation are not well defined.  Methods: Using lipopolysaccharide (LPS) and ATP (ATP) activated murine macrophages as the testing model, cytokine release and protein expression were quantified by ELISA and Western blot, resp.  ROS was scavenged by N-acetyl cysteine; NADPH oxidase, the major source of ROS, was inhibited by diphenyliodonium, apocynin or gp91-phox siRNA transfection; and protein kinase was inhibited by its specific inhibitor.  Results: LPS-induced NLRP3 protein expression was regulated through the NADPH oxidase/ROS/NF-κB-dependent, JAK2/PI3-kinase/AKT/NF-κB-dependent, and MAPK-dependent pathways, while ATP-induced caspase-1 activation was regulated through the NADPH oxidase/ROS-dependent pathway.  Conclusions: These results demonstrate that ROS regulates not only the priming stage, but also the activation stage, of NLRP3 inflammasome activation in LPS + ATP-activated macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFOSgjDrCW07Vg90H21EOLACvtfcHk0lhVFX_Q4no6uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVeqsA%253D%253D&md5=0233c591b70a4a04f6a96a8b1a7c4e8f</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1007%2Fs00011-012-0555-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00011-012-0555-2%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DP.%2BC.%26aulast%3DChao%26aufirst%3DL.%2BK.%26aulast%3DChou%26aufirst%3DJ.%2BC.%26aulast%3DDong%26aufirst%3DW.%2BC.%26aulast%3DLin%26aufirst%3DC.%2BN.%26aulast%3DLin%26aufirst%3DC.%2BY.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DKa%26aufirst%3DS.%2BM.%26aulast%3DHo%26aufirst%3DC.%2BL.%26aulast%3DHua%26aufirst%3DK.%2BF.%26atitle%3DLipopolysaccharide%252Fadenosine%2520triphosphate-mediated%2520signal%2520transduction%2520in%2520the%2520regulation%2520of%2520NLRP3%2520protein%2520expression%2520and%2520caspase-1-mediated%2520interleukin-1%25CE%25B2%2520secretion%26jtitle%3DInflammation%2520Res.%26date%3D2013%26volume%3D62%26spage%3D89%26epage%3D96%26doi%3D10.1007%2Fs00011-012-0555-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Dostert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrilli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Bruggen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mossman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, J.</span><span> </span><span class="NLM_article-title">Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">674</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span><span class="refDoi"> DOI: 10.1126/science.1156995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1126%2Fscience.1156995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=18403674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFyis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2008&pages=674-677&author=C.+Dostertauthor=V.+Petrilliauthor=R.+Van+Bruggenauthor=C.+Steeleauthor=B.+T.+Mossmanauthor=J.+Tschopp&title=Innate+immune+activation+through+Nalp3+inflammasome+sensing+of+asbestos+and+silica&doi=10.1126%2Fscience.1156995"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica</span></div><div class="casAuthors">Dostert, Catherine; Petrilli, Virginie; Van Bruggen, Robin; Steele, Chad; Mossman, Brooke T.; Tschopp, Juerg</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">5876</span>),
    <span class="NLM_cas:pages">674-677</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The inhalation of airborne pollutants, such as asbestos or silica, is linked to inflammation of the lung, fibrosis, and lung cancer.  How the presence of pathogenic dust is recognized and how chronic inflammatory diseases are triggered are poorly understood.  Asbestos and silica are sensed by the Nalp3 inflammasome, whose subsequent activation leads to interleukin-1β secretion.  Inflammasome activation is triggered by reactive oxygen species, which are generated by a NADPH oxidase upon particle phagocytosis.  (NADPH is the reduced form of NADP.).  In a model of asbestos inhalation, Nalp3-/- mice showed diminished recruitment of inflammatory cells to the lungs, paralleled by lower cytokine prodn.  The authors' findings implicate the Nalp3 inflammasome in particulate matter-related pulmonary diseases and support its role as a major proinflammatory "danger" receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0IlhnfJR5DLVg90H21EOLACvtfcHk0lhVFX_Q4no6uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFyis7c%253D&md5=551595f3d70002b0ec9b891a0852db57</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1126%2Fscience.1156995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1156995%26sid%3Dliteratum%253Aachs%26aulast%3DDostert%26aufirst%3DC.%26aulast%3DPetrilli%26aufirst%3DV.%26aulast%3DVan%2BBruggen%26aufirst%3DR.%26aulast%3DSteele%26aufirst%3DC.%26aulast%3DMossman%26aufirst%3DB.%2BT.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DInnate%2520immune%2520activation%2520through%2520Nalp3%2520inflammasome%2520sensing%2520of%2520asbestos%2520and%2520silica%26jtitle%3DScience%26date%3D2008%26volume%3D320%26spage%3D674%26epage%3D677%26doi%3D10.1126%2Fscience.1156995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Jabaut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ather, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taracanova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poynter, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ckless, K.</span><span> </span><span class="NLM_article-title">Mitochondria-targeted drugs enhance Nlrp3 inflammasome-dependent IL-1β secretion in association with alterations in cellular redox and energy status</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2013.01.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.freeradbiomed.2013.01.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=23376234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFSltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2013&pages=233-245&author=J.+Jabautauthor=J.+L.+Atherauthor=A.+Taracanovaauthor=M.+E.+Poynterauthor=K.+Ckless&title=Mitochondria-targeted+drugs+enhance+Nlrp3+inflammasome-dependent+IL-1%CE%B2+secretion+in+association+with+alterations+in+cellular+redox+and+energy+status&doi=10.1016%2Fj.freeradbiomed.2013.01.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-targeted drugs enhance Nlrp3 inflammasome-dependent IL-1β secretion in association with alterations in cellular redox and energy status</span></div><div class="casAuthors">Jabaut, Joshua; Ather, Jennifer L.; Taracanova, Alexandra; Poynter, Matthew E.; Ckless, Karina</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">233-245</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Nlrp3 inflammasome is activated in response to an array of environmental and endogenous mols. leading to caspase-1-dependent IL-1β processing and secretion by myeloid cells.  Several identified Nlrp3 inflammasome activators also trigger reactive oxygen species (ROS) prodn.  However, the initial concept that NADPH oxidases are the primary source of ROS prodn. during inflammasome activation is becoming less accepted.  Therefore, the importance of mitochondria-derived ROS has been recently explored.  In this study, the authors explore the impact of mitochondria dysfunction and ROS prodn. on Nlrp3 inflammasome stimulation and IL-1β secretion induced by serum amyloid A (SAA) in primary mouse peritoneal macrophages.  To induce mitochondrial dysfunction, the authors utilized antimycin A, which blocks electron flow at complex III, and carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP), a mitochondrial oxidative phosphorylation uncoupler.  The authors also utilized a superoxide dismutase mimetic, MnTBAP, which targets the mitochondria, as well as the broad-spectrum antioxidants DPI (diphenyleneiodonium chloride) and ebselen.  The authors' findings demonstrate that SAA alone induces mitochondrial ROS in a time-dependent manner.  The authors obsd. that MnTBAP and ebselen blocked IL-1β secretion caused by SAA only when added before stimulation, and DPI augmented IL-1β secretion.  Surprisingly, these effects were not directly related to intracellular or mitochondrial ROS levels.  The authors also found that mitochondria-targeted drugs increased IL-1β secretion regardless of their impact on mitochondrial function and ROS levels, suggesting that mitochondrial ROS-dependent and -independent mechanisms play a role in the Nlrp3 inflammasome/IL-1β secretion axis in SAA-stimulated cells.  Finally, the authors found that FCCP significantly sustained the assocn. of the Nlrp3 inflammasome complex, which could explain the most robust effect among the drugs tested in enhancing IL-1β secretion in SAA-treated cells.  Overall, the authors' data suggest that the Nlrp3 inflammasome/IL-1β secretion axis is a very highly regulated inflammatory pathway that is susceptible not only to changes in mitochondrial or intracellular ROS, but also to changes in overall mitochondrial function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo17bZqXX6B1rVg90H21EOLACvtfcHk0lhVFX_Q4no6uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFSltrc%253D&md5=d3a2b3bb3bc9abf167cd3bfc8b4ceef3</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2013.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2013.01.025%26sid%3Dliteratum%253Aachs%26aulast%3DJabaut%26aufirst%3DJ.%26aulast%3DAther%26aufirst%3DJ.%2BL.%26aulast%3DTaracanova%26aufirst%3DA.%26aulast%3DPoynter%26aufirst%3DM.%2BE.%26aulast%3DCkless%26aufirst%3DK.%26atitle%3DMitochondria-targeted%2520drugs%2520enhance%2520Nlrp3%2520inflammasome-dependent%2520IL-1%25CE%25B2%2520secretion%2520in%2520association%2520with%2520alterations%2520in%2520cellular%2520redox%2520and%2520energy%2520status%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2013%26volume%3D60%26spage%3D233%26epage%3D245%26doi%3D10.1016%2Fj.freeradbiomed.2013.01.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Rajamaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lappalainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oorni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valimaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matikainen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovanen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eklund, K. K.</span><span> </span><span class="NLM_article-title">Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e11765</span><span class="refDoi"> DOI: 10.1371/journal.pone.0011765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1371%2Fjournal.pone.0011765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20668705" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e11765&author=K.+Rajamakiauthor=J.+Lappalainenauthor=K.+Oorniauthor=E.+Valimakiauthor=S.+Matikainenauthor=P.+T.+Kovanenauthor=K.+K.+Eklund&title=Cholesterol+crystals+activate+the+NLRP3+inflammasome+in+human+macrophages%3A+a+novel+link+between+cholesterol+metabolism+and+inflammation&doi=10.1371%2Fjournal.pone.0011765"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0011765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0011765%26sid%3Dliteratum%253Aachs%26aulast%3DRajamaki%26aufirst%3DK.%26aulast%3DLappalainen%26aufirst%3DJ.%26aulast%3DOorni%26aufirst%3DK.%26aulast%3DValimaki%26aufirst%3DE.%26aulast%3DMatikainen%26aufirst%3DS.%26aulast%3DKovanen%26aufirst%3DP.%2BT.%26aulast%3DEklund%26aufirst%3DK.%2BK.%26atitle%3DCholesterol%2520crystals%2520activate%2520the%2520NLRP3%2520inflammasome%2520in%2520human%2520macrophages%253A%2520a%2520novel%2520link%2520between%2520cholesterol%2520metabolism%2520and%2520inflammation%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De11765%26doi%3D10.1371%2Fjournal.pone.0011765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Schroder, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, J.</span><span> </span><span class="NLM_article-title">The inflammasomes</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">832</span><span class="refDoi"> DOI: 10.1016/j.cell.2010.01.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.cell.2010.01.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20303873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2010&pages=821-832&author=K.+Schroderauthor=J.+Tschopp&title=The+inflammasomes&doi=10.1016%2Fj.cell.2010.01.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">The inflammasomes</span></div><div class="casAuthors">Schroder, Kate; Tschopp, Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">821-832</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Inflammasomes are mol. platforms activated upon cellular infection or stress that trigger the maturation of proinflammatory cytokines such as interleukin-1β to engage innate immune defenses.  Strong assocns. between dysregulated inflammasome activity and human heritable and acquired inflammatory diseases highlight the importance this pathway in tailoring immune responses.  Here, the authors comprehensively review mechanisms directing normal inflammasome function and its dysregulation in disease.  Agonists and activation mechanisms of the NLRP1, NLRP3, IPAF, and AIM2 inflammasomes are discussed.  Regulatory mechanisms that potentiate or limit inflammasome activation are examd., as well as emerging links between the inflammasome and pyroptosis and autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkn9iIPQld9bVg90H21EOLACvtfcHk0lhhptEfxfSsdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSgu78%253D&md5=6a94a8c8cbae8e360f7b918524fc8d40</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.01.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.01.040%26sid%3Dliteratum%253Aachs%26aulast%3DSchroder%26aufirst%3DK.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DThe%2520inflammasomes%26jtitle%3DCell%26date%3D2010%26volume%3D140%26spage%3D821%26epage%3D832%26doi%3D10.1016%2Fj.cell.2010.01.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Heid, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keyel, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, R. D.</span><span> </span><span class="NLM_article-title">Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">5230</span><span class="NLM_x">–</span> <span class="NLM_lpage">5238</span><span class="refDoi"> DOI: 10.4049/jimmunol.1301490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.1301490" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2013&pages=5230-5238&author=M.+E.+Heidauthor=P.+A.+Keyelauthor=C.+Kamgaauthor=S.+Shivaauthor=S.+C.+Watkinsauthor=R.+D.+Salter&title=Mitochondrial+reactive+oxygen+species+induces+NLRP3-dependent+lysosomal+damage+and+inflammasome+activation&doi=10.4049%2Fjimmunol.1301490"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1301490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1301490%26sid%3Dliteratum%253Aachs%26aulast%3DHeid%26aufirst%3DM.%2BE.%26aulast%3DKeyel%26aufirst%3DP.%2BA.%26aulast%3DKamga%26aufirst%3DC.%26aulast%3DShiva%26aufirst%3DS.%26aulast%3DWatkins%26aufirst%3DS.%2BC.%26aulast%3DSalter%26aufirst%3DR.%2BD.%26atitle%3DMitochondrial%2520reactive%2520oxygen%2520species%2520induces%2520NLRP3-dependent%2520lysosomal%2520damage%2520and%2520inflammasome%2520activation%26jtitle%3DJ.%2520Immunol.%26date%3D2013%26volume%3D191%26spage%3D5230%26epage%3D5238%26doi%3D10.4049%2Fjimmunol.1301490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Niemi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teirila, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lappalainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oorni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovanen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matikainen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eklund, K. K.</span><span> </span><span class="NLM_article-title">Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">6119</span><span class="NLM_x">–</span> <span class="NLM_lpage">6128</span><span class="refDoi"> DOI: 10.4049/jimmunol.1002843</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.1002843" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=6119-6128&author=K.+Niemiauthor=L.+Teirilaauthor=J.+Lappalainenauthor=K.+Rajamakiauthor=M.+H.+Baumannauthor=K.+Oorniauthor=H.+Wolffauthor=P.+T.+Kovanenauthor=S.+Matikainenauthor=K.+K.+Eklund&title=Serum+amyloid+A+activates+the+NLRP3+inflammasome+via+P2X7+receptor+and+a+cathepsin+B-sensitive+pathway&doi=10.4049%2Fjimmunol.1002843"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1002843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1002843%26sid%3Dliteratum%253Aachs%26aulast%3DNiemi%26aufirst%3DK.%26aulast%3DTeirila%26aufirst%3DL.%26aulast%3DLappalainen%26aufirst%3DJ.%26aulast%3DRajamaki%26aufirst%3DK.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DOorni%26aufirst%3DK.%26aulast%3DWolff%26aufirst%3DH.%26aulast%3DKovanen%26aufirst%3DP.%2BT.%26aulast%3DMatikainen%26aufirst%3DS.%26aulast%3DEklund%26aufirst%3DK.%2BK.%26atitle%3DSerum%2520amyloid%2520A%2520activates%2520the%2520NLRP3%2520inflammasome%2520via%2520P2X7%2520receptor%2520and%2520a%2520cathepsin%2520B-sensitive%2520pathway%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26spage%3D6119%26epage%3D6128%26doi%3D10.4049%2Fjimmunol.1002843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Biswas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, R. F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holian, A.</span><span> </span><span class="NLM_article-title">Role of lysosomes in silica-induced inflammasome activation and inflammation in absence of MARCO</span> <span class="citation_source-journal">J. Immunol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2014</span><span class="NLM_x">, </span> <span class="NLM_fpage">304180</span><span class="refDoi"> DOI: 10.1155/2014/304180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1155%2F2014%2F304180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=25054161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADC%252BC2cblsFWguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=304180&author=R.+Biswasauthor=R.+F.+Hamiltonauthor=A.+Holian&title=Role+of+lysosomes+in+silica-induced+inflammasome+activation+and+inflammation+in+absence+of+MARCO&doi=10.1155%2F2014%2F304180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Role of lysosomes in silica-induced inflammasome activation and inflammation in absence of MARCO</span></div><div class="casAuthors">Biswas Rupa; Hamilton Raymond F Jr; Holian Andrij</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunology research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2014</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">304180</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MARCO is the predominant scavenger receptor for recognition and binding of silica particles by alveolar macrophages (AM).  Previously, it was shown that mice null for MARCO have a greater inflammatory response to silica, but the mechanism was not described.  The aim of this study was to determine the relationship between MARCO and NLRP3 inflammasome activity.  Silica increased NLRP3 inflammasome activation and release of the proinflammatory cytokine, IL-1β, to a greater extent in MARCO(-/-) AM compared to wild type (WT) AM.  Furthermore, in MARCO(-/-) AM there was greater cathepsin B release from phagolysosomes, Caspase-1 activation, and acid sphingomyelinase activity compared to WT AM, supporting the critical role played by lysosomal membrane permeabilization (LMP) in triggering silica-induced inflammation.  The difference in sensitivity to LMP appears to be in cholesterol recycling since increasing cholesterol in AM by treatment with U18666A decreased silica-induced NLRP3 inflammasome activation, and cells lacking MARCO were less able to sequester cholesterol following silica treatment.  Taken together, these results demonstrate that MARCO contributes to normal cholesterol uptake in macrophages; therefore, in the absence of MARCO, macrophages are more susceptible to a greater inflammatory response by particulates known to cause NLRP3 inflammasome activation and the effect is due to increased LMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT3HeveT8EGok2yPDyEFiigfW6udTcc2eZESA7oDBLZ-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cblsFWguw%253D%253D&md5=8d93360a8d28f2e64fefab04fc213ec0</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1155%2F2014%2F304180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F304180%26sid%3Dliteratum%253Aachs%26aulast%3DBiswas%26aufirst%3DR.%26aulast%3DHamilton%26aufirst%3DR.%2BF.%26aulast%3DHolian%26aufirst%3DA.%26atitle%3DRole%2520of%2520lysosomes%2520in%2520silica-induced%2520inflammasome%2520activation%2520and%2520inflammation%2520in%2520absence%2520of%2520MARCO%26jtitle%3DJ.%2520Immunol.%2520Res.%26date%3D2014%26volume%3D2014%26spage%3D304180%26doi%3D10.1155%2F2014%2F304180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Hentze, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, A. G.</span><span> </span><span class="NLM_article-title">Critical role for cathepsin B in mediating caspase-1-dependent interleukin-18 maturation and caspase-1-independent necrosis triggered by the microbial toxin nigericin</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">956</span><span class="NLM_x">–</span> <span class="NLM_lpage">968</span><span class="refDoi"> DOI: 10.1038/sj.cdd.4401264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fsj.cdd.4401264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=12934070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFeju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=956-968&author=H.+Hentzeauthor=X.+Y.+Linauthor=M.+S.+Choiauthor=A.+G.+Porter&title=Critical+role+for+cathepsin+B+in+mediating+caspase-1-dependent+interleukin-18+maturation+and+caspase-1-independent+necrosis+triggered+by+the+microbial+toxin+nigericin&doi=10.1038%2Fsj.cdd.4401264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Critical role for cathepsin B in mediating caspase-1-dependent interleukin-18 maturation and caspase-1-independent necrosis triggered by the microbial toxin nigericin</span></div><div class="casAuthors">Hentze, H.; Lin, X. Y.; Choi, M. S. K.; Porter, A. G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">956-968</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The potassium ionophore nigericin induces cell death and promotes the maturation and release of IL-1β in lipopolysaccharide (LPS)-primed monocytes and macrophages, the latter depending on caspase-1 activation by an unknown mechanism.  Here, we investigate the pathway that triggers cell death and activates caspase-1.  We show that without LPS priming, nigericin alone triggered caspase-1 activation and IL-18 generation in THP-1 monocytic cells.  Simultaneously, nigericin induced caspase-1-independent necrotic cell death, which was blocked by the cathepsin B inhibitor CA-074-Me and other cathepsin inhibitors.  Cathepsin B activation after nigericin treatment was detd. biochem. and corroborated by rapid lysosomal leakage and translocation of cathepsin B to the cytoplasm.  IL-18 maturation was prevented by both caspase-1 and cathepsin B inhibitors in THP-1 cells, primary mouse macrophages and human blood monocytes.  Moreover, IL-18 generation was reduced in THP-1 cells stably transformed either with cystatin A (an endogenous cathepsin inhibitor) or antisense cathepsin B cDNA.  Collectively, our study establishes a crit. role for cathepsin B in nigericin-induced caspase-1-dependent IL-18 maturation and caspase-1-independent necrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxqDtsvRNxl7Vg90H21EOLACvtfcHk0lhKYp8YeSKwkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFeju74%253D&md5=0a791211cca0b2dcc17f156fd2c08910</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401264%26sid%3Dliteratum%253Aachs%26aulast%3DHentze%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DX.%2BY.%26aulast%3DChoi%26aufirst%3DM.%2BS.%26aulast%3DPorter%26aufirst%3DA.%2BG.%26atitle%3DCritical%2520role%2520for%2520cathepsin%2520B%2520in%2520mediating%2520caspase-1-dependent%2520interleukin-18%2520maturation%2520and%2520caspase-1-independent%2520necrosis%2520triggered%2520by%2520the%2520microbial%2520toxin%2520nigericin%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2003%26volume%3D10%26spage%3D956%26epage%3D968%26doi%3D10.1038%2Fsj.cdd.4401264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Newman, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppla, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moayeri, M.</span><span> </span><span class="NLM_article-title">CA-074Me protection against anthrax lethal toxin</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">4327</span><span class="NLM_x">–</span> <span class="NLM_lpage">4336</span><span class="refDoi"> DOI: 10.1128/IAI.00730-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1128%2FIAI.00730-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=19635822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Ghu73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2009&pages=4327-4336&author=Z.+L.+Newmanauthor=S.+H.+Lepplaauthor=M.+Moayeri&title=CA-074Me+protection+against+anthrax+lethal+toxin&doi=10.1128%2FIAI.00730-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">CA-074Me protection against anthrax lethal toxin</span></div><div class="casAuthors">Newman, Zachary L.; Leppla, Stephen H.; Moayeri, Mahtab</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4327-4336</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Anthrax lethal toxin (LT) activates the NLRP1b (NALP1b) inflammasome and caspase-1 in macrophages from certain inbred mouse strains, but the mechanism by which this occurs is poorly understood.  The authors report here that similar to several NLRP3 (NALP3, cryopyrin)-activating stimuli, LT activation of the NLRP1b inflammasome involves lysosomal membrane permeabilization (LMP) and subsequent cytoplasmic cathepsin B activity.  CA-074Me, a potent cathepsin B inhibitor, protects LT-sensitive macrophages from cell death and prevents the activation of caspase-1.  RNA interference knockdown of cathepsin B expression, however, cannot prevent LT-mediated cell death, suggesting that CA-074Me may also act on other cellular proteases released during LMP.  CA-074Me appears to function downstream of LT translocation to the cytosol (as assessed by mitogen-activated protein kinase kinase cleavage), K+ effluxes, and proteasome activity.  The initial increase in cytoplasmic activity of cathepsin B occurs at the same time or shortly before caspase-1 activation but precedes a larger-scale lysosomal destabilization correlated closely with cytolysis.  The authors present results suggesting that LMP may be involved in the activation of the NLRP1b inflammasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC_dn4VijRO7Vg90H21EOLACvtfcHk0lhKYp8YeSKwkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Ghu73F&md5=6681a78216494c6029865c213875ae6b</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1128%2FIAI.00730-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00730-09%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DZ.%2BL.%26aulast%3DLeppla%26aufirst%3DS.%2BH.%26aulast%3DMoayeri%26aufirst%3DM.%26atitle%3DCA-074Me%2520protection%2520against%2520anthrax%2520lethal%2520toxin%26jtitle%3DInfect.%2520Immun.%26date%3D2009%26volume%3D77%26spage%3D4327%26epage%3D4336%26doi%3D10.1128%2FIAI.00730-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Gross, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poeck, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bscheider, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dostert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannesschlager, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endres, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardivel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweighoffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocsai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruland, J.</span><span> </span><span class="NLM_article-title">Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">459</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">436</span><span class="refDoi"> DOI: 10.1038/nature07965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnature07965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=19339971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvV2ksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=459&publication_year=2009&pages=433-436&author=O.+Grossauthor=H.+Poeckauthor=M.+Bscheiderauthor=C.+Dostertauthor=N.+Hannesschlagerauthor=S.+Endresauthor=G.+Hartmannauthor=A.+Tardivelauthor=E.+Schweighofferauthor=V.+Tybulewiczauthor=A.+Mocsaiauthor=J.+Tschoppauthor=J.+Ruland&title=Syk+kinase+signalling+couples+to+the+Nlrp3+inflammasome+for+anti-fungal+host+defence&doi=10.1038%2Fnature07965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence</span></div><div class="casAuthors">Gross, Olaf; Poeck, Hendrik; Bscheider, Michael; Dostert, Catherine; Hannesschlaeger, Nicole; Endres, Stefan; Hartmann, Gunther; Tardivel, Aubry; Schweighoffer, Edina; Tybulewicz, Victor; Mocsai, Attila; Tschopp, Juerg; Ruland, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">459</span>
        (<span class="NLM_cas:issue">7245</span>),
    <span class="NLM_cas:pages">433-436</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Fungal infections represent a serious threat, particularly in immunocompromised patients.  Interleukin-1β (IL-1β) is a key pro-inflammatory factor in innate antifungal immunity.  The mechanism by which the mammalian immune system regulates IL-1β prodn. after fungal recognition is unclear.  Two signals are generally required for IL-1β prodn.: an NF-κB-dependent signal that induces the synthesis of pro-IL-1β (p35), and a second signal that triggers proteolytic pro-IL-1β processing to produce bioactive IL-1β (p17) via Caspase-1-contg. multiprotein complexes called inflammasomes.  Here we demonstrate that the tyrosine kinase Syk, operating downstream of several immunoreceptor tyrosine-based activation motif (ITAM)-coupled fungal pattern recognition receptors, controls both pro-IL-1β synthesis and inflammasome activation after cell stimulation with Candida albicans.  Whereas Syk signalling for pro-IL-1β synthesis selectively uses the Card9 pathway, inflammasome activation by the fungus involves reactive oxygen species prodn. and potassium efflux.  Genetic deletion or pharmalogical inhibition of Syk selectively abrogated inflammasome activation by C. albicans but not by inflammasome activators such as Salmonella typhimurium or the bacterial toxin nigericin.  Nlrp3 (also known as NALP3) was identified as the crit. NOD-like receptor family member that transduces the fungal recognition signal to the inflammasome adaptor Asc (Pycard) for Caspase-1 (Casp1) activation and pro-IL-1β processing.  Consistent with an essential role for Nlrp3 inflammasomes in antifungal immunity, we show that Nlrp3-deficient mice are hypersusceptible to Candida albicans infection.  Thus, our results demonstrate the mol. basis for IL-1β prodn. after fungal infection and identify a crucial function for the Nlrp3 inflammasome in mammalian host defense in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK4a_GDL8lrrVg90H21EOLACvtfcHk0liwzzMbgDj6Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvV2ksLs%253D&md5=7a8d5d412df3bcd7e34dc5e6affe7a42</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1038%2Fnature07965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07965%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DO.%26aulast%3DPoeck%26aufirst%3DH.%26aulast%3DBscheider%26aufirst%3DM.%26aulast%3DDostert%26aufirst%3DC.%26aulast%3DHannesschlager%26aufirst%3DN.%26aulast%3DEndres%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DG.%26aulast%3DTardivel%26aufirst%3DA.%26aulast%3DSchweighoffer%26aufirst%3DE.%26aulast%3DTybulewicz%26aufirst%3DV.%26aulast%3DMocsai%26aufirst%3DA.%26aulast%3DTschopp%26aufirst%3DJ.%26aulast%3DRuland%26aufirst%3DJ.%26atitle%3DSyk%2520kinase%2520signalling%2520couples%2520to%2520the%2520Nlrp3%2520inflammasome%2520for%2520anti-fungal%2520host%2520defence%26jtitle%3DNature%26date%3D2009%26volume%3D459%26spage%3D433%26epage%3D436%26doi%3D10.1038%2Fnature07965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Shio, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenbarth, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savaria, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinet, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellemare, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harder, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutterwala, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohle, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Descoteaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flavell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, M.</span><span> </span><span class="NLM_article-title">Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1000559</span><span class="refDoi"> DOI: 10.1371/journal.ppat.1000559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1371%2Fjournal.ppat.1000559" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=e1000559&author=M.+T.+Shioauthor=S.+C.+Eisenbarthauthor=M.+Savariaauthor=A.+F.+Vinetauthor=M.+J.+Bellemareauthor=K.+W.+Harderauthor=F.+S.+Sutterwalaauthor=D.+S.+Bohleauthor=A.+Descoteauxauthor=R.+A.+Flavellauthor=M.+Olivier&title=Malarial+hemozoin+activates+the+NLRP3+inflammasome+through+Lyn+and+Syk+kinases&doi=10.1371%2Fjournal.ppat.1000559"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1000559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1000559%26sid%3Dliteratum%253Aachs%26aulast%3DShio%26aufirst%3DM.%2BT.%26aulast%3DEisenbarth%26aufirst%3DS.%2BC.%26aulast%3DSavaria%26aufirst%3DM.%26aulast%3DVinet%26aufirst%3DA.%2BF.%26aulast%3DBellemare%26aufirst%3DM.%2BJ.%26aulast%3DHarder%26aufirst%3DK.%2BW.%26aulast%3DSutterwala%26aufirst%3DF.%2BS.%26aulast%3DBohle%26aufirst%3DD.%2BS.%26aulast%3DDescoteaux%26aufirst%3DA.%26aulast%3DFlavell%26aufirst%3DR.%2BA.%26aulast%3DOlivier%26aufirst%3DM.%26atitle%3DMalarial%2520hemozoin%2520activates%2520the%2520NLRP3%2520inflammasome%2520through%2520Lyn%2520and%2520Syk%2520kinases%26jtitle%3DPLoS%2520Pathog.%26date%3D2009%26volume%3D5%26spage%3De1000559%26doi%3D10.1371%2Fjournal.ppat.1000559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Lin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, W. W.</span><span> </span><span class="NLM_article-title">Syk is involved in NLRP3 inflammasome-mediated caspase-1 activation through adaptor ASC phosphorylation and enhanced oligomerization</span> <span class="citation_source-journal">J. Leukocyte Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">835</span><span class="refDoi"> DOI: 10.1189/jlb.3HI0814-371RR</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1189%2Fjlb.3HI0814-371RR" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovVyisLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=825-835&author=Y.+C.+Linauthor=D.+Y.+Huangauthor=J.+S.+Wangauthor=Y.+L.+Linauthor=S.+L.+Hsiehauthor=K.+C.+Huangauthor=W.+W.+Lin&title=Syk+is+involved+in+NLRP3+inflammasome-mediated+caspase-1+activation+through+adaptor+ASC+phosphorylation+and+enhanced+oligomerization&doi=10.1189%2Fjlb.3HI0814-371RR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Syk is involved in NLRP3 inflammasome-mediated caspase-1 activation through adaptor ASC phosphorylation and enhanced oligomerization</span></div><div class="casAuthors">Lin, Ying-Cing; Huang, Duen-Yi; Wang, Jang-Shiun; Lin, Yi-Ling; Hsieh, Shie-Liang; Huang, Kuo-Chin; Lin, Wan-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">825-835</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Society for Leucocyte Biology</span>)
        </div><div class="casAbstract">NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived mols. assocd. with cellular damage.  Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases.  Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear.  In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1.  Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells.  The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1.  Herein, we find that Syk can assoc. directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1.  Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is crit. to enhance ASC oligomerization and the recruitment of procaspase-1.  Together, our results reveal a new mol. pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC.  Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlnXzcOq-TvrVg90H21EOLACvtfcHk0liwzzMbgDj6Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovVyisLw%253D&md5=2bcf6ff04d8e32a1d516e39dcf395fc5</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1189%2Fjlb.3HI0814-371RR&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.3HI0814-371RR%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DY.%2BC.%26aulast%3DHuang%26aufirst%3DD.%2BY.%26aulast%3DWang%26aufirst%3DJ.%2BS.%26aulast%3DLin%26aufirst%3DY.%2BL.%26aulast%3DHsieh%26aufirst%3DS.%2BL.%26aulast%3DHuang%26aufirst%3DK.%2BC.%26aulast%3DLin%26aufirst%3DW.%2BW.%26atitle%3DSyk%2520is%2520involved%2520in%2520NLRP3%2520inflammasome-mediated%2520caspase-1%2520activation%2520through%2520adaptor%2520ASC%2520phosphorylation%2520and%2520enhanced%2520oligomerization%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2015%26volume%3D97%26spage%3D825%26epage%3D835%26doi%3D10.1189%2Fjlb.3HI0814-371RR" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Pine, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoettler, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banquerigo, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brahn, E.</span><span> </span><span class="NLM_article-title">Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor</span> <span class="citation_source-journal">Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span><span class="refDoi"> DOI: 10.1016/j.clim.2007.03.543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.clim.2007.03.543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=17537677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1eltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2007&pages=244-257&author=P.+R.+Pineauthor=B.+Changauthor=N.+Schoettlerauthor=M.+L.+Banquerigoauthor=S.+Wangauthor=A.+Lauauthor=F.+Zhaoauthor=E.+B.+Grossbardauthor=D.+G.+Payanauthor=E.+Brahn&title=Inflammation+and+bone+erosion+are+suppressed+in+models+of+rheumatoid+arthritis+following+treatment+with+a+novel+Syk+inhibitor&doi=10.1016%2Fj.clim.2007.03.543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor</span></div><div class="casAuthors">Pine, Polly R.; Chang, Betty; Schoettler, Nathan; Banquerigo, Mona L.; Wang, Su; Lau, Angela; Zhao, Feifei; Grossbard, Elliott B.; Payan, Donald G.; Brahn, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Immunology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">244-257</span>CODEN:
                <span class="NLM_cas:coden">CLIIFY</span>;
        ISSN:<span class="NLM_cas:issn">1521-6616</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk), a key mediator of immunoreceptor signaling in inflammatory cells, is essential for immune complex-mediated signal transduction initiated by activated receptors for IgG.  In collagen-induced arthritis, R788/R406, a novel and potent small mol. Syk inhibitor suppressed clin. arthritis, bone erosions, pannus formation, and synovitis.  Serum anti-collagen type II antibody levels were unaltered, while the half-life of exogenous antibody was extended when co-administered with R406.  Expression of the targeted kinase (Syk) in synovial tissue correlated with the joint level of inflammatory cell infiltrates and was virtually undetectable in treated rats.  Syk inhibition suppressed synovial cytokines and cartilage oligomeric matrix protein (COMP) in serum, suggesting a sensitive and reliable biomarker for R406 activity.  These results highlight the role of activating Fcgamma receptors in inflammatory synovitis and suggest that interruption of the signaling cascade with a novel Syk inhibitor may be a useful addn. to immunosuppressive disease-modifying anti-rheumatic drugs currently used in the treatment of human autoimmune diseases such as rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Nm2XObIb37Vg90H21EOLACvtfcHk0liwzzMbgDj6Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1eltb0%253D&md5=98b5020fb23cc209e5b7c322024748fb</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.clim.2007.03.543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clim.2007.03.543%26sid%3Dliteratum%253Aachs%26aulast%3DPine%26aufirst%3DP.%2BR.%26aulast%3DChang%26aufirst%3DB.%26aulast%3DSchoettler%26aufirst%3DN.%26aulast%3DBanquerigo%26aufirst%3DM.%2BL.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DBrahn%26aufirst%3DE.%26atitle%3DInflammation%2520and%2520bone%2520erosion%2520are%2520suppressed%2520in%2520models%2520of%2520rheumatoid%2520arthritis%2520following%2520treatment%2520with%2520a%2520novel%2520Syk%2520inhibitor%26jtitle%3DClin.%2520Immunol.%26date%3D2007%26volume%3D124%26spage%3D244%26epage%3D257%26doi%3D10.1016%2Fj.clim.2007.03.543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Weinblatt, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgos-Vargas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikranian, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medrano-Ramirez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales-Torres, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musser, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straniero, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente-Gonzales, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E.</span><span> </span><span class="NLM_article-title">Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3309</span><span class="NLM_x">–</span> <span class="NLM_lpage">3318</span><span class="refDoi"> DOI: 10.1002/art.23992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1002%2Fart.23992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=18975322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2hs7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=3309-3318&author=M.+E.+Weinblattauthor=A.+Kavanaughauthor=R.+Burgos-Vargasauthor=A.+H.+Dikranianauthor=G.+Medrano-Ramirezauthor=J.+L.+Morales-Torresauthor=F.+T.+Murphyauthor=T.+K.+Musserauthor=N.+Stranieroauthor=A.+V.+Vicente-Gonzalesauthor=E.+Grossbard&title=Treatment+of+rheumatoid+arthritis+with+a+Syk+kinase+inhibitor%3A+a+twelve-week%2C+randomized%2C+placebo-controlled+trial&doi=10.1002%2Fart.23992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial</span></div><div class="casAuthors">Weinblatt, Michael E.; Kavanaugh, Arthur; Burgos-Vargas, Ruben; Dikranian, Ara H.; Medrano-Ramirez, Gabriel; Morales-Torres, Jorge L.; Murphy, Frederick T.; Musser, Theresa Kane; Straniero, Nicholas; Vicente-Gonzales, Angela V.; Grossbard, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3309-3318</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: Spleen tyrosine kinase (Syk) has been identified as an important modulator of immune signaling in B cells and cells bearing Fcγ-activating receptors.  R788, a prodrug of active metabolite R406, has been shown to be an inhibitor of Syk kinase, active in a variety of in vitro and in vivo models, suggesting potential activity in the treatment of rheumatoid arthritis (RA).  Methods: We enrolled 189 patients with active RA despite methotrexate therapy in a 3-mo, multicenter, ascending-dose, double-blind, placebo-controlled trial.  The primary end point was the American College of Rheumatol. 20% improvement criteria (ACR20) response rate at week 12.  Results: Twice-daily oral doses of 100 mg and 150 mg of R788 were significantly superior to placebo or twice-daily oral doses of 50 mg at week 12 (ACR20 achieved in 65% and 72% vs. 38% and 32% of patients, resp. [P < 0.01]).  ACR50 (achieved in 49% and 57% vs. 19% and 17% of patients, resp.) and ACR70 (achieved in 33% and 40% vs. 4% and 2% of patients, resp.) scores showed a similar pattern.  Clin. effect was noted as early as 1 wk after initiation of therapy.  Redns. in serum interleukin-6 and matrix metalloproteinase 3 levels also occurred as early as week 1 in the groups receiving 100 mg and 150 mg R788.  The major adverse effects were gastrointestinal side effects (predominantly diarrhea) and neutropenia (<1,500/mm3), both of which were dose related.  Conclusion: These results indicate that an inhibitor of Syk kinase produces significant clin. benefits at 12 wk in a population of patients with active RA receiving methotrexate therapy.  Syk kinase may be an important new therapeutic target in RA and related autoimmune conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqomUu-KV6uvbVg90H21EOLACvtfcHk0lj6FLSUuT8lFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2hs7jF&md5=a49db998eb1a011d8ae59580f4c868c6</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1002%2Fart.23992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.23992%26sid%3Dliteratum%253Aachs%26aulast%3DWeinblatt%26aufirst%3DM.%2BE.%26aulast%3DKavanaugh%26aufirst%3DA.%26aulast%3DBurgos-Vargas%26aufirst%3DR.%26aulast%3DDikranian%26aufirst%3DA.%2BH.%26aulast%3DMedrano-Ramirez%26aufirst%3DG.%26aulast%3DMorales-Torres%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DF.%2BT.%26aulast%3DMusser%26aufirst%3DT.%2BK.%26aulast%3DStraniero%26aufirst%3DN.%26aulast%3DVicente-Gonzales%26aufirst%3DA.%2BV.%26aulast%3DGrossbard%26aufirst%3DE.%26atitle%3DTreatment%2520of%2520rheumatoid%2520arthritis%2520with%2520a%2520Syk%2520kinase%2520inhibitor%253A%2520a%2520twelve-week%252C%2520randomized%252C%2520placebo-controlled%2520trial%26jtitle%3DArthritis%2520Rheum.%26date%3D2008%26volume%3D58%26spage%3D3309%26epage%3D3318%26doi%3D10.1002%2Fart.23992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Currie, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kropf, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomgren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallion, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitney, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansdon, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciejewski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macaluso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Paolo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, S. A.</span><span> </span><span class="NLM_article-title">Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3856</span><span class="NLM_x">–</span> <span class="NLM_lpage">3873</span><span class="refDoi"> DOI: 10.1021/jm500228a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500228a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1CrsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3856-3873&author=K.+S.+Currieauthor=J.+E.+Kropfauthor=T.+Leeauthor=P.+Blomgrenauthor=J.+Xuauthor=Z.+Zhaoauthor=S.+Gallionauthor=J.+A.+Whitneyauthor=D.+Maclinauthor=E.+B.+Lansdonauthor=P.+Maciejewskiauthor=A.+M.+Rossiauthor=H.+Rongauthor=J.+Macalusoauthor=J.+Barbosaauthor=J.+A.+Di+Paoloauthor=S.+A.+Mitchell&title=Discovery+of+GS-9973%2C+a+selective+and+orally+efficacious+inhibitor+of+spleen+tyrosine+kinase&doi=10.1021%2Fjm500228a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine Kinase</span></div><div class="casAuthors">Currie, Kevin S.; Kropf, Jeffrey E.; Lee, Tony; Blomgren, Peter; Xu, Jianjun; Zhao, Zhongdong; Gallion, Steve; Whitney, J. Andrew; Maclin, Deborah; Lansdon, Eric B.; Maciejewski, Patricia; Rossi, Ann Marie; Rong, Hong; Macaluso, Jennifer; Barbosa, James; Di Paolo, Julie A.; Mitchell, Scott A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3856-3873</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk) is an attractive drug target in autoimmune, inflammatory, and oncol. disease indications.  The most advanced Syk inhibitor, R406, (or its prodrug form fostamatinib), has shown efficacy in multiple therapeutic indications, but its clin. progress has been hampered by dose-limiting adverse effects that have been attributed, at least in part, to the off-target activities of R406.  It is expected that a more selective Syk inhibitor would provide a greater therapeutic window.  Herein the authors report the discovery and optimization of a novel series of imidazo[1,2-a]pyrazine Syk inhibitors.  This work culminated in the identification of GS-9973, a highly selective and orally efficacious Syk inhibitor which is currently undergoing clin. evaluation for autoimmune and oncol. indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRyEcx9jKxCbVg90H21EOLACvtfcHk0lj6FLSUuT8lFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1CrsL4%253D&md5=fc53448de1f5416f2c6600876f8c6385</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1021%2Fjm500228a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500228a%26sid%3Dliteratum%253Aachs%26aulast%3DCurrie%26aufirst%3DK.%2BS.%26aulast%3DKropf%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DBlomgren%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DGallion%26aufirst%3DS.%26aulast%3DWhitney%26aufirst%3DJ.%2BA.%26aulast%3DMaclin%26aufirst%3DD.%26aulast%3DLansdon%26aufirst%3DE.%2BB.%26aulast%3DMaciejewski%26aufirst%3DP.%26aulast%3DRossi%26aufirst%3DA.%2BM.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DMacaluso%26aufirst%3DJ.%26aulast%3DBarbosa%26aufirst%3DJ.%26aulast%3DDi%2BPaolo%26aufirst%3DJ.%2BA.%26aulast%3DMitchell%26aufirst%3DS.%2BA.%26atitle%3DDiscovery%2520of%2520GS-9973%252C%2520a%2520selective%2520and%2520orally%2520efficacious%2520inhibitor%2520of%2520spleen%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3856%26epage%3D3873%26doi%3D10.1021%2Fjm500228a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Fernandes-Alnemri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E. S.</span><span> </span><span class="NLM_article-title">Cutting edge: TLR signaling licenses IRAK1 for rapid activation of the NLRP3 inflammasome</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">3995</span><span class="NLM_x">–</span> <span class="NLM_lpage">3999</span><span class="refDoi"> DOI: 10.4049/jimmunol.1301681</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.1301681" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2013&pages=3995-3999&author=T.+Fernandes-Alnemriauthor=S.+Kangauthor=C.+Andersonauthor=J.+Sagaraauthor=K.+A.+Fitzgeraldauthor=E.+S.+Alnemri&title=Cutting+edge%3A+TLR+signaling+licenses+IRAK1+for+rapid+activation+of+the+NLRP3+inflammasome&doi=10.4049%2Fjimmunol.1301681"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1301681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1301681%26sid%3Dliteratum%253Aachs%26aulast%3DFernandes-Alnemri%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DC.%26aulast%3DSagara%26aufirst%3DJ.%26aulast%3DFitzgerald%26aufirst%3DK.%2BA.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26atitle%3DCutting%2520edge%253A%2520TLR%2520signaling%2520licenses%2520IRAK1%2520for%2520rapid%2520activation%2520of%2520the%2520NLRP3%2520inflammasome%26jtitle%3DJ.%2520Immunol.%26date%3D2013%26volume%3D191%26spage%3D3995%26epage%3D3999%26doi%3D10.4049%2Fjimmunol.1301681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Lin, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasare, C.</span><span> </span><span class="NLM_article-title">IRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span><span class="refDoi"> DOI: 10.1073/pnas.1320294111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1073%2Fpnas.1320294111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=775-780&author=K.+M.+Linauthor=W.+Huauthor=T.+D.+Troutmanauthor=M.+Jenningsauthor=T.+Brewerauthor=X.+Liauthor=S.+Nandaauthor=P.+Cohenauthor=J.+A.+Thomasauthor=C.+Pasare&title=IRAK-1+bypasses+priming+and+directly+links+TLRs+to+rapid+NLRP3+inflammasome+activation&doi=10.1073%2Fpnas.1320294111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1320294111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1320294111%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DK.%2BM.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DTroutman%26aufirst%3DT.%2BD.%26aulast%3DJennings%26aufirst%3DM.%26aulast%3DBrewer%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DNanda%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DThomas%26aufirst%3DJ.%2BA.%26aulast%3DPasare%26aufirst%3DC.%26atitle%3DIRAK-1%2520bypasses%2520priming%2520and%2520directly%2520links%2520TLRs%2520to%2520rapid%2520NLRP3%2520inflammasome%2520activation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D775%26epage%3D780%26doi%3D10.1073%2Fpnas.1320294111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Chaudhary, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, D. L.</span><span> </span><span class="NLM_article-title">Recent advances in the discovery of small molecule inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4) as a therapeutic target for inflammation and oncology disorders</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1021/jm5016044</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5016044" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVCjsLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=96-110&author=D.+Chaudharyauthor=S.+Robinsonauthor=D.+L.+Romero&title=Recent+advances+in+the+discovery+of+small+molecule+inhibitors+of+interleukin-1+receptor-associated+kinase+4+%28IRAK4%29+as+a+therapeutic+target+for+inflammation+and+oncology+disorders&doi=10.1021%2Fjm5016044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Discovery of Small Molecule Inhibitors of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) as a Therapeutic Target for Inflammation and Oncology Disorders</span></div><div class="casAuthors">Chaudhary, Divya; Robinson, Shaughnessy; Romero, Donna L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-110</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  IRAK4, a serine/threonine kinase, plays a key role in both inflammation and oncol. diseases.  Herein, we summarize the compelling biol. surrounding the IRAK4 signaling node in disease, review key structural features of IRAK4 including selectivity challenges, and describe efforts to discover clin. viable IRAK4 inhibitors.  Finally, a view of knowledge gained and remaining challenges is provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1K6ExwztfCLVg90H21EOLACvtfcHk0lhI0KGnUTPiew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVCjsLzL&md5=795797f7f3f07597ecd0b5899498804b</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fjm5016044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5016044%26sid%3Dliteratum%253Aachs%26aulast%3DChaudhary%26aufirst%3DD.%26aulast%3DRobinson%26aufirst%3DS.%26aulast%3DRomero%26aufirst%3DD.%2BL.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520of%2520small%2520molecule%2520inhibitors%2520of%2520interleukin-1%2520receptor-associated%2520kinase%25204%2520%2528IRAK4%2529%2520as%2520a%2520therapeutic%2520target%2520for%2520inflammation%2520and%2520oncology%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D96%26epage%3D110%26doi%3D10.1021%2Fjm5016044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Martinon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, J.</span><span> </span><span class="NLM_article-title">The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-1β</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span><span class="refDoi"> DOI: 10.1016/S1097-2765(02)00599-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2FS1097-2765%2802%2900599-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=417-426&author=F.+Martinonauthor=K.+Burnsauthor=J.+Tschopp&title=The+inflammasome%3A+a+molecular+platform+triggering+activation+of+inflammatory+caspases+and+processing+of+proIL-1%CE%B2&doi=10.1016%2FS1097-2765%2802%2900599-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2802%2900599-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252802%252900599-3%26sid%3Dliteratum%253Aachs%26aulast%3DMartinon%26aufirst%3DF.%26aulast%3DBurns%26aufirst%3DK.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DThe%2520inflammasome%253A%2520a%2520molecular%2520platform%2520triggering%2520activation%2520of%2520inflammatory%2520caspases%2520and%2520processing%2520of%2520proIL-1%25CE%25B2%26jtitle%3DMol.%2520Cell%26date%3D2002%26volume%3D10%26spage%3D417%26epage%3D426%26doi%3D10.1016%2FS1097-2765%2802%2900599-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Brydges, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeough, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misaghi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putnam, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestein, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horner, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soroosh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watford, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastner, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, H. M.</span><span> </span><span class="NLM_article-title">Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">875</span><span class="NLM_x">–</span> <span class="NLM_lpage">887</span><span class="refDoi"> DOI: 10.1016/j.immuni.2009.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.immuni.2009.05.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=875-887&author=S.+D.+Brydgesauthor=J.+L.+Muellerauthor=M.+D.+McGeoughauthor=C.+A.+Penaauthor=A.+Misaghiauthor=C.+Gandhiauthor=C.+D.+Putnamauthor=D.+L.+Boyleauthor=G.+S.+Firesteinauthor=A.+A.+Hornerauthor=P.+Sorooshauthor=W.+T.+Watfordauthor=J.+J.+O%27Sheaauthor=D.+L.+Kastnerauthor=H.+M.+Hoffman&title=Inflammasome-mediated+disease+animal+models+reveal+roles+for+innate+but+not+adaptive+immunity&doi=10.1016%2Fj.immuni.2009.05.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2009.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2009.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DBrydges%26aufirst%3DS.%2BD.%26aulast%3DMueller%26aufirst%3DJ.%2BL.%26aulast%3DMcGeough%26aufirst%3DM.%2BD.%26aulast%3DPena%26aufirst%3DC.%2BA.%26aulast%3DMisaghi%26aufirst%3DA.%26aulast%3DGandhi%26aufirst%3DC.%26aulast%3DPutnam%26aufirst%3DC.%2BD.%26aulast%3DBoyle%26aufirst%3DD.%2BL.%26aulast%3DFirestein%26aufirst%3DG.%2BS.%26aulast%3DHorner%26aufirst%3DA.%2BA.%26aulast%3DSoroosh%26aufirst%3DP.%26aulast%3DWatford%26aufirst%3DW.%2BT.%26aulast%3DO%2527Shea%26aufirst%3DJ.%2BJ.%26aulast%3DKastner%26aufirst%3DD.%2BL.%26aulast%3DHoffman%26aufirst%3DH.%2BM.%26atitle%3DInflammasome-mediated%2520disease%2520animal%2520models%2520reveal%2520roles%2520for%2520innate%2520but%2520not%2520adaptive%2520immunity%26jtitle%3DImmunity%26date%3D2009%26volume%3D30%26spage%3D875%26epage%3D887%26doi%3D10.1016%2Fj.immuni.2009.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Cogswell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godlevski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisely, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clay, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leesnitzer, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ways, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. G.</span><span> </span><span class="NLM_article-title">NF-κB regulates IL-1β transcription through a consensus NF-κB binding site and a nonconsensus CRE-like site</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=1994&pages=712-723&author=J.+P.+Cogswellauthor=M.+M.+Godlevskiauthor=G.+B.+Wiselyauthor=W.+C.+Clayauthor=L.+M.+Leesnitzerauthor=J.+P.+Waysauthor=J.+G.+Gray&title=NF-%CE%BAB+regulates+IL-1%CE%B2+transcription+through+a+consensus+NF-%CE%BAB+binding+site+and+a+nonconsensus+CRE-like+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCogswell%26aufirst%3DJ.%2BP.%26aulast%3DGodlevski%26aufirst%3DM.%2BM.%26aulast%3DWisely%26aufirst%3DG.%2BB.%26aulast%3DClay%26aufirst%3DW.%2BC.%26aulast%3DLeesnitzer%26aufirst%3DL.%2BM.%26aulast%3DWays%26aufirst%3DJ.%2BP.%26aulast%3DGray%26aufirst%3DJ.%2BG.%26atitle%3DNF-%25CE%25BAB%2520regulates%2520IL-1%25CE%25B2%2520transcription%2520through%2520a%2520consensus%2520NF-%25CE%25BAB%2520binding%2520site%2520and%2520a%2520nonconsensus%2520CRE-like%2520site%26jtitle%3DJ.%2520Immunol.%26date%3D1994%26volume%3D153%26spage%3D712%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Small, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McColl, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allmendinger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pahle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Castejon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothwell, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knowles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kell, D. B.</span><span> </span><span class="NLM_article-title">Efficient discovery of anti-inflammatory small-molecule combinations using evolutionary computing</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">902</span><span class="NLM_x">–</span> <span class="NLM_lpage">908</span><span class="refDoi"> DOI: 10.1038/nchembio.689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1038%2Fnchembio.689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=22020553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=902-908&author=B.+G.+Smallauthor=B.+W.+McCollauthor=R.+Allmendingerauthor=J.+Pahleauthor=G.+Lopez-Castejonauthor=N.+J.+Rothwellauthor=J.+Knowlesauthor=P.+Mendesauthor=D.+Broughauthor=D.+B.+Kell&title=Efficient+discovery+of+anti-inflammatory+small-molecule+combinations+using+evolutionary+computing&doi=10.1038%2Fnchembio.689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient discovery of anti-inflammatory small-molecule combinations using evolutionary computing</span></div><div class="casAuthors">Small, Ben G.; McColl, Barry W.; Allmendinger, Richard; Pahle, Juergen; Lopez-Castejon, Gloria; Rothwell, Nancy J.; Knowles, Joshua; Mendes, Pedro; Brough, David; Kell, Douglas B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">902-908</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The control of biochem. fluxes is distributed, and to perturb complex intracellular networks effectively it is often necessary to modulate several steps simultaneously.  However, the no. of possible permutations leads to a combinatorial explosion in the no. of expts. that would have to be performed in a complete anal.  We used a multiobjective evolutionary algorithm to optimize reagent combinations from a dynamic chem. library of 33 compds. with established or predicted targets in the regulatory network controlling IL-1β expression.  The evolutionary algorithm converged on excellent solns. within 11 generations, during which we studied just 550 combinations out of the potential search space of ∼9 billion.  The top five reagents with the greatest contribution to combinatorial effects throughout the evolutionary algorithm were then optimized pairwise.  A p38 MAPK inhibitor together with either an inhibitor of IκB kinase or a chelator of poorly liganded iron yielded synergistic inhibition of macrophage IL-1β expression.  Evolutionary searches provide a powerful and general approach to the discovery of new combinations of pharmacol. agents with therapeutic indexes potentially greater than those of single drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo7fSr1-34EbVg90H21EOLACvtfcHk0lhox7B9kGMBMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7nK&md5=5b36a491c9331206abef4903daf932a8</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.689%26sid%3Dliteratum%253Aachs%26aulast%3DSmall%26aufirst%3DB.%2BG.%26aulast%3DMcColl%26aufirst%3DB.%2BW.%26aulast%3DAllmendinger%26aufirst%3DR.%26aulast%3DPahle%26aufirst%3DJ.%26aulast%3DLopez-Castejon%26aufirst%3DG.%26aulast%3DRothwell%26aufirst%3DN.%2BJ.%26aulast%3DKnowles%26aufirst%3DJ.%26aulast%3DMendes%26aufirst%3DP.%26aulast%3DBrough%26aufirst%3DD.%26aulast%3DKell%26aufirst%3DD.%2BB.%26atitle%3DEfficient%2520discovery%2520of%2520anti-inflammatory%2520small-molecule%2520combinations%2520using%2520evolutionary%2520computing%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D902%26epage%3D908%26doi%3D10.1038%2Fnchembio.689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Cocco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Stilo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borretto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevanato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantozzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miglio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertinaria, M.</span><span> </span><span class="NLM_article-title">Electrophilic warhead-based design of compounds preventing NLRP3 inflammasome-dependent pyroptosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10366</span><span class="NLM_x">–</span> <span class="NLM_lpage">10382</span><span class="refDoi"> DOI: 10.1021/jm501072b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501072b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10366-10382&author=M.+Coccoauthor=D.+Garellaauthor=A.+Di+Stiloauthor=E.+Borrettoauthor=L.+Stevanatoauthor=M.+Giorgisauthor=E.+Mariniauthor=R.+Fantozziauthor=G.+Miglioauthor=M.+Bertinaria&title=Electrophilic+warhead-based+design+of+compounds+preventing+NLRP3+inflammasome-dependent+pyroptosis&doi=10.1021%2Fjm501072b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Fjm501072b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501072b%26sid%3Dliteratum%253Aachs%26aulast%3DCocco%26aufirst%3DM.%26aulast%3DGarella%26aufirst%3DD.%26aulast%3DDi%2BStilo%26aufirst%3DA.%26aulast%3DBorretto%26aufirst%3DE.%26aulast%3DStevanato%26aufirst%3DL.%26aulast%3DGiorgis%26aufirst%3DM.%26aulast%3DMarini%26aufirst%3DE.%26aulast%3DFantozzi%26aufirst%3DR.%26aulast%3DMiglio%26aufirst%3DG.%26aulast%3DBertinaria%26aufirst%3DM.%26atitle%3DElectrophilic%2520warhead-based%2520design%2520of%2520compounds%2520preventing%2520NLRP3%2520inflammasome-dependent%2520pyroptosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10366%26epage%3D10382%26doi%3D10.1021%2Fjm501072b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Bae, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. H.</span><span> </span><span class="NLM_article-title">Crystal structure of NALP3 protein pyrin domain (PYD) and its implications in inflammasome assembly</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">39528</span><span class="NLM_x">–</span> <span class="NLM_lpage">39536</span><span class="refDoi"> DOI: 10.1074/jbc.M111.278812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1074%2Fjbc.M111.278812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=21880711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSqtLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=39528-39536&author=J.+Y.+Baeauthor=H.+H.+Park&title=Crystal+structure+of+NALP3+protein+pyrin+domain+%28PYD%29+and+its+implications+in+inflammasome+assembly&doi=10.1074%2Fjbc.M111.278812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of NALP3 Protein Pyrin Domain (PYD) and Its Implications in Inflammasome Assembly</span></div><div class="casAuthors">Bae, Ju Young; Park, Hyun Ho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">39528-39536, S39528/1-S39528/2</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">NALP3 inflammasome, composed of the three proteins NALP3, ASC, and Caspase-1, is a macromol. complex responsible for the innate immune response against infection with bacterial and viral pathogens.  Formation of the inflammasome can lead to the activation of inflammatory caspases, such as Caspase-1, which then activate pro-inflammatory cytokines by proteolytic cleavage.  The assembly of the NALP3 inflammasome depends on the protein-interacting domain known as the death domain superfamily.  NALP3 inflammasome is assembled via a pyrin domain (PYD)/PYD interaction between ASC and NALP3 and a caspase recruitment domain/caspase recruitment domain interaction between ASC and Caspase-1.  As a first step toward elucidating the mol. mechanisms of inflammatory caspase activation by formation of inflammasome, the authors report the crystal structure of the PYD from NALP3 at 1.7-Å resoln.  Although NALP3 PYD has the canonical six-helical bundle structural fold similar to other PYDs, the high resoln. structure reveals the possible biol. important homodimeric interface and the dynamic properties of the fold.  Comparison with other PYD structures shows both similarities and differences that may be functionally relevant.  Structural and sequence analyses further implicate conserved surface residues in NALP3 PYD for ASC interaction and inflammasome assembly.  The most interesting aspect of the structure was the unexpected disulfide bond between Cys-8 and Cys-108, which might be important for regulation of the activity of NALP3 by redox potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHEyUe6A6AKrVg90H21EOLACvtfcHk0lhox7B9kGMBMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSqtLzL&md5=9a9fdbd99a3e8aba9fcba7f2c8b48902</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.278812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.278812%26sid%3Dliteratum%253Aachs%26aulast%3DBae%26aufirst%3DJ.%2BY.%26aulast%3DPark%26aufirst%3DH.%2BH.%26atitle%3DCrystal%2520structure%2520of%2520NALP3%2520protein%2520pyrin%2520domain%2520%2528PYD%2529%2520and%2520its%2520implications%2520in%2520inflammasome%2520assembly%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D39528%26epage%3D39536%26doi%3D10.1074%2Fjbc.M111.278812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Nobel, C. S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orrenius, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slater, A. F. G.</span><span> </span><span class="NLM_article-title">Disulfiram is a potent inhibitor of proteases of the caspase family</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1319</span><span class="NLM_x">–</span> <span class="NLM_lpage">1324</span><span class="refDoi"> DOI: 10.1021/tx970131m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx970131m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1997&pages=1319-1324&author=C.+S.+I.+Nobelauthor=M.+Kimlandauthor=D.+W.+Nicholsonauthor=S.+Orreniusauthor=A.+F.+G.+Slater&title=Disulfiram+is+a+potent+inhibitor+of+proteases+of+the+caspase+family&doi=10.1021%2Ftx970131m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Ftx970131m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx970131m%26sid%3Dliteratum%253Aachs%26aulast%3DNobel%26aufirst%3DC.%2BS.%2BI.%26aulast%3DKimland%26aufirst%3DM.%26aulast%3DNicholson%26aufirst%3DD.%2BW.%26aulast%3DOrrenius%26aufirst%3DS.%26aulast%3DSlater%26aufirst%3DA.%2BF.%2BG.%26atitle%3DDisulfiram%2520is%2520a%2520potent%2520inhibitor%2520of%2520proteases%2520of%2520the%2520caspase%2520family%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D1997%26volume%3D10%26spage%3D1319%26epage%3D1324%26doi%3D10.1021%2Ftx970131m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Haddad, J. J.</span><span> </span><span class="NLM_article-title">A redox microenvironment is essential for MAPK-dependent secretion of pro-inflammatory cytokines: modulation by glutathione (GSH/GSSG) biosynthesis and equilibrium in the alveolar epithelium</span> <span class="citation_source-journal">Cell. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span><span class="refDoi"> DOI: 10.1016/j.cellimm.2011.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.cellimm.2011.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=21550026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlygtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=2011&pages=53-61&author=J.+J.+Haddad&title=A+redox+microenvironment+is+essential+for+MAPK-dependent+secretion+of+pro-inflammatory+cytokines%3A+modulation+by+glutathione+%28GSH%2FGSSG%29+biosynthesis+and+equilibrium+in+the+alveolar+epithelium&doi=10.1016%2Fj.cellimm.2011.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">A redox microenvironment is essential for MAPK-dependent secretion of pro-inflammatory cytokines: Modulation by glutathione (GSH/GSSG) biosynthesis and equilibrium in the alveolar epithelium</span></div><div class="casAuthors">Haddad, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-61</span>CODEN:
                <span class="NLM_cas:coden">CLIMB8</span>;
        ISSN:<span class="NLM_cas:issn">0008-8749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The characterization of oxidant (glutathione)-dependent regulation of MAPKp38/RK-mediated TNF-α secretion was undertaken in vitro, and the ramifications of the influence of a redox microenvironment were unraveled.  Intermittent exposure of alveolar epithelial cells (FATEII) to LPS (endotoxin) transiently and temporally induced the expression of MAPKp38/RK.  This upregulation was assocd. with the activation of MAPKAP-K2, manifested by the specific phosphorylation of the downstream heat-shock protein (Hsp)-27.  Selective blockading of the MAPKp38/RK pathway using the pyridinyl imidazole SB-203580 abrogated the LPS-dependent release of TNF-α.  N-acetyl-L-cysteine (NAC), a precursor of glutathione, reduced TNF-α secretion and increased [GSH].  Conversely, L-buthionine-(S,R)-sulfoximine (BSO), an irreversible inhibitor of γ-glutamylcysteine synthetase (γ-GCS), the rate-limiting enzyme in the pathway mediating GSH biosynthesis, augmented the secretion of TNF-α and [GSSG] accumulation.  Whereas NAC abrogated the phosphorylation of MAPKp38/RK, BSO reversibly amplified this effect.  Furthermore, intermittent exposure of FATEII cells to the exogenous oxidants X/XO and H2O2 upregulated the secretion of pro-inflammatory cytokines IL-1β, IL-6 and TNF-α; this upregulation was correlated with increasing activity of key glutathione-related enzymes, closely involved with maintaining the cyclic GSH/GSSG equil.  These results indicate that a redox microenvironment plays a major role in regulating MAPK-dependent prodn. of cytokines in the alveolar epithelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbDh0qzWNlC7Vg90H21EOLACvtfcHk0lhEwKMAXBm-aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlygtbk%253D&md5=bf407b714443461b527b70a69f762579</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1016%2Fj.cellimm.2011.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellimm.2011.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DHaddad%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520redox%2520microenvironment%2520is%2520essential%2520for%2520MAPK-dependent%2520secretion%2520of%2520pro-inflammatory%2520cytokines%253A%2520modulation%2520by%2520glutathione%2520%2528GSH%252FGSSG%2529%2520biosynthesis%2520and%2520equilibrium%2520in%2520the%2520alveolar%2520epithelium%26jtitle%3DCell.%2520Immunol.%26date%3D2011%26volume%3D270%26spage%3D53%26epage%3D61%26doi%3D10.1016%2Fj.cellimm.2011.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Rider, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guttman, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braiman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voronov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinarello, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apte, R. N.</span><span> </span><span class="NLM_article-title">IL-1α and IL-1β recruit different myeloid cells and promote different stages of sterile inflammation</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">187</span><span class="NLM_x">, </span> <span class="NLM_fpage">4835</span><span class="NLM_x">–</span> <span class="NLM_lpage">4843</span><span class="refDoi"> DOI: 10.4049/jimmunol.1102048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.1102048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2011&pages=4835-4843&author=P.+Riderauthor=Y.+Carmiauthor=O.+Guttmanauthor=A.+Braimanauthor=I.+Cohenauthor=E.+Voronovauthor=M.+R.+Whiteauthor=C.+A.+Dinarelloauthor=R.+N.+Apte&title=IL-1%CE%B1+and+IL-1%CE%B2+recruit+different+myeloid+cells+and+promote+different+stages+of+sterile+inflammation&doi=10.4049%2Fjimmunol.1102048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1102048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1102048%26sid%3Dliteratum%253Aachs%26aulast%3DRider%26aufirst%3DP.%26aulast%3DCarmi%26aufirst%3DY.%26aulast%3DGuttman%26aufirst%3DO.%26aulast%3DBraiman%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DI.%26aulast%3DVoronov%26aufirst%3DE.%26aulast%3DWhite%26aufirst%3DM.%2BR.%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26aulast%3DApte%26aufirst%3DR.%2BN.%26atitle%3DIL-1%25CE%25B1%2520and%2520IL-1%25CE%25B2%2520recruit%2520different%2520myeloid%2520cells%2520and%2520promote%2520different%2520stages%2520of%2520sterile%2520inflammation%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D187%26spage%3D4835%26epage%3D4843%26doi%3D10.4049%2Fjimmunol.1102048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Miller, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Connell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietras, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahangian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thirumala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modlin, R. L.</span><span> </span><span class="NLM_article-title">MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against <i>Staphylococcus aureus</i></span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">91</span><span class="refDoi"> DOI: 10.1016/j.immuni.2005.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.immuni.2005.11.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=79-91&author=L.+S.+Millerauthor=R.+M.+O%27Connellauthor=M.+A.+Gutierrezauthor=E.+M.+Pietrasauthor=A.+Shahangianauthor=C.+E.+Grossauthor=A.+Thirumalaauthor=A.+L.+Cheungauthor=G.+Chengauthor=R.+L.+Modlin&title=MyD88+mediates+neutrophil+recruitment+initiated+by+IL-1R+but+not+TLR2+activation+in+immunity+against+Staphylococcus+aureus&doi=10.1016%2Fj.immuni.2005.11.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2005.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2005.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DL.%2BS.%26aulast%3DO%2527Connell%26aufirst%3DR.%2BM.%26aulast%3DGutierrez%26aufirst%3DM.%2BA.%26aulast%3DPietras%26aufirst%3DE.%2BM.%26aulast%3DShahangian%26aufirst%3DA.%26aulast%3DGross%26aufirst%3DC.%2BE.%26aulast%3DThirumala%26aufirst%3DA.%26aulast%3DCheung%26aufirst%3DA.%2BL.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DModlin%26aufirst%3DR.%2BL.%26atitle%3DMyD88%2520mediates%2520neutrophil%2520recruitment%2520initiated%2520by%2520IL-1R%2520but%2520not%2520TLR2%2520activation%2520in%2520immunity%2520against%2520Staphylococcus%2520aureus%26jtitle%3DImmunity%26date%3D2006%26volume%3D24%26spage%3D79%26epage%3D91%26doi%3D10.1016%2Fj.immuni.2005.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Miller, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietras, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uricchio, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Connell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modlin, R. L.</span><span> </span><span class="NLM_article-title">Inflammasome-mediated production of IL-1β is required for neutrophil recruitment against <i>Staphylococcus aureus</i> in vivo</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">6933</span><span class="NLM_x">–</span> <span class="NLM_lpage">6942</span><span class="refDoi"> DOI: 10.4049/jimmunol.179.10.6933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.4049%2Fjimmunol.179.10.6933" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2007&pages=6933-6942&author=L.+S.+Millerauthor=E.+M.+Pietrasauthor=L.+H.+Uricchioauthor=K.+Hiranoauthor=S.+Raoauthor=H.+Linauthor=R.+M.+O%27Connellauthor=Y.+Iwakuraauthor=A.+L.+Cheungauthor=G.+Chengauthor=R.+L.+Modlin&title=Inflammasome-mediated+production+of+IL-1%CE%B2+is+required+for+neutrophil+recruitment+against+Staphylococcus+aureus+in+vivo&doi=10.4049%2Fjimmunol.179.10.6933"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.179.10.6933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.179.10.6933%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DL.%2BS.%26aulast%3DPietras%26aufirst%3DE.%2BM.%26aulast%3DUricchio%26aufirst%3DL.%2BH.%26aulast%3DHirano%26aufirst%3DK.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DO%2527Connell%26aufirst%3DR.%2BM.%26aulast%3DIwakura%26aufirst%3DY.%26aulast%3DCheung%26aufirst%3DA.%2BL.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DModlin%26aufirst%3DR.%2BL.%26atitle%3DInflammasome-mediated%2520production%2520of%2520IL-1%25CE%25B2%2520is%2520required%2520for%2520neutrophil%2520recruitment%2520against%2520Staphylococcus%2520aureus%2520in%2520vivo%26jtitle%3DJ.%2520Immunol.%26date%3D2007%26volume%3D179%26spage%3D6933%26epage%3D6942%26doi%3D10.4049%2Fjimmunol.179.10.6933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group">Galloway, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyrich, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BSRBR Control Centre Consortium</span><span class="NLM_x">; </span><span class="NLM_contrib-group">British Society for Rheumatology Biologics Register</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symmons, D. P. M.</span><span> </span><span class="NLM_article-title">BSRBR Control Centre Consortium; Symmons, D. P.; on behalf of the British Society for Rheumatology Biologics Register. The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register</span> <span class="citation_source-journal">Rheumatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1341</span><span class="NLM_x">–</span> <span class="NLM_lpage">1342</span><span class="refDoi"> DOI: 10.1093/rheumatology/ker146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1093%2Frheumatology%2Fker146" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=1341-1342&author=J.+B.+Gallowayauthor=K.+L.+Hyrichauthor=L.+K.+Mercerauthor=W.+G.+Dixonauthor=K.+D.+Watsonauthor=M.+Luntauthor=BSRBR+Control+Centre+Consortiumauthor=British+Society+for+Rheumatology+Biologics+Registerauthor=D.+P.+M.+Symmons&title=BSRBR+Control+Centre+Consortium%3B+Symmons%2C+D.+P.%3B+on+behalf+of+the+British+Society+for+Rheumatology+Biologics+Register.+The+risk+of+serious+infections+in+patients+receiving+anakinra+for+rheumatoid+arthritis%3A+results+from+the+British+Society+for+Rheumatology+Biologics+Register&doi=10.1093%2Frheumatology%2Fker146"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fker146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fker146%26sid%3Dliteratum%253Aachs%26aulast%3DGalloway%26aufirst%3DJ.%2BB.%26aulast%3DHyrich%26aufirst%3DK.%2BL.%26aulast%3DMercer%26aufirst%3DL.%2BK.%26aulast%3DDixon%26aufirst%3DW.%2BG.%26aulast%3DWatson%26aufirst%3DK.%2BD.%26aulast%3DLunt%26aufirst%3DM.%26aulast%3D%26aulast%3D%26aulast%3DSymmons%26aufirst%3DD.%2BP.%2BM.%26atitle%3DBSRBR%2520Control%2520Centre%2520Consortium%253B%2520Symmons%252C%2520D.%2520P.%253B%2520on%2520behalf%2520of%2520the%2520British%2520Society%2520for%2520Rheumatology%2520Biologics%2520Register.%2520The%2520risk%2520of%2520serious%2520infections%2520in%2520patients%2520receiving%2520anakinra%2520for%2520rheumatoid%2520arthritis%253A%2520results%2520from%2520the%2520British%2520Society%2520for%2520Rheumatology%2520Biologics%2520Register%26jtitle%3DRheumatology%26date%3D2011%26volume%3D50%26spage%3D1341%26epage%3D1342%26doi%3D10.1093%2Frheumatology%2Fker146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group">Brassard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kezouh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suissa, S.</span><span> </span><span class="NLM_article-title">Antirheumatic drugs and the risk of tuberculosis</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">722</span><span class="refDoi"> DOI: 10.1086/506935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1086%2F506935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=16912945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFSktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2006&pages=717-722&author=P.+Brassardauthor=A.+Kezouhauthor=S.+Suissa&title=Antirheumatic+drugs+and+the+risk+of+tuberculosis&doi=10.1086%2F506935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Antirheumatic drugs and the risk of tuberculosis</span></div><div class="casAuthors">Brassard, Paul; Kezouh, Abbas; Suissa, Samy</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">717-722</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">The study aimed to quantify the rate of Mycobacterium tuberculosis disease (TB) among a cohort of patients with rheumatoid arthritis (RA) and to assess whether the independent use of disease-modifying antirheumatic drugs (DMARDs) is assocd. with the risk of developing TB.  The study was performed using the PharMetrics Patient-Centric database.  The cohort consisted of all subjects with ≥1 occurrence of a diagnosis of RA during an inpatient or outpatient visit during the period of Sept. 1998 through Dec. 2003.  Conditional logistic regression was used in a nested case-control anal. to est. the rate ratio (RR) of TB with any use of biol. or traditional DMARDs during the year before the index date.  The interaction between DMARDs and the current use of corticosteroids was also assessed.  The cohort consisted of 112,300 patients with RA.  A total of 386 cases of TB were identified, which resulted in an overall rate of 2.19 cases per 1000 person-years.  The adjusted RR of TB for biol. DMARD use is 1.5 (95% Cl, 1.1-1.9).  Use of traditional DMARDs was also independently assocd. with TB (RR, 1.2; 95% Cl, 1.0-1.5).  RRs of developing TB disease with the use of biol. or traditional DMARD were lower among current users of corticosteroids than among noncurrent users of corticosteroids.  The use of biol. and traditional DMARDs is assocd. with an increased risk of developing TB in patients with RA, mainly among noncurrent users of corticosteroids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC44D8LIIlkbVg90H21EOLACvtfcHk0ljrrAEL4xAuNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFSktrw%253D&md5=92c28359aa1cc923f7e8293e1cc4ab27</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1086%2F506935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F506935%26sid%3Dliteratum%253Aachs%26aulast%3DBrassard%26aufirst%3DP.%26aulast%3DKezouh%26aufirst%3DA.%26aulast%3DSuissa%26aufirst%3DS.%26atitle%3DAntirheumatic%2520drugs%2520and%2520the%2520risk%2520of%2520tuberculosis%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2006%26volume%3D43%26spage%3D717%26epage%3D722%26doi%3D10.1086%2F506935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group">Salliot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougados, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossec, L.</span><span> </span><span class="NLM_article-title">Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span><span class="refDoi"> DOI: 10.1136/ard.2007.083188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1136%2Fard.2007.083188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=18203761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FhtlOrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2009&pages=25-32&author=C.+Salliotauthor=M.+Dougadosauthor=L.+Gossec&title=Risk+of+serious+infections+during+rituximab%2C+abatacept+and+anakinra+treatments+for+rheumatoid+arthritis%3A+meta-analyses+of+randomised+placebo-controlled+trials&doi=10.1136%2Fard.2007.083188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials</span></div><div class="casAuthors">Salliot C; Dougados M; Gossec L</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the rheumatic diseases</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Tumour necrosis factor alpha blockers in rheumatoid arthritis are known to increase the risk of serious infections defined as life-threatening, requiring hospitalisation or intravenous antibiotics.  Recently, new biological agents have become available.  Their safety is an important issue.  PURPOSE:  To assess if biological agents, ie rituximab, abatacept and anakinra increase the risk of serious infections in patients with rheumatoid arthritis in published randomised controlled trials.  DATA SOURCE:  A systematic review of the literature using PUBMED, EMBASE, Cochrane library and abstracts databases (American College of Rheumatology and European League Against Rheumatism annual meetings) was performed up to October 2007.  This search was completed with data from the Food and Drug Administration, the European Agency for the Evaluation of Medicinal Products and manufacturers.  DATA EXTRACTION:  Three fixed-effect meta-analyses were performed to compare serious infection rates between each biological agent and placebo.  Pooled odds ratios (ORs) were calculated, using the Mantel-Haenszel method with a continuity correction.  DATA SYNTHESIS:  Twelve randomised controlled trials with data concerning serious infections were analysed (three for rituximab, five for abatacept and four for anakinra).  They included 745 patients, 1960 patients, 2062 patients and 2112 patients treated by rituximab, abatacept, anakinra and placebo respectively.  The overall pooled ORs did not reveal a statistically significant increased risk of serious infection for abatacept and rituximab; this risk was increased for high doses of anakinra (> or =100 mg daily) versus low dose and placebo (ORs = 9.63 (95% CI, 1.31 to 70.91) and 3.40 (95% CI, 1.11 to 10.46) respectively).  CONCLUSIONS:  These meta-analyses did not reveal a significant increase in the risk of serious infections during rituximab or abatacept treatments in patients with rheumatoid arthritis; however, high doses of anakinra may increase this risk, especially when patients have comorbidity factors.  Large studies must be performed to confirm this safety profile in daily practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-ty7EjBoZkxjv2lLSLOxFfW6udTcc2ebfSUyqkfj7z7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FhtlOrsg%253D%253D&md5=968211a7838fb14f3a329c2c27a49c4c</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1136%2Fard.2007.083188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fard.2007.083188%26sid%3Dliteratum%253Aachs%26aulast%3DSalliot%26aufirst%3DC.%26aulast%3DDougados%26aufirst%3DM.%26aulast%3DGossec%26aufirst%3DL.%26atitle%3DRisk%2520of%2520serious%2520infections%2520during%2520rituximab%252C%2520abatacept%2520and%2520anakinra%2520treatments%2520for%2520rheumatoid%2520arthritis%253A%2520meta-analyses%2520of%2520randomised%2520placebo-controlled%2520trials%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2009%26volume%3D68%26spage%3D25%26epage%3D32%26doi%3D10.1136%2Fard.2007.083188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group">Monteleone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stow, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, K.</span><span> </span><span class="NLM_article-title">Mechanisms of unconventional secretion of IL-1 family cytokines</span> <span class="citation_source-journal">Cytokine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span><span class="refDoi"> DOI: 10.1016/j.cyto.2015.03.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1016%2Fj.cyto.2015.03.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2015&pages=213-218&author=M.+Monteleoneauthor=J.+L.+Stowauthor=K.+Schroder&title=Mechanisms+of+unconventional+secretion+of+IL-1+family+cytokines&doi=10.1016%2Fj.cyto.2015.03.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1016%2Fj.cyto.2015.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cyto.2015.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DMonteleone%26aufirst%3DM.%26aulast%3DStow%26aufirst%3DJ.%2BL.%26aulast%3DSchroder%26aufirst%3DK.%26atitle%3DMechanisms%2520of%2520unconventional%2520secretion%2520of%2520IL-1%2520family%2520cytokines%26jtitle%3DCytokine%26date%3D2015%26volume%3D74%26spage%3D213%26epage%3D218%26doi%3D10.1016%2Fj.cyto.2015.03.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group">Sweeny, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clough, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhamidipati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baluom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, D. T.</span><span> </span><span class="NLM_article-title">Metabolism of fostamatinib, the oral methylene phosphate prodrug of the spleen tyrosine kinase inhibitor R406 in humans: contribution of hepatic and gut bacterial processes to the overall biotransformation</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1166</span><span class="NLM_x">–</span> <span class="NLM_lpage">1176</span><span class="refDoi"> DOI: 10.1124/dmd.110.032151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=10.1124%2Fdmd.110.032151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=20371637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Klsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1166-1176&author=D.+J.+Sweenyauthor=W.+Liauthor=J.+Cloughauthor=S.+Bhamidipatiauthor=R.+Singhauthor=G.+Parkauthor=M.+Baluomauthor=E.+Grossbardauthor=D.+T.+Lau&title=Metabolism+of+fostamatinib%2C+the+oral+methylene+phosphate+prodrug+of+the+spleen+tyrosine+kinase+inhibitor+R406+in+humans%3A+contribution+of+hepatic+and+gut+bacterial+processes+to+the+overall+biotransformation&doi=10.1124%2Fdmd.110.032151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of fostamatinib, the oral methylene phosphate prodrug of the spleen tyrosine kinase inhibitor R406 in humans: Contribution of hepatic and gut bacterial processes to the overall biotransformation</span></div><div class="casAuthors">Sweeny, David J.; Li, Weiqun; Clough, Jeffrey; Bhamidipati, Somasekhar; Singh, Rajinder; Park, Gary; Baluom, Muhammad; Grossbard, Elliott; Lau, David T.-W.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1166-1176</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The metab. of the spleen tyrosine kinase inhibitor N4-(2,2-dimethyl-3-oxo-4-pyrid[1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethyoxyphenyl)-2,4-pyrimidinediamine (R406) and its oral prodrug N4-(2,2-dimethyl-4-[(dihydrogenphosphonoxy)methyl]-3-oxo-5-pyrid[1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethyoxyphenyl)-2,4-pyrimidinediamine disodium hexahydrate (R788, fostamatinib) was detd. in vitro and in humans.  R788 was rapidly converted to R406 by human intestinal microsomes, and only low levels of R788 were obsd. in plasma of human subjects after oral administration of 14C-R788.  R406 was the major drug-related compd. in plasma from human subjects, and only low levels of metabolites were obsd. in plasma.  The plasma metabolites of R406 were identified as a sulfate conjugate and glucuronide conjugate of the para-O-demethylated metabolite of R406 (R529) and a direct N-glucuronide conjugate of R406.  Elimination of drug-related material into the urine accounted for 19% of the administered dose, and the major metabolite in urine from all the human subjects was the lactam N-glucuronide of R406.  On av., 80% of the total drug was recovered in feces.  Two drug-related peaks were obsd.; one peak was identified as R406, and the other peak was identified as a unique 3,5-benzene diol metabolite of R406.  The 3,5-benzene diol metabolite appeared to result from the subsequent O-demethylations and dehydroxylation of R529 by anaerobic gut bacteria because only R529 was converted to this metabolite after the in vitro incubation with human fecal samples.  These data indicate that the major fecal metabolite of R406 obsd. in humans is a product of a hepatic cytochrome P 450-mediated O-demethylation and subsequent O-demethylations and dehydroxylation by gut bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjYey4HpvXGbVg90H21EOLACvtfcHk0lhzJ-5mflsGMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Klsb0%253D&md5=391fda31851968948d538f70319979e1</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.032151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.032151%26sid%3Dliteratum%253Aachs%26aulast%3DSweeny%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DClough%26aufirst%3DJ.%26aulast%3DBhamidipati%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DG.%26aulast%3DBaluom%26aufirst%3DM.%26aulast%3DGrossbard%26aufirst%3DE.%26aulast%3DLau%26aufirst%3DD.%2BT.%26atitle%3DMetabolism%2520of%2520fostamatinib%252C%2520the%2520oral%2520methylene%2520phosphate%2520prodrug%2520of%2520the%2520spleen%2520tyrosine%2520kinase%2520inhibitor%2520R406%2520in%2520humans%253A%2520contribution%2520of%2520hepatic%2520and%2520gut%2520bacterial%2520processes%2520to%2520the%2520overall%2520biotransformation%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D1166%26epage%3D1176%26doi%3D10.1124%2Fdmd.110.032151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01091&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-5%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01091%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01091" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996c329e5c3c64","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
